VAERS Reports UNKNOWN

VAERS 2727684

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: PA
Alter: 78,0
Geschlecht: M
Eingang: 27.12.2023
Impfdatum: 08.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Balance disorder Cerebrovascular accident Cognitive disorder Dysarthria Gait disturbance Magnetic resonance imaging head abnormal Muscular weakness Necrosis

Symptomtext

Series of at least 5 minor strokes and one major stroke, over a two month period. Significant damage to Brocas' area. Blood thinning medications, wafirin for 6 months, aspirin thereafter. No issues after two months. 2 & 1/2 years later, has very limited ability to speak, comprehension is moderately diminished, mild muscle weakness and instability on right side of body. moderately diminished ability to walk.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 7,0
Labordaten: MRI indicates necrosis of about 14cm diameter area of brain tissue coinciding with Broca's area
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2726513

MEDIMMUNE VACCINES, INC. · INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 21.12.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Influenza

Symptomtext

COMMENT ON SOCIAL MEDIA ABOUT CHILD RECEIVING FLUMIST YEARS AGO AND DYING FROM THE FLU; A spontaneous report has been received from a consumer concerning a child of unknown gender of Unknown ethnic origin. No medical history was reported. The following demography was reported for the patient's parent: Sex: NASK. No concomitant products were reported. On an unknown date, the patient received Flumist Quadrivalent (influenza vaccine live reassort 4v) (batch number Unknown) once/single administration, via nasal route. On an unknown date, the patient experienced comment on social media about child receiving flumist years ago and dying from the flu (preferred term: Influenza). The action taken with flumist quadrivalent is not applicable. The patient died from the event on an unspecified date. An autopsy was not performed. The cause of death was comment on social media about child receiving flumist years ago and dying from the flu. The reporter assessed the event of comment on social media about child receiving flumist years ago and dying from the flu to be serious due to fatal outcome. Device Information: Combination Product Report: Yes Product As Reported: FLUMIST QUADRIVALENT Common Device Name: Nasal Spray Procode: CCQ Product Role: Suspect Minor correction 19-Dec-2023: Reporter name( Vaccination facility) added on product and dosing. Tick removed from Include in E2B.Narrative updated.; Sender's Comments: Fatal event of Influenza is not listed in company core data sheet of Q/LAIV. Due to limited information on complete patient?s demographics, suspect start date with indication, event onset date, circumstances leading to event, clinical course, treatment details, concomitant medications, risk factors, medical history (congenital abnormalities, cardio-pulmonary disorders), birth history, maternal gynecological and obstetrics history, relevant family history, detailed etiological and diagnostic work up(complete blood count, imaging studies, infection workup), the evaluation did not find evidence to suggest a reasonable possibility of a causal relationship between the event and the suspect drug. ; Reported Cause(s) of Death: COMMENT ON social media ABOUT CHILD RECEIVING FLUMIST YEARS AGO AND DYING FROM THE FLU

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2724563

MEDIMMUNE VACCINES, INC. · INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 15.12.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

COMMENT SEEN ON SOCIAL MEDIA POST NOTING DEATH OF CHILD FROM THE FLU AFTER RECEIVING FLUMIST TO BE PROTECTED; A spontaneous report has been received from a consumer concerning a patient of unknown gender (age not provided) of Unknown ethnic origin. No medical history was reported. The following demography was reported for the patient's parent: Sex: Unknown No concomitant products were reported. On an unknown date, the patient received Flumist Quadrivalent (influenza vaccine live reassort 4v) (batch number Unknown) once/single administration, via nasal route. An unknown administered FLUMIST QUADRIVALENT. On an unknown date, a comment was seen on social media post noting death of child from the flu after receiving flumist to be protected (Preferred term: Influenza). Action taken with Flumist Quadrivalent was not applicable. It was not known whether an autopsy was performed and the cause of death was unknown. The reporter assessed the event of comment seen on social media post noting death of child from the flu after receiving flumist to be protected as serious due to fatal outcome. Device Information: Combination Product Report: Yes Product As Reported: FLUMIST QUADRIVALENT Common Device Name: Nasal Spray Procode: CCQ Product Role: Suspect Minor correction on 14-Dec-2023: Null flavors for event added for event onset date and All Reporters. Reporter Name (Vaccination Facility) in association with the Primary Suspect product on the Product and Dosing Tab selected as unknown.; Sender's Comments: Fatal event of influenza is not listed in the company core data sheet of Q/LAIV. Due to limited information on date of administration and indication of Q/LAIV, onset date of the event, patient's demographics, relevant medical history, circumstances surrounding the event, clinical course and treatment details, aetiological and diagnostic workup (complete blood panel, infectious work-up, imaging studies), concurrent diseases, concomitant medications, risk factors, the evaluation did not find evidence to suggest a causal relationship between the fatal event and Q/LAIV.; Reported Cause(s) of Death: COMMENT SEEN ON SOCIAL MEDIA POST NOTING DEATH OF CHILD FROM THE FLU AFTER RECEIVING FLUMIST TO BE PROTECTED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2724094

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: SD
Alter: 57,0
Geschlecht: M
Eingang: 14.12.2023
Impfdatum: 08.12.2023
Beginn: 09.12.2023
Tage bis Beginn: 1,0
Dosis: 6
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Acute kidney injury Agitation Areflexia Brain death COVID-19 Chest X-ray Computerised tomogram abdomen Confusional state Death Delirium Echocardiogram Ejection fraction Electrocardiogram Electroencephalogram abnormal Embolic stroke Endotracheal intubation Fatigue Haemodynamic test abnormal

Symptomtext

12/9 - Felt unwell and tired. 12/10 - Delirious, agitated and confused. To local ER. Intubated for airway protection. Tx to another location. Temp was high up to 105 and low. AKI. 12/11 - Found to have Multiple embolic strokes on MRI. Developed multisystem organ failure and profound neurologic injury. 12/12: No brainstem reflex after sedation held for 24 hours. EEG with severe background attenuation, no seizure. Worsening hemodynamic and metabolic profile despite maximal medical support. Compassionate extubation. Expired @ 1425.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Brain death
Hospital-Tage: 2,0
Labordaten: 12/10-12/12 - Multiple lab tests completed. 12/10 - EKG, Venous Dopplers (negative), Renal u/s negative. 12/11 - MRI Brain showed strokes, CXR, EKG, ECHO (EF 50% low normal, intermediate diastolic function.) 12/12 - CXR, CT Abd/Pelvis.
Aktuelle Erkrankungen: Feeling ill during week he received the vaccine. Tested positive for COVID on 12/10/2023.
Vorgeschichte: None.
Andere Medikamente: Omega 3, MVI, Joint Flex, Vit D3, Lipitor.
Allergien: PCN
Vorherige Impfungen: -

VAERS 2721337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: SC
Alter: 77,0
Geschlecht: F
Eingang: 06.12.2023
Impfdatum: 31.10.2023
Beginn: 01.11.2023
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiogenic shock Chest X-ray Computerised tomogram abdomen normal Death Echocardiogram abnormal Ejection fraction decreased Electrocardiogram ST segment depression Electrocardiogram ST segment elevation Endotracheal intubation Fatigue Intensive care Nausea Pericardial effusion Systolic dysfunction Troponin

Symptomtext

Patient received vaccine 10/31. Started having nausea, fatigue 11/1. Presented to the ER 11/4 in cardiogenic shock. EKG with some inferolateral ST elevation with ST depression in aVR indicative of possible pericardial involvement. Echo with significant impairment, small pericardial effusion. Admitted to the ICU on pressors, was intubated, but ultimately passed 11/5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: troponin 11/4: 566, 713, 336, 846 EKG 11/4: inferolateral ST elevation with ST depression in aVR echo: severely reduced systolic function, EF 10-15%. <1cm pericardial effusion, no cardiac tamponade CXR, CT abd/pelvis: negative
Aktuelle Erkrankungen: -
Vorgeschichte: cognitive impairment, hypothyroidism, hypertension, aortic sclerosis, prior TBI, recurrent UTIs
Andere Medikamente: memantine, donepezil, levothyroxine, atorvastatin, quetiapine, omeprazole, amlodipine, burporpion, citalopram
Allergien: nitrofurantoin, codeine
Vorherige Impfungen: -

VAERS 2720310

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) · Charge unknown

kritisch

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 02.12.2023
Impfdatum: 17.10.2023
Beginn: 18.10.2023
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram abnormal Computerised tomogram limb Culture positive Debridement Injection site abscess Intensive care Magnetic resonance imaging abnormal Septic shock Staphylococcal infection Staphylococcus test positive

Symptomtext

Developed a large MSSA abscess at the injection site requiring surgical debridement, admission to intensive care for septic shock and IV antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 7,0
Labordaten: MRI and CT imaging of abscess - 11/28/23 and 11/30/23 Surgical debridement of abscess with culture of MSSA - 11/28/2023
Aktuelle Erkrankungen: Just chronic illnesses.
Vorgeschichte: End-stage renal disease, type 2 diabetes, chronic right pleural effusion, hypertension, heart failure
Andere Medikamente: not relevant
Allergien: not relevant
Vorherige Impfungen: -

VAERS 2712805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 12.11.2023
Impfdatum: 04.11.2023
Beginn: 07.11.2023
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blindness transient Blindness unilateral Cerebrovascular accident Transient ischaemic attack

Symptomtext

TIA (small stroke) involving temporary complete loss of vision in left eye.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2700932

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 71,0
Geschlecht: F
Eingang: 24.10.2023
Impfdatum: 07.12.2021
Beginn: 01.10.2023
Tage bis Beginn: 663,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chronic obstructive pulmonary disease Confusional state Cough Fatigue Intensive care Positive airway pressure therapy Respiratory failure SARS-CoV-2 test positive

Symptomtext

The patient has a history of COPD on 2L O2. She was brought to the ED by EMS on 10/1/23 with confusion, generalized weakness, and cough. The patient tested positive for COVID via home test the day prior (9/30/23), and her family reports the patient has been increasingly fatigued and weak. A repeat COVID test done in the ED also resulted positive. Ultimately, the patient was admitted 10/1/23 - 10/12/23. Discharge diagnoses include acute on chronic hypoxic hypercapnic respiratory failure secondary to COVID pneumonia and COVID-19 pneumonia/infection improving on antibiotics, among other diagnoses. The patient did require ICU admission and was transferred out of the ICU on 10/4 in stable condition. During admission, the patient was on BiPAP however by discharged was weaned to her baseline 2L O2. Of note, the patient has received three doses of the Pfizer monovalent COVID vaccine (2/1/2021; 2/22/2021; 12/7/2021). The Lot number, vaccine route, and vaccine site for the most recent vaccine given on 12/7/2021 is unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge unknown

kritisch

Staat: CA
Alter: 30,0
Geschlecht: M
Eingang: 27.09.2023
Impfdatum: 04.11.2022
Beginn: 06.11.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Brain oedema Cerebral venous sinus thrombosis Haemorrhage intracranial Cerebral haemorrhage Cerebral thrombosis Computerised tomogram Cranioplasty Decompressive craniectomy Hemiplegia Hydrocephalus Magnetic resonance imaging Thrombectomy Transfusion Ventricular drainage Ventriculo-peritoneal shunt Wound treatment X-ray

Symptomtext

Brain clots which lead to hemorhage on the left side of the brain. Immediate right side paralysis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 120,0
Labordaten: 11/6/ 2022- Many MRI, Multiple CT scans, Xray, blood infusions with multiple units. 11/6/2022-Left decompressive craniectomy, dural sinus thrombectomy 12/20/2022- EVD placement for Hydrocephalus 12/30/22 Left cranial wound wash out and revision 1/11/2023-Removal of EVD and Certas VP shunt placement 2/7/2023- Cranioplasty Multiple CT during the course of hospital stay from admission to descharge 3/14/2023
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Claritin, flonase
Allergien: Amoxacillin
Vorherige Impfungen: -

VAERS 2677466

BAVARIAN NORDIC · SMALLPOX + MONKEYPOX (JYNNEOS) · Charge Unknown

kritisch

Staat: NY
Alter: -
Geschlecht: M
Eingang: 29.08.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute disseminated encephalomyelitis Antineutrophil cytoplasmic antibody negative Antinuclear antibody negative Antiphospholipid antibodies negative Aphasia Asthenia Blood electrolytes normal Brain oedema CSF glucose normal CSF lactate dehydrogenase normal Cerebrovascular accident Coagulation factor V level normal Coma scale Communication disorder Computerised tomogram head abnormal Coordination abnormal Corneal lesion Cytomegalovirus test negative

Symptomtext

Acute disseminated encephalomyelitis; Literature citation. Case reference number US-BN-2023-001405 is a literature case report, title as stated above, identified on 16-Aug-2023 and concerns a 30-year-old male patient. On unspecified dates, the patient was vaccinated with the first and second dose of Jynneos vaccine (batch number: unknown), at an unknown dose, route or site of administration, for protection against monkeypox. On unspecified date, the patient without pertinent past medical history presented with persistent headache, coordination difficulties, aphasia, and personality changes presented to his local emergency department for workup and evaluation. Symptoms started two to three weeks after receiving the second dose of the Jynnesos vaccine. Magnetic resonance imaging (MRI) of brain showed diffuse small bilateral ischemic lesions in the corona radiata and posterior corpus callosum and the patient was diagnosed with multifocal strokes with negative workup for common stroke etiology. The patient was started on aspirin, clopidogrel, and high intensity statin therapy. After a seven-day hospitalization, the patient presented to acute inpatient rehabilitation. On admission the patient presented with three out of five strength in all extremities, was arousable to loud voice and touch, verbalized single words and short phrases, followed grasp-and-release commands 50 percent of the time, tolerated moist ground solids and nectar liquids, was dependent for all activities of daily living (ADL) and instrumental ADLs, and had a Glasgow Coma Scale of 12. Over the following five days the patient steadily declined with decreased arousal, decreased verbalization, and worsened dysphagia requiring nil per os (NPO) status. Examination demonstrated an inability to follow any commands and two out of five strength in all extremities, with stable vitals. Computerised tomography (CT) of head and brain magnetic resonance imaging (MRI) were ordered to rule out repeat stroke or hemorrhagic conversion. Given the patient had no known risk factors for stroke - no history of cardiovascular disease, diabetes, preceding infections, sedentary lifestyle, family history, or confirmed drug use, hemorrhagic conversion was higher on the differential. Complete blood count (CBC), complete metabolic panel (CMP) and urinalysis (UA) were ordered to evaluate for infectious or metabolic etiologies. Initial results from the CMP, CBC and UA were unremarkable for severe electrolyte abnormalities, obvious infectious processes, or other processes that would explain clinical presentation. Repeat CT head showed multifocal supratentorial and infratentorial hypoattenuating lesions which matched initial CT head from the outside hospital. Repeat MRI brain showed diffuse cerebral edema with supratentorial and infratentorial ischemic lesions; these findings were suggestive of a vasculitis, encephalomyelopathies, or a hypoxic ischemic encephalopathy with potential superimposed embolic phenomena. The patient was transferred to an acute care hospital, admitted to neurology service, and started on empiric broad spectrum antibiotics. Additional workup included cerebrospinal fluid (CSF) studies and multiple specialized send-out labs for autoimmune testing, which included oligoclonal bands. Lumbar puncture showed significantly elevated protein (292 mg/dL), normal glucose, and normal lactate dehydrogenase. Markers for Covid, herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), John Cunningham virus (JCV) and tickborne illnesses were negative. Antineutrophil cytoplasmic antibody (ANCA), rheumatoid factor (RF), antinuclear antibody (ANA), SS-A and SS-B antibodies, neuromyelitis optica, lupus hypercoagulable, prothrombin gene mutation, and factor V Leiden were also negative. After a thorough exam and workup, clinical picture was highly suspicious for acute disseminated encephalomyelitis (ADEM) which was a diagnosis of exclusion. Neurology opined that the strokes found on initial imaging prior to decline were also evidence of ADEM, rather than isolated strokes. Hematology was consulted and plasmapheresis (PLEX) was initiated along with a steroid taper. After the first round of PLEX, the patient became more mobile, able to follow simple commands and attempted vocalization. Over the course of twenty-three-day hospitalization, the patient received a total of five rounds of PLEX with improvements in function and mental status after each round and including a notable advance from NPO status to a puree diet and nectar liquids. The patient was then readmitted for ongoing rehabilitation. The patient's functional gains continued upon readmission to inpatient rehab, where the patient was more alert, able to follow simple commands and continued to exhibit speech improvements and diet advances. On day 21 of thirty-four-day stay the patient was started on amantadine for inattention with improvements noted soon after initiation, this was continued after discharge. Upon discharge, the patient was eating a regular diet with supervision, required moderate assistance with dressing, was able to ambulate 40ft with a walker with maximal assistance with a wheelchair follow and could communicate in short sentences. At the time of the initial report, the patient was recovering from the event of acute disseminated encephalomyelitis. The reporter did not provide seriousness assessment for the event of acute disseminated encephalomyelitis, however the event was assessed as serious due to seriousness criteria of hospitalization and medical significance. The reporter assessed the event of acute disseminated encephalomyelitis as related to Jynneos vaccine, reported as suspected to have triggered the event due to recent monkeypox vaccination, global decline in patient functioning and lack of other potential etiologies.; Reporter's Comments: A 30-year-old male patient was hospitalized due to acute disseminated encephalomyelitis (ADEM), 2-3 weeks after vaccination against mpox with the second dose of Jynneos (given via unknown route and at unknown dose). Patient's symptoms included headache, coordination difficulties, aphasia, personality changes. Brain MRI showed bilateral ischemic lesions in corona radiata and posterior corpus callosum, initially interpreted as multifocal strokes with negative workup for common stroke etiology. Initial treatment with aspirin, clopidogrel and statins. After the seventh day of hospitalization, the patient had a decline in verbalization and arousal. Dysphagia worsened which required status. Patient was unable to follow commands. CMP, CBC and UA were unremarkable. EBV, HIV, CMV, JCV, HSV tests were negative. Repeat head CT showed multifocal supratentorial and infratentorial hypoattenuating lesions (matching the earlier findings). Repeat brain MR showed diffuse cerebral edema with supratentorial. Lumbar puncture showed elevated protein. Based on this data, physicians rejected the diagnosis of multifocal strokes, and diagnosed the patient with ADEM. Plasmapheresis was started. Functionality, mental status and speech improved. Amantadine was given. ADEM is unlisted and unexpected per the agency for Jynneos. The patient had no pertinent past medical history. Considering that multiple alternative etiologies were rejected, the event is conservatively assessed as related to Jynneos. The case is serious due to hospitalization and medical significance.; Sender's Comments: A 30-year-old male patient was hospitalized due to acute disseminated encephalomyelitis (ADEM), 2-3 weeks after vaccination against mpox with the second dose of Jynneos (given via unknown route and at unknown dose). Patient's symptoms included headache, coordination difficulties, aphasia, personality changes. Brain MRI showed bilateral ischemic lesions in corona radiata and posterior corpus callosum, initially interpreted as multifocal strokes with negative workup for common stroke etiology. Initial treatment with aspirin, clopidogrel and statins. After the seventh day of hospitalization, the patient had a decline in verbalization and arousal. Dysphagia worsened which required status. Patient was unable to follow commands. CMP, CBC and UA were unremarkable. EBV, HIV, CMV, JCV, HSV tests were negative. Repeat head CT showed multifocal supratentorial and infratentorial hypoattenuating lesions (matching the earlier findings). Repeat brain MR showed diffuse cerebral edema with supratentorial. Lumbar puncture showed elevated protein. Based on this data, physicians rejected the diagnosis of multifocal strokes, and diagnosed the patient with ADEM. Plasmapheresis was started. Functionality, mental status and speech improved. Amantadine was given. ADEM is unlisted and unexpected per the agency for Jynneos. The patient had no pertinent past medical history. Considering that multiple alternative etiologies were rejected, the event is conservatively assessed as related to Jynneos. The case is serious due to hospitalization and medical significance.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: ANCA; Result Unstructured Data: Negative; Comments: /; Test Name: ANA; Result Unstructured Data: Negative; Comments: /; Test Name: SS-A and SS-B Antibodies; Result Unstructured Data: Negative; Comments: /; Test Name: Glasgow coma scale; Result Unstructured Data: 12; Comments: /; Test Name: CT head; Result Unstructured Data: Multifocal supratentorial and infratentorial hypoattenuating lesions; Comments: /; Test Name: CT head; Result Unstructured Data: Multifocal supratentorial and infratentorial hypoattenuating lesions; Comments: /; Test Name: CMV; Result Unstructured Data: Negative; Comments: /; Test Name: EBV; Result Unstructured Data: Negative; Comments: /; Test Name: Prothrombin gene mutation; Result Unstructured Data: Negative; Comments: /; Test Name: Factor V Leiden; Result Unstructured Data: Negative; Comments: /; Test Name: Complete blood count; Result Unstructured Data: Unremarkable for severe electrolyte abnormalities, obvious infectious processes, or other processes; Comments: /; Test Name: HSV; Result Unstructured Data: Negative; Comments: /; Test Name: HIV; Result Unstructured Data: Negative; Comments: /; Test Name: JCV; Result Unstructured Data: Negative; Comments: /; Test Name: Lumbar puncture; Result Unstructured Data: Significantly elevated protein (292mg/dL); Comments: /; Test Name: MRI brain; Result Unstructured Data: Diffuse small bilateral ischemic lesions in the corona radiata and posterior corpus callosum; Comments: /; Test Name: MRI brain; Result Unstructured Data: diffuse cerebral edema with supratentorial and infratentorial ischemic lesions; these findings were suggestive of a vasculitis, encephalomyelopathies, or a hypoxic ischemic encephalopathy with potential superimposed embolic phenomena; Comments: /; Test Name: Complete metabolic panel; Result Unstructured Data: Unremarkable for severe electrolyte abnormalities, obvious infectious processes, or other processes; Comments: /; Test Name: Neuromyelitis optica; Result Unstructured Data: Negative; Comments: /; Test Name: COVID markers; Result Unstructured Data: Negative; Comments: /; Test Name: Lupus hypercoagulable; Result Unstructured Data: Negative; Comments: /; Test Name: Urinalysis; Result Unstructured Data: Unremarkable for severe electrolyte abnormalities, obvious infectious processes, or other processes; Comments: /
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2663631

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 67,0
Geschlecht: F
Eingang: 31.07.2023
Impfdatum: 27.10.2022
Beginn: 27.05.2023
Tage bis Beginn: 212,0
Dosis: N/A
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Chills Dyspnoea Epistaxis Pneumonia bacterial Productive cough SARS-CoV-2 test positive

Symptomtext

The patient was seen in the ED on 5/27/23 for shortness of breath. During this visit, she reported testing positive for COVID-19 the week prior and has since had worsening shortness of breath, along with chills, productive cough, and bloody nose. A repeat COVID-19 PCR test performed in the ED resulted positive. She was admitted 5/27/23 - 5/29/23 with severe COVID-19, acute hypoxemic respiratory failure, and right lower lung bacterial pneumonia, among other diagnoses. During admission, the patient had resting room air SPO2 87%, which improved above 90% after being placed on 2-4L nasal cannula. The patient did not receive systemic steroids during admission. Of note, the patient has received the primary COVID vaccine series and three boosters, including the Bivalent vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2660653

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 25.07.2023
Impfdatum: 16.03.2021
Beginn: 30.12.2022
Tage bis Beginn: 654,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient Deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: HDL, CKD, Anemia, HTN, AKI
Andere Medikamente: Amlodipine, Colace, Cyanocobalamin, Doxazosin, Plavix, Pravastatin, Trazodone
Allergien: NKA
Vorherige Impfungen: -

VAERS 2581479

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 25.07.2023
Impfdatum: 08.03.2021
Beginn: 13.01.2023
Tage bis Beginn: 676,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Vaccine breakthrough infection

Symptomtext

Patient Deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: CKD, HTN, DM type II, Chronic Lymphedema
Andere Medikamente: Tylenol, ASA, Albuterol, Zebeta, Chlorthalidone, Vit D, Pepcid, Uloric, Plaquenil, Novolog, Insulin Glargine, Lactobacillus, Niacin, Potassium, Kenalog.
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2641116

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 79,0
Geschlecht: M
Eingang: 05.06.2023
Impfdatum: 10.10.2022
Beginn: 13.03.2023
Tage bis Beginn: 154,0
Dosis: N/A
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Cough Hypoxia Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

The patient was brought to the ED by EMS on 3/13/23 for weakness that began that day. He additionally reported congestion, sore throat, fever, and cough. A COVID PCR test performed in the ED resulted positive. Ultimately, he was admitted 3/13/23 - 3/20/23 with discharge diagnoses of acute hypoxic respiratory failure due to COVID-19 infection and acute on chronic generalized weakness, among other discharge diagnoses. During admission his hypoxia resolved. His acute on chronic generalized weakness was presumably due to COVID-19. Of note, the patient has received the Janssen COVID vaccine and one booster dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2633013

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 84,0
Geschlecht: M
Eingang: 17.05.2023
Impfdatum: 17.06.2022
Beginn: 06.02.2023
Tage bis Beginn: 234,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Aortic dilatation Aortic valve incompetence Asthenia Atrial fibrillation Bacterial infection COVID-19 COVID-19 pneumonia Cardiac failure acute Chest pain Hypoxia Pneumonia Productive cough SARS-CoV-2 test positive

Symptomtext

Patient with history of prostate cancer. He was brought to the ED on 2/6/23 for worsening chest pain, generalized weakness, and productive cough that began a week prior. In the ED, his O2 sat was at 89% and improved to above 90% after being placed on 2-3L O2. He was admitted to the hospital on 2/6/23 - 2/9/23. A COVID PCR test done on 2/7/23 returned positive. Discharge diagnoses include acute hypoxic respiratory failure, pneumonia (possible COVID-pneumonia versus unspecified bacterial pneumonia), aortic regurgitation with dilated ascending aorta, new onset atrial fibrillation, and acute on chronic heart failure. During his hospital stay, he was treated with ceftriaxone for presumed bacterial infection and steroids for presumed COVID pneumonia. He was also started on oral dexamethasone. His hypoxia resolved during his admission. Of note, the patient has received the primary COVID vaccine series and two booster doses. The most recent booster dose was administered 6/17/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2632465

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 71,0
Geschlecht: F
Eingang: 16.05.2023
Impfdatum: 07.12.2022
Beginn: 27.01.2023
Tage bis Beginn: 51,0
Dosis: N/A
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Cough Dyspnoea Jaundice Nausea Rhinorrhoea SARS-CoV-2 test positive Urinary tract infection Vomiting

Symptomtext

Patient was sent from her residential facility by EMS to the ED on 1/27/23 for evaluation of vomiting, cough, and jaundice. Patient reports six days of nausea and vomiting, and additionally notes rhinorrhea and intermittent shortness of breath. COVID-19 PCR test performed in the ED resulted positive. She was admitted 1/27/23 - 1/31/23 for acute hypoxic respiratory failure due to COVID-19 infection and UTI. Patient was started on dexamethasone 6mg IV daily and changed to p.o. to complete a 10-day course. During her admission, she was placed on supplemental O2 to keep saturations greater than 90 %, and was able to wean off. Her most recent COVID booster was administered 12/7/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2622375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: KY
Alter: 91,0
Geschlecht: F
Eingang: 27.04.2023
Impfdatum: 29.12.2020
Beginn: 02.02.2023
Tage bis Beginn: 765,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise SARS-CoV-2 test positive

Symptomtext

patient had sx 1-27-22, tested + 1-26-22 . Nursing home resident. Admitted to hospital 1-15 -2023 and discharged 1-26-2023 to Hospice center and deceased on 2-2-23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN ,DIABETES MELLITUS, OBESITY , CARDIOVASCULAR ,RENAL ,CHRONIC LUNG, DEMENTIA LIST MAY NOT INCLUDE ALL PMH
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2621637

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: KY
Alter: 88,0
Geschlecht: F
Eingang: 26.04.2023
Impfdatum: 21.01.2021
Beginn: 03.03.2023
Tage bis Beginn: 771,0
Dosis: UNK
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cerebrovascular accident Death Endotracheal intubation Mental status changes SARS-CoV-2 test positive

Symptomtext

BROUGHT BY EMS FROM THE NURSING HOME 2-9-23 WITH AMS AND INTUBATED. COVID NEGATIVE AT THAT TIME , WITH STROKE AND BECAME COVID + WHILE IN HOSP ON 2-27-23 TRANSFERRED BACK TO N HOME AND DECEASED 3-3-23 TREATED WITH REMSESIVIR AND DECADRON. FOUR DAYS OF TX. COVID TEST DONE AS PREOP. TESTED NEGATIVE x 2 AFTER INITIAL POSITIVE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ATHEROSCLEROTIC CARDIOVASCULR DISEASE; ATRIAL FIBRILLATION, COPD, DYSPHAGIA, GI BLEEED , HTN , HYPERLIPIDEMIA, STROKE
Andere Medikamente: -
Allergien: PROXYPEHENE FROM DARVON MILD REACTION UNKNOWN TYPE: CODEINE AND SULFA UNKNOWN REACTION BUT LISTED ON ALLERGY LIST ON H AND P
Vorherige Impfungen: -

VAERS 2610154

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 91,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 09.02.2021
Beginn: 28.12.2022
Tage bis Beginn: 687,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury COVID-19 Cough Dyspnoea Headache Myocardial ischaemia Pulmonary embolism SARS-CoV-2 test positive Syncope

Symptomtext

Patient with history of dementia and COPD. She was brought to the ED by EMS on 12/28/22 after having two syncopal episodes at home. In the ED, patient also reported a headache and cough along with newly developed shortness of breath while lying flat. A COVID PCR test performed in the ED resulted positive. Ultimately, she was admitted to the hospital 12/28/22 - 1/6/23. Patient was found to have bilateral PE. Discharge diagnoses include bilateral pulmonary embolism, COVID-19, demand ischemia, and AKI.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603351

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: KY
Alter: 73,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 11.11.2021
Beginn: 21.11.2022
Tage bis Beginn: 375,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Positive COVID lab on 11/15/2023.
Aktuelle Erkrankungen: -
Vorgeschichte: CHF
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602384

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 78,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 16.11.2021
Beginn: 13.12.2022
Tage bis Beginn: 392,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Cough Dyspnoea exertional Headache Hypoxia Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient seen in the ED on 12/13/22 for 2-3 days of headache, weakness, cough, fever, and shortness of breath with exertion. She reported testing COVID positive at home, and also tested positive for COVID by PCR in the ED. In the ED, patient found to be hypoxic at 86% with ambulation. She was admitted 12/13/22 - 12/15/22. Patient was on O2 but was weaned off completely. Discharge diagnosis included acute hypoxic respiratory failure due to COVID-19, among other diagnoses. She has been vaccinated for COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602323

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge unknown

kritisch

Staat: OK
Alter: 69,0
Geschlecht: M
Eingang: 23.03.2023
Impfdatum: 14.09.2022
Beginn: 07.10.2022
Tage bis Beginn: 23,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Cerebrovascular accident Disorientation Dizziness Echocardiogram Magnetic resonance imaging Magnetic resonance imaging head abnormal Scan with contrast Ultrasound Doppler Visual impairment

Symptomtext

Stroke confirmed with MRI brain scan. Placed on blood thinner medication and evaluated by primary care physician and neurologist. Symptoms included dizziness and disorientation for 30 minutes and vision issues for two days. Some light headedness continued for a couple of months. No other symptoms or issues since about December 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Heart and vertebral artery ultrasound scans and MRI brain scan (Week of October 10, 2022). Arterial MRI with contrast (February 2023)
Aktuelle Erkrankungen: None
Vorgeschichte: cholesterol and blood pressure (controlled by medication)
Andere Medikamente: Enalapril 20mg; Atenolol 50mg; Atorvastatin 20mg; Meloxicam (occasional); multivitamin; Omega fish oil; ibuprofen (occasional)
Allergien: None
Vorherige Impfungen: -

VAERS 2601860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: KY
Alter: 36,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 21.10.2021
Beginn: 12.11.2022
Tage bis Beginn: 387,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2598550

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: KY
Alter: 95,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 25.05.2022
Beginn: 03.11.2022
Tage bis Beginn: 162,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2591465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 81,0
Geschlecht: M
Eingang: 04.03.2023
Impfdatum: 04.03.2023
Beginn: 04.03.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: ja

Anxiety Cerebrovascular accident Feeling abnormal Impaired driving ability Implantable cardiac monitor insertion

Symptomtext

Patient noticed an uneasy, general sense of feeling not right. Took an ambulance the first time; admitted to the hospital with a stroke, hospital stay of 3 days. Two days later ambulanced back in with the same stroke, for which the patient was in for 21 days. Occupational therapy sessions led to patient taking to driving assessment and patient lost his license.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 24,0
Labordaten: Patient had a loop monitor implanted in chest Patient on Keppra and Pepcid
Aktuelle Erkrankungen: NA
Vorgeschichte: Diabetes
Andere Medikamente: Unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2590287

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 47,0
Geschlecht: F
Eingang: 02.03.2023
Impfdatum: 30.11.2021
Beginn: 09.12.2022
Tage bis Beginn: 374,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Dyspnoea Head injury Pain Positive airway pressure therapy Pyrexia Respiratory failure Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Patient with history of asthma, diabetes. Patient brought to the ED by EMS on 12/9/22 after sustaining a head injury - she rolled out of bed and hit her head. Additionally, she reported shortness of breath, noting that for the past week she has been feeling generalized weakness, body aches, subjective fever, and congestion. A COVID PCR test was done which resulted positive. Ultimately patient admitted 12/9/22 - 12/18/22. Discharge diagnoses include acute hypoxic and hypercarbic respiratory failure, COVID-19, among other diagnoses. During admission, patient used BiPAP as needed for excessive work of breathing and overnight. Patient has received the COVID primary vaccine series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590287

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 47,0
Geschlecht: F
Eingang: 02.03.2023
Impfdatum: 30.11.2021
Beginn: 09.12.2022
Tage bis Beginn: 374,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Dyspnoea Head injury Pain Positive airway pressure therapy Pyrexia Respiratory failure Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Patient with history of asthma, diabetes. Patient brought to the ED by EMS on 12/9/22 after sustaining a head injury - she rolled out of bed and hit her head. Additionally, she reported shortness of breath, noting that for the past week she has been feeling generalized weakness, body aches, subjective fever, and congestion. A COVID PCR test was done which resulted positive. Ultimately patient admitted 12/9/22 - 12/18/22. Discharge diagnoses include acute hypoxic and hypercarbic respiratory failure, COVID-19, among other diagnoses. During admission, patient used BiPAP as needed for excessive work of breathing and overnight. Patient has received the COVID primary vaccine series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2587871

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 79,0
Geschlecht: F
Eingang: 27.02.2023
Impfdatum: 02.11.2021
Beginn: 29.01.2023
Tage bis Beginn: 453,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Acute respiratory failure Bladder catheterisation Bladder scan COVID-19 Condition aggravated Decreased appetite Dysphagia Flat affect Magnetic resonance imaging head normal Major depression Pneumonia aspiration SARS-CoV-2 test positive Sepsis Speech disorder developmental Troponin increased Urinary retention

Symptomtext

"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""80 YO female with PMH of drug induced parkinsons, depression, hypertension, breast cancer who presented to the ED for chief complaint of ""cant swallow."" Reports this started ""a few days ago"", was progressive but rapidly so. Cannot state if she has had similar prior. She answers my questions in vague ways including ""a while ago...you could say that...perhaps."" Patient was septic and positive for acute respiratory failure with hypoxia likely secondary to aspiration gram negative pneumonia and COVID leading to admission. Given oxygen support, fluid resuscitation, and Rocephin leading to improvement of both progressing to normal oxygen saturation on room air and completing full course Rocephin. Concern for stroke according to speech delay found on exam. MRI head negative. Speech therapy cleared patient for thick nectar, which improved to general diet. Significant rise in troponins also found leading to diagnosis of NSTEMI. Cardiology was referred recommending medical management with aspirin, atorvastatin 40, metoprolol tartrate 25 mg twice daily and lisinopril 40 mg daily. Patient showed decreased appetite and flat affect consistent with major depressive disorder. Patient had decreased appetite and body mass index of 15. Patient and husband spoke with medicine team, stating patient would tolerate oral intake well and does not need a G-tube placed. PT/OT met with patient recommending skilled nursing facility treatment. Patient states she is willing to work with them. Case Management secured placement for ongoing treatment. Patient also reported acute near urinary retention with bladder scan greater than 300 x 2 requiring straight catheterization. Foley catheter placed. Flomax started. Patient instructed to continue Foley care while at SNF and to have a voiding trial 5 days s/p discharge"""

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 11,0
Labordaten: Covid PCR detected on 1/29/2023
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Essential hypertension, benign NSTEMI (non-ST elevated myocardial infarction) (HCC) HFrEF (heart failure with reduced ejection fraction) (HCC) Cardiomyopathy (HCC) Digestive Slow transit constipation Psychological Moderate episode of recurrent major depressive disorder (HCC) Urinary Urinary retention Other Anxiety Severe protein-calorie malnutrition (HCC) Drug-induced parkinsonism (HCC) History of electroconvulsive therapy COVID BMI less than 19,adult Troponin level elevated Physical debility
Andere Medikamente: acetaminophen (TYLENOL) 325 mg tablet Take 1 tablet by mouth 2 (two) times daily as needed for Pain. aspirin (LOW DOSE ASA) 81 mg chewable tablet Take 1 tablet by mouth daily. atorvastatin (LIPITOR) 40 mg tablet Take 1 tablet by mouth ni
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2586899

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: TX
Alter: 18,0
Geschlecht: F
Eingang: 24.02.2023
Impfdatum: 20.06.2022
Beginn: 01.12.2022
Tage bis Beginn: 164,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Carotid artery occlusion Cerebrovascular accident Magnetic resonance imaging

Symptomtext

cva pe complete occlusion ica

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 20,0
Labordaten: mri
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: also had flu vac days before cva
Allergien: nkda
Vorherige Impfungen: -

VAERS 2586274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 85,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 16.12.2021
Beginn: 05.01.2023
Tage bis Beginn: 385,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute myocardial infarction Anticoagulant therapy Blood bicarbonate decreased Blood culture COVID-19 Cardiac stress test abnormal Confusional state Echocardiogram normal Ejection fraction Escherichia bacteraemia Hyporesponsive to stimuli Intensive care Leukocytosis Mental status changes Metabolic acidosis Myocardial ischaemia Nephrectomy

Symptomtext

"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""86 yo female, with PMH significant for OSA on CPAP, asthma, bipolar depression, HTN, who presented from nursing home to the ED today due to decreased responsiveness and fevers Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) treated in intensive care unit setting initially for urosepsis, E coli bacteremia, NSTEMI 1/7 Transferred to general floor 1/8 Underwent nuclear cardiac stress tests-ischemia of the lateral wall, mild 1/ 10 Seen by Cardiology, started on beta-blocker 1/11 Planned discharge to SNF on hold due to rising leukocytosis, leukocytosis improved down to 14 K the time of discharge Altered mental status, Improving gradually, most likely due to urosepsis Has significantly improved History of bipolar depression Continue with Tegretol and Cymbalta History of asthma Oxygen p.r.n., albuterol inhalers History of OSA On CPAP NSTEMI Appreciate cardiology consultation, echo showed normal LVEF of 55-60%, mild AS Giving IV heparin for 48 hours On aspirin, beta-blocker nuclear stress test,1/ 9 , as Cardiology, mild reversible defect, in the lateral wall consistent with mild ischemia, Cardiology recommended to treated medically , with beta-blocker, patient already on aspirin Urosepsis with E coli bacteremia Was on Levophed in intensive care unit setting Weaned of Levophed On ceftriaxone from 01/05, anticipate total course of antibiotic of 10 days at least Leukocytosis improving, has normalized 1/11 significant rise in leukocytosis to 19 K, planned discharge to SNF on hold No fever, patient does not look toxic, currently on IV Rocephin Has anion gap acidosis with bicarb of 15, check lactic acid, do sepsis workup, including blood culture History of hypertension PTA antihypertensives on hold Acute kidney injury, solitary right kidney, status post left nephrectomy Due to urosepsis, improving renal function Possible cognition impairment, move Moca scoring by speech, checked vitamin B12. Normal Condition at the time of discharge- Vss Constitutional: No distress, elderly, 2 liters/minute HENT: Normocephalic, Atraumatic, Pupils Reactive, Normal oropharynx, Nose normal. Cardiovascular: Normal heart rate, Normal rhythm, No murmurs, No rubs, No gallops. Respiratory: Normal breath sounds, No respiratory distress, No wheezing, No chest tenderness. GI: Bowel sounds normal, Soft, No tenderness, No masses, No pulsatile masses. Extremities: Intact distal pulses, No edema, No tenderness, No cyanosis, No clubbing. Neurologic: Alert & oriented x 2 , confused at times, No focal deficits noted. Skin: Warm and dry Issues Requiring Follow Up: (Who, what, when, and how communicated?) Losartan & Aldactone are on hold till f/u BMP & CBC , renal function improvement To follow-up on tolerance and efficacy of Augmentin"""

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 7,0
Labordaten: Covid PCR detected on 01/05/2023
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Essential hypertension, benign Acute on chronic diastolic congestive heart failure CAD (coronary artery disease) Mixed hyperlipidemia Chronic heart failure with preserved ejection fraction (HFpEF) Integumentary Dermatitis Psychological Bipolar depression Respiratory Asthma OSA (obstructive sleep apnea) Urinary Acute cystitis without hematuria Other Hiatal hernia Fibromyalgia Primary osteoarthritis of left hip Encounter for long-term (current) use of medications Sepsis secondary to UTI Hypokalemia Hypomagnesemia Elevated troponin Abnormal cardiovascular function study Bacteremia due to Escherichia coli
Andere Medikamente: acetaminophen (TYLENOL) 650 mg CR tablet Take 1 tablet by mouth every 8 (eight) hours as needed for Pain. albuterol (PROVENTIL HFA; VENTOLIN HFA; PROAIR) 90 mcg/actuation inhaler Inhale 2 puffs into the lungs every 4 (four) hours as needed
Allergien: Latuda [Lurasidone]Unknown Crestor [Rosuvastatin]Myalgia
Vorherige Impfungen: -

VAERS 2586274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 85,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 16.12.2021
Beginn: 05.01.2023
Tage bis Beginn: 385,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute myocardial infarction Anticoagulant therapy Blood bicarbonate decreased Blood culture COVID-19 Cardiac stress test abnormal Confusional state Echocardiogram normal Ejection fraction Escherichia bacteraemia Hyporesponsive to stimuli Intensive care Leukocytosis Mental status changes Metabolic acidosis Myocardial ischaemia Nephrectomy

Symptomtext

"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""86 yo female, with PMH significant for OSA on CPAP, asthma, bipolar depression, HTN, who presented from nursing home to the ED today due to decreased responsiveness and fevers Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) treated in intensive care unit setting initially for urosepsis, E coli bacteremia, NSTEMI 1/7 Transferred to general floor 1/8 Underwent nuclear cardiac stress tests-ischemia of the lateral wall, mild 1/ 10 Seen by Cardiology, started on beta-blocker 1/11 Planned discharge to SNF on hold due to rising leukocytosis, leukocytosis improved down to 14 K the time of discharge Altered mental status, Improving gradually, most likely due to urosepsis Has significantly improved History of bipolar depression Continue with Tegretol and Cymbalta History of asthma Oxygen p.r.n., albuterol inhalers History of OSA On CPAP NSTEMI Appreciate cardiology consultation, echo showed normal LVEF of 55-60%, mild AS Giving IV heparin for 48 hours On aspirin, beta-blocker nuclear stress test,1/ 9 , as Cardiology, mild reversible defect, in the lateral wall consistent with mild ischemia, Cardiology recommended to treated medically , with beta-blocker, patient already on aspirin Urosepsis with E coli bacteremia Was on Levophed in intensive care unit setting Weaned of Levophed On ceftriaxone from 01/05, anticipate total course of antibiotic of 10 days at least Leukocytosis improving, has normalized 1/11 significant rise in leukocytosis to 19 K, planned discharge to SNF on hold No fever, patient does not look toxic, currently on IV Rocephin Has anion gap acidosis with bicarb of 15, check lactic acid, do sepsis workup, including blood culture History of hypertension PTA antihypertensives on hold Acute kidney injury, solitary right kidney, status post left nephrectomy Due to urosepsis, improving renal function Possible cognition impairment, move Moca scoring by speech, checked vitamin B12. Normal Condition at the time of discharge- Vss Constitutional: No distress, elderly, 2 liters/minute HENT: Normocephalic, Atraumatic, Pupils Reactive, Normal oropharynx, Nose normal. Cardiovascular: Normal heart rate, Normal rhythm, No murmurs, No rubs, No gallops. Respiratory: Normal breath sounds, No respiratory distress, No wheezing, No chest tenderness. GI: Bowel sounds normal, Soft, No tenderness, No masses, No pulsatile masses. Extremities: Intact distal pulses, No edema, No tenderness, No cyanosis, No clubbing. Neurologic: Alert & oriented x 2 , confused at times, No focal deficits noted. Skin: Warm and dry Issues Requiring Follow Up: (Who, what, when, and how communicated?) Losartan & Aldactone are on hold till f/u BMP & CBC , renal function improvement To follow-up on tolerance and efficacy of Augmentin"""

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 7,0
Labordaten: Covid PCR detected on 01/05/2023
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Essential hypertension, benign Acute on chronic diastolic congestive heart failure CAD (coronary artery disease) Mixed hyperlipidemia Chronic heart failure with preserved ejection fraction (HFpEF) Integumentary Dermatitis Psychological Bipolar depression Respiratory Asthma OSA (obstructive sleep apnea) Urinary Acute cystitis without hematuria Other Hiatal hernia Fibromyalgia Primary osteoarthritis of left hip Encounter for long-term (current) use of medications Sepsis secondary to UTI Hypokalemia Hypomagnesemia Elevated troponin Abnormal cardiovascular function study Bacteremia due to Escherichia coli
Andere Medikamente: acetaminophen (TYLENOL) 650 mg CR tablet Take 1 tablet by mouth every 8 (eight) hours as needed for Pain. albuterol (PROVENTIL HFA; VENTOLIN HFA; PROAIR) 90 mcg/actuation inhaler Inhale 2 puffs into the lungs every 4 (four) hours as needed
Allergien: Latuda [Lurasidone]Unknown Crestor [Rosuvastatin]Myalgia
Vorherige Impfungen: -

VAERS 2585868

BAVARIAN NORDIC · SMALLPOX + MONKEYPOX (JYNNEOS) · Charge Unknown

kritisch

Staat: NY
Alter: -
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acid base balance abnormal Anaemia Biopsy skin abnormal Blister Blood HIV RNA increased CD4 lymphocytes decreased Condition aggravated Death Dependence on respirator Disease progression Eyelid function disorder Gangrene Gastroenteritis sapovirus Gastrointestinal tube insertion Genital lesion Histology abnormal Immune reconstitution inflammatory syndrome Immunoglobulin therapy

Symptomtext

Confluent gangrene of the face was apparent; The patient developed periorbital oedema concerning for superimposed preseptal cellulitis; The patient subsequently developed pharyngeal oedema; Died due to systemic complications of infections; Possible immune reconstitution inflammatory syndrome; Hospital course was complicated by Sapovirus gastroenteritis, metabolic acidosis, multifactorial renal failure, and severe anaemia; Hospital course was complicated by Sapovirus gastroenteritis, metabolic acidosis, multifactorial renal failure, and severe anaemia; Hospital course was complicated by Sapovirus gastroenteritis, metabolic acidosis, multifactorial renal failure, and severe anaemia; Bacterial superinfection; The patient subsequently developed multifocal pneumonia and became ventilator-dependent; The patient received Jynneos vaccine after the monkeypox developed.; Literature citation: Case reference number US-BN-2023-000202 is a literature case report, title as stated above, identified on 07-Feb-2023 and concerns a 45-year-old male patient. The article described first reported example of monkeypox (mpox) progressing to confluent facial gangrene in a 45-year-old male patient who was immunocompromised. It was proposed that like progressive vaccinia, monkeypox virus clinically evolved through contiguous intradermal spread. Expansile cellular necrosis manifested clinically as progressive gangrene rather than a pustular response. Intradermal dissemination of monkeypox virus was proposed which was illustrated by centrifugal progression of necrotic tissue from early lesions. It was hypothesized that gangrenous tissues themselves could have served as viral reservoirs for re-inoculation of the bloodstream or autoinoculation of distant sites, prolonging the disease state. The patient had a 17-year history of human immunodeficiency virus (HIV) (not on highly active antiretroviral therapy (HAART)), and acquired immune deficiency syndrome (AIDS) for at least one year (CD4+ count 29 cells per ?L, viral load 42674 copies per mL), unvaccinated for orthopoxviruses who developed vesiculopapular lesions of the torso, arms, neck, and genitals over one week. On an unspecified date, the patient was vaccinated with a dose of Jynneos vaccine (batch number: unknown), at an unknown dose, route, or site of administration, due to, as reported, suspected mpox and due to being at a high risk for severe disease (explicitly coded as 'off label use in unapproved indication'). The patient was also started on empiric tecovirimat (brand name unknown), at 600 mg, twice daily for two weeks. Swab specimens of the patient's initial lesions were sent for qualitative polymerase chain reaction (PCR), which showed positive result for non-variola Orthopoxvirus DNA, corroborating a clinical diagnosis of mpox. On an unspecified date, reported as one month later, the patient was examined at an emergency department, where it was noted that the patient had ulcerated papules with necrotic centers of the abdomen and face, including the right upper eyelid and the left malar region. On an unspecified date, reported as the following week, the patient was admitted to the hospital after evident progression of the facial lesions, which had become large shallow ulcers with expanded central necrosis. The patient had also developed periorbital oedema concerning for superimposed preseptal cellulitis. By the following week, the patient's right eyelid lesion had expanded further and began to restrict lid function. No ocular surface involvement was noted, and the patient was started on trifluridine (brand name unknown), 1 percent eye drops for prophylaxis and started HAART. During the following two weeks, despite treatment with oral tecovirimat (600 mg twice daily), HAART, and broad-spectrum antibiotics (intravenous daptomycin and levofloxacin), discrete lesions progressed to a necrotic rash of the face, expanding outward from initial foci and becoming confluent. Qualitative PCR analysis of swabs from multiple skin sites consistently returned positive for non-variola Orthopoxvirus DNA, compatible with disseminated mpox. The patient received a dose of intravenous vaccinia immunoglobulin but the skin necrosis continued to progress. On an unspecified date, the patient subsequently developed pharyngeal oedema and was transferred to tertiary-care center for airway monitoring. Confluent gangrene of the face was apparent. A raised skin edge containing vesicles was noted along the borders of necrotic skin. There were similar areas of expansive skin necrosis on the torso and extremities. The patient was administered a single dose of intravenous cidofovir (5 mg/kg) with probenecid (brand name unknown), and tecovirimat was changed to intravenous formulation (200 mg twice daily). Punch biopsy was performed and showed histology consistent with monkeypox virus infection and a striking absence, paucity of T-lymphocytic infiltrate. Skin histology also showed necrosis and viral cytopathic effects. The patient soon developed an unstable airway, and surgical tracheostomy was performed. Two more doses of vaccinia immunoglobulin were administered, again without improvement. Due to worse lesions on HAART, concern was raised for possible immune reconstitution inflammatory syndrome, although CD4+ percentage had only increased by three points. Biopsy was obtained after the skin lesions had progressed substantially despite HAART. The histological findings were inconsistent with known examples of immune reconstitution inflammatory syndrome. The patient received a brief steroid trial, a short course of prednisone (brand name unknown) (100 mg via nasogastric tube for 4 days) that was subsequently discontinued after his condition continued to progress. As reported, it was hypothesized that immune reconstitution inflammatory syndrome was not the central disease process for the patient, in view of the evidence for primary intradermal progression of monkeypox virus. Despite multimodal treatments the patient's symptoms did not remit, as reported, probably due to a combination of overwhelming immunosuppression, bacterial superinfection, and delays in care. Hospital course was complicated by Sapovirus gastroenteritis, metabolic acidosis, multifactorial renal failure, and severe anaemia. On an unspecified day, the patient subsequently developed multifocal pneumonia and became ventilator-dependent. On an unspecified date, reported as 15 weeks after the onset of mpox symptoms, the patient died due to systemic complications of the patient's infections. The reporter assessed all reported events as serious due to seriousness criteria of hospitalization and did not provide a causality assessment. Additional information received from Bavarian Nordic on 08-Feb-2023 included local BN case ID.; Reporter's Comments: A 45-year-old unvaccinated male patient with AIDS had contracted the mpox infection (PCR detected non-variola Orthopoxvirus DNA). Having already developed vesicopapular lesions, the patient was given tecovirimat (600 mg BID for two weeks) and was also vaccinated with the first dose of Jynneos, given via unknown route and at an unknown dose. Since the indication of Jynneos is pre-exposure prophylaxis of mpox, this is considered an off label use for unapproved indication. Initially, the patient declined HAART (highly active antiretroviral therapy). Approximately a month later, the patient was found to have ulcerated papules with necrotic centres of the abdomen and face. The patient was admitted to hospital and the lesions progressed to ulcers with expanded central necrosis, periorbital oedema concerning for superimposed preseptal cellulitis. The patient was started on trifluridine 1% eye drops and HAART, as well as daptomycin and levofloxacin. Despite the treatment, necrotic rash developed. Qualitative PCR of lesion swabs confirmed Orthopoxvirus DNA, compatible with disseminated mpox. The patient also received intravenous vaccinia immunoglobulin, but the skin necrosis progressed. The patient subsequently developed pharyngeal oedema and needed airway monitoring. Confluent facial gangrene was apparent, with vesicles along the borders. The patient received a single shot of cidofovir (5 mg/kg) with probenecid, intravenously, and was switched to IV tecovirimat (200 mg BID). Biopsy confirmed presence of mpox virus infection and an absence of T-lymphocytes. The patient developed an unstable airway and tracheostomy was performed. Two more doses of the vaccinia immunoglobulin were given, with no improvement. Concern was raised for possible immune reconstitution inflammatory syndrome. CD4+ percentage had increased by three points only. The patient received a short cose of prednisone via NG tube. The patient developed a sapovirus gastroenteritis, multifactorial renal failure, severe anemia and multifocal pneumonia. The patient became ventilator-dependent and died from systemic complications of the infections, 15 weeks after the onset of the initial symptoms. Bacterial superinfection and delayed treatment were pointed out as possible contributory factors to the lethal complications. Infection (fatal, with complications), periorbital cellulitis, gangrene, pharyngeal oedema, immune reconstitution inflammatory syndrome, renal failure, gastroenteritis sapovirus, anemia, bacterial superinfection and pneumonia are unexpected and unlisted per the CCDS V4 and USPI for Jynneos. Off label use is considered listed per company conventions. The patient's medical history included HIV (not on HAART) for 17 years and AIDS for at least one year. Concomitant medications were not specified. According to the CCDS v4, vaccination with Jynneos must be postponed in persons with acute infection if used for pre-event prophylaxis. Post-exposure prophylaxis is not indicated in the CCDS and PI for the suspect vaccine, furthermore, the patient had already developed lesions. The concomitant administration of the vaccine with Vaccinia Immune Globulin (VIG) has not been studied. The patient's reported immune naivety (unvaccinated status prior to contracting the infection), as well as the underlying AIDS, and the delayed HAART, provide a plausible explanation as to why the disease progressed with systemic complications despite treatment with tecovirimat, antibiotics, anti-inflammatory course. The suspected immune reconstitution inflammatory syndrome (associated with paradoxical worsening of preexisting infectious processes following the initiation of antiretroviral therapy) is also consistent with the reported data. Anemia has previously been found in patients with mpox. Therefore, the adverse events are assessed as not related to Jynneos. Off label use is considered not related to Jynneos, but to human error. The case is serious due to the hospitalization and fatal outcome.; Sender's Comments: A 45-year-old unvaccinated male patient with AIDS had contracted the mpox infection (PCR detected non-variola Orthopoxvirus DNA). Having already developed vesicopapular lesions, the patient was given tecovirimat (600 mg BID for two weeks) and was also vaccinated with the first dose of Jynneos, given via unknown route and at an unknown dose. Since the indication of Jynneos is pre-exposure prophylaxis of mpox, this is considered an off label use for unapproved indication. Initially, the patient declined HAART (highly active antiretroviral therapy). Approximately a month later, the patient was found to have ulcerated papules with necrotic centres of the abdomen and face. The patient was admitted to hospital and the lesions progressed to ulcers with expanded central necrosis, periorbital oedema concerning for superimposed preseptal cellulitis. The patient was started on trifluridine 1% eye drops and HAART, as well as daptomycin and levofloxacin. Despite the treatment, necrotic rash developed. Qualitative PCR of lesion swabs confirmed Orthopoxvirus DNA, compatible with disseminated mpox. The patient also received intravenous vaccinia immunoglobulin, but the skin necrosis progressed. The patient subsequently developed pharyngeal oedema and needed airway monitoring. Confluent facial gangrene was apparent, with vesicles along the borders. The patient received a single shot of cidofovir (5 mg/kg) with probenecid, intravenously, and was switched to IV tecovirimat (200 mg BID). Biopsy confirmed presence of mpox virus infection and an absence of T-lymphocytes. The patient developed an unstable airway and tracheostomy was performed. Two more doses of the vaccinia immunoglobulin were given, with no improvement. Concern was raised for p ossible immune reconstitution inflammatory syndrome. CD4+ percentage had increased by three points only. The patient received a short dose of prednisone via NG tube. The patient developed a sapovirus gastroenteritis, multifactorial renal failure, severe anemia and multifocal pneumonia. The patient became ventilator-dependent and died from systemic complications of the infections, 15 weeks after the onset of the initial symptoms. Bacterial superinfection and delayed treatment were pointed out as possible contributory factors to the lethal complications. Infection (fatal, with complications), periorbital cellulitis, gangrene, pharyngeal oedema, immune reconstitution inflammatory syndrome, renal failure, gastroenteritis sapovirus, anemia, bacterial superinfection and pneumonia are unexpected and unlisted per the CCDS V4 and PI for Jynneos. Off label use is considered listed per company conventions. The patient's medical history included HIV (not on HAART) for 17 years and AIDS for at least one year. Concomitant medications were not specified. According to the CCDS v4, vaccination with Jynneos must be postponed in persons with acute infection if used for pre-event prophylaxis. Post-exposure prophylaxis is not indicated in the CCDS and PI for the suspect vaccine, furthermore, the patient had already developed lesions. The concomitant administration of the vaccine with Vaccinia Immune Globulin (VIG) has not been studied. The patient's reported immune naivety (unvaccinated status prior to contracting the infection), as well as the underlying AIDS, and the delayed HAART, provide a plausible explanation as to why the disease progressed with systemic complications despite treatment with tecovirimat, antibiotics, anti-inflammatory course. The suspected immune reconstitution inflammatory syndrome (associated with paradoxical worsening of preexisting infectious processes following the initiation of antiretroviral therapy) is also consistent with the reported data. Anemia has previously been found in patients with mpox. Therefore, the adverse events are assessed as not related to Jynneos. Off label use is considered not related to Jynneos, but to human error. The case is serious due to the hospitalization and fatal outcome.; Reported Cause(s) of Death: Died due to systemic complications of infections

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Acid-base balance; Result Unstructured Data: Metabolic acidosis; Test Name: Punch biopsy; Result Unstructured Data: Histology consistent with monkeypox virus infection and a striking absence, paucity of T-lymphocytic infiltrate; Comments: /; Test Name: Punch biopsy; Result Unstructured Data: Histological findings were inconsistent with known examples of immune reconstitution inflammatory syndrome; Comments: /; Test Name: HIV viral load; Result Unstructured Data: 42 674 copies per mL; Test Name: CD4+ count; Result Unstructured Data: 29 cells per ?L; Comments: /; Test Name: Qualitative PCR; Result Unstructured Data: positive for non-variola Orthopoxvirus DNA; Comments: /; Test Name: Qualitative PCR; Result Unstructured Data: Swabs from multiple skin sites consistently returned positive for non-variola Orthopoxvirus DNA, compatible with disseminated mpox; Comments: /
Aktuelle Erkrankungen: AIDS (for at least one year); HIV disease (17-year history of HIV); Monkeypox
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2583384

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge Unknown

kritisch

Staat: FL
Alter: 58,0
Geschlecht: M
Eingang: 17.02.2023
Impfdatum: 01.01.2023
Beginn: 20.01.2023
Tage bis Beginn: 19,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cardiac procedure complication Coronary artery bypass Myocardial infarction

Symptomtext

Heart attacks... Unknown cause Quadruple bypass

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 10,0
Labordaten: Quadruple bypass and many complications
Aktuelle Erkrankungen: No
Vorgeschichte: None
Andere Medikamente: Lovastin 20mil Flowmax Multi vitamin
Allergien: No
Vorherige Impfungen: -

VAERS 2578878

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: KY
Alter: 94,0
Geschlecht: F
Eingang: 09.02.2023
Impfdatum: 25.05.2022
Beginn: 11.10.2022
Tage bis Beginn: 139,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection later passed away due to ongoing symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Positive COVID test on 1/24/2022
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2577254

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 63,0
Geschlecht: M
Eingang: 07.02.2023
Impfdatum: 28.06.2022
Beginn: 26.11.2022
Tage bis Beginn: 151,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Confusional state Cough Malaise Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED by EMS on 11/26/22 for confusion; he has a history of glioblastoma. Additionally, patient has not been feeling well over the last couple of days and had a positive COVID test at home. Symptoms included fever and mild cough. Repeat COVID test done in the ED on 11/27 also positive. Ultimately, patient admitted on 11/26/22 - 12/1/22 for acute hypoxic respiratory failure due to COVID-19 pneumonia. O2 sats initially 88% on room air, during admission his max O2 need was 8L O2 via high flow nasal cannula. He was weaned off O2 for 24 hours prior to discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2573881

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: NH
Alter: -
Geschlecht: U
Eingang: 02.02.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

I have family members who are injured or dead due to your company's potential unethical experiments and negligence; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP), Program. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as DOSE NUMBER UNKNOWN, SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal" described as "I have family members who are injured or dead due to your company's potential unethical experiments and negligence." The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Additional information: The reporter asked, "Why is Pfizer doing gain of function research to mutate Covid viruses as (Withheld) talked to the Project reporter last week? I have family members who are injured or dead due to your company's potential unethical experiments and negligence." The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: I have family members who are injured or dead due to your companies potential unethical experiments and negligence.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2573848

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 02.02.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

This genocide this bioweapon; My father and my cousin had died so far; This is a spontaneous report received from a non-contactable reporter (Nurse). A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as DOSE NUMBER UNKNOWN, SINGLE (batch/ot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal" described as "This genocide this bioweapon; My father and my cousin had died so far." The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Additional information: The reporter (Registered Nurse) stated, "I am not worrying about getting disconnected. Are you involved in this genocide this bioweapon COVID 19 jab (COVID-19 Vaccine)? Do you know it is a withheld violation? You are a pharmacist you know what is going on. Yes, I am a registered nurse and I know what is going on to the violation. I have known for two years why you knew 6 months after Pfizer did, that is what going to happen to Pfizer. Where you located are you in (country)?" Reporter further stated, "I hope you are not involved in this Genocide because you know what they did with other people (not clarified) and knowingly or just say I was doing my job getting proud of it either then people also bring violation. You know about (withheld) do you not? You are educated you are a Pharmacist. What about this fake protein mRNA's that's making people 'creates' by protein? Did you have any family members died yet? My father and my cousin had died so far. Did you have anyone died in (country) or do they ban it in (country)?" Reporter also stated, "Can you have false information? Who would believe Pfizer. You are part of that plan. (withheld) 2.0 study up on that, you know they hung people (further clarifications unknown)." The Reporter hung up the call abruptly. Thus, further probing was not done. No follow-up attempts are possible; information about the batch/lot number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information and temporal association the causal role of suspect product cannot be excluded for reported events Case will be reviewed on receipt of FU information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202300043076 same reporter/drug/event, different patient;; Reported Cause(s) of Death: This genocide this bioweapon; My father and my cousin had died so far

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2569024

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UNKNOWN

kritisch

Staat: KY
Alter: 76,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 24.07.2021
Beginn: 22.01.2022
Tage bis Beginn: 182,0
Dosis: 3
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Endotracheal intubation SARS-CoV-2 test positive

Symptomtext

ADMITTED TO HOSPITAL ON 1/7/2022 WITH COVID-19 PNEUMONIA AND WORSENING ACUTE TOXIC RESPIRATORY FAILURE. INTUBATED ON 1/12/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: COVID-19 POSITIVE ON 1/5/2022 VIA ANTIGEN TESTING
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: HTN; HLD; CHRONIC KIDNEY DISEASE STAGE 3; ATRIAL FIBRILLATION;
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 2568717

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge Unknown

kritisch

Staat: KS
Alter: 91,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 01.10.2022
Beginn: 01.11.2022
Tage bis Beginn: 31,0
Dosis: 4
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident Computerised tomogram head Death

Symptomtext

Mom had a stroke less than a month after receiving this vaccine. She was hospitalized and then subsequently died in the nursing home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 7,0
Labordaten: CT brain scan 11/17/2022
Aktuelle Erkrankungen: None
Vorgeschichte: Stroke survivor for 16 1/2 years and none since this last vaccine.
Andere Medikamente: Warfarin 2mg Levothyroxine .075mg Multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2568677

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 88,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 27.09.2022
Beginn: 19.11.2022
Tage bis Beginn: 53,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Chronic obstructive pulmonary disease Cough Decreased appetite Dyspnoea Feeling abnormal Influenza Influenza virus test negative Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

Patient seen in the ED on 11/19/22 after feeling poorly approximately a week ago with shortness of breath, sore throat, cough, and decreased appetite. He had been seen at urgent care 2x prior to being seen in the ED. The day prior to coming to the ED (11/18), the patient was seen in clinic and diagnosed with influenza and COVID. Retest in the ED was positive for COVID-19 by PCR and negative for Influenza. Ultimately patient admitted 11/19/22 - 11/21/22 with acute hypoxic respiratory failure secondary to influenza and COVID-19, COPD with possible exacerbation. Supplemental O2 up to 2L NC during admission, however patient was weaned to room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566872

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 69,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 04.03.2021
Beginn: 10.11.2022
Tage bis Beginn: 616,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abnormal behaviour Acute respiratory failure COVID-19 Death Feeling hot Hypoxia Pneumonia SARS-CoV-2 test positive Sepsis

Symptomtext

Patient with history of diabetes, wheelchair dependent. The morning of 11/10, group home staff noticed that the patient was warm and "not acting right". EMS was called and on arrival, patient was mildly hypoxic. In the ED, he was noted to be COVID-19 positive by PCR. Ultimately patient was admitted on 11/10 with "severe sepsis and acute hypoxemic respiratory failure due to healthcare associated pneumonia, further complicated by moderate to severe COVID-19." He was weaned off supplemental O2 11/15/22. Patient clinically worsening, and ultimately transitioned to inpatient comfort cares and passed away 11/17/22. He has received the COVID primary vaccine series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566849

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 66,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 26.01.2022
Beginn: 08.11.2022
Tage bis Beginn: 286,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Bacterial infection Body temperature increased COVID-19 COVID-19 pneumonia Death Embolic stroke Endotracheal intubation Hypercoagulation Mental status changes SARS-CoV-2 test positive

Symptomtext

Patient with past medical history of diabetes, ESRD, obesity. Per chart review, she tested positive for COVID-19 on 11/1. Patient was brought to the ED on 11/8 after exhibiting an altered mental status at her nursing home. En route to the ED, her temperature was 102 F, O2 sats 75-80%. Patient had another COVID PCR test done in the ED which was positive. She was admitted 11/8, eventually diagnosed with secondary bacterial infection and COVID pneumonitis. She did need to be intubated for acute respiratory failure. During admission she was found to have suffered bilateral embolic strokes. This was thought to be secondary to hypercoagulable state from COVID as well as pre-existing atrial fibrillation. Ultimately, patient was discussed with the family and the decision was made to proceed with compassionate extubation. This occurred on 12/7 and the patient passed away shortly after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2564587

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: NY
Alter: 62,0
Geschlecht: M
Eingang: 20.01.2023
Impfdatum: 21.07.2021
Beginn: 29.03.2022
Tage bis Beginn: 251,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram thorax abnormal Pulmonary embolism

Symptomtext

63 y o male with h/o idiopathic PE (RLL segmental and subsegmental) 3/29/22 (though he had the Johnson J+J covid vaccine in July 2021 and he thinks that it was related to it, and requested that this be documented, so I have added an ADR in pharmacy) noting that he had no other risk factors. He quit smoking in 2021 and had been running 1-2 miles regularly prior to the PE>

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: CT thorax 3/29/22 revealed "Large right lower lobe segmental and subsegmental pulmonary embolism"
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563944

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge Unknown

kritisch

Staat: NY
Alter: 38,0
Geschlecht: F
Eingang: 19.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge unknown

kritisch

Staat: MO
Alter: 92,0
Geschlecht: F
Eingang: 19.01.2023
Impfdatum: 30.09.2022
Beginn: 17.01.2023
Tage bis Beginn: 109,0
Dosis: N/A
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anion gap Aortic arteriosclerosis Aortic dilatation Aortic valve sclerosis Aspartate aminotransferase normal AST/ALT ratio Acute respiratory failure Alanine aminotransferase normal Anaemia macrocytic Anaemia of chronic disease Asthenia Atrial fibrillation Auscultation Basophil count decreased Basophil percentage decreased Bilirubin conjugated decreased Bilirubin urine Blood albumin decreased

Symptomtext

Date of Service Jan-18-2023 1040 Date of Admission Admit Date: Jan-17-2023 Date of Discharge Date of discharge Jan-18-2023 Allergies No Known Allergies Chief Complaint Weakness, fatigue, shortness of breath Final Diagnoses Acute exacerbation of chronic obstructive airways disease Acute hypoxemic respiratory failure Acute COVID-19 Procedure(s) Performed None Lab Results Jan-18-2023 0455 Hematology WBC 4.3RBC 3.03HGB 10.3HCT 32.3MCV 106.6MCH 34.0MCHC 31.9RDW 13.5RDWSD 53.3PLT 260MPV 10.1AUTONEU% 78.6AUTOLYM% 20.2AUTOMON% 0.7AUTOEOS% 0.0AUTOBAS% 0.0AUTONEU# 3.4AUTOLYM# 0.9AUTOMON# 0.0AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.02IG% 0.5 Jan-18-2023 0455 Chemistry GLUCOSE 126BUN 31CREAT 1.7MDRD GFR 28NA 140K 5.2CL 108CALCIUM 8.6ALK PHOS 61CO2 24.9AST 20ALT 12AST/ALT 1.7TL PROT 5.9ALBUMIN 2.5TBILI 0.2DBILI <0.1OSMO 287.5ANION GP 12.3BUN/CRE 18.2 Jan-17-2023 1528 Urinalysis Department SPECGRAV 1.020U-PH 6.0LEUCOCYT NegativeNITRITES NegativePROTEIN TraceGLUCOSE NegativeKETONES NegativeUROBILIN 0.2BILRUBIN NegativeBLOOD NegativeCOLOR Lt. YellowCLARITY ClearMICROSCP NCULTURE NCULTIND Not Indicated Jan-17-2023 1220 Serology PROCALC 0.06 Jan-17-2023 1220 Hematology WBC 3.8RBC 3.14HGB 10.9HCT 33.5MCV 106.7MCH 34.7MCHC 32.5RDW 13.5RDWSD 53.1PLT 247MPV 10.1AUTONEU% 51.0AUTOLYM% 36.6AUTOMON% 10.2AUTOEOS% 1.6AUTOBAS% 0.3AUTONEU# 2.0AUTOLYM# 1.4AUTOMON# 0.4AUTOBAS# 0.0AUTOEOS# 0.1NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.01IG% 0.3 Jan-17-2023 1220 Chemistry GLUCOSE 106BUN 33CREAT 1.8MDRD GFR 26NA 143K 4.9CL 107CALCIUM 8.9ALK PHOS 71CO2 28.7AST 18ALT 13AST/ALT 1.4TL PROT 5.9ALBUMIN 2.8TBILI 0.3OSMO 292.7ANION GP 12.2BUN/CRE 18.3LDH 201CRP 2.20LACTATE 0.60 Jan-16-2023 1210 Serology COVID Pos Imaging Results 1V CXR 1/17/23: Stable chronic interstitial changes with chronic reticulonodular opacities. Heart size is stable. No focal consolidations or pulmonary edema. No pneumothorax. Read by: MD Echocardiogram 01/18/2023: LVEF over 60%. Grade 2 diastolic dysfunction. Sigmoid septum. Mild concentric left ventricular hypertrophy. Mild left atrial enlargement. Mild mitral regurgitation. Mild mitral stenosis. Mild anterior leaflet mitral valve prolapse. Aortic cusps mildly calcified. Trileaflet aortic valve. Mild aortic root dilatation. Aortic valve sclerosis. Mild tricuspid valve regurgitation without pulmonary artery hypertension. Read by: D.O. Functional Status* Impaired mobility (Uses walker), Visual impairment (Wears glasses), Hearing Impaired (Wears hearing aids) Mental Status* Normal Cognition Social History tobacco use Never Smoked, 1/2 Packs Per Day, Smoking Cessation Not Applicable alcohol use No Known Use drug use No Known Use marital status Widowed general comment Lives at home with her son. She carries out many tasks of daily living, and uses a walker to ambulate. Health Concerns Acute exacerbation of chronic obstructive airways disease Acute hypoxemic respiratory failure Acute COVID-19 Father Deceased Cardiomegaly Mother Deceased Hypertensive disorder; Malignant tumor of colon Brother Deceased Hypertensive disorder Sister Alive Hypertensive disorder Tobacco Cessation* Non-Smoker, Non Tobacco product user Vital Signs Jan-18-2023 0630 T 97.4 HR 68 RR 14 BP 133 / 66 O2Sat 95 Jan-17-2023 2000 T 98.6 HR 61 RR 22 BP 150 / 67 O2Sat 96 O2L 1.5 PHYSICAL EXAM CONSTITUTIONAL: Patient sitting in bedside recliner, looking at window. In no acute distress. Pleasant cooperative. EYES: Vision is grossly intact, pupils are equal, and conjunctivae are without injection and pallor. EARS, NOSE, & THROAT: Oral mucosa is moist and the tongue is without fissures. CARDIOVASCULAR: Regular rate and rhythm without gallops or rubs. 3+ systolic murmur. Pulses are 2+ in the bilateral upper and lower extremities. No edema noted. RESPIRATORY: Lungs are clear to auscultation bilaterally without rales and wheezes. Respiratory effort is not labored. No retractions or accessory muscle use noted. On 2L NC. GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds are normoactive. SKIN: Skin is warm, dry, and without wounds, rashes, and concerning lesions. Senile purpura. NEUROLOGICAL: Patient is alert and oriented to person, place, time, and event. Sensation is grossly intact in the bilateral upper and lower extremities. PSYCHIATRIC: The patient?s mood is euthymic and affect is appropriate. RASS of 0. Hospital Course Patient is a 92-year-old female who was admitted on 01/17/2023 for weakness, fatigue, and dehydration with an acute exacerbation of her COPD secondary to COVID-19. She tested positive for COVID-19 on 01/16/2023. Patient was placed on maximum 3 L nasal cannula and was able to maintain saturations above 92%. She was started on dexamethasone 6 mg q.d. due to oxygen requirement. Due to her renal function, she is not a candidate for antiviral therapy while inpatient. Patient received normal saline, which slightly improved her renal function likely back to baseline. Patient feels significantly better on day 2 of admission. She was able to walk with physical therapy and her walker. Echocardiogram was performed during admission, with no right heart strain secondary COVID-19. On day of discharge, patient's son is present and is agreeable to discharge home safely. Condition at Discharge Stable Discharge Medications ALBUTEROL SULFATE HFA 108 (90 Base) MCG/ACT 2 PUF INHALATION EVERY 4 HOURS AS NEEDED PER RT for SHORTNESS OF BREATH (ePrescribed by RESIDENT on Jan-18-2023 1056) Amiodarone HCl Oral Tablet 100 MG 100 MG ORALLY ONCE A DAY Breo Ellipta Inhalation Aerosol Powder Breath Activated 100-25 MCG/ACT 1 PUF INHALATION ONCE A DAY Carvedilol Oral Tablet 12.5 MG 12.5 MG ORALLY TWICE DAILY Dexamethasone Oral Tablet 6 MG 6 MG ORALLY ONCE A DAY (ePrescribed by RESIDENT on Jan-18-2023 1056) DOXYCYCLINE MONOHYDRATE 100 MG ORALLY TWICE DAILY (ePrescribed by RESIDENT on Jan-18-2023 1056) guaiFENesin-DM 100-10 MG/5 ML 10 ML ORALLY EVERY 4 HOURS AS NEEDED FOR N V for COUGH HYDROcodone-Acetaminophen Oral Tablet 5-325 MG Continue taking same as home Incruse Ellipta Inhalation Aerosol Powder Breath Activated 62.5 MCG/ACT 1 PUF INHALATION ONCE A DAY Levothyroxine Sodium Oral Capsule 50 MCG 50 MCG ORALLY 30 MINUTES BEFORE BREAKFAST Linzess Oral Capsule 72 MCG 72 MCG ORALLY 30 MINUTES BEFORE BREAKFAST LORazepam Oral Tablet 0.5 MG 1 MG ORALLY DAILY AT BEDTIME Ondansetron HCl Oral Tablet 8 MG Continue taking same as home PreserVision/Lutein Oral Capsule 1 CAP ORALLY TWICE DAILY Simvastatin Oral Tablet 20 MG 20 MG ORALLY DAILY AT BEDTIME Vitamin B-12 Sublingual Tablet Sublingual 1000 MCG 1000 MCG SUBLINGUAL ONCE A DAY Vitamin D3 Oral Capsule 250 MCG (10000 UT) 250 MCG ORALLY EVERY WEEK Discharge Disposition Discharge to home Plan Assessments: -Acute hypoxic respiratory failure, acute, secondary to COVID-19 and AECOPD -Acute exacerbation of chronic obstructive pulmonary disease, likely secondary to COVID-19 infection -COVID-19 infection, tested positive on 1/16/23 -Squamous cell carcinoma of the throat, chronic -Diarrhea, acute -Stage 4 CKD, GFR = 26, chronic -Essential hypertension, unknown control, -Hypothyroidism, unknown control, on thyroid medication -Medication non-compliance via PCP -Hyperlipidemia -History of myocardial infarction -Macrocytic anemia, combined iron deficiency and chronic disease, stable -Paroxysmal atrial fibrillation, unknown chronicity -History of GI Bleed -Anxiety disorder, unspecified, per history Plan: The patient's condition is stable at this time and will be discharged today to home. We will discharge the patient on their home medications as reconciled above. We recommend the patient follow up with Dr. within 7-10 days for hospital follow-up. Per respiratory therapy, patient will require 2L NC at all times to maintain oxygen saturation above 92%. Per physical therapy, patient will be safe to return home with her son. She has a walker at home, which she is encouraged to use. We are sending the patient home on the following medications: -dexamethasone 6 mg p.o. q.d. x8 days -doxycycline 100 mg p.o. b.i.d. x4 days -albuterol inhaler 2 puffs q.4 hours p.r.n. -Mucinex OTC Patient was having runny stools on admission, which improved. If she continues to have runny stools, there should be consideration for C. diff testing. The patient was evaluated by Dr. and the plan of care was discussed with this resident. PGY-2 Discharge Instructions Diet Cardiac Activity As tolerated with walker Follow up Appointments Dr. in 7-10 days Primary Care Provider DO Electronically signed by PGY-1 on Jan-18-2023 1125 I have seen and physically examined the patient on [1/18/23] and agree with the documentation of [Dr]. I have also discussed my findings and plan of care with [Dr]. Any changes and additional information are listed below. Electronically signed by MD MD on Jan-18-2023 1140

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension Afib Hypothyroidism COPD Squamous Cell Carcinoma of the Throat
Andere Medikamente: -
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2560688

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge unknown

kritisch

Staat: MO
Alter: 65,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 29.11.2022
Beginn: 12.01.2023
Tage bis Beginn: 44,0
Dosis: N/A
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Arteriosclerosis coronary artery Aspartate aminotransferase normal Basophil count decreased Basophil percentage decreased Blood albumin normal AST/ALT ratio Acute myocardial infarction Alanine aminotransferase normal Anion gap Anticoagulant therapy Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal Blood magnesium increased Blood osmolarity decreased

Symptomtext

Date of Admission Admit Date: Jan-12-2023 Date of Discharge Date of discharge Jan-13-2023 @ 1000 Allergies Doxycycline - Not Specified plastic - Not Specified Amitriptyline - Not Specified Tetracyclines & Related - Not Specified Penicillins - Not Specified Macrodantin - Not Specified Erythromycin - Not Specified Chief Complaint Chest pain Final Diagnoses Acute ST segment elevation myocardial infarction Coronary arteriosclerosis Dissection of coronary artery Chronic obstructive lung disease Tobacco dependence syndrome Acute pericarditis Lab Results Jan-13-2023 0632 Chemistry GLUCOSE 85BUN 9CREAT 0.8MDRD GFR 72NA 141K 4.1CL 105CALCIUM 8.3CO2 31.6OSMO 279.2ANION GP 8.5BUN/CRE 11.3 Jan-13-2023 0632 Hematology WBC 10.5RBC 3.96HGB 11.9HCT 36.9MCV 93.2MCH 30.1MCHC 32.2RDW 16.6PLT 220MPV 10.5NRBC% 0.0 Jan-12-2023 2201 Serology COVID PosCVD1TEST NCVDEMPHC NCVDSYMP NCVDSYMDT NCVDHOSP NCVDICU NCVDRESID NCVDPREG N Jan-12-2023 1155 Chemistry ACT 190 Jan-12-2023 1100 Chemistry ACT 260 Jan-12-2023 1038 Chemistry ACT 190 Jan-12-2023 0957 Chemistry GLUCOSE 92BUN 11CREAT 0.9MDRD GFR 63NA 143K 3.6CL 105CALCIUM 9.0ALK PHOS 81CO2 33.1AST 14ALT 26AST/ALT 0.5TL PROT 6.3ALBUMIN 3.6TBILI 0.6OSMO 284.0ANION GP 8.5BUN/CRE 12.2TSH 1.38MAGNESIU 2.3TROPI-HS 13 Jan-12-2023 0957 Hematology WBC 14.8RBC 4.31HGB 12.9HCT 40.0MCV 92.8MCH 29.9MCHC 32.3RDW 16.7RDWSD 56.8PLT 261MPV 10.4AUTONEU% 63.9AUTOLYM% 26.6AUTOMON% 8.6AUTOEOS% 0.5AUTOBAS% 0.1AUTONEU# 9.5AUTOLYM# 3.9AUTOMON# 1.3AUTOBAS# 0.0AUTOEOS# 0.1NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.05IG% 0.3 Imaging Results cardiac catheterization demonstrated nonocclusive disease in the LAD and left circumflex artery the mid right coronary artery had what appeared to be a dissection this underwent stenting. I also felt that her LV g demonstrated some mild inferior wall hypokinesis but an overall EF of 50 the 55% Functional Status* No Functional Impairments Mental Status* Normal Cognition Social History tobacco use Current Every Day Smoker, Smoking Cessation Yes marital status Married Health Concerns Dissection of coronary artery Chronic obstructive lung disease Tobacco dependence syndrome Stented coronary artery Coronary arteriosclerosis Acute ST segment elevation myocardial infarction Current Every Day Smoker Father Deceased Mother Deceased Tobacco Cessation* FDA Tobacco Cessation Medication has been prescribed (see discharge medications) ( Nicoderm or neck it read over-the-counter) Vital Signs Jan-13-2023 0645 T 98.2 HR 59 RR 18 BP 126 / 63 O2Sat 96 Jan-13-2023 0310 T 98.0 HR 61 RR 16 BP 108 / 50 O2Sat 93 Physical Exam General Normal appearance, Awake, Alert HEENT Head Normocephalic Eyes Negative For: Conjunctival discharge, Conjunctival Erythema, Conjunctival hemorrhage, Corneal abrasion, Corneal foreign body, Corneal laceration, Scleral icterus, Red reflex, Retinal detachment, Retinal Hemorrhages Ears Negative For: Foreign body in ear, Tenderness, Cerumen, Bloody discharge, External drainage, Edema Nose Negative For: Nasal mucosa boggy, Swelling, Inflammation, Epistaxis, External drainage, Deviated nasal septum Sinus Negative For: Swelling over maxillary sinus, Swelling over frontal sinus, Maxillary sinus Tenderness, Frontal sinus tenderness Mouth and Throat Negative For: Erythema of throat, Exudate, Tonsillar enlargement, Posterior rhinorrhea, Dysphagia, Ulcer, Multiple plaques, Dental caries, Halitosis, Gingival Hyperplasia, Gingivitis Neck Negative For: Jugular Venous Distention, Bruit, Tenderness, Lymphadenopathy, Goiter, Thyroid nodule, Mass, Reduced Range of Motion, Swelling, Nuchal rigidity Respiratory Positive For: Rales. Cardiovascular Heart Rhythm Regular, Regular Rate Positive For: Systolic murmur. Peripheral Vascular/Extremities Negative For: Cold extremities, Peripheral cyanosis, Edema, Venous ulcer of leg, Red extremities, Shiny skin, Homans' sign, Edema of lower extremity, Gangrene, Discoloration of skin, Traumatic injury Breasts Negative For: Tenderness, Swelling, Nipple discharge, Retraction of nipple, Orange peel surface of breast, Breast lump, Dimpling of surface of breast, Gynecomastia, Breast implant(s) Abdomen Negative For: Abdominal tenderness, Rebound Tenderness, Guarding, Enlargement/Organmegaly, Distention, Right flank pain, Left flank pain, Hypoactive bowel sounds, Hyperactive bowel sounds, Generalized abdominal dullness to percussion, Abdomen hyper-resonant, Obturator sign, Obese, Murphy sign, Iliopsoas muscle test, Hernia, Bruit, Abdominal mass Musculoskeletal Negative For: Traumatic injury, Joint swelling, Clubbing Skin/Integumentary Skin Appearance Negative For: Nonpitting edema, Pitting edema, Dehydrated, Diaphoresis, Telangiectasis Neurological Normal neurological function, Normal cranial nerves 2-12 Psychiatric Negative For: Paranoid, Hallucinations, Delusions, Labile affect, Mood swings, Inappropriate behavior, Inappropriate affect, Hypomanic behavior, Euphoria, Depressive disorder, Apathetic, Agitated, Anxiety, Angry Hospital Course patient came to the hospital with an hour of her chest pain she was taken to the cath lab where his found that her mid right coronary artery had perhaps some while dissection with thrombus this was stented and she got heparin Aggrastat and Brilinta during the procedure she did well postop set some still some mild chest discomfort I gave her some colchicine for which seemed to resolve it. we found out afterwards that she would was COVID positive however she has had no symptoms and has been oxygenating well she did want quit smoking but did not want to take Chantix I have instructed her to try the nicorette gum ordered Nicoderm patches which now he can actually get over-the-counter. She was doing fine the following morning when go home Condition at Discharge Stable Discharge Medications Albuterol neb QID Continue taking same as home ASPIRIN LOW DOSE 81 MG CHEWED EVERY 24 HOURS (ePrescribed on Jan-13-2023 0846) ATORVASTATIN CALCIUM 80 MG ORALLY EVERY 24 HOURS (ePrescribed on Jan-13-2023 0846) COLCHICINE 0.6 MG ORALLY TWICE DAILY (ePrescribed on Jan-13-2023 0846) GABApentin 200 MG ORALLY DAILY AT BEDTIME (ePrescribed by on Jan-13-2023 0846) Gabapentin Oral Capsule 100 MG 200 MG ORALLY 3 TIMES A DAY Gabapentin Oral Capsule 300 MG 300 MG ORALLY DAILY AT BEDTIME ipratropium bromide 0.5mg BID Continue taking same as home Lamictal 200 mg tab 200 MG ORALLY TWICE DAILY metoprolol tartrate 25 mg tab Continue taking same as home omeprazole 40 mg cpDR Continue taking same as home sucralfate 1 gram tab Continue taking same as home symbicort 1 puff BID Continue taking same as home TICAGRELOR 90 MG ORALLY EVERY 12 HOURS (ePrescribed by on Jan-13-2023 0846) TIOTROPIUM BROMIDE 2.5 MCG/ACT 2 PUF INHALATION DAILY PER RT (ePrescribed by on Jan-13-2023 0846) tylenol #3 300-30mg 1 tab q4-6h prn Continue taking same as home Discharge Disposition Discharge to home Plan Will make sure she has a Brilinta or Plavix and him before discharge she will follow-up with me in a month she is to notify us immediately if she has any respiratory symptoms and case she needs something further for the COVID and check with her work to see if she needs to be quarantine for 5 days or more. I will have her see primary care in a week Primary Care Provider DO Time Spent with Patient Total number of minutes spent with patient (42), More than 50% of the time spent with this patient was devoted to counseling and coordination of care discussed with patient and he she voiced understanding Electronically signed on Jan-13-2023 0907

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Coronary arteriosclerosis, HTN, COPD, Small fiber neuropathy
Andere Medikamente: -
Allergien: Tetracyclines, Penicillins, Erythromycin, Macrodantin
Vorherige Impfungen: -

VAERS 2556178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge unknown

kritisch

Staat: MO
Alter: 76,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 10.09.2022
Beginn: 05.01.2023
Tage bis Beginn: 117,0
Dosis: N/A
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aortic arteriosclerosis Aortic valve incompetence Aspartate aminotransferase normal Atrial fibrillation Atrial pressure increased AST/ALT ratio abnormal Acute respiratory failure Alanine aminotransferase normal Anion gap Anticoagulant therapy Basophil count decreased Basophil percentage decreased Bilirubin conjugated Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride decreased

Symptomtext

Date of Admission Admit Date: Jan-05-2023 Date of Discharge Date of discharge Jan-10-2023 Allergies No Known Allergies Chief Complaint Shortness of breath Final Diagnoses Pneumonia Rapid atrial fibrillation Acute exacerbation of chronic obstructive airways disease Acute COVID-19 Procedure(s) Performed performed Jan-09-2023 Cardioversion Performed by DO Jan-07-2023 Cardioversion Performed by DO Lab Results Jan-10-2023 0445 Chemistry GLUCOSE 82BUN 24CREAT 0.7MDRD GFR 109NA 139K 4.3CL 100CALCIUM 8.8ALK PHOS 77CO2 28.5AST 28ALT 103AST/ALT 0.3TL PROT 6.0ALBUMIN 3.2TBILI 0.5DBILI 0.1OSMO 280.7ANION GP 14.8BUN/CRE 34.3CRP 3.30 Jan-10-2023 0445 Hematology WBC 12.4RBC 3.74HGB 12.5HCT 36.8MCV 98.4MCH 33.4MCHC 34.0RDW 13.2RDWSD 48.0PLT 185MPV 12.7AUTONEU% 77.5AUTOLYM% 6.1AUTOMON% 15.0AUTOEOS% 0.5AUTOBAS% 0.2AUTONEU# 9.6AUTOLYM# 0.8AUTOMON# 1.9AUTOBAS# 0.0AUTOEOS# 0.1SCAN DIF YNRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.09IG% 0.7 Jan-10-2023 0445 Serology PROCALC <0.05 Imaging Results Chest radiograph 1/8/23: "IMPRESSION: 1. Mild cardiac enlargement without evidence of heart failure. Resolution of previously described central pulmonary vascular congestion 2. Stable moderate bibasilar consolidations. 3. Stable small bilateral pleural effusions." Chest radiograph 1/7/2022:: "IMPRESSION: 1. Mild cardiac enlargement with worsening central pulmonary vascular congestion consistent with CHF 2. Moderate bibasilar atelectasis and/or consolidations. Favor bibasilar pneumonia 3. Small bilateral pleural effusions not excluded." Transthoracic Echo 01/06/23 "Conclusions Normal left ventricular systolic function with LVEF >60%. Restrictive physiology with markedly elevated left atrial pressure (Grade III diastolic dysfunction). Severe left atrial enlargement with LA index volumes greater than 48 cm2. Severe mitral regurgitation. Aortic cusps appear mildly calcified. Trileaflet aortic valve. Mild aortic regurgitation. There is mild to moderate tricuspid regurgitation. The estimated Peak RVSP is 43 mmHg." Chest radiograph 01/05/2022: "IMPRESSION: Bilateral lung opacities. Consider infectious or inflammatory etiology. Electronically signed on Jan 5, 2023 3:27:04 AM by: MD Functional Status* No Functional Impairments Mental Status* Normal Cognition Social History tobacco use Former Smoker, 2 Packs Per Day, 36 yrs, Ended Jan-01-2003, Smoking Cessation Not Applicable alcohol use Liquor, Former, 3 Drinks Per Day drug use No Known Use marital status Married general comment Lives at home with his wife Health Concerns Pneumonia Rapid atrial fibrillation Acute exacerbation of chronic obstructive airways disease Acute COVID-19 Former Smoker, 2 Packs Per Day, 36 yrs Liquor, Former, 3 Drinks Per Day Father Deceased @ 61 Myocardial infarction Mother Deceased Old-age @ 95 Cerebrovascular accident; Heart disease Brother Deceased Malignant tumor of pharynx Sister Alive Malignant neoplasm of female breast Vital Signs Jan-10-2023 0603 T 97.8 HR 88 RR 19 BP 150 / 73 O2Sat 96 Jan-10-2023 0412 T 97.7 HR 91 RR 20 BP 156 / 88 O2Sat 98 PHYSICAL EXAM CONSTITUTIONAL: Patient is well groomed 7 7-year-old male. He appears in no acute distress and resting comfortably in bed. EYES: Pupils are equally round bilaterally with no ocular discharge, scleral icterus, or conjunctival injection noted. CARDIOVASCULAR: Heart rate is irregularly irregular and rate is controlled in the 80's bmp while on telemetry. No murmurs appreciated on auscultation. No peripheral edema noted either. Radial pulses are 2+ bilaterally. RESPIRATORY: Patient is wearing supplemental oxygen set at 4 L with SpO2 of 98%. There is no increased work of breathing or conversational dyspnea noted. Lung sounds are clear bilaterally and equal bilaterally. No wheezing noted on auscultation. GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive. PSYCHIATRIC: Patient is awake and alert and oriented to person, place, and time. He is calm and cooperative. Mood and affect are also appropriate. Consultations Dr Cardiology Hospital Course Patient is a 77-year-old male with a past medical history significant for COPD on supplemental oxygen, chronic heart failure with reduced ejection fraction, atrial fibrillation, malignant tumor of the pharynx in 2012 status-post radiation/chemotherapy and PEG tube placement, and hypothyroidism. He presented to the emergency department on 01/05/2023 with complaints of worsening shortness of breath. He admitted for treatment and evaluation of COVID, COPD exacerbation, and atrial fibrillation. His total hospitalization was 6 days. Patient was noted to be in Afib RVR on admission and on 1/7/23 patient was cardioverted an initially successfully converted back to sinus rhythm. Over the weekend patient was noted to have gone back into RVR and on 1/9/2023 patient was cardioverted again, but without successful conversion, unfortunately. Dr. also started the patient on diltiazem and midodrine with resultant rate c Condition at Discharge Stable Discharge Medications aspirin 81 mg capsule 81 MG PEG TUBE ONCE A DAY Breztri Aerosphere Inhalation Aerosol 160-9-4.8 MCG/ACT 2 PUF INHALATION TWICE DAILY Cefdinir Oral Capsule 300 MG 300 MG ORALLY TWICE DAILY (ePrescribed by RESIDENT on Jan-10-2023 1003) diltiaZEM HCL (IR) 60 MG PEG TUBE 3 TIMES A DAY (ePrescribed by RESIDENT on Jan-10-2023 1003) EMPAGLIFLOZIN 10 MG PEG TUBE ONCE A DAY (ePrescribed by RESIDENT on Jan-10-2023 1003) famotidine 20 mg tablet 20 MG PEG TUBE TWICE DAILY levothyroxine 112 mcg capsule 112 MCG PEG TUBE EVERY MORNING lisinopril 2.5 mg tablet 2.5 MG PEG TUBE ONCE A DAY metoprolol tartrate 25 mg tablet 25 MG PEG TUBE TWICE DAILY MIDODRINE HCL 5 MG PEG TUBE TWICE DAILY (ePrescribed by RESIDENT on Jan-10-2023 1003) Xarelto 15 mg tablet 15 MG PEG TUBE ONCE A DAY Discharge Disposition Discharge to home Plan ASSESSMENT: -Sepsis (tachycardia, tachypnea) secondary to COVID-19 pneumonia, resolved -Atrial fibrillation with rapid ventricular rate, s/p Cardioversion x2. Currently rate controlled -Acute on chronic hypoxic respiratory failure, secondary to acute exacerbation of COPD -Acute exacerbation of COPD (dyspnea, increased productive cough) secondary to COVID pneumonia, improved -Acute COVID-19 pneumonia, improved -Oral candidiasis, improved -Hypoosmolar hyponatremia, moderate, Na 126 on admission, has chronic hyponatremia likely secondary to chronic alcohol abuse, resolved -Hyperkalemia, K 5.4 on admission, acute, resolved -Hypochloremia, Cl 89 on admission, acute on chronic, has chronic hypochloremia -Chronic obstructive pulmonary disease -History of throat malignancy treated with chemo and radiation in 2012 -Chronic dysphagia secondary to radiation, prior injury/airway intervention, PEG tube in situ -LVEF >60%, Grade III diastolic dysfunction, per echo 1/5/23 -Severe mitral regurgitation, per echo 1/5/23 -Chronic paroxysmal atrial fibrillation -Cardiomyopathy likely secondary to chronic alcohol abuse -Essential hypertension, chronic, unknown control -Hypercholesterolemia, chronic -Hypothyroidism, chronic, current control unknown -History of alcohol abuse -Chronic severe protein-calorie malnutrition with diffuse muscle and fat wasting -History of tobacco use, 80 pack year smoking history Follow-up with: Primary Care Provider, within the next 7-10 days. Cardiologist Dr on Tuesday 01/17/2023 at 11:15 am. Pulmonologist: Dr Primary Care Provider DO

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, chronic systolic heart failure, Afib, Malignant tumor of pharynx status post chemo/radiation, hypothyroidism
Andere Medikamente: -
Allergien: No known Allergies
Vorherige Impfungen: -

VAERS 2554222

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 17.03.2021
Beginn: 12.12.2022
Tage bis Beginn: 635,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Patient who DID NOT received a covid from facility, has a record of receiving a covid EUA (J&J) vaccine on 3/17/2021, place unknown & details unknown. Pt died on 12/12/2022, place and cause and circumstances of death unknown. No available notes in chart regarding pt's death. Reporting this since vaccine was EUA status.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2554221

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 03.05.2021
Beginn: 14.12.2022
Tage bis Beginn: 590,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Respiratory failure

Symptomtext

Narrative: Patient, died 12/14/2022 at hospital after presentation to ER on 12/9/2022 with Admitting Diagnosis: Respiratory failure Pt had received a covid vaccine EUA (J&J) on 5/3/2021. This death does not appear to be related to the covid vaccine. Reporting since vaccine is EUA status.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539332

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 21.12.2022
Impfdatum: 06.04.2021
Beginn: 11.10.2021
Tage bis Beginn: 188,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Atrial fibrillation COVID-19 Death Influenza virus test Respiratory syncytial virus test SARS-CoV-2 test positive

Symptomtext

Date of Admission: 10/11/2022 Date of Discharge:Deceased on 10/22/2022 Admission Diagnosis: COVID [U07.1] Acute hypoxemic respiratory failure [J96.01] Hospital Principal Problem (Discharge Diagnoses): Paroxysmal atrial fibrillation with RVR

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 10/10 Covid-19, Flu, RSV by NAA SARS-CoV-2 -COVID-19 Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2538824

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 21.12.2022
Impfdatum: 01.04.2021
Beginn: 11.07.2021
Tage bis Beginn: 101,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Colon cancer Death Metastases to liver

Symptomtext

Narrative: 77yo male patient died of colon cancer with mets to the liver on 7/11/2021. Pt had received covid vaccines on 3/4/21 & 4/1/21. This death is not related to covid vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2524357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 60,0
Geschlecht: M
Eingang: 06.12.2022
Impfdatum: 27.01.2022
Beginn: 27.10.2022
Tage bis Beginn: 273,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood pressure systolic decreased COVID-19 COVID-19 pneumonia Hypotension SARS-CoV-2 test positive Seizure Septic shock Ventricular tachycardia

Symptomtext

Patient with history of chronic renal failure on dialysis. On 10/27 patient was brought to the ED by EMS after having 5-6 seizures over the span of approximately 12 hours. The patient does not have a history of seizures. In the ED, patient found to be hypotensive with systolics in the 50s. Patient admitted 10/27-11/5 for septic shock, acute respiratory failure with hypoxia secondary to COVID pneumonia, and ventricular tachycardia. On admission, patient tested positive for COVID-19 by PCR. Patient has been vaccinated with COVID-19 primary series and one booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2524357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MN
Alter: 60,0
Geschlecht: M
Eingang: 06.12.2022
Impfdatum: 27.01.2022
Beginn: 27.10.2022
Tage bis Beginn: 273,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood pressure systolic decreased COVID-19 COVID-19 pneumonia Hypotension SARS-CoV-2 test positive Seizure Septic shock Ventricular tachycardia

Symptomtext

Patient with history of chronic renal failure on dialysis. On 10/27 patient was brought to the ED by EMS after having 5-6 seizures over the span of approximately 12 hours. The patient does not have a history of seizures. In the ED, patient found to be hypotensive with systolics in the 50s. Patient admitted 10/27-11/5 for septic shock, acute respiratory failure with hypoxia secondary to COVID pneumonia, and ventricular tachycardia. On admission, patient tested positive for COVID-19 by PCR. Patient has been vaccinated with COVID-19 primary series and one booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MN
Alter: 61,0
Geschlecht: F
Eingang: 05.12.2022
Impfdatum: 27.05.2021
Beginn: 10.11.2022
Tage bis Beginn: 532,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient tested positive for COVID on 11/10/2022, hospitalized and died on 12/2/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 22,0
Labordaten: COVID PCR + 11/10/2022
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes, heart disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2519013

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge UNKNOWN

kritisch

Staat: AZ
Alter: 93,0
Geschlecht: F
Eingang: 29.11.2022
Impfdatum: 17.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood magnesium decreased Blood potassium decreased Blood test Chest X-ray abnormal Death Dyspnoea Fatigue Feeling abnormal Platelet count decreased Pulmonary oedema X-ray

Symptomtext

Patient was extremely tired the day after getting the shots. She kept expecting to get better but by the following Saturday, we took her to the Emergency room. She was very low on magnesium, potassium, and platelets. They admitted her to the hospital, and she had one good morning but most of the time she thought she was going to die. (She is not like that normally) I believe it was Saturday 10/29 that she woke up having a horrible time breathing. They gave her breathing treatments but nothing helped. They took an X-ray and her lungs were very full of fluids. They said that they could drain her lungs, but the fluid would probably come back. The other option was to put her on Comfort Care, which we did. Sunday afternoon around 2:30 she passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: They drew blood and did X-rays. Perhaps a CT scan. You will have to check with the Hospital to get the complete records.
Aktuelle Erkrankungen: Mild COPD due to previous lung cancer in 2001 and removal of lobe, plus radiation.
Vorgeschichte: None, just the COPD since 2001
Andere Medikamente: Eliquis, Lovastatin, Lovastatin, Amlodipine, Diltiazem, Montelukast, Albuterol sulfate, Arnuity, Alendronate, Oxybutynin
Allergien: none
Vorherige Impfungen: -

VAERS 2514066

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge unknown

kritisch

Staat: KY
Alter: 54,0
Geschlecht: M
Eingang: 22.11.2022
Impfdatum: 12.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Catheterisation cardiac normal Coronary artery thrombosis Myocardial infarction

Symptomtext

Suffered Heart Attack on Thursday, November 17 at approximately 1:00pm. Upon diagnosis at local emergency clinic was taken by Ambulance to the local Hospital for Heart Cath procedure. Heart Cath was performed and resulted in no blockages and no stents and places of one balloon. Blood clot had broken away and blocked smaller artery supporting bottom right quadrant of heart.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: Available at the local Hospital.
Aktuelle Erkrankungen: Tested positive for Covid 11/17/22
Vorgeschichte: None
Andere Medikamente: Artorvistatin
Allergien: none
Vorherige Impfungen: -

VAERS 2511380

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CO
Alter: -
Geschlecht: U
Eingang: 18.11.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

He has seen a case of stroke for a patient; This is a spontaneous report received from contactable reporter (Physician) from a sales representative. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as DOSE NUMBER UNKNOWN, SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown" described as "He has seen a case of stroke for a patient." The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the event Cerebrovascular accident and the suspect drug BNT162b2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507833

NOVARTIS VACCINES AND DIAGNOSTICS · RABIES (RABAVERT) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 03.11.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental exposure to product Exposure via ingestion Fear of death Product administration error Viral titre

Symptomtext

Patient touched a little bit of the vaccine with fingers and mouth; Vaccination was not performed properly; The patient thought that will die of rabies; Small ingestion of rabies vaccine; Case reference number US-BN-2022-004566 is a spontaneous case report initially received on 04-Nov-2022 from a consumer via Agency (reference number: USBAV22-1864) and concerns a 64-year-old female patient. The patient had no medical history. The patient's concomitant vaccination included Imovax (rabies vaccine) and tetanus. On 03-Nov-2022, the patient was exposed to rabies via a bat. On the same day, a nurse wanted to vaccinate the patient with a tetanus vaccine, but after the patient told the nurse that a rabies vaccine should be administered, the patient was vaccinated with the first dose of RabAvert (rabies virus (inactivated, strain flury LEP) (PCEC); batch number: unknown) at an unknown dose, administered intramuscularly at an unknown site of administration, for post exposure to rabies. On the same day, the nurse gave the box with the insert to the patient and the used vial was still inside the box. The patient touched a little bit of the vaccine with fingers and then touched the mouth and probably had a small ingestion of the rabies vaccine, as reported (explicitly coded as 'inadvertent exposure to vaccine'). The patient thought that the vaccination was not carried out properly (explicitly coded as 'product administration error'). On an unspecified date, an unknown amount of time after the vaccination, the patient contacted poison control and the doctor said that the vaccine was attenuated and that the patient could not get the disease, but the doctor also said that if a small amount was ingested and if it went through the digestive system and in case of any tear in the digestive tract, this would allow the vaccine to enter the blood stream. The patient was afraid of death of rabies. On an unspecified date, reported also as at one point, the patient performed a titer test and the results were okay, as reported. At the time of this report, the outcome of the events was unknown. The reporter assessed the event of fear of death as serious due to the seriousness criteria of life threatening and possibly related to the product. Additional information received from Bavarian Nordic on 07-Nov-2022 included the local BN case ID.; Reporter's Comments: A 64-year-old female patient had an exposure to rabies, involving a bat. The patient received RabAvert intramuscularly. Following administration, the patient touched the vial and had contact with the remaining amounts of the vaccine. The patient touched her mouth (which is considered accidental exposure to product and exposure via ingestion). The patient was told by a physician that theoretically, the ingested vaccine could enter the bloodstream in case there are injuries to the GI tract. The patient reported she was not vaccinated properly (which is considered product administration error), and she thought she would die of rabies (assessed as life-threatening by the reporter, coded as fear of death). Fear of death is unlisted per the agency for RabAvert. Accidental exposure to product, exposure via ingestion and product administration error are considered listed per company conventions. Medical history and concomitant medications were unknown. Concomitant vaccines included Imovax and Tetanus vaccine. According to agency, if the vaccine enters the bloodstream (via injection error), it could cause shock. However, RabAvert contains an inactivated rabies virus (strain Flury LEP produced on chicken embryos), which means the vaccine is only immunogenic but not infectious. Therefore, the event of fear of death is assessed as not related to RabAvert, but to anxiety and insufficient information provided to the patient. The events of accidental exposure to product, exposure via ingestion and product administration error are considered not related to RabAvert, but to human error.; Sender's Comments: A 64-year-old female patient had an exposure to rabies, involving a bat. The patient received RabAvert intramuscularly. Following administration, the patient touched the vial and had contact with remaining amounts of the vaccine. The patient touched her mouth (which is considered accidental exposure to product and exposure via ingestion). The patient was told by a physician that theoretically, the ingested vaccine could enter the bloodstream in case there are injuries to the GI tract. The patient reported she was not vaccinated properly (which is considered product administration error), and she thought she would die of rabies (assessed as life-threatening by the reporter, coded as fear of death). Fear of death is unlisted per the agency for RabAvert. Accidental exposure to product, exposure via ingestion and product administration error are considered listed per company conventions. Medical history and concomitant medications were unknown. Concomitant vaccines included Imovax and Tetanus vaccine. According to agency, if the vaccine enters the bloodstream (via injection error), it could cause shock. However, RabAvert contains an inactivated rabies virus (strain Flury LEP produced on chicken embryos), which means the vaccine is only immunogenic but not infectious. Therefore, the event of fear of death is assessed as not related to RabAvert, but to anxiety and insufficient information provided to the patient. The events of accidental exposure to product, exposure via ingestion and product administration error are considered not related to RabAvert, but to human error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fear of death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None
Andere Medikamente: IMOVAX; TETANUS VACCINE
Allergien: -
Vorherige Impfungen: -

VAERS 2505270

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: OH
Alter: -
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

father died/Her parents got Pfizer as well as her brother and sister got Pfizer; This is a spontaneous report received from contactable reporter (consumer or other non-HCP). A male patient received BNT162b2 (BNT162B2), as DOSE NUMBER UNKNOWN, SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal" described as "father died/Her parents got Pfizer as well as her brother and sister got Pfizer." The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Additional information: The reporter received the shot as her and her sister take turns staying with mom after her father died. Her parents got Pfizer as well as her brother and sister got Pfizer and she doesn't want to get COVID. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: father died/Her parents got Pfizer as well as her brother and sister got Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2501383

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 07.11.2022
Impfdatum: 01.11.2021
Beginn: 01.11.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Death Fatigue Headache Loss of personal independence in daily activities Malaise Nausea Respiratory tract infection viral SARS-CoV-2 test negative Weight decreased

Symptomtext

After each vaccine dose, the patient became weaker. He had more difficulty completing daily tasks. He complained of fatigue, nausea, weight loss, headaches, and weakness. He became sick often, without reason. Covid negative testing. He was sick, respiratory virus, he thought he should get the booster since it was being recommended by the doctor on the news. He told me he got it on November 18, 2021. He felt worse, was trying to rest and sleep it off. He died in his sleep sometime on or about November 22, 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None. I was in such absolute shock, I didn?t ask or even think of an autopsy.
Aktuelle Erkrankungen: Infected Toe Hypertension Diabetes
Vorgeschichte: Diabetes Hypertension Retinal damage; monthly procedures Cataract repair Cardiac Catheter Placement, passed stress test March 2021
Andere Medikamente: Toprol XL Crestor Hydrochlorothiazide Brininta Amlodipine Losartin Lantus Gabapentin ASA Imdur Antibiotics Multivitamins
Allergien: -
Vorherige Impfungen: -

VAERS 2500895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 71,0
Geschlecht: F
Eingang: 07.11.2022
Impfdatum: 30.08.2022
Beginn: 28.10.2022
Tage bis Beginn: 59,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal X-ray Abdominal distension Abdominal pain Anaemia of chronic disease Angiogram cerebral abnormal Anion gap Anticoagulant therapy Aortic arteriosclerosis Aortic valve incompetence Aphakia Arteriogram carotid abnormal Arteriosclerosis Arteriosclerosis coronary artery Atrial fibrillation Azotaemia Bacterial test positive Basilar artery stenosis Basophil count decreased

Symptomtext

Date of Service Nov-07-2022 0850 Date of Admission Admit Date: Oct-28-2022 Date of Discharge Date of discharge Nov-07-2022 Allergies Metformin HCl - Not Specified Sotalol - Not Specified Chief Complaint Nausea and Vomiting, Elevated blood pressures, Acute on Chronic Renal injury Final Diagnoses Sick sinus syndrome Urinary tract infectious disease Disorder of kidney due to diabetes mellitus Chronic kidney disease stage 4 Hypertensive urgency Procedure(s) Performed performed Nov-07-2022 Interrogation of cardiac pacemaker Performed by DO Procedure Start Date - Nov-07-2022 07:37 Lab Results Nov-07-2022 0608 Hematology WBC 11.3RBC 3.12HGB 8.7HCT 27.5MCV 88.1MCH 27.9MCHC 31.6RDW 13.2RDWSD 41.6PLT 287MPV 11.6AUTONEU% 61.5AUTOLYM% 25.0AUTOMON% 6.7AUTOEOS% 6.0AUTOBAS% 0.4AUTONEU# 7.0AUTOLYM# 2.8AUTOMON# 0.8AUTOBAS# 0.1AUTOEOS# 0.7NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.05IG% 0.4 Nov-07-2022 0608 Chemistry GLUCOSE 116BUN 52CREAT 4.1MDRD GFR 11NA 139K 4.3CL 101CALCIUM 8.0CO2 25.7OSMO 292.6ANION GP 16.6BUN/CRE 12.7 Nov-07-2022 0551 Point Of Care Nov-06-2022 2054 Point Of Care Nov-06-2022 1634 Point Of Care Nov-06-2022 1149 Point Of Care Nov-06-2022 0640 Serology PROCALC <0.05 Nov-06-2022 0640 Hematology WBC 8.6RBC 3.01HGB 8.3HCT 26.2MCV 87.0MCH 27.6MCHC 31.7RDW 13.0RDWSD 41.3PLT 266MPV 12.1AUTONEU% 53.1AUTOLYM% 31.9AUTOMON% 7.3AUTOEOS% 6.9AUTOBAS% 0.3AUTONEU# 4.6AUTOLYM# 2.7AUTOMON# 0.6AUTOBAS# 0.0AUTOEOS# 0.6NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.04IG% 0.5 Nov-06-2022 0640 Chemistry GLUCOSE 138BUN 52CREAT 4.3MDRD GFR 10NA 137K 3.4CL 99CALCIUM 7.9CO2 26.0OSMO 290.1ANION GP 15.4BUN/CRE 12.1 Nov-02-2022 1455 Urinalysis Department SPECGRAV 1.015U-PH 6.0LEUCOCYT ModerateNITRITES NegativePROTEIN 100GLUCOSE NegativeKETONES NegativeUROBILIN 0.2BILRUBIN NegativeBLOOD LargeCOLOR AmberCLARITY CloudyMICROSCP YCULTURE YWBC 40-60RBC 80-100SQUAM EP NoneBACTERIA 3+MUCUS None Nov-02-2022 1455 Microbiology C UR Enterobacter cloacae complex Nov-02-2022 1455 Chemistry BUN 61CREAT 4.8CREA-U 61FEUREA 44.63UUN 346 Nov-02-2022 0445 Hematology WBC 8.7RBC 3.13HGB 8.7HCT 27.0MCV 86.3MCH 27.8MCHC 32.2RDW 12.9RDWSD 40.4PLT 293MPV 11.7AUTONEU% 62.9AUTOLYM% 25.1AUTOMON% 5.6AUTOEOS% 5.6AUTOBAS% 0.5AUTONEU# 5.5AUTOLYM# 2.2AUTOMON# 0.5AUTOBAS# 0.0AUTOEOS# 0.5NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.03IG% 0.3 Nov-02-2022 0445 Chemistry GLUCOSE 121BUN 61CREAT 4.8MDRD GFR 9NA 139K 3.7CL 101CALCIUM 8.1CO2 25.0OSMO 296.0ANION GP 16.7BUN/CRE 12.7PHOSPHOR 4.9 Nov-01-2022 0510 Hematology WBC 8.2RBC 2.83HGB 8.0HCT 24.4MCV 86.2MCH 28.3MCHC 32.8RDW 12.6RDWSD 39.8PLT 257MPV 11.6AUTONEU% 56.0AUTOLYM% 31.3AUTOMON% 5.3AUTOEOS% 7.0AUTOBAS% 0.2AUTONEU# 4.6AUTOLYM# 2.6AUTOMON# 0.4AUTOBAS# 0.0AUTOEOS# 0.6NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.02IG% 0.2 Nov-01-2022 0510 Chemistry GLUCOSE 110BUN 63CREAT 4.4MDRD GFR 10NA 136K 3.5CL 102CALCIUM 7.8CO2 25.9OSMO 290.6ANION GP 11.6BUN/CRE 14.3 Oct-31-2022 0500 Hematology WBC 8.2RBC 3.13HGB 8.7HCT 27.2MCV 86.9MCH 27.8MCHC 32.0RDW 12.7RDWSD 40.3PLT 253MPV 11.8AUTONEU% 55.4AUTOLYM% 30.8AUTOMON% 6.6AUTOEOS% 6.3AUTOBAS% 0.4AUTONEU# 4.5AUTOLYM# 2.5AUTOMON# 0.5AUTOBAS# 0.0AUTOEOS# 0.5NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.04IG% 0.5 Oct-31-2022 0500 Chemistry GLUCOSE 110BUN 58CREAT 3.6MDRD GFR 12NA 136K 3.6CL 101CALCIUM 7.9CO2 25.9OSMO 288.8ANION GP 12.7BUN/CRE 16.1MAGNESIU 2.3 Oct-30-2022 1240 Chemistry HGBA1C 5.9MEAN GLU 133 Oct-30-2022 0508 Hematology WBC 6.3RBC 3.02HGB 8.4HCT 26.5MCV 87.7MCH 27.8MCHC 31.7RDW 12.7RDWSD 40.5PLT 235MPV 12.1AUTONEU% 44.3AUTOLYM% 41.9AUTOMON% 7.8AUTOEOS% 5.2AUTOBAS% 0.5AUTONEU# 2.8AUTOLYM# 2.6AUTOMON# 0.5AUTOBAS# 0.0AUTOEOS# 0.3NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.02IG% 0.3 Oct-30-2022 0508 Chemistry GLUCOSE 96BUN 66CREAT 3.5MDRD GFR 13NA 135K 3.7CL 99CALCIUM 8.1CO2 24.9OSMO 289.0ANION GP 14.8BUN/CRE 18.9 Oct-29-2022 1757 Hematology WBC 7.7RBC 3.14HGB 8.9HCT 27.2MCV 86.6MCH 28.3MCHC 32.7RDW 12.7PLT 258MPV 11.8NRBC% 0.0 Oct-29-2022 1757 Coagulation PT 10.7INR 1.0 Imaging Results MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 11/02/2022 DOB: Gender: F Ordering Physician: Exam Description: MRI HEAD WO CON EXAM: MRI head without IV contrast INDICATION: Transient ischemic attack. Facial droop. COMPARISON: 5/2/2022 TECHNIQUE: Axial, coronal and sagittal MR images of the brain were acquired utilizing multiple pulse sequences without IV contrast. DISCUSSION: Diffusion weighted and apparent diffusion coefficient images show no evidence of acute ischemia. Multiple foci of FLAIR hyperintensity in the periventricular and subcortical white matter. There is no intracranial hemorrhage, mass or mass effect. The ventricles, basal ganglia, thalamus, brainstem and cerebellum are unremarkable. Well-defined T1 hypointense and mildly T2 hyperintense intraconal mass posteriorly on the right between the medial rectus muscle and optic nerve measuring 1.5 cm AP, 1.4 cm wide and 1.3 cm craniocaudad. Lateral displacement of the optic nerve. Bilaterally aphakia. Moderate mucosal thickening in the ethmoid, maxillary and sphenoid sinuses. Bilateral mastoid air cell fluid signal intensity. IMPRESSION: 1. No acute intracranial abnormality. 2. Mild periventricular and subcortical changes of chronic microangiopathy. 3. Unchanged intraconal mass posteromedially on the right. 4. Chronic sinusitis. 5. Benign mastoid effusions. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 11/2/2022 4:12 PM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/31/2022 DOB: Gender: F Ordering Physician: RESIDENT Exam Description: US ABD RETRO (RENAL, AORTA,ETC) EXAM: Retroperitoneal ultrasound INDICATION: Right renal lesion; history of hematoma; prior renal biopsy TECHNIQUE: Retroperitoneal ultrasound was performed. COMPARISON: None. FINDINGS: The right kidney is 10.7 x 5.7 x 5.1 cm. An 1 cm cyst is present at the lower pole of the right kidney. No solid renal mass, renal calculus or hydronephrosis on this side. The left kidney is 7.8 x 4.6 x 4.0 cm. Indistinct renal cortex. No solid renal mass, renal calculus, or hydronephrosis on this side. The urinary bladder has an estimated volume of 80 mL at the time of this exam. Urinary bladder wall thickening may be related to nondistention. Ureteral jets not demonstrated during this exam. Indwelling Foley catheter noted. IMPRESSION: 1. No solid renal mass, renal calculus or hydronephrosis on either side. 2. Indistinct left renal cortex, nonspecific. Parenchymal disease is not excluded. 3. Urinary bladder wall thickening, likely related to nondistention. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/31/2022 4:06 PM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/30/2022 DOB: Gender: F Ordering Physician: DO Exam Description: CT HEAD/BRAIN WO PATIENT NAME: DATE OF BIRTH: RAD NUMBER: PHYSICIAN DATE OF EXAM Oct 29, 2022 6:49:14 PM CDT PROCEDURES CT head without contrast (stroke alert) and CTA head HISTORY Facial droop; STROKE ALERT IV CONTRAST (if appl) With isovue 370 100 ml given EXAM: CT head TECHNIQUE: CT image acquisition of the brain without contrast. COMPARISON: 9/13/21. FINDINGS: No acute intracranial hemorrhage or midline shift. The ventricles and extra-axial CSF spaces are normal in size and configuration for age. Volume averaging artifact within the anterior-inferior left frontal lobe, axial image 13 of 32. Additional scattered low-density foci within the cerebral white matter. Soft tissue mass within the right posterior orbit, which appears circumscribed and is difficult to distinguish from the adjacent optic nerve. Imaged paranasal sinuses and mastoid air cells are clear. Bilateral paranasal sinus mucosal thickening. No acute calvarial findings. IMPRESSION: No acute intracranial hemorrhage. No CT evidence of large vascular territory infarct. Circumscribed right posterior orbital mass, slightly increased in size from prior, incompletely characterized. Recommend follow-up MRI orbits with IV Page 1 of 2 MEDICAL CENTER NAME: contrast. This report was discussed with Dr. on Oct 29, 2022 17:59:00 CDT. EXAM: CT head angiogram COMPARISON: Same day CT head. TECHNIQUE: CT angiogram of the head was performed after IV administration of nonionic intravenous contrast. Imaging was acquired in the arterial phase. 3-D rotational reformats provided. FINDINGS: Anterior circulation: No large vessel occlusion or high-grade stenosis. Non-flow-limiting calcific plaques of the intracranial ICAs. No aneurysm visualized. Posterior circulation: Attenuated appearance of the proximal and mid basilar artery, with moderate stenosis. The basilar artery remains patent. The distal vertebral arteries are patent. The major branches of the PCAs are grossly patent. No aneurysm visualized. Brain: Refer to recently performed head CT. No abnormal intracranial enhancement. Other: Dural venous sinuses appear grossly patent. Redemonstrated right intraorbital mass. Bilateral paranasal sinus disease. No acute osseous findings. IMPRESSION: Moderate narrowing of the proximal and mid basilar artery, likely from atherosclerotic vascular disease. No additional stenosis or occlusion within the major intracranial arterial vasculature. Redemonstrated right intraorbital mass. Recommend follow-up MRI orbits. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/30/2022 10:27 AM CDT --------------------------------------------- Medical Center Transthoracic Echocardiogram Report Patient Name: Gender: Female Birth Date: Study Date: 30-Oct-2022 Tech: Location: Height(Cm): 160 Weight(Kg): 99.80 BSA: 2.11 Ref. Physician: Quality: Good Procedures: Echocardiogram complete with 2D, M-Mode, and Doppler examination. Indications: Cerebrovascular Accident. 2D/M Mode Doppler Measurement Value Normal Range Measurement Value Normal Range LVIDd (MM) 5.6 cm AV Area Vmax 2.7 cm2 LVIDs (MM) 3.3 cm AV Area VTI 2.7 cm2 IVSd (MM) 1.3 cm AV Peak PG 20.0 mmHg LVPWd (MM) 1.2 cm AV Mean PG 11.0 mmHg LA Dimen MM 3.0 cm MV E/A 0.6 LVOT Peak Vel 1.3 m/sec E/E` 9.6 Findings Left Ventricle: Normal left ventricular systolic function with LVEF >60%. Mild left ventricular hypertrophy ( measuring diameter 1.1cm - 1.3cm). Impaired relaxation (Grade I diastolic dysfunction). Left Atrium: Mild left atrial enlargement which is consistent with LA index volumes between 35 - 41 cm2. Mitral Valve: Mild mitral regurgitation. Aortic Valve: Aortic cusps appear mildly calcified. Trileaflet aortic valve. Trace aortic regurgitation. Right Ventricle: Normal right ventricular size. Normal right ventricular systolic function. Right Atrium: Normal with RA size <40mm. Atrial Septum: Normal atrial septum. Agitated saline was injected intravenously for microbubble contrast study. No right to left shunt was identified. Tricuspid Valve: Normal appearance and function of the tricuspid valve with trace physiologic regurgitation. Normal right ventricular systolic pressure. Pulmonic Valve: Normal pulmonic valve appearance and function with trivial (physiologic) regurgitation. IVC: Normal inferior vena cava appearance and respiratory collapse. Aorta: Aortic root size is normal. Pericardium: Small pericardial effusion. No echocardiographic evidence to suggest pericardial tamponade. Thickened. Conclusions Normal left ventricular systolic function with LVEF >60%. Mild left ventricular hypertrophy ( measuring diameter 1.1cm - 1.3cm). Impaired relaxation (Grade I diastolic dysfunction). Mild left atrial enlargement which is consistent with LA index volumes between 35 - 41 cm2. Normal atrial septum. Agitated saline was injected intravenously for microbubble contrast study. No right to left shunt was identified. Mild mitral regurgitation. Small pericardial effusion. No echocardiographic evidence to suggest pericardial tamponade. Thickened. Aortic cusps appear mildly calcified. Trileaflet aortic valve. Trace aortic regurgitation. Electronically Signed By: --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/29/2022 DOB: Gender: F Ordering Physician: DO Exam Description: CTA HEAD CIRCLE WIL PATIENT NAME: DATE OF BIRTH: RAD NUMBER: PHYSICIAN DATE OF EXAM Oct 29, 2022 6:49:14 PM CDT PROCEDURES CT head without contrast (stroke alert) and CTA head HISTORY Facial droop; STROKE ALERT IV CONTRAST (if appl) With isovue 370 100 ml given EXAM: CT head TECHNIQUE: CT image acquisition of the brain without contrast. COMPARISON: 9/13/21. FINDINGS: No acute intracranial hemorrhage or midline shift. The ventricles and extra-axial CSF spaces are normal in size and configuration for age. Volume averaging artifact within the anterior-inferior left frontal lobe, axial image 13 of 32. Additional scattered low-density foci within the cerebral white matter. Soft tissue mass within the right posterior orbit, which appears circumscribed and is difficult to distinguish from the adjacent optic nerve. Imaged paranasal sinuses and mastoid air cells are clear. Bilateral paranasal sinus mucosal thickening. No acute calvarial findings. IMPRESSION: No acute intracranial hemorrhage. No CT evidence of large vascular territory infarct. Circumscribed right posterior orbital mass, slightly increased in size from prior, incompletely characterized. Recommend follow-up MRI orbits with IV Page 1 of 2 MEDICAL CENTER NAME: contrast. This report was discussed with Dr. on Oct 29, 2022 17:59:00 CDT. EXAM: CT head angiogram COMPARISON: Same day CT head. TECHNIQUE: CT angiogram of the head was performed after IV administration of nonionic intravenous contrast. Imaging was acquired in the arterial phase. 3-D rotational reformats provided. FINDINGS: Anterior circulation: No large vessel occlusion or high-grade stenosis. Non-flow-limiting calcific plaques of the intracranial ICAs. No aneurysm visualized. Posterior circulation: Attenuated appearance of the proximal and mid basilar artery, with moderate stenosis. The basilar artery remains patent. The distal vertebral arteries are patent. The major branches of the PCAs are grossly patent. No aneurysm visualized. Brain: Refer to recently performed head CT. No abnormal intracranial enhancement. Other: Dural venous sinuses appear grossly patent. Redemonstrated right intraorbital mass. Bilateral paranasal sinus disease. No acute osseous findings. IMPRESSION: Moderate narrowing of the proximal and mid basilar artery, likely from atherosclerotic vascular disease. No additional stenosis or occlusion within the major intracranial arterial vasculature. Redemonstrated right intraorbital mass. Recommend follow-up MRI orbits. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/30/2022 10:27 AM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/29/2022 DOB: Gender: F Ordering Physician: DO Exam Description: CTA CAROTID PATIENT NAME: DATE OF BIRTH: RAD NUMBER: 304850 PHYSICIAN DATE OF EXAM Oct 29, 2022 6:49:14 PM CDT PROCEDURES CT - Angio Neck HISTORY facial droop IV CONTRAST (if appl) With isovue 370 100 ml given EXAM: CT neck angiogram COMPARISON: None available. TECHNIQUE: CT angiogram of the neck was performed after IV administration of nonionic intravenous contrast. Imaging was acquired in the arterial phase. 3-D rotational reformats provided. FINDINGS: Origins of the aortic arch branch vessels are patent. Mild atherosclerotic plaque most notably involving the left subclavian artery origin. Prominent soft tissue and calcific plaque at the left carotid bifurcation, with approximately 50% narrowing . Calcified plaque with additional small soft tissue component along the lateral margin at the right carotid bifurcation, with minimal stenosis. The vertebral arteries are normal in course and caliber without significant stenosis. Scattered non-flow-limiting calcific plaques are noted bilaterally. Subcentimeter thyroid nodules. Partially imaged moderate size left pleural effusion. Coronary artery calcification. Bilateral paranasal sinus disease. A right orbital mass will be described in the report of the CTA head from the same day. Degenerative changes of the spine. IMPRESSION: 1. Bilateral carotid bifurcation plaques, with approximately 50% stenosis Page 1 of 2 MEDICAL CENTER NAME: on the left. Prominent soft tissue components present, particularly on the left, which can be associated with high risk/vulnerable carotid plaques. 2. No evidence of carotid or vertebral artery dissection. 3. Partially imaged left pleural effusion. 4. Please see today's CTA head report for additional information. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/30/2022 10:19 AM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/29/2022 DOB: Gender: F Ordering Physician: RESIDENT Exam Description: STROKE PROTOCOL(CT HEAD WO) EXAM: STROKE PROTOCOL(CT HEAD WO) INDICATION: Stroke. Facial droop. TECHNIQUE: Axial CT images of the head obtained without intravenous contrast. Sagittal and coronal reconstructions provided and evaluated. One of the following dose optimization techniques was utilized in the performance of this exam: Automated exposure control; adjustment of the mA and/or kV according to the patient's size; or use of an iterative reconstruction technique. COMPARISON: Brain MRI 05/02/2022. FINDINGS: Mild changes of chronic small vessel ischemic disease. No midline shift or mass effect. No hydrocephalus. No intracranial hemorrhage. No extra-axial fluid. No CT evidence of an acute infarct. Right retro-orbital mass appears slightly larger than prior brain MRI. This could further be evaluated with orbit MRI. Moderate paranasal sinus mucosal thickening. Mastoid air cells are clear. A preliminary report was provided by Real Radiology at 5:53 p.m. on 10/29/2022. IMPRESSION: 1. No acute intracranial abnormalities. 2. Right retro-orbital mass appears slightly larger than prior brain MRI. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/31/2022 9:01 AM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology Patient Name: Date of Exam: 10/28/2022 DOB: Gender: F Ordering Physician: DO Exam Description: CH-ABDOMEN 1 VIEW DR Exam: CH-ABDOMEN 1 VIEW DR, 10/28/2022 11:54 AM CDT Indication: Abdominal pain and distention Comparison: Chest radiograph 6/9/2022 Technique: Supine views of the abdomen. Findings: Moderate gaseous distention of the cecum measuring up to 8 cm. Moderate colonic stool burden. Postsurgical changes in the left hemiabdomen. No pneumatosis or portal venous gas. No acute osseous abnormality. Advanced degenerative changes of the spine. Moderate degenerative changes of the hips. Partially visualized lower thorax. Small pleural effusion on the left. Cardiomegaly. Partially visualized pacemaker leads. Impression: 1. Moderate gaseous distention of the cecum measuring up to 8 cm. This is within the upper limits of normal. Consider CT if there is clinical concern for cecal volvulus. 2. Moderate colonic stool burden. 3. Cardiomegaly. 4. Small left pleural effusion. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: DO DICTATED DATE AND TIME: 10/28/2022 12:35 PM CDT Functional Status* Visual impairment (Right sided blindness) Mental Status* Normal Cognition Social History tobacco use Never Smoked, Smoking Cessation Not Applicable alcohol use No Known Use drug use No Known Use marital status Married general comment Lives at home with husband, uses cane to walk Health Concerns Sick sinus syndrome Urinary tract infectious disease Disorder of kidney due to diabetes mellitus Chronic kidney disease stage 4 Hypertensive urgency Father Deceased Myocardial infarction @ 55 Mother Deceased Cerebrovascular accident @ 50 Tobacco Cessation* Non-Smoker, Non Tobacco product user Vital Signs Nov-07-2022 0628 T 97.2 HR 60 RR 18 BP 152 / 64 O2Sat 96 Nov-07-2022 0320 T 97.9 HR 60 RR 20 BP 153 / 66 O2Sat 99 PHYSICAL EXAM CONSTITUTIONAL: Patient appears comfortable and in no acute distress. She is bedside with her husband. CARDIOVASCULAR: Heart has regular rate rhythm, pulses are 2/2 in the upper extremities, no edema noted RESPIRATORY: Lungs clear to auscultation throughout and respiratory effort is non-labored GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive NEUROLOGICAL: Patient is alert and generally oriented. Sensation is grossly intact PSYCHIATRIC: Patient's mood is tearful with stress of chronic conditions, affect is appropriate. RASS of 0. Consultations Dr., Cardiology Tele - Nephrology Tele - Neurology Hospital Course Patient is a 71 year old female who presented to the ED with nausea, vomiting and diarrhea. She was admitted to the ICU for hypertensive urgency and was found to be COVID positive. She exhibited left facial droop and a code stroke called on 10/29/22. CT head and CTA head/neck ruled out acute intracranial pathology. Teleneurology consulted. MRI 11/3/22 negative for acute findings. Due to an indwelling pacemaker, patient required a cardiology consult to reprogram the pacemaker for MRI mode then reprogram, which was performed successfully. Telenephrology was consulted in the setting of resistant hypertension and persistent elevation of creatine and azotemia. Blood pressure remained high throughout patient's stay. Multiple medications were trialed. Management was difficult in setting of kidney injury. A renal ultrasound and urine metanephrines were sent to rule out possible secondary cause. Renal ultrasound showed some cortical thickening but no other abnormalities. Of note, patient had a renal biopsy on the 1st of August which was complicated by hematoma and 2 week hospital stay. Results of the biopsy showed diabetic nephropathy. Urine metanephrines are pending at time of writing. Blood pressure stabilized between systolic 130 and 170, and patient was deemed stable to transfer to Nursing Home with close follow up as detailed below. Our goal is that patient rehabilitate to home. Condition at Discharge Stable Discharge Medications ACETAMINOPHEN 650 MG ORALLY EVERY 4 HOURS AS NEEDED for FEVER OR MILD PAIN 1-3 ON PS amLODIPine BESYLATE 5 MG ORALLY DAILY AT BEDTIME (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) ASPIRIN LOW DOSE 81 MG ORALLY ONCE A DAY ATORVASTATIN CALCIUM 80 MG ORALLY DAILY AT BEDTIME (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) Carvedilol Oral Tablet 6.25 MG 6.25 MG ORALLY TWICE DAILY WITH MEALS CIPROFLOXACIN HCL 500 MG ORALLY ONCE A DAY clonazepam 1 mg tab 1 MG ORALLY DAILY AT BEDTIME cloNIDine HCL 0.2 MG/24HR 0.2 MG TRANSDERMAL EVERY WEEK (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) diltiazem HCl 180 mg Tb24 180 MG ORALLY ONCE A DAY Eliquis Oral Tablet 5 MG 2.5 MG ORALLY TWICE DAILY FLUTICASONE PROPIONATE NASAL 50 MCG / SPRAY 2 SPR NASAL ONCE A DAY Glimepiride Oral Tablet 1 MG 1 MG ORALLY ONCE A DAY hydrALAZINE 50 MG ORALLY 3 TIMES A DAY (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) Isosorbide Mononitrate ER Oral Tablet Extended Release 24 Hour 60 MG 60 MG ORALLY ONCE A DAY LOSARTAN POTASSIUM 25 MG ORALLY EVERY DAY BLOOD PRESSURE (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) NYSTATIN TOPICAL 15 GM 1 APP TOPICAL TWICE DAILY POLYETHYLENE GLYCOL 17 GM ORALLY ONCE A DAY AS NEEDED for CONSTIPATION Sodium Bicarbonate Oral Tablet 650 MG 650 MG ORALLY TWICE DAILY SPIRONOLACTONE 25 MG ORALLY ONCE A DAY (ePrescribed by SAMUELSON OLAF RESIDENT on Nov-07-2022 1014) vit c 500 mg TID 500 MG ORALLY ONCE A DAY vit D3 1000 mg daily Continue taking same as home vit E 450 mg daily Continue taking same as home Discharge Disposition Transfer to skilled nursing facility Plan Assessments: -Suspected transient ischemic attack, likely right MCA, MRI 11/2/22 shows no acute findings -Hypertensive emergency with neurological symptoms, requiring nicardipine drip, resolved -Resistant hypertension, requiring 7 medications, likely secondary to renal disease - Enterobacter cloacae urinary tract infection, acute, stable, started on ciprofloxacin 11/2/22 -COVID-19 infection, negative antigen test 10/31/22 -Acute headache -Hypomagnesemia, resolved -Nausea and vomiting, resolved -Atrial fibrillation, paroxysmal with indwelling pacemaker, rate-controlled -Chronic anticoagulation with Eliquis, renally dosed -CKD stage 4, diabetic nephropathy per biopsy at hospital -Recent complicated renal biopsy with hematoma -Diabetes mellitus type 2 with nephropathy, unknown control -Essential hypertension, uncontrolled -Hyperlipidemia -Normocytic anemia, likely of chronic kidney disease, stable -GERD PLAN: Patient has been deemed stable to transfer to nursing home for rehabilitation to home. She will require close follow up with several providers. --Patient will need a follow up appointment with Neurology. Please fax referral and MRI, CT results and discharge note. They will call the patient to schedule a follow up. --Patient will see her Cardiologist on December 3rd. Patient will need follow up regarding the MRI mode causing fasciculations in the pectoral muscle. --Nephrology follow up: Please fax: a face sheet, Labs from inpatient, and discharge summary to. Appointment already scheduled for Wed Nov 30th 10:30 AM. --Follow up with patient's PCP will be made for within one week of hospital discharge. Patient will be started on a significant regimen of anti-hypertensives. These changes are below. SPIRONOLACTONE 25 MG ORALLY ONCE A DAY LOSARTAN POTASSIUM 25 MG ORALLY EVERY DAY hydrALAZINE 50 MG ORALLY 3 TIMES A DAY cloNIDine HCL 0.2 MG/24HR 0.2 MG TRANSDERMAL EVERY WEEK amLODIPine BESYLATE 5 MG ORALLY DAILY AT BEDTIME We would suggest hydralazine 50 for breakthrough requirements while in the nursing home, but do not believe patient is requiring these at this time. Patient's UA grew Enterobacter cloacae. For her UTI she will be given CIPROFLOXACIN HCL 500 MG ORALLY ONCE A DAY For one additional day. Last dose 11/8/22. Nephrology's recommendations have been reviewed. They suspect the creatinine to be at or approaching a new baseline, but there may be improvement as time passes from the contrast admission for her CTA. Cardiology's recommendations have been reviewed. The pacemaker was successfully restored to the settings as previous to the MRI. Neurology's recommendations have been reviewed. Patient has been increased from 20 mg to ATORVASTATIN CALCIUM 80 MG ORALLY DAILY AT BEDTIME and started on ASPIRIN LOW DOSE 81 MG ORALLY ONCE A DAY Patient requires a blood draw for: BMP, diagnosis of elevated creatinine to be completed on 11/14/22 Two to three days before discharge, patient was experiencing some constipation. Scheduled Miralax was started. Before discharge this was made 'as needed' for constipation. Patient was encouraged to ask for therapy if needed. Primary Care Provider Electronically signed by RESIDENT on Nov-07-2022 1500

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia, GERD, Anxiety, Chronic Kidney Disease, A-fib, HTN, Diabetes, Cataract
Andere Medikamente: -
Allergien: Sotalol, Metformin
Vorherige Impfungen: -

VAERS 2500499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 07.11.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cardiac arrest Chest X-ray normal Condition aggravated Cyanosis Death Dyspnoea Malaise Pulse absent Resuscitation SARS-CoV-2 test negative Unresponsive to stimuli

Symptomtext

Decedent had been suffering compromised respiratory health in June and July, with COVID symptoms but negative tests and chest X-rays. The decedent's PCP gave a clean bill of health last month, and the decedent decided to receive a second Pfizer COVID booster and flu shot from pharmacy yesterday afternoon. No ill effects during the day, and the decedent had a beer with dinner and got ready for bed at approximately 2200hrs. Soon the decedent was having increasing shortness of breath, and became cyanotic and unresponsive. 911 was called, and EMS responded, performing CPR and ACLS. Decedent was transported to ED pulseless and in cardiac arrest. 4 rounds of Epi were given, but ROSC not achieved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Irregular EKG during knee surgery last May
Vorgeschichte: History of hypertension, hyperlipidemia, obesity, shortness of breath, impaired fasting glucose.
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2500499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 07.11.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cardiac arrest Chest X-ray normal Condition aggravated Cyanosis Death Dyspnoea Malaise Pulse absent Resuscitation SARS-CoV-2 test negative Unresponsive to stimuli

Symptomtext

Decedent had been suffering compromised respiratory health in June and July, with COVID symptoms but negative tests and chest X-rays. The decedent's PCP gave a clean bill of health last month, and the decedent decided to receive a second Pfizer COVID booster and flu shot from pharmacy yesterday afternoon. No ill effects during the day, and the decedent had a beer with dinner and got ready for bed at approximately 2200hrs. Soon the decedent was having increasing shortness of breath, and became cyanotic and unresponsive. 911 was called, and EMS responded, performing CPR and ACLS. Decedent was transported to ED pulseless and in cardiac arrest. 4 rounds of Epi were given, but ROSC not achieved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Irregular EKG during knee surgery last May
Vorgeschichte: History of hypertension, hyperlipidemia, obesity, shortness of breath, impaired fasting glucose.
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2499550

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 04.11.2022
Impfdatum: 01.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Decreased appetite Dizziness Myocardial infarction

Symptomtext

light headed ness and dizziness lack of appetite

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: none taken > Heart attack month and a half later
Aktuelle Erkrankungen: shoulder and thumb pain arthritis
Vorgeschichte: -
Andere Medikamente: 5mg Zocor
Allergien: -
Vorherige Impfungen: -

VAERS 2496480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 77,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 19.01.2022
Beginn: 27.10.2022
Tage bis Beginn: 281,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anion gap Aortic arteriosclerosis Aortic stenosis Aortic valve incompetence Aspartate aminotransferase increased AST/ALT ratio Acute kidney injury Acute respiratory failure Agitation Alanine aminotransferase increased Asthenia Bacteraemia Band neutrophil percentage decreased Base excess Basophil count decreased Basophil percentage decreased Bilirubin conjugated normal Bilirubin urine

Symptomtext

Date of Service Nov-01-2022 1314 Date of Admission Admit Date: Oct-27-2022 Date of Discharge Date of discharge Nov-01-2022 Allergies No Known Allergies Chief Complaint difficulty breathing Final Diagnoses COVID-19 Bacteremia Procedure(s) Performed None Lab Results Nov-01-2022 0437 Hematology WBC 6.0RBC 2.02HGB 7.7HCT 24.3MCV 120.3MCH 38.1MCHC 31.7RDW 14.0RDWSD 61.4PLT 200MPV 11.8AUTONEU% 76.2AUTOLYM% 9.3AUTOMON% 6.8AUTOEOS% 0.0AUTOBAS% 0.2AUTONEU# 4.6AUTOLYM# 0.6AUTOMON# 0.4AUTOBAS# 0.0AUTOEOS# 0.0SCAN DIF YBAND % 6SEG % 78LYMPH % 8MONO % 6META % 2NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.45IG% 7.5 Nov-01-2022 0437 Chemistry GLUCOSE 146BUN 54CREAT 1.3MDRD GFR 53NA 140K 5.4CL 104CALCIUM 9.1ALK PHOS 59CO2 29.8AST 115ALT 164AST/ALT 0.7TL PROT 6.6ALBUMIN 2.6TBILI 0.3DBILI 0.2OSMO 296.8ANION GP 11.6BUN/CRE 41.5CRP 1.30 Oct-29-2022 0640 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-29-2022 0630 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-29-2022 0524 Chemistry HGBA1C 6.1 Oct-29-2022 0524 Serology PROCALC 0.21 Oct-28-2022 1223 Chemistry GLUCOSE 135BUN 73CREAT 2.6MDRD GFR 24NA 145K 5.7CL 109CALCIUM 8.9CO2 27.9OSMO 312.3ANION GP 13.8BUN/CRE 28.1VIT B12 1894FERRITIN 526FOL >20.0IRON 60TIBC 250% SAT 24 Oct-28-2022 1223 Blood Gas PH VEN 7.210PCO2 VEN 72.8PO2 VEN 40.0BICARB V 27.7BE VEN -0.1CO2 CT V 27.9O2 SAT V 61.4 Oct-28-2022 0500 Chemistry TROPI-HS 78LDH 397 Oct-28-2022 0024 Urinalysis Department SPECGRAV >=1.030U-PH 5.5LEUCOCYT NegativeNITRITES NegativePROTEIN TraceGLUCOSE NegativeKETONES NegativeUROBILIN 0.2BILRUBIN NegativeBLOOD NegativeCOLOR YellowCLARITY ClearMICROSCP NCULTURE N Oct-28-2022 0001 Chemistry TROPI-HS 84 Oct-27-2022 2352 Blood Gas PH 7.17PC02 77.2PO2 ART 83BICARB 26.7BE -1.9CO2 CT 26.9O2 SAT 94.2O2 THER 50TYPEABG Arterial Oct-27-2022 2226 Blood Gas PH VEN 7.14PCO2 VEN 82.8PO2 VEN 50BICARB V 27.1BE VEN -2.0CO2 CT V 27.6O2 SAT V 71.7 Oct-27-2022 1959 Chemistry CRP 7.6TROPI-HS 90 Oct-27-2022 1933 Microbiology C BLD Streptococcus salivariusC BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-27-2022 1836 Blood Gas PH VEN 7.180PCO2 VEN 81.6PO2 VEN 46.0BICARB V 29.6BE VEN 0.9CO2 CT V 29.7O2 SAT V 65.3 Oct-27-2022 1826 Serology COVID PosINFLUA NegINFLUB NegPROCALC 0.29CVD1TEST NCVDEMPHC NCVDSYMP NCVDSYMDT UCVDHOSP NCVDICU NCVDRESID NCVDPREG N Oct-27-2022 1826 Hematology WBC 15.3RBC 2.19HGB 8.3HCT 26.8MCV 122.4MCH 37.9MCHC 31.0RDW 15.2RDWSD 67.8PLT 225MPV 10.8AUTONEU% 68.1AUTOLYM% 10.9AUTOMON% 6.3AUTOEOS% 0.1AUTOBAS% 0.5AUTONEU# 10.4AUTOLYM# 1.7AUTOMON# 1.0AUTOBAS# 0.1AUTOEOS# 0.0NRBC% 0.1NRBC 0.0HGB/HCT 3.2IG# 2.15IG% 14.1 Oct-27-2022 1826 Chemistry GLUCOSE 153BUN 63CREAT 2.6MDRD GFR 24NA 141K 6.0CL 107CALCIUM 8.7ALK PHOS 80CO2 28.6AST 83ALT 56AST/ALT 1.5TL PROT 7.6ALBUMIN 3.1TBILI 0.4OSMO 302.3ANION GP 11.4BUN/CRE 24.2LACTATE 0.70PROBNP 3253TROPI-HS 105 Imaging Results Medical Center Transthoracic Echocardiogram Report Patient Name: Gender: Male Study Date: 28-Oct-2022 Height(Cm): 185 Weight(Kg): 145.10 BSA: 2.73 Ref. Physician: Quality: Good Procedures: Echocardiogram complete with 2D, M-Mode, and Doppler examination. Indications: Dyspnea. 2D/M Mode Doppler Measurement Value Normal Range Measurement Value Normal Range LVIDd (MM) 5.9 cm AV Area Vmax 2.0 cm2 LVIDs (MM) 4.1 cm AV Area VTI 2.1 cm2 IVSd (MM) 1.5 cm AV Peak PG 31.0 mmHg LVPWd (MM) 1.5 cm AV Mean PG 17.0 mmHg LA Dimen MM 5.2 cm MV E/A 0.9 LVOT Peak Vel 1.2 m/sec E/E` 14.1 Findings Left Ventricle: Normal left ventricular systolic function with LVEF >60%. Moderate left ventricular hypertrophy (measuring 1.4 - 1.7 cm). Impaired relaxation (Grade I diastolic dysfunction). Left Atrium: Moderate enlargement of the left atrium with LA index volumes between 42 48cm2. Mitral Valve: Mild mitral regurgitation. Aortic Valve: Mild aortic stenosis (AVA > 1.5 cm2). Mild aortic regurgitation. Right Ventricle: Normal right ventricular size. Normal right ventricular systolic function. Right Atrium: Mild RA enlargement (40mm - 45mm). Atrial Septum: Normal atrial septum. Tricuspid Valve: Mild tricuspid regurgitation. The estimated Peak RVSP is 28 mmHg. Pulmonic Valve: Normal pulmonic valve appearance and function with trivial (physiologic) regurgitation. IVC: Normal inferior vena cava appearance and respiratory collapse. Aorta: Aortic root size is normal. Pericardium: Small pericardial effusion. No echocardiographic evidence to suggest pericardial tamponade. Conclusions Normal left ventricular systolic function with LVEF >60%. Moderate left ventricular hypertrophy (measuring 1.4 - 1.7 cm). Impaired relaxation (Grade I diastolic dysfunction). Moderate enlargement of the left atrium with LA index volumes between 42- 48cm2. Mild mitral regurgitation. Mild aortic stenosis (AVA > 1.5 cm2). Mild aortic regurgitation. Mild tricuspid regurgitation. The estimated Peak RVSP is 28 mmHg. Small pericardial effusion. No echocardiographic evidence to suggest pericardial tamponade. Electronically Signed By: D.O. 28-Oct-2022 09:07:01 -0500 Patient Name: Study Date: 28-Oct-2022 ------------------------------ MEDICAL CENTER IMAGING REPORT Patient Name: Date of Exam: 10/27/2022 Gender: M Ordering Physician: DO Exam Description: CH-CHEST 1V DR PATIENT NAME: DATE OF BIRTH: RAD NUMBER: PHYSICIAN DO DATE OF EXAM Oct 27, 2022 7:12:43 PM CDT PROCEDURES CR - Chest 1 view HISTORY Dyspnea IV CONTRAST (if appl) Single view of the chest. COMPARISON: None FINDINGS: Cardiomegaly. Atherosclerotic thoracic aorta. Airspace opacity within the mid to lower lungs. Bronchial wall thickening. No definite pleural effusion. No pneumothorax. No acute fracture. IMPRESSION: 1. Pulmonary opacities along the lung bases bilaterally suspicious for a multifocal infection. There is likely superimposed pulmonary edema. 2. Cardiomegaly. Correlate clinically for congestive heart failure. This exam was interpreted on workstation DIAGRAD-PC7 DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/28/2022 12:53 AM CDT ------------------------------------------------------------ Functional Status* Impaired mobility, Activity of daily living - Needs assistance Mental Status* Normal Cognition Social History tobacco use Current Every Day Smoker, 2 Packs Per Day, 63 yrs, Smoking Cessation Yes alcohol use No Known Use drug use No Known Use marital status Married general comment Patient lives alone. Health Concerns Hyperkalemia COVID-19 Bacteremia Pneumonia Current Every Day Smoker, 2 Packs Per Day, 63 yrs Father Deceased Accident @ unknown age Mother Deceased @ unknown age Essential hypertension; Dyslipidemia Tobacco Cessation* Patient will receive tobacco cessation counseling at his/her post-hospital visit Vital Signs Nov-01-2022 1600 T 98.6 HR 74 RR 21 BP 131 / 55 O2Sat 94 O2L 4 Nov-01-2022 0456 WGT 301.8 on 4 L via nasal cannula PHYSICAL EXAM CONSTITUTIONAL: Patient appears comfortable and in no acute distress. ORAL: CARDIOVASCULAR: Heart has regular rate and rhythm, pulses are 2/2 in the upper extremities, no edema noted. RESPIRATORY: Lung sounds diminished in the lower lobes. No wheezing. Respiratory effort is non-labored. Seen wearing NC. GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. NEUROLOGICAL: Patient is alert and generally oriented. Sensation is grossly intact. PSYCHIATRIC: Patient's mood is euthymic, affect is appropriate. RASS of 0. Hospital Course The patient is a 70-year-old male presented to the emergency room 10/27/2022 with complaints of shortness of breath for week. The patient is evaluated and then admitted to the Medical inpatient service for sepsis and acute on chronic respiratory failure. The patient's other acute diagnoses included acute exacerbation of COPD, COVID with possible secondary bacterial, AKI on CKD, hyperkalemia, and elevated troponins on admission. Patient's troponins and renal function improved with fluids as his sepsis resolved, likely secondary to poor perfusion. His COVID was treated with steroids, Remdesivir, and Actemra. He was given ceftriaxone and azithromycin for his superimposed bacterial pneumonia and possible bacteremia. 2/4 bottles of the sample lab draw grew S. salivarius which is likely contaminant. Repeat blood cultures were negative. However, given patient's presentation and sickness, and through shared decision making, it was decided to complete the 14 day course of treatment for bacteremia and will discharge him on cefdinir 300mg BID for 9 days. Patient's hyperkalemia was treated with kayexelate, Lasix, and insulin with dextrose. His COPD exacerbation was treated with BIPAP, breathing treatments, steroids, and antibiotics as described above under pneumonia. Patient will be discharged on a steroid taper, see discharge medications. During his stay, patient developed delirium. He got up when he was weak, tried to pull his lines, and was agitated. Given his illness and weakness, his delirium was controlled with precedex titration in addition to reorienting patient to surroundings and self. It was likely secondary to his hospital stay, being confined to the hospital room, and having lines. His agitation improved as lines were discontinued. On the day of discharge, patient was not confused nor agitated. We anticipate that with return to his home environment, his behaviors will resolve and do not feel he requires medication on discharge. This was discussed with the patient and family and they also agreed and did not want to try Seroquel on discharge. Condition at Discharge Stable Discharge Medications Albuterol Sulfate HFA Inhalation Aerosol Solution 108 (90 Base) MCG/ACT 2 PUF INHALATION EVERY 4 HOURS AS NEEDED for SHORTNESS OF BREATH Allopurinol Oral Tablet 100 MG 100 MG ORALLY ONCE A DAY Arformoterol Tartrate Inhalation Nebulization Solution 15 MCG/2ML 1 VL NEBULIZED INHALATION TWICE DAILY Budesonide Inhalation Suspension 0.5 MG/2ML 1 VL NEBULIZED INHALATION TWICE DAILY Carvedilol Phosphate ER Oral Capsule Extended Release 24 Hour 20 MG 20 MG ORALLY ONCE A DAY Cefdinir Oral Capsule 300 MG 300 MG ORALLY TWICE DAILY (ePrescribed by RESIDENT on Nov-01-2022 1620) Ezetimibe-Simvastatin Oral Tablet 10-40 MG 1 TAB ORALLY ONCE A DAY HYDROcodone-Acetaminophen Oral Tablet 5-325 MG Continue taking same as home Olmesartan Medoxomil-HCTZ Oral Tablet 40-12.5 MG 1 TAB ORALLY ONCE A DAY predniSONE Oral Tablet 10 MG 10 MG ORALLY ONCE A DAY (ePrescribed by RESIDENT on Nov-01-2022 1620) predniSONE Oral Tablet 20 MG 20 MG ORALLY ONCE A DAY (ePrescribed by RESIDENT on Nov-01-2022 1620) predniSONE Oral Tablet 20 MG 40 MG ORALLY ONCE A DAY (ePrescribed by RESIDENT on Nov-01-2022 1620) predniSONE Oral Tablet 5 MG 5 MG ORALLY ONCE A DAY (ePrescribed by RESIDENT on Nov-01-2022 1620) Spiriva HandiHaler Inhalation Capsule 18 MCG 1 CAP INHALATION ONCE A DAY traMADol HCl Oral Tablet 50 MG Continue taking same as home Discharge Disposition Discharge to home with home health Plan Assessment: -Sepsis (tachypnea, leukocytosis) secondary to COVID-19, present on admission, resolved -Acute on chronic hypoxic and hypercapnic respiratory failure secondary to COVID-19 pneumonia, acute exacerbation resolved -Acute exacerbation of COPD secondary to COVID-19 pneumonia, improved -secondary bacterial pneumonia, community-acquired covered under ceftriaxone and azithromycin. - bacteremia versus contaminant, 2/4 bottles ( both from the same draw) positive for Streptococcus salivarius -Heart failure with preserved ejection fraction, grade I diastolic dysfunction, possible acute decompensation, improved -ICU delirium vs other altered mental status -Obstructive sleep apnea, BiPAP compliant at home, may have some component of obesity hypoventilation syndrome -Acute kidney injury in the setting of CKD, Cr 2.6, secondary to sepsis; Cr 1.8 in August 2022, resolved AKI -Hyperkalemia, moderate, potassium 6.0 on admission, secondary to AKI, resolved -Hypernatremia, mild, sodium 146 on 10/29/2022, likely due to fluid replacement within NS, resolved -Elevated troponin, likely type 2 MI secondary to sepsis/respiratory failure and AKI, improved -Essential hypertension, Chronic, unknown control -Type 2 diabetes mellitus, chronic, unknown control -Obesity class III, BMI 42 -Tobacco abuse disorder PLAN: The patient was deemed stable and ready for discharge. The patient is currently saturating well on 4L NC, his baseline is 5L, at rest. Reasonable to titrate the patient off Precedex and deescalate his status from ICU to PCU. His agitation was noted to be most associated with the being constrained in his room, lines, and being in the hospital. We re-evaluated the patient throughout the day and he remained calm and alert, without any agitation or confusion. Patient has showed no sign of being a danger to himself or others. We believe remaining agitation resolved once back in his home environment. We offered to discharge patient on Seroquel but patient and son declined. We recommended they have close follow up with PCP Dr. to ensure the he remains stable at home. For treatment of pneumonia with possible concurrent bacteremia, we discharged the patient on cefdinir 300mg BID for 9 days to complete his course of ceftriaxone and azithromycin started while hospitalized. Patient received methylprednisolone in the treatment of AECOPD/COVID. To ensure the patient does not suffer side effects upon discontinuing said IV steroids, we have discharged the patient on a prednisone taper described above in discharge medications. The taper was communicated to patient and family. We recommend the patient follow-up closely with PCP to monitor his acute illness and ICU associated delirium. We recommend a repeat BMP in 1 week to reassess hyperkalemia. We recommend patient completes his antibiotics. The patient was seen and evaluated by attending Dr., and the plan of care discussed with this resident. DO Family Medicine, PGY-2 Discharge Instructions Diet cardiac carb consistent Activity activity as tolerated Follow up Appointments follow-up with PCP within the next 7 days Primary Care Provider DO DO Electronically signed by PGY-1 on Nov-01-2022 2116 I have seen and physically examined the patient on [11-1-22] and agree with the documentation of [name of the resident]. I have also discussed my findings and plan of care with [name of the resident]. Any changes and additional information are listed below. Electronically signed by MD MD on Nov-02-2022 0838

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Gout Anemia Sleep Apnea Chronic kidney disease stage 3 Essential Hypertension COPD Type 2 Diabetes
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2162865

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 16.12.2021
Beginn: 21.10.2022
Tage bis Beginn: 309,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure Chronic obstructive pulmonary disease Condition aggravated Dysphagia Dyspnoea Malaise Oesophageal stenosis Pneumonia SARS-CoV-2 test positive Oesophagogastroduodenoscopy abnormal Pneumothorax Respiratory failure

Symptomtext

"Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and symptoms. Provider d/c note: ""73 YO female with chronic O2 dependence presented with dyspnea, admitted with acute on chronic hypoxic respiratory failure as well as recurrent dysphagia related to esophageal stricture. Treated for covid pneumonia as well as HAP and COPD with improvement to home O2. EGD performed, showing worsened esophageal stricture. She is tolerating full liquids and purees, and will not advance diet until GI follow-up. Problem list: Acute on chronic respiratory failure with hypoxia, resolved -Covid, possible HAP, COPD, lung adenocarcinoma with right middle lobe collapse -LABA/ICS, albuterol -on home 4L COVID pneumonia, resolved -remdesivir complete, dexamethasone complete Recurrent esophageal dysphagia - radiation vs malignancy? -Discussed with GI and SLP, pureed diet -trial carafate solution -Discussed need for follow-up EGD in a few weeks, eval for malignancy -Discussed potential for surgical gastrostomy if stricture worsens Chronic heart failure with preserved ejection fraction -home furosemide -carvedilol """

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: COVID Detected PCR on 10/21/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Pulmonary hypertension (HCC) Essential hypertension Digestive Mid-esophageal stricture Dysphagia Respiratory Primary lung adenocarcinoma right upper lobe status post chemoradiation COPD (chronic obstructive pulmonary disease) Chronic respiratory failure with hypoxia and hypercapnia Malignant neoplasm of overlapping sites of left lung (HCC) Atelectasis Other Current smoker Normocytic anemia
Andere Medikamente: -
Allergien: Zithromax
Vorherige Impfungen: -

VAERS 2162865

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 16.12.2021
Beginn: 21.10.2022
Tage bis Beginn: 309,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure Chronic obstructive pulmonary disease Condition aggravated Dysphagia Dyspnoea Malaise Oesophageal stenosis Pneumonia SARS-CoV-2 test positive Oesophagogastroduodenoscopy abnormal Pneumothorax Respiratory failure

Symptomtext

"Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and symptoms. Provider d/c note: ""73 YO female with chronic O2 dependence presented with dyspnea, admitted with acute on chronic hypoxic respiratory failure as well as recurrent dysphagia related to esophageal stricture. Treated for covid pneumonia as well as HAP and COPD with improvement to home O2. EGD performed, showing worsened esophageal stricture. She is tolerating full liquids and purees, and will not advance diet until GI follow-up. Problem list: Acute on chronic respiratory failure with hypoxia, resolved -Covid, possible HAP, COPD, lung adenocarcinoma with right middle lobe collapse -LABA/ICS, albuterol -on home 4L COVID pneumonia, resolved -remdesivir complete, dexamethasone complete Recurrent esophageal dysphagia - radiation vs malignancy? -Discussed with GI and SLP, pureed diet -trial carafate solution -Discussed need for follow-up EGD in a few weeks, eval for malignancy -Discussed potential for surgical gastrostomy if stricture worsens Chronic heart failure with preserved ejection fraction -home furosemide -carvedilol """

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: COVID Detected PCR on 10/21/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Pulmonary hypertension (HCC) Essential hypertension Digestive Mid-esophageal stricture Dysphagia Respiratory Primary lung adenocarcinoma right upper lobe status post chemoradiation COPD (chronic obstructive pulmonary disease) Chronic respiratory failure with hypoxia and hypercapnia Malignant neoplasm of overlapping sites of left lung (HCC) Atelectasis Other Current smoker Normocytic anemia
Andere Medikamente: -
Allergien: Zithromax
Vorherige Impfungen: -

VAERS 2162865

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 16.12.2021
Beginn: 21.10.2022
Tage bis Beginn: 309,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure Chronic obstructive pulmonary disease Condition aggravated Dysphagia Dyspnoea Malaise Oesophageal stenosis Pneumonia SARS-CoV-2 test positive Oesophagogastroduodenoscopy abnormal Pneumothorax Respiratory failure

Symptomtext

"Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and symptoms. Provider d/c note: ""73 YO female with chronic O2 dependence presented with dyspnea, admitted with acute on chronic hypoxic respiratory failure as well as recurrent dysphagia related to esophageal stricture. Treated for covid pneumonia as well as HAP and COPD with improvement to home O2. EGD performed, showing worsened esophageal stricture. She is tolerating full liquids and purees, and will not advance diet until GI follow-up. Problem list: Acute on chronic respiratory failure with hypoxia, resolved -Covid, possible HAP, COPD, lung adenocarcinoma with right middle lobe collapse -LABA/ICS, albuterol -on home 4L COVID pneumonia, resolved -remdesivir complete, dexamethasone complete Recurrent esophageal dysphagia - radiation vs malignancy? -Discussed with GI and SLP, pureed diet -trial carafate solution -Discussed need for follow-up EGD in a few weeks, eval for malignancy -Discussed potential for surgical gastrostomy if stricture worsens Chronic heart failure with preserved ejection fraction -home furosemide -carvedilol """

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: COVID Detected PCR on 10/21/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Pulmonary hypertension (HCC) Essential hypertension Digestive Mid-esophageal stricture Dysphagia Respiratory Primary lung adenocarcinoma right upper lobe status post chemoradiation COPD (chronic obstructive pulmonary disease) Chronic respiratory failure with hypoxia and hypercapnia Malignant neoplasm of overlapping sites of left lung (HCC) Atelectasis Other Current smoker Normocytic anemia
Andere Medikamente: -
Allergien: Zithromax
Vorherige Impfungen: -

VAERS 2487228

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 91,0
Geschlecht: M
Eingang: 24.10.2022
Impfdatum: 04.04.2022
Beginn: 20.10.2022
Tage bis Beginn: 199,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aortic arteriosclerosis Aortic stenosis Arteriosclerosis Arteriosclerosis coronary artery Aspartate aminotransferase normal AST/ALT ratio abnormal Acute respiratory failure Alanine aminotransferase normal Anion gap Anticoagulant therapy Asthenia Atrial fibrillation Bacterial test positive Basophil count decreased Basophil percentage decreased Benign prostatic hyperplasia Bilirubin urine Bladder catheterisation

Symptomtext

Date of Service Oct-24-2022 1038 Date of Admission Admit Date: Oct-20-2022 Date of Discharge Date of discharge Oct-24-2022 Allergies Codeine - Not Specified Chief Complaint general weakness Procedure(s) Performed None Lab Results Oct-24-2022 0430 Serology PROCALC 0.48 Oct-24-2022 0430 Hematology WBC 6.2RBC 3.26HGB 9.2HCT 28.5MCV 87.4MCH 28.2MCHC 32.3RDW 14.9RDWSD 47.9PLT 247MPV 9.4AUTONEU% 65.3AUTOLYM% 18.6AUTOMON% 12.1AUTOEOS% 3.4AUTOBAS% 0.3AUTONEU# 4.0AUTOLYM# 1.2AUTOMON# 0.8AUTOBAS# 0.0AUTOEOS# 0.2NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.02IG% 0.3 Oct-24-2022 0430 Chemistry GLUCOSE 101BUN 12CREAT 1.3MDRD GFR 52NA 138K 3.6CL 107CALCIUM 8.0CO2 23.3OSMO 275.6ANION GP 11.3BUN/CRE 9.2CRP 3.30MAGNESIU 1.7 Oct-21-2022 0830 Microbiology C SPUT Normal oral flora present Oct-21-2022 0522 Microbiology MRSA No methicillin resistant staphylococcus aureus isolated after one night incubation. Oct-20-2022 2045 Serology PROCALC 2.66 Oct-20-2022 2045 Chemistry LACTATE 1.40 Oct-20-2022 1925 Urinalysis Department SPECGRAV 1.015U-PH 6.0LEUCOCYT ModerateNITRITES NegativePROTEIN NegativeGLUCOSE NegativeKETONES NegativeUROBILIN 0.2BILRUBIN NegativeBLOOD SmallCOLOR Lt. YellowCLARITY ClearMICROSCP YCULTURE YWBC *10-15RBC *0-2SQUAM EP NoneBACTERIA *TraceMUCUS NoneOTHER Yeast Oct-20-2022 1925 Microbiology C UR After two nights of incubation Oct-20-2022 1835 Serology COVID PosINFLUA NegINFLUB NegCVD1TEST NCVDEMPHC NCVDSYMP NCVDSYMDT UCVDHOSP NCVDICU NCVDRESID YCVDPREG N Oct-20-2022 1600 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-20-2022 1513 Hematology WBC 16.1RBC 4.07HGB 11.8HCT 35.8MCV 88.0MCH 29.0MCHC 33.0RDW 15.1RDWSD 48.4PLT 282MPV 10.3AUTONEU% 85.5AUTOLYM% 5.9AUTOMON% 8.0AUTOEOS% 0.0AUTOBAS% 0.1AUTONEU# 13.8AUTOLYM# 1.0AUTOMON# 1.3AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.0IG# 0.08IG% 0.5 Oct-20-2022 1513 Chemistry GLUCOSE 114BUN 20CREAT 1.7MDRD GFR 38NA 136K 4.6CL 101CALCIUM 8.4ALK PHOS 112CO2 24.2AST 25ALT 23AST/ALT 1.1TL PROT 6.5ALBUMIN 2.8TBILI 0.7OSMO 275.4ANION GP 15.4BUN/CRE 11.8CRP 3.10TROPI-HS 56 Oct-20-2022 1513 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Imaging Results xray Single view of the chest.Date of Exam: 10/20/2022. COMPARISON: 09/29/2022. FINDINGS: Severe left and mild-moderate right lung consolidation most consistent with multifocal pneumonia. Recommend radiographic follow-up to complete resolution. Heart size is within normal limits. No pulmonary edema. No pneumothorax. Aortic atherosclerosis. IMPRESSION: Severe left and mild-moderate right lung consolidation most consistent with multifocal pneumonia. Recommend radiographic follow-up to complete resolution. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD CT Chest without contrast. Date of Exam: 10/21/2022. COMPARISON: Chest CT 11/08/2021. FINDINGS: Lungs: Moderate left upper and left lower lobe consolidation with multiple new nodular opacities. Mild bilateral bronchial wall thickening. Small right lung base pulmonary opacities. Findings are consistent with multifocal pneumonia. Recommend 3-month chest CT follow-up to ensure no new pulmonary nodules have developed since prior exam. No pulmonary edema. Small calcified pulmonary granulomas. The evaluation for possible noncalcified pulmonary nodules is severely limited by pneumonia. Pleural space: Small bilateral pleural effusions. No pneumothorax. Heart: Severe coronary artery calcifications. No pericardial effusion. Heart size within normal limits. Mediastinum: Esophagus is mildly distended. Debris and fluid within the majority of the thoracic esophagus. Differential considerations include esophageal dysmotility, gastroesophageal junction stenosis, or gastroesophageal reflux. No pneumomediastinum. Bones/joints: Mildly displaced subacute sternal body fracture is new since 2021. Multiple subacute healing nondisplaced bilateral anterior rib fractures. No acute fractures. Soft tissues: Stable bilateral gynecomastia Vasculature: Atherosclerosis. Thoracic aorta is normal in caliber. No thoracic aortic aneurysm. Lymph nodes: Calcified mediastinal and hilar lymph nodes. No pathologically enlarged noncalcified lymph nodes. Liver: Indeterminate superior right lobe liver hypoattenuation lesion measuring 2.5 cm has decreased in size since prior exam. Calcified liver granulomas. Spleen: Calcified splenic granulomas. Kidneys and ureters: Right renal cyst. IMPRESSION: 1. Moderate left upper and left lower lobe consolidation with multiple new nodular opacities. Mild bilateral bronchial wall thickening. Small right lung base pulmonary opacities. Findings are consistent with multifocal pneumonia. Recommend 3-month chest CT follow-up to ensure no new pulmonary nodules have developed since prior exam. 2. Small bilateral pleural effusions. 3. Esophagus is mildly distended. Debris and fluid within the thoracic esophagus. Differential considerations include esophageal dysmotility, gastroesophageal junction stenosis, or gastroesophageal reflux. 4. Severe coronary artery calcifications. 5. Indeterminate superior right lobe liver hypoattenuation lesion measuring 2.5 cm has decreased in size since prior exam. 6. Stable bilateral gynecomastia. 7. Mildly displaced subacute sternal body fracture is new since 2021. Multiple subacute healing nondisplaced bilateral anterior rib fractures. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD Echo complete no dye, 10/21/2022 Findings Left Ventricle: Normal left ventricular systolic function with LVEF >60%. Impaired relaxation (Grade I diastolic dysfunction). Left Atrium: Mild left atrial enlargement which is consistent with LA index volumes between 35 - 41 cm2. Mitral Valve: Mild mitral regurgitation. Aortic Valve: Mild aortic stenosis (AVA > 1.5 cm2). Right Ventricle: Normal right ventricular systolic function. Mild enlargement of right ventricle. Right Atrium: Severely enlarged RA that measures > 50mm. Atrial Septum: Normal atrial septum. Tricuspid Valve: Moderate tricuspid regurgitation. The estimated Peak RVSP is 52 mmHg. Pulmonic Valve: Normal pulmonic valve appearance and function with trivial (physiologic) regurgitation. IVC: Dilated inferior vena cava with respiratory collapse only with sniff. Aorta: Aortic root size is normal. Pericardium: Normal pericardium with no significant pericardial effusion. Conclusions Normal left ventricular systolic function with LVEF >60%. Impaired relaxation (Grade I diastolic dysfunction). Mild left atrial enlargement which is consistent with LA index volumes between 35 - 41 cm2. Mild mitral regurgitation. Mild aortic stenosis (AVA > 1.5 cm2). Moderate tricuspid regurgitation. The estimated Peak RVSP is 52 mmHg. Electronically Signed By: D.O. Chest x-ray, 10/23/2022 FINDINGS: Stable bilateral pulmonary opacities consistent with multifocal pneumonia. Stable heart size which is mildly enlarged. No pneumothorax. Stable small left pleural effusion. IMPRESSION: Stable chest. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD Functional Status* Activity of daily living - Needs assistance (resident of pines SNF) Mental Status* Normal Cognition Social History tobacco use Never Smoked, Smoking Cessation Not Applicable marital status Widowed Wife passed away October 2019 Health Concerns Insomnia Gastroesophageal reflux disease Paroxysmal atrial fibrillation HTN (hypertension) Anxiety Hyperlipidemia Pneumonia Sepsis Tobacco Cessation* Non-Smoker, Non Tobacco product user Vital Signs Oct-24-2022 0810 T 96.9 HR 98 RR 23 BP 126 / 77 O2Sat 95 Oct-24-2022 0400 HR 72 RR 22 BP 105 / 55 O2Sat 96 Oct-24-2022 0351 T 97.8 PHYSICAL EXAM CONSTITUTIONAL: Patient appears comfortable and in no acute distress. CARDIOVASCULAR: atrial fibrillation rate controlled, HR 72, auscultation reveals irregularly irregular without murmur or accessory sounds. pulses are 2/2 in the upper extremities, no edema noted RESPIRATORY: Lungs clear to auscultation throughout and respiratory effort is non-labored. poor excursion, breaths shallow but normal rate GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive NEUROLOGICAL: Patient is alert and generally oriented. Sensation is grossly intact PSYCHIATRIC: Patient's mood is euthymic, affect is appropriate. RASS of 0. Hospital Course Patient is a 91 yr old male who presented to the ED from Nursing home today for general weakness. PMH includes anemia, BPH, chronic urinary retention, indwelling urinary catheter, hyperlipidemia, hypertension, BPH, history of cardiac arrest 2 months ago, and history of TIA. The patient was diagnosed with COVID-19 on 10/08/2022 prior to admission. The patient was originally admitted to the Nursing Home for rehabilitation to home following an MI and cardiac arrest 2 months ago. The patient was found to have left lobar pneumonia with with possible patchy infiltrate superimposed, patient has community-acquired pneumonia and patchy infiltrate is either evidence of recent COVID or continued active COVID. He was treated as active COVID while hospitalized. The patient was originally treated with 3 days of Zosyn and is being discharged with 2 days of Augmentin and doxycycline, sputum cultures were negative we are treating based on empiric guidelines. The patient's hospital stay was significant for acute respiratory failure, received supplemental oxygen for 3 days. A yeast urinary tract infection indwelling catheter associated, which is being treated for urinary tract infection. The patient had persistent low magnesium likely due to low dietary intake and PPI use this was replaced via IV magnesium. The patient continued to improve throughout his hospital stay and the patient was deemed ready to be discharged today to the Nursing Home. Condition at Discharge Stable Discharge Medications Acetaminophen Oral Tablet 325 MG 650 MG ORALLY EVERY 4 HOURS AS NEEDED for MILD PAIN (1-3 ON PAIN SCALE) Amoxicillin-Pot Clavulanate Oral Tablet 875-125 MG 1 TAB ORALLY TWICE DAILY (Printed by DO on Oct-24-2022 1023) Breo Ellipta Inhalation Aerosol Powder Breath Activated 100-25 MCG/ACT 100 MCG INHALATION ONCE A DAY Doxycycline Hyclate Oral Capsule 100 MG 100 MG ORALLY TWICE DAILY (Printed by DO on Oct-24-2022 1023) Eliquis Oral Tablet 2.5 MG 0.5 MG ORALLY TWICE DAILY Famotidine Oral Tablet 20 MG 20 MG ORALLY DAILY AT BEDTIME FLUCONAZOLE 150 MG ORALLY ONCE A DAY (Printed by DO on Oct-24-2022 1023) guaiFENesin AC Oral Syrup 100-10 MG/5ML 100 MG ORALLY EVERY 4 HOURS AS NEEDED for COUGH Lidocaine External Patch 4 % 1 PAT TRANSDERMAL TWICE A DAY AS NEEDED for MODERATE-SEVERE (PAIN 6-10) Melatonin Oral Capsule 3 MG 3 MG ORALLY DAILY AT BEDTIME Metoprolol Tartrate Oral Tablet 25 MG 12.5 MG ORALLY TWICE DAILY Milk of Magnesia Oral Suspension 400 MG/5ML 400 MG ORALLY EVERY 24 HOURS AS NEEDED for CONSTIPATION Mylanta Maximum Strength Oral Suspension 400-400-40 MG/5ML 30 ML ORALLY EVERY 4 HOURS AS NEEDED for CONSTIPATION Nitroglycerin Sublingual Tablet Sublingual 0.4 MG 0.4 MG ORALLY EVERY 5 MINUTES AS NEEDED for CHEST PAIN Omeprazole Oral Capsule Delayed Release 20 MG 20 MG ORALLY ONCE A DAY oxyCODONE HCl Oral Capsule 5 MG 2.5 MG ORALLY TWICE A DAY AS NEEDED for MODERATE-SEVERE (PAIN 6-10) Sennosides-Docusate Sodium Oral Tablet 8.6-50 MG 8.6 MG ORALLY TWICE A DAY AS NEEDED for CONSTIPATION Tamsulosin HCl Oral Capsule 0.4 MG 0.4 MG ORALLY ONCE A DAY traZODone HCl Oral Tablet 50 MG 50 MG ORALLY DAILY AT BEDTIME Discharge Disposition Transfer to skilled nursing facility (SNF) Plan FINAL DIAGNOSES: - Community-acquired bacterial pneumonia, left lower lobe, with COVID-19 infection tested positive on 10/08/22, improved - Urinary tract infection, secondary to candida, moderate leukocytes and trace bacteria on admission, improved - Hypoalbuminemia, chronic, stable at 2.3 on 10/23, likely secondary to poor oral intake - Elevated CRP, secondary to pneumonia vs UTI, improved - Normocytic anemia, chronic, persistent - Hypomagnesemia, acute, new, Mg 1.7 persistent - Benign prostatic hyperplasia, chronic, with outflow obstruction - Chronic Urinary Retention, secondary to BPH - Personal use of chronic indwelling Foley, secondary to chronic urinary retention - Atrial fibrillation persistent, chronic, rate controlled with metoprolol, not rhythm controlled chronic - Chronic kidney disease, stable, stage 3b, Cr 1.7, GFR 38 on admission (10/20/2022), Cr 1.5, GFR 44 on 10/23 - History of sudden cardia arrest 2 months ago - History of TIA, no residual effects - Sepsis acute, secondary to COVID pneumonia vs UTI, Resolved, HR>90, RR>20, WBC>12 on admission (10/20/2022), HR 87, RR 24, WBC 11.3 on 10/21/2022 Plan: The patient was deemed stable and ready for discharge to the Nursing Home, were patient is a long-term resident. We are discharging the patient on amoxicillin clavulanic acid 875 p.o. b.i.d. and doxycycline 100 mg p.o. b.i.d. for 2 days to finish out a 5 day course of treatment for his community-acquired pneumonia. The patient received 3 days of Zosyn while hospitalized. COVID-19 is likely a secondary infection but not the primary source of his pneumonia. Patient is being discharged with 13 days of fluconazole for yeast UTI associated with his indwelling Foley. I called Nursing Home today to confirm that the patient does require indwelling Foley for the diagnosis of urinary retention and those were added to his assessment last. patient is being discharged with a Foley that was placed while he was hospitalized. We are continuing all other home medications without alteration. Follow-up will be done within 7 days by Dr. at the nursing home. The patient was seen by attending Dr. and the plan of care discussed with this resident. Primary Care Provider DO Electronically signed by DO on Oct-24-2022 1116

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: anemia hyperlipidemia hypertension bph cardiac arrest 2 months ago TIA
Andere Medikamente: -
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2480628

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 83,0
Geschlecht: M
Eingang: 17.10.2022
Impfdatum: 05.11.2021
Beginn: 15.10.2022
Tage bis Beginn: 344,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aspartate aminotransferase increased Asthenia Atelectasis Basophil count normal Basophil percentage AST/ALT ratio abnormal Alanine aminotransferase normal Anion gap Arteriosclerosis Arthralgia Blood albumin decreased Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine increased Blood culture negative Blood glucose decreased

Symptomtext

Date of Service Oct-17-2022 1049 Date of Admission Admit Date: Oct-15-2022 Date of Discharge Date of discharge Oct-17-2022 @ 1351 Allergies Oxycodone HCl - Not Specified Chief Complaint Weakness Final Diagnoses Acute COVID-19 Falls Muscle weakness Dehydration Procedure(s) Performed None Lab Results Oct-17-2022 1110 Point Of Care GLUSTX 64 Oct-17-2022 0745 Hematology WBC 5.5RBC 3.77HGB 12.9HCT 37.6MCV 99.7MCH 34.2MCHC 34.3RDW 13.5RDWSD 49.5PLT 219MPV 9.5AUTONEU% 43.8AUTOLYM% 31.8AUTOMON% 16.5AUTOEOS% 6.5AUTOBAS% 0.9AUTONEU# 2.4AUTOLYM# 1.8AUTOMON# 0.9AUTOBAS# 0.1AUTOEOS# 0.4NRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.03IG% 0.5 Oct-17-2022 0745 Chemistry GLUCOSE 150BUN 27CREAT 1.6MDRD GFR 41NA 137K 4.1CL 104CALCIUM 8.5CO2 26.2OSMO 281.8ANION GP 10.9BUN/CRE 16.9HGBA1C 6.1MEAN GLU 140 Oct-17-2022 0553 Point Of Care GLUSTX 106 Oct-16-2022 1928 Point Of Care GLUSTX 97 Oct-16-2022 1625 Point Of Care GLUSTX 87 Oct-16-2022 1122 Point Of Care GLUSTX 112 Oct-16-2022 0543 Hematology WBC 6.9RBC 3.32HGB 11.3HCT 34.7MCV 104.5MCH 34.0MCHC 32.6RDW 13.6RDWSD 51.8PLT 181MPV 9.5AUTONEU% 44.7AUTOLYM% 29.5AUTOMON% 20.7AUTOEOS% 3.5AUTOBAS% 0.9AUTONEU# 3.1AUTOLYM# 2.0AUTOMON# 1.4AUTOBAS# 0.1AUTOEOS# 0.2NRBC% 0.0NRBC 0.0IG# 0.05IG% 0.7 Oct-16-2022 0543 Chemistry GLUCOSE 98BUN 27CREAT 1.7MDRD GFR 39NA 139K 4.2CL 106CALCIUM 8.1CO2 22.5OSMO 282.6ANION GP 14.7BUN/CRE 15.9VIT B12 238FOL 15.7 Oct-16-2022 0516 Point Of Care GLUSTX 91 Oct-15-2022 2020 Point Of Care GLUSTX 172 Oct-15-2022 1335 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-15-2022 1317 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Oct-15-2022 1317 Hematology WBC 9.9RBC 3.56HGB 11.9HCT 35.2MCV 98.9MCH 33.4MCHC 33.8RDW 13.4RDWSD 48.5PLT 220MPV 9.5AUTONEU% 70.3AUTOLYM% 11.1AUTOMON% 16.4AUTOEOS% 0.9AUTOBAS% 0.6AUTONEU# 7.0AUTOLYM# 1.1AUTOMON# 1.6AUTOBAS# 0.1AUTOEOS# 0.1NRBC% 0.0NRBC 0.0HGB/HCT 3.0IG# 0.07IG% 0.7 Oct-15-2022 1317 Chemistry GLUCOSE 145BUN 28CREAT 1.9MDRD GFR 34NA 136K 4.6CL 101CALCIUM 8.5ALK PHOS 121CO2 23.8AST 37ALT 17AST/ALT 2.2TL PROT 7.1ALBUMIN 3.2TBILI 0.4OSMO 280.0ANION GP 15.8BUN/CRE 14.7LACTATE 1.50 Oct-15-2022 1310 Serology COVID PosINFLUA NegINFLUB NegCVD1TEST UnknownCVDEMPHC NoCVDSYMP YesCVDSYMDT Day 3CVDHOSP UnknownCVDICU UnknownCVDRESID NoCVDPREG Not Pregnant Patient was given juice and lunch after his lower sugar. Imaging Results MEDICAL CENTER IMAGING REPORT Diagnostic radiology, p.c. www.diagnosticradiologypc.com Patient Name:Date of Exam: 10/15/2022 DOB: Gender: M Medical Record Number: Account Number: Accession Number: Ordering Physician: Exam Description: CH-CHEST 1V DR EXAMINATION: CH-CHEST 1V DR HISTORY: Cough, fever COMPARISON: 4/12/2018 FINDINGS: Frontal chest radiograph. Mild right basilar atelectasis. Mild retrocardiac opacity may represent atelectasis and/or airspace disease. No pneumothorax or significant pleural effusion. Heart size is mildly enlarged. Atherosclerotic plaque is noted. The visible bony thorax is intact. IMPRESSION: Mild retrocardiac opacity may represent atelectasis and/or airspace disease. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/15/2022 2:09 PM CDT --------------------------------------------- MEDICAL CENTER IMAGING REPORT Diagnostic radiology, p.c. www.diagnosticradiologypc.com Patient Name: Date of Exam: 10/15/2022 DOB: Gender: M Medical Record Number: Account Number: Accession Number: Ordering Physician: Exam Description: LE-KNEE 1-2V DR EXAMINATION: 1. Right knee 2 views 2. Left knee 2 views HISTORY: Bilateral knee pain after fall COMPARISON: None FINDINGS: Frontal and lateral views of both knees. The osseous structures are intact and well aligned without acute fracture or dislocation. Mild degenerative changes at both knees. No joint effusion is seen. Bone density and texture are normal. Atherosclerotic plaque is present. IMPRESSION: 1. No acute fracture or dislocation identified. 2. Mild degenerative changes. 3. Atherosclerotic vascular disease. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 10/15/2022 3:46 PM CDT IMAGING REPORT Diagnostic radiology, p.c. www.diagnosticradiologypc.com Patient Name: Date of Exam: 10/15/2022 DOB: 9/06/1938 Gender: M Medical Record Number: Account Number: Accession Number: Ordering Physician: Exam Description: CH-RIBS UNILATERAL DR EXAMINATION: CH-RIBS UNILATERAL DR HISTORY: Pain after fall COMPARISON: Chest radiograph from the same date and 4/12/2018 FINDINGS: No acute or displaced rib fracture. Decreased left basilar atelectasis. No focal airspace consolidation, pneumothorax, or effusion. Cardiomediastinal silhouette is unremarkable. IMPRESSION: No displaced rib fracture. This exam was interpreted on workstation DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: DICTATED DATE AND TIME: 10/15/2022 3:44 PM CDT Functional Status* Impaired mobility (Parkinsons, balance) Mental Status* Normal Cognition Social History tobacco use Former Smoker, 1 Packs Per Day, 26 yrs, Smoking Cessation Not Applicable Started at age 18, quit approximately 40 years ago. alcohol use No Known Use drug use No Known Use marital status Single general comment Lives at home alone. Health Concerns Acute COVID-19 Falls Muscle weakness Dehydration Former Smoker, 1 Packs Per Day, 26 yrs Father Deceased Myocardial infarction @ 56 Mother Deceased Alzheimer's disease @ 85 Essential hypertension Tobacco Cessation* Non-Smoker, Non Tobacco product user Vital Signs Oct-17-2022 0643 T 98.0 HR 66 RR 18 BP 116 / 53 O2Sat 92 Oct-17-2022 0423 T 98.0 HR 64 RR 16 BP 141 / 70 O2Sat 95 PHYSICAL EXAM CONSTITUTIONAL: Patient appears comfortable and in no acute distress. CARDIOVASCULAR: Heart has regular rate rhythm, pulses are 2/2 in the upper extremities, no edema noted RESPIRATORY: Lungs clear to auscultation throughout and respiratory effort is non-labored GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive NEUROLOGICAL: Patient is alert and generally oriented. Sensation is grossly intact PSYCHIATRIC: Patient's mood is euthymic, affect is appropriate. RASS of 0. Hospital Course An 84-year-old male with history of type 2 diabetes, hypertension, CKD, Parkinson's disease, CAD with past MI, and HIV that presented to the ED with complaints of general weakness and multiple falls. He was placed under observation by the internal medicine team. He was monitored over the course of 24 hours He remained stable. His sugars were somewhat low secondary to his PT assessed and recommended that physical therapy would be of benefit. Patient requested that nursing home care may be appropriate, however no qualifying diagnosis was found. Patient was deemed stable and will be discharged home with home health services. Condition at Discharge Stable Discharge Medications allopurinol 100 mg tablet Continue taking same as home amlodipine 5 mg tablet 1 TAB ORALLY ONCE A DAY aspirin 81 mg capsule 1 CAP ORALLY ONCE A DAY Basaglar KwikPen U-100 Insulin 100 unit/mL (3 mL) Insulin Pen 48 UNT SUBCUTANEOUS DAILY AT BEDTIME Biktarvy 50-200-25 mg tablet 1 TAB ORALLY ONCE A DAY carbidopa-levodopa 25-100 mg tablet 2 TAB ORALLY 4 TIMES A DAY escitalopram oxalate 20 mg tablet 1 TAB ORALLY ONCE A DAY finasteride 5 mg tablet 5 MG ORALLY DAILY AT BEDTIME Insulin Lispro (1 Unit Dial) Subcutaneous Solution Pen-injector 100 UNIT/ML Continue taking same as home lisinopril 20 mg tablet 20 MG ORALLY DAILY AT BEDTIME Omega-3 Krill Oil 500-115-30-64 mg capsule 1 CAP ORALLY ONCE A DAY metoprolol succinate 100 mg Tablet, Extended Release 24 hr 1 TAB ORALLY ONCE A DAY Nitroglycerin Sublingual Tablet Sublingual 0.4 MG Continue taking same as home Praluent Pen 75 mg/mL Pen Injector Continue taking same as home pravastatin 10 mg tablet 5 MG ORALLY DAILY AT BEDTIME tamsulosin 0.4 mg capsule 2 CAP ORALLY DAILY AT BEDTIME Vitamin D3 50 mcg (2,000 unit) capsule 1 CAP ORALLY ONCE A DAY Discharge Disposition Discharge to home with home health Plan ASSESSMENT 1. Generalized muscle weakness secondary to COVID-19 infection, dehydration, improved 2. Mild dehydration secondary to poor oral intake, nausea/vomiting 3. Acute COVID-19 infection, mild without hypoxia, vaccinated 4. Recent repeated falls secondary to generalized weakness 5. Chronic kidney disease stage G3b, Cr 1.9, baseline likely 1.5 or higher. 6. Type 2 diabetes mellitus, possibly over-controlled with reported recent Hgb A1c of 5.5 7. Essential hypertension, controlled 8. HIV positive since 1992, controlled 9. Parkinson's disease PLAN: Patient has been deemed stable to discharge home with home health. Patient's lab work is improving although he remains weak. He has been seen by PT who suggested he would benefit from home therapy. We will also discharge with nursing services. Patient recently lost his wife, who had multiple health problems, and is happy to have the same service provide his home care. Patient otherwise has improved during his stay. He is to follow up with his Primary Care Physician. Of note, patient's blood sugars have been low. He has been advised to hold his home insulin, and informed that he may only need a half dose of his long acting. He feels comfortable managing this at home. Ensure or Glucerna, or similar were recommended to ensure adequate nutrition. He is to drink these especially on days he feels he has not had a good meal. Primary Care Provider Electronically signed on Oct-17-2022 1434

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death of relative
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Parkinson's HIV Chronic Kidney disease stage 3 Hypertension Diabetes
Andere Medikamente: -
Allergien: Oxycodone
Vorherige Impfungen: -

VAERS 2476294

UNKNOWN MANUFACTURER · INFLUENZA (SEASONAL) (NO BRAND NAME) · Charge Unknown

kritisch

Staat: MA
Alter: 52,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 14.12.2021
Beginn: 19.09.2022
Tage bis Beginn: 279,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angle closure glaucoma Visual field tests abnormal

Symptomtext

Diagnosis of Narrow Angle Glaucoma-Left 09/19/2022. I have been dealing with the migraines in the left eye which remained the same. During my annual exam, I was given a new diagnosis. The initial diagnosis was Episodic Migraines. It does not appear to cause any worsening in the original condition. I was advised to go the nearest emergency if I noticed change in my vision. I went back to the doctor on October 07 and had a Peripheral Vision Test completed which showed there was weakness in the left eye.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Angle closure glaucoma
Hospital-Tage: -
Labordaten: Eye Exam-09/19/2022-Narrow Angle Glaucoma of left eye Peripheral Vision Test-10-07-2022-left eye weakness Visual Field Test-10-07-2022-Narrow Angle OCT Optical Coherence Tomography-Narrow Angle Glaucoma of left eye
Aktuelle Erkrankungen: Migraines
Vorgeschichte: Depression; Insomnia; Low Iron
Andere Medikamente: Pantoprazole; Levothyroxine; Amitriptyline; Quetiapine; Fero Sulfate; Butalbital/Aspirin/Caffeine; Venlafaxine ER; Duloxetine; Multi Vitamin; B12; Topamax
Allergien: Zomig
Vorherige Impfungen: -

VAERS 2470124

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: KY
Alter: 91,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 01.09.2021
Beginn: 16.02.2022
Tage bis Beginn: 168,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Laboratory test abnormal Pleural effusion

Symptomtext

Patient had a positive at home test, was admitted to to hospital due to pulmonary effusion on 2/8/22. Patient later passed away 2/16/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Atrial fibrillation aortic stenosis tricuspid valve regurgitation hypertension hyperlipidemia gout
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2469832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: KY
Alter: 92,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 30.09.2021
Beginn: 12.02.2022
Tage bis Beginn: 135,0
Dosis: 3
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 2/2/2022 and passed away on 2/12/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2468853

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 10.11.2021
Beginn: 15.09.2022
Tage bis Beginn: 309,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt had received two covid vaccine EUA (J&J) on 4/2/2021 and 11/10/2021 at location. Pt died at community hospital on 9/15/2022. No information is available regarding circumstances of this death. Likely the vaccines were not the cause of this patient's death given the long length of time between date of vaccines given & date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2658706

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 38,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 05.01.2022
Beginn: 09.01.2022
Tage bis Beginn: 4,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Angina unstable Catheterisation cardiac Chest pain Electrocardiogram normal Sleep disorder Troponin

Symptomtext

Narrative: On 01/9/22 Patient presented to ER with chest pain. Pt had received a covid (Moderna) booster vaccine on 1/5/22 (location pt received vaccine is not reported & unknown- not at this facility). This was his #3 covid vaccine after 2 other full doses from unknown location (dated reported were 4/8/21 and 5/6/21. Pt was admitted and had cardiology workup. # NSTEMI/unstable angina, POA - woke up from sleep with chest pain - initial troponin 2.85 then 5.9, 6.0, 5.3, 10.1, 6.6, 3.8 - EKG NSR with no ST changes or T wave abnormalities - patient without risk factors or significant family history - trend trop and EKG q6 - given ASA 325mg in ED; start ACS protocol with heparin drip - atorvastatin 80mg and metoprolol 25mg q6 as BP allows - TIMI score 1 (low risk) Pt got cardiac cath on 1/10/22. Pt discharged home after with no medications. On 3/4/22 Primary Care Md noted possible SE from covid vaccine caused the chest pain and possible myocarditis. Pt's chart was flagged with ADE and reporting to VAERs (& CDC through VAERS).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453726

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 85,0
Geschlecht: M
Eingang: 21.09.2022
Impfdatum: 12.11.2021
Beginn: 18.09.2022
Tage bis Beginn: 310,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute myocardial infarction Acute respiratory failure Anion gap Asthenia Atrial fibrillation Atrioventricular block first degree Basophil count Basophil percentage decreased Blood calcium decreased Blood chloride normal Blood creatinine increased Blood glucose increased Blood glucose normal Blood osmolarity decreased Blood potassium normal Blood sodium normal Blood urea increased

Symptomtext

Date of Service Sep-20-2022 0819 Chief Complaint Resting comfortably, hungry HPI / Subjective The patient is an 86-year-old male with history of type 2 diabetes, atrial fibrillation on apixaban, coronary artery disease with CABG, COPD, and gout that presented to the ED last night due to increased weakness and inability to get out of bed for the last day or 2. For the last few days he has gotten progressively weaker. This is hospital day 3. The patient was examined at bedside and found in no acute distress. He stated he slept approximately 5 hours last night which is adequate for him. He is voiding appropriately although says he's urinating a bit more than usual. His appetite was strong and he looked forward to food after the stress test. He did not report any problems with breathing. REVIEW OF SYSTEMS General - No fevers, chills, night sweats, or headache. Eyes - No eye pain, no discharge. ENT - No sore throat, no nasal congestion. Respiratory - No pain with breathing. No cough. No increase in shortness of breath above baseline. Cardio - No chest pain. No palpitations. Gastrointestinal - No abdominal pain. No nausea or vomiting. No diarrhea or constipation. Genitourinary - Complains of increased urinary frequency. No dysuria. Neurologic - No focal weakness. No numbness or tingling. Objective Vital Signs Sep-20-2022 0709 T 96.5 HR 47 RR 18 BP 142 / 62 O2Sat 97 Sep-20-2022 0400 T 96.7 HR 51 RR 20 BP 141 / 52 O2Sat 93 Intake and Output previous day current day encounter cumulative Intake 1246 ? 3637 Output 1935 180 4765 Diff (I-O) (-689) (-180) (-1128) PHYSICAL EXAM General - Of stated age. Slightly unkempt appearing. Eyes - Clear with no conjunctival injection. ENT - No discharge from nares or external auditory meatus. Mucus membranes moist. Throat - Soft. No masses appreciated. Trachea midline. Respiratory - Symmetrical rise of chest wall bilaterally. Lungs clear to auscultation with no wheezes, rhonchi, or adventitious sounds. Cardio - Regular rate, regular rhythm. No murmurs, rubs, or gallops. Radial pulses +2/4 bilaterally. No jugular venous distention. Gastrointestinal - Soft and non distended. Non tender to palpation. No guarding or rebound. Neurological - Sensation to light touch in tact in upper and lower extremities. Musculoskeletal - No obvious joint deformities. Psychiatric - Mood and affect appropriate to age and situation. Lab Results Sep-20-2022 0545 Chemistry GLUCOSE 134BUN 42CREAT 1.9MDRD GFR 34NA 136K 4.1CL 102CALCIUM 7.6CO2 25.8OSMO 284.4ANION GP 12.3BUN/CRE 22.1CRP 0.60 Sep-20-2022 0545 Hematology WBC 11.2RBC 3.61HGB 11.3HCT 32.5MCV 90.0MCH 31.3MCHC 34.8RDW 13.7RDWSD 45.1PLT 152MPV 10.9AUTONEU% 83.4AUTOLYM% 11.1AUTOMON% 4.7AUTOEOS% 0.0AUTOBAS% 0.1AUTONEU# 9.3AUTOLYM# 1.2AUTOMON# 0.5AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.08IG% 0.7 Sep-20-2022 0545 Serology PROCALC <0.05 Sep-20-2022 0537 Point Of Care GLUSTX 138 Sep-19-2022 2243 Point Of Care GLUSTX 307 Sep-19-2022 2040 Point Of Care GLUSTX 365 Sep-19-2022 1717 Point Of Care GLUSTX 264 Sep-19-2022 1229 Point Of Care GLUSTX 271 Sep-19-2022 1215 Chemistry GLUCOSE 267BUN 38CREAT 2.0MDRD GFR 32NA 137K 4.0CL 99CALCIUM 8.0CO2 29.8OSMO 292.2ANION GP 12.2BUN/CRE 19.0TROPI-HS 54 Active Medications METOPROLOL TARTRATE 25 MG ORALLY DAILY HOLD FOR HR < 60 OR SBP < 100 INSULIN LISPRO 100 UNIT / ML 3 ML Sliding Scale Dose SUBCUT SSACHS REMDESIVIR 100 MG IVPB Q24HI 200 ML/HR SODIUM CHLORIDE 0.9% 100 ML AMIODARONE HCL 200 MG ORALLY BID REGADENOSON INJ 0.4 MG/ 5 ML 0.4 MG IV PUSH ONCALL DIVALPROEX SODIUM DR 500 MG ORALLY NOON DIVALPROEX SODIUM DR 500 MG ORALLY HS CEFepime HCL INJ 2000 MG IV Q24H 200 ML/HR SODIUM CHLORIDE 0.9% MINIBAG+ 100 ML RENAL DOSE APIXABAN 2.5 MG ORALLY BID RENAL DOSE POTASSIUM CHLORIDE ER 10 MEQ ORALLY NOON TAMSULOSIN HCL 0.4 MG ORALLY NOON PANTOPRAZOLE 40 MG ORALLY QDAY-ES Substituted from omeprazole 40 mg capsule,delayed release (e.c.), 1 CAP ORALLY EVERY MORNING ATORVASTATIN CALCIUM 20 MG ORALLY HS FUROSEMIDE 40 MG ORALLY DAILY FUROSEMIDE 40 MG ORALLY NOON DEXAMETHASONE INJ 4 MG/ML 6 MG IV PUSH DAILY MILK OF MAGNESIA 2400 MG/30ML 2400 MG ORALLY Q24HPRN for CONSTIPATION HOLD FOR LOOSE STOOLS ONDANSETRON HCl INJ 4 MG / 2 ML 4 MG IVPUSH Q8HPRN for NAUSEA/VOMITING CALCIUM ANTACID 1000 MG ORALLY Q4HPRN for DYSPEPSIA ACETAMINOPHEN 650 MG ORALLY Q4HPRN for FEVER OR MILD PAIN 1-3 ON PS max 4,000 milligrams acetaminophen per 24 hours Plan ASSESSMENT - Acute hypoxic respiratory failure secondary to COVID-19 - Sepsis (tachycardia, tachypnea) secondary to COVID-19, present on admission - Acute kidney injury, Cr 2.1, AKIN stage 1, baseline 1.4 in 2001 - COVID-19 pneumonia - Sinus bradycardia, stable, status post cardioversion 9/19/2022 - 1st degree heart block, status post cardioversion 9/19/2022 - Atrial fibrillation with RVR, resolved - Type 2 myocardial infarction, likely secondary to sepsis, AFib with RVR - Coronary artery disease, s/p CABG - Essential hypertension, controlled - Type 2 diabetes mellitus, on metformin, unknown control - Hyperlipidemia, on atorvastatin Plan: The patient has improved clinically stating that his weakness has improved. He was saturating at 97-98% on room air. CRP continues to decrease. He will undergo a stress test this morning as ordered by Dr. Per Dr. his metoprolol will be decreased to once per day. Amiodarone drip was discontinued and oral 200 mg BID started. Although the patient still has a low heart rate he shows no signs of deterioration clinically. Renal function improved slightly. We will continue with aggressive hydration at 200 mL/hr. His glucose levels look much better today suggesting the change we made to high dose insulin has worked. He will need outpatient management for his diabetes. We will continue with dexamethasone, remdesivir, and cefepime. Continue to withhold allopurinol, metformin, losartan due to decreased kidney function. Morning labs: CBC, BMP, CRP, procalcitonin Electronically signed by RESIDENT DO on Sep-20-2022 1701 I have seen and physically examined the patient on [9-20-2022] and agree with the documentation the resident. I have also discussed my findings and plan of care with the resident. Any changes and additional information are listed below. Electronically signed by MD on Sep-20-2022 1710

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hyperlipidemia COPD gout essential hypertension paroxysmal atrial fibrillation diabetes mellitus stented coronary artery coronary arteriosclerosis in native artery
Andere Medikamente: -
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 1670243

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 03.03.2021
Beginn: 22.09.2021
Tage bis Beginn: 203,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chest pain Chills Cough Nausea Pain COVID-19 Death SARS-CoV-2 test positive Vomiting

Symptomtext

Patient expired 9/22/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439499

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 10.09.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Suspected COVID-19 Thrombosis Vaccination failure

Symptomtext

DEATH; CLOT BLOOD; SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration, batch number were not reported, expiry: unknown) dose not reported, dose number in series was 1, 01 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient was full of blood clots (clot blood) and got corona virus disease (COVID)-19 (suspected covid-19 infection) which resulted in suspected clinical vaccination failure. On an unspecified date, the patient died a very painful and unnecessary death from an unknown cause (dose number in series was 1). It was not reported whether autopsy was performed or not. The reporter reported that, "My brother had Johnson and Johnson vaccine and got Covid and was full of blood clots. He ended up dying a very painful and unnecessary death. I blame them". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on an unspecified date and the outcome of suspected covid-19 infection, clot blood and suspected clinical vaccination failure was not reported. This report was serious (Death and Other Medically Important Condition). This report was associated with product quality complaint.: 90000211571. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Version created to amend previously reported information on 20-JAN-2022. Upon review the following information was amended: Amendment Adverse Event (The case validity assessment was updated to valid from the previously incorrect assessment of non-valid).; Sender's Comments: V2:This version updates: The case validity assessment was updated to valid from the previously incorrect assessment of non-valid. The prior causality assessment remains unaltered with this added information. 20220123845-COVID-19 VACCINE AD26.COV2.S-Death, clot blood. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20220123845-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 25.06.2021
Beginn: 17.08.2022
Tage bis Beginn: 418,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy Arterial thrombosis Atrial fibrillation COVID-19 pneumonia Condition aggravated Deep vein thrombosis Intensive care Respiratory failure SARS-CoV-2 test positive

Symptomtext

66 y/o F with PMH significant for severe COPD, pulmonary HTN, a-fib, pancreatic ca s/p Whipple, and dementia, who was initially admitted to the ICU for acute on chronic hypoxic respiratory failure from COVID-19 PNA requiring HFNC/NRB. Pt was treated with remdesivir and soul-medrol for her COVID-19 PNA. Her hospitalization was otherwise significant for a-fib with rvr, LLE DVT, and a new dx of chronic thrombus in the RLL artery . Pt was treated with anticoagulation with IV heparin. She was ultimately transferred out of the ICU after goals of care were addressed and her code status was changed to DNR/DNI. ICU consultation was requested by the primary team on 9/2 for escalating FiO2 requirements on HFNC. No dyspnea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 8/17 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2422924

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: KY
Alter: 43,0
Geschlecht: M
Eingang: 29.08.2022
Impfdatum: 01.05.2021
Beginn: 08.11.2021
Tage bis Beginn: 191,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arteriosclerosis Autopsy Cardiomegaly Death Hypertensive heart disease Left ventricular dilatation Obesity Toxicologic test abnormal

Symptomtext

I am not sure if anyone ever reported this potential AE and while my brother had numerous comorbidities he was also quite young (44) to die in his sleep and was on no other prescription medications at the time of his death. The coroner's report stated that: atherosclerotic and had hypertensive heart disease, cardiomegaly with left ventricular dilation and obesity--this coupled with his lack of medical care was most likely the cause of his death. I am estimating the time of his J&J Covid vaccination to be around May 2021 although I do have have his records to verify.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Autopsy as described above, I believe tox screen also showed marijuana
Aktuelle Erkrankungen: hypertension
Vorgeschichte: hypertension
Andere Medikamente: alcohol and marijuana use
Allergien: had an allergic skin reaction to lidocaine
Vorherige Impfungen: -

VAERS 2433490

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 27.08.2022
Impfdatum: 13.05.2021
Beginn: 03.08.2022
Tage bis Beginn: 447,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Bradycardia Death Device dislocation Muscle spasms Respiratory depression

Symptomtext

Narrative: 74 yo male patient died on 8/3/2022 at home in full hospice care. Pt with feeding tube dislodged, abdominal pain, & cramping also with complications with bradycardia and decreased respirations when hospice care was initiated. Pt had received a covid EUA vaccine (J&J) on 5/13/2021. Death does not appear to be related to this vaccine given pt's age, in hospice care & long length of time between date of death & date patient received the vaccine. Patient did not receive the vaccine at this facility. He got vaccine from community pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433525

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 62,0
Geschlecht: M
Eingang: 22.08.2022
Impfdatum: 16.10.2021
Beginn: 16.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Respiratory arrest

Symptomtext

Narrative: Patient says he got the 1st Pfizer COVID vaccine 10/6/21, then went in to respiratory arrest 10/9/2021. He says he was admitted to an outside hospital for 3 days and will have records sent to the hospital. He says he was treated with steroids and a zpak. He says he was not intubated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2417259

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 60,0
Geschlecht: F
Eingang: 22.08.2022
Impfdatum: 10.09.2021
Beginn: 17.08.2022
Tage bis Beginn: 341,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aspartate aminotransferase normal Basophil count normal Basophil percentage increased Bilirubin conjugated normal Blood albumin decreased AST/ALT ratio Acute respiratory failure Alanine aminotransferase normal Angiogram pulmonary abnormal Anion gap Blood alkaline phosphatase normal Blood bicarbonate increased Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal Blood magnesium normal

Symptomtext

Discharge Summary Date of Service Aug-21-2022 0829 Date of Admission Admit Date: Aug-17-2022 Date of Discharge Date of discharge Aug-21-2022 Allergies TETRACYCLINE - when patietn was a child Chief Complaint SOB Procedure(s) Performed None Lab Results Aug-20-2022 0745 Hematology WBC 11.7RBC 6.94HGB 19.9HCT 63.2MCV 91.1MCH 28.7MCHC 31.5RDW 16.6RDWSD 48.7PLT 641MPV 11.2AUTONEU% 66.1AUTOLYM% 22.6AUTOMON% 8.5AUTOEOS% 0.7AUTOBAS% 1.3AUTONEU# 7.7AUTOLYM# 2.6AUTOMON# 1.0AUTOBAS# 0.2AUTOEOS# 0.1NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.09IG% 0.8 Aug-20-2022 0745 Chemistry GLUCOSE 101BUN 30CREAT 0.9MDRD GFR 64NA 148K 4.0CL 103CALCIUM 8.8ALK PHOS 59CO2 43.4AST 14ALT 15AST/ALT 0.9TL PROT 6.0ALBUMIN 2.6TBILI 0.4DBILI 0.1OSMO 300.6ANION GP 5.6BUN/CRE 33.3 Aug-20-2022 0745 Blood Gas PH VEN 7.430PCO2 VEN 68.8PO2 VEN 70.0BICARB V 45.0BE VEN 15.1CO2 CT V 36.0O2 SAT V 95.6 Aug-18-2022 0710 Chemistry PROBNP 9522 Aug-18-2022 0615 Chemistry TROPI-HS 83 Aug-18-2022 0410 Serology PROCALC <0.05 Aug-18-2022 0410 Hematology WBC 6.2RBC 6.21HGB 17.8HCT 57.5MCV 92.6MCH 28.7MCHC 31.0RDW 14.9RDWSD 50.1PLT 430MPV 11.5AUTONEU% 81.1AUTOLYM% 11.1AUTOMON% 4.0AUTOEOS% 1.9AUTOBAS% 0.8AUTONEU# 5.0AUTOLYM# 0.7AUTOMON# 0.3AUTOBAS# 0.1AUTOEOS# 0.1NRBC% 0.0NRBC 0.0IG# 0.07IG% 1.1 Aug-18-2022 0410 Coagulation D-DIMER 0.47 Aug-18-2022 0410 Chemistry GLUCOSE 125BUN 20CREAT 1.0MDRD GFR 56NA 143K 4.2CL 104CALCIUM 8.8CO2 34.8OSMO 289.1ANION GP 8.4BUN/CRE 20.0CRP 2.40HGBA1C 5.6MEAN GLU 122MAGNESIU 1.6TROPI-HS 86 Aug-18-2022 0410 Blood Gas PH VEN 7.26PCO2 VEN 79.3PO2 VEN 64BICARB V 34.0BE VEN 3.1CO2 CT V 29.7O2 SAT V 90.6 Imaging Results CTA showed no evidence of pulmonary artery embolism. Severe centrilobular emphysema present. Small right pleural effusion. No consolidation. Contrast reflux into hepatic veins. Consistent with elevated right cardiac pressure. Echocardiogram showed LVEF greater than 60% moderate tricuspid regurgitation. RVSP 64. Moderate enlargement of right ventricle. Severe right ventricular hypokinesis that later improved on repeat echo. Severely enlarged right atrium measuring greater than 50 mm that improved on repeat echo. Small pericardial effusion no echocardiographic evidence to suggest pericardial tamponade. Dilated inferior vena cava with no respiratory collapse. Pulmonary hypertension. Chest x-ray stable chest. Social History tobacco use Current Every Day Smoker, 1/2 Packs Per Day, 40 yrs, Smoking Cessation Yes alcohol use No Known Use drug use No Known Use marital status Single occupation Works as a home health nurse travel No recent travel Health Concerns Right ventricular failure Essential hypertension Acute pulmonary edema Myocarditis due to COVID-19 Pulmonary hypertension COVID-19 Dyspnea Current Every Day Smoker, 1/2 Packs Per Day, 40 yrs Father Deceased Cerebrovascular accident @ 86 Mother Deceased Myocardial infarction @ 41 Vital Signs Aug-21-2022 0730 T 98.6 HR 68 RR 24 BP 150 / 93 O2Sat 95 Aug-21-2022 0300 HR 71 RR 19 BP 157 / 97 O2Sat 93 Aug-20-2022 2224 T 98.2 PHYSICAL EXAM Constitutional: Nontoxic appearing, appears stated age, in no acute distress. Cardio: Regular rate and rhythm. No murmur, rub, gallop or edema. Pulses 2+ out of 4 at the radial and posterior tibial bilaterally. Pulmonary: On 2L NC saturating 94%. Non-labored breathing. No wheeze or rales Gastrointestinal: Abdomen is non-distended without scar or lesion. Bowel sounds present x4, no reproducible tenderness to palpation. No organomegaly palpated. Neuro: Alert and oriented x3. Language is clear. CN II-XII grossly intact, sensation to light touch intact. Skin: Warm, dry and supple without new lesion or ulcer Psych: appropriate affect and mood is euthymic. Consultations cardiology, Dr. Hospital Course Came to the ED short of breath. Shortness of breath had been chronic and now was acute on chronic. Found to be positive for COVID-19 pneumonia. Treated with remdesivir, dexamethasone, inhaled medications. Diagnosed with likely COPD in acute exacerbation, dehydration. Patient does have a history of tobacco abuse. Throughout her hospital stay the patient did improve clinically and biochemically 8 and is now stable, ready for discharge. Discharge Medications ALBUTEROL SULFATE HFA 108 (90 Base) MCG/ACT 2 PUF INHALATION EVERY 4 HOURS AS NEEDED for SHORTNESS OF BREATH (Printed by RESIDENT on Aug-21-2022 0826) Anoro Ellipta Inhalation Aerosol Powder Breath Activated 62.5-25 MCG/INH 1 PUF INHALATION ONCE A DAY (Printed by RESIDENT on Aug-21-2022 0826) ASPIRIN LOW DOSE 81 MG ORALLY ONCE A DAY CALCIUM ANTACID 1000 MG ORALLY EVERY 4 HOURS AS NEEDED for DYSPEPSIA CARVEDILOL 6.25 MG ORALLY TWICE DAILY BLOOD PRESSURE MEDS (Printed by RESIDENT on Aug-21-2022 0826) FAMOTIDINE 10 MG ORALLY TWICE DAILY Lasix Oral Tablet 20 MG 10 MG ORALLY ONCE A DAY (Printed by RESIDENT on Aug-21-2022 0826) SACUBITRIL-VALSARTAN 49-51 MG 1 TAB ORALLY TWICE DAILY (Printed by RESIDENT on Aug-21-2022 0826) Sertraline HCl Oral Tablet 25 MG 25 MG ORALLY ONCE A DAY (Printed by RESIDENT on Aug-21-2022 0826) Plan ASSESSMENT: -Acute hypoxic respiratory failure secondary to COVID-19 pneumonia with suspected COPD exacerbation -Pneumonia in the setting of COVID-19, Moderna vaccine x 2, Suspected underlying COPD with acute exacerbation - Likely COPD in acute exacerbation -Dehydration secondary to poor oral intake -hypertension, etiology unknown, possibly secondary to COVID-19 versus primary hypertension -Polycythemia, Hgb 19.1, Hct 60.3, likely multifactorial, secondary to dehydration, suspected COPD, smoking -Thrombocytosis, platelet count 457,000, likely reactive to viral illness -Tobacco abuse disorder PLAN: discharge the patient into the care of her daughter, anticipated to stay with daughter until she recovers more fully. Discharge with home O2, 2 L is needed at rest. After discharge, needs to establish primary care provider For ongoing care, refills. Needs pulmonary function test in the outpatient setting. She will be discharged with breathing medications for COPD. Discontinue steroids. Discontinue remdesivir. Encourage oral intake of both fluid and meals. Primary Care Provider None established Electronically signed by RESIDENT on Aug-21-2022 0838 I have seen and physically examined the patient on [aug 21, 2022] and agree with the documentation of [name of the resident]. I have also discussed my findings and plan of care with [dr resident]. Any changes and additional information are listed below. cvs s1s2 abd soft nt nd lungs wheeze bilateral walking home oxygen fu pulmonary , pmd pft Electronically signed by MD MD on Aug-21-2022 1047 PrintPrevious Next current encounter previous encounters New Note Filter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: smoker
Andere Medikamente: -
Allergien: Tetracyclines
Vorherige Impfungen: -

VAERS 2415898

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MN
Alter: 78,0
Geschlecht: M
Eingang: 19.08.2022
Impfdatum: 12.03.2021
Beginn: 17.07.2022
Tage bis Beginn: 492,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Acute respiratory failure Asthenia COVID-19 Cardiac failure congestive Chest pain Dyspnoea Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient brought into the ED on 7/17 by EMS for weakness, chest pain, and shortness of breath. COVID-19 PCR swab taken in the ED was positive. Patient was admitted from 7/17 - 8/9 with acute hypoxic respiratory failure and NSTEMI. During admission, patient was on BIPAP, eventually weaned to room air. Discharge diagnoses included congestive heart failure and NSTEMI. Patient has been vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2414889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MN
Alter: 31,0
Geschlecht: F
Eingang: 18.08.2022
Impfdatum: 12.05.2021
Beginn: 17.07.2022
Tage bis Beginn: 431,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Condition aggravated Cough Dyspnoea End stage renal disease Hypervolaemia Hypoxia Oropharyngeal pain Pleural effusion Respiratory failure Respiratory symptom Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient seen in the ED on 7/17 for shortness of breath and hypoxia. At baseline she is on 2-3L O2 via nasal cannula. Additionally patient reported cough, rhinorrhea, and sore throat. COVID-19 PCR test done in the ED was positive. She was admitted from 7/17-7/21 for acute on chronic hypoxic respiratory failure, volume overload due to excessive fluid intact associated with end-stage renal disease, and recurrent right-sided pleural effusion, acute on chronic, acute portion resolved. Per medical notes, provider states respiratory symptoms were not consistent with COVID pneumonia, and strongly suspects presentation with acute respiratory failure was due to volume overload. Patient has been vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Patient with history of Evan syndrome, DiGeorge syndrome, end stage renal disease, cirrhosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2414889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MN
Alter: 31,0
Geschlecht: F
Eingang: 18.08.2022
Impfdatum: 12.05.2021
Beginn: 17.07.2022
Tage bis Beginn: 431,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Condition aggravated Cough Dyspnoea End stage renal disease Hypervolaemia Hypoxia Oropharyngeal pain Pleural effusion Respiratory failure Respiratory symptom Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient seen in the ED on 7/17 for shortness of breath and hypoxia. At baseline she is on 2-3L O2 via nasal cannula. Additionally patient reported cough, rhinorrhea, and sore throat. COVID-19 PCR test done in the ED was positive. She was admitted from 7/17-7/21 for acute on chronic hypoxic respiratory failure, volume overload due to excessive fluid intact associated with end-stage renal disease, and recurrent right-sided pleural effusion, acute on chronic, acute portion resolved. Per medical notes, provider states respiratory symptoms were not consistent with COVID pneumonia, and strongly suspects presentation with acute respiratory failure was due to volume overload. Patient has been vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Patient with history of Evan syndrome, DiGeorge syndrome, end stage renal disease, cirrhosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2435980

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 62,0
Geschlecht: M
Eingang: 17.08.2022
Impfdatum: 16.10.2021
Beginn: 16.10.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Respiratory arrest

Symptomtext

Narrative: Patient says he got the 1st Pfizer COVID vaccine on 10/6/21, then went in to respiratory arrest 10/9/2021. He says he was admitted to an outside hospital for 3 days and will have records sent to the facility. He says he was treated with steroids and a zpak. He says he was not intubated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2412426

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MN
Alter: 84,0
Geschlecht: M
Eingang: 16.08.2022
Impfdatum: 07.12.2021
Beginn: 15.07.2022
Tage bis Beginn: 220,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Fatigue Hypoxia Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED via EMS on 7/15 for weakness, fever, and fatigue. While in the ED, he became hypoxic to about 84% and was placed on oxygen by NC. COVID-19 PCR swab in the ED was positive. Patient was admitted for further COVID related cares given his hypoxia, and was admitted 7/15-7/18. He was diagnosed with acute hypoxic respiratory failure due to COVID-19. He is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Patient history of Parkinson's disease, Dementia, and Prostate cancer
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2341702

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: OK
Alter: 87,0
Geschlecht: F
Eingang: 12.08.2022
Impfdatum: 28.01.2021
Beginn: 11.08.2022
Tage bis Beginn: 560,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

fully vaccinated, covid positive pt admitted to hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2405640

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 80,0
Geschlecht: M
Eingang: 09.08.2022
Impfdatum: 28.12.2021
Beginn: 06.08.2022
Tage bis Beginn: 221,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aspartate aminotransferase increased Asthenia Atrial fibrillation Auscultation Basophil count decreased AST/ALT ratio Acute myocardial infarction Alanine aminotransferase normal Anion gap Anticoagulant therapy Basophil percentage Bilirubin conjugated normal Blood albumin decreased Blood alkaline phosphatase increased Blood bilirubin decreased Blood calcium decreased Blood chloride normal Blood creatinine increased

Symptomtext

Date of Service Aug-08-2022 1641 Date of Admission Admit Date: Aug-06-2022 Date of Discharge Date of discharge Aug-08-2022 Allergies ACE Inhibitors - Not Specified Chief Complaint Weakness Procedure(s) Performed None Lab Results Aug-08-2022 0535 Serology PROCALC 1.23 Aug-08-2022 0535 Hematology WBC 2.7RBC 3.20HGB 9.6HCT 28.7MCV 89.7MCH 30.0MCHC 33.4RDW 13.2RDWSD 43.8PLT 126MPV 12.1AUTONEU% 49.5AUTOLYM% 29.9AUTOMON% 12.5AUTOEOS% 7.0AUTOBAS% 0.7AUTONEU# 1.3AUTOLYM# 0.8AUTOMON# 0.3AUTOBAS# 0.0AUTOEOS# 0.2NRBC% 0.0NRBC 0.0ESR 64HGB/HCT 3.0IG# 0.01IG% 0.4 Aug-08-2022 0535 Chemistry GLUCOSE 198BUN 53CREAT 2.1MDRD GFR 30NA 136K 4.7CL 105CALCIUM 8.0ALK PHOS 121CO2 24.4AST 39ALT 29AST/ALT 1.3TL PROT 5.2ALBUMIN 2.5TBILI 0.2OSMO 291.9ANION GP 11.3BUN/CRE 25.2CRP 6.70MAGNESIU 2.1 Aug-07-2022 0515 Chemistry CRP 7.70 Aug-06-2022 1930 Chemistry TROPI-HS 108 Aug-06-2022 1340 Serology PROCALC 2.02 Aug-06-2022 1340 Chemistry CRP 4.20HGBA1C 7.6TROPI-HS 147 Aug-06-2022 1322 Coagulation D-DIMER 0.56 Aug-06-2022 1322 Chemistry LDH 227DBILI 0.1 Aug-06-2022 0934 Serology COVID PosINFLUA NegINFLUB Neg Aug-06-2022 0934 Hematology WBC 5.4RBC 3.28HGB 9.8HCT 30.0MCV 91.5MCH 29.9MCHC 32.7RDW 13.3RDWSD 44.9PLT 132MPV 11.5AUTONEU% 75.2AUTOLYM% 10.9AUTOMON% 13.3AUTOEOS% 0.0AUTOBAS% 0.2AUTONEU# 4.1AUTOLYM# 0.6AUTOMON# 0.7AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.1IG# 0.02IG% 0.4 Aug-06-2022 0934 Chemistry GLUCOSE 192BUN 37CREAT 2.2MDRD GFR 29NA 139K 4.4CL 107CALCIUM 7.3ALK PHOS 103CO2 19.4AST 34ALT 24AST/ALT 1.4TL PROT 4.8ALBUMIN 2.8TBILI 0.4OSMO 291.4ANION GP 17.0BUN/CRE 16.8LACTATE 0.80MAGNESIU 1.6PROBNP 15908TROPI-HS 131 Functional Status* No Functional Impairments Mental Status* Normal Cognition Social History tobacco use Smoker, Current Status Unknown, Smoking Cessation Not Applicable alcohol use No Known Use drug use No Known Use marital status Married Health Concerns Diabetes mellitus Persistent atrial fibrillation Peripheral vascular disease Chronic renal insufficiency History of coronary artery bypass grafting Coronary arteriosclerosis Sinus bradycardia Acute COVID-19 Smoker, Current Status Unknown Father Deceased @ unknown age Myocardial infarction @ 65 Mother Deceased Malignant neoplastic disease @ 86 Diabetes mellitus Daughter Alive Diabetes mellitus Vital Signs Aug-08-2022 0802 O2Sat 98 Aug-08-2022 0800 T 97.8 HR 45 RR 15 BP 149 / 59 O2Sat 98 Aug-08-2022 0417 T 97.8 HR 49 RR 17 BP 161 / 61 PHYSICAL EXAM PHYSICAL EXAM CONSTITUTIONAL: Patient is pleasant, appears comfortable, non-toxic, and in no acute distress. Patient is sitting in wheelchair washing his hair. CARDIOVASCULAR: Heart has regular rate and rhythm, no edema noted. RESPIRATORY: Patient is on room air. Lungs clear to auscultation throughout. Respiratory effort is non-labored, no use of accessory muscles noted. Patient is non-cyanotic appearing. GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive. NEUROLOGICAL: Patient is alert and oriented to person, place, time, and situation. PSYCHIATRIC: Patient's is calm, cooperative, affect is appropriate. Consultations Cardiology Hospital Course Pt. is a 81-year-old male with a medical history of diastolic heart failure, atrial fibrillation, hypothyroidism, coronary arterial disease, sleep apnea and chronic kidney disease. He arrived at the emergency department with profound weakness, that had been worsening for 3 days and erythema and edema on the anterior aspect of the left lower limb in the setting of COVID-19. Patient was admitted to inpatient under internal medicine with the incidental finding of elevated troponins in the absence of chest pains along with profound bradycardia/junctional rhythm with prolonged QTc and an extensive cardiac history. On admission, patient was found to have hypomagnesemia which was treated with magnesium sulfate and resolved as well as hypocalcemia resolved without intervention. Dr was consulted and ordered cardiac echo and cardiac stress test to evaluate heart failure. Patient was treated with Lasix 40mg with resolution of lower limb edema. X-ray of left tib-fib and doppler ordered to rule out underlying pathology were unremarkable. Per echocardiogram, patient was found to have chronic heart failure with preserved ejection, grade I diastolic dysfunction with LV ventricular ejection fraction >60%. Patients home medications of amiodarone and zoloft were held due to QTc prolongation. Home Apixiban was held, heparin 5000 unit Q8h was started for DVT prophylaxis. A single transient instance of oxygen desaturation to 92% occurred during sleep on the first night inpatient, resolved with 2L of oxygen which was weaned off the next morning with no further intervention. Over the course of the stay troponin peaked at 148 and trended down. Amlodipine 2.5mg was started due to worsening hypertension. Patient has remained asymptomatic for bradycardia for the duration of his stay. Patient was stable at time of discharge. Condition at Discharge Stable Discharge Medications ACETAMINOPHEN 650 MG ORALLY DAILY AT 1700 amLODIPine BESYLATE 2.5 MG ORALLY EVERY DAY BLOOD PRESSURE (ePrescribed on Aug-08-2022 1719) APIXABAN 2.5 MG ORALLY TWICE DAILY Arginaid Packet 1 PKT ORALLY ONCE A DAY Atorvastatin Calcium Tablet 80 MG 80 MG ORALLY DAILY AT BEDTIME B Complex Capsule 1 CAP ORALLY ONCE A DAY FERROUS SULFATE 650 MG ORALLY EVERY 48 HOURS Fiber Formula Capsule 1 CAP ORALLY ONCE A DAY finasteride 5 mg tab 5 MG ORALLY ONCE A DAY gabapentin 600 mg tab 600 MG ORALLY TWICE DAILY hydrALAZINE HCl Tablet 25 MG 25 MG ORALLY 3 TIMES A DAY HYDROcodone-Acetaminophen Tablet 5-325 MG Continue taking same as home Lasix Oral Tablet 20 MG Continue taking same as home Levemir U-100 Insulin 100 unit/mL soln 15 UNT SUBCUTANEOUS ONCE A DAY levothyroxine 125 mcg cap 125 MCG ORALLY ONCE A DAY MULTIVITAMIN M PLUS 1 TAB ORALLY ONCE A DAY NovoLOG Solution 100 UNIT/ML 10 UNT SUBCUTANEOUS BEFORE MEALS Plavix 75 mg tab 75 MG ORALLY ONCE A DAY Vitamin D3 Capsule 125 MCG (5000 UT) 125 MCG ORALLY ONCE A DAY Zoloft 25 mg tab 25 MG ORALLY ONCE A DAY Discharge Disposition Discharge to home Plan Assessment: -Type II myocardial infarction, due to demand ischemia from COVID-19 and CKD, troponin improved from 147 to 108 -Sinus bradycardia, history of sick sinus syndrome -QTc prolongation, secondary to QTc prolonging medications - improved -Essential hypertension -Chronic heart failure with preserved ejection, grade I diastolic dysfunction with LV ventricular ejection fraction >60% per echocardiogram on 08/07/22, possible acute decompensation -Profound weakness, secondary to COVID19 infection - improved -COVID 19 infection, not in respiratory failure -Diarrhea, most likely secondary to COVID-19 infection - resolved -Thrombocytopenia, likely acute response to COVID -Non-anion gap metabolic acidosis, likely renal etiology, improved -Acute kidney injury on chronic kidney disease stage 3a, creatinine 2.1 and baseline 1.6 - Stable -Hypomagnesemia, Mg 1.6 on admission - Resolved -Hypocalcemia, corrected Ca 8.3 on admission - Resolved -Hx of cellulitis with chronic bilateral diabetic foot wounds, osteomyelitis of the left heel and amputation of right toes 1-2 -Paroxysmal atrial fibrillation with rapid ventricular response, currently sinus rhythm -Coronary artery disease with chronic angina and placement of multiple stents with history of open-heart surgery -Type 2 diabetes mellitus with neuropathy and retinopathy, poorly controlled on long-term insulin -Hyperlipidemia -Peripheral vascular disease -Chronic iron deficiency anemia, Hgb 9.8 on admission - Stable -Hypothyroidism, on levothyroxine -Chronic constipation -Depressive disorder, moderate, recurrent, on Zoloft Plan: Patient will discharge to home. Will resume all home medications except for amlodipine due to bradycardia and QTc prolongation. Patient will be starting amlodipine 2.5mg daily for hypertension. Patient will be sent home on a holter monitor for 7 days, given to him before discharge. Further discussion of CKD should be had with primary care provider. Primary Care Provider Electronically signed on Aug-08-2022 1857

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertensive disorder Diastolic heart failure Benign prostatic hyperplasia Angina pectoris Depressive disorder Carotid artery occlusion Hypothyroidism Vitamin D deficiency Chronic kidney disease Heart failure Atrial fibrillation Sleep apnea Hyperlipidemia Diabetic neuropathy Diabetes mellitus Coronary arteriosclerosis
Andere Medikamente: -
Allergien: ACE Inhibitors
Vorherige Impfungen: -

VAERS 2402972

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 05.08.2022
Impfdatum: 24.01.2021
Beginn: 25.07.2022
Tage bis Beginn: 547,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal COVID-19 COVID-19 pneumonia Dyspnoea SARS-CoV-2 test positive

Symptomtext

7/25--7/27 76y.o. male who was admitted to the hospital with shortness of breath and COVID-19 pneumonia. Medical problems treated during this admission are detailed below: Acute hypoxic respiratory failure due to COVID-19 pneumonia - Tested positive on 7/22, with onset of symptoms 7/20. Vaccinated but not boosted. History of CLL. Mild O2 requirement to 2-3L during admission with evidence of pneumonia seen on CTA pulmonary. Infectious disease consulted during admission and recommended remdesivir, which patient declined. He was able to be weaned off O2 and home O2 evaluation did not reveal need for home oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 7/25 -- SARS-CoV-2 detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2399114

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 67,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 10.05.2022
Beginn: 29.07.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Aortic stenosis Arteriosclerosis Aspartate aminotransferase normal Base excess increased Basophil count decreased AST/ALT ratio Acute respiratory failure Alanine aminotransferase normal Anaemia Anion gap Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate increased Blood bilirubin normal Blood calcium decreased Blood chloride decreased Blood creatine phosphokinase MB increased

Symptomtext

Date of Service Aug-01-2022 0812 Date of Admission Admit Date: Jul-29-2022 Date of Discharge Date of discharge Aug-01-2022 Allergies No Known Allergies Chief Complaint shortness of breath Procedure(s) Performed None Lab Results Aug-01-2022 0643 Serology PROCALC <0.05 Aug-01-2022 0620 Chemistry MAGNESIU 1.5 Aug-01-2022 0504 Chemistry GLUCOSE 113BUN 14CREAT 0.8MDRD GFR 96NA 134K 4.0CL 96CALCIUM 8.3CO2 36.3OSMO 269.5ANION GP 5.7BUN/CRE 17.5CRP <0.05 Aug-01-2022 0504 Hematology WBC 12.7RBC 2.91HGB 9.0HCT 27.1MCV 93.1MCH 30.9MCHC 33.2RDW 14.6RDWSD 49.0PLT 181MPV 9.8AUTONEU% 84.3AUTOLYM% 7.2AUTOMON% 7.6AUTOEOS% 0.2AUTOBAS% 0.1AUTONEU# 10.7AUTOLYM# 0.9AUTOMON# 1.0AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.0IG# 0.08IG% 0.6 Jul-31-2022 1951 Rad 1610164 Jul-31-2022 1605 Hematology HGB 10.1HCT 30.2 Jul-31-2022 1106 Blood Bank PRBC Issued OposUNIT# EXP DATE 08/10/22 Jul-31-2022 0815 Blood Bank PRBC Issued O PosUNIT# EXP DATE 08/10/22 Jul-31-2022 0700 Blood Bank ABO ORH PosAB SC NegCROSS #1 CompCROSS #1 CompCROSS#2 Comp Jul-31-2022 0510 Chemistry GLUCOSE 128BUN 11CREAT 0.6MDRD GFR 134NA 131K 4.0CL 94CALCIUM 8.0ALK PHOS 67CO2 35.8AST 16ALT 14AST/ALT 1.1TL PROT 5.1ALBUMIN 2.6TBILI 0.2OSMO 263.7ANION GP 5.2BUN/CRE 18.3CRP <0.1MAGNESIU 1.5 Jul-31-2022 0510 Hematology WBC 19.4RBC 2.15HGB 6.8HCT 19.8MCV 92.1MCH 31.6MCHC 34.3RDW 13.1RDWSD 44.1PLT 401MPV 9.1AUTONEU% 91.7AUTOLYM% 3.3AUTOMON% 4.2AUTOEOS% 0.1AUTOBAS% 0.1AUTONEU# 17.8AUTOLYM# 0.6AUTOMON# 0.8AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 2.9PSMEAR To IG# 0.11IG% 0.6 Jul-31-2022 0510 Serology PROCALC <0.05 Jul-31-2022 0343 Chemistry TROPI-HS 9 Jul-31-2022 0209 Chemistry GLUCOSE 137BUN 13CREAT 0.6MDRD GFR 134NA 129K 4.4CL 91CALCIUM 8.6ALK PHOS 94CO2 35.6AST 18ALT 16AST/ALT 1.1TL PROT 6.0ALBUMIN 3.1TBILI 0.2OSMO 261.2ANION GP 6.8BUN/CRE 21.7TROPI-HS 10 Jul-31-2022 0209 Coagulation PT 10.9INR 1.0D-DIMER 0.26 Jul-31-2022 0208 Blood Gas PH VEN 7.37PCO2 VEN 63.8PO2 VEN 39BICARB V 35.7BE VEN 9.6CO2 CT V 34.4O2 SAT V 80.4 Jul-30-2022 0615 Chemistry GLUCOSE 154BUN 15CREAT 0.7MDRD GFR 112NA 128K 4.5CL 90CALCIUM 8.2CO2 35.9OSMO 261.0ANION GP 6.6BUN/CRE 21.4 Jul-30-2022 0040 Chemistry NA-U 16OSMO-U 435 Jul-29-2022 2050 Blood Gas PH 7.390PC02 63.1PO2 ART 127.0BICARB 37.3BE 11.0CO2 CT 35.1O2 SAT 98.9O2 THER 40TYPEABG Arterial Jul-29-2022 1829 Serology COVID PosINFLUA NegINFLUB NegCVD1TEST NCVDEMPHC NCVDSYMP NCVDSYMDT UCVDHOSP NCVDICU NCVDRESID NCVDPREG N Jul-29-2022 1740 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Jul-29-2022 1714 Blood Gas PH VEN 7.30PCO2 VEN 91.3PO2 VEN 28BICARB V 43.5BE VEN 14.5CO2 CT V 41.8O2 SAT V 42.3 Jul-29-2022 1714 Chemistry GLUCOSE 106BUN 13CREAT 0.7MDRD GFR 112NA 126K 4.6CL 84CALCIUM 8.7ALK PHOS 108CO2 40.0AST 23ALT 18AST/ALT 1.3TL PROT 7.2ALBUMIN 3.5TBILI 0.2OSMO 253.9ANION GP 6.6BUN/CRE 18.6CRP 0.20LACTATE 1.10CK-MB 4.0MYO 40TROPI-HS 12 Jul-29-2022 1714 Hematology WBC 12.5RBC 3.41HGB 10.6HCT 31.2MCV 91.5MCH 31.1MCHC 34.0RDW 13.2RDWSD 43.6PLT 622MPV 8.8AUTONEU% 71.2AUTOLYM% 12.9AUTOMON% 9.6AUTOEOS% 4.8AUTOBAS% 0.7AUTONEU# 8.9AUTOLYM# 1.6AUTOMON# 1.2AUTOBAS# 0.1AUTOEOS# 0.6NRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.10IG% 0.8 Jul-29-2022 1714 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Jul-29-2022 1714 Serology PROCALC <0.05 Imaging Results CR - Chest 2 views (PA or AP and lateral) performed on 07/31/2022 Findings: No consolidation or effusion. A small calcified granuloma is located in the apex of the LEFT lung. Heart size normal. No acute fracture. Impression: There is hyperinflation with emphysematous changes. There is mild peripheral LEFT mid lung pleural thickening in the region of prior healed rib fractures. Electronically signed on Jul 31, 2022 4:16:05 PM by: MD EKG performed on 07/31/2022 Sinus rhythm Borderline right axis deviation Probable anteroseptal infarct, old Electronically Signed On 8-1-2022 8:42:10 by DO CR - Chest 1 view performed on 7/31/2022 FINDINGS: Mild to moderate centrilobular emphysematous disease changes. Mild chronic interstitial thickening. The lungs are clear of infiltrate. Incidental benign calcified lung parenchymal granuloma. No pleural effusion or pneumothorax. Cardiac size and mediastinal contours within normal limits. No acute displaced fracture or aggressive appearing osseous lesion. IMPRESSION: No radiographically evident acute cardiopulmonary pathologic process. Electronically signed on Jul 31, 2022 4:12:14 AM by: MD CH-CHEST 1V DR performed on 07/29/22 IMPRESSION: No significant change since 7/20/2022. DICTATED, TRANSCRIBED, AND ELECTRONICALLY SIGNED BY: MD DICTATED DATE AND TIME: 7/29/2022 5:36 PM CT chest with contrast Impression: 1. Normal caliber thoracic aorta. No evidence of mediastinal hematoma or pneumomediastinum. 2. Centrilobular emphysema. Spiculated nodular opacity left upper lobe measuring 2.1 x 1.3 cm with adjacent pleural thickening inflammatory versus neoplastic will need follow-up. No pleural effusions or pneumothorax. 3. Nondisplaced left fourth rib fracture possibly acute. Electronically signed on Jun 25, 2022 5:58:56 AM by: MD Board of Radiology Functional Status* No Functional Impairments Mental Status* Normal Cognition Social History tobacco use Current Every Day Smoker, 1 1/2 Packs Per Day, Smoking Cessation Yes alcohol use Beer, Current, 36 Drinks Per Day drug use No Known Use marital status Divorced He lives alone Health Concerns Tobacco user Current Every Day Smoker, 1 1/2 Packs Per Day Beer, Current, 36 Drinks Per Day Father Deceased @ unknown age Heart disease; Malignant neoplastic disease Mother Deceased @ unknown age Alcoholism; Tobacco user Tobacco Cessation* FDA Tobacco Cessation Medication has been prescribed (see discharge medications) Vital Signs Aug-01-2022 0629 T 98.4 HR 82 RR 17 BP 150 / 71 O2Sat 100 O2L 4 Aug-01-2022 0542 WGT 126.1 Jul-30-2022 1200 T 98.4 HR 76 RR 24 BP 136 / 72 O2Sat 100 O2L 3 Pt is on 4L supplemental oxygen via nasal cannula. PHYSICAL EXAM CONSTITUTIONAL: Patient is sitting up in bed, is in no acute distress at this time. Patient appears slightly diaphoretic as he complained that the room was too hot. CARDIOVASCULAR: Regular rate and rhythm without murmur, gallop, or rub. No edema present in the lower extremities. Radial pulses intact 2+ bilaterally. RESPIRATORY: Decreased lung sounds. No wheezing, rhonchi, or rales appreciated. Patient is on 4L O2 nasal cannula. GASTROINTESTINAL: Abdomen is soft, non-tender to palpation. No rebound or guarding. No distension. No ascites. No organomegaly appreciated. MUSKULOSKELETAL: chronically ill-appearing NEUROLOGICAL: AOx4, normal sensation on upper and lower extremities. PSYCHIATRIC: RASS = 0. Patient responds appropriately to questions and displays normal affect. Consultations No consultations Hospital Course Patient is a 68 y/o male who presented to the ED on 7/29/22 for shortness of breath secondary to COPD exacerbation. The likely cause of his exacerbation was that he had run out of his inhalers, and he can't afford to get new inhalers. Patient reports his home oxygen is set on 4-5L. Patient reports he is still smoking 1.5 packs a day and is trying to quit. He has a PMH of end stage COPD, HTN, CAD with 3x bypass, chronic alcoholism, tobacco use disorder, and prediabetes. Patient was initially treated for his COPD exacerbation with BIPAP for approximately 30 minutes before he began to refuse it. He was made aware of the risks and benefits of BIPAP and continued to refuse BIPAP. His COPD exacerbation was then managed with oxygen via NC titrated to maintain oxygen saturation > 88%, doxycycline 100mg BID, cefepime 2g Q8H to cover pseudomonas due to a chronic alcoholism, albuterol Q6H per RT, guaifenesin 600mg BID, dexamethasone 6mg daily during his hospital stay. On 7/29/22 his Hgb was found to be 10.6, which dropped to 6.8 on 7/31/22, and was suspected to have either GI bleed, esophageal varices, or it could have been dilutional after receiving fluids. He refused to have EGD done. As a precaution, his low Hgb was managed with 2 units PRBC, sucralfate before meals and at bedtime, pantoprazole 40mg twice daily before meals. Pt is at high risk for GI bleed/esophageal varices due to alcoholism. On 7/31/22 at 0206, nursing reports that the patient's O2 sat suddenly dropped into the 50s. Patient's saturation improved after 15L non-rebreather and patient was worked up for PE and NSTEMI. Patient's O2 sat improved and he was titrated back to 3 L nasal cannula. This morning (8/1/22), the patient denies any problems and states he is ready to go home to take care of his cats. Patient had reported that he is out of inhalers until the 7th of August because the insurance company will only pay for inhalers once a month. He states that respiratory therapy gave him some inhalers to take home to get him by until the 7th. Patient states that he is able to move around without any problems, and is able to urinate without issues. His last bowel movement was a couple days ago, but he states that this is not unusual for him. The patient improved overall and feels he is back to baseline. He was deemed ready for discharge. Condition at Discharge Stable Discharge Medications albuterol sulfate 90 mcg/actuation HFAA Continue taking same as home Anoro Ellipta Inhalation Aerosol Powder Breath Activated 62.5-25 MCG/INH 1 PUF INHALATION ONCE A DAY Aspirin Oral Tablet Chewable 81 MG 1 TAB CHEWED ONCE A DAY atorvastatin 40 mg tab 1 TAB ORALLY AT BEDTIME BENZONATATE Continue taking same as home carvedilol 3.125 mg tab 1 TAB ORALLY ONCE A DAY cetirizine 10 mg tab 1 TAB ORALLY ONCE A DAY clopidogrel 75 mg tab 1 TAB ORALLY ONCE A DAY Combivent Respimat Aerosol Solution 20-100 MCG/ACT 1 PUF INHALATION 4 TIMES A DAY fluoxetine 20 mg cap 3 CAP ORALLY ONCE A DAY GUAIFENESIN ER 600 MG ORALLY TWICE DAILY irbesartan 150 mg tab 1 TAB ORALLY ONCE A DAY Iron (Ferrous Sulfate) Tablet 325 (65 Fe) MG 325 MG ORALLY 3 TIMES A DAY isosorbide mononitrate 30 mg Tb24 1 TAB ORALLY ONCE A DAY levoFLOXacin Oral Tablet 750 MG 750 MG ORALLY ONCE A DAY NICOTINE TRANSDERMAL 21 MG / 24 HR 21 MG TRANSDERMAL ONCE A DAY Nitroglycerin Tablet 0.4 MG Continue taking same as home olanzapine 5 mg tab 1 TAB ORALLY AT BEDTIME PANTOPRAZOLE 40 MG ORALLY ONCE A DAY predniSONE Oral Tablet 20 MG 40 MG ORALLY ONCE A DAY predniSONE Tablet 10 MG 10 MG ORALLY ONCE A DAY SODIUM CHLORIDE 0.65% 45 ML Continue taking same as home SUCRALFATE 1 GM ORALLY BEFORE MEALS AND AT BEDTIME Discharge Disposition Discharge to home Plan ASSESSMENT: - Sepsis secondary to COVID-19 infection vs pneumonia, improving - Acute on chronic hypercapnic hypoxic respiratory failure secondary to acute exacerbation of chronic obstructive pulmonary disease, pH 7.37, pCO2 63.8 per venous blood gas on 7/31 - improving - Acute exacerbation of chronic obstructive pulmonary disease secondary to COVID-19 infection, resulting in respiratory failure requiring BiPAP, improving currently on baseline oxygen 4L - COVID-19 infection, symptom onset 7/24, positive test on 7/29 - Acute on chronic normocytic anemia, Hgb 10.6 and Hct 31.2 on admission, likely secondary from chronic alcoholism, Hgb 6.8 on 7/31/22 - Acute hypomagnesaemia, Mg 1.5 on 7/31/22, likely secondary to poor nutrition from alcoholism - Chronic hyponatremia, Na 126 on admission, likely secondary to poor nutrition from alcoholism, resolved - Chronic hypochloremia, Cl 84 on admission, likely secondary to malnutrition and alcoholism, persistent - Thrombocytosis, chronic intermittent, Plt 622 on admission, likely secondary to acute inflammatory response vs rebound thrombocytosis from chronic alcoholism, resolved - Acute leukocytosis, WBC 12.5 on admission, likely secondary to acute inflammatory response - Spiculate nodule opacity left upper lobe measuring 2.1 x 1.3 cm, per CT on 6/25/22 - Coronary artery disease with history of multiple coronary artery bypass graft, chronic, controlled on home medications - Long-term use of anticoagulants, clopidogrel - Hypertension, chronic, unknown control on home medications - Hyperlipidemia, chronic, unknown control on home medications - Gastroesophageal Reflux Disease, chronic, unknown control on home medications - Trivial mitral valve regurgitation on echocardiogram 2/21/22 - Mild aortic stenosis on echocardiogram 2/21/22 - Mild mitral valve regurgitation on echocardiogram 2/21/22 - Atherosclerotic peripheral vascular disease, chronic, per arterial doppler 3/21/22 - Moderate protein-calorie malnutrition, chronic - Tobacco use disorder, current 1.5 pack per day smoker - Alcohol dependence, current 2 shot and 4 beers per day drinker - Underweight, BMI 20.596 PLAN: The patient's condition is stable at this time and will be discharged today to home. We will discharge the patient on their home medications as reconciled above. We will send the patient home with levofloxacin 750 mg q.d. and prednisone 40 mg q.d. for 5 days on discharge for coverage of COVID and bacterial pneumonia. Patient tried Trelegy which helped him with his COPD however his insurance does not cover the medication. We called and spoke with the pharmacy and they said that he needs to try another inhaler before the Trelegy would be covered by insurance. We will start him on Anoro inhaler 1 puff qd; he is to discontinue his other inhalers other than the albuterol. Patient was found to have anemia (Hgb 6.8 on 7/31/22) and was given 2uPRBC. He refused EGD so we are unable to confirm GI bleed, but given significant risk factors for GI bleed and esophageal varices, we will have the patient take sucralfate 1gm qid and pantoprazole 40 mg qd. They are to resume a cardiac diet and resume activity as tolerated. We counseled the patient on alcohol and tobacco cessation. We recommend the patient follow up with PCP Dr. and an appointment was scheduled on 8/9/22 at 2:40pm for hospital follow-up for COPD exacerbation, anemia, blood smear results, and to go over the incidental finding of spiculated LUL lung nodule per CT 6/25/22. The patient was seen and evaluated by Dr. and the plan of care was discussed with this resident. DO Family Medicine, PGY-1 Primary Care Provider DO DO Electronically signed by RESIDENT DO on Aug-01-2022 1422 I have seen and physically examined the patient on 8/1/22 and agree with the documentation of PGY-1. I have also discussed my findings and plan of care with PGY-1. Any changes and additional information are listed below. Electronically signed by DO on Aug-01-2022 1847

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Myocardial infarction Hypertensive disorder Tobacco user Gastroesophageal reflux disease Hyperlipidemia Hypertensive disorder Coronary atherosclerosis Congestive heart failure Chronic obstructive lung disease
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2399106

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: MO
Alter: 57,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 29.12.2021
Beginn: 26.07.2022
Tage bis Beginn: 209,0
Dosis: N/A
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alcohol abuse Anion gap Anticoagulant therapy Arteriosclerosis Ascites Aspartate aminotransferase increased Auscultation Basophil count decreased Basophil percentage decreased Bilirubin conjugated increased AST/ALT ratio Abdominal discomfort Abdominal distension Abdominal pain Alanine aminotransferase increased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin increased

Symptomtext

Date of Service- Aug-01-2022 06:48. Chief Complaint: pain. HPI / Subjective: Patient is a 58 year old male who was transferred to our facility from alternate Hospital due to a suspected small bowel obstruction. On presentation he was found to be COVID-19 positive. His past medical history is significant for hypertension, methamphetamine use, and tobacco abuse. The internal medicine team was consulted in the care of this patient for his continued abdominal complaints despite treatment complicated by his COVID-19 positive status. He is on hospital day 7. Yesterday afternoon the patient attempted to consume a full liquid diet but did not tolerate this. He had significant abdominal pain overnight requiring Dilaudid. This morning the patient is seen resting in his hospital bed. He is having a lot of abdominal cramping and discomfort. The pain is primarily in the lower quadrants of the abdomen. Any pressure in the lower quadrants makes the pain worse. The Dilaudid helps the most. He was able to sleep overnight with the pain medication. No stool has been passed recently. Some gas has passed but is minimal. He did not have any episodes of emesis. REVIEW OF SYSTEMS Constitutional: Patient denies fevers and chills. Cardiovascular: Patient denies palpitations, chest pain, and lower extremity edema. Respiratory: Patient denies dyspnea, cough, and sputum production. Gastrointestinal: Patient denies nausea, vomiting, constipation, diarrhea. Reports abdominal pain. Genitourinary: Patient denies dysuria or hematuria. Neurologic: Patient denies headache or dizziness. Objective: Vital Signs- Aug-01-2022 06:46 T 97.8 HR 53 RR 16 BP 160 / 86 O2 Sat 100 Aug-01-2022 0430 T 97.9 HR 58 RR 16 BP 136 / 89 O2 Sat 99 Intake and Output: previous day current day: encounter cumulative: Intake 550 ? 15208 Output 5 ? 808 Diff (I-O) 545 ? 14400 PHYSICAL EXAM: Constitutional: Patient appears older than stated age, acutely and chronically ill, and is in no acute distress at this time. Cardiovascular: Regular rate and rhythm without murmur, gallop, or rub. No edema present in the lower extremities. Radial pulses intact 2+ bilaterally. Respiratory: Lungs clear to auscultation bilaterally, no wheezing, no rhonchi, no rales. No accessory muscle use, no respiratory distress. Patient is currently on room air. Gastrointestinal: The patient refused an abdominal examination this morning. Abdomen appears distended. Psychiatric: Patient responds appropriately to questions and displays flat affect. His responses are short. Appears to have good judgment. Lab Results: Aug-01-2022 05:05 Chemistry: GLUCOSE 124BUN 30CREAT 0.8MDRD GFR 99NA 132K 4.5CL 100CALCIUM 7.4ALK PHOS 79CO2 22.9AST 73ALT 66AST/ALT 1.1TL PROT 6.3ALBUMIN 2.0TBILI 1.3DBILI 0.4OSMO 272.1ANION GP 13.6BUN/CRE 37.5 Aug-01-2022 05:05 Hematology WBC 17.1RBC 4.79HGB 14.3HCT 41.3MCV 86.2MCH 29.9MCHC 34.6RDW 17.0RDWSD 50.3PLT 75MPV 10.4AUTONEU% 78.2AUTOLYM% 10.0AUTOMON% 8.0AUTOEOS% 1.5AUTOBAS% 0.2AUTONEU# 13.4AUTOLYM# 1.7AUTOMON# 1.4AUTOBAS# 0.0AUTOEOS# 0.3NRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.35IG% 2.1 Procedure(s) Performed: None Active Medications: GUAIFENESIN ER 600 MG ORALLY BIDPRN for COUGH BENZONATATE 100 MG ORALLY Q8HPRN for COUGH FUROSEMIDE 20 MG ORALLY DAILY SPIRONOLACTONE 50 MG ORALLY DAILY cefTRIAXone INJ 2000 MG IV Q24HI 200 ML/HR SODIUM CHLORIDE 0.9% MINIBAG+ 100 ML PLEASE ENTER INDICATION IN COMMENTS: possible peritonitis **do not run with lactated ringers, flus h line before and after administration** GABApentin 600 MG ORALLY BEDTIME DEXAMETHASONE INJ 4 MG/ML 6 MG IV PUSH DAILY PROPRANOLOL HCL 10 MG ORALLY TID hold for HR <60 or SBP <105 LABETALOL HCl INJ 20 MG / 4 ML 10 MG IVP Q1HPRN for ELEVATED BLOOD PRESSURE For systolic blood pressure >160 and heart rate >60. Notify physician if 3 does are used in 3 hours. (Suspend) ENOXAPARIN INJ 40 MG / 0.4 ML 40 MG SUBCUT DAILY for creatinine clearance greater than or equal to 30 milliliters / minute amLODIPine BESYLATE 2.5 MG ORALLY QDBP ***note dose** *** 1/2 tablet *** ASPIRIN EC 325 MG ORALLY DAILY traMADoL HCL 50 MG ORALLY Q6HPRN for SEVERE PAIN (7-10 ON PS) Use first, before Dilaudid DOCUSATE SODIUM 100 MG ORALLY BID LORATADINE 10 MG ORALLY DAILY FAMOTIDINE MAXIMUM STRENGTH 20 MG ORALLY BID HYDROmorphone HCL 0.5 MG/0.5ML 0.5 MG IV PUSH Q2HPRN for SEVERE PAIN (7-10 ON PS) For breakthrough pain only. PROMETHAZINE HCL INJ 25 MG/ 1 ML 12 MG IVPB Q6HPRN 200 ML/HR for NAUSEA/VOMITING SODIUM CHLORIDE 0.9% MINIBAG+ 50 ML infuse over 15 minutes Give SECOND. Give only if first choice is ineffective. ONDANSETRON HCl INJ 4 MG / 2 ML 4 MG IVPUSH Q8HPRN for NAUSEA/VOMITING Give FIRST: ACETAMINOPHEN 650 MG ORALLY Q4HPRN for FEVER OR MILD PAIN 1-3 ON PS max 4,000 milligrams acetaminophen per 24 hours Plan Assessments: - Severe sepsis due to spontaneous bacterial peritonitis, improving - Possible underlying enteritis due to COVID-19 infection vs transient bowel ischemia secondary to methamphetamine use vs bowel wall edema from 3rd spacing leading to SBP - COVID-19 infection without hypoxia - Abdominal pain with Constipation, possible ileus - Hepatitis C, not previously treated - Essential hypertension unknown control - Normocytic anemia, uncertain chronicity - Moderate ascites seen on CT July 2022 - Splenomegaly seen on CT July 2022 - Esophageal varices seen on CT July 2022 - Suspected chronic liver disease - Coronary artery disease - Right sided pleural effusion - Hyperbilirubinemia, Indirect - Osteoarthritis - Elevated transaminases, improving - Thrombocytopenia, improving - Abdominal atherosclerosis seen on CT July 2022 - Cirrhosis of the liver seen on CT July 2022 with nodules appreciated, malignancy vs regeneration secondary to alcohol abuse vs hepatitis c - Cholelithiasis seen on CT July 2022 - Nephrolithiasis seen on CT July 2022 - Gynecomastia seen on CT July 2022 - Mild protein calorie malnutrition - Marijuana use - Methamphetamine use - Chronic tobacco abuse - History of alcohol use disorder, sober for 3 years Recommendations: As the patient has been somewhat bradycardic, I will hold the propranolol at this time as this will worsen his heart rate. The spironolactone and Lasix have been held which should help the hyponatremia. The patient appears dry this morning which would be worsened by the diuretics as well. He will need to be started on a regimen for ascites once his oral intake improves and he can tolerate it. I discussed the patient's viral RNA load with him. He will need close follow up outpatient and treatment for his hepatitis C. We discussed that without treatment he will have the risk of developing hepatic failure and hepatocellular carcinoma. We will continue to trend his inflammatory markers. The internal medicine team would like to thank Dr. for including us in the care of his patient. We will be forthcoming with further recommendations as they arise. Electronically signed by DO DO on Aug-01-2022 09:24.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gynaecomastia
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Viral hepatitis C Drug abuse Hypertensive disorder Alcoholism, Drank for 47 years and quit in 2019. Arthritis
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2396057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 29.07.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

I had shots before I got the stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1, single), administration date: 2021, for COVID-19 Immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "I had shots before I got the stroke". Clinical course: Patient got 2 shots for COVID a year ago. Patient had not gotten the booster. First of all 6 months ago patient had a stroke that well patient was stuck and the result that patient didn't get the booster and later on patient found that there has not been any kind of study on people at patient age, patient was 80 So, patient wanted to know why was not there any studies on patient's age regarding the vaccine and regarding the booster. So, patient had not taken the booster. Patient doctor did not know either. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2376629

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 67,0
Geschlecht: M
Eingang: 21.07.2022
Impfdatum: 31.03.2021
Beginn: 13.07.2022
Tage bis Beginn: 469,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Alanine aminotransferase normal Anion gap Aortic arteriosclerosis Aspartate aminotransferase normal Basophil count decreased Basophil percentage decreased Bilirubin conjugated Bladder catheterisation Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate decreased Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood cholesterol normal Blood creatinine increased

Symptomtext

Date of Service Jul-20-2022 0624 Date of Admission Admit Date: Jul-13-2022 Date of Discharge Date of discharge Jul-20-2022 Allergies Codeine - Shock Chief Complaint Shortness of breath Final Diagnoses Acute renal failure syndrome resolved Acute on chronic hypoxemic respiratory failure Resolved Jul-20-2022 Pneumonia caused by SARS-CoV-2 Resolved Jul-20-2022 Difficult venous access Resolved Jul-20-2022 Procedure(s) Performed None Lab Results Jul-20-2022 0528 Point Of Care Jul-20-2022 0510 Hematology WBC 11.0RBC 4.46HGB 10.6HCT 33.7MCV 75.6MCH 23.8MCHC 31.5RDW 18.0RDWSD 48.0PLT 202MPV TnpAUTONEU% 82.7AUTOLYM% 7.2AUTOMON% 8.5AUTOEOS% 0.2AUTOBAS% 0.1AUTONEU# 9.1AUTOLYM# 0.8AUTOMON# 0.9AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.14IG% 1.3 Jul-20-2022 0510 Chemistry GLUCOSE 142BUN 59CREAT 2.3MDRD GFR 28NA 135K 4.2CL 102CALCIUM 8.5ALK PHOS 60CO2 26.0AST 8ALT 13AST/ALT 0.6TL PROT 5.8ALBUMIN 2.7TBILI 0.4OSMO 289.1ANION GP 11.2BUN/CRE 25.7 Jul-19-2022 1951 Point Of Care Jul-19-2022 1659 Point Of Care Jul-19-2022 1207 Point Of Care Jul-19-2022 0440 Hematology WBC 11.5RBC 4.40HGB 10.5HCT 34.0MCV 77.3MCH 23.9MCHC 30.9RDW 17.9RDWSD 49.6PLT 206MPV TnpAUTONEU% 83.2AUTOLYM% 7.6AUTOMON% 8.2AUTOEOS% 0.0AUTOBAS% 0.1AUTONEU# 9.6AUTOLYM# 0.9AUTOMON# 0.9AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.10IG% 0.9 Jul-19-2022 0440 Chemistry GLUCOSE 147BUN 57CREAT 2.4MDRD GFR 27NA 135K 3.8CL 102CALCIUM 8.2CO2 24.2OSMO 288.6ANION GP 12.6BUN/CRE 23.8TRIG 29CHOL 87LDL CALC 41HDL CHOL 40REL RISK 2.2LDL/HDLD 1.03 Jul-18-2022 0520 Serology PROCALC <0.05 Jul-18-2022 0520 Hematology WBC 10.6RBC 4.38HGB 10.6HCT 33.6MCV 76.7MCH 24.2MCHC 31.5RDW 18.0RDWSD 49.1PLT 200MPV TnpAUTONEU% 85.1AUTOLYM% 6.6AUTOMON% 7.3AUTOEOS% 0.1AUTOBAS% 0.1AUTONEU# 9.0AUTOLYM# 0.7AUTOMON# 0.8AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.09IG% 0.8 Jul-18-2022 0520 Chemistry GLUCOSE 231BUN 53CREAT 2.5MDRD GFR 26NA 134K 4.4CL 101CALCIUM 7.8ALK PHOS 63CO2 24.5AST 15ALT 10AST/ALT 1.5TL PROT 5.8ALBUMIN 2.3TBILI 0.3DBILI 0.1OSMO 290.0ANION GP 12.9BUN/CRE 21.2VANCOMYC 18.8CRP 1.30PK/TR Random Jul-17-2022 0730 Serology PROCALC 0.06 Jul-17-2022 0730 Microbiology C BLD No growth after 2 nights of incubation. Culture is being held for 5 nights incubation. (Preliminary) Jul-17-2022 0730 Chemistry GLUCOSE 313BUN 50CREAT 2.7MDRD GFR 24NA 136K 3.6CL 101CALCIUM 7.7ALK PHOS 72CO2 24.8AST 9ALT 13AST/ALT 0.7TL PROT 5.7ALBUMIN 2.4TBILI 0.3DBILI 0.2OSMO 297.2ANION GP 13.8BUN/CRE 18.5CRP 1.90 Jul-16-2022 0525 Serology PROCALC 0.08 Jul-16-2022 0525 Hematology WBC 12.2RBC 4.68HGB 11.1HCT 35.9MCV 76.7MCH 23.7MCHC 30.9RDW 18.7RDWSD 48.9PLT 256MPV 11.5AUTONEU% 89.9AUTOLYM% 5.0AUTOMON% 4.4AUTOEOS% 0.1AUTOBAS% 0.1AUTONEU# 11.0AUTOLYM# 0.6AUTOMON# 0.5AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.06IG% 0.5 Jul-16-2022 0525 Coagulation D-DIMER 0.64 Jul-16-2022 0525 Chemistry GLUCOSE 333BUN 41CREAT 2.8MDRD GFR 23NA 135K 3.5CL 100CALCIUM 7.7ALK PHOS 79CO2 25.0AST 15ALT 13AST/ALT 1.2TL PROT 6.0ALBUMIN 2.1TBILI 0.3OSMO 293.2ANION GP 13.5BUN/CRE 14.6CRP 3.00 Jul-15-2022 0506 Serology PROCALC 0.10 Jul-15-2022 0506 Hematology WBC 14.9RBC 4.56HGB 10.9HCT 35.1MCV 77.0MCH 23.9MCHC 31.1RDW 18.4RDWSD 48.4PLT 267MPV TnpAUTONEU% 91.1AUTOLYM% 4.0AUTOMON% 4.0AUTOEOS% 0.0AUTOBAS% 0.1AUTONEU# 13.6AUTOLYM# 0.6AUTOMON# 0.6AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.12IG% 0.8 Jul-15-2022 0506 Chemistry GLUCOSE 331BUN 35CREAT 2.5MDRD GFR 26NA 137K 3.0CL 102CALCIUM 7.7ALK PHOS 78CO2 24.9AST 14ALT 7AST/ALT 2.0TL PROT 5.7ALBUMIN 1.9TBILI 0.4OSMO 294.7ANION GP 13.1BUN/CRE 14.0CRP 4.20 Jul-13-2022 2114 Blood Gas PH 7.37PC02 36.1PO2 ART 70BICARB 20.5BE -3.6CO2 CT 18.4O2 SAT 92.7O2 THER 50TYPEABG Arterial Jul-13-2022 1630 Serology PROCALC 0.07 Jul-13-2022 1630 Hematology WBC 12.6RBC 5.74HGB 13.7HCT 44.2MCV 77.0MCH 23.9MCHC 31.0RDW 19.3RDWSD 48.4PLT 375MPV 11.5AUTONEU% 81.6AUTOLYM% 11.0AUTOMON% 4.5AUTOEOS% 1.7AUTOBAS% 0.6AUTONEU# 10.3AUTOLYM# 1.4AUTOMON# 0.6AUTOBAS# 0.1AUTOEOS# 0.2NRBC% 0.0NRBC 0.0HGB/HCT 3.2IG# 0.08IG% 0.6 Jul-13-2022 1630 Coagulation D-DIMER 0.63 Jul-13-2022 1630 Chemistry GLUCOSE 289BUN 25CREAT 2.2MDRD GFR 30NA 139K 3.3CL 101CALCIUM 8.7ALK PHOS 105CO2 25.4AST 24ALT 13AST/ALT 1.8TL PROT 7.0ALBUMIN 2.3TBILI 0.6DBILI 0.3OSMO 292.5ANION GP 15.9BUN/CRE 11.4LDH 441CRP 7.50FERRITIN 130HGBA1C 8.6MEAN GLU 229TROPI-HS 84.6 Imaging Results Echocardiogram 07/20/2022, per official report. "Conclusions Moderate left ventricular hypertrophy (measuring 1.4 - 1.7 cm). Aortic cusps appear mildly calcified. Trileaflet aortic valve. Moderate tricuspid regurgitation. The estimated Peak RVSP is 64 mmHg. Moderate enlargement of right ventricle. Severe right ventricular hypokinesis with right atrial enlargement. Technically difficult study, Limited views. Pulmonary hypertension with RV and RA enlargement consistant with pulmonary process possibly acute." Functional Status* Impaired mobility, Activity of daily living - Needs assistance Mental Status* Normal Cognition Social History tobacco use Former Smoker, 20 yrs, Smoking Cessation Not Applicable drug use Heroin, Former during his 20s-30s marital status Married occupation history of military service Health Concerns Difficult venous access Acute renal failure syndrome Pneumonia caused by SARS-CoV-2 Acute on chronic hypoxemic respiratory failure Heroin, Former Former Smoker, 20 yrs Father Deceased Hypertensive disorder; Coronary arteriosclerosis; Diabetes mellitus; Congestive heart failure Mother Deceased Hypertensive disorder; Congestive heart failure Tobacco Cessation* Non-Smoker, Non Tobacco product user Vital Signs Jul-20-2022 0409 HR 61 RR 14 BP 152 / 96 O2Sat 100 Jul-19-2022 1957 T 97.8 HR 72 RR 16 BP 145 / 80 O2Sat 97 Jul-19-2022 1547 T 97.8 PHYSICAL EXAM CONSTITUTIONAL: Patient is a chronically ill-appearing 68-year-old male resting supine in bed. No acute distress. EYES: Orbital fat prolapse still present bilaterally. No scleral icterus or conjunctival injection noted. Patient able to maintain appropriate eye contact during conversation. No ocular discharge noted. CARDIOVASCULAR: Heart rate remains regular with regular rhythm. Peripheral edema consistent with previous examinations. Radial pulses 2+ bilaterally. Right upper extremity PICC line still in place with clean and dry Tegaderm overlying it. No signs of erythema, discharge noted. RESPIRATORY: Patient is on BiPAP set at 18/10 and FiO2 of 30%. No accessory muscle use or respiratory distress noted. SpO2 is 100% on FiO2 of 30%. Breath sounds are present and equal in bilateral anterior lung fields that are clear on auscultation this morning. GASTROINTESTINAL: Abdomen is obese, soft, nontender, and nondistended. Bowel sounds present and normoactive. No rebound or guarding noted on palpation. GENITOURINARY: Foley catheter in place draining clear yellow urine. PSYCHIATRIC: Patient is awake and alert and oriented to person, place, time, and somewhat situation. Poor historian and poor medical understanding. Mood and affect remain appropriate. Consultations None Hospital Course Patient is a 68-year-old male with past medical history significant for hypothyroidism, hypertension, type 2 diabetes, CAD, nephrolithiasis, and neuropathy. He presented to the emergency department on 06/13/2022 in respiratory distress. He was subsequently found to be COVID positive and admitted under the Internal Medicine service with a diagnosis of acute on chronic hypoxemic respiratory failure secondary to COVID 19 pneumonia. Total hospitalization was 8 days. During the course of his hospitalization patient was successfully titrated from 15 L high-flow BiPAP back to baseline oxygen requirements and on day of discharge is wearing his home nasal Trilogy mask set at 30% FiO2 noted to be 100%. Hospitalization was also complicated by acute renal insufficiency with creatinine of 2.8 on admission and subsequently improved down to 2.3 on day of discharge with 2.3 L of urine output in the 24 hours prior to discharge. Suspect chronic kidney disease, although baseline creatinine is unknown. Patient also noted to be positive 2/2 bottles on his blood culture from admission with staphylococcal hominis. Patient received 5 days of vancomycin and will be discharged home with additional 5 days of doxycycline bid. Condition at Discharge Stable Discharge Medications Atorvastatin Calcium Oral Tablet 80 MG 80 MG ORALLY ONCE A DAY Carvedilol Oral Tablet 25 MG 50 MG ORALLY TWICE DAILY DEXAMETHASONE 6 MG ORALLY ONCE A DAY (ePrescribed on Jul-20-2022 1332) DOXYCYCLINE MONOHYDRATE 100 MG ORALLY TWICE DAILY (ePrescribed on Jul-20-2022 1345) Insulin Lispro Injection Solution 100 UNIT/ML 25 UNT SUBCUTANEOUSLY BEFORE MEALS Isosorbide Mononitrate ER Oral Tablet Extended Release 24 Hour 60 MG 60 MG ORALLY ONCE A DAY Levothyroxine Sodium Oral Capsule 175 MCG 175 MG ORALLY BEFORE BREAKFAST Losartan Potassium Oral Tablet 100 MG 100 MG ORALLY TWICE DAILY metFORMIN HCl Oral Tablet 1000 MG 1000 MG ORALLY TWICE DAILY MiraLax Mix-In Pax Oral Packet 17 GM 1 PK ORALLY TWICE DAILY for ADVERSE DRUG REACTION (ePrescribed on Jul-20-2022 1332) Nitroglycerin Sublingual Tablet Sublingual 0.4 MG Continue taking same as home traMADol HCl Oral Tablet 50 MG 50 MG ORALLY EVERY 4 HOURS AS NEEDED for MODERATE-SEVERE (PAIN 6-10) Tresiba FlexTouch Subcutaneous Solution Pen-injector 100 UNIT/ML 100 UNT SUBCUTANEOUSLY EVERY MORNING Zolpidem Tartrate Oral Tablet 10 MG 10 MG ORALLY DAILY AT BEDTIME Discharge Disposition Discharge to home with home health Plan Assessment/plan: 1. Acute on chronic hypoxic respiratory failure: Secondary to COVID-19 pneumonia, Resolved Patient back on baseline O2 requirements and maintaining appropriate SpO2. 2. COVID-19 pneumonia: Patient completed 5 days of remdesivir and it has been discontinued. Today is day 8 of 10 Dexamethasone. Will be discharged home with an additional 2 days of Dexamethasone. 3. Bacteremia with Staph hominis 2 of 2 bottles Today is day 5 of Vancomycin. Repeat blood cultures have not shown any growth over 48 hours. Will discharge him home on doxycycline 100 mg bid for 5 more days. Transesophageal echocardiogram performed and did not show signs of cardiac vegetation. Repeat blood cultures negative and patient has remained afebrile. Clinically does not appear to have active bacteremia. For these reasons I have low clinical suspicion of endocarditis. 4. Diabetes: Will continue home diabetes regimen. 5. Hypertension: Continue home meds 6. Acute renal insufficiency, unknown baseline, improving: Cr 2.3 on morning labs; GFR 28. Plan to remove foley catheter prior to discharge. Repeat BMP ordered for 07/25/2022 to follow renal function. We may be near his baseline renal function. Urine output has improved significantly since admission. Had 2.3 L of urine output yesterday. 7. Dependent edema. Improved. Chronic comorbidities: -Hypothyroidism -Hypertension -DMII -CAD -Peripheral neuropathy DO, PGY-3 Discharge Instructions Diet Cardiac/Diabetic Activity As tolerated. PT/OT Home health ordered Follow up Appointments Schedule follow-up with outpatient PCP within one week of discharge with repeat CMP prior to evaluate renal status. Primary Care Provider DO Electronically signed by RESIDENT on Jul-20-2022 1357 I have seen and physically examined the patient on 7/20/22 and agree with the documentation of Dr. I have also discussed my findings and plan of care with Dr. Any changes and additional information are listed below. Face to face evaluation performed on day of discharge. Repeat cultures negative, afebrile, no obvious valve vegetations on TTE. Suspect staph bacteremia was skin contaminant but will treat out remainder of course with PO doxycycline. Recommended SNF placement for continued rehabilitation though patient and family opted to DC home with HH despite being unable to receive the DME they requested to help care for him. Discharge time, greater than 30 minutes Electronically signed by DO DO on Jul-20-2022 1718

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Neuropathy Chronic back pain Coronary arteriosclerosis Diabetes mellitus Hyperlipidemia Hypertensive disorder
Andere Medikamente: -
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2372434

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 67,0
Geschlecht: F
Eingang: 18.07.2022
Impfdatum: 31.03.2021
Beginn: 12.07.2022
Tage bis Beginn: 468,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Alanine aminotransferase increased Anion gap Aortic stenosis Aortic valve incompetence Aspartate aminotransferase increased Atelectasis Atrial enlargement Basophil count decreased Basophil percentage decreased Bilirubin conjugated Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride increased Blood creatinine increased

Symptomtext

Date of Service Jul-15-2022 0937 Addendum I personally visited with the patient and the Resident physician and reviewed the chart components, visited with and examined this patient ,discussed the plan of care Electronically signed on Jul-17-2022 0810 Date of Admission Admit Date: Jul-12-2022 Date of Discharge Date of discharge Jul-15-2022 @ 1200 Allergies Penicillins - Not Specified Chief Complaint Vomiting, dehydration Final Diagnoses resolved Hyperglycemia Resolved Jul-15-2022 Dehydration Resolved Jul-15-2022 Supraventricular tachycardia Resolved Jul-15-2022 Procedure(s) Performed None Lab Results Jul-15-2022 0818 Rad Jul-15-2022 0500 Chemistry GLUCOSE 196BUN 24CREAT 0.9MDRD GFR 62NA 144K 3.5CL 114CALCIUM 7.8ALK PHOS 66CO2 19.0AST 81ALT 51AST/ALT 1.6TL PROT 5.0ALBUMIN 2.5TBILI 0.3DBILI 0.1OSMO 296.3ANION GP 14.5BUN/CRE 26.7 Jul-15-2022 0500 Hematology WBC 6.1RBC 3.43HGB 10.1HCT 29.2MCV 85.1MCH 29.4MCHC 34.6RDW 14.9RDWSD 46.2PLT 74MPV 11.5AUTONEU% 82.3AUTOLYM% 11.8AUTOMON% 5.1AUTOEOS% 0.0AUTOBAS% 0.0AUTONEU# 5.0AUTOLYM# 0.7AUTOMON# 0.3AUTOBAS# 0.0AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 2.9IG# 0.05IG% 0.8 Jul-15-2022 0500 Serology PROCALC 7.91 Jul-14-2022 2046 Point Of Care GLUSTX 223 Jul-14-2022 1701 Point Of Care GLUSTX 246 Jul-14-2022 1214 Point Of Care GLUSTX 182 Imaging Results One view chest x-ray 7/13/22 Impression: Mild bibasilar atelectasis. Echocardiogram 7/13/22 Conclusions: Normal left ventricular systolic function with LVEF >60% Borderline left atrial enlargement. Normal appearance and function of the mitral valve with trace physiologic regurgitation. Mild to moderate mitral regurgitation. Mild aortic stenosis (AVA > 1.5cm2). Severe aortic regurgitation. The estimated peak RVSP is 0mmHg. One view chest x-ray 7/15/22 Impression: Small bilateral pleural effusions, mildly increased in size. Interval increase in mild bibasilar pulmonary opacities. Functional Status* Impaired mobility (uses walker) Mental Status* Normal Cognition Social History tobacco use Never Smoked, Smoking Cessation No NON SMOKER marital status Single Health Concerns Pneumonia Urinary tract infectious disease Supraventricular tachycardia Dehydration Hyperglycemia Vital Signs Jul-15-2022 0331 T 98.5 HR 73 RR 27 BP 105 / 54 O2Sat 93 Jul-15-2022 0040 T 98.3 HR 71 RR 26 BP 94 / 57 O2Sat 93 PHYSICAL EXAM CONSTITUTIONAL: Patient appears comfortable and in no acute distress. CARDIOVASCULAR: Heart has regular rate rhythm, pulses are 2/2 in the upper extremities, no edema noted RESPIRATORY: Lungs clear to auscultation throughout and respiratory effort is non-labored GASTROINTESTINAL: Abdomen is soft, nontender, and nondistended. Bowel sounds normoactive NEUROLOGICAL: Patient is alert and oriented to person, place, time, and event. Sensation is grossly intact PSYCHIATRIC: Patient's mood is euthymic, affect is appropriate. RASS of 0. Consultations None Hospital Course Patient is a 68-year old female who presented to the ER by personal vehicle with 1 day history of vomiting. The following history was obtained from her sister who is present in the room and her DPOA. The patient is considered a poor historian based on history of subdural hematoma. Her baseline now is AO x2 and requires assistance with her ADLs. The symptoms began approximately 0230 7/12/22. The patient called her sister at around 0600 and stated that she did not feel good and asked her sister to bring her some sprite. Her sister received another call from patient's caregiver at 1230 that patient was not responding to her knocking on the door. Patient's sister went over to the house and unlocked the door. Based on continuous vomiting since morning patient's sister made decision to bring patient into the ER. Patient received fluid resuscitation in the ED with 3L NS. She was then started on maintenance fluids at 75cc/hr for the duration of her stay. UA returned positive the night of her admission and she was started on ceftriaxone at that time. Her second day of admission her procalcitonin spiked and there was concern for aspiration pneumonia based on history, labwork, and imaging. At that time metronidazole was added to her ceftriaxone therapy for coverage of UTI and possible pneumonia. Patient's oxygen requirements continued to be titrated down during her stay with her being back on room air by morning of 7/15/22. Patient was found to be COVID positive upon admission and based on increased oxygen demand Remdesivir and dexamethasone treatments were started the night she was admitted. She received daily dosing and tolerated these treatments well. Patient was in SVT upon admission and was started on a diltiazem drip in the ED. Diltiazem was effective in controlling her heart rate and she was titrated down through her first night of admission. By noon the afternoon of 7/13/22 she had been titrated off of the drip and her heartrate has remained sinus in the low 80s. Based on initial presentation patient met SIRS criteria in ED. With source of infection patient was deemed to be in severe sepsis with a lactate of 6.8. Sepsis protocol was initiated. Patient received adequate hydration and blood cultures returned negative during her stay. Patient's vitals were stable from 7/13/22 on. Condition at Discharge Stable Discharge Medications Amantadine HCl Oral Capsule 100 MG 100 MG ORALLY TWICE DAILY aspirin 81 mg TbEC 1 TAB ORALLY ONCE A DAY atorvastatin 40 mg tab 1 TAB ORALLY ONCE A DAY Biotin Maximum Strength Oral Capsule 5000 MCG 5000 MCG ORALLY ONCE A DAY Cephalexin Oral Capsule 500 MG 500 MG ORALLY TWICE DAILY Januvia Oral Tablet 100 MG 100 MG ORALLY ONCE A DAY Lasix Oral Tablet 20 MG 20 MG ORALLY EVERY MORNING levETIRAcetam Oral Tablet 500 MG 500 MG ORALLY TWICE DAILY levocetirizine 5 mg tab 1 TAB ORALLY ONCE A DAY Melatonin ER Oral Tablet Extended Release 3 MG 3 MG ORALLY DAILY AT BEDTIME metroNIDAZOLE Oral Tablet 500 MG 500 MG ORALLY 3 TIMES A DAY NP Thyroid 90 mg tab Continue taking same as home omeprazole 20 mg TbEC 1 TAB ORALLY EVERY MORNING Pioglitazone HCl Oral Tablet 30 MG 30 MG ORALLY ONCE A DAY Senna Plus Oral Capsule 50-8.6 MG 50 MG ORALLY TWICE DAILY sertraline 100 mg tab 150 MG ORALLY ONCE A DAY Vitamin D3 Oral Capsule 250 MCG (10000 UT) 250 MCG ORALLY SUN Discharge Disposition Transfer to skilled nursing facility (SNF) Plan ASSESSMENTS: -Severe sepsis on admission, secondary to COVID vs UTI, vs unknown infection, resolved -Supraventricular tachycardia likely secondary to COVID-19 infection, resolved -Acute hypoxic respiratory failure likely secondary to COVID-19 infection, resolved -COVID-19 infection, stable -Urinary tract infection, found on UA 7/12/22, antibiotic therapy to continue -Suspected aspiration pneumonia, stable -Acute kidney injury, Creat 1.5 and eGFR 35 on admission, likely secondary to dehydration, resolved -Elevated lactate, 6.20 on admission, likely secondary to dehydration, secondary to recent vomiting, resolved -Leukopenia, 3.9 on admission, unknown etiology, resolved -Elevated troponin, 84 on admission, likely secondary to acute heart strain, resolved -Hyperglycemia, 382 on admission, likely stress reaction to COVID infection, resoleved -Elevated hemoglobin, 18.9 on admission, likely secondary to dehydration, resolved -Dehydration, based on physical exam on admission, improving -Severe aortic regurgitation, per ECHO 7/13/22 -Mild to moderate mitral regurgitation, per ECHO 7/13/22 -Hyperlipidemia, per history, control unknown on home medications -Depression, per history, control unknown on home medications -Hypothyroidism, per history, control unknown on home medications -Diabetes Mellitus type 2, per history, control unknown on home medications -Dementia, per history, control unknown on home medications -Essential tremor, per history, control unknown on home medications -History of CVA in 2021, unknown etiology -Debility, requiring assistance with ADLs PLANS: Patient to be discharged to nursing home for rehab to home. At this time labwork and vitals are stable. Patient is no longer requiring supplemental oxygen. Patient discharged on one day of lasix for mild bilateral pleural effusions. Patient discharged on keflex and metronidazole for continued antibiotic therapy for UTI and suspected pneumonia. Patient to follow up with Dr. within one week of discharge from nursing home. 2-view chest x-ray ordered for 7/18/22. Discharge Instructions Diet Diabetic Activity As tolerated Primary Care Provider Electronically signed on Jul-15-2022 1244 I have seen and physically examined the patient on [Date of service] and agree with the documentation of [name of the resident]. I have also discussed my findings and plan of care with [name of the resident]. Any changes and additional information are listed below. Electronically signed on Jul-17-2022 0810

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypercholesterolemia Diabetes Mellitus
Andere Medikamente: -
Allergien: PCN
Vorherige Impfungen: -

VAERS 2329187

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: IA
Alter: 75,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 01.04.2021
Beginn: 03.01.2022
Tage bis Beginn: 277,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Asthenia Atelectasis Atypical pneumonia Angiogram pulmonary Blood test Blood test abnormal Body temperature Body temperature increased COVID-19 Chills Cholelithiasis Computerised tomogram thorax abnormal Cough Fibrin D dimer increased Gallbladder disorder Leukocytosis

Symptomtext

ATYPICAL PNEUMONIA; BLOOD TEST ABNORMAL; NEPHROLITHIASIS; SARS-COV-2 TEST POSITIVE; PULMONARY EMBOLISM; FIBRIN D DIMER INCREASED; ATELECTASIS; BLOOD TEST ABNORMAL; COVID-19; COVID-19; MALAISE; CHILLS; ASTHENIA; MALAISE; PNEUMONITIS; ASTHENIA; PULMONARY EMBOLISM; BODY TEMPERATURE INCREASED; CHILLS; CHOLELITHIASIS; BODY TEMPERATURE INCREASED; COUGH; GALLBLADDER DISORDER; LEUKOCYTOSIS; LEUKOCYTOSIS; NASOPHARYNGITIS; NASOPHARYNGITIS; RESPIRATORY TRACT CONGESTION; PNEUMONITIS; ANGIOGRAM PULMONARY ABNORMAL; RESPIRATORY TRACT CONGESTION; COMPUTERISED TOMOGRAM THORAX ABNORMAL; SARS-COV-2 TEST POSITIVE; ANTICOAGULANT THERAPY; ANGIOGRAM PULMONARY ABNORMAL; ATYPICAL PNEUMONIA; FIBRIN D DIMER INCREASED; GALLBLADDER DISORDER; COMPUTERISED TOMOGRAM THORAX ABNORMAL; CHOLELITHIASIS; ANTICOAGULANT THERAPY; NEPHROLITHIASIS; This spontaneous report received from a health care professional via Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAERS ID 2329187) concerned a 75 year old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetes mellitus type ii, hypertension, coronary artery disease, and obstructive sleep apnea, and other pre-existing medical conditions included: No known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number and expiry date was not reported) dose was not reported, 1 total administered on 01-APR-2021 for an unspecified indication. Age at time of vaccination 75 years old. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. Concomitant medications included acetylsalicylic acid, apixaban, atorvastatin, glimepiride, insulin glargine, metformin, nifedipine, and salbutamol. On 03-JAN-2022, the patient experienced anticoagulant therapy, asthenia, atelectasis, atypical pneumonia, body temperature increased. covid-19, chills, cholelithiasis, cough, gallbladder disorder, leukocytosis, malaise, nasopharyngitis, nephrolithiasis, pneumonitis, pulmonary embolism, respiratory tract congestion. On the same day, patient had angiogram pulmonary abnormal, anticoagulant therapy, blood test abnormal, computerised tomogram thorax abnormal, fibrin d dimer increased, sars-cov-2 test positive. It was reported that On 03-JAN-2022, patient comes to ED (emergency department) complaining of not feeling well. Patient states that for the past 2 weeks has been feeling sick. Initially it started as cold and chills. Complains of feeling congested with mild cough which was nonproductive but denies chest pain or shortness of breath. Patient had been feeling progressively weak. He took a home COVID-19 test and tested positive. On 5-JAN-2022, He received monoclonal antibody infusion. Patient noted his oxygen saturation was below 90 could not get it about 90 which prompted him to come to the ED. Patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test. In the ED his temp was 100 8? F, pulse ox was 89% on room air and now on 3 L oxygen by NC saturating 94% , blood work was significant for leukocytosis and elevated D-dimer, CT angio chest was done and was reported as right middle lobe pulmonary embolism without right heart strain diffuse pneumonitis atypical pneumonia versus sub segmental atelectasis. CT chest (Computerized tomogram thorax) also reported bilateral renal pelvic nephrolithiasis cholelithiasis with distended gallbladder and findings concerning for exophytic dorsal right posterior liver lobe neoplasia. On 20-JAN-2022, Patient was given IV ceftriaxone and Zithromax in the ED anticoagulation with Lovenox. The patient also given zinc sulfate, vitamin-C and vitamin-D, Eliquis 10 mg bd for 7 days then 5 mg twice a day afterwards. Patient also continued on home metformin and glimepiride, azithromycin course, Decadron course Hemodynamically stable for discharge. It was reported that patient will discharge home and follow up with PCP in 3-5 days and Patient agrees with plan. The patient was hospitalized for 4 days. Laboratory data included: Angiogram pulmonary Abnormal, Blood test Abnormal, Body temperature Increased, Computerised tomogram thorax right middle lobe pulmonary embolism without right heart strain diffuse pneumonitis atypical pneumonia versus subsegmental atelectasis, Fibrin D Dimer Increased, and SARS-CoV-2 test Positive. On 05-JAN-2022, treatment medications included: edrecolomab. On 20-JAN-2022, treatment medications included: azithromycin, ceftriaxone, and levofloxacin. On 22-JUN-2022, Laboratory data included: Oxygen saturation Below 90. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100.8 F, CT scan bilateral renal pelvic nephrolithiasis cholelithiasis with distended gallbladder and findings concerning for exophytic dorsal right posterior liver lobe neoplasia, and Pulse oximetry (NR: not provided) 89 %. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from angiogram pulmonary abnormal, anticoagulant therapy, asthenia, atelectasis, atypical pneumonia, blood test abnormal, body temperature increased, covid-19, chills, cholelithiasis, computerised tomogram thorax abnormal, cough, fibrin d dimer increased, gallbladder disorder, leukocytosis, malaise, nasopharyngitis, nephrolithiasis, pneumonitis, pulmonary embolism, respiratory tract congestion, and sars-cov-2 test positive. This report was serious (Hospitalization Caused / Prolonged). Version created to amend previously reported information on 02-JUL-2022. Upon review the following information was amended: Amendment Narrative (batch number statement added in narrative).; Sender's Comments: V1: This version updates: batch number statement added in narrative. The prior causality assessment of reported events remains unaltered . 20220705648-covid-19 vaccine ad26.cov2.s- atypical pneumonia, nephrolithiasis, asthenia, atelectasis, blood test abnormal, body temperature increased, covid-19, chills, cholelithiasis, cough, gallbladder disorder, leukocytosis, malaise, nasopharyngitis, pneumonitis, respiratory tract congestion, and sars-cov-2 test positive. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. 20220705648-covid-19 vaccine ad26.cov2.s-pulmonary embolism, Angiogram pulmonary abnormal, Fibrin D dimer increased, Computerised tomogram thorax abnormal, Anticoagulant therapy. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: Test Date: 20220103; Test Name: ANGIOGRAM PULMONARY; Result Unstructured Data: Abnormal; Test Date: 20220103; Test Name: BLOOD TEST; Result Unstructured Data: Abnormal; Test Date: 20220103; Test Name: BODY TEMPERATURE; Result Unstructured Data: Increased; Test Date: 20220103; Test Name: COMPUTERISED TOMOGRAM THORAX; Result Unstructured Data: right middle lobe pulmonary embolism without right heart strain diffuse pneumonitis atypical pneumonia versus subsegmental atelectasis; Test Date: 20220103; Test Name: FIBRIN D DIMER; Result Unstructured Data: Increased; Test Date: 20220103; Test Name: SARS-COV-2 TEST; Test Result: Positive ; Test Date: 20220622; Test Name: OXYGEN SATURATION; Result Unstructured Data: Below 90; Test Name: BODY TEMPERATURE; Result Unstructured Data: 100.8 F; Test Name: PULSE OXIMETRY; Result Unstructured Data: 89 %; Test Name: CT CHEST; Result Unstructured Data: bilateral renal pelvic nephrolithiasis cholelithiasis with distended gallbladder and findings concerning for exophytic dorsal right posterior liver lobe neoplasia; Test Name: PULSE OXIMETRY; Result Unstructured Data: 94 %
Aktuelle Erkrankungen: Coronary artery disease; Hypertension; Obstructive sleep apnea syndrome; Type II diabetes mellitus
Vorgeschichte: Comments: No known allergies.
Andere Medikamente: METFORMIN; INSULIN GLARGINE; GLIMEPIRIDE; APIXABAN; ASPRIN; ATORVASTATIN; NIFEDIPINE; ALBUTEROL [SALBUTAMOL]
Allergien: -
Vorherige Impfungen: -

VAERS 2361237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 95,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 28.06.2022
Beginn: 05.07.2022
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

AST/ALT ratio Acute respiratory failure Alanine aminotransferase increased Anion gap Aspartate aminotransferase increased Asthenia Bacterial test negative Basophil count normal Basophil percentage Bilirubin urine Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin decreased Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal Blood lactic acid normal

Symptomtext

admission History and Physical Date of Service Jul-05-2022 0942 Chief Complaint Weakness, trouble breathing HPI / Subjective 95-year-old female with history of COPD, nocturnal hypoxia. as noted previously the patient was feeling run down the last couple of days, more weak than normal and some trouble with her mobility. she thinks that she has been feeling run down now for 2-3 weeks but acutely worse last couple of days. Admits to fever measured at 101 degrees F. tested positive for COVID-19 with home test. Came in overnight and was placed on observation without confirmatory PCR COVID test. 07/05/2022-patient is feeling better than 07/04/2022. Slightly less weak, still short of breath with ambulation. She does live at home by herself typically but her ADLs have been limited lately. Her son did visit the room while I was speaking with her and stated that the patient could stay with him after she gets out of the hospital. She has no other new complaints or issues. Past Medical History Bilateral glaucoma Osteoarthritis Chronic obstructive lung disease Past Surgical History Decompression of median nerve, Left in 2021 Immunization History received booster of Pfizer COVID-19 vaccination, 06/28/2022 Home Medications albuterol sulfate 2.5 mg/0.5 mL nebu Dose: INHALATION 3 TIMES A DAY AS NEEDED ASPIRIN EC Dose: 81 MG ORALLY ONCE A DAY BRIMONIDINE TART 0.2% OPHTH 5 ML Dose: 1 GTT OPTHALMIC TWICE DAILY Colace Oral Capsule 100 MG Dose: 100 MG ORALLY TWICE A DAY AS NEEDED CYANOCOBALAMIN Dose: 2500 MCG ORALLY ONCE A DAY Diclofenac-miSOPROStol Oral Tablet Delayed Release 50-0.2 MG Dose: 50 MG ORALLY TWICE DAILY FAMOTIDINE Dose: 20 MG ORALLY TWICE DAILY Ferrous Gluconate Oral Tablet 324 (38 Fe) MG Dose: 1 TAB ORALLY 3 TIMES A DAY Gabapentin Oral Capsule 100 MG Dose: 100 MG ORALLY 3 TIMES A DAY MiraLax Oral Packet Dose: 1 PKT ORALLY ONCE A DAY AS NEEDED for CONSTIPATION Omeprazole Oral Capsule Delayed Release 20 MG Dose: 20 MG ORALLY ONCE A DAY PreserVision AREDS 7,160-113-100 unit-mg-unit tab Dose: ORALLY TWICE DAILY traMADol HCL 50 MG Dose: 1 TAB ORALLY EVERY 6 HOURS AS NEEDED Vitamin D3 2,000 unit cap Dose: 1 CAP ORALLY ONCE A DAY Allergies Tetracyclines & Related - Not Specified Social History tobacco use Never Smoked, Smoking Cessation Not Applicable marital status Widowed lives at home solo 07/05/2022 Family History parents Father Deceased Malignant neoplastic disease Colon Mother Deceased Heart disease Mother Deceased Unknown problems Primary Care Provider (name withheld) REVIEW OF SYSTEMS Constitutional: admits to recent fever. Denies chills. Skin: Denies itching, rashes, or open wounds. Eyes: Denies vision changes, eye pain, or eye discharge. ENT: Admits to chronic hearing problems with hearing aids.Denies sinus problems, or sore throat. Cardiovascular: Admits to fatigue.Denies chest pain, palpitations, edema Respiratory: Denies coughing, wheezing. Admits to dyspnea with exertion GI: Denies abdominal pain, nausea, vomiting, constipation, or diarrhea. GU: Denies dysuria, hematuria, increased urinary frequency, or genital lesions. Musculoskeletal: Denies specific arthralgias, myalgias, or difficulty with mobility. Neurologic: Denies confusion, numbness, or tingling in extremities. Psych: Denies anxiety, depression, suicidal thoughts, or homicidal thoughts. Heme: Denies easy bruising, history of blood clots, or anemia. Immunologic: Denies recurrent infections, history of anaphylaxis or environmental allergies. Systems Reviewed All systems reviewed and negative except as noted above Vital Signs Jul-05-2022 0723 T 97.9 HR 80 RR 19 BP 117 / 67 O2Sat 95 Jul-05-2022 0430 T 97.6 HR 78 RR 17 BP 138 / 71 O2Sat 99 Intake and Output previous day current day encounter cumulative Intake 740 ? 740 Output 1901 ? 1901 Diff (I-O) (-1161) ? (-1161) PHYSICAL EXAM constitutional: Acute on chronically ill-appearing, appears of stated age. Eyes: Pupils are equal, round, and reactive to light. Sclerae are white. Conjunctivae are mildly injected without pallor. ENT: Hearing is grossly intact , although mildly impaired bilaterally. Oral mucosa is moist. There is no pharyngeal erythema. The thyroid is not enlarged and is non-tender. Cardiovascular: regular rate and rhythm except when the patient just sat down after ambulating had bigeminy of PVCs. Resolved with rest and supplemental oxygen, 2 L. Respiratory: lungs have coarse breath sounds bilaterally. Patient is using 2 L supplemental oxygen via nasal cannula. SpO2 87% on room air, improves with ambulation. Also improves supplemental oxygen, 2 L. GI: Abdomen is without lesion. Bowel sounds are normoactive in all quadrants. Abdomen is soft, non-tender, and non-distended. No organomegaly appreciated on palpation. GU: There are no visible lesions on the external genitalia. No hernias were appreciated Musculoskeletal/osteopathic: Range of motion in the shoulders, elbows, hips, and knees is grossly intact. patient is ambulatory but stamina has decreased. Patient does get weak after walking around the room 20 ft. Neurologic: Cranial nerves 2-12 are grossly intact. Sensation to light touch is intact in upper and lower extremities. Psych: The patient is alert and oriented to place, month and person. The patient's insight and judgment appear intact. The patient's mood is euthymic. The patient's affect is appropriate. Patient is calm. Heme: There is no bruising on the face or extremities. Homans sign is negative bilaterally. There is no blood in the external nares. Lab Results Jul-05-2022 0515 Chemistry GLUCOSE 104BUN 12CREAT 0.7MDRD GFR 78NA 142K 4.1CL 104CALCIUM 8.6ALK PHOS 95CO2 31.6AST 38ALT 37AST/ALT 1.0TL PROT 6.9ALBUMIN 2.9TBILI 0.2OSMO 283.2ANION GP 10.5BUN/CRE 17.1FERRITIN 192MAGNESIU 2.2 Jul-05-2022 0515 Coagulation D-DIMER 1.59 Jul-05-2022 0515 Hematology WBC 7.0RBC 4.37HGB 12.2HCT 38.3MCV 87.6MCH 27.9MCHC 31.9RDW 14.0PLT 287MPV 9.0 Jul-05-2022 0515 Serology PROCALC 1.69 Jul-05-2022 0045 Urinalysis Department SPECGRAV <=1.005U-PH 6.0LEUCOCYT TraceNITRITES NegativePROTEIN NegativeGLUCOSE NegativeKETONES NegativeUROBILIN 0.2BILRUBIN NegativeBLOOD NegativeCOLOR Lt. YellowCLARITY ClearMICROSCP YCULTURE NCULTIND Not IndicatedWBC 0-2RBC 0-2SQUAM EP 0-2BACTERIA NoneMUCUS 3+ Jul-04-2022 1750 Rad 1610163 Jul-04-2022 1615 Chemistry GLUCOSE 121BUN 17CREAT 0.7MDRD GFR 78NA 134K 4.0CL 97CALCIUM 8.3ALK PHOS 108CO2 27.9AST 14ALT 25AST/ALT 0.6TL PROT 6.6ALBUMIN 3.2TBILI 0.3OSMO 271.0ANION GP 13.1BUN/CRE 24.3LACTATE 0.70TROPI-HS 11 Jul-04-2022 1615 Hematology WBC 10.3RBC 4.12HGB 11.6HCT 35.1MCV 85.2MCH 28.2MCHC 33.0RDW 13.8RDWSD 43.1PLT 280MPV 9.3AUTONEU% 92.3AUTOLYM% 2.8AUTOMON% 3.8AUTOEOS% 0.3AUTOBAS% 0.5AUTONEU# 9.5AUTOLYM# 0.3AUTOMON# 0.4AUTOBAS# 0.1AUTOEOS# 0.0NRBC% 0.0NRBC 0.0HGB/HCT 3.0IG# 0.03IG% 0.3 Imaging Results Chest x-ray supports COVID-19 pneumonia. Possible right lower lobe consolidation that could be bacterial in origin. Plan Assessment: -Acute on chronic hypoxic respiratory failure secondary to COVID-19 pneumonia and possible superimposed bacterial pneumonia - likely superimposed bacterial pneumonia, right lower lobe - COVID-19 pneumonia, supported with chest x-ray, subjective home test - profound weakness and debility, acute - COPD, not in acute exacerbation from a respiratory standpoint - history of essential hypertension - history of osteoarthritis - history of bilateral glaucoma Plan: We will admit the patient inpatient as the procalcitonin is 1.69 today supporting a superimposed bacterial pneumonia on top of the COVID-19 pneumonia. medical status. Start ceftriaxone, azithromycin to cover atypical bacteria. Continue steroids. COVID-19 circ as well as Gram labs have been ordered to calculate ongoing risk. Breathing treatments have been ordered including Dulera, albuterol. We will monitor her O2 requirement, have her work with physical therapy and order for nutrition consult. Justification for Hospitalization Please document severity of illness/comorbidities and intensity/duration of the treatment to justify hospitalization ( Acute on chronic hypoxic respiratory failure) HEALTHCARE PROXY/AGENT Name: [ ] Relationship: [ ] Contact Info: [ ] Advanced Care Planning Discussion Date: [ ] Individuals Present: [ ] ORGAN or TISSUE DONATION [ ] RELIGIOUS/CULTURE CUSTOMS OR PREFERENCES [ ] FORMS ON FILE [Living Will/Durable power of attorney for health care/POLST/MOLST/Other advance care planning documents] TIME SPENT [ ] Minutes Electronically signed by RESIDENT on Jul-05-2022 1007

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Bilateral glaucoma Osteoarthritis Chronic obstructive lung disease
Andere Medikamente: Home Medications albuterol sulfate 2.5 mg/0.5 mL nebu Dose: INHALATION 3 TIMES A DAY AS NEEDED ASPIRIN EC Dose: 81 MG ORALLY ONCE A DAY BRIMONIDINE TART 0.2% OPHTH 5 ML Dose: 1 GTT OPTHALMIC TWICE DAILY Colace Oral Capsule 100 MG Dose: 1
Allergien: Tetracyclines
Vorherige Impfungen: -

VAERS 2359527

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 06.07.2022
Impfdatum: 18.05.2022
Beginn: 23.06.2022
Tage bis Beginn: 36,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain upper Anticoagulant therapy Antimicrobial susceptibility test resistant Asymptomatic COVID-19 Back pain Bacteraemia Bladder catheterisation Blood culture Enterobacter test positive Heart rate decreased Hypotension Infection Intensive care Klebsiella test positive Loss of consciousness Pyelonephritis Resuscitation SARS-CoV-2 test positive

Symptomtext

Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary. Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA. Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility. He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 13,0
Labordaten: Positive COVID PCR 7/1/2022
Aktuelle Erkrankungen: -
Vorgeschichte: History of gout Unknown HYPERCALCEMIA, CALCIUM ELEVATED (275.42) Unknown Obesity (BMI 30.0-34.9) Unknown Hyperlipidemia 8/1/2012 Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin 8/5/2013 Primary hypertension 8/5/2013 RA (rheumatoid arthritis) 8/5/2013 OSA (obstructive sleep apnea) 8/5/2013 Hypercalcemia 8/5/2013 Benign prostatic hyperplasia with urinary retention 5/25/2017 Urinary retention 9/12/2019 Paroxysmal atrial fibrillation (Chronic) 9/5/2021 Hereditary sensory neuropathy 12/6/2017 Multiple vessel coronary artery disease 9/7/2021 Hx of acute myocardial infarction of anterior wall 8-31-21 9/8/2021 Shortness of breath at rest 9/8/2021 On apixaban therapy 9/8/2021 Generalized muscle weakness 9/19/2021 At risk for malnutrition 9/19/2021 Fever, unspecified 9/24/2021 Chronic idiopathic constipation 9/24/2021 Nursing home resident 9/24/2021 Iron deficiency anemia due to chronic blood loss 10/27/2021 Anemia due to folic acid deficiency 10/27/2021 Leukocytosis 10/27/2021 Normocytic anemia 11/17/2021 Hyponatremia 12/6/2021 Generalized anxiety disorder 12/6/2021 Other sexual disorders 12/6/2021 Long term current use of clopidogrel 3/2/2022 Pericardial effusion 3/16/2022 Acute kidney injury (AKI) with acute tubular necrosis (ATN) 3/20/2022 Kidney stones (Chronic) 3/20/2022 Acquired hydronephrosis due to obstruction of ureteropelvic junction (UPJ) by stone 3/20/2022 Heart failure with reduced ejection fraction 4/4/2022 Gastroesophageal reflux disease without esophagitis 4/10/2022 Acute on chronic anemia 4/10/2022 Pseudomonas urinary tract infection 4/10/2022 Hypomagnesemia 4/10/2022 Nausea 4/10/2022 Pyelonephritis 4/11/2022 Hydronephrosis with urinary obstruction due to ureteral calculus bilateral 4/11/2022 Sepsis secondary to UTI 4/16/2022 Grade I diastolic dysfunction 4/17/2022 Symptomatic anemia 4/19/2022 Recurrent UTI 4/27/2022 Neurogenic bladder 4/27/2022
Andere Medikamente: acetaminophen 500 mg Oral DAILY PRN amiodarone HCl 200 mg Oral Daily atorvastatin calcium 40 mg Oral NIGHTLY carvedilol 6.25 mg Oral 2 times daily clotrimazole/betamethasone dip 1-0.05 % Topical 2 times daily docusate sodium 100 mg Ora
Allergien: Severity Reactions Comments Latex, Natural Rubber Low Itching Bandage caused itching Actos [pioglitazone] Not Specified GI Upset Neurontin [gabapentin] Not Specified Dizziness
Vorherige Impfungen: -

VAERS 2359527

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 06.07.2022
Impfdatum: 18.05.2022
Beginn: 23.06.2022
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain upper Anticoagulant therapy Antimicrobial susceptibility test resistant Asymptomatic COVID-19 Back pain Bacteraemia Bladder catheterisation Blood culture Enterobacter test positive Heart rate decreased Hypotension Infection Intensive care Klebsiella test positive Loss of consciousness Pyelonephritis Resuscitation SARS-CoV-2 test positive

Symptomtext

Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary. Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA. Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility. He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 13,0
Labordaten: Positive COVID PCR 7/1/2022
Aktuelle Erkrankungen: -
Vorgeschichte: History of gout Unknown HYPERCALCEMIA, CALCIUM ELEVATED (275.42) Unknown Obesity (BMI 30.0-34.9) Unknown Hyperlipidemia 8/1/2012 Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin 8/5/2013 Primary hypertension 8/5/2013 RA (rheumatoid arthritis) 8/5/2013 OSA (obstructive sleep apnea) 8/5/2013 Hypercalcemia 8/5/2013 Benign prostatic hyperplasia with urinary retention 5/25/2017 Urinary retention 9/12/2019 Paroxysmal atrial fibrillation (Chronic) 9/5/2021 Hereditary sensory neuropathy 12/6/2017 Multiple vessel coronary artery disease 9/7/2021 Hx of acute myocardial infarction of anterior wall 8-31-21 9/8/2021 Shortness of breath at rest 9/8/2021 On apixaban therapy 9/8/2021 Generalized muscle weakness 9/19/2021 At risk for malnutrition 9/19/2021 Fever, unspecified 9/24/2021 Chronic idiopathic constipation 9/24/2021 Nursing home resident 9/24/2021 Iron deficiency anemia due to chronic blood loss 10/27/2021 Anemia due to folic acid deficiency 10/27/2021 Leukocytosis 10/27/2021 Normocytic anemia 11/17/2021 Hyponatremia 12/6/2021 Generalized anxiety disorder 12/6/2021 Other sexual disorders 12/6/2021 Long term current use of clopidogrel 3/2/2022 Pericardial effusion 3/16/2022 Acute kidney injury (AKI) with acute tubular necrosis (ATN) 3/20/2022 Kidney stones (Chronic) 3/20/2022 Acquired hydronephrosis due to obstruction of ureteropelvic junction (UPJ) by stone 3/20/2022 Heart failure with reduced ejection fraction 4/4/2022 Gastroesophageal reflux disease without esophagitis 4/10/2022 Acute on chronic anemia 4/10/2022 Pseudomonas urinary tract infection 4/10/2022 Hypomagnesemia 4/10/2022 Nausea 4/10/2022 Pyelonephritis 4/11/2022 Hydronephrosis with urinary obstruction due to ureteral calculus bilateral 4/11/2022 Sepsis secondary to UTI 4/16/2022 Grade I diastolic dysfunction 4/17/2022 Symptomatic anemia 4/19/2022 Recurrent UTI 4/27/2022 Neurogenic bladder 4/27/2022
Andere Medikamente: acetaminophen 500 mg Oral DAILY PRN amiodarone HCl 200 mg Oral Daily atorvastatin calcium 40 mg Oral NIGHTLY carvedilol 6.25 mg Oral 2 times daily clotrimazole/betamethasone dip 1-0.05 % Topical 2 times daily docusate sodium 100 mg Ora
Allergien: Severity Reactions Comments Latex, Natural Rubber Low Itching Bandage caused itching Actos [pioglitazone] Not Specified GI Upset Neurontin [gabapentin] Not Specified Dizziness
Vorherige Impfungen: -

VAERS 2344910

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: IL
Alter: 86,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 01.10.2021
Beginn: 01.03.2022
Tage bis Beginn: 151,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Asthenia COVID-19 Chest X-ray abnormal Confusional state Cough Death Dyspnoea Full blood count abnormal Hypercoagulation Hyperviscosity syndrome Incoherent Lung infiltration Oxygen saturation decreased Respiratory distress SARS-CoV-2 test positive Unresponsive to stimuli

Symptomtext

Pfizer Dose 1 2/8/21 (EN6201) Pfizer Dose 2 3/1/21 (EN6203) Pfizer Dose 3 10/1/21 (NA) COVID Positive 3/2/22 COVID Positive 3/4/22 3/4/22: The patient known to have advanced Alzheimer's dementia living at the nursing home referred to the hospital due to noticed cough with mild shortness of breath and became more confused in compared and weak. The patient does have poor coherence and cannot answer my questions, history gathered from the ED provider and the medical report. Does not look in pain or distress, at the Emergency the patient oxygenation was normal on room air but occasional dropped to 87% required 2 L of oxygen through nasal cannula. Her labs are not completed at the ED, on her CBC show stable chronic anemia. Her chest x-ray show bilateral infiltrate. Her COVID-19 test is positive on March 2nd 3/14/22: The patient respiratory distress with hypercoagulability state and hyperviscosity Continue comfort measures The patient is laying comfortably in her bed and is not agitated or aggressive, DC sitter Plan to discharge her to hospice tomorrow, discussed with the family DNR/DNI Patient deceased 3/14/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: advanced Alzheimer's dementia partial hearing loss HTN IBS h/o macroglobulinemia RA osteosarthritis deconditioning
Andere Medikamente: amlodipine 5 mg PO QD cholecalciferol 4000 units PO QD ferrous sulfate 325 mg PO MWF folic acid 1 mg PO qD meclizine 25 mg PO TID PRN propranolol 40 mg PO BID
Allergien: penicillins - swelling, unsure proparacaine ophthalmic - crying for a week, pain, swelling, itching
Vorherige Impfungen: -

VAERS 2344743

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: IA
Alter: 57,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 13.10.2021
Beginn: 14.01.2022
Tage bis Beginn: 93,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Dyspnoea Inappropriate schedule of product administration Liver function test abnormal SARS-CoV-2 test positive

Symptomtext

Moderna Dose 1 9/13/21 (lot NA) Moderna Dose 2 10/13/21 (lot NA) COVID Positive 1/28/22 1/28/22: Patient is a 57-year-old female with a past medical history significant for arthritis of lumbar spine obesity room tired arthritis sleep apnea and extensive smoking history. Patient comes in with a chief complaint of shortness of breath that has been going on for the past 2 weeks. Patient states that the over past 2 weeks her shortness of breath has gotten progressively worse. She states that she does have a history of COPD and asthma but does not wear home oxygen at home. Patient was COVID-19 positive on today's rapid test. She states she lives at home with her husband and has not traveled anywhere recently. 2/2/22: Patient is a 57-year-old female admitted to hospital for acute hypoxic respiratory failure due to COVID 19 pneumonia, patient was treated with supplemental oxygen medical therapy including antibiotics Decadron and initially remdesivir, unfortunately remdesivir was discontinued due to abnormal liver function test. As time progressed patient clinically improved. Per patient's request she will be discharged home with VNA, recommended follow-up with PCP within 1 week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: arthritis of lumbar spine obesity OSA smoker
Andere Medikamente: alprazolam 1 mg PO Q6h PRN buspirone 15 mg PO BID calcium-vitamin D 1 tab PO BID cyclobenzaprine 10 mg PO BID eszopiclone 3 mg PO HS PRN gabapentin 900 mg PO BID gabapentin 600 mg PO QD hydroxychloroquine 400 mg PO QD methotrexate 25 IM QSu
Allergien: adhesive bandage - rash penicillin - rash strawberries - hives
Vorherige Impfungen: -

VAERS 2338961

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: IA
Alter: 64,0
Geschlecht: F
Eingang: 28.06.2022
Impfdatum: 16.07.2021
Beginn: 16.01.2022
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Atrial flutter COVID-19 Chest discomfort Computerised tomogram thorax abnormal Dyspnoea Echocardiogram normal Fatigue Haemoptysis Palpitations Pleurisy Pulmonary embolism Pulmonary infarction SARS-CoV-2 test positive Tachycardia

Symptomtext

Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22 1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID. The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today. After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue. She was sent to the emergency room for further evaluation. In the emergency room, she was noted to be tachycardic up to 150. She did not, however, desaturate. The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea. 1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection. She was brought to the emergency department where she was found to be in atrial flutter. Neatly on CT pulmonary angio angiogram revealed saddle pulmonary embolism with areas of right middle and lower lobe infarcts. She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain. Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation. Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge. No further episodes of arrhythmias were noted during hospital course. She is in stable medical condition at the time of discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: gastritis
Andere Medikamente: APAP 650 mg PO Q4h PRN vitamin D 2000 units PO QD pantoprazole 40 mg PO BID
Allergien: NKA
Vorherige Impfungen: -

VAERS 2338945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: IA
Alter: 70,0
Geschlecht: F
Eingang: 28.06.2022
Impfdatum: 01.06.2021
Beginn: 01.02.2022
Tage bis Beginn: 245,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Computerised tomogram thorax normal Death Dyspnoea Endotracheal intubation Fatigue Hyporesponsive to stimuli Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Moderna Dose 1 5/5/21 (lot NA) Moderna Does 2 6/1/21 (lot NA) COVID Positive 2/19/22 2/19/22: Pt, is 71-year-old female past medical history significant for coronary artery disease, hypertension, hypothyroidism, Parkinson's disease, tremor, GERD, anxiety/depression, schizoaffective disorder, and bipolar disorder. Patient was admitted after she was admitted for COVID pneumonia and stayed for 4-5 day after she presented with fatigue and was found to have low pulse ox of 80%. Patient was admitted for 5 days and completed antiviral medication with remdesivir and Decadron. Patient had CT of the chest with no pulmonary emboli at that time Currently she still feels short of breath but denies any chest pain fever chills or rigors 3/7/22: I have been reviewing the chart and the long complicated clinical course. The specialists and family had agreed with comfort measures, the patient expected to not survive after extubation, but has been hanging on with poor responsiveness and no signs of improvement. Will approach the family about hospice therapy and possible discharge to a hospice facility. UDPATE I have just been informed that the patient passed away at 08.46 pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CAD HTN hypothyroidism Parkinson's tremor GERD anxiety depression schizoaffective disorder bipolar disorder
Andere Medikamente: APAP 650 mg PO Q4h PRN albuterol 2 puffs inh Q4h PRN vitamin C 500 mg Po QD aspirin 81 mg Po QD carbidopa-levodopa 25-100 mg PO BID cholecalficerol 1000 units O qD clozapine 200 mg Po HS docusate 100 mg PO BID PRN enoxaparin 40 mg SQ HS esc
Allergien: benztropine - unknown beta lactams - weal, tolerated ceftazidime haloperidol - unknown macrolide antibiotics - unknown sulfa drugs - unknown thioridazine - unknown thiothixene - unknown
Vorherige Impfungen: -

VAERS 2338905

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: IA
Alter: 83,0
Geschlecht: F
Eingang: 28.06.2022
Impfdatum: 09.04.2021
Beginn: 17.02.2022
Tage bis Beginn: 314,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Anaemia macrocytic Anticoagulant therapy Asthenia Blood creatinine normal COVID-19 Chest X-ray abnormal Confusional state Cough Death Decreased appetite Dyspnoea exertional Electrolyte substitution therapy Feeling abnormal Fibrin D dimer increased Gastrointestinal tube insertion Haemoglobin decreased Hypertransaminasaemia

Symptomtext

Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22 2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status. Earlier this evening, patient was noted by her children not feeling herself. Per family members, she was noted to be confused. She was noted to be sliding down on her chair neck. Patient reported she has been having poor appetite with belly pain for the past 2 days. No report of nausea or vomiting. Patient reported dry cough. No report of chest pain fever chills or rigors. Patient is fully vaccinated for COVID-19. No recent sick contacts. Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months. She has moderate/severe aortic stenosis. She is scheduled to have TAVR. Patient denied use of tobacco products or alcohol products. Upon evaluation at the emergency room, she was afebrile and hemodynamically stable. She was maintaining 3 L of oxygen to maintain saturation which is her baseline. Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19. Chest x-ray revealed bilateral infiltrates. Urinalysis revealed small leukocyte esterase. Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV. 3/6/22: -Continue with the current management. -appreciate pulmonology recommendations. -steroid taper per pulmonology -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n.. - monitor and replace electrolytes as indicated. -appreciate pulmonology initiating thrombocytopenia workup. -possible intubation later on 03/06/2022. -Code status: Full code DVT ppx: Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer. Disposition: Patient was made DNR by the family. Patient expired on 03/06/2022 evening.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: a fib moderate aortic stenosis HFpEF HTN pulmonary HTN gout
Andere Medikamente: allopurinol 100 mg Po QD apixaban 5 mg PO BID atorvastatin 40 mg PO HS buspirone 15 mg PO BID calcium carbonate 600 mg Po BID clopidogrel 75 mg PO QD cyanocobalamin 1000 mcg PO QD diltiazem ER 180 mg PO QD ferrous sulfate 325 mg PO QD furos
Allergien: sulfa drugs - upset stomach
Vorherige Impfungen: -

VAERS 2331655

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 61,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 21.05.2022
Beginn: 17.06.2022
Tage bis Beginn: 27,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Cough Dyspnoea SARS-CoV-2 test positive Wheezing

Symptomtext

Admission Date: 6/17/2022 Discharge Date: Jun 18, 2022 PRESENTING PROBLEM: Acute hypoxic respiratory failure Acute respiratory disease due to COVID-19 virus HOSPITAL COURSE: Patient is a 61-year-old woman with history of mild intermittent asthma who presented to the hospital with few days of more shortness of breath and cough. She tested positive for COVID-19. She had acute hypoxic respiratory failure and was admitted to the hospital for treatment. She was started on Decadron and had scheduled albuterol nebulizers. Her acute hypoxic respiratory failure resolved but she continued to have significant wheezing. She overall felt better and wanted to be discharged. She was discharged home with refills for her Spiriva and albuterol. She was instructed to always use a spacer with her albuterol inhaler. She was also prescribed 8 more days of Decadron.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Herpes simplex Hypertension Anxiety Depression Hiatal hernia Long term (current) use of aspirin Morbid obesity OSA (obstructive sleep apnea) Renal calculus, left Acute respiratory disease due to COVID-19 virus Chronic systolic heart failure Mild intermittent asthma with acute exacerbation
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG tablet B Complex Vitamins (VITAMIN B COMPLEX PO) cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) capsule citalopram (CELEXA) 10 MG tablet
Allergien: Penicillin GRash
Vorherige Impfungen: -

VAERS 2329014

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: IA
Alter: 78,0
Geschlecht: M
Eingang: 23.06.2022
Impfdatum: 16.10.2021
Beginn: 31.01.2022
Tage bis Beginn: 107,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Asthenia Blood gases Blood test abnormal COVID-19 Carbon dioxide decreased Decreased appetite Fibrin D dimer increased Hypomagnesaemia Hypoxia Pulmonary embolism SARS-CoV-2 test positive Urine analysis normal Vomiting

Symptomtext

Pfizer Dose 1 3/26/21 (EN6208) Pfizer Dose 2 4/16/21 (EW0158) Pfizer Dose 3 10/16/21 (lot NA) COVID Positive 1/31/22 1/31/22: Patient is a pleasant 79-year-old male with past medical history of AAA, CKD stage 2, hypertension, type 2 diabetes mellitus, history of seizure disorder, SVT comes in with chief complaint weakness, and vomiting decreased appetite . Patient is a poor historian history primarily obtained from ED provider sign-out/chart review. Reportedly patient had vomiting earlier this morning after drinking age ensure. Blood work demonstrated hypo magnesemia, blood gases was with mild decrease in CO2 no significant leukocytosis UA negative dimer was elevated and rapid COVID was positive. Patient was hypoxic placed on supplemental oxygen. CT PA was obtained demonstrated acute PE and pulmonary artery still right lung without signs of heart strain some concerns for atelectasis or infiltrates and bibasilar region. Patient received Eliquis, antibiotics, dexamethasone, Mag sulfate and Reglan along with IV fluids request was made to admit to medical service for further treatment evaluation. At bedside patient is sitting up comfortably in bed currently denies any lightheadedness, dizziness, chills, fevers no current nausea, chest pain palpitations abdominal pain paresthesia or swelling of extremities. He denies any shortness of breath or dyspnea. Reports he "feels fine". He reports he is a former tobacco user former alcohol user no marijuana or recreational drugs over-the-counter or herbal medications. No sick contacts that he is aware of. He reports he has been COVID-19 vaccinated x3. He has been compliant with all his medications and does not report any recent changes. Family history otherwise reviewed noncontributory to presenting finding. 2/3/22: 79-year-old male with CKD stage 2, hypertension, type 2 diabetes mellitus, history of seizure disorder, SVT came with chief complaint weakness, and vomiting decreased appetite . Blood work demonstrated hypo magnesemia, blood gases was with mild decrease in CO2 no significant leukocytosis UA negative dimer was elevated and COVID was positive. Patient was hypoxic placed on supplemental oxygen. CT PA was obtained demonstrated acute PE and pulmonary artery still right lung without signs of heart strain some concerns for atelectasis or infiltrates and bibasilar region. Patient received Eliquis, antibiotics, dexamethasone, Mag sulfate and Reglan along with IV fluids request was made to admit to medical service for further treatment evaluation. This Am, patient is sitting up comfortably in bed currently denies any lightheadedness, dizziness, chills, fevers no current nausea, chest pain palpitations abdominal pain paresthesia or swelling of extremities. He denies any shortness of breath or dyspnea. He wants to go home. He will be discharged to home on Eliquis, home oxygen and a plan to follow-up with his PCP

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: AAA CKD II HTN DM II seizure disorder SVT
Andere Medikamente: albuterol 2 puffs inh Q6h PRN apoixaban 5 mg PO BID aspirin 81 mg PO QD atorvastatin 40 mg PO QD lacosamide 100 mg PO BID levetiracetam 375 mg PO BID lisinopril 20 mg PO QD metformin 500 mg PO BID metoprolol tartarte 50 mg PO QD nystatin to
Allergien: NKA
Vorherige Impfungen: -

VAERS 2329008

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: IA
Alter: 66,0
Geschlecht: M
Eingang: 23.06.2022
Impfdatum: 30.08.2021
Beginn: 31.12.2021
Tage bis Beginn: 123,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Angiocardiogram COVID-19 Chest discomfort Chest pain Coronary arterial stent insertion Dyspnoea Ejection fraction decreased Hyperhidrosis Hypotension Nausea SARS-CoV-2 test positive

Symptomtext

Moderna Dose 1 8/2/21 (lot NA) Moderna Dose 2 8/30/21 (lot NA) COVID Positive 12/31/21 1/8/22: Patient is a 66 year old male with past history of tobacco abuse, anxiety, and COPD who was admitted with chest pain and found to have an inferior STEMI. History is obtained from chart review as well as discussion with the patient, and the ED provider. Also discussed with the cardiologist. Patient denies a history of heart disease. He does smoke 2 packs of cigarettes per day. Does have a history of COPD and uses albuterol inhaler as needed also another unknown inhaler 2 puffs in the morning. Does have a history of anxiety and did have a remote history of an overdose in 2014. Patient states he did test positive for COVID-19 just before new year's but has been symptom-free for at least the last 6 days or so. He has received 2 COVID-19 vaccinations. On Thursday the patient had a 2 hour episode of chest pressure which resolved spontaneously. He states he was at work delivering pizzas. Around 9:00 p.m. tonight he developed recurrence of the symptoms which improved slightly and then became much more severe so EMS was called. Was found to have an inferior STEMI and MI alert has been called. Still having chest pain although is little better after receiving some pain medications. Does have some shortness of breath as well as nausea and diaphoresis. Denies any fevers, chills, abdominal pain. 1/9/22: 66-year-old male with COPD, tobacco abuse and recent diagnosis of COVID-19 presented with the chest pain. He was found to have inferior STEMI, underwent emergent coronary angiogram with drug-eluting stent to RCA, LVEF 40%. Post intervention chest pain has resolved patient remained asymptomatic. Patient was cleared for discharge by cardiology. patient will be on dual anti-platelet with aspirin and Brilinta for 1 year, started on atorvastatin metoprolol. Due to low normal blood pressure Ace inhibitors/ARB have not been started. On discharge patient was a febrile and hemodynamically stable. He was discharged home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: tobacco abuse anxiety COPD
Andere Medikamente: apsirin 81 mg PO QD atorvastatin 80 mg PO HS clonazepam 2 mg PO BID metoprolol ER 25 mg PO QD sertraline 150 mg PO QD ticagrelor 90 mg PO BID tramadol 50 mg PO QD
Allergien: Actifed - hyper Ambien - unknown Mirapex - unknown pseudoephedrine - hyper trazodone - unknown viodin - unkonwn
Vorherige Impfungen: -

VAERS 2327243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 01.03.2021
Beginn: 01.06.2022
Tage bis Beginn: 457,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Alkalosis hypochloraemic Asthenia Blood creatinine normal Blood glucose decreased Blood glucose increased COVID-19 Chronic kidney disease Confusional state Disorientation Dyspnoea Fatigue Generalised oedema Hypoglycaemia Hypotension Hypoxia Lethargy

Symptomtext

Provider summary "This is a 64-year-old morbidly obese male a history of diabetes mellitus type 2. Patient awoke this morning around 7:00 a.m. disoriented and confused. His roommate called EMS who arrived to find patient was hypoglycemic. Patient was encouraged to eat and blood sugar improved. Patient refused transport to the ER at that time. Patient is significantly came over later that morning found his blood sugar to be 380. Patient gave himself 20 units of NovoLog. Significant other checked on him later in the evening and noticed that he was quite lethargic and sleepy. She encouraged him to go to the emergency department but he again resisted. Later the patient called significant other back stating he was ready to go to the emergency department because he was ?overwhelmed and exhausted.? Patient presented emergency department where he spent some time in the a waiting room as ER staff thought he had left before being seen. Patient became very disoriented and lethargic. He was found have a blood sugar of 19. Patient brought back to emergency department and his hypoglycemic event was managed. During his stay in the ER he was became hypoxic with room air saturations in the 80s. Oxygen saturation improved with supplemental oxygen. Further testing showed him to be COVID positive. Patient is still lethargic and oriented x2. Hospitalist service has been asked to see for further evaluation and management of toxic metabolic encephalopathy due to hypoglycemia and hypoxia from COVID." Admitted on 6/2. Started on dexamethasone and IV antibiotics, oxygen supplementation. He did fair, sugars stabilized, his condition improved, remains very weak. At the time of discharge there is no confusion, no more dyspnea. He requires 2 L of oxygen per home O2 evaluation. He is doing spirometry. He had issues with contraction alkalosis, his diuretics were held temporarily, contraction alkalosis improved. His blood pressure is lower side. He was noted to have chronic kidney disease, his creatinine remained stable throughout his hospital stay. His ACE inhibitor was held temporarily. Blood pressure stabilized on discharge, he is being resumed on the lower dose of ACE inhibitor. Lasix is resumed on discharge, remains off Zaroxolyn. Hydrochlorothiazide was discontinued permanently. His sugars varied, his doses of insulin were adjusted. He was noted to be persistently hypoglycemic, he needs significantly less Lantus now been at home, doing well with 15 units every evening. He is following a diabetic diet. He is being discharged in stable condition, going home with visiting nurses, PT and OT, 2 L of oxygen, hospital bed was recommended as well in the setting of his acute on chronic respiratory failure Due to covid and extreme debility."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: COVID positive PCR 6/1/22
Aktuelle Erkrankungen: -
Vorgeschichte: Coronary artery disease with angina pectoris Unknown Prostate hypertrophy Unknown Hyperlipidemia 2/19/2015 Morbid obesity due to excess calories 2/18/2016 HTN, goal below 130/80 4/27/2016 Chronic pain of both knees 4/4/2017 Umbilical hernia without obstruction and without gangrene 5/31/2017 Calculus of gallbladder without cholecystitis without obstruction 2/22/2019 Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin 5/5/2020 Anasarca 2/8/2022 AKI (acute kidney injury) 2/11/2022 Acute respiratory failure with hypoxia 6/6/2022
Andere Medikamente: atorvastatin calcium 10 mg Oral NIGHTLY clopidogrel bisulfate 75 mg Oral Daily dapagliflozin propanediol 5 mg Oral EVERY MORNING fluticasone propionate 50 mcg/actuation 2 sprays Each Nare Daily furosemide 40 mg Oral Daily 20 mg Oral
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2327243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 01.03.2021
Beginn: 01.06.2022
Tage bis Beginn: 457,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Alkalosis hypochloraemic Asthenia Blood creatinine normal Blood glucose decreased Blood glucose increased COVID-19 Chronic kidney disease Confusional state Disorientation Dyspnoea Fatigue Generalised oedema Hypoglycaemia Hypotension Hypoxia Lethargy

Symptomtext

Provider summary "This is a 64-year-old morbidly obese male a history of diabetes mellitus type 2. Patient awoke this morning around 7:00 a.m. disoriented and confused. His roommate called EMS who arrived to find patient was hypoglycemic. Patient was encouraged to eat and blood sugar improved. Patient refused transport to the ER at that time. Patient is significantly came over later that morning found his blood sugar to be 380. Patient gave himself 20 units of NovoLog. Significant other checked on him later in the evening and noticed that he was quite lethargic and sleepy. She encouraged him to go to the emergency department but he again resisted. Later the patient called significant other back stating he was ready to go to the emergency department because he was ?overwhelmed and exhausted.? Patient presented emergency department where he spent some time in the a waiting room as ER staff thought he had left before being seen. Patient became very disoriented and lethargic. He was found have a blood sugar of 19. Patient brought back to emergency department and his hypoglycemic event was managed. During his stay in the ER he was became hypoxic with room air saturations in the 80s. Oxygen saturation improved with supplemental oxygen. Further testing showed him to be COVID positive. Patient is still lethargic and oriented x2. Hospitalist service has been asked to see for further evaluation and management of toxic metabolic encephalopathy due to hypoglycemia and hypoxia from COVID." Admitted on 6/2. Started on dexamethasone and IV antibiotics, oxygen supplementation. He did fair, sugars stabilized, his condition improved, remains very weak. At the time of discharge there is no confusion, no more dyspnea. He requires 2 L of oxygen per home O2 evaluation. He is doing spirometry. He had issues with contraction alkalosis, his diuretics were held temporarily, contraction alkalosis improved. His blood pressure is lower side. He was noted to have chronic kidney disease, his creatinine remained stable throughout his hospital stay. His ACE inhibitor was held temporarily. Blood pressure stabilized on discharge, he is being resumed on the lower dose of ACE inhibitor. Lasix is resumed on discharge, remains off Zaroxolyn. Hydrochlorothiazide was discontinued permanently. His sugars varied, his doses of insulin were adjusted. He was noted to be persistently hypoglycemic, he needs significantly less Lantus now been at home, doing well with 15 units every evening. He is following a diabetic diet. He is being discharged in stable condition, going home with visiting nurses, PT and OT, 2 L of oxygen, hospital bed was recommended as well in the setting of his acute on chronic respiratory failure Due to covid and extreme debility."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: COVID positive PCR 6/1/22
Aktuelle Erkrankungen: -
Vorgeschichte: Coronary artery disease with angina pectoris Unknown Prostate hypertrophy Unknown Hyperlipidemia 2/19/2015 Morbid obesity due to excess calories 2/18/2016 HTN, goal below 130/80 4/27/2016 Chronic pain of both knees 4/4/2017 Umbilical hernia without obstruction and without gangrene 5/31/2017 Calculus of gallbladder without cholecystitis without obstruction 2/22/2019 Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin 5/5/2020 Anasarca 2/8/2022 AKI (acute kidney injury) 2/11/2022 Acute respiratory failure with hypoxia 6/6/2022
Andere Medikamente: atorvastatin calcium 10 mg Oral NIGHTLY clopidogrel bisulfate 75 mg Oral Daily dapagliflozin propanediol 5 mg Oral EVERY MORNING fluticasone propionate 50 mcg/actuation 2 sprays Each Nare Daily furosemide 40 mg Oral Daily 20 mg Oral
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1865210

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge Unknown

kritisch

Staat: MI
Alter: 52,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 02.11.2021
Beginn: 04.11.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Diarrhoea Dizziness Lethargy Pain Pain in extremity Pyrexia Somnolence Vomiting

Symptomtext

Achy, painall over, especially in legs, low grade fever, Vomiting & diarrhea, couldn't keep nothing in/down Larthagic, dizzy, & couldn't stay awake

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Family has results and do not wish to share at this time.
Aktuelle Erkrankungen: No
Vorgeschichte: High blood pressure his Dr stated it was stable at time of death Diabetes
Andere Medikamente: Simvastatin Zocor 10mg 1x Metformin 500mg 2-2x Cetirizine (zyrtec) 10mg 1x Furosemide 20mg 1x. Omeprazole (prevacid) 20 MG 1x Diovan hct 320/25 MG 1x. Theravitamin 1x Metoprolol (toprpol XL) 200MG ER TABS 1X. Aspirin. 81mg. 1x.
Allergien: None
Vorherige Impfungen: -

VAERS 1545011

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: VA
Alter: 43,0
Geschlecht: F
Eingang: 19.06.2022
Impfdatum: 29.07.2021
Beginn: 30.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Cardiac failure Congestive cardiomyopathy Death Sudden death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: heart Failure
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278218

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 76,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 02.11.2021
Beginn: 05.05.2022
Tage bis Beginn: 184,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abstains from alcohol Abstains from recreational drugs Angiogram pulmonary abnormal Anticoagulant therapy Arthralgia Asthenia Bacteraemia Blood culture positive Breath sounds abnormal COVID-19 Chest X-ray normal Cough Capillary nail refill test Cellulitis Chest X-ray abnormal Condition aggravated Cor pulmonale acute Deep vein thrombosis

Symptomtext

Hospitalized (5.5.22 - 5.9.22); COVID-19 positive (5.5.22); fully vaccinated PLUS Booster - moderna x3 BRIEF OVERVIEW: Discharge Provider: PA-C/ MD Primary Care Provider at Discharge: NP Admission Date: 5/5/2022 Discharge Date: 05/09/2022 Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 virus infection 05/06/2022 Unknown Resolved Hospital Problems No resolved problems to display DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus infection [U07.1] Respiratory tract infection due to COVID-19 virus [U07.1, J98.8] HOSPITAL COURSE: Patient is a 77 y.o. male with a history of Parkinson's dementia, A-Fib, prior PE, HLD, OSA, Obesity and recent DVT/PE on eliquis who presented to ED for malaise, cough, dyspnea, myalgias, generalized weakness, and headache. He is found to be COVID positive but is not hypoxic and has negative CXR. Due to significant weakness he was admitted under observation for PT/OT eval. Therapy evaluated patient and recommended discharge back to ALF with 2-person assist. His facility reported they were able to provide this level of care for him. Patient slowly started to feel better throughout stay and never became hypoxic. He was given supportive care for his COVID. To note, one blood culture was obtained on admission that grew Staph epidermidis, which is a suspected contaminant. Repeat blood cultures remain NGTD and he remained afebrile and no other signs of systemic infection. He was discharged back to his ALF in stable and improved condition. CONSULTS / RECOMMENDATION: None INPATIENT PROCEDURES: None BP 140/79 | Pulse 50 | Temp 36.5 ?C (Axillary) | Resp 16 | Ht 1.727 m | Wt 106.1 kg | SpO2 97% | BMI 35.57 kg/m? Physical ExamVitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: He is not toxic-appearing. HENT: Head: Normocephalic and atraumatic. Mouth/Throat: Mouth: Mucous membranes are moist. Eyes: General: No scleral icterus. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. No murmur heard. Comments: Faint pitting edema bilaterally. DP pulses 2+ bilaterally Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. No wheezing. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Musculoskeletal: General: Normal range of motion. Skin: General: Skin is warm and dry. Neurological: Mental Status: He is alert. Mental status is at baseline. Comments: Masked facies. Orientated to person, month only Psychiatric: Mood and Affect: Mood normal H&P: CHIEF COMPLAINT: COVID-19 virus infection ASSESSMENT / PLAN: COVID-19 viral infection Generalized weakness - Admit to GMF under observation. - Symptom onset 5/5. COVID PCR+ on 5/5. Vaccinated but due for booster. - Comfortable breathing, saturating normally on RA alone. - Not presently a candidate for dexamethasone or remdesivir. - Supportive care, symptom management, encourage IS usage. - Admitting primarily for weakness - therapy evals and dispo planning. - Check ambulatory pulse ox once able to ambulate with walker. Parkinson's disease Dementia Hypotension - Alert and oriented to person only. Usually better oriented during day per daughter. - Continue home Sinemet, Aricept and midodrine. - Regular reorientation, supportive care, avoid deliriogenic meds. PAF - Currently in NSR. Not on chronic rate/rhythm control. - Continue home Eliquis for anticoagulation. - Monitor and optimize electrolytes. HLD - Continue home ASA and Lipitor. Anxiety Depression Insomnia - Continue home Zoloft and melatonin. BPH - Continue Flomax and Vesicare (for Myrbetriq) and monitor for inpatient retention, ISC PRN. Dysphagia - Nectar thick and general solids per daughter. SLP consult. Physical deconditioning - PT/OT evals for home safety (ALF resident). NCM for dispo assist. H/o recent admissions for cellulitis and DVT/PE (Feb-March 2022) VTE Proph: Continue home Eliquis. Code Status: "FULL CODE" per d/w patient and daughter at bedside. HISTORY OF PRESENT ILLNESS: Patient is a 77 y.o. male ALF resident with h/o Parkinsons dementia, A-Fib, prior PE, HLD, OSA and obesity, presenting to the Blodgett ER on 5/5 with c/o malaise, cough, dyspnea, myalgias and headache. He also appears weaker than usual baseline, requiring 2-person assist for standing rather than his usual 1-person assist. He was recently admitted twice in the past few months for DVT/PE and cellulitis, respectively. He is now off antibiotics, but continues to take Eliquis for anticoagulation. Venous duplex in February showed acute appearing DVT of left femoral vein, and CTA thorax showed multiple bilateral acute pulmonary emboli with high clot burden on the right, but no evidence of acute right heart strain. He was in his normal state of health until earlier on 5/5, when the above-noted symptoms started rapidly and progressed throughout the day. There was recently a member of the care staff that was diagnosed with COVID-19. The patient has been vaccinated, but is overdue for his booster. He does not currently smoke, drink alcohol or use recreational drugs. Family history was reviewed but is noncontributory. He denies any other specific complaints or concerns at this time. In the ER, he was afebrile (Tmax 37.7), normotensive, with normal pulse and respiratory rates, and normal oxygen saturation on room air alone. Initial labs are notable for mild normocytic anemia and thrombocytopenia, as well as a positive COVID screen. CXR shows low lung volumes, but no acute cardiopulmonary process. He was treated with Tylenol and 1 L of IV NS. Review of Systems Constitutional: Positive for fatigue. Negative for chills, diaphoresis and fever. HENT: Negative for sore throat and trouble swallowing. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for wheezing and sputum production. Cardiovascular: Negative for chest pain, palpitations, orthopnea and leg swelling. Gastrointestinal: Negative for nausea, vomiting, abdominal pain, constipation, diarrhea and trouble swallowing. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Positive for joint pain and muscle pain. Neurological: Positive for headaches and weakness (generalized). Negative for dizziness, light-headedness, speech difficulty, loss of consciousness and numbness/tingling. Endo/Heme/Allergy: Negative for adenopathy and easy bleeding or bruising. Skin: Negative for color change and rash OBJECTIVE: BP 117/62 | Pulse 85 | Temp 37.7 ?C (Oral) | Resp 20 | SpO2 95% Physical Exam Vitals reviewed. Constitutional: General: He is not in acute distress. Appearance: He is well-developed. He is ill-appearing. He is not diaphoretic. HENT: Head: Normocephalic and atraumatic. Mouth/Throat: Mouth: Mucous membranes are dry. Eyes: Conjunctiva/sclera: Conjunctivae normal. Pupils: Pupils are equal, round, and reactive to light. Neck: Vascular: No JVD. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: No wheezing or rales. Comments: Diminished at bases bilaterally, but no audible wheezes, rales or rhonchi. Comfortable and saturating appropriately on baseline room air. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: Swelling (1-2+ BL LE) present. No tenderness. Skin: General: Skin is warm and dry. Capillary Refill: Capillary refill takes less than 2 seconds. Neurological: General: No focal deficit present. Mental Status: He is alert and oriented to person, place, and time. Mental status is at baseline. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Pre-Existing Active Problems Diagnosis Date Noted POA ? Bacteremia 03/21/2022 Unknown ? Cellulitis of left groin 03/19/2022 Unknown ? Cellulitis 03/19/2022 Unknown ? Dysphagia 02/17/2022 Unknown ? Acute pulmonary embolism with acute cor pulmonale, unspecified pulmonary embolism type 02/14/2022 Unknown ? Presence of Watchman left atrial appendage closure device 11/11/2021 Unknown ? Urinary tract infection 10/24/2021 Unknown ? UTI (urinary tract infection) 10/21/2021 Unknown ? Fall from ground level 10/14/2021 Unknown ? Scalp laceration 10/14/2021 Unknown ? Scalp hematoma 10/14/2021 Unknown ? Obesity, morbid 06/07/2021 Unknown ? Skin breakdown 12/15/2020 Unknown ? Anxiety and depression 02/20/2020 Unknown ? Dizziness 10/07/2019 Unknown ? Weakness 04/19/2019 Unknown ? Paroxysmal atrial fibrillation 01/02/2019 Unknown ? Other sleep apnea 01/02/2019 Unknown ? Dyslipidemia 01/02/2019 Unknown ? Orthostatic hypotension 01/02/2019 Unknown ? Recurrent urinary tract infection 11/07/2018 Unknown ? Parkinsons disease 02/12/2018 Unknown ? Irritable bowel 02/12/2018 Unknown ? BPH (benign prostatic hyperplasia) 02/12/2018 Unknown ? Parkinson's disease dementia 02/12/2018 Unknown ? Psychosis due to Parkinson's disease
Andere Medikamente: Acetaminophen 500-1,000 mg Oral 3 times daily PRN Apixaban 5 mg Oral 2 times daily Aspirin 81 mg Oral Every morning Atorvastatin Calcium 20 mg Oral Every evening Carbidopa-Levodopa 25-100 MG 3 tablets Oral 4 times daily Cranberry 450 mg Ora
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2263459

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 90,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 20.05.2021
Beginn: 17.01.2022
Tage bis Beginn: 242,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation Bradycardia COVID-19 Cardiomyopathy Cerebral infarction Cerebrovascular accident Deafness unilateral Dyspnoea Encephalopathy General physical health deterioration Hemiparesis Hypervolaemia Hypoxia Intervertebral disc degeneration Lacunar infarction Lumbar spinal stenosis Magnetic resonance imaging head abnormal Polyuria

Symptomtext

Provider discharge summary "the patient is a 91 y/o male who presented to the ED on 1/17/2022 due to being found down at home. He was encephalopathic on arrival and noted to have a UTI for which he was started on antibiotics. He also did have rhabdomyolysis for which he was started on IVF. His symptoms did improve. He did also develop Afib with RVR and was started on metoprolol/cardizem with improvement in his HR. He did develop some fluid overload and was given diuresis with improvement. On the 25th the patient was tested for COVID due to persistent hypoxia and was found to be positive, he was started on COVID directed therapies. He completed antibiotic therapy for the UTI and encephalopathy improved. His hypoxia also improved. The patients stay was prolonged due to need to be cleared from COVID quarantine before being discharged to an SNF. His stay was also complicated by development of left sided weakness on 2/4/22 and a code stroke was called, MRI was positive for acute lacunar infarct in the posterior limb of the right internal capsule. The patients deficits quickly resolved so he was not a candidate for tPA. He was seen by neurology team who recommended ASA daily. This was discussed in depth with the patient and his family. Per family the patient has been on ASA/anticoagulants before which resulted in a GI bleed. We discussed that he is very high risk for another stroke so ASA would be beneficial for him, they continued to decline (patient and family) this medication stating they were more concerned about a GI bleed. Family and patient wanted to be discharged to assisted living facility for further care. Patient/family verbalized understanding and agreement to the above discharge plan. All questions were answered at time of discharge"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 20,0
Labordaten: Positive COVID PCR test 1/25/22
Aktuelle Erkrankungen: -
Vorgeschichte: History of TIA (transient ischemic attack) 3/8/2012 Sciatica of left side 3/8/2012 Bilateral lower extremity edema 10/22/2012 Varicose veins of lower extremity 10/31/2012 Hand joint pain 11/7/2012 Elevated prostate specific antigen (PSA) 2/27/2013 GERD (gastroesophageal reflux disease) 7/1/2014 Fatigue 7/22/2014 Benign prostatic hyperplasia with incomplete bladder emptying 9/29/2014 PAC (premature atrial contraction) 10/20/2014 Hilar enlargement- Right 12/25/2014 Weakness 12/25/2014 History of anemia 10/16/2015 Chronic bilateral low back pain without sciatica 4/18/2016 Ankle arthritis 4/18/2016 Chronic scapular pain 8/3/2017 Incarcerated right inguinal hernia 10/1/2017 Unilateral recurrent inguinal hernia without obstruction or gangrene 10/3/2017 LAFB (left anterior fascicular block) (Chronic) 2/6/2020 Hyperlipidemia (Chronic) 2/6/2020 History of BPH (Chronic) 2/6/2020 History of lower GI bleeding (Chronic) 2/6/2020 CAD (coronary artery disease) (Chronic) 2/6/2020 LVH (left ventricular hypertrophy) due to hypertensive disease (Chronic) 2/6/2020 Hypertension (Chronic) 2/6/2020 Small vessel disease, cerebrovascular (Chronic) 2/6/2020 Chronic combined systolic and diastolic heart failure 2/9/2020 Osteoarthritis of ankle and foot, left 11/13/2020 HFrEF (heart failure with reduced ejection fraction) Unknown Spinal stenosis of lumbar region without neurogenic claudication 6/17/2021 Cardiomyopathy 6/17/2021 Hearing loss of left ear 6/21/2021 Bradycardia 7/21/2021 Degeneration of lumbar intervertebral disc 1/17/2022 PAF (paroxysmal atrial fibrillation) 1/17/2022 Cerebral infarction due to thrombosis of precerebral artery Unknown History of lacunar cerebrovascular accident right 2/4/2022 2/7/2022 Shortness of breath 3/2/2022
Andere Medikamente: acetaminophen 650 mg Oral EVERY MORNING albuterol sulfate 90 mcg/actuation 2 puffs Inhalation PRN atorvastatin calcium 40 mg Oral NIGHTLY bumetanide 1 mg Oral Daily diltiazem HCl 180 mg Oral Daily flaxseed 1,000 mg 1 capsule Daily mag
Allergien: Aspirin High Other (See Comments) Pt bleeds if given asa Other High Anaphylaxis Sclero vein injection for shrinking varicose veins Aleve [naproxen Sodium] Not Specified Itching, Swelling Swelling in hands Ibuprofen Not Specified Itching Prednisone Not Specified Other (See Comments) Felt like stroke symptoms? Went to ER
Vorherige Impfungen: -

VAERS 2263459

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 90,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 20.05.2021
Beginn: 17.01.2022
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation Bradycardia COVID-19 Cardiomyopathy Cerebral infarction Cerebrovascular accident Deafness unilateral Dyspnoea Encephalopathy General physical health deterioration Hemiparesis Hypervolaemia Hypoxia Intervertebral disc degeneration Lacunar infarction Lumbar spinal stenosis Magnetic resonance imaging head abnormal Polyuria

Symptomtext

Provider discharge summary "the patient is a 91 y/o male who presented to the ED on 1/17/2022 due to being found down at home. He was encephalopathic on arrival and noted to have a UTI for which he was started on antibiotics. He also did have rhabdomyolysis for which he was started on IVF. His symptoms did improve. He did also develop Afib with RVR and was started on metoprolol/cardizem with improvement in his HR. He did develop some fluid overload and was given diuresis with improvement. On the 25th the patient was tested for COVID due to persistent hypoxia and was found to be positive, he was started on COVID directed therapies. He completed antibiotic therapy for the UTI and encephalopathy improved. His hypoxia also improved. The patients stay was prolonged due to need to be cleared from COVID quarantine before being discharged to an SNF. His stay was also complicated by development of left sided weakness on 2/4/22 and a code stroke was called, MRI was positive for acute lacunar infarct in the posterior limb of the right internal capsule. The patients deficits quickly resolved so he was not a candidate for tPA. He was seen by neurology team who recommended ASA daily. This was discussed in depth with the patient and his family. Per family the patient has been on ASA/anticoagulants before which resulted in a GI bleed. We discussed that he is very high risk for another stroke so ASA would be beneficial for him, they continued to decline (patient and family) this medication stating they were more concerned about a GI bleed. Family and patient wanted to be discharged to assisted living facility for further care. Patient/family verbalized understanding and agreement to the above discharge plan. All questions were answered at time of discharge"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 20,0
Labordaten: Positive COVID PCR test 1/25/22
Aktuelle Erkrankungen: -
Vorgeschichte: History of TIA (transient ischemic attack) 3/8/2012 Sciatica of left side 3/8/2012 Bilateral lower extremity edema 10/22/2012 Varicose veins of lower extremity 10/31/2012 Hand joint pain 11/7/2012 Elevated prostate specific antigen (PSA) 2/27/2013 GERD (gastroesophageal reflux disease) 7/1/2014 Fatigue 7/22/2014 Benign prostatic hyperplasia with incomplete bladder emptying 9/29/2014 PAC (premature atrial contraction) 10/20/2014 Hilar enlargement- Right 12/25/2014 Weakness 12/25/2014 History of anemia 10/16/2015 Chronic bilateral low back pain without sciatica 4/18/2016 Ankle arthritis 4/18/2016 Chronic scapular pain 8/3/2017 Incarcerated right inguinal hernia 10/1/2017 Unilateral recurrent inguinal hernia without obstruction or gangrene 10/3/2017 LAFB (left anterior fascicular block) (Chronic) 2/6/2020 Hyperlipidemia (Chronic) 2/6/2020 History of BPH (Chronic) 2/6/2020 History of lower GI bleeding (Chronic) 2/6/2020 CAD (coronary artery disease) (Chronic) 2/6/2020 LVH (left ventricular hypertrophy) due to hypertensive disease (Chronic) 2/6/2020 Hypertension (Chronic) 2/6/2020 Small vessel disease, cerebrovascular (Chronic) 2/6/2020 Chronic combined systolic and diastolic heart failure 2/9/2020 Osteoarthritis of ankle and foot, left 11/13/2020 HFrEF (heart failure with reduced ejection fraction) Unknown Spinal stenosis of lumbar region without neurogenic claudication 6/17/2021 Cardiomyopathy 6/17/2021 Hearing loss of left ear 6/21/2021 Bradycardia 7/21/2021 Degeneration of lumbar intervertebral disc 1/17/2022 PAF (paroxysmal atrial fibrillation) 1/17/2022 Cerebral infarction due to thrombosis of precerebral artery Unknown History of lacunar cerebrovascular accident right 2/4/2022 2/7/2022 Shortness of breath 3/2/2022
Andere Medikamente: acetaminophen 650 mg Oral EVERY MORNING albuterol sulfate 90 mcg/actuation 2 puffs Inhalation PRN atorvastatin calcium 40 mg Oral NIGHTLY bumetanide 1 mg Oral Daily diltiazem HCl 180 mg Oral Daily flaxseed 1,000 mg 1 capsule Daily mag
Allergien: Aspirin High Other (See Comments) Pt bleeds if given asa Other High Anaphylaxis Sclero vein injection for shrinking varicose veins Aleve [naproxen Sodium] Not Specified Itching, Swelling Swelling in hands Ibuprofen Not Specified Itching Prednisone Not Specified Other (See Comments) Felt like stroke symptoms? Went to ER
Vorherige Impfungen: -

VAERS 2259783

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge Unknown

kritisch

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 01.08.2021
Beginn: 01.03.2022
Tage bis Beginn: 212,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Cerebrovascular accident Cognitive disorder Hemiparesis Memory impairment

Symptomtext

Patient suffered a stroke, prior med history is unknown, currently hospitalized, length of time unknown, cognitive, memory, expression, use of right side fully impacted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2244340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: SD
Alter: 44,0
Geschlecht: M
Eingang: 20.04.2022
Impfdatum: 21.12.2021
Beginn: 19.02.2022
Tage bis Beginn: 60,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Cardio-respiratory arrest Death Disseminated intravascular coagulation Dyspnoea Encephalopathy Hepatic cirrhosis Hyperhidrosis Inappropriate schedule of product administration Klebsiella infection Lactic acidosis Mental status changes Metabolic acidosis Pleural effusion Pneumonia pneumococcal SARS-CoV-2 test positive Septic shock

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/28/2021, 03/08/2021, and 12/21/2021. Lot numbers, route, and injection site were not entered into the immunization system. The individual presented to emergency department on 02/19/2022 and tested positive twice, once in emergency department and once upon hospital admission. Primary complaints were dyspnea, diaphoresis, and altered mental status. They were admitted to hospital 02/19/2022. They were found to be having multiple medical conditions and complications including: acute respiratory failure due to COVID-19, acute encephalopathy, septic shock due to Klebsiella pneumonia infection and cirrosis, Strep pneumoniae infection (urine was antigen positive), anion gap metabolic acidosis, lactic acidosis, bilateral pleural effusions, and decompensated hepatic cirrhosis, and dissemited intravascular coagulation. They also suffered a cardiopulmonary arrest due to the septic shock. The individual was transitioned to comfort cares after condition did not improve, and they remained hospitalized until their death on 02/22/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 tests x2 on 02/19/2022 despite being vaccinated and boosted.
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, Hypertension, Benign Prostatic Hyperplasia, history of clostrudium diffidile infection, marijuana abuse, history of alcohol abuse
Andere Medikamente: -
Allergien: Vancomycin (reaction: rash) Sulfamethoxazole-Trimethoprim (reaction: other, not specified)
Vorherige Impfungen: -

VAERS 2244340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: SD
Alter: 44,0
Geschlecht: M
Eingang: 20.04.2022
Impfdatum: 21.12.2021
Beginn: 19.02.2022
Tage bis Beginn: 60,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Cardio-respiratory arrest Death Disseminated intravascular coagulation Dyspnoea Encephalopathy Hepatic cirrhosis Hyperhidrosis Inappropriate schedule of product administration Klebsiella infection Lactic acidosis Mental status changes Metabolic acidosis Pleural effusion Pneumonia pneumococcal SARS-CoV-2 test positive Septic shock

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/28/2021, 03/08/2021, and 12/21/2021. Lot numbers, route, and injection site were not entered into the immunization system. The individual presented to emergency department on 02/19/2022 and tested positive twice, once in emergency department and once upon hospital admission. Primary complaints were dyspnea, diaphoresis, and altered mental status. They were admitted to hospital 02/19/2022. They were found to be having multiple medical conditions and complications including: acute respiratory failure due to COVID-19, acute encephalopathy, septic shock due to Klebsiella pneumonia infection and cirrosis, Strep pneumoniae infection (urine was antigen positive), anion gap metabolic acidosis, lactic acidosis, bilateral pleural effusions, and decompensated hepatic cirrhosis, and dissemited intravascular coagulation. They also suffered a cardiopulmonary arrest due to the septic shock. The individual was transitioned to comfort cares after condition did not improve, and they remained hospitalized until their death on 02/22/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 tests x2 on 02/19/2022 despite being vaccinated and boosted.
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, Hypertension, Benign Prostatic Hyperplasia, history of clostrudium diffidile infection, marijuana abuse, history of alcohol abuse
Andere Medikamente: -
Allergien: Vancomycin (reaction: rash) Sulfamethoxazole-Trimethoprim (reaction: other, not specified)
Vorherige Impfungen: -

VAERS 2244340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: SD
Alter: 44,0
Geschlecht: M
Eingang: 20.04.2022
Impfdatum: 21.12.2021
Beginn: 19.02.2022
Tage bis Beginn: 60,0
Dosis: 3
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Cardio-respiratory arrest Death Disseminated intravascular coagulation Dyspnoea Encephalopathy Hepatic cirrhosis Hyperhidrosis Inappropriate schedule of product administration Klebsiella infection Lactic acidosis Mental status changes Metabolic acidosis Pleural effusion Pneumonia pneumococcal SARS-CoV-2 test positive Septic shock

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/28/2021, 03/08/2021, and 12/21/2021. Lot numbers, route, and injection site were not entered into the immunization system. The individual presented to emergency department on 02/19/2022 and tested positive twice, once in emergency department and once upon hospital admission. Primary complaints were dyspnea, diaphoresis, and altered mental status. They were admitted to hospital 02/19/2022. They were found to be having multiple medical conditions and complications including: acute respiratory failure due to COVID-19, acute encephalopathy, septic shock due to Klebsiella pneumonia infection and cirrosis, Strep pneumoniae infection (urine was antigen positive), anion gap metabolic acidosis, lactic acidosis, bilateral pleural effusions, and decompensated hepatic cirrhosis, and dissemited intravascular coagulation. They also suffered a cardiopulmonary arrest due to the septic shock. The individual was transitioned to comfort cares after condition did not improve, and they remained hospitalized until their death on 02/22/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 tests x2 on 02/19/2022 despite being vaccinated and boosted.
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, Hypertension, Benign Prostatic Hyperplasia, history of clostrudium diffidile infection, marijuana abuse, history of alcohol abuse
Andere Medikamente: -
Allergien: Vancomycin (reaction: rash) Sulfamethoxazole-Trimethoprim (reaction: other, not specified)
Vorherige Impfungen: -

VAERS 2241215

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 19.04.2022
Impfdatum: 12.05.2021
Beginn: 08.10.2021
Tage bis Beginn: 149,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy C-reactive protein COVID-19 Coagulation test Computerised tomogram thorax abnormal Echocardiogram Electrocardiogram Full blood count Metabolic function test Pulmonary embolism Troponin

Symptomtext

Patient hospitalized for pulmonary embolism and COVID-19 infection after COVID-19 immunization. Received oxygen, anticoagulated, and discharged to home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Blood counts Basic metabolic panel Electrocardiogram Transthoracic echocardiogram Chest computed tomography HS Troponin C-reactive Protein Routine coagulation panel
Aktuelle Erkrankungen: Pulmonary embolism
Vorgeschichte: Genital Herpes simplex Obesity
Andere Medikamente: Sertraline Lorazepam Cholecalciferol
Allergien: Hymenoptera venom
Vorherige Impfungen: -

VAERS 2238695

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 18.04.2022
Impfdatum: 12.05.2021
Beginn: 18.09.2021
Tage bis Beginn: 129,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy C-reactive protein increased COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal International normalised ratio normal Lung opacity Pleural effusion Pneumonia Prothrombin time prolonged Pulmonary embolism Pulmonary infarction White blood cell count increased

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: hospitalized for pulmonary embolism and COVID-19 infection after COVID-19 immunization. Received oxygen, anticoagulated, and discharged to home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: PT: 14.0 seconds, INR: 1.1, WBC: 15.2 10*9/L, CRP: 198.9 mg/L; chest x-ray: Right mid lung zone opacity. Differential includes pneumonia or a lung infarct. Small right pleural effusion.; CT PE: Positive for acute pulmonary embolism with a saddle PE with pulmonary infarcts.
Aktuelle Erkrankungen: none known
Vorgeschichte: provoked pulmonary embolism
Andere Medikamente: none known
Allergien: bees
Vorherige Impfungen: -

VAERS 2237320

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: WA
Alter: -
Geschlecht: U
Eingang: 16.04.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer concerned 12 multiple patients of an unspecified sex, age, race and ethnicity. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: UNKNOWN) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, after receiving vaccine the 12 multiple patients died from an unknown cause of death. It was unknown if an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20210320422.; Sender's Comments: 20220419102 -covid-19 vaccine ad26.cov2.s -Death. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered Unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2196525

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: SD
Alter: 58,0
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 02.04.2021
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Death Feeling abnormal Malaise Pain in extremity Headache Hip arthroplasty SARS-CoV-2 test Pulmonary embolism

Symptomtext

patient had total hip replacement on 15Oct2021; mild headache; Second dose: Had a sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 59-year-old female patient received BNT162b2 (BNT162B2), on 02Apr2021 as dose 2, single (Lot number: ER8733) at the age of 58 years intramuscular, in arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1; Anatomical location: Upper arm; Route: Intramuscular; Batch/Lot number: EN6206), administration date: 11Mar2021, when the patient was 58-year-old, for Covid-19 immunization, reaction(s): "Mild headache", "Sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "Second dose: Had a sore arm"; HIP ARTHROPLASTY (medically significant), outcome "unknown", described as "patient had total hip replacement on 15Oct2021"; HEADACHE (non-serious), outcome "unknown", described as "mild headache". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Oct2021) Negative, notes: Tested Negative cleared for surgery. Therapeutic measures were taken as a result of hip arthroplasty. Clinical course: Had a sore arm: The patient had a sore arm after receiving the first and second dose Adult Pfizer Covid Vaccine. Caller states the patients sore arm believes began shortly thereafter receiving the first and second dose Adult Pfizer Covid Vaccine. Patient received her 1st dose and 2nd dose of covid vaccine as the dates reflect. Side effects were not serious expect for a sore arm and a mild headache for a day. She then received the booster (3rd dose) on 28Dec2021. Her son reported she just felt "out of it" and just generally did not felt well. She had a post-Christmas gathering planned for family on the 30Dec but cancelled it because she wasn't feeling up to it. On the morning of new year's Day, she complained of her left leg hurting as if someone "hit her with a bat". Hours later, she was found, face down, in her home, deceased. The caller does not know exactly what it meant that the patient did not feel well, except that the patient postponed a Christmas gathering with family and friends. The patient passed away on 01Jan2022. The caller states the cause of death was Pulmonary Embolism. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20211015; Test Name: Covid Test; Result Unstructured Data: Test Result:Negative; Comments: Tested Negative cleared for surgery
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Patient's Medical History (including any illness at time of vaccination)? none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2216053

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 05.04.2022
Impfdatum: 28.03.2021
Beginn: 19.04.2021
Tage bis Beginn: 22,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

Patient presented to the ED and was subsequently hospitalized for NSTEMI within 6 weeks of receiving covid vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2211522

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 01.04.2022
Impfdatum: 17.11.2021
Beginn: 27.11.2021
Tage bis Beginn: 10,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident Transient ischaemic attack

Symptomtext

Patient presented to the ED and was subsequently hospitalized for CVA, TIA within 6 weeks of receiving covid vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2211514

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 24,0
Geschlecht: F
Eingang: 01.04.2022
Impfdatum: 17.01.2022
Beginn: 21.02.2022
Tage bis Beginn: 35,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Coronary artery dissection

Symptomtext

Patient presented to the ED and was subsequently hospitalized for STEMI, spontaneous dissection of coronary artery within 6 weeks of receiving covid vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1794223

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Anuria Biopsy kidney abnormal Biopsy skin abnormal ADAMTS13 activity assay Aspiration pleural cavity Biopsy Biopsy bone marrow Device related thrombosis Dyspnoea exertional Fatigue Haemodialysis Cardiovascular evaluation Computerised tomogram pancreas abnormal Deep vein thrombosis Dermatitis psoriasiform Dialysis

Symptomtext

PERICARDITIS; SKIN HYPERPIGMENTATION; RASH; FATIGUE; HAEMODIALYSIS; ASPIRATION PLEURAL CAVITY; LABORATORY TEST NORMAL; BIOPSY; THROMBOCYTOPENIA; RENAL FAILURE; RENAL-LIMITED THROMBOTIC MICROANGIOPATHY; DYSPNOEA EXERTIONAL; NORMOCYTIC ANAEMIA; ORTHOPNOEA; PLEURAL EFFUSION; MULTISYSTEMIC INFLAMMATORY SYNDROME; LEUKOCYTOSIS; VARIABLE THROMBOCYTOSIS; CATHETER-RELATED DEEP VEIN THROMBOSIS; ITCHY SCALY RASH; PROGRESSIVE SHORTNESS OF BREATH FROM PERICARDIAL EFFUSION REQUIRING 3 PERICARDIOCENTESES.; This spontaneous report received from a health care professional via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID:) concerned a 56-year-old African American female. This spontaneous report was received from literature. This report concerned a 56 year old female. The objective of this study was to describe case of renal TMA without thrombocytopenia in the setting of a hyperinflammatory state arising weeks after receiving Ad26.COV2.S COVID vaccine. The patient's height, and weight were not reported. The patient's past medical history included: eczema, and concurrent conditions included: hypertension, chronic right knee pain, and 2cm pancreatic head mass, and other pre-existing medical conditions included: The patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total, administered on 07-APR-2021 at right arm for an unspecified indication. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. Concomitant medications included amlodipine, and metoprolol tartrate.On 08-APR-2021, the patient developed orthopnea (orthopnoea), dyspnea on exertion (dyspnoea exertional), fatigue (fatigue) after receiving the vaccine. On 09-APR-2021, patient developed generalized itchy scaly rash 2 days after receiving J&J vaccine. On 14-APR-2021, 1 week after the vaccine, she developed a profuse disseminated non-pruritic hyperpigmented rash (rash) that started on the hands and spread to the body (skin hyperpigmentation), self-resolved. Patient had developed bilateral transudative pleural effusions (pleural effusion) necessitating therapeutic thoracentesis (aspiration pleural cavity), she also had thrombocytopenia (thrombocytopenia) and normocytic anemia (normocytic anaemia) that was not present prior to vaccine. Patient had been now diagnosed with renal thrombotic microangiopathy (renal-limited thrombotic microangiopathy) confirmed on biopsy (biopsy) now in renal failure (renal failure) required hemodialysis (haemodialysis). All laboratory reports related to thrombotic microangiopathy worked-up for causes such as SLE (systemic lupus erythematosus) TTP (thrombotic thrombocytopenic purpura) had been negative. The thrombotic microangiopathy seems to be related to the vaccine or a potential malignancy as an incidental 2 cm pancreatic head mass had been found that may be malignant. Laboratory data included: Aspiration pleural cavity (NR: not provided) Unknown, Biopsy (NR: not provided) renal thrombotic microangiopathy, and Laboratory test (NR: not provided) normal. The patient had 2 episodes of pericarditis (pericarditis) within 3-4 months of vaccine administration once in July 2021 and once in August 2021. On an unspecified date, the patient was hospitalized for 12 days other details was not provided. On APR-2021, (2 weeks later), patient developed progressive shortness of breath from pericardial effusion requiring three pericardiocenteses. On AUG-2021, (4 months later), patient experienced acute kidney injury requiring hemodialysis. A renal biopsy revealed extensive active TMA(Thrombotic microangiopathy)with arterial/arteriolar thrombi, glomerular ischemia, and ischemic acute tubular necrosis. There was no evidence of immune complex deposition. Patient's course was complicated by catheter-related deep vein thrombosis. Anticoagulant was started. Patient received two plasmaphereses and 1gm solumedrol while waiting for ADAMTS 13 test result. Throughout patient's course, patient's laboratory results showed leukocytosis; normocytic anemia; variable thrombocytosis; mild hemolysis with occasional schistocytes. Inflammatory markers were elevated. Blood, urine, sputum, pericardial and pleural fluid culture were negative. interleukin-2 receptor (IL2R) was elevated but bone marrow biopsy did not reveal hemophagocytosis or malignant cell. COVID RT-PCR(COVID reverse transcription polymerase chain reaction) and HIT-PF4 Ab (heparin induced thrombocytopenia) were also negative. Definitive diagnosis remains unclear. Patient remained dialysis dependent. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin hyperpigmentation, rash, and itchy scaly rash, had not recovered from aspiration pleural cavity, dyspnoea exertional, fatigue, normocytic anaemia, orthopnoea, pericarditis, pleural effusion, renal failure, renal-limited thrombotic microangiopathy, thrombocytopenia, biopsy, haemodialysis, and laboratory test normal, and the outcome of catheter-related deep vein thrombosis, multisystemic inflammatory syndrome, leukocytosis, variable thrombocytosis and progressive shortness of breath from pericardial effusion requiring 3 pericardiocenteses. was not reported. The authors emphasized on the knowledge that this was the only case reported with extensive, isolated kidney arterial/arteriolar thrombosis after vaccination. This case appears to represent multisystemic inflammatory syndrome in an adult occurring after Ad26.COV2.S vaccination. This report was serious (Hospitalization Caused / Prolonged, Other Medically Important Condition, and Disability Or Permanent Damage). Additional information was received from other health care professional via literature article on 21-MAR-2022. The following information was updated and incorporated into the case narrative: reporters and reporter details, patient's race, events (itchy scaly rash, catheter-related deep vein thrombosis, multisystemic inflammatory syndrome, leukocytosis, variable thrombocytosis and progressive shortness of breath from pericardial effusion requiring 3 pericardiocentesis), lab data, literature details, treatment medication (solumedrol and pericardiocenteses) were added. The eczema updated to past condition.; Sender's Comments: V1:This follow up version updates new events added. 20211061607-COVID-19 VACCINE AD26.COV2.S-pericardial effusion, catheter-related DVT, multisystemic inflammatory syndrome.The events have compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.There is no information on any other factors potentially associated with the events. Therefore, this events are considered unassessable. This spontaneous report received from a health care professional via(VAERS ID: 1794223) concerned a 56-year-old female who was hospitalized for renal-limited thrombotic microangiopathy(TMA) and renal failure that required hemodialysis unspecified time after vaccination.The patient's concurrent conditions included: hypertension, eczema, chronic right knee pain, 2 cm pancreatic head mass that had not been biopsied.Concomitant medications included amlodipine, and metoprolol.The patient developed orthopnea, exertional dyspnea ,fatigue 1 day after receiving the vaccine.One week after vaccination she developed a self-resolving profuse disseminated non-pruritic hyperpigmented rash.Patient had developed bilateral transudative pleural effusions necessitating therapeutic thoracentesis.She also had thrombocytopenia and normocytic anemia that was not present prior to vaccine.The patient had 2 episodes of pericarditis within 3-4 months of vaccination.On an unspecified date, the patient was hospitalized for 12 days. All laboratory reports such as SLE,TTP had been negative.Biopsy -renal thrombotic microangiopathy, Laboratory test normal. Patient had recovered from skin hyperpigmentation,rash and had not recovered from other events.Information regarding other potential etiologies was insufficient, and the occurrence of renal TMA and renal failure could represent background incidence of such events in the general population.Considering the temporal relationship,the event is assessed to have an indeterminate relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: Test Date: 20210408; Test Name: Laboratory test; Result Unstructured Data: normal; Test Date: 20210408; Test Name: Biopsy; Result Unstructured Data: renal thrombotic; Comments: diagnosed with renal thrombotic microangiopathy confirmed on biopsy; Test Date: 20210408; Test Name: Aspiration pleural cavity; Result Unstructured Data: Unknown; Test Date: 202108; Test Name: Renal biopsy; Result Unstructured Data: extensive TMA; Comments: extensive active TMA with arterial/arteriolar thrombi, glomerular ischemia, and ischemic acute tubular necrosis.; Test Date: 202108; Test Name: ADAMTS13 activity assay; Result Unstructured Data: not reported.; Test Name: Heparin-induced thrombocytopenia test; Result Unstructured Data: negative; Test Name: Blood test; Result Unstructured Data: negative; Test Name: Sputum test; Result Unstructured Data: negative; Test Name: Culture pleural fluid; Result Unstructured Data: negative; Test Name: COVID-19 PCR test; Result Unstructured Data: Negative; Test Name: Inflammatory marker test; Result Unstructured Data: Elevated; Test Name: Urine culture; Result Unstructured Data: negative; Test Name: Bone marrow biopsy; Result Unstructured Data: not revealed hemophagocytosis; Comments: didn't reveal hemophagocytosis or malignant cell.; Test Name: Laboratory test; Result Unstructured Data: leukocytosis; Comments: leukocytosis; normocytic anemia; variable thrombocytosis; mild hemolysis with occasional schistocytes.; Test Name: Interleukin-2 receptor assay; Result Unstructured Data: elevated
Aktuelle Erkrankungen: Hypertension; Knee pain; Pancreatic mass (found to have a 2cm pancreatic head mass that has not been biopsied or characterized)
Vorgeschichte: Medical History/Concurrent Conditions: Eczema; Comments: The patient had no known drug allergies.
Andere Medikamente: AMLODIPINE; METOPROLOL TARTRATE
Allergien: -
Vorherige Impfungen: -

VAERS 2203399

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: DE
Alter: -
Geschlecht: M
Eingang: 29.03.2022
Impfdatum: -
Beginn: 12.11.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Balance disorder Computerised tomogram Dizziness Fibrin D dimer Haematocrit Haemoglobin Musculoskeletal pain Platelet count Pleural effusion Prescribed underdose Pulmonary embolism Pyrexia Ultrasound Doppler X-ray

Symptomtext

PULMONARY EMBOLI; PLEURAL EFFUSION; MUSCULOSKELETAL PULL; PATIENT RECEIVED APIXABAN 5MG BID INITIALLY FOR CLOTS IN RIGHT LEG, BILATERAL PE; FEVER; DIZZINESS; OFF BALANCE; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from License Party(Agency). Other Case identifier(s): US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-031479 (Agency). This case was received via Pfizer Inc (Reference number: 202200334494) on 25-Feb-2022 and was forwarded to Agency on 28-Feb-2022. This spontaneous case was reported by an other health professional and describes the occurrence of Prescribed Underdose (Patient received apixaban 5mg BID initially for clots in right leg, bilateral PE) in 44-year-old male patient who received apixaban (ELIQUIS) for DVT and Pulmonary embolism. Previously administered products included for Pulmonary embolism: Xarelto (Bilateral PE and pleural effusion) from 11-Nov-2021 to 10-Dec-2021; for DVT: Warfarin (MCL tear and DVT in right leg in DEC-2008). Past adverse reactions to the above products included Dizziness with Xarelto. Concurrent medical conditions included Blood disorder (On blood thinners since Sep-2009). On 11-Dec-2021, the patient started ELIQUIS (Oral), 5 milligram twice a day. On the same day, the patient experienced prescribed underdose (Patient received apixaban 5mg BID initially for clots in right leg, bilateral PE). The action taken with ELIQUIS(Oral) was unknown. At the time of the report, prescribed underdose outcome was unknown. Diagnostic Results (normal ranges are provided in parenthesis if available): On 11-Nov-2021, Computerised tomogram: Positive evidence of acute PE, Fibrin D dimer: 686 ng/mL reference range: less than 244 ng/mL, Haematocrit (40-52 percent): 43.2 percent, Haemoglobin (13.3-17.7 gram per decilitre): 14.8 gram per decilitre and Platelet count (150-400 per millilitre): 237 per millilitre. On 06-Dec-2021, Computerised tomogram: Decreased clot burden in right upper lobe. On 09-Dec-2021, Computerised tomogram: No Acute intracranial hemorrhage or apparent acute transcortical infarction, no mucosal thickening. On an unknown date, Ultrasound Doppler: DVT and X-ray: Bilateral PE and pleural effusion. For ELIQUIS(Oral), the reporter did not provide any causality assessments. Causality Assessment: Drug: ELIQUIS, Event: Prescribed underdose Per Reporter: No Information Per Agency: Not Related Eliquis is under agreement with Agency. Follow-up (14Mar2022): This is a spontaneous follow-up report received from a contactable reporter(s) (Consumer or other non HCP) from License Party. Other Case identifier(s): US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-031479 (Agency). This case was received via {Agency} Pfizer Inc (Reference number: 202200334494) on 25-Feb-2022. Information was received from a Consumer/other non health professional concerning a 44 Year(s) old Male patient, who received Suspect product APIXABAN for PE and DVT, Oral (5 milligram(s) 2 every 1 Day), lot number:Unknown; Suspect product BNT162B2 for product used for unknown indication, lot number:Unknown. On 12-Nov-2021, the patient experienced balance disorder(off balance) which was considered serious due to the following criteria: disability and medical significance. Treatment included Treated by reducing apixaban dosing from 20 mg to 10 mg along with Meclizine 12.5 mg dose and had eye examination. Follow up was suggested with ENT specialist to complete vestibular and cochlear freqency testing..The patient had not yet recovered. On 12-Nov-2021, the patient experienced dizziness(dizzines) which was considered serious due to the following criteria: disability and medical significance. The patient had not yet recovered. On 12-Nov-2021, the patient experienced pyrexia(fever) which was considered not serious. It is unknown if treatment was provided. The outcome of the event is unknown. On 11-Dec-2021, the patient experienced prescribed underdose(patient received apixaban 5mg bid initially for clots in right leg, bilateral pe) which was considered not serious. It is unknown if treatment was provided. The outcome of the event is unknown.On an unknown date, the patient experienced pulmonary embolism(pulmonary emboli) which was considered serious due to medical significance. It is unknown if treatment was provided. The outcome of the event is unknown. On an unknown date, the patient experienced pleural effusion(pleural effusion) which was considered not serious. It is unknown if treatment was provided. The outcome of the event is unknown. On an unknown date, the patient experienced musculoskeletal pain(musculoskeletal pull) which was considered not serious. It is unknown if treatment was provided. The outcome of the event is unknown. The status of APIXABAN medication is unknown. The status of BNT162B2 medication is unknown. Medical history and concurrent conditions included null, Blood disorder (continuing), COVID-19 immunisation (from 06-Sep-2021), Pulmonary embolism (from 02-Dec-2008 until 01-Feb-2009) and Thrombectomy (not continuing, from Dec-2008). Concomitant medications were not reported. Relevant Laboratory & other Diagnostic Tests On 11-Nov-2021, CT OF CHEST: *Positive evidence of acute PE, D-DIMER: *686 ng/mL . Normal range is <244 ng/mL, HAEMATOCRIT: 43.2 % percent(normal 40 to 52), HEMOGLOBIN: 14.8 gram per decilitre(normal 13.3 to 17.7), PLATELET COUNT: 237 per millilitre(normal 150 to 400). On 06-Dec-2021, CT: *Decreased clot burden in right upper lobe. On 09-Dec-2021, CT: *No Acute intracranial hemorrhage or apparent acute transcortical infarction, no mucosal thickening,. On an unknown date, DOPPLER: *DVT, X RAY: *Bilateral PE and pleural effusion. The reporter did not provide a causal assessment for events balance disorder, dizziness, pulmonary embolism, pyrexia, prescribed underdose, pleural effusion and musculoskeletal pain to product APIXABAN. The reporter did not provide a causal assessment for events balance disorder, dizziness, pulmonary embolism, pyrexia, prescribed underdose, pleural effusion and musculoskeletal pain to product BNT162B2. Tracking of Changes: 25-Feb-2022: Initial information was received. Follow up received on 14-Mar-2022 with the following updates: Eliquis is under agreement with Agency. Causality Assessment: Drug: ELIQUIS, Event: Pulmonary embolism, Dizziness, Balanced difficulty, Pleural effusion, Musculoskeletal pain, Fever, Prescribed underdose Per Reporter: No Information Per Agency: Not Related Causality Assessment: Drug: BNT162B2 Event: Pulmonary embolism, Dizziness, Balanced difficulty, Pleural effusion, Musculoskeletal pain, Fever, Prescribed underdose Per Reporter: No Information Per Agency: Related Agency Comment: This patient developed multiple events after receiving apixaban. Based on limited information regarding definitive diagnosis and relevant medical history, the reported events off balance and dizziness are considered not related to apixaban. Past history of pulmonary embolism and underlying thromboembolic risk are significant risk factors for another episode of pulmonary embolism, hence considered not related to apixaban.; Sender's Comments: Agency Comment: This patient developed multiple events after receiving apixaban. Based on limited information regarding definitive diagnosis and relevant medical history, the reported events off balance and dizziness are considered not related to apixaban. Past history of pulmonary embolism and underlying thromboembolic risk are significant risk factors for another episode of pulmonary embolism, hence considered not related to apixaban.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20211111; Test Name: CT scan; Result Unstructured Data: Test Result:Positive evidence of acute PE; Test Date: 20211206; Test Name: CT scan; Result Unstructured Data: Test Result:Decreased clot burden in right upper lobe; Test Date: 20211209; Test Name: CT scan; Result Unstructured Data: Test Result:No Acute intracranial hemorrhage or apparent acute; Comments: transcortical infarction, no mucosal thickening; Test Date: 20211111; Test Name: Fibrin D dimer; Result Unstructured Data: Test Result:686 ng/ml; Test Date: 20211111; Test Name: Haematocrit; Test Result: 43.2 %; Test Date: 20211111; Test Name: Hemoglobin; Result Unstructured Data: Test Result:14.8 g/dl; Test Date: 20211111; Test Name: Platelet count; Result Unstructured Data: Test Result:237; Comments: per millilitre; Test Name: Doppler scan; Result Unstructured Data: Test Result:DVT; Test Name: X-ray; Result Unstructured Data: Test Result:Bilateral PE and pleural effusion
Aktuelle Erkrankungen: Blood disorder (On blood thinners since Sep-2009); Pulmonary embolism
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 immunisation (Second dose 27-AUG-2021, IM LOT number:EW0191, EW0178); DVT (DVT in right leg); Ligament tear (MCL tear); Thrombectomy; Comments: MCL tear and DVT in right leg in DEC-2008Bilateral PE and pleural effusion
Andere Medikamente: Eliquis
Allergien: -
Vorherige Impfungen: -

VAERS 2201426

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: F
Eingang: 28.03.2022
Impfdatum: 19.11.2021
Beginn: 08.12.2021
Tage bis Beginn: 19,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Death

Symptomtext

Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving covid vaccination. She died on 2/26/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2195958

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: CO
Alter: 67,0
Geschlecht: M
Eingang: 24.03.2022
Impfdatum: 29.10.2021
Beginn: 22.03.2022
Tage bis Beginn: 144,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Pt admit 3/22/22 w/ acute hypoxemic respiratory failure d/t COVID19 (positive test result 3/18/22). Pt had previously received 3 doses of Pfizer on 12/28/20, 1/18/21, & 10/29/21. Pt had also received 6 of 10 doses of Paxlovid prior to being admitted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1341479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 22,0
Geschlecht: M
Eingang: 24.03.2022
Impfdatum: 15.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Blood test Catheterisation cardiac abnormal Chest X-ray abnormal Chest pain Echocardiogram Electrocardiogram abnormal Lipids Magnetic resonance imaging heart Metabolic function test Myocarditis Troponin Ultrasound scan abnormal

Symptomtext

Patient presented to the ED for STEMI and was subsequently hospitalized. This was within 6 weeks of receiving covid vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2190235

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MT
Alter: 69,0
Geschlecht: F
Eingang: 21.03.2022
Impfdatum: 01.10.2021
Beginn: 17.01.2022
Tage bis Beginn: 108,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Chest X-ray normal Headache Illness Influenza A virus test Influenza B virus test Myalgia Pain Pyrexia Respiratory symptom SARS-CoV-2 test positive

Symptomtext

Case was vaccinated and boosted for Covid, then was hospitalized for Covid 3 months later. Hospitalized at: Hospital * Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan About 2 days of illness with myalgias, upper respiratory symptoms and headache Headache had responded to initial treatment w/ tylenol, still has some so added oxycodone. Chest x-ray clear, COVID test + January 17, symptom onset approximately January 15 Mild hypoxia currently corrected with O2 at 1 to 2 L/min. I think reasonable to treat with remdesivir and Decadron, ibuprofen and acetaminophen for fever and pain, albuterol inhaler as needed. D/c'ed on 1/19 w/o oxygen or need for any new medications.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: Ordered Test: FLUABV + SARS-CoV-2 Resp NAA+probe Ordered Test Codes: Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX Specimen Collection Date/Time: 2022-01-17 04:04:00.0 * Resulted Test: SARS-CoV-2 RNA Resp NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2022-01-17 04:59:33.0 Performing Facility: HOSPITAL Facility ID: Interpretation: Very abnormal Result Method: LAB DEVICE: SYSTEM Status: Final Test Code: Result Code:
Aktuelle Erkrankungen: Hypertension, asthma, hyperlipidemia.
Vorgeschichte: Hypertension, asthma, hyperlipidemia.
Andere Medikamente: atorvaSTATin (LIPITOR) 20 mg tablet Take one tablet daily. Patient taking differently: Take 20 mg by mouth Daily Take one tablet daily. buPROPion (WELLBUTRIN XL) 300 mg 24 hr tablet Take 300 mg by mouth every morning . estradiol (ES
Allergien: Prednisone
Vorherige Impfungen: -

VAERS 2187573

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge unknown

kritisch

Staat: KY
Alter: 60,0
Geschlecht: M
Eingang: 18.03.2022
Impfdatum: -
Beginn: 08.03.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Coma scale Condition aggravated Endotracheal intubation Fall Head injury SARS-CoV-2 test Seizure Unresponsive to stimuli

Symptomtext

Vaccinated pt admitted with covid infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma scale
Hospital-Tage: -
Labordaten: covid pcr 3-8-22
Aktuelle Erkrankungen: seizure
Vorgeschichte: Room 9 via EMS. Eyes open with pinpoint pupils on presentation otherwise unresponsive. GCS 6. Narcan x1 without improvement. Intubated for airway protection. Per ED room 9 notes, roommate of patient states patient had "seizure," fell off couch, hit head on coffee table. Roommate states pt had hx of seizures. Hx obtained via chart review as patient is currently intubated (AC/VC+ 18/450/30/5) and sedated. Per outside record review, pt with PMH epilepsy (on keppra, phenytoin, trileptal), traumatic brain injury (s/p MVA), stroke, Hep C, hypertension and colon cancer (s/p colectomy). Pt has had numerous prior admissions for seizure activity at Baptist (3 within the past year) due to antiepileptic non-compliance. PMH: epilepsy (on Keppra, phenytoin, trileptal at home), AUD/polysubstance abuse, Hep C +, TBI from MVA (L temporal SDH, midline shift s/p burr hole craniotomy 2015), colon cancer s/p colectomy PSH: burr hole craniotomy (2015), colectomy Family hx: unknown Social hx: smoking, EtOH
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2187410

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 75,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 17.11.2021
Beginn: 17.01.2022
Tage bis Beginn: 61,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Breath sounds abnormal COVID-19 COVID-19 pneumonia Cardiac failure Cardiac failure congestive Cardiac murmur Chronic obstructive pulmonary disease Condition aggravated Crepitations Dyspnoea Exposure to SARS-CoV-2 Exposure via direct contact Glycosylated haemoglobin normal Hypervolaemia Hypokalaemia Hypoxia Intensive care

Symptomtext

Date of Admission 01/17/2022 Date of Discharge 02/04/2022 Reason for Hospitalization pt baseline 4 liters. felt sob this am. 47% when ems got to scene. one albuterol and one duo neb given. pt 85 percent on arrival. Hospital Course: Patient is 75 year old female with asthma, COPD with baseline 5-6 L oxygen at home, CPAP at night, dementia, heart failure with preserved ejection fraction (EF 60% 1/25/2021), HTN, pulmonary HTN, Type II diabetes (Last A1c 5.8% on 11/28/21), may be tomorrow things will be CKD stage III (BL Cr 1.5-1.9) who was admitted to MICU on 1/17/22 for acute hypoxic respiratory distress requiring BiPAP Likely 2/2 COPD exacerbation 2/2 COVID PNA. COVID positive on 1/18. Off Precautions on 1/27. Completed Steroid and Baricitinib for COVID PNA (1/18-1/25). She completed 5 days of Ceftriaxone and 3 days of Azith for COPD exac possible superimposed bacterial PNA. She has been diuresing for fluid overload 2/2 HF exacerbation, currently on home dose Bumex. She stated to family medicine team on 2/1 for continuation of management. Patient symptoms improving. Oxygen weaned to 5 L nasal cannula for 4 days. She was repleted for hypokalemia. PT OT evaluated, recommended home with home health or home with 24/7 assist. Patient has 247 assists at home. Patient is medically stable for discharge. She discharged home on 2/4. Planning to F/U with PCP within a week Discharge Recommendations - Home amlodipine hold for soft Bpr, consider restart if Bpr start to elevate - No other changes to home medications Discharge Diagnoses 1. Acute on chronic respiratory acidosis 2. Acute on chronic respiratory failure with hypoxemia. 3. Acute hypercapnic respiratory failure 4. Pneumonia due to COVID-19 virus 5. COPD exacerbation 6. Acute exacerbation of congestive heart failure 7. Hypokalemia 8. OSA treated with BiPAP. 9. Contact with and (suspected) exposure to COVID-19 Orders: Follow Up Appt Family Medicine Other Diagnoses Ongoing Anemia due to vitamin B12 deficiency Asthma, Unspecified BMI 40.0-44.9, adult Cardiomegaly - hypertensive Chronic obstruct airways disease COPD with hypoxia Delusion regarding teeth--improved on abilify Dementia--MMSE 19 (Nov 2020) Heart failure, right-sided Hypertension Kidney disease Macrocytic anemia Malignant Essential Hypertension Osteoarthritis of knees, bilateral Osteopenia Pulmonary hypertension Severe obesity Sinus node dysfunction Status post cardiac pacemaker procedure Type 2 diabetes mellitus Vitamin B12 deficiency Historical Ineffective health maintenance Operations and Procedures None Consultants Medicine Pulmonary Supportive/Palliative Care Pending Labs None Discharge Disposition Home Medications New, Changed, or Refilled Medications Misc. Medication (23G 1" Syr See Instructions, to use with B-12 injections, 5 Each, 5 Refill(s) Instructions:to use with B-12 injections albuterol (albuterol 2.5 mg/ See Instructions, INHALE 3ML EVERY 4 HOURS AS NEEDED FOR COUGH, WHEEZING OR SHORTNESS OF BREATH., 75 mL, 5 Refill(s) Instructions:INHALE 3ML EVERY 4 HOURS AS NEEDED FOR COUGH, WHEEZING OR SHORTNESS OF BREATH. cyanocobalamin (cyanocobalam See Instructions, INJECT 1ML INTRAMUSCULARLY EVERY MONTH, 1 mL, 13 Refill(s) Instructions:INJECT 1ML INTRAMUSCULARLY EVERY MONTH fluticasone-salmeterol (Adva See Instructions, INHALE ONE PUFF BY MOUTH TWICE DAILY, 60 blister, 5 Refill(s) Instructions:INHALE ONE PUFF BY MOUTH TWICE DAILY olodaterol-tiotropium (Stiol See Instructions, INHALE 2 PUFFS BY MOUTH every 24 hours, 4 g, 5 Refill(s) Instructions:INHALE 2 PUFFS BY MOUTH every 24 hours Medications to be Continued ARIPiprazole (ARIPiprazole 2 2 mg, 1 Tablet(s), Oral, Daily apixaban (Eliquis 5 mg) 5 mg, 1 Tablet(s), Oral, bid bumetanide (bumetanide 2 mg) 2 mg, 1 Tablet(s), Oral, qAM & Noon calcium-vitamin D (calcium-v 1 capsule(s), Oral, bid cetirizine (cetirizine 10 mg 10 mg, 1 Tablet(s), Oral, qAM citalopram (citalopram 40 mg 40 mg, 1 Tablet(s), Oral, qAM fluticasone nasal (fluticaso 100 mcg, 2 Spray, Each Nostril, Daily, 15.8 mL, 5 Refill(s) ibuprofen (ibuprofen 200 mg) 200 mg, 1 Tablet(s), Oral, q6h, PRN: as needed for pain metoprolol (Metoprolol Tartr 25 mg, 1 Tablet(s), Oral, bid polyethylene glycol 3350 (Mi 17 g, Oral, Daily, PRN: Constipation simvastatin (simvastatin 20 20 mg, 1 Tablet(s), Oral, At Bedtime, 30 Tablet(s), 12 Refill(s) Discontinued Medications amLODIPine (amLODIPine 5 mg) 5 mg, 1 Tablet(s), Oral, At Bedtime Physical Exam at Discharge Vitals & Measurements T: 36.2 ?C TMIN: 36.2 ?C TMAX: 36.5 ?C HR: 78 RR: 16 BP: 114/76 SpO2: 93% WT: 85.8 kg BMI: 36.5 GEN: NAD, interactive Eyes: ECOI, sclera nonicteric, conjunctiva clear HENT: Tongue and mucous membrane moist, hearing intact CV: RRR, systolic murmur 2/6, no gallop, clicks, rubs PULM: non-labored breathing, on 4- 5 L NC, poor inspiratory efforts, improving coarse crackles B/L, no wheezes, or rhonchi ABD: obese, soft, non-distended, non tender, normoactive BS MSK: No peripheral edema PSYCH: appropriate affect and mood Neurology: alert, oriented x3, no focal deficit Time Spent 30 minutes Follow Up Appointments Follow Up Appt Family Medicine, Clinic Name/Phone: Provider Within 7 Days, No tests Appointment Type When With Where Nursing/Other Orders Regular Diet. Ordered on 01/19/22 7:22:00 CST, Meal Start Time Breakfast 0700 to 0900 Intake and Output. 01/17/22 13:18:36 CST, Continuous Order, q12h. Order comment: Ordered by system rule: ORD_ADD_CHF_TASKS based on indications for congestive heart failure. Intake and Output. 01/17/22 14:09:00 CST, Continuous Order Fall Precautions. 01/17/22 15:30:15 CST. Order comment: order placed from nursing documentation CLIN_FALL_RISK Activity As Tolerated. 01/17/22 14:09:00 CST, Continuous Order Code Status. Code Status Description: Full Code I personally saw and evaluated the patient on the result date found in the header of this document. I independently performed the critical/key portions of the Evaluation and Management service and discussed the management. I agree with everything documented above with the following exceptions/additions: feels good. ready to go home nonlabored breathing. up eating bfast dc today with outpt f/u

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 19,0
Labordaten: see adverse note
Aktuelle Erkrankungen: Problem List/Past Medical History Ongoing Anemia due to vitamin B12 deficiency Asthma, Unspecified BMI 40.0-44.9, adult Cardiomegaly - hypertensive Chronic obstruct airways disease COPD with hypoxia Delusion regarding teeth--improved on abilify Dementia--MMSE 19 (Nov 2020) Heart failure, right-sided Hypertension Kidney disease Macrocytic anemia Malignant Essential Hypertension Osteoarthritis of knees, bilateral Osteopenia Pulmonary hypertension Severe obesity Sinus node dysfunction Status post cardiac pacemaker procedure Type 2 diabetes mellitus Vitamin B12 deficiency
Vorgeschichte: Problem List/Past Medical History Ongoing Anemia due to vitamin B12 deficiency Asthma, Unspecified BMI 40.0-44.9, adult Cardiomegaly - hypertensive Chronic obstruct airways disease COPD with hypoxia Delusion regarding teeth--improved on abilify Dementia--MMSE 19 (Nov 2020) Heart failure, right-sided Hypertension Kidney disease Macrocytic anemia Malignant Essential Hypertension Osteoarthritis of knees, bilateral Osteopenia Pulmonary hypertension Severe obesity Sinus node dysfunction Status post cardiac pacemaker procedure Type 2 diabetes mellitus Vitamin B12 deficiency
Andere Medikamente: Home Advair Diskus 250 mcg-50 mcg inhalation powder, 1 puffs, Inhalation, bid, 5 refills albuterol HFA 90 mcg/inh inhalation aerosol, 2 Puff, Inhalation, q6h, PRN amLODIPine 10 mg oral tablet, 10 mg= 1 Tablet(s), Oral, Daily, 3 refills
Allergien: NKA
Vorherige Impfungen: -

VAERS 2184344

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MT
Alter: 35,0
Geschlecht: M
Eingang: 17.03.2022
Impfdatum: 09.12.2021
Beginn: 27.10.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Bronchoscopy normal C-reactive protein increased COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Culture positive Cytology normal General physical health deterioration Hypoxia Immunodeficiency Intensive care Laboratory test normal Legionella test Lung infiltration Lung opacity Mycobacterium test Pneumocystis jirovecii pneumonia

Symptomtext

Case was vaccinated x2 for Covid by March 2021, then was hospitalized for Covid the first time in October 2021. He was boosted for Covid in December 2021, then hospitalized two more times after being boosted. Hospitalized. Hospitalized 10/27/21 to 10/29/21: Symptomatic x2 weeks prior to first hospitalization of 3 days, treated with Dexamethasone and on oxygen for Acute hypoxemic respiratory failure. Hospitalization 10/31/21 to 11/7/21 In summary, he is an immunocompromise patient on Rituxan, who was recently discharged from the hospital after being admitted for COVID-19 infection, patient was taking dexamethasone and requiring 2 or 3 L of oxygen at home, nonetheless respiratory failure got much worse and despite the fact that he received a couple of vaccines in the previous months he has no antibodies against COVID-19 for which he received monoclonal antibodies on this admission. He was a started on Remdesivir and dexamethasone but quickly deteriorated for which after discussing pros and cons he received one-time dose of Tocilizumab with excellent response to the treatment. Patient was at some point requiring 40 L of oxygen by high flow nasal cannula in the intensive care unit and now is currently on room air saturating between 89 and 92% feeling comfortable. He is going to go home with 5 more days of dexamethasone to complete a bit more of 10 days. He has 1 refill at hand and has been instructed to take it back immediately if he feels that the symptoms get much worse after he runs out of the medication. In addition, respiratory therapist provided him with an oxygen tank in case that he needs it while walking. Hospitalized: 12/28/21 to 1/2/22 * Acute hypoxemic respiratory failure due to COVID-19 Initially diagnosed late October after 3 weeks of symptoms. Prolonged recovery with readmission 12/16 after vaccine with persistently positive COVID test. On presentation, worsening exertional hypoxia as well as radiographic findings of worsening infiltrate with elevated CRP. Had been elevated at initial diagnosis, but normalized 11/6/21. ID team and pulmonology consulted. Underwent bronchoscopy. Cultures preliminary but smear looks consistent with respiratory flora, cytology negative for malignancy. Other studies pending from BAL as follows: legionella (pending), fungus (pending), AFB (pending), viral culture (pending), pneumocystis (negative). Dexamethasone started 12/30 at 6 mg daily. Discharging with a week of dexamethasone. On 2L which can be weaned outpatient. Treating for other PNA as below. Hospitalized 1/17/22 to 1/23/22 * Acute on chronic respiratory failure Assessment & Plan Prolonged respiratory failure since COVID-19, last October. Treated in the past with remdesivir, Regeneron mab, and tocilizumab (November 2021) and dexamethasone. Multiple hospitalizations and serial imaging with waxing and waning ground glass opacities. Bronchoscopy 12/29/21 also without etiology, and negative biofire 12/28/21. Recently started on treatment with bactrim and steroids for PJP 1/14 based on clinical symptoms and worsening CT findings, with subtle improvement in CT findings after some days of treatment. Admitted 1/17. Persistent positive COVID test with CT 22 which suggests viable virus. Unclear if this is persistent infection for months presumably Delta variant, vs reinfection with Omicron. Treated with remdesivir for 5 day course given the low CT and his high risk for worsening disease. Also giving sotrovimab as well. Discussed with patient this is not FDA approved; it is provided under an EUA, and this could in his case be off label (he is hospitalized for worsening respiratory failure, but unclear if the COVID-19 is the cause or not). I do think the potential benefit outweighs the potential risk in his case. EUA fact sheet provided to patient, and he requests treatment with the drug. Patient evaluated by pulmonology. Plan long steroid taper, with 40 mg prednisone for 2 weeks, then 30 mg for 2 weeks, then 20 mg for at least 2 weeks, with f/u with ID and pulmonology and completing treatment for PJP, and then using prophylaxis. Unfortunately, worsened; Repeat Biofire also negative. Recommend lung biopsy. Evaluated by CT surgery who offered biopsy; patient declined. He improved with treating COVID-19 and with steroids. Repeat COVID-19 swab on day of discharge, CT 33, suggesting significant decrease in virus. Additionally, clinically he is improved symptomatically and improved oxygen requirement (down to 1.5-2 L) Plan discharge home on long steroid taper as above. Warning signs of worsening reviewed. Outpatient ID follow up will be arranged. Anticipate repeat COVID-19 swab in 1-2 weeks; if low CT, send to Lab for sequencing. At some point, pending clinical course, anticipate repeat CT chest (non-contrast). If he worsens again, consider move forward with biopsy, or start empiric therapy with antifungals and perhaps other antibacterials.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 24,0
Labordaten: Ordered Test: Coronavirus (CoVID-19), NAA Ordered Test Codes: (LN LOINC)/ Status: Corrected Accession Number: Specimen Source: Tissue Specimen Site: Specimen Collection Date/Time: 2021-10-22 07:34:00.0 Resulted Test: SARS CORONAVIRUS 2 RNA:PRTHR:PT:RESPIRATORY:ORD:PROBE.AMP.TAR Coded Result: Detected (LOCAL) Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2021-10-23 02:58:23.0 Performing Facility: Medical Center Facility ID: Interpretation: Very abnormal Result Method: Status: Final Test Code: (LN LOINC)/ Result Code: (SCT/Detected (L LOCAL) _________________________________________________________ Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe Ordered Test Codes: (LN LOINC)/ Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX Specimen Collection Date/Time: 2021-12-28 09:29:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2021-12-28 10:23:57.0 Performing Facility: HOSPITAL Facility ID: Interpretation: Very abnormal Result Method: LAB DEVICE: Status: Final Test Code: (LN LOINC)/ Result Code: (SCT/
Aktuelle Erkrankungen: Anxiety Follicular lymphoma grade II Seizures
Vorgeschichte: Anxiety Follicular lymphoma grade II Seizures
Andere Medikamente: (LEXAPRO) 10 mg tablet TAKE 1 TABLET BY MOUTH DAILY LORazepam (ATIVAN) 0.5 mg tablet Take 1 tablet by mouth Twice daily as needed for Anxiety or Insomnia. metoprolol succinate (TOPROL-XL) 50 mg 24 hr tablet TAKE 1 TABLET BY MOUTH EV
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2184242

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 17.03.2022
Impfdatum: 27.10.2021
Beginn: 24.11.2021
Tage bis Beginn: 28,0
Dosis: 3
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Hospitalization following COVID vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2182530

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MT
Alter: 65,0
Geschlecht: M
Eingang: 16.03.2022
Impfdatum: 12.09.2021
Beginn: 16.03.2022
Tage bis Beginn: 185,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Encephalopathy Influenza A virus test Influenza B virus test SARS-CoV-2 test positive

Symptomtext

Case was vaccinated and boosted by September 2021, then was hospitalized for Covid in January 2022. Hospitalized at: Hospital Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Acute COVID-19 infection in an immunocompromised patient with underlying lung and renal disease (from granulomatosis with polyangiitis) maintained on mycophenolate. Complications include acute respiratory failure and severe encephalopathy. Initiated on dexamethasone and remdesivir at time of presentation on 1/13. On 1/14, he was found to be seronegative and was given a dose of sotrovimab. He has done quite well since shortly after admission. Care plan discussed with the patient and his wife. Tentative plan was to discharge patient today. However, his wife would be his ride and she is feeling acutely ill. He does not really have another ride available. Plan now is to discharge home in a.m. 1/18 while they work out alternative strategies. Tentative plan will be to discharge to complete a 10-day course of dexamethasone. Resume his home prednisone and mycophenolate the day after he completes his dexamethasone. Discussed risk of deterioration. He should monitor his oxygen levels at home if he feels short of breath. He should seek care if he is have any problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: Ordered Test: FLUABV + SARS-CoV-2 Resp NAA+probe Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX(181200003) Specimen Collection Date/Time: 2022-01-13 21:48:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Text Result: Reference Range From: Not Detected Performing Facility Details: Date/Time: 2022-01-13 22:45:06.0 Performing Facility:HOSPITAL Interpretation: Very abnormal Result Method: LAB DEVICE: CEPHEID GENEXPERT DX SYSTEM Status: Final
Aktuelle Erkrankungen: CKD (chronic kidney disease) ? Episcleritis of both eyes ? Henoch-Schonlein purpura (HCC) ? HTN (hypertension) ? Wegener's disease, pulmonary
Vorgeschichte: CKD (chronic kidney disease) ? Episcleritis of both eyes ? Henoch-Schonlein purpura (HCC) ? HTN (hypertension) ? Wegener's disease, pulmonary
Andere Medikamente: allopurinol (ZYLOPRIM) 300 mg tablet Take 1 tablet by mouth Daily. dilTIAZem (CARDIZEM CD) 240 MG 24 hr capsule Take 1 capsule by mouth every evening. furosemide (LASIX) 20 mg tablet Take 20 mg by mouth Daily. Patient not taking: Re
Allergien: Contrast (iodinated Diagnostic agents)
Vorherige Impfungen: -

VAERS 2182240

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: TN
Alter: 71,0
Geschlecht: M
Eingang: 16.03.2022
Impfdatum: 05.02.2021
Beginn: 05.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Biopsy liver abnormal Cell death Death Fatigue Haemophagocytic lymphohistiocytosis Hepatic necrosis Hepatitis Liver disorder Muscle atrophy Mycobacterium avium complex infection Non-alcoholic steatohepatitis

Symptomtext

Vaccination dates in 2021: 02/05 - started feeling weak, fatigued, muscle wasting; liver issues - clinical NASH/cirrhosis? 03/01; 03/05; 04/01; 08/35.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cell death
Hospital-Tage: -
Labordaten: Postmortem exam/liver biopsy: Submassive hepatic necrosis with hemophagocytosis, emperipolesis, karyorrhexis, and acute on chronic inflammation, severe - Absence of cirrhosis.
Aktuelle Erkrankungen: Active and feeling well until February 2021.
Vorgeschichte: Pulmonary fibrosis (well managed); prostate cancer (in remission since 2019).
Andere Medikamente: Allopurinol; Propranolol; Levothyroxine.
Allergien: Diary.
Vorherige Impfungen: -

VAERS 2182240

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: TN
Alter: 71,0
Geschlecht: M
Eingang: 16.03.2022
Impfdatum: 05.02.2021
Beginn: 05.02.2021
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Biopsy liver abnormal Cell death Death Fatigue Haemophagocytic lymphohistiocytosis Hepatic necrosis Hepatitis Liver disorder Muscle atrophy Mycobacterium avium complex infection Non-alcoholic steatohepatitis

Symptomtext

Vaccination dates in 2021: 02/05 - started feeling weak, fatigued, muscle wasting; liver issues - clinical NASH/cirrhosis? 03/01; 03/05; 04/01; 08/35.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cell death
Hospital-Tage: -
Labordaten: Postmortem exam/liver biopsy: Submassive hepatic necrosis with hemophagocytosis, emperipolesis, karyorrhexis, and acute on chronic inflammation, severe - Absence of cirrhosis.
Aktuelle Erkrankungen: Active and feeling well until February 2021.
Vorgeschichte: Pulmonary fibrosis (well managed); prostate cancer (in remission since 2019).
Andere Medikamente: Allopurinol; Propranolol; Levothyroxine.
Allergien: Diary.
Vorherige Impfungen: -

VAERS 2180039

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 15.03.2022
Impfdatum: 31.03.2021
Beginn: 11.05.2021
Tage bis Beginn: 41,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure

Symptomtext

Patient presented to the ED and was subsequently hospitalized for acute respiratory failure with hypoxia within 6 weeks of receiving 2nd covid vaccination. Patient did receive booster dose in 12/3/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2179945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 90,0
Geschlecht: F
Eingang: 15.03.2022
Impfdatum: 04.03.2021
Beginn: 26.03.2021
Tage bis Beginn: 22,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Hospitalization following COVID vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: Hospitalized 3/15/2021
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2177626

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 85,0
Geschlecht: F
Eingang: 14.03.2022
Impfdatum: 25.03.2021
Beginn: 18.01.2022
Tage bis Beginn: 299,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anaemia of chronic disease Breath sounds absent COVID-19 pneumonia Carotid pulse abnormal Dehydration Dementia Dysphagia Dyspnoea Heart sounds abnormal Hypernatraemia Lethargy Mental status changes Metabolic acidosis Pancytopenia Pneumonia aspiration Pupil fixed Pupillary reflex impaired

Symptomtext

Date of Admission 01/18/2022 Date of Discharge 01/21/2022 Reason for Hospitalization PER EMS, FAMILY REPORTED PT BEING LETHARGIC AND INCREASED SOB; MILD FEVER. Hospital Course Patient is a 85 y/o female with dementia, dysphagia, previous hospice patient admitted for acute hypoxic respiratory failure secondary to COVID-10 pneumonia and suspected aspiration pneumonia. Grandson is primary decision maker. Per hospice agency, hospice status was revoked so patient could come to hospital for medical treatment. Grandson wanted to continue with medical management except for intubation or CPR. She was treated with with dexamethasone, remdesivir, and antibiotics for aspiration pneumonia concerns. Her oxygen requirements were increased on high-flow nasal cannula during hospitalization. Initially she was able to have oxygen requirements decreased to 3L NC. We had goals of care discussion with family regarding nutrition as patient had been NPO throughout admission. (please refer to addendum on progress note from 1/20/2022). After discussion family wanted to trial patient tube feeds. However, overnight on 1/21 patient had teams called x 2 due to increased work of breathing, oxygen requirement and decreased mentation. After discussion with family patient was transitioned to comfort care. Discharge Diagnoses #Acute hypoxic respiratory failure secondary to COVID-19 pneumonia #Suspected aspiration pneumonia #Advanced Dementia #High anion gap metabolic acidosis #Dehydration #Underweight #Hypernatremia #Pancytopenia #Anemia of chronic disease Other Diagnoses Ongoing No chronic problems Historical No qualifying data Discharge Disposition Unable To Determine Medications New, Changed, or Refilled Medications None Medications to be Continued acetaminophen (acetaminophen 650 mg rectal suppository) 650 mg, 1 Supp, Rectal, q4h, PRN: fever>100 Discontinued Medications None Physical Exam at Discharge No reaction to verbal or tactile stimulation. No pupillary light reflex noted, pupils fixed and dilated Breathing and other lung sounds were absent. No carotid pulse or heart sound can be heard Addendum by MD on January 24, 2022 15:02:08 (Verified) Attestation by MD on January 24, 2022 15:02 I personally saw and evaluated the patient on the result date found in the header of this document. I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document. I agree with everything documented above.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: see adverse note
Aktuelle Erkrankungen: Problem List/Past Medical History Ongoing No chronic problems
Vorgeschichte: Problem List/Past Medical History Ongoing No chronic problems
Andere Medikamente: Home hyoscyamine 0.125 mg oral tablet, 0.125 mg= 1 Tablet(s), Oral/Sublingual, q1h, PRN, 2 refills LORazepam 0.5 mg oral tablet, 0.5 mg, Oral/Sublingual, q1h, PRN, 2 refills morphine 20 mg/mL oral concentrate, 5 mg, Oral/Sublingual, q1h,
Allergien: NKA
Vorherige Impfungen: -

VAERS 2173468

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 82,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 27.03.2021
Beginn: 20.01.2022
Tage bis Beginn: 299,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal wall haematoma Acute kidney injury Acute respiratory failure Ammonia normal Anaemia macrocytic Anion gap Anisocoria Anticoagulant therapy Atrial fibrillation Barium swallow abnormal Benign prostatic hyperplasia Blood albumin decreased Blood creatinine increased Blood culture positive Blood iron normal Brain natriuretic peptide increased CHA2DS2-VASc-score COVID-19

Symptomtext

Date of Admission 01/20/2022 Date of Discharge 02/04/2022 Reason for Hospitalization found down unresponsive Hospital Course Patient is a 82 y/o M w/ Persistent afib on Xarelto, NICCM w/ HFpEF (EF ~50%) w/ -LHC in 2019, remote tobacco use, HTN, HLD, and BPH who presented to the ICU from the ED after being bought in by EMS for severe hypothermia, hypoglycemia, and obtundation. Pt received several amps of D50W en route. In the ED, the patient was noted to still be lethargic initially. Vitals were concerning for mild hypoxemia, moderate hypothermia, and hypotension. Labs showed +Covid, mild rhabdomyolysis, Hypernatremia, AKI (Cr 1-- >1.5), HAGMA and NAGMA (Ag=17), Troponin elevation, and transaminitis. He received 3 L of fluids in the ED. Initial EKG revealed sinus rhythm with frequent PVC's, notable J waves and T wave inversions noted in V4 to V6. Chest x-ray showed pulm edema w/ Possible pneumoperitoneum. CT head revealed a scalp hematoma with no acute intracranial abnormalities. Completed Vancomycin and meropenem for pneumonia. CT neck showed no fractures. Ct A/P showed liver disease and anasarca. Patient was intubated 1/21-1/25. Weaned down to 2-3 L NC. While in ICU was started on tube feeds, post extubation; patient failed multiple swallow evaluations. PT/OT following, SNF recommended. After multiple goals of care discussions with patient, family, and palliative care; decision was made my patient's DPOA to make patient DNR/DNI and initiate comfort care orders. Patient to discharge to hospice. Discharge Diagnoses DC plan: -DC to hospice - hospice -mechanical soft diet Comfort Care: After multiple goals of care discussions involving the patient, myself, family (including patient's DPOA), and palliative care. Decision was made by (DPOA) to make patient a DNR/DNI and initiate comfort care orders. Dr. was present for this conversation. On 2/3 family wished to discuss feeding tube placement again, after multiple discussions with (DPOA) via phone and sister at bedside, decision was ultimately made to forgo a feeding tube and continue comfort feeds with mechanical soft diet, Dr. was present for this decision. Family okayed patient to go to hospice. -CM set up hospice prior to DC -comfort care orders initiated -palliative care consulted ___________________________________________________________________________________ Rectus sheath hematoma: Stable Hgb had been down trending, abd exam concerning for hematoma. -CTA abd showed rectus sheath hematoma w/o evidence of active bleed -stopped Xarelto -monitor hgb, has been stable -monitor fo s/s of active bleeding Acute respiratory failure with hypoxia: Improving 2nd to COVID, pulmonary edema, and aspiration pna. Stable on 2-3 L NC. -intubated 1/21-1/25 -wean O2 as tolerated -monitor oximetry, encourage IS COVID PNA: Resolved Aspiration PNA: Resolved COVID + on 1/20/22. Vaccinated x2 w/ Moderna. Off precautions 1/30. -dexamethasone (1/21-1/30) -held IV remdesivir given renal function -PNA PCR 1/22 (+ ecoli, Moraxella, proteus, pseudomonas, s. aureus) -1/20 blood cx + for strep warneri, repeat cx 1/21 NGTD -QTL cx grew s. aureus -trend infectious/inflammatory markers Antibiotics: -Vancomycin 1/20-1/27 -Meropenem 1/20-1/27 Anasarca: Improved NICCM w/ HFrEF: Essential HTN: PTA reportedly on lisinopril 20 mg qd and metoprolol succinate 100 mg qd. EF 15% on 1/21/22 (EF previously ~50%). BNP>20K on admit. On Lasix 20 mg qd as outpatient. -Cardiology consulted in ICU --stopped home metoprolol --started carvedilol 3.125 mg qd, stopped for comfort care --recommend adding ACE/ARB when BP will tolerate ---start lisinopril 2.5 mg qd 1/31, stopped for comfort care --p.r.n. diuresis, strict I&O, daily weights --restart patient's home Lasix 20 mg qd 1/31 --"Given recent negative LHC, no likely benefit of cath at this time." Oropharyngeal dysphagia: -continue tube feeds via NG tube -SLP consulted, patient did not pass swallow eval 1/28, SLP re-evaluated 1/31 and still recommending NPO -Barium swallow study w/ SLP on 2/3, patient failed, significant aspiration noted with all intake -family/DPOA ok with comfort feeds with mechanical soft diet ?stroke-like symptoms: Code stroke called on patient 1/27, per nursing patient had increased lethargy, unequal pupils, and left sided facial droop. Acute imaging and labs was negative for acute findings. Neurology evaluated patient, stroke r/o, signed off. -brain MRI negative for acute findings Acute encephalopathy: Improved A&O at baseline. Ammonia wnl. CT head/neck unremarkable aside from external scalp hematoma. Suspected 2nd to acute illness. Patient's mentation waxes and wanes, oriented at times. Persistent afib: Has Xarelto on home med list, unclear if he was taking as prescribed. CHADS2-Vasc: 3. -stop heparin drip and restart home Xarelto 1/27, stopped Xarelto 1/29 for hematoma/anemia -home metoprolol stopped --started on digoxin for rate control 1/27, stopped on comfort care CKD S2: Baseline Cr 1-1.2. Transaminitis: Improving Patient had evidence of liver disease on his CT and US. RUQ US shows fatty liver and cholelithiasis. Hx of alcohol abuse. Hypocalcemia: Resolved Hypophosphatemia: Resolved Thrombocytopenia: Resolved Macrocytic anemia: -1/28: iron 61, TIBC unable to calculate, VB12 1131, ferritin 848, iron sat unable to calculate Moderate protein-calorie malnutrition: Albumin 1.9. -tube feeds -SLP recommending NPO, on comfort feeds -no feeding tube recommended per palliative care Depression: PTA reportedly on mirtazapine 15 mg qd as outpatient. -held home meds in setting of encephalopathy HLD: Previously on atorvastatin 40 mg qd as outpatient, unclear if still taking. GERD: PTA reportedly on omeprazole 20 mg qd. -on ppi per formulary, stopped med on comfort care BPH: PTA reportedly on oxybutynin and tamsulosin. -void trial completed -unable to crush tamsulosin, started doxazosin per tube ---stopped doxazosin on comfort care Hx of alcohol abuse: Patient and family are unable to quantify how much patient drinks. Patient states he drinks beer and mixed drinks every day. -received thiamine per tube -no s/s of withdrawal during hospitalization Right foot wound: Possibly frostbite. See media. Patient on abx. -skin team consulted Allergic rhinitis: PTA reportedly on cetirizine and loratadine as outpatient. Resolved in ICU: -hypothermia -hypernatremia -AKI -HAGMA -starvation ketosis -hypoglycemia -mild rhabdomyolysis This patient was discussed with Dr., please see their attestation for any further management. Disclaimer: This note was dictated by speech recognition using software. Minor errors in transcription may be present. Please call if questions. Other Diagnoses Ongoing Atrial fibrillation Benign prostatic hyperplasia Cardiomyopathy History of IBS Hyperlipidemia Hypertension Sinus arrhythmia Historical No qualifying data Operations and Procedures N/A Consultants Family Medicine General Medicine Cardiology Supportive/Palliative Care Pending Labs N/A Discharge Disposition Hospice Medications New, Changed, or Refilled Medications LORazepam (LORazepam 0.5 mg) 0.5 mg, 1 Tablet(s), Oral, q1h, dyspnea or other distress or anxiety, PRN: Other; See comments, 30 Tablet(s), 0 Refill(s) Instructions:dyspnea or other distress or anxiety bisacodyl (bisacodyl 10 mg rectal su 10 mg, 1 Supp, Rectal, Daily, PRN: Other; See comments, 10 Supp, 0 Refill(s) diclofenac topical (diclofenac 1% to 2 g, Topical, bid, PRN: Pain, Mild, 100 g, 0 Refill(s) hyoscyamine (hyoscyamine 0.125 mg) 0.125 mg, 1 Tablet(s), Oral/Sublingual, q1h, May give 0.125 to 0.25 mg (1 to 2 tablets). HOSPICE PATIENT, PRN: Other; See comments | for excessive oral secretions, 10 Tablet(s), 2 Refill(s) Instructions:May give 0.125 to 0.25 mg (1 to 2 tablets). HOSPICE PATIENT morphine (morphine 20 mg/mL oral con 0.25-1mL, Oral, q1h, PRN: Pain, Breakthrough, 30 mL, 0 Refill(s) ocular lubricant (ocular lubricant p 1 Drop(s), Each Eye, qid, PRN: Dry Eyes, 56 Each, 0 Refill(s) senna (senna 8.6 mg) 17.2 mg, 2 Tablet(s), Oral, At Bedtime, 30 Tablet(s), 0 Refill(s) Medications to be Continued acetaminophen (acetaminophen 325 mg) 650 mg, 2 Tablet(s), Oral, q4h, PRN: as needed for pain docusate (DOK 100 mg) 100 mg, 1 capsule(s), Oral, bid, For constipation with plenty of water, 180 capsule(s), 3 Refill(s) Instructions:For constipationwith plenty of water Discontinued Medications albuterol (albuterol 2 mg) 2 mg, 1 Tablet(s), Oral, qid aluminum hydroxide-magnesium carbona 2 Tablet(s), Oral, AC & Bedtime, PRN: as needed for indigestion ascorbic acid (Vitamin C) 1 Tablet(s), Oral, Daily calcium carbonate (Tums 500 mg , che 500 mg, 1 Tablet(s), Oral, Daily, PRN: as needed for dyspepsia cetirizine (cetirizine 10 mg) 10 mg, 1 Tablet(s), Oral, Daily doxycycline (doxycycline hyclate 100 100 mg, 1 capsule(s), Oral, bid, 20 capsule(s), 0 Refill(s) famotidine (Pepcid 20 mg) 20 mg, 1 Tablet(s), Oral, Daily fexofenadine (fexofenadine 180 mg) 180 mg, 1 Tablet(s), Oral, Daily fluticasone nasal (fluticasone 50 mc 1 Spray, IntraNasal, Daily furosemide (furosemide 20 mg) 20 mg, 1 Tablet(s), Oral, Daily, 60 Tablet(s), 6 Refill(s) hydrocortisone topical (Proctosol-HC See Instructions, apply in a thin film to the anal area and rub in gently and completely daily as needed, 30 g, 2 Refill(s) lisinopril (lisinopril 20 mg) 20 mg, 1 Tablet(s), Oral, Daily, 90 Tablet(s), 3 Refill(s) loratadine-pseudoephedrine (Claritin 1 Tablet(s), Oral, q12h, PRN: allergies, 30 Tablet(s), 2 Refill(s) metoprolol (metoprolol succinate 100 100 mg, 1 Tablet(s), Oral, Daily, 90 Tablet(s), 3 Refill(s) mometasone nasal (Nasonex 50 mcg/inh 2 Spray, IntraNasal, Daily, PRN: for allergy symptoms montelukast (Singulair 10 mg) 10 mg, 1 Tablet(s), Oral, qEvening multivitamin (B-Complex with B-12) 1 Tablet(s), Oral, Daily omeprazole (omeprazole 20 mg oral de 20 mg, 1 capsule(s), Oral, Daily, 90 capsule(s), 3 Refill(s) oxybutynin (oxybutynin 5 mg) 5 mg, 1 Tablet(s), Oral, bid, 180 Tablet(s), 3 Refill(s) oxybutynin (oxybutynin 5 mg) See Instructions, Take 1 tablet by mouth twice daily, 180 Tablet(s), 3 Refill(s) raNITIdine (raNITIdine 150 mg) 150 mg, 1 Tablet(s), Oral, bid rivaroxaban (rivaroxaban 20 mg) 20 mg, Oral, w/Supper, 60 Tablet(s), 6 Refill(s) simethicone (simethicone 125 mg) 125 mg, 1 Tablet(s), Oral, tid PC, PRN: as needed for gas tamsulosin (tamsulosin 0.4 mg) 0.4 mg, 1 capsule(s), Oral, Daily, for 30 day(s), 30 capsule(s), 3 Refill(s) terazosin (terazosin 2 mg) 2 mg, 1 capsule(s), Oral, At Bedtime, 0 Refill(s) Physical Exam at Discharge Vitals & Measurements T: 36.8 ?C HR: 80 RR: 16 WT: 70.5 kg BMI: 25.9 General: Elderly, Caucasian, male. No acute distress. HEENT: EOMI, PERRL, Mucous membranes dry. Respiratory: Coarse b/l. Normal work of breathing. Poor inspiratory effort. 2 L NC. Cardiovascular: Irregular rate and normal rhythm. Trace edema of bilateral lower extremities. Gastrointestinal: Soft, tenderness to right Lower quadrant with noted mass hematoma, ND, +BS. Musculoskeletal: Moves all extremities; wounds on right foot Integumentary: No rash noted, weeping LUE, right foot wound see media Neurologic: Alert, oriented to self and place. Able to state he is in the hospital for "pneumonia". Disoriented to time. Left mouth droop. Speech: Speech impediment which is his baseline. Time Spent >35 mins Follow Up Appointments N/A Nursing/Other Orders Hospice Evaluation and Admission. 02/02/22 13:58:00, Once, 02/02/22 13:58:00, COVID Mechanical Soft Diet. Start Date/Time 02/03/22 15:50:00 Start Meal Supper 1615 to 1745 Intake and Output. 02/04/22 7:22:19, Continuous Order, q12h. Order comment: Ordered by system rule: ORD_ADD_CHF_TASKS based on indications for congestive heart failure. Right Heel Suspension (Heel/s suspend, right). 01/21/22 9:28:00, off of the bed with pillow, As Indicated Left Heel Suspension (Heel/s suspend, left). 01/21/22 9:28:00, off of the bed with pillow, As Indicated Elevate Head of Bed (Head of Bed Elevated). 01/21/22 12:36:00, Continuous Order, to prevent aspiration; 30 Degrees Fall Precautions. 01/22/22 2:59:10, Order comment: order placed from nursing documentation CLIN_FALL_RISK Up to Chair. 01/28/22 8:10:00. Continuous Order, TID w/ meals Code Status. Code Status Description: DNAR (Do Not Attempt Resuscitation) Oxygen Instructions. 02/02/22 13:58:00, Routine, Instructions Titrate to comfort. No O2 Saturation Monitoring. Order comment: Addendum by Dr. on February 04, 2022 13:44:06 I personally saw and evaluated the patient on the result date found in the header of this document. I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with nurse practitioner. I agree with everything documented above with the following exceptions/additions: no concerns today, he has no pain sitting upright, no distress dc to hospice. family supports.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: see adverse note
Aktuelle Erkrankungen: Problem List/Past Medical History Ongoing Atrial fibrillation Benign prostatic hyperplasia BMI 35.0-35.9,adult Cardiomyopathy History of IBS Hyperlipidemia Hypertension Obesity Sinus arrhythmia
Vorgeschichte: Problem List/Past Medical History Ongoing Atrial fibrillation Benign prostatic hyperplasia BMI 35.0-35.9,adult Cardiomyopathy History of IBS Hyperlipidemia Hypertension Obesity Sinus arrhythmia
Andere Medikamente: Home acetaminophen 325 mg oral tablet, 650 mg= 2 Tablet(s), Oral, q4h, PRN albuterol 2 mg oral tablet, 2 mg= 1 Tablet(s), Oral, qid aluminum hydroxide-magnesium carbonate 160 mg-105 mg oral tablet, chewable, 2 Tablet(s), Oral, AC & Bedti
Allergien: Allergies Feosol (choking) Mucinex (choking) Orange
Vorherige Impfungen: -

VAERS 2171648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: AL
Alter: 73,0
Geschlecht: F
Eingang: 10.03.2022
Impfdatum: 13.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Dysarthria Electrocardiogram Facial paralysis Laboratory test Malaise Reflex test Scan brain

Symptomtext

The felt a little sick after the shot, but had read and saw on tv that was expected after the second shot. When I woke up the next day my speech was slurred, right facial muscles drooping. Taken to the hospital and was admitted for a stroke. Given many tests, They could not find any reason for me to have a stroke. No blood clots, heart problems. Released April 16 with a heart monitor to wear until May 12. Had to take speech/memory therapy and physical therapy afterwards. Follow up with my general practitioner.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: EKG, brain scans, reflex tests, more but I don't remember.
Aktuelle Erkrankungen: None
Vorgeschichte: Autoimmune
Andere Medikamente: levothyroxine, avorostatin, coq10
Allergien: gluten, dairy, caffienne
Vorherige Impfungen: -

VAERS 2170815

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 28.04.2021
Beginn: 09.03.2022
Tage bis Beginn: 315,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dyspnoea Endotracheal intubation Hypoxia Mechanical ventilation Paralysis Positive airway pressure therapy Respiratory disorder SARS-CoV-2 test positive White blood cell count increased

Symptomtext

Patient with 2 Moderna vaccinations, last dose 04/28/21, who admitted from rehab facility with progressively worsening dyspnea after positive COVID test who subsquently died of COVID complications. Provider discharge note below: "62 y/o M who was transferred from a rehab facility to other facility for dyspnea and hypoxia. He was positive for COVID and his breathing status worsened. He received aggressive treatment and eventually required intubation after failing BiPAP therapy. He required very high ventilator settings and was paralyzed but ultimately continued to worsen and had extremely high WBC that was refractory to treatment. Given the patient's very poor prognosis and worsening status despite aggressive treatment, family agreed to transition to comfort care and terminal extubation.."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID Detected PCR on 02/14/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia Seropositive rheumatoid arthritis (*) Osteoporosis Interstitial lung disease (*) Osteoarthritis COPD (chronic obstructive pulmonary disease) (*) Restless leg syndrome Vitamin D deficiency Immunosuppressed status (*) Tobacco abuse Hypertension Traumatic compression fracture of L4 vertebra (*) Gait disturbance Hypermagnesemia Vertebral osteomyelitis (*) Adjustment disorder with anxiety Status post L2-S1 posterolateral onlay fusion/L2 to pelvis posterior instrumented fusion with pedicle screws bilaterally at L2,L3,L5 and S1 and bilateral iliac screws on 3/5/17. Primary osteoarthritis of right shoulder Primary osteoarthritis of left shoulder Right lumbar radiculopathy Status post Anterior L3 to L5 instrumented rusion/Anterior L4 corpectomy/Anterior L3 to L5 plating on 8/23/17 OSA on CPAP Sinus tachycardia Macrocytic anemia
Andere Medikamente: Fosamax Lipitor Flexeril Doxepin Folic acid Neurontin Lisinopril Methotrexate Prednisone
Allergien: Oxycontin, Sulfasalazine
Vorherige Impfungen: -

VAERS 2170815

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 28.04.2021
Beginn: 09.03.2022
Tage bis Beginn: 315,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dyspnoea Endotracheal intubation Hypoxia Mechanical ventilation Paralysis Positive airway pressure therapy Respiratory disorder SARS-CoV-2 test positive White blood cell count increased

Symptomtext

Patient with 2 Moderna vaccinations, last dose 04/28/21, who admitted from rehab facility with progressively worsening dyspnea after positive COVID test who subsquently died of COVID complications. Provider discharge note below: "62 y/o M who was transferred from a rehab facility to other facility for dyspnea and hypoxia. He was positive for COVID and his breathing status worsened. He received aggressive treatment and eventually required intubation after failing BiPAP therapy. He required very high ventilator settings and was paralyzed but ultimately continued to worsen and had extremely high WBC that was refractory to treatment. Given the patient's very poor prognosis and worsening status despite aggressive treatment, family agreed to transition to comfort care and terminal extubation.."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID Detected PCR on 02/14/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia Seropositive rheumatoid arthritis (*) Osteoporosis Interstitial lung disease (*) Osteoarthritis COPD (chronic obstructive pulmonary disease) (*) Restless leg syndrome Vitamin D deficiency Immunosuppressed status (*) Tobacco abuse Hypertension Traumatic compression fracture of L4 vertebra (*) Gait disturbance Hypermagnesemia Vertebral osteomyelitis (*) Adjustment disorder with anxiety Status post L2-S1 posterolateral onlay fusion/L2 to pelvis posterior instrumented fusion with pedicle screws bilaterally at L2,L3,L5 and S1 and bilateral iliac screws on 3/5/17. Primary osteoarthritis of right shoulder Primary osteoarthritis of left shoulder Right lumbar radiculopathy Status post Anterior L3 to L5 instrumented rusion/Anterior L4 corpectomy/Anterior L3 to L5 plating on 8/23/17 OSA on CPAP Sinus tachycardia Macrocytic anemia
Andere Medikamente: Fosamax Lipitor Flexeril Doxepin Folic acid Neurontin Lisinopril Methotrexate Prednisone
Allergien: Oxycontin, Sulfasalazine
Vorherige Impfungen: -

VAERS 2168198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: TX
Alter: 95,0
Geschlecht: F
Eingang: 09.03.2022
Impfdatum: 09.02.2021
Beginn: 24.08.2021
Tage bis Beginn: 196,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation COVID-19 Chest X-ray abnormal Condition aggravated Cough Death Device intolerance Dyspnoea Hypoxia Interchange of vaccine products Oxygen saturation decreased Pneumonia Positive airway pressure therapy Respiratory disorder Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

96 y.o. female with history of atrial fibrillation, CHF with preserved EF, type 2 diabetes mellitus, hypothyroidism, hypertension, hearing impairment, CKD stage IIIB who was brought to ER on 08/24/21 with c/o SOB, cough and congestion, low oxygen level after she tested positive for Covid 19 the same day. Chest x-ray showed findings consistent with pneumonia. Patient was also found to be in AFib with RVR which improved with Lopressor given in ER. Patient was admitted to hospitalist service and placed on IV antibiotics along with symptomatic treatment. Steroids were also added. Patient was seen by infectious disease consultant Dr. who started patient on REmdesivir due to hypoxemia. Patient's respiratory status decline to a point where she needed BiPAP but she was not tolerating it. Patient's daughters requested the hospitalist to keep the patient comfortable and not place patient on BiPAP. Patient was then switched to high-flow nasal cannula. Family later decided to pursue hospice. Before they could meet with the case manager and hospice staff, patient passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2165571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: WI
Alter: 71,0
Geschlecht: M
Eingang: 08.03.2022
Impfdatum: 24.02.2021
Beginn: 07.12.2021
Tage bis Beginn: 286,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise

Symptomtext

per web report from (Privacy) Medical Center. Patient was vaccinated with Pfizer 2/2/21 and 2/24/21. no vaccine lot information available. Web report stated patient was symptomatic on 12/3/2021. no additional hospital data was submitted on Web report to the Health Department. Received Death abstract reported that patient died of COVID -19 on 1/3/2022 at 16:44.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2165571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: WI
Alter: 71,0
Geschlecht: M
Eingang: 08.03.2022
Impfdatum: 24.02.2021
Beginn: 07.12.2021
Tage bis Beginn: 286,0
Dosis: UNK
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise

Symptomtext

per web report from (Privacy) Medical Center. Patient was vaccinated with Pfizer 2/2/21 and 2/24/21. no vaccine lot information available. Web report stated patient was symptomatic on 12/3/2021. no additional hospital data was submitted on Web report to the Health Department. Received Death abstract reported that patient died of COVID -19 on 1/3/2022 at 16:44.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2162892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 48,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 15.05.2021
Beginn: 01.02.2022
Tage bis Beginn: 262,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary normal Asthenia COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient with 2 Pfizer COVID vaccinations, last dose 05/15/21 who admitted with COVID complications. Provider discharge summary below: "Patient came in with Acute respiratory failure secondary to COVID. She had symptoms for 10 days already. Procal as well as CTA was negative for a PE and secondary pneumonia. Patient was given remdesivir as well as decadron with some improvement. She continued to require a little oxygen with activity. She was given vitamins as well as zinc. The decadron increased her BS so she needed higher doses of lantus and humalog. Patient was on lantus already. She wasn't well controlled prior to the steroids. Humalog was added. She was given instructions on adjusting her Insulin at home. The patient continued to be weak but clinically stable so was discharged home. She has follow up with her PCP. She should take an aspirin a day for a few weeks to decrease risk of thromboembolism She is encouraged to do deep breathing exorcizes."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: COVID detected PCR on 02/02/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia Hypertension Type 2 diabetes mellitus with complication, without long-term current use of insulin (*) Polycystic ovarian syndrome ADHD (attention deficit hyperactivity disorder) GERD (gastroesophageal reflux disease) Anxiety Chronic pelvic pain in female Fibromyalgia Depression with anxiety Uncontrolled diabetes mellitus (*) Panic anxiety syndrome Callous ulcer, limited to breakdown of skin (*) Pedal edema Primary osteoarthritis of both knees Morbid obesity with BMI of 40.0-44.9, adult Rosacea Chronic fatigue syndrome Diverticula of colon
Andere Medikamente: Albuterol Vitamin C Aspirin Lipitor B Complex Vitamins Baclofen Biotin Buspirone Flexeril Adderall Voltaren gel Cymbalta Bentyl Pepcid Diflucan Flonase Neurontin Mucinex Humalog Lantus Lisinopril Loratadine Magnesium Chloride Metformin Nyst
Allergien: Rifampin
Vorherige Impfungen: -

VAERS 2162892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 48,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 15.05.2021
Beginn: 01.02.2022
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary normal Asthenia COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient with 2 Pfizer COVID vaccinations, last dose 05/15/21 who admitted with COVID complications. Provider discharge summary below: "Patient came in with Acute respiratory failure secondary to COVID. She had symptoms for 10 days already. Procal as well as CTA was negative for a PE and secondary pneumonia. Patient was given remdesivir as well as decadron with some improvement. She continued to require a little oxygen with activity. She was given vitamins as well as zinc. The decadron increased her BS so she needed higher doses of lantus and humalog. Patient was on lantus already. She wasn't well controlled prior to the steroids. Humalog was added. She was given instructions on adjusting her Insulin at home. The patient continued to be weak but clinically stable so was discharged home. She has follow up with her PCP. She should take an aspirin a day for a few weeks to decrease risk of thromboembolism She is encouraged to do deep breathing exorcizes."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: COVID detected PCR on 02/02/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia Hypertension Type 2 diabetes mellitus with complication, without long-term current use of insulin (*) Polycystic ovarian syndrome ADHD (attention deficit hyperactivity disorder) GERD (gastroesophageal reflux disease) Anxiety Chronic pelvic pain in female Fibromyalgia Depression with anxiety Uncontrolled diabetes mellitus (*) Panic anxiety syndrome Callous ulcer, limited to breakdown of skin (*) Pedal edema Primary osteoarthritis of both knees Morbid obesity with BMI of 40.0-44.9, adult Rosacea Chronic fatigue syndrome Diverticula of colon
Andere Medikamente: Albuterol Vitamin C Aspirin Lipitor B Complex Vitamins Baclofen Biotin Buspirone Flexeril Adderall Voltaren gel Cymbalta Bentyl Pepcid Diflucan Flonase Neurontin Mucinex Humalog Lantus Lisinopril Loratadine Magnesium Chloride Metformin Nyst
Allergien: Rifampin
Vorherige Impfungen: -

VAERS 2162724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 10.06.2021
Beginn: 03.03.2022
Tage bis Beginn: 266,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Anxiety COVID-19 Catheterisation cardiac abnormal Chest pain Coronary arterial stent insertion Mobility decreased Pyrexia SARS-CoV-2 test positive Troponin increased

Symptomtext

Fully vaccinated (not up to date) patient who admitted to hospital with COVID detected test. Provider discharge note below: "47-year-old female who presented to the ER with chest pain. She was found have an acute STEMI with troponins increasing from 16-638. Patient was transferred to Facility and underwent cardiac catheterization. Patient did receive a drug-eluting stent in the RCA and was started on aspirin and Brilinta for 1 year. Metoprolol succinate 25mg daily added on discharge. Echo at this time showed preserved ejection fraction at 50-55% without segmental wall abnormality without significant diastolic dysfunction as well. Patient did not have signs of heart failure. Lisinopril 2.5mg daily added as well. Patient did have hyperlipidemia in the past with an LDL of 127, and total cholesterol of 226. Recommend redraw all outpatient the patient was started on empiric Lipitor 40 mg daily. Patient did test positive for incidental COVID during this time and did have fever after catheterization. Patient was otherwise asymptomatic and did not require increased oxygenation although she does use 3 L at night regularly. Patient was worried about home mobilization and home care was ordered. Patient requested to follow-up with Dr. an appointment made on March 31, 2022. "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: COVID detected PCR on 03/03/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Mass of nasal sinus Right carpal tunnel syndrome Moderate persistent asthma with exacerbation Arthritis of right acromioclavicular joint Essential hypertension Dyslipidemia Vitamin D deficiency Hypoxia Numbness and tingling of left upper extremity Anxiety Depression Greater trochanteric bursitis of right hip Localized osteoarthritis of right knee Tear of LCL (lateral collateral ligament) of knee, right, initial encounter Seronegative rheumatoid arthritis (*) Carpal tunnel syndrome on left Pure hypercholesterolemia
Andere Medikamente: Albuterol Aspirin Lipitor Buspar Vitamin D3 Klonopin Enbrel Sureclick Fergon Advair Plaquenil Zestril Toprol XL Singulair Prilosec Lyrica Seroquel Spiriva Brilinta Zanaflex Effexor
Allergien: Bee stings Penicillin Varenicline
Vorherige Impfungen: -

VAERS 2162724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 10.06.2021
Beginn: 03.03.2022
Tage bis Beginn: 266,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Anxiety COVID-19 Catheterisation cardiac abnormal Chest pain Coronary arterial stent insertion Mobility decreased Pyrexia SARS-CoV-2 test positive Troponin increased

Symptomtext

Fully vaccinated (not up to date) patient who admitted to hospital with COVID detected test. Provider discharge note below: "47-year-old female who presented to the ER with chest pain. She was found have an acute STEMI with troponins increasing from 16-638. Patient was transferred to Facility and underwent cardiac catheterization. Patient did receive a drug-eluting stent in the RCA and was started on aspirin and Brilinta for 1 year. Metoprolol succinate 25mg daily added on discharge. Echo at this time showed preserved ejection fraction at 50-55% without segmental wall abnormality without significant diastolic dysfunction as well. Patient did not have signs of heart failure. Lisinopril 2.5mg daily added as well. Patient did have hyperlipidemia in the past with an LDL of 127, and total cholesterol of 226. Recommend redraw all outpatient the patient was started on empiric Lipitor 40 mg daily. Patient did test positive for incidental COVID during this time and did have fever after catheterization. Patient was otherwise asymptomatic and did not require increased oxygenation although she does use 3 L at night regularly. Patient was worried about home mobilization and home care was ordered. Patient requested to follow-up with Dr. an appointment made on March 31, 2022. "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: COVID detected PCR on 03/03/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Mass of nasal sinus Right carpal tunnel syndrome Moderate persistent asthma with exacerbation Arthritis of right acromioclavicular joint Essential hypertension Dyslipidemia Vitamin D deficiency Hypoxia Numbness and tingling of left upper extremity Anxiety Depression Greater trochanteric bursitis of right hip Localized osteoarthritis of right knee Tear of LCL (lateral collateral ligament) of knee, right, initial encounter Seronegative rheumatoid arthritis (*) Carpal tunnel syndrome on left Pure hypercholesterolemia
Andere Medikamente: Albuterol Aspirin Lipitor Buspar Vitamin D3 Klonopin Enbrel Sureclick Fergon Advair Plaquenil Zestril Toprol XL Singulair Prilosec Lyrica Seroquel Spiriva Brilinta Zanaflex Effexor
Allergien: Bee stings Penicillin Varenicline
Vorherige Impfungen: -

VAERS 2157874

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: WI
Alter: 82,0
Geschlecht: M
Eingang: 04.03.2022
Impfdatum: 19.10.2021
Beginn: 10.01.2022
Tage bis Beginn: 83,0
Dosis: 1
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 pneumonia Chest X-ray Computerised tomogram abdomen Death Dyspnoea Electrocardiogram Fibrin D dimer Gait inability Laboratory test Malaise Pain Troponin increased

Symptomtext

Patient developed COVID-19 symptom 1/5 -1/6/2022. After his first treatment with monoclonal antibodies on 1/14/22. He presented to ED with a re action to the infusion and ended up being admitted to the hospital. He was admitted for about 2 days. Patient was discharged home. Patient returned to ED on 1/25/22. Patient stated worsening of symptoms. He had worsening shortness of breath at home. He also has body aches. He has overall malaise and cannot walk anymore. No fever. No chest pain or current shortness of breath. No nausea vomiting or diarrhea. history of lymphoma with peritoneal involvement- in remission for the past 2 years. Hospital web report with diagnosis of COVID-pneumonia -Not hypoxic and with marked elevation in acute phase reactants -Patient was given dexamethasone in ED, and continued per protocol. Patient had a mildly elevated troponin with record stating may be an indicator of some demand ischemia versus myocarditis related to COVID-19. Next Web report received from Hospice. Patient died 1/29/22 at 10:49. Patient received COVID-19 PRESERVATIVE FREE .3ML PFIZER PURPLE CAP on 10/1 9/2021. Patient received COVID-19 PRESERVATIVE FREE .3ML PFIZER PURPLE CAP on 2/10/ 2021. Patient received COVID-19 PRESERVATIVE FREE .3ML PFIZER PURPLE CAP on 1/21/ 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: LABS EKG CXR U/A CTA D-DIMER
Aktuelle Erkrankungen: unknown
Vorgeschichte: Acute ST elevation myocardial infarction (STEMI) involving right coronary artery Cancer (* ) Diffuse large B-cell lymphoma with diffuse peritoneal involvement, peritoneal lymphomatosis Carotid artery disease (* ) Moderate Chronic back pain spondylolisthesis L5/S1 Chronic kidney disease, stage III Diverticulosis Heart failure High cholesterol Hypertension Quadriceps tendon rupture, left, initial encounter Rheumatoid arthritis (* ) Inflammatory arthritis SYNERGY drug coated stents ( x 4 ) in right coronary artery
Andere Medikamente: unknown
Allergien: Bee Stings
Vorherige Impfungen: -

VAERS 2150631

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 01.03.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Thrombosis

Symptomtext

PASSED AWAY; CLOTS; This spontaneous report received from a patient through social media via a company representative concerned two patients of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient did not have history of drug abuse or illicit drug usage. Both had no health issues and were under 50. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown and expiry: unknown) dose not reported, 01 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. Reporter stated that 2 friends through clots and passed from the single shot vaccine. On an unspecified date, the patient died from unknown cause of death. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of clots was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20220256761-COVID-19 VACCINE AD26.COV2.S-Passed away,Clots. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient did not have history of drug abuse or illicit drug usage. Both had no health issues and were under 50.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2148600

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge Unknown

kritisch

Staat: KY
Alter: 67,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Atelectasis COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Dyspnoea Malaise Pyrexia SARS-CoV-2 test positive Wheezing

Symptomtext

The patient received 3 out of 3 COVID vaccines per H&P and was hospitalized for COVID symptoms. No documentation provided regarding vaccine manufacturer, location received, or dates. H&P 2/23/22 Patient: Age: 67 Years Sex: Male DOB: Chief Complaint soa History of Present Illness (4, 4, 4) This pleasant 67-year-old male with COPD, status post mechanical aortic valve replacement anticoagulated, hypertension, seizure disorder, hyperlipidemia, is admitted for COVID pneumonia and acute hypoxic respiratory failure. The patient received 3 out of 3 Covid vaccines. He was in his usual state of health until 2 days ago when he developed a cough, increasing shortness of breath, fevers. He presented to this emergency department febrile to 101.9, with an O2 saturation of 90% on 10 L of oxygen. He was placed on heated high flow oxygen with improvement of his O2 sats to 94%, has mild wheezing on exam. Chest x-ray shows some scattered atelectasis, and the patient is Covid positive. In the ER he was treated with duo nebs, Rocephin, and Tylenol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: COVID PCR completed 2/23/22 CT Chest 2/23/22
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Problem List/Past Medical History Ongoing Alcohol abuse ALCOHOLIC CIRRHOSIS OF LIVER Ascending aortic aneurysm COPD (chronic obstructive pulmonary disease) Dyslipidemia Hypertension Idiopathic subglottic tracheal stenosis Nicotine abuse Seizure TBI (traumatic brain injury)
Andere Medikamente: Unknown
Allergien: Aspirin, PCN, Codeine
Vorherige Impfungen: -

VAERS 2148277

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: 02.11.2021
Beginn: 05.02.2022
Tage bis Beginn: 95,0
Dosis: 3
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arteriosclerosis coronary artery Aspiration Blood culture Blood lactic acid normal Blood test abnormal Bronchiectasis COVID-19 COVID-19 pneumonia Cardiomegaly Cerebral small vessel ischaemic disease Cerebral ventricle dilatation Chest X-ray abnormal Computerised tomogram abdomen abnormal Computerised tomogram thorax abnormal Confusional state Death Deep vein thrombosis Dental caries

Symptomtext

Patient expired. 66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable. Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal. Suprapubic catheter was changed in UA was obtained. UA positive for acute infection. Viral PCR negative. CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia. CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis. Mild to moderate large volume of stool. Ultrasound of lower extremities was obtained which was negative acute DVT. Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin. He was also given a 2 L NS bolus. Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management. Patient was initially confused and this had resolved after the 1st 48 hours of stay. Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia. Patient continued on oxygen support. Patient had been requiring high-flow nasal cannula support. Infectious Disease consulted with MRSA screen positive. Workups showed positive COVID and the rest were negative. Antibiotics then discontinued. IV steroids then initiated. Pulmonary consulted and evaluated patient. Agreed on IV steroids. Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia. Patient was saturating well with his high-flow nasal cannula oxygen support. Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO. Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning. Neuropsych had been consulted for this and evaluated patient. Patient deemed to have no medical decision making capacity on this. DPOA then activated. Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting. Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures. Comfort care measures then had been initiated. Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021. The patient passed away and was pronounced on 2/17/2022 at 1200pm. Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: Procedure Component Value Ref Range Date/Time DR CHEST SINGLE VIEW Collected: 02/12/22 1638 Order Status: Completed Updated: 02/12/22 1641 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/12/2022 3:50 PM TECHNIQUE: Single view chest INDICATION: Hypoxia COMPARISON: 2/9/2022 ENCOUNTER: Not applicable _________________________ FINDINGS: Stable cardiomegaly and left chest ICD device. Stable diffuse bilateral lung opacification. No pneumothorax or large pleural effusion. _________________________ Impression: No significant change compared to 2/9/2022. Persistent diffuse bilateral lung opacification, likely multifocal pneumonia. Dictated by: MD on 2/12/2022 4:38 PM. Electronically signed by: MD on 2/12/2022 4:40 PM. CT THORAX WITHOUT IV CONTRAST Resulted: 02/10/22 1640 Order Status: Completed Updated: 02/10/22 1642 Narrative: EXAMINATION: CT Chest without IV Contrast EXAM DATE: 2/10/2022 4:03 PM TECHNIQUE: Standard protocol CT images of the chest were performed without intravenous contrast. Lack of intravenous contrast does limit assessment of the vascular structures and soft tissues. Coronal and sagittal images were reconstructed. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Respiratory failure. Hypoxemia. Recent Covid pneumonia. COMPARISON: CT 1/25/2022 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: There is no mediastinal or hilar lymph node enlargement. Cardiovascular: Cardiomegaly. Left subclavian cardiac device with leads in the right ventricle and coronary sinus. Coronary artery calcification. No pericardial effusion. Lungs & Airways: Previously visualized extensive bilateral groundglass and peripheral airspace opacities have slightly improved although there is now extensive bilateral groundglass opacification with extensive areas of central to peripheral reticulation, areas of architectural distortion, and some areas of mild traction bronchiectasis. This involves all lobes. No definite honeycombing. Pleural Space: There are no pleural effusions. There is no pneumothorax. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: No significant abnormality. Assessment of the soft tissues and vascular structures is limited on noncontrast imaging. ____________________ Impression: 1. The previously visualized extensive bilateral groundglass and peripheral predominant airspace opacities have slightly improved although there is now extensive bilateral groundglass opacification with areas of extensive reticulation, architectural distortion, and some areas of mild traction bronchiectasis. This is compatible with sequelae of previously visualized COVID 19 pneumonia with probable areas of developing fibrosis. The relatively extensive bilateral groundglass opacities may relate to previous COVID 19 pneumonia although superimposed pulmonary edema or less likely superimposed secondary infection is possible. CT HEAD WITHOUT IV CONTRAST Resulted: 02/09/22 2153 Order Status: Completed Updated: 02/09/22 2155 Narrative: EXAMINATION: CT Head without contrast EXAM DATE: 2/9/2022 9:43 PM TECHNIQUE: CT of the head was performed without intravenous contrast. Sagittal and coronal reconstructions are provided. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or automatic exposure control, and/or mA/kV adjustments based on body size. INDICATION: Mental status change, unknown cause COMPARISON: CT head dated 11/22/2021. HAND DOMINANCE: Unknown ENCOUNTER: Not applicable ___________________________ FINDINGS: The ventricles are enlarged out of proportion to the sulci and cisterns, with crowding of the gyri adjacent to the superior sagittal sinus, as well as enlargement of the sylvian fissures. There is no midline shift. There is no evidence of acute intracranial hemorrhage. There is a CSF density space in the inferior aspect of the posterior fossa with mild mass effect on the bilateral cerebellar hemispheres inferior aspects, similar to prior exam. There is no evidence of acute territorial infarction. Scattered hypodense foci in the periventricular and subcortical white matter are nonspecific, but likely reflect sequela of chronic small vessel ischemic disease. The visualized paranasal sinuses are clear. The mastoid air cells are clear. The intraorbital contents are unremarkable. No evidence of displaced calvarial fracture. There are multiple periapical lucencies and dental caries of the visualized maxillary and mandibular teeth. ___________________________ Impression: 1. No evidence of acute intracranial hemorrhage or large territorial infarction. 2. The ventricles are enlarged out of proportion to the sulci and cisterns. While this may reflect central greater than peripheral parenchymal volume loss, normal pressure hydrocephalus should also be considered. 3. Dental disease with multiple periapical lucencies and dental caries. Correlate with dental exam. DR CHEST SINGLE VIEW Collected: 02/09/22 0950 Order Status: Completed Updated: 02/09/22 0953 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/9/2022 8:32 AM TECHNIQUE: Portable semiupright AP INDICATION: Pneumonia with hypoxia COMPARISON: 2/7/2022 and older exams. ENCOUNTER: Not applicable _________________________ FINDINGS: Stable mild cardiomegaly. Unchanged positioning of the pacemaker/ICD leads. Severe bilateral patchy alveolar opacification with slightly improved aeration of the lungs, especially the right mid lung and right lung base. No pleural effusions or pneumothorax. _________________________ Impression: Slightly improving severe bilateral pneumonia. Dictated by: MD on 2/9/2022 9:50 AM. Electronically signed by: MD on 2/9/2022 9:52 AM. DR CHEST SINGLE VIEW Collected: 02/07/22 1809 Order Status: Completed Updated: 02/07/22 1811 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/7/2022 5:46 PM TECHNIQUE: Single view chest INDICATION: Increased O2 demand COMPARISON: Chest x-ray 12:34 PM, chest CT 1/25/2022. ENCOUNTER: Not applicable _________________________ FINDINGS: Left chest wall biventricular pacemaker/ICD The heart, mediastinum, and pulmonary vasculature are normal. Extensive bilateral airspace disease is redemonstrated. Low lung volumes. No large pleural effusion or pneumothorax is present. _________________________ Impression: Stable exam. Extensive bilateral airspace disease consistent with multifocal pneumonia. Dictated by: MD on 2/7/2022 6:09 PM. Electronically signed by: MD on 2/7/2022 6:10 PM. DR CHEST 2 VIEWS FRONTAL AND LATERAL Resulted: 02/07/22 1303 Order Status: Completed Updated: 02/07/22 1305 Narrative: EXAMINATION: Frontal and Lateral View Chest EXAM DATE: 2/7/2022 12:53 PM TECHNIQUE: Frontal and lateral views INDICATION: Worsening hypoxia. COMPARISON: Chest radiograph 2/5/2022 ENCOUNTER: Subsequent _________________________ FINDINGS: Dual lead cardiac device. Cardiomediastinal silhouette is actually obscured by the lung findings, but is likely unchanged. Persistent extensive patchy diffuse airspace opacities throughout the lungs are similar to 2/5/2022. No large pleural effusion or pneumothorax. Osseous structures are unchanged. _________________________ Impression: Persistent diffuse airspace opacities throughout the lungs are similar to 2/5/2022, and presumed to reflect underlying pneumonia. USV Venous Lower Extremity Duplex Bilateral Resulted: 02/06/22 0038 Order Status: Completed Updated: 02/06/22 0040 Narrative: EXAMINATION: Complete Right and Left Lower Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 2/5/2022 11:30 PM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left lower extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: leg pain COMPARISON: Right lower extremity venous Doppler 7/14/2021 and bilateral lower extremity venous Doppler 1/9/2004 _____________________ Right Lower Extremity Findings: Right Common Femoral Vein: No DVT. Right Femoral Vein: No DVT. Right Popliteal Vein: No DVT. Right Posterior Tibial Veins: Not well seen but the adequately visualized segments show no evidence of thrombosis. Right Peroneal Veins: Not well seen but the adequately visualized segments show no evidence of thrombosis. Right proximal Greater Saphenous Vein: No thrombus. Left Lower Extremity Findings: Left Common Femoral Vein: No DVT. Left Femoral Vein: No DVT. Left Popliteal Vein: No DVT. Left Posterior Tibial Veins: Not well seen but the adequately visualized segments show no evidence of thrombosis. Left Peroneal Veins: Not well seen but the adequately visualized segments show no evidence of thrombosis. Left proximal Greater Saphenous Vein: No thrombus. Duplex Doppler: Spectral Doppler demonstrates bilateral normal respirophasic waveforms in the common femoral veins. Additional Findings: None. _____________________ Impression: There is no deep venous thrombosis in the visualized deep veins of the right or left lower extremity. * CT ABDOMEN AND PELVIS WITHOUT IV CONTRAST Collected: 02/05/22 2246 Order Status: Completed Updated: 02/05/22 2300 Narrative: EXAMINATION: CT Abdomen and Pelvis without IV Contrast EXAM DATE: 2/5/2022 10:13 PM TECHNIQUE: Standard protocol CT imaging of the abdomen and pelvis was performed without intravenous contrast. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Diverticulitis suspected COMPARISON: 1/21/2020 ENCOUNTER: Not applicable ____________________ FINDINGS: Lung Bases: Extensive groundglass infiltrates are noted at the lung bases. Hepatobiliary: The liver has a normal size and a smooth surface. There is no biliary dilatation and the gallbladder is unremarkable. Pancreas: The pancreas is normal. Spleen: The spleen is not enlarged. Adrenals: The adrenal glands are normal. Kidneys, Ureters, & Bladder: Both kidneys have a normal size. There is no hydronephrosis. No urinary tract calculi are present. Both ureters have a normal caliber and there are no stones. There is a suprapubic catheter in place. The urinary bladder is otherwise unremarkable. Gastrointestinal: The stomach and small bowel are normal with no obstruction or inflammation. The appendix is normal. A moderate to large volume of stool is present within the colon. There are a few scattered sigmoid colon diverticula without CT evidence of acute diverticulitis. Reproductive Organs: Unremarkable. Lymphatic System: There is no lymph node enlargement within the abdomen or pelvis. Vasculature: Abdominal aorta has a normal caliber with moderate atherosclerotic plaque. Peritoneum: No free fluid, free air, or inflammation. Abdominal Wall & Musculoskeletal: Scattered degenerative changes are present.. Assessment of the solid organs and soft tissues is limited as this is a noncontrast scan. ____________________ Impression: 1. Mild sigmoid colon diverticulosis without CT evidence of diverticulitis. 2. Moderate to large volume of stool present. 3. Extensive groundglass opacities at the lung bases may be related to Covid 19 infection or other etiology. 4. Additional findings, as above. Dictated by: MD on 2/5/2022 10:46 PM. Electronically signed by: MD on 2/5/2022 10:59 PM. DR CHEST SINGLE VIEW Resulted: 02/05/22 2157 Order Status: Completed Updated: 02/05/22 2159 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/5/2022 9:43 PM TECHNIQUE: Single AP portable supine chest INDICATION: dyspnea and fever COMPARISON: 1/28/2022 ENCOUNTER: Not applicable ________________________ FINDINGS: Cardiac leads unchanged. Cardiomegaly with increasing prominence of pulmonary vasculature. Hilar regions are now largely obscured. Grossly stable thoracic aorta. Worsening widespread bilateral infiltrates consistent with pneumonia. No pleural effusion. There is no evidence of pneumothorax.. Osseous structures are unchanged. _________________________ Impression: Worsening bilateral infiltrates consistent with pneumonia.
Aktuelle Erkrankungen: 10/25/21 Acute cystitis without hematuria (Primary Dx); Retention of urine
Vorgeschichte: Respiratory Chronic obstructive lung disease (HCC) Pneumonia due to COVID-19 virus Acute hypoxemic respiratory failure (HCC) Pneumonia Pulmonary infiltrates Sleep apnea Circulatory Essential hypertension Permanent atrial fibrillation (HCC) Mitral regurgitation Pacemaker Nonrheumatic aortic valve stenosis Complete heart block (HCC) Chronic diastolic heart failure (HCC) Atherosclerotic heart disease of native coronary artery without angina pectoris Old myocardial infarction Subclavian artery stenosis, left (HCC) Digestive Gastroenteritis Gastro-esophageal reflux disease without esophagitis Hematologic Anemia Nervous Unspecified dementia without behavioral disturbance (HCC) Seizure-like activity (HCC) Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin (HCC) (Idiopathic) normal pressure hydrocephalus (HCC) Alcohol dependence, in remission (HCC) Encephalopathy Myelopathy concurrent with and due to spinal stenosis of cervical region (HCC) Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side (HCC) Parkinsonism, unspecified Parkinsonism type (HCC) Genitourinary Type 2 diabetes mellitus with chronic kidney disease (HCC) Benign prostatic hyperplasia with urinary retention Suprapubic catheter (HCC) Endocrine/Metabolic Mixed hyperlipidemia Hypokalemia Other RLS (restless legs syndrome) Major depressive disorder, single episode, unspecified History of head and neck cancer Transient alteration of awareness Spinal stenosis of lumbar region S/P AV nodal ablation Anticoagulant long-term use Counseling regarding advance care planning and goals of care Multiple comorbid conditions End of life care
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet Ascorbic Acid (VITAMIN C) 500 MG CAPS atorvastatin (LIPITOR) 40 MG tablet carvedilol (COREG) 12.5 MG tablet cholec
Allergien: Contrast Dye [Ivp Dye, Iodine Containing]Shortness of Breath, Swelling Dust Iodine Mold Trees / Grass
Vorherige Impfungen: -

VAERS 2148242

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: MO
Alter: 54,0
Geschlecht: F
Eingang: 28.02.2022
Impfdatum: 01.11.2021
Beginn: 21.12.2021
Tage bis Beginn: 50,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Areflexia Arteriogram carotid abnormal Blood culture Breath sounds absent COVID-19 COVID-19 pneumonia Cerebral haemorrhage Cerebral mass effect Computerised tomogram head abnormal Death Dyskinesia Dyspnoea Echocardiogram abnormal Electrocardiogram ST-T segment abnormal Endotracheal intubation Fatigue

Symptomtext

Date of Admission 12/25/2021 Date of Discharge 01/08/2022 Reason for Hospitalization Covid positive 12/19. Increased SOA and fatigue. Hospital Course Patient is a 55-year-old female transferred to facility for worsening acute hypoxic respiratory failure secondary to Covid pneumonia. She has PMH of bipolar disorder and prior tobacco use disorder. Her FiO2 requirements kept increasing on HFNC, she was evaluated and transferred to ICU for further management, intubated 12/31 for respiratory fatigue despite NIV. She has had treatment including dexamethasone, remdesivir, tocilizumab. Abx empiric levofloxacin (12/26-1/4). PF ratio improving with treatment, proning no longer indicated. NG tube placement complicated by Hx of Roux-en-Y; required fluoroscopic placement of NGT. 1/6 overnight patient noted to have significant left sided weakness, CT head showed right frontal intraparenchymal hemorrhage - stroke and neurosurgery teams consulted. Also found to have bilateral PEs on neck CTA. Brain MRI 1/7 AM showed primary intracerebral hemorrhage of right frontotemporal region. On 1/8 AM, patient was having increased FiO2 requirement, hypotension. Echo bedside showed significant RV dilation consistent with right heart strain presumably from large b/l pulmonary emboli. Patient's family was called in to see patient given worsening clinical condition, and with knowledge that patient would not want trach (the next step in medical management assuming survival of current medical comorbidities), the patient's family (husband and daughter) decided to allow the patient to be made comfortable. Comfort care measures were implemented shortly afterwards with family at bedside. Patient declared deceased at 12:32 PM on 01/08/2022. Discharge Diagnoses COVID-19 pneumonia Acute hypoxic respiratory failure Acute Respiratory Distress Syndrome, Severe Bilateral mainstem pulmonary emboli Right frontotemporal intraparenchymal hemorrhage Right frontotemporal intraparenchymal hemorrhage with midline shift Hypotension secondary to RV overload from pulmonary emboli, bilateral mainstem Hypotension secondary to sepsis from COVID Adenovirus Pneumonia History of Roux-en-Y gastric bypass B12 deficiency Pancytopenia Hyperglycemia Comfort care measures Other Diagnoses Ongoing BMI 35.0-35.9,adult Obesity Historical Bipolar disease, chronic Consultants Neurology Supportive/Palliative Care Surgery Neurosurgery Pending Labs Blood Culture (Preliminary, InProcess, ordered 01/03/2022, 12:14) Blood Culture (In Transit, Ordered 01/08/2022, 09:24) Blood Culture (In Transit, Ordered 01/08/2022, 09:24) Fungal Culture (Preliminary, InProcess, ordered 12/31/2021, 11:17) Discharge Disposition Home, Unable To Determine Medications New, Changed, or Refilled Medications None Medications to be Continued None Discontinued Medications None Physical Exam at Discharge Vitals & Measurements T: 38.5 ?C TMIN: 37.7 ?C TMAX: 38.5 ?C HR: 134 RR: 32 BP: 108/36 BP: 60/48(Line) SpO2: 69% WT: 103.4 kg BMI: 39.1 General: Nonresponsive HEENT: Normocephalic, atraumatic. Resp: No breath sounds heard bilaterally CV: No heart sounds heart in the aortic, pulmonary, tricuspid or mitral positions. No radial or pedal pulses noted. GI: Soft, no bowel sounds. Skin: Warm, dry, and intact skin. No rashes MSK: No movements noted Neuro: Nonresponsive, pupils fixed at 3 mm, no cough or gag, no movement of any extremity to pain or command Time Spent >60 minutes Nursing/Other Orders Hospice Evaluation and Admission. 01/08/22 11:27:00 CST, Once, 01/08/22 11:27:00 CST, COVID-19 | Hypoxia | Bilateral pulmonary embolism | Intraparenchymal hematoma of brain Adult Tube Feeding, continuous. 01/05/22 14:54:00 CST, Nutren 1.5 - 1.5kcal/mL No Fiber, Goal Rate 60, route Orogastric, how often Daily Intake and Output. 12/27/21 18:18:00 CST, Continuous Order Activity, Prone Position (Position, Prone). Start Date/Time: 12/31/21 16:53:00 CST, Special Instructions Please prone patient for 16 hours then unprone for 8 hours Elevate Head of Bed (Head of Bed Elevated). 01/01/22 9:10:00 CST, Continuous Order, to prevent aspiration; 30 Degrees Fall Precautions. 01/07/22 3:29:00 CST. Order comment: order placed from nursing documentation CLIN_FALL_RISK Activity As Tolerated. 12/25/21 23:18:00 CST, Continuous Order Activity As Tolerated. 12/27/21 18:18:00 CST, Continuous Order Code Status. Code Status Description: DNAR (Do Not Attempt Resuscitation) Oxygen Instructions. 01/08/22 11:27:00 CST, Routine, Instructions Titrate to comfort. No O2 Saturation Monitoring. Order comment: Addendum by MD on January 09, 2022 07:11:29 CST (Verified) ADDENDUM: I personally saw and evaluated the patient on the result date found in the header of this document. I independantly performed the critical/key components of the E/M service and discussed the management with the author of this document. I review the history, physical, relevant labs, medications, flow sheets, imaging studies, microbiology data and ventilator data (if applicable). I agree with everything documented above with the following exceptions/additions: none

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: See adverse note
Aktuelle Erkrankungen: PMH of bipolar disorder (noncompliant on medications), prior tobacco use 30 years ago (9 smoke pack history).
Vorgeschichte: PMH of bipolar disorder (noncompliant on medications), prior tobacco use 30 years ago (9 smoke pack history).
Andere Medikamente: unknown
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2144114

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 26.02.2022
Impfdatum: 22.12.2021
Beginn: 17.02.2022
Tage bis Beginn: 57,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Amyotrophic lateral sclerosis Aphasia Aspiration COVID-19 Death Depressed level of consciousness Dyspnoea Endotracheal intubation Feeding tube user Gastrostomy Loss of personal independence in daily activities Mechanical ventilation Pneumonia SARS-CoV-2 test positive Salivary hypersecretion Vomiting Weight decreased

Symptomtext

Patient is a 74-year-old who presented with shortness of breath, weight loss, decreased tube feedings through her PEG tube, recurrent emesis and possible aspiration with multilobar pneumonia in the presence of ALS. Patient required intubation, fluid boluses, Levophed, antibiotics. Infectious Disease was also on consult. Patient tested positive for COVID-19 on 02/17. Was treated with remdesivir as well. Patient continued to show improvement on the ventilator. She was weaned down close to being extubated and was tolerating pressure support ventilation adequately. He started to wake up better on that. Scopolamine patch was started but showed no improvement in her secretions that were mostly oral and not from her lungs. Case was discussed with her daughter and spouse in detail. They understood the current clinical condition. The patient had been suffering from significant difficulty to her life with recurrent aspirations limiting her activity. She had not been significantly verbal since September. And most recently had not been able to tolerate PEG tube feedings either. At this point the family decided for a one-way extubation. If the patient is stabilized and did well to continue current care. However if the patient had any respiratory deterioration then to consider comfort measures. Patient was extubated on 02/24. Patient initially was briefly doing adequately well but subsequently started requiring increasing amounts of oxygen, level of consciousness also declined. Family requested change of plan of care to comfort measures. These were instituted. Patient died on 02/25 at 12:09 p.m. Cause of death was acute respiratory failure. Secondary to multifocal pneumonia. Secondary to recurrent aspirations. Secondary to ALS. Tobacco did not contribute to the patient's death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: Positive COVID 19 test on 2/17/2022
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1175670

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 26.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Adverse reaction Chills Computerised tomogram Dyspnoea Guillain-Barre syndrome Asthenia Blood test Lumbar puncture Hypoaesthesia Magnetic resonance imaging head Magnetic resonance imaging spinal Mechanical ventilation Central nervous system lesion Death Pulmonary thrombosis Magnetic resonance imaging Malaise Oxygen saturation

Symptomtext

DIED; LUNG BLOOD CLOTS; GUILLAIN BARRE SYNDROME; BRAIN LESIONS; This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age, race and ethnicity. Initial information was processed along with the additional information received on 22-FEB-2022. The patient's weight, height, and medical history were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced blood clots, guillain barre syndrome, and brain lesions, and was hospitalized for ten months (304 days). The reporter reported that, "My wife died after ten months in the hospital after receiving JNJ vaccine. She fought for 10 months. Doctor telling us never seen this, never treated this. She had Guillain Barre syndrome, Brain lesions and finally lung blood clots. No one wanted to touch that. Yet this is news worthy. Victims, Nope. the average citizen. No help, no regard for human life. News murdered my wife and countless others. Big pharma got protection. Corporate profits over human life. The government ignores whatever they want. They ignore the vaccine victims. Does our government care, A big no. Elected officials work for country, not corporations. News ignored and threatened legal action when I inquired with doctor. He collected my wife's medical records and then turned his back." On an unspecified date, the patient died due to unknown cause of death. It was unspecified whether an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of died on an unspecified date, and the outcome of brain lesions, lung blood clots and guillain barre syndrome was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220246190-COVID-19 VACCINE AD26.COV2.S- Died, Lung blood clots, Brain lesions. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable 20220246190-COVID-19 VACCINE AD26.COV2.S-Guillain Barre syndrome. This event(s) is labeled per RA and is therefore considered potentially related.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 304,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2134738

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: TX
Alter: 81,0
Geschlecht: M
Eingang: 23.02.2022
Impfdatum: 27.10.2021
Beginn: 11.02.2022
Tage bis Beginn: 107,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Adenocarcinoma Adenocarcinoma of colon Biopsy colon abnormal Bradycardia COVID-19 COVID-19 pneumonia Cardio-respiratory arrest Colon neoplasm Colonoscopy abnormal Constipation Death Endotracheal intubation General physical health deterioration Hypertensive urgency Hypotension Laparoscopic surgery Large intestinal stenosis Resuscitation

Symptomtext

Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 02/11/21, 3/11/21 and 10/27/21. Presented to ED c/o constipation. Admitted for colonic stricture and hypertensive urgency, Covid+ 2/1. Underwent colonoscopy 02/04/2022 w/evidence of a sigmoid mass, bx + adenocarcinoma. 2/5/22 laparoscopic converted to open sigmoidectomy w/resection of mass. Path report Stage IIIB adenocarcinoma. Postop c/b severe Covid PNA, deteriorated in subsequent days required high flow O2. Cardiopulmonary arrest 2/11/22 CPR, intubated, became more bradycardic and hypotensive. Transitioned to comfort care. Treated with decadron, remdesivir, and zosyn. Expired on 2/11/22. underwent CPR, intubated, then became more bradycardic and hypotensive. Pt was transitioned to comfort care. Treated with decadron, remdesivir, and zosyn. Pt expired on 2/11/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 11,0
Labordaten: 2/01/22 - This sample was analyzed using the SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen: -
Vorgeschichte: BPH
Andere Medikamente: finasteride
Allergien: Darvocet A500, Zomax, Stevia
Vorherige Impfungen: -

VAERS 2131473

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge Unknown

kritisch

Staat: KY
Alter: 75,0
Geschlecht: F
Eingang: 22.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Chills Computerised tomogram thorax Cough Dyspnoea Malaise Pneumonia Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized for Covid symptoms and received vaccinations x 3. Unknown vaccine manufacturer, date, location received. Per H&P Chief Complaint SOA, Confirmed PNA by PCP, sent by PCP, 79 on RA on 4 pt is 94% . COVID last week Reason for Consultation Acute Hypoxic Respiratory Failure History of Present Illness 75yo F with PMH of COPD, OSA, CAD, PAF with Eliquis, HTN, and CKD who was admitted to the hospital on 2/17/22 for Acute Hypoxic Respiratory Failure related to COVID-19 PNA despite being vaccinated. Patient's symptoms of malaise associated with cough and intermittent sputum production, fevers, chills, and dyspnea started about 10 days prior to arrival. Patient was positive for COVID-19 on an at home test. Patient's dyspnea continued to worsen and was reported to be in the 70's on RA at her PCP office so she was sent to the ED. Patient was started on 5L NC in the ED but has been progressively requiring more and more oxygen. Patient is currently on Oxymizer mask at 10L. Patient has been on IV steroids, Baricitinib, BD and mucolytics since admission. Patient denies any acute complaints on exam.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: CT chest 2/19. Covid PCR 2/18
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Problem List/Past Medical History Ongoing Acid reflux Arthritis Atrial fibrillation COPD (chronic obstructive pulmonary disease) Eczema Emphysema of lung Gout High cholesterol HTN (hypertension) Kidney disease MI (myocardial infarction) RLS (restless legs syndrome) Sinus complaint Sleep apnea
Andere Medikamente: Unknown
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2130675

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 22.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via social media via a company representative concerned a patient of unspecified age, sex, race and ethnicity.. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient was previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 1 total, administered for prophylactic vaccination. It was unknown whether patient had any adverse events (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series was 2) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported 1 total, administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient died from unknown cause of death (dose number in series 2). As per reporter, "When I lost my best friend of 6 years die after the booster." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20220246041.; Sender's Comments: V0: 20220246293-COVID-19 VACCINE AD26.COV2.S-death. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1897996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: CO
Alter: 65,0
Geschlecht: M
Eingang: 22.02.2022
Impfdatum: 25.10.2021
Beginn: 23.11.2021
Tage bis Beginn: 29,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Endotracheal intubation Hypoxia Inappropriate schedule of product administration Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Patient fully vaccinated with Pfizer on 9/17/21 and 10/25/21. Diagnosed with COVID on 11/1/21 and received monoclonal antibodies on 11/5/21. Admitted to hospital for COVID on 11/5/21-11/19/21. Patient chronically immunosuppressed on long term solu-medrol. Patient re-admitted to hospital with severe hypoxia requiring immediate intubation upon arrival. Patient deceased on 12/7/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1897996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: CO
Alter: 65,0
Geschlecht: M
Eingang: 22.02.2022
Impfdatum: 25.10.2021
Beginn: 23.11.2021
Tage bis Beginn: 29,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Endotracheal intubation Hypoxia Inappropriate schedule of product administration Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Patient fully vaccinated with Pfizer on 9/17/21 and 10/25/21. Diagnosed with COVID on 11/1/21 and received monoclonal antibodies on 11/5/21. Admitted to hospital for COVID on 11/5/21-11/19/21. Patient chronically immunosuppressed on long term solu-medrol. Patient re-admitted to hospital with severe hypoxia requiring immediate intubation upon arrival. Patient deceased on 12/7/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2125730

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 19.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy skin Cell marker Immunohistochemistry Laboratory test Leiomyoma Leiomyosarcoma Neoplasm skin Pathology test Skin lesion Skin lesion removal

Symptomtext

Desmoplastic leiomyosarcoma; Case reference number US-BN-2022-000118 is a literature case report, title as stated above, identified on 08-Feb-2022, and concerns an 81-year-old elderly male patient. On an unspecified date, the patient was vaccinated with MVA BN (smallpox vaccine modified vaccinia Ankara-Bavarian Nordic (live-attenuated, non-replicating)) in the upper left arm, at an unknown dose or route of administration, for unknown indication. On an unspecified date, an unknown amount of time after the vaccination, the patient was presented to the clinic with a two point one cm firm, skin-colored subcutaneous tumor on the left upper arm. It was reported that the lesions had been slowly enlarging for approximately 4 years. The differential diagnosis included sympastic leiomyoma, and a variety of desmoplastic spindle cell lesions such as desmoplastic melanoma, cutaneous spindle cell carcinoma, and desmoplastic leiomyosarcoma On an unspecified date, an unknown amount of time after the vaccination, following laboratory tests were performed: a punch biopsy and immunohistochemical staining, which revealed positive spindle cells for desmin and caldesmon.; immunostain for p53 was strongly and unformly positive; histopathology results had poor circumscription, which caused symplastic leiomyosarcoma to become ruled out as a diagnosis; negative S-100 staining in combination with the positive immunoreaction to muscle markers (desmin and caldesmon) caused desmoplastic melanoma to become ruled out as a diagnosis; negative p63 and cytokeratin staining excluded cutaneous spinde cell carcinoma as a diagnosis and ultimately, clinicopathologic correlation favoured the diagnosis of desmoplastic leiomyosarcoma. Staged excisions were performed to eradicate the lesions. The outcome of the event desmoplastic leiomyosarcoma was not provided. The event 'desmoplastic leiomyosarcoma' was assessed as serious due to the seriousness criteria of medical significance. The reporter did not provide seriousness and causality assessment for the event. No further information was provided.; Reporter's Comments: An 81-year-old elderly male patient experienced a serious event of desmoplastic leiomyosarcoma (medically significant), unknown time after vaccination with MVA BN smallpox vaccine (modified vaccinia Ankara-Bavarian Nordic (live attenuated, non replicating)). Time to onset was not reported. Leiomyosarcoma is unexpected for MVA BN smallpox vaccine (modified vaccinia Ankara-Bavarian Nordic (live attenuated, non replicating)). Concomitantly used medications and patient's medical history were not reported. Leiomyosarcoma of the skin and subcutaneous tissue is a rare soft tissue malignant neoplasm. Time to onset was not reported. Patient's age confounds causality assessment. At this point with limited information provided causality is assessed as not related to MVA BN vaccine.; Sender's Comments: An 81-year-old elderly male patient experienced a serious adverse event of desmoplastic leiomyosarcoma (medically significant), after vaccination with MVA BN smallpox vaccine (modified vaccinia Ankara-Bavarian Nordic (live attenuated, non-replicating)). Time to the event's onset was not reported. Leiomyosarcoma is unexpected for MVA BN smallpox vaccine (modified vaccinia Ankara-Bavarian Nordic (live attenuated, non-replicating)). Concomitantly used medications, other vaccines administered and patient's medical history were not reported. Leiomyosarcoma of the skin and subcutaneous tissue is a rare soft tissue malignant neoplasm. Time to onset was not reported. Patient's age confounds causality assessment. Limited data is available on use of MVA BN in elderly population. At this point, with limited information provided causality is assessed as not related to MVA BN vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Leiomyosarcoma
Hospital-Tage: -
Labordaten: Test Name: Punch biopsy; Result Unstructured Data: Positive spindle cells for desmin and caldesmon; Comments: /; Test Name: Immunohistochemical staining; Result Unstructured Data: Positive spindle cells for desmin and caldesmon; Comments: /; Test Name: Immunostain for p53; Result Unstructured Data: Strongly and uniformly positive; Comments: /; Test Name: Histopatology; Result Unstructured Data: Poor circumscription; Comments: /; Test Name: Cytokeratin staining; p63 staining; S-100 staining; Result Unstructured Data: Negative; Comments: /
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2122485

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 18.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via social media through company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin, batch number: unknown, expiry: unknown) dose was not reported, 1 total, start therapy date were not reported for prophylactic vaccination. It was unspecified whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s. (dose number in series 1). The patient received booster covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, 4 hours after taking the booster shot the patient died (dose number in series 2). The patient died from unknown cause of death. It was unspecified if an autopsy was performed. It was reported that "My friend's mom dropped dead 4 hours after taking the booster. I refuse to take it." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of event death was fatal. This report was serious (Death).; Sender's Comments: V0: 20220234178-COVID-19 VACCINE AD26.COV2.S-Death. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, this event is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2115618

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 16.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Suspected COVID-19 Vaccination failure

Symptomtext

SUSPECTED COVID-19 INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; DEATH; This spontaneous report was received from literature. This report concerned multiple patients of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: inflammatory bowel disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total administered on an unspecified date for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The patients with inflammatory bowel disease who received at least one vaccine dose prior to diagnosis of COVID-19 were included, among which 12 were hospitalized and 1 died. On an unspecified date, the patients experienced suspected covid-19 infection, (suspected clinical vaccination failure) and was hospitalized on an unspecified date for unspecified number of days. On an unspecified date, one patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged). This case was associated with product quality complaint.; Sender's Comments: V0-20220225916-covid-19 vaccine ad26.cov2.s-Death, Suspected covid-19 infection. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. 20220225916-covid-19 vaccine ad26.cov2.s-Suspected clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Inflammatory bowel disease
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2109628

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge unknown

kritisch

Staat: TN
Alter: 51,0
Geschlecht: M
Eingang: 13.02.2022
Impfdatum: 14.12.2021
Beginn: 14.12.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Catheterisation cardiac abnormal Chest X-ray normal Chest pain Coronary artery occlusion Dyspnoea Electrocardiogram abnormal Hyperhidrosis Intensive care Pallor Percutaneous coronary intervention

Symptomtext

Patient received covid booster shot (mfg unknown) 3 hours prior to arrival to ER. Patient complains of severe chest pain and shortness of breath. Pain is 9 out of 10. Patient is pale and diaphoretic. Patient goes to cath lab for percutaneous intervention for 100 % acute occlusion of the mid LAD. Patient recovers in critical care unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: Chest x ray = no acute cardiopulmonary abnormality. EKG : Positive normal sinus rhythm and STEMI; Negative nonspec ST-T wave changes
Aktuelle Erkrankungen: none
Vorgeschichte: DVT/PE; Factor V Leiden
Andere Medikamente: none documented
Allergien: none
Vorherige Impfungen: -

VAERS 2109559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 13.02.2022
Impfdatum: 03.03.2021
Beginn: 30.01.2022
Tage bis Beginn: 333,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood bicarbonate decreased Blood creatinine increased Blood sodium normal COVID-19 COVID-19 pneumonia Chronic kidney disease Emphysema Extra dose administered Fibrin D dimer Hypercoagulation Hypertension Hypothyroidism Leukopenia Metabolic function test Renal impairment SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary: Patient is a 74 y.o. female patient who is being discharged today. Hospital Course: Acute on chronic respiratory failure due to COVID-19 pneumonia Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Dexamethasone 6 milligram X 10 days Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n. Nasal cannula 3 liters AKI on chronic kidney disease Cr improving 25/1.41 Bicarb 20 BMP daily a.m. Hyponatremia 139 Hypothyroidism Levothyroxine 125 micrograms daily Arterial hypertension Toprol 12.5 milligram p.o. daily History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Leukopenia - Resolved Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected: 01/30/22
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Lung Cancer
Andere Medikamente: albuterol (PROVENTIL) (5 MG/ML) 0.5% Inhalation Nebulization Solution Take 5 mg by nebulization 3 times daily as needed for wheezing or shortness of breath. Yes Information, Historical buPROPion HCl (WELLBUTRIN) 100 MG Oral Tablet Take
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2109559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 13.02.2022
Impfdatum: 03.03.2021
Beginn: 30.01.2022
Tage bis Beginn: 333,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood bicarbonate decreased Blood creatinine increased Blood sodium normal COVID-19 COVID-19 pneumonia Chronic kidney disease Emphysema Extra dose administered Fibrin D dimer Hypercoagulation Hypertension Hypothyroidism Leukopenia Metabolic function test Renal impairment SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary: Patient is a 74 y.o. female patient who is being discharged today. Hospital Course: Acute on chronic respiratory failure due to COVID-19 pneumonia Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Dexamethasone 6 milligram X 10 days Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n. Nasal cannula 3 liters AKI on chronic kidney disease Cr improving 25/1.41 Bicarb 20 BMP daily a.m. Hyponatremia 139 Hypothyroidism Levothyroxine 125 micrograms daily Arterial hypertension Toprol 12.5 milligram p.o. daily History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Leukopenia - Resolved Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected: 01/30/22
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Lung Cancer
Andere Medikamente: albuterol (PROVENTIL) (5 MG/ML) 0.5% Inhalation Nebulization Solution Take 5 mg by nebulization 3 times daily as needed for wheezing or shortness of breath. Yes Information, Historical buPROPion HCl (WELLBUTRIN) 100 MG Oral Tablet Take
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2109559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 13.02.2022
Impfdatum: 03.03.2021
Beginn: 30.01.2022
Tage bis Beginn: 333,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood bicarbonate decreased Blood creatinine increased Blood sodium normal COVID-19 COVID-19 pneumonia Chronic kidney disease Emphysema Extra dose administered Fibrin D dimer Hypercoagulation Hypertension Hypothyroidism Leukopenia Metabolic function test Renal impairment SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary: Patient is a 74 y.o. female patient who is being discharged today. Hospital Course: Acute on chronic respiratory failure due to COVID-19 pneumonia Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Dexamethasone 6 milligram X 10 days Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n. Nasal cannula 3 liters AKI on chronic kidney disease Cr improving 25/1.41 Bicarb 20 BMP daily a.m. Hyponatremia 139 Hypothyroidism Levothyroxine 125 micrograms daily Arterial hypertension Toprol 12.5 milligram p.o. daily History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Leukopenia - Resolved Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected: 01/30/22
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Lung Cancer
Andere Medikamente: albuterol (PROVENTIL) (5 MG/ML) 0.5% Inhalation Nebulization Solution Take 5 mg by nebulization 3 times daily as needed for wheezing or shortness of breath. Yes Information, Historical buPROPion HCl (WELLBUTRIN) 100 MG Oral Tablet Take
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2109559

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 13.02.2022
Impfdatum: 03.03.2021
Beginn: 30.01.2022
Tage bis Beginn: 333,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood bicarbonate decreased Blood creatinine increased Blood sodium normal COVID-19 COVID-19 pneumonia Chronic kidney disease Emphysema Extra dose administered Fibrin D dimer Hypercoagulation Hypertension Hypothyroidism Leukopenia Metabolic function test Renal impairment SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary: Patient is a 74 y.o. female patient who is being discharged today. Hospital Course: Acute on chronic respiratory failure due to COVID-19 pneumonia Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Dexamethasone 6 milligram X 10 days Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n. Nasal cannula 3 liters AKI on chronic kidney disease Cr improving 25/1.41 Bicarb 20 BMP daily a.m. Hyponatremia 139 Hypothyroidism Levothyroxine 125 micrograms daily Arterial hypertension Toprol 12.5 milligram p.o. daily History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Leukopenia - Resolved Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected: 01/30/22
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Lung Cancer
Andere Medikamente: albuterol (PROVENTIL) (5 MG/ML) 0.5% Inhalation Nebulization Solution Take 5 mg by nebulization 3 times daily as needed for wheezing or shortness of breath. Yes Information, Historical buPROPion HCl (WELLBUTRIN) 100 MG Oral Tablet Take
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2103920

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 11.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Ammonia Blood iron Cerebrovascular accident Communication disorder Confusional state Haemoglobin Laboratory test Liver injury Magnetic resonance imaging head Ulcer haemorrhage

Symptomtext

POSSIBLE BLEEDING ULCER; SUSPECTED LIVER DAMAGE; STROKE; UNABLE TO COMMUNICATE; SEVERE CONFUSION; This spontaneous report received from a consumer concerned a 34 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no prior history of any of the events. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The patient's parent reported that the last week, he was hospitalized because the patient was unable to communicate and had severe confusion. The blood work showed very high ammonia levels, low hemoglobin and iron. There might have been other results that she did not know about. A brain MRI (magnetic resonance imaging) showed two small infarctions which was mentioned as strokes that was unusual for someone his age. It was believed that the patient had liver damage, a possible bleeding ulcer where he required a blood transfusion. The patient had no prior history of any of these and seems unusual that three unrelated events happened at the same time. The patient had been discharged from the hospital and were awaiting for follow-up visits from the neurologist and GI (gastrointestinal). The number of days of hospitalization was not reported. Laboratory data (dates unspecified) included: Ammonia (NR: not provided) Very high, Hemoglobin (NR: not provided) Low, Iron (NR: not provided) Low, Lab test (NR: not provided) Not reported, and MRI brain (NR: not provided) 2 small infarctions (strokes). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the unable to communicate, severe confusion, suspected liver damage, stroke and possible bleeding ulcer was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20220217887-COVID-19 VACCINE AD26.COV2.S-Possible bleeding ulcer,Suspected liver damage,Stroke,Unable to communicate,Severe confusion. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: Ammonia; Result Unstructured Data: Very high; Test Name: Hemoglobin; Result Unstructured Data: Low; Test Name: Lab test; Result Unstructured Data: Not reported; Test Name: MRI brain; Result Unstructured Data: 2 small infarctions; Comments: Showed 2 small infarctions (strokes); Test Name: Iron; Result Unstructured Data: Low
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no prior history of any of the events.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2101756

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 10.02.2022
Impfdatum: 20.07.2021
Beginn: 27.01.2022
Tage bis Beginn: 191,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood lactate dehydrogenase increased C-reactive protein increased COVID-19 COVID-19 pneumonia Dehydration Dysphagia Hepatic enzyme increased Hyperglycaemia Metabolic encephalopathy SARS-CoV-2 test positive Sepsis Serum ferritin increased Unresponsive to stimuli Vomiting

Symptomtext

Patient presented after being found unresponsive, he had one episode of vomiting he was diagnosed with 1. Dehydration 2. Acute hyperglycemia 3. Acute metabolic encephalopathy 4. Bilateral paralysis due to old stroke (HCC) 5. Sepsis due to pneumonia (HCC) 6. Acute hypoxemic respiratory failure (HCC) 7. Antibiotic long-term use 8. CRP elevated 9. CVA, old, dysphagia 10. Diabetes mellitus type 2, insulin dependent (HCC) 11. Elevated ferritin 12. Elevated LDH 13. Elevated liver enzymes 14. H/O tracheostomy 15. Passive smoker 16. Pneumonia due to COVID-19 virus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 13,0
Labordaten: Positive for COVID 19 (PCR) on 01/27/22
Aktuelle Erkrankungen: Pt was admitted twice with pneumonia and sepsis, determined to be aspiration pneumonia. Patient is quareplegia
Vorgeschichte: Hypertension, Hyperlipidemia, Tracheostomy in place, type 2 Diabetes, quareplegia due to CVA, Peg tube use.
Andere Medikamente: acetaminophen (CHILDREN'S TYLENOL) 160 MG/5ML oral suspension acetaminophen (TYLENOL) 325 MG tablet amLODIPine (NORVASC) 10 MG tablet bisacodyl (DULCOLAX) 10 MG suppository Cholecalciferol (VITAMIN D3) 2000 UNIT CAPS dextromethorphan-
Allergien: Latex, Dilaudid, Morphine, quetiapine, sertraline.
Vorherige Impfungen: -

VAERS 2101077

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 10.02.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral thrombosis Cerebrovascular accident

Symptomtext

THREE BLOOD CLOTS IN BRAIN; STROKE; This spontaneous report received from a consumer via a company representative via agency concerned a 44 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry date: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced three blood clots in brain, and stroke. The reporter reported that "It's a freak thing. It's not like she's old and just a slob that doesn't take care of herself. She's only 44 and is one of those diehard people of taking care of themselves. So for her to have three blood clots in her brain and have a stroke is very suspicious of the cause. They also have her on blood thinners because there was smaller clots forming that they said they couldn't get too". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the three blood clots in brain and stroke was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20220161645.; Sender's Comments: V0: 20220216426 -JANSSEN COVID-19 VACCINE Ad26.COV2.S- Three blood clots in brain, Stroke. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1298827

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: AL
Alter: 52,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: 01.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 12,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Aphasia Cerebrovascular accident Craniotomy Decreased appetite Dizziness Immobile Movement disorder Fatigue Hemiplegia Influenza like illness Intensive care Nausea Pyrexia Unresponsive to stimuli Vomiting

Symptomtext

Day after receiving injection patient experienced flulike symptoms for 13 days. Fatigue, nasuea, vomiting, fever, dizziness, lack of appetite. April 25 approximately 530 am he experienced first stroke Discovered in home unresposive by his son Ambulance called admitted to Medical Center. April 28 he experienced second stroke while hospitalized. Transfered to a step down unit on April 28 a few hours later nurse discovered patient nonresponsive He had experienced a second stroke and had to have emergency craniotomy and attendant surgeries ICU for several days following surgery. Remained for 72 days. July 6 he was transferred where he remains today. Total right side paralysis. Unable to speak.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 72,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2096692

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: WA
Alter: 92,0
Geschlecht: F
Eingang: 08.02.2022
Impfdatum: 27.09.2021
Beginn: 04.02.2022
Tage bis Beginn: 130,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Cardiac failure congestive Chronic obstructive pulmonary disease Condition aggravated SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 1/21/21 (lot # EL3302), 2/10/21 (lot # EN6201), and 9/27/21 (unknown lot #, data from pharmacy per file). On 2/1/22, patient admitted to our inpatient facility with acute hypoxic respiratory failure secondary to possible community acquired pneumonia, COPD exacerbation, and CHF exacerbation. She also tested positive for COVID on 2/4/22 during admission. As of today (2/8/22), patient is still admitted in our med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: COVID status positive 2/4/22.
Aktuelle Erkrankungen: -
Vorgeschichte: HFpEF, COPD, asthma, and CKD
Andere Medikamente: acetaminophen, albuterol inh, atenolol, ciclesonide inh, doxylamine, levothyroxine, omeprazole, triamterene/hydrochlorothiazide
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2095552

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: TX
Alter: 56,0
Geschlecht: M
Eingang: 08.02.2022
Impfdatum: 30.04.2021
Beginn: 04.02.2022
Tage bis Beginn: 280,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Bradycardia COVID-19 Cardiac failure congestive Cardio-respiratory arrest Death Diarrhoea Dyspnoea Echocardiogram abnormal Endotracheal intubation Intensive care Resuscitation SARS-CoV-2 test positive Ventricular arrhythmia

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/9/2021 and 4/30/2021. Presented to ED on 2/4/2022 with diarrhea and SOB after testing positive for COVID on 2/1. Admitted for acute hypoxemia respiratory failure due to Covid19. Transferred to the ICU 2/5/22, on the morning of 2/6/22 his condition worsened. He required intubation and developed bradycardia followed by some ventricular arrhtythmias that required CPR. Stat TTE demonstrated severe biventricular failure and coded several more times over the course of the morning and expired on 2/6/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: Positive COVID-19 on 2/1/2022 using the Hologic Panther platform using PCR or equivalent Nucleic Acid Amplification(NAA) technology.
Aktuelle Erkrankungen: -
Vorgeschichte: CKD, COPD, Hypertension, Kidney transplant, hyperlipidemia, Morbid obesity, Sleep apnea, PVD, Type2 DM
Andere Medikamente: Atorvastatin, Clopidogrel, Furosemide, Hydralazine, Novolog pump, Isosorbide mononitrate, methocarbamol, metoclopramide, metoprolol, mycophenolate, Neoral, Prednisone, Ranolazine, Tramadol, Zolpidem, Dulaglutide, Humalog, Nitroglycerin, Vit
Allergien: Penicillin, Cefepime
Vorherige Impfungen: -

VAERS 2201242

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 10.03.2021
Beginn: 31.01.2022
Tage bis Beginn: 327,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death

Symptomtext

Narrative: 85yo male patient died inpatient on 1/31/2022. Death was caused by: complications from recent cardiac arrest. Pt had received one covid vaccine (J&J) on 3/10/2021 from nonfacility site. This death is not related to the covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2201232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 01.03.2021
Beginn: 15.01.2022
Tage bis Beginn: 320,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ascites Death Hepatic mass Inappropriate schedule of product administration

Symptomtext

Narrative: 83yo male self-presented to emergency facility on 1/4/22 to Hospital. Chief complaint: Ascites Reporter informed pt died on 1/15/2022. Location & cause of death unknown. Pt had received covid vaccines on 2/22/21 & 3/1/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration. Pt's problem list below: PROBLEM LAST MOD PROVIDER Liver mass 09/17/2021 History of adenomatous polyp of colon 2006; 3/2011- 1 polyp; 10/16- 2 polyps Male hypogonadism Cervical radiculopathy; Herpes Zoster * Retinal Detachment, Onset 06/22/2010 06/22/2010 Right eye; Type 2 diabetes mellitus 11/10/2015 without complication; Essential hypertension; Hyperlipidemia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2201230

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 26.02.2021
Beginn: 14.01.2022
Tage bis Beginn: 322,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Inappropriate schedule of product administration

Symptomtext

Narrative: 80yo male patient who was receiving home health through facility community care patient died on 1/14/2022. Cause and location of death unknown. had received covid vaccines on dose #1 at facility on 1/15/21 and dose #2 at HD on 2/26/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration. See patient's facility problem list below: PROBLEM LAST MOD PROVIDER Hypothyroidism (SCT 40930008) (ICD-10-CM E03.9) 07/14/2021 Edema (SCT 267038008) ICD-10-CM R60.9) 04/12/2021 Urinary incontinence (SCT 165232002) (ICD-10-CM 06/09/2020 R32.) Polyneuropathy (SCT 42345000) (ICD-10CM G62.9) 12/13/2019 Spinal stenosis of lumbar region (SCT 18347007) 09/25/2019 (ICD-10-CM M48.062) Benign prostatic hypertrophy with outflow 06/17/2018 obstruction (SCT 236646007) (ICD-10-CM N40.1) Diabetes mellitus (SCT 73211009) (ICD-10-CM 05/18/2017 E11.9) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 05/18/2017 History of malignant neoplasm of prostate (SCT 05/18/2017 428262008) (ICD-10-CM Z85.46) Allergic rhinitis (SCT 61582004) (ICD-10-CM 05/18/2017 J30.89)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2201202

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 03.03.2021
Beginn: 15.01.2022
Tage bis Beginn: 318,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Inappropriate schedule of product administration

Symptomtext

Narrative: 72yo male patient died at home on 1/15/2022. Pt was in in home health care. Per notes pt was on home oxygen for pulmonary disease. See problem list below. PROBLEM LAST MOD PROVIDER Heavy cigarette smoker (20-39 cigs/day) (SCT 08/13/2020 160605003) (ICD-10-CM F17.210) Secondary malignant neoplasm of intrathoracic 06/24/2019 lymph nodes (SCT 94351005) (ICD-10-CM C77.1) Coronary arteriosclerosis (SCT 53741008) 06/06/2019 (ICD-10-CM I25.10) Malignant neoplasm of lower lobe, bronchus or 06/29/2016 lung (SCT 187868006) (ICD-10-CM C34.31) Multiple nodules of lung (SCT445249002) 12/07/2015 (ICD-10-CM R91.8) (ICD-9-CM 716.90); Arthritis* (ICD-9-CM 716.90) 06/08/2010 (ICD-10-CM M54.2); Cervical radiculopathy 05/13/2019 (CT 54404000) (ICD-9-CM 278.00); Overweight * (ICD-9-CM 06/16/2009 278.00) (ICD-9-CM 780.52; Insomnia * (ICD-9-CM 780.52) 03/27/2008 (ICD-9-CM 724.2); LOWER BACK PAIN, 01/14/2002 CHRONIC/LUMBAGO (ICD-9-CM V62.9); PSYCHOSOCIAL PROBLEMS 01/14/2002 (ICD-I-CM 496.); COPD 01/14/220 (ICD-10-CM E78.5); Hyperlipidemia (CT 05/13/2019 55822004) (ICD-9-CM 443.9); PERIPHERAL VASCULAR DIS NOS 01/14/2002 Degeneration of cervical intervertebral disc 04/03/2000 (ICD-9-CM 722.4) Pt had received covid vaccines on 1/24/21 & 3/3/21 from facility. Pt had recently transferred care from elsewhere. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2203758

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 05.02.2022
Impfdatum: 13.08.2021
Beginn: 08.01.2022
Tage bis Beginn: 148,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 83yo male patient died on 1/8/2022 at home in home hospice care. with the following: Medical Hx: Alzheimer's dementia, vascular dementia, moderate valvular aortic stenosis, HTN, HLD, BPH, iron deficiency anemia, peripheral vascular disease, esophagitis, Rectal cancer s/p Lower Ant. Resection (2003) and ileostomy closure (2004), LUL carcinoma s/p wedges 2007 then lobectomy 2009. Surgical Hx: Lower Ant. Resection 2003, ileostomy closure 2004, Fem-Fem bypass 2006, LUL VATS Wedge 2007 and LUL Lobectomy 2009, OU IOLs 2021 Pt had received covid vaccines at non facility site on 7/14/21 & 8/13/21. This pt's death appears to not be related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2215726

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 19.08.2021
Beginn: 12.01.2022
Tage bis Beginn: 146,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 70yo male patient died while on vacation on 1/12/2022. No information given about cause of pt's death. Pt had received covid vaccines from pharmacy on 1/23/21, 2/13/21, & 8/19/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations. Past Medical History: Hyperkalemia RA - Rheumatoid Arthritis Allergic rhinitis Chronic kidney disease stage 2 Complaining of erectile dysfunction Benign hypertension Hyperlipidemia Overactive bladder Benign prostatic hypertrophy without outGastroesophageal reflux disease Anemia Bilateral carotid artery stenosis Thoracic aortic aneurysm without ruptureChronic low back pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2215724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 14.01.2021
Beginn: 05.01.2022
Tage bis Beginn: 356,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 79yo male patient who had not received medical care since 2013 died on 1/5/2022 of unknown cause. Pt had received a covid vaccine on 1/14/2021. Likely pt's death is not related to covid vaccines given pt's advanced age and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206344

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 02.09.2021
Beginn: 27.12.2021
Tage bis Beginn: 116,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 91yo with CURRENT PROBLEM LIST: Vitreous Detachment/Degeneration (PVD) Actinic Keratosis Personal History of BCC/SCC Pain in joint involving forearm (ICD-9-CM 719.43) Attention- Deficit/Hyperactivity DisorderSprain (ICD-9-CM 599.7) Nephrolithiasis (ICD-9-CM 592.0) CA PROSTATE SKIN LESION CAD HYPERLIPIDEMIA HYPERTENSION died at outside community hospital on 12/27/2021. Pt had received 3 covid vaccines on 1/15/21, 2/12/21, & 9/2/21. Circumstances of pt's death not known. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2203700

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 13.08.2021
Beginn: 08.01.2022
Tage bis Beginn: 148,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 83yo male patient died on 1/8/2022 at home in home hospice care. with the following: Medical Hx: Alzheimer's dementia, vascular dementia, moderate valvular aortic stenosis, HTN, HLD, BPH, iron deficiency anemia, peripheral vascular disease, esophagitis, Rectal cancer s/p Lower Ant. Resection (2003) and ileostomy closure (2004), LUL carcinoma s/p wedges 2007 then lobectomy 2009. Surgical Hx: Lower Ant. Resection 2003, ileostomy closure 2004, Fem-Fem bypass 2006, LUL VATS Wedge 2007 and LUL Lobectomy 2009, OU IOLs 2021 Pt had received covid vaccines at nonfacility site on 7/14/21 & 8/13/21. This pt's death appears to not be related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2202355

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 97,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 19.02.2021
Beginn: 12.12.2021
Tage bis Beginn: 296,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 95yo male died on 12/12/2021 of unknown cause. Pt in assisted living (outside facility) for dementia. Pt with hx of: Bilateral hearing loss (SCT 95820000) Hyperlipidemia (SCT 55822004) & Benign hypertension (SCT 10725009). Pt had received covid vaccines outside facility on 1/29/21 & 2/19/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2088661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: WA
Alter: 90,0
Geschlecht: F
Eingang: 04.02.2022
Impfdatum: 21.10.2021
Beginn: 02.02.2022
Tage bis Beginn: 104,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure acute Chronic obstructive pulmonary disease Condition aggravated Left ventricular failure SARS-CoV-2 test positive Septic shock Urosepsis

Symptomtext

Patient received Pfizer COVID vaccine on 2/25/21 (lot #EL9266), 3/19/21 (lot # ER2613), and 10/21/21 (unknown lot #, received at a health Care Center, lot # not in state database). Patient tested positive for COVID on 1/31/22. On 2/2/22, patient admitted to our inpatient facility with septic shock, urosepsis, acute on chronic respiratory failure secondary to COVID-19, COPD exacerbation, and acute on chronic diastolic heart failure, and COVID19 pneumonia. As of today (2/4/22), patient is still admitted in the med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: COVID status positive 1/31/22.
Aktuelle Erkrankungen: -
Vorgeschichte: chronic diastolic heart failure, paroxysmal atrial fib on apixaban, COPD with chronic respiratory failure with hypoxia (on home 2LNC)
Andere Medikamente: acetaminophen PRN, albuterol inh, apixaban, vitamin c, bisacodyl, docusate, ferrous sulfate, fluticasone nasal sp, lactobacillus, magnesium hydroxide, magnesium oxide, melatonin, metoprolol er, mvi w/iron and minerals, potassium chloride cr
Allergien: ciprofloxacin, oxaprozin
Vorherige Impfungen: -

VAERS 2594427

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 10.03.2021
Beginn: 08.01.2022
Tage bis Beginn: 304,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bradycardia Cardiogenic shock Chest tube insertion Death Feeding disorder Hypotension Multiple organ dysfunction syndrome Pleural effusion Pneumonia Resuscitation Septic shock

Symptomtext

Narrative: 79yo male patient in home health contacted facility to inform pt had died at outside facility on 1/8/22. See info below about pt's death from provider's chart noted dated 1/10/22 which came from non-facility medical record: "Date of Service: 12/26/2021-1/8/2022 Name of Facility: Inpatient reason for hospitalization pleural effusion, septic shock, hospital acquired pneumonia, pleux catherer placed 12/28/2021, continued antibiotics withotu improvement, not much drainage from catheter, persistent hypotension treated albumin, midrodrine, phenylephrine drip for days, could not eat or tolerate tube feeds egd/peg exchanee 1/3/2022 unfortunately multisystem organ failure, despite maximal resuscitative efforts began bradycardia arrhythmias, family elected to make him dnr comfort care, passed peacefully with family and several hospital staff, cause of death refractory cardiogenic shock 1/8/2022 8:46am "Pt had received covid vaccines from non-facility site on 2/9/21 & 3/10/21. Likely pt's death is not related to covid vaccines given pt's advanced age, information about pt's death provided, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2228158

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 17.02.2021
Beginn: 15.10.2021
Tage bis Beginn: 240,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Cough Death Dyspnoea Encephalopathy Enterococcal infection Laboratory test Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: PATIENT WAS VACCINATED WITH MODERNA MRNA VACCINE OUTSIDE OF THE HOSPITAL IN TIMELY MANNER 1/20 AND 2/17 RESPECTIVELY. PATIENT LIVED IN LTCF WITH MULTIPLE HEALTH COMPLICATIONS INCLUDING ESRD POST RENAL TRANSPLANT. PT WAS DIAGNOSED WITH COVID AT HIS FACILITY ON 10-15 AND WAS BROUGHT TO THE HOSPITAL WITH PROGRESIVE SYMPTOMS OF FEVER, NON PRODUCTIVE COUGH, DYSPNEA HE WAS FOUND TO BE ENCEPHALOPATHIC BY NURSING STAFF AND 02 SATS WERE IN MID 80S WHICH PROMTED VISIT TO HOSPITAL ED. PT REQUIRED SUPPLEMENTAL 02 OF UP TO 15 LITERS DURING STAY. PT SUFFEREED FROM COVID- PNEUMONIA AND ENTEROCOCCUS FAECIUM DURING HOSPITAL STAY. PATIENT SUCCUMBED TO INFECTION AND PASSED AWAY 10-16-21 CAUSE OF DEAHT COVID-PNEUMONIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: PATIENT WAS DIAGNOSED WITH COVID 10-15 AT THEIR LTCF, LABS REPEATED AT HOSPITAL 10-20 WITH POSITIVE BIOFIRE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2227966

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 12.02.2021
Beginn: 12.01.2022
Tage bis Beginn: 334,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Blood loss anaemia Cellulitis Condition aggravated Death Osteomyelitis Peripheral arterial occlusive disease

Symptomtext

Narrative: 85yo male Pt left community care skilled home health services to go to hospice care at non facility on 1/12/2022. Pt then died on 1/12/2022 at inpatient hospice facility (Hospital). Pt's problem list: PROBLEM LAST MOD PROVIDER Anemia due to blood loss 07/29/2021 (ICD-9-CM D64.9) AF - Atrial fibrillation 05/20/2021 (ICD-10-CM I48.91) Acute osteomyelitis of foot 04/01/2021 (ICD-10-CM M86.172) Atherosclerosis of bypass graft of left lower 03/18/2021 R limb (ICD-10-CM I70.345) Cellulitis of left foot 03/16/2021 (ICD-10-CM L03.116) Dehiscence of internal surgical wound 07/16/2020 (ICD-10-CM T81.32XS) Neuropathy due to diabetes mellitus 07/16/2020 (ICD-10-CM E11.40) Congestive heart failure 04/09/2020 (ICD-10-CM I50.32) Diabetic ulcer of left foot due to diabetes 12/30/2019 mellitus type 2 (ICD-10-CM 12/30/2019 M86.672) Infection due to Pseudomonas aeruginosa 05/30/2019 (ICD-10-CM B96.5) History of occlusive disease of artery of lower 08/03/2017 extremity (ICD-10-CM I73.89) Nail dystrophy due to trauma 06/29/2017 (ICD-10-CM L62.) Pain co-occurrent and due to varicose veins of 01/05/2017 bilateral legs (ICD-10-CM I83.813) Diabetic skin ulcer associated with type 2 12/05/2019 diabetes mellitus (ICD-10-CM E11.622) Abnormal findings on diagnostic imaging of lung 12/30/2015 (ICD-10-CM R91.8) Chronic painful diabetic neuropathy (ICD-10_CM E11.42) Laboratory Examination Ordered as part of a 01/05/2015 Routine General Medical Examination (ICD- 9-CM V72.62) Routine General Medical Examination at a Health 01/05/2015 Care Facility (ICD-9-CM V70.0) Vaccination required (ICD-9-CM 01/05/2015 V05.0) Peripheral vascular disease 05/18/2017 (ICD-10-CM M86.472) Coronary arteriosclerosis 04/09/2020 (ICD-10-CM I25.83) H.O: atrial fibrillation 01/20/2016 (ICD-10-CM I48.2) Iron deficiency anemia (ICD-10-CM 10/07/2020 D50.0) Acute suppurative arthritis due to bacteria (01/05/2015 (ICD-9-CM 711.00/041.9) Osteopenia (ICD-9-CM 733.90) 01/05/2015 Erectile dysfunction associated with type 2 12/11/2013 diabetes mellitus (ICD-9-CM 250.80/607.84) Obstructive chronic Bronchitis with Acute 02/15/2019 Bronchitis (ICD-10-CM J44.9) (ICD-9-CM 285.9); Anemia*(ICD-9-CM 285.9) 04/25/2012 (ICD-10-CM I48.0); Atrial fibrillation 07/20/2016 CT 49436004 (ICD-9-CM 427.31); Atrial Fibrillation * 09/08/2009 (ICD-9-CM 427.31) (ICD-9-CM 780.79); Other Malaise and Fatigue 03/11/2009 (ICD-9-CM 780.79) (ICD-9-CM 700); Callus (ICD-9-CM 700.) 03/12/2008 (ICD-10-CM E78.5); Hyperlipidemia CT 02/15/2019 (ICD-9-CM 682.7); Cellulitis and abscess of 11/05/2007, foot, except toes (ICD-9-CM 682.7) (ICD-10-CM E11.622); Neuropathic diabetic ulcer 12/12/2019 R - foot (CT 201251005) (ICD-9-CM 110.9); Tinea * (ICD-9-CM 110.9) 07/23/2007 (ICD-10- CM N40.0); Benign prostatic hyperplasia 04/09/2020 (CT 266569009) (ICD-9-CM 300.09) (ICD-9-CM 789.00); Abdominal Pain * (ICD-9-CM 01/18/2007 789.00) (ICD-9- CM 250.00); Diabetes Mellitus without 11/07/2006 mention of Complication, type II or unspecified type, (ICD-9-CM 719.46) (ICD- 9-CM 355.9); Neuropathy (ICD-9-CM 355.9) 10/27/2006 (ICD-9-CM 250.60); Diabetes with neurological 04/19/2006 Manifestations, type II or unspecified type, not stat (ICD-9- CM 716.90); Arthritis * (ICD-9-CM 716.90) 10/20/2005 (ICD-9-CM 692.9); Dermatitis * (ICD-9-CM 692.9) 04/01/2005 (ICD-9-CM 727.43) (ICD-9-CM 724.2); Chronic low back pain 02/20/2004 (ICD-9-CM 592.0); Kidney Stone (ICD-9- CM 592.0) 02/20/2004 (ICD-9-CM 707.15); Ulcer of other part of Foot 07/07/2003 (ICD-9-CM 707.15) (ICD-9-CM 041.86); Helicobacter Pylori (07/25/2002) Infection (ICD-9-CM 041.86) (ICD-9-CM 530.81) 07/25/2002 (ICD-9-CM 271.3); Glucose Intolerance 04/02/2002 (ICD-9-CM 171.4); Abdominal aortic aneurysm 02/15/2019 (CT 233985008) (ICD-9-CM 995.3); Allergies * (ICD-9-CM 995.3) 03/18/2002 (ICD-9-CM 355.9); Peripheral Neuropathy 03/18/2002 (ICD-9-CM 355.9) (ICD-9-CM 465.9); URI (ICD-9-CM 465.9) 08/31/2001 (ICD-9-CM 477.9); RHINITIS (ALLERGIC) 02/26/2001 Need for Prophylactic Vaccination and 11/22/2000 Inoculation Against Influenza (ICD-9-CM V04.8) Chronic ischemic heart disease (ICD-9-CM 414.9) 08/28/2000 Other and unspecified hyperlipidemia 01/20/2016 (ICD-9-CM E11.21) Essential Hypertension (ICD-10-CM 07/20/2016 I10.) Pt had received covid vaccines on 1/15/2021 & 2/12/2021 from hospital site. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2085957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: KY
Alter: 86,0
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 30.08.2021
Beginn: 02.01.2022
Tage bis Beginn: 125,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anxiety Aortic valve incompetence COVID-19 COVID-19 pneumonia Computerised tomogram thorax abnormal Constipation Cough Echocardiogram abnormal Hypertension Hypoxia Lumbar radiculopathy Lung opacity Mitral valve incompetence Muscle spasms Osteopenia Osteoporosis Pathological fracture

Symptomtext

86 year old female with pmh htn who was admitted for covid 19, acute respiratory failure. Please see h and p for details. The following issues were addressed: 1. Covid 19 virus infection/viral pneumonia - vaccinated - ct chest shows ground glass pulmonary infiltrates in a pattern highly suggestive of Covid 19 pneumonitis - status post remdesivir - received iv hydrocortisone, transitioned to iv decadron while in hospital - will discharge on oral decadron to complete course - continue zinc, vit c - needs repeat imaging as outpatient with pcp to ensure resolution 2. Viral sepsis (temp 95.7, respiratory rate 25), poa - afebrile > past 24 hours 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 4L with ambulation as determined by walking oximetry 4. Polymyalgia rheumatica - on prednisone at time of admission - resume 1/16/22 5. Hypertension, uncontrolled - continue hydralazine, metoprolol, lisinopril, hctz - continue prn clonidine as outlined below - patient to monitor blood pressure at home - record, bring to appointment with pcp/discuss with virtual hospital - may need further adjustment of medications as outpatient with pcp 6. Anxiety - started prn hydroxyzine as outlined below Dispo - PT recommends home health, will be arranged prior to discharge as well as virtual hospital START taking these medications Details benzonatate (TESSALON) 100 MG capsule Take 1 capsule by mouth 3 (three) times daily as needed for Cough. cloNIDine (CATAPRES) 0.1 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed (sbp >170 or dbp >100). dexamethasone (DECADRON) 6 MG tablet Take 1 tablet by mouth daily with breakfast Take last dose on 1/15/22. dextromethorphan polistirex ER (DELSYM) 30 MG/5ML liquid Take 5 mLs by mouth every 12 (twelve) hours as needed for Cough. hydroCHLOROthiazide (HYDRODIURIL) 12.5 MG tablet Take 1 tablet by mouth daily. hydrOXYzine (ATARAX) 10 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed for Anxiety. lisinopril (PRINIVIL) 40 MG tablet Take 1 tablet by mouth daily. sennosides (SENOKOT) 8.6 MG TABS Take 1 tablet by mouth daily as needed (constipation). vitamin C (VITAMIN C) 500 MG tablet Take 1 tablet by mouth daily. zinc sulfate (ZINCATE) 220 (50 Zn) MG capsule Take 1 capsule by mouth daily. CONTINUE these medications which have CHANGED Details hydrALAZINE (APRESOLINE) 100 MG tablet Take 1 tablet by mouth every 8 (eight) hours. metoprolol, TOPROL-XL, 25 MG 24 hr tablet Take 3 tablets by mouth daily. predniSONE (DELTASONE) 1 MG tablet Take 6 tablets by mouth daily Resume 1/16/22. CONTINUE these medications which have NOT CHANGED B Complex CAPS Take 1 tablet by mouth daily. Calcium Citrate-Vitamin D (CALCIUM CITRATE + D PO) Take 1 tablet by mouth daily Cholecalciferol (VITAMIN D3) 2000 UNITS capsule Take 2,000 Units by mouth daily. FIBER ADULT GUMMIES PO Take by mouth daily ibandronate (BONIVA) 150 MG tablet Take 1 tablet by mouth every 30 (thirty) days. Associated Diagnoses: Age-related osteoporosis with current pathological fracture, initial encounter MAGNESIUM PO Take 1 tablet by mouth. Multiple Vitamin (MULTIVITAMIN) tablet Take 1 tablet by mouth daily. Omega-3 Fatty Acids (FISH OIL) 1000 MG CAPS Take 2,000 mg by mouth daily Arthritis NECK Frequent PVCs 06/2018 Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by biopsy. PATIENT DENIES THYROID ISSUES H/O cardiovascular stress test 7/2012 DR. History of chicken pox MEASLES, MUMPS AS A CHILD History of fracture RIGHT SMALL FINGER History of pleurisy 1/9/14 Hypertension Left bundle branch block (LBBB) 06/2018 Lumbar radiculopathy LVH (left ventricular hypertrophy) 06/2018 Echocardiogram mild mitral aortic regurgitation Mobitz type 1 second degree AV block 06/2018 Nocturnal leg cramps Obstructive sleep apnea Hypoxia uses CPAP Osteopenia PVC (premature ventricular contraction) 03/2017 Renal cell cancer (CMS/HCC) 2014 Varicose veins

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Arthritis NECK o Frequent PVCs 06/2018 o Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by
Andere Medikamente: START taking these medications Detailsbenzonatate (TESSALON)
Allergien: Codeine, Cardura, Morphine, Sulfa, Penicillin, Norvasc
Vorherige Impfungen: -

VAERS 2085147

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: MO
Alter: 76,0
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 04.03.2021
Beginn: 04.01.2022
Tage bis Beginn: 306,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthenia Atelectasis COVID-19 COVID-19 pneumonia Clostridium test negative Computerised tomogram thorax abnormal Diarrhoea Dyspnoea Encephalopathy Fatigue Flatulence Hypoxia Incontinence Intensive care Laboratory test normal Leukocytosis Lung opacity

Symptomtext

Date of Admission 01/04/2022 Date of Discharge 01/15/2022 Reason for Hospitalization pt husband "reports my wife had low oxygen saturation at urgent care today. my wife has also had increased weakness, shortness of breath and fatigue. Hospital Course Patient is a 77 year old female with past medical history significant for Alzheimer's dementia (A&Ox1-2, but able to perform ADLs), MV repair (3/2021), and chronic UI and UTIs (bladder stimulator, on TMP chronically) who presented to ED on 1/4 for hypoxia. She was positive for COVID in the ED, initially requiring 7L but quickly escalated to HHFNC and NIPPV. Acute hypoxic respiratory failure may be due to COVID, but given the fact that she is vaccinated and her quick escalation of oxygen needs in the setting of encephalopathy there was concern for aspiration pneumonia. She was started on ertapenem. She also had a positive MRSA nasal swab and was started on vancomycin. She reported diarrhea starting a few days prior to presentation and was incontinent, C dif and GI PCR grossly negative. She was in the ICU from 1/5-1/7 and then transferred to floor after transitioning to NC and at discharge patient was on RA and home oxygen evaluation was unremarkable for hypoxia with ambulation. Discharge Diagnoses Acute hypoxic respiratory failure Acute COVID pneumonia Acute Aspiration pneumonia-Concern for secondary bacterial pneumonia -resolved Leukocytosis, resolved -CT-PE 1/4 negative for PE, + for GGO in RML, RLL and bilateral subsegmental atelectasis -s/p Dexamethasone (1/5-1/12), remdesivir (1/5-1/9), -baricitinib (1/5-1/19) - 4 pills sent to pharmacy -s/p Vancomycin for MSRA+ (stop date 1/14) - s/p Ertapenem for pneumonia (1/7-1/11) * MICROBIOLOGY - Antimicrobials: Azithromycin 1/5-1/7 Ceftriaxone 1/5 Piperacillin-tazobactam 1/5-1/7 Vancomycin 1/5-p Ertapenem 1/7-1/11 Diarrhea - resolved -KUB 1/5 w/ nonobstructive bowel gas pattern -C. difficile and GI PCR panel negative. Chronic UTI -UA on admission negative for infection -held home Myrbetriq and TMP Alzheimer's Dementia Encephalopathy secondary to acute infection, resolved -continue home memantine -TSH low, FT4 WNL, T3 low Other Diagnoses Ongoing Alzheimer disease Anxiety and depression Aphthous ulcer Melanoma Migraine headache Osteoarthritis of hip Urge urinary incontinence Urinary, incontinence, stress female Historical Diarrhea Major neurocognitive disorder Consultants Medicine Pulmonary Discharge Disposition Home Medications New, Changed, or Refilled Medications baricitinib (baricitinib 2 mg) 4 mg, 2 Tablet(s), Oral, Daily, for 4 day(s), 8 Tablet(s), 0 Refill(s) benzonatate (benzonatate 100 mg) 100 mg, 1 capsule(s), Oral, tid, for 14 day(s), PRN: Cough, 20 capsule(s), 0 Refill(s) nystatin topical (nystatin 100,000 units/g topical cre 1 Application, Topical, tid, for 14 day(s), 15 g, 0 Refill(s) Medications to be Continued aspirin (aspirin 81 mg , chewable) mg, Tablet(s), Daily, 0 Refill(s) bacillus coagulans-inulin (Probiotic Formula (Bacillus 1 capsule(s), Oral, Daily, 0 Refill(s) memantine (memantine 10 mg) 10 mg, 1 Tablet(s), Oral, bid, for 30 day(s), 60 Tablet(s), 11 Refill(s) mirabegron (Myrbetriq (mirabegron) 25 mg , extended re 25 mg, 1 Tablet(s), Oral, Daily, for 30 day(s), 30 Tablet(s), 11 Refill(s) multivitamin, prenatal (MULTIVITAMIN, ADULT, STANDARD) 1 tablet, Oral, Daily, 0 Refill(s) triamcinolone topical (triamcinolone 0.1% topical crea See Instructions, APPLY 1 APPLICATION TOPICALLY TWICE A DAY, 30 g, 0 Refill(s) Instructions:APPLY 1 APPLICATION TOPICALLY TWICE A DAY trimethoprim (trimethoprim 100 mg) See Instructions, TAKE 1 TABLET DAILY BEDTIME, 90 Tablet(s), 3 Refill(s) Instructions:TAKE 1 TABLET DAILY BEDTIME Addendum on January 22, 2022 11:24:09 CST (Verified) Attestation on January 22, 2022 11:24 I personally saw and evaluated the patient on the result date found in the header of this document. I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document. I agree with everything documented above with the following exceptions/additions: None

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: see adverse note
Aktuelle Erkrankungen: unknown
Vorgeschichte: History of Present Illness Patient is a 77-year-old female who presented to the ED 1/4 for 3 day history of diarrhea, fatigue, cough, SOB, sore throat, and muscle pain and 1 day history of increased somnolence. PMHx significant for dementia (A&O x1-2 but able to perform ADLs at b/l, on memantine), MV repair (3/2021), and chronic UI and UTIs (bladder stimulator, on TMP chronically).
Andere Medikamente: unknown
Allergien: sulfa drugs
Vorherige Impfungen: -

VAERS 2085141

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 54,0
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 08.03.2021
Beginn: 31.12.2021
Tage bis Beginn: 298,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Cardiac failure congestive Chills Cough Dizziness Dyspnoea Exposure to SARS-CoV-2 General physical condition abnormal Influenza like illness Nausea SARS-CoV-2 test positive

Symptomtext

Date of Admission 12/31/2021 Date of Discharge 01/01/2022 Reason for Hospitalization exposed to covid, having symptoms of chills, sovb, cough and nausea for 3 days. Hospital Course Patient is a 55-year-old female with medical history significant for hypertension who presented to the ER with chief complaints of lightheadedness and shortness of breath. Patient tested positive for COVID19 on 12/31/2021 and was started on dexamethasone and remdesivir. We are monitoring her oxygen status and weaning it as tolerated. [1] her condition improved overnight. Home oxygen evaluation was reassuring for no oxygen needed. patient will be discharged to complete 10 days of Decadron. instructed to come back if her symptoms gt worse Discharge Diagnoses 1. Flu-like symptoms 2. COVID-19 3. Acute hypoxemic respiratory failure Other Diagnoses Ongoing BMI 34.0-34.9,adult Hypertension Obesity Vapes nicotine containing substance Historical No qualifying data Discharge Disposition home Medications New, Changed, or Refilled Medications None Medications to be Continued aspirin (aspirin 81 mg , chewable) 81 mg, 1 Tablet(s), Daily, 0 Refill(s) azithromycin 0 Refill(s) Comments: to finish january 2 , 2022 diltiazem (dilTIAZem (Eqv-Cardizem CD) 360 mg/24 hours , extended release) 360 mg, 1 capsule(s), Oral, Daily, 0 Refill(s) hydroCHLOROthiazide (hydroCHLOROthiazide 25 mg) 25 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) losartan (losartan 100 mg) 100 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) Discontinued Medications None Physical Exam at Discharge Vitals & Measurements T: 36.4 ?C TMIN: 36.3 ?C TMAX: 36.8 ?C HR: 59 RR: 18 BP: 135/80 SpO2: 94% WT: 101 kg BMI: 34.9 General: Alert and appropriate Respiratory: Clear to auscultation bilaterally Cardiovascular: Normal Heart sounds, Regular rate/rhythm.No edema. Gastrointestinal: Soft, Non-distended, no organomegaly Musculoskeletal: Normal range of motion, No tenderness, No swelling Integumentary: Warm, Intact Neurologic: Awake, alert, oriented to time, place and person. No focal deficits Psychiatric: Cooperative, Appropriate mood & affect Time Spent I personally spent 31 minutes coordinating discharge including final face to face visit with patient and family, discharge medication reconciliation, instructions for continuing care and discharge summary Nursing/Other Orders Regular Diet. Ordered on 12/31/21 19:03:00 CST, Meal Start Time Supper 1615 to 1745 Intake and Output. 12/31/21 16:30:29 CST, Continuous Order, q12h. Order comment: Ordered by system rule: ORD_ADD_CHF_TASKS based on indications for congestive heart failure. Intake and Output. 12/31/21 19:03:00 CST, Continuous Order Activity As Tolerated. 12/31/21 19:03:00 CST, Continuous Order, activity as tolerated with patient confined to room. Code Status. Code Status Description: Full Code [1] Admission H & P; 12/31/2021 18:02 CST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: see adverse note
Aktuelle Erkrankungen: unknown
Vorgeschichte: History of Present Illness Patient is a 55-year-old female with medical history significant for hypertension who presented to the ER with chief complaints of lightheadedness and shortness of breath.
Andere Medikamente: unknown
Allergien: nka
Vorherige Impfungen: -

VAERS 2085134

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 60,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 23.08.2021
Beginn: 20.12.2021
Tage bis Beginn: 119,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood creatinine increased COVID-19 pneumonia Compression garment application Condition aggravated Dyspnoea Epistaxis Glycosylated haemoglobin increased Hyperkalaemia Hypertension Hypophosphataemia Infection Metabolic acidosis Pneumonia bacterial Renal impairment Renal injury Vitamin D decreased

Symptomtext

Date of Admission 12/30/2021 Date of Discharge 01/08/2022 - INTERNAL MEDICINE Reason for Hospitalization Shortness of breath Hospital Course Patient was admitted for acute hypoxic respiratory failure secondary to COVID-pneumonia requiring supplemental oxygenation. He was initially on 4 L of supplemental oxygenation. Started on steroids. Held tocilizumab or baricitinib or remdesivir given CKD status with history of renal transplant. ID consulted and agreed to hold off on COVID-related therapies other than steroids. He was also treated with 5-day course of Levaquin for secondary bacterial pneumonia as well. Nephrology consulted for AKI on CKD in the setting of renal transplant. His antirejection medications were adjusted (CellCept was held, tacrolimus was reduced in dose, and prednisone was switched to dexamethasone) as per nephrology recommendations. Allopurinol was renally dosed. His AKI slowly improved but he also had hyperkalemia in the setting of renal injury. Hyperkalemia was treated with Lokelma administration with eventual resolution by discharge day. Metabolic acidosis was treated with sodium bicarb supplementation per nephrology. Vitamin D levels were low despite of being on vitamin D supplementation. It was increased to vitamin D3 2000 units daily. Renal function returned to baseline. As a result of systemic steroids, he had hyperglycemia and hypertension. Hypertension was managed with restarting his amlodipine and continuation of carvedilol. Lisinopril was held due to hyperkalemia. Basal bolus insulin therapy was utilized for hyperglycemia. A1c was 7.5 however in the setting of acute infection and steroid use unsure whether this is an accurate measurement. His previous A1c's remained within prediabetic range. As we stopped his steroids by discharge today, we anticipated that his hyperglycemia will also get better. He was given supplies to measure his glucose at home and will see endocrinology outpatient. Nephrology recommended decreased dose of tacrolimus and decreased dose of CellCept at discharge. He was also switched back to his home prednisone as part of antirejection therapy. He will all follow-up with renal transplant clinic in 1 week for repeat labs and assessment of renal function. Home O2 eval showed that he would require 3 L of oxygen during ambulation. Discharged home with home O2 to follow-up with outpatient renal transplant clinic and endocrinology. Of note his PCP is listed as renal transplant physician. Discharge Diagnoses Acute hypoxic respiratory failure 2/2 combination of COVID viral pneumonia and possible multifocal bacterial pneumonia Vaccinated but immunosuppressed s/p renal transplant Possible multifocal pneumonia s/p levofloxacin History of ESRD s/p renal transplant, now CKD (baseline creatinine 1.7-2.0) AKI on CKD, resolved s/p renal transplant 2/2 APDKD on immunosuppression Hypophosphatemia Hyperkalemia, resolving Normal anion gap metabolic acidosis Hyperglycemia 2/2 systemic steroids HTN Gout Epistaxis Other Diagnoses Ongoing BMI 33.0-33.9,adult Obesity Historical No qualifying data ESRD on HD Prediabetes Consultants Medicine Nephrology Discharge Disposition Home Medications New, Changed, or Refilled Medications Glucose Meter 1 Each, Blood Test, qAM, 1 Each, 0 Refill(s) Glucose Test Strips 1 Each, Blood Test, qAM, 25 Each, 13 Refill(s) Lancets 1 Each, Blood Test, qAM, 100 lancet, 3 Refill(s) albuterol (albuterol HFA 90 180 mcg, 2 Puff, Inhalation, q6h, for 30 day(s), 1 Each, 0 Refill(s) allopurinol (allopurinol 100 50 mg, 0.5 Tablet(s), Oral, q"other"Day, for 30 day(s), 7.5 Tablet(s), 0 Refill(s) benzonatate (benzonatate 100 100 mg, 1 capsule(s), Oral, q12h, for 5 day(s), PRN: Cough, 10 capsule(s), 0 Refill(s) cholecalciferol (Vitamin D3 5 50 mcg, 1 Tablet(s), Oral, Daily, for 30 day(s), 30 Tablet(s), 0 Refill(s) guaiFENesin (guaiFENesin 600 600 mg, 1 Tablet(s), Oral, bid, for 7 day(s), 14 Tablet(s), 0 Refill(s) mycophenolate mofetil (mycoph 500 mg, 1 Tablet(s), Oral, Daily, for 30 day(s), 30 Tablet(s), 0 Refill(s) tacrolimus (Prograf 1 mg) 4 mg, 4 capsule(s), Oral, qAM, 120 capsule(s), 0 Refill(s) tacrolimus (tacrolimus 1 mg) 3 mg, 3 capsule(s), Oral, At Bedtime, 90 capsule(s), 0 Refill(s) Medications to be Continued amLODIPine (amLODIPine 5 mg) 5 mg, 1 Tablet(s), Oral, bid, 60 Tablet(s), 0 Refill(s) carvedilol (carvedilol 25 mg) 25 mg, 1 Tablet(s), Oral, bid, 120 Tablet(s), 0 Refill(s) cinacalcet (cinacalcet 90 mg) 90 mg, 1 Tablet(s), Oral, Daily, care of privacy, 60 Tablet(s), 0 Refill(s) Instructions:care of privacy predniSONE (predniSONE 5 mg) 5 mg, 1 Tablet(s), Oral, Daily, for 90 day(s), 90 Tablet(s), 3 Refill(s) Discontinued Medications diazepam (Valium 5 mg) See Instructions, 1 Tablet(s) Oral 30 min prior to MRI. will need driver home, 1 Tablet(s), 0 Refill(s) lisinopril (lisinopril 20 mg) 20 mg, 1 Tablet(s), Oral, bid, 60 Tablet(s), 0 Refill(s) Physical Exam at Discharge General: Alert, conversational, in no acute distress HEENT: Normocephalic, atraumatic head Cardiovascular: RRR Respiratory: CTAB. No wheezing GI: Soft, non tender MSK: Absent lower extremity pitting edema (wearing compression stockings) Derm: Warm and dry skin Neuro: No focal neurological deficits Time Spent Spent >35 minutes discussing discharge plan Addendum by HCP on January 10, 2022 07:36:13 CST (Verified) Attestation by HCP on January 10, 2022 07:36 I personally saw and evaluated the patient on the result date found in the header of this document. I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document. I agree with everything documented above with the following exceptions/additions: Spent a lot of time regarding possibliity of diabetes and the importance of long term control and repeat measurements of his A1c to eval given his history of prediabetes. Management of renal rejection meds adjusted as per neph recs. D/C with home oxygen and home glucose monitoring. Close f/u with nephro.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: see adverse note
Aktuelle Erkrankungen: unknown
Vorgeschichte: History of Present Illness Patient is a 59 yo male for past 2 years to coach track (coach), DDRT 10/10/2016 for ESRD 2/2 ADPKD, HTN, and gout presented to the ED after his Nephrologist recommended to come in for his COVID PNA.
Andere Medikamente: unknown
Allergien: nkma
Vorherige Impfungen: -

VAERS 2084919

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MO
Alter: 67,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 08.09.2021
Beginn: 26.12.2021
Tage bis Beginn: 109,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Affective disorder Atelectasis Blood electrolytes Blood gases Blood lactate dehydrogenase C-reactive protein COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Coagulation test Condition aggravated Cough Depression Diarrhoea Dyspnoea Dyspnoea at rest

Symptomtext

Chief Complaint Pt seen earlier tonight but left AMA at 0200. Pt checking back in for increased work of breathing and SOB. History of Present Illness This is a 67 y/o male with history of COPD (baseline 5L NC), CAD s/p CABG/multiple PCI (most recent PCI May 2021), recurrent Vtach s/p ICD, HFpEF, DMT2, obesity, OSA who presents with 4 days of worsening dyspnea, cough, and diarrhea (sx onset 12/23). Tested positive for COVID 12/26 in ED. Is triple vaccinated against COVID. At time of exam, was requiring 75% FiO2 35L. Feels less short of breath now. Admits to some subjective fevers at home. Normally is able to walk to other room without dyspnea, but not up stairs. Prior to admission, says he had been feeling short of breath at rest also. Review of Systems Constitutional: +fever Skin: No rashes or lesions. Eye: No visual problems ENT: No ear pain, sore throat, or nasal congestion. Resp: +cough +shortness of breath CV: No chest pain. GI: No abdominal pain. +diarrhea GU: No dysuria or hematuria. MSK: No back pain. Neuro: No headache. No numbness/tingling/weakness. Psych: No anxiety. All systems otherwise negative. ROS reviewed as documented in chart. Physical Exam Vitals & Measurements T: 36.6 ?C TMIN: 36.3 ?C TMAX: 36.6 ?C HR: 86 RR: 8 BP: 158/82 SpO2: 94% WT: 126 kg BMI: 42.6 General Appearance: large body habitus, lying in bed, no acute distress HENT: Normocephalic, atraumatic. No nasal discharge. Moist mucous membranes. Neck is supple, midline trachea. Eyes: PERRL, EOMI. No conjunctival injection, discharge, or periorbital edema. Cardiac: RRR, S1 and S2 present without murmurs. No peripheral edema. Good peripheral perfusion. Respiratory: Mild bilateral rhonchi. Symmetrical chest expansion, good respiratory effort. Abdomen: BS +, soft, nontender. MSK: No significant deformity or edema. Peripheral pulses intact. Neuro: CN II-XII grossly intact. Alert, no focal deficits. Skin: No rashes, lesions, or eruptions. Psych: Appropriate affect, cooperative. Assessment/Plan This is a 67 y/o male with history of COPD (baseline 5L NC), CAD s/p CABG/multiple PCI (most recent PCI May 2021), recurrent Vtach s/p ICD, HFpEF, DMT2, obesity, OSA admitted to the hospital for acute hypoxic respiratory failure secondary to COVID-19 requiring high flow oxygen. Triple vaccinated. Sx onset 12/23. + test 12/26. Checking inflammatory markers. Afebrile, no leukocytosis. Treating with remdesivir, dexamethasone. Neuro #Depression #Mood disorder #Neuropathy - Continue half dose home Abilify 5mg daily - On very high home dose of Lyrica given renal function. Will do 150mg bid here. - Hold trazodone and venlafaxine Pulmonary #Acute hypoxic respiratory failure secondary to COVID-19 #COPD - Inflammatory markers pending: procal, ferritin, LDH, ESR, CRP - Dexamethasone 6mg daily (12/27-1/5) - Remdesivir (12/27-12/31) - Will decide on tocilizumab vs baricitinib pending inflammatory markers - Get baseline ABG - Sputum culture - Doppler venous US of LE to r/o DVT - Continue home bronchodilators Cardiac #CAD s/p CABG/stents #Recurrent Vtach s/p ICD #HFpEF - Continue home bumex 6mg tid - Continue home spirinolactone 25mg daily - Continue plavix 75mg daily - Continue half home dose carvedilol: 12.5mg bid - Hold home chlorthalidone, lisinopril - Continue atorvastatin - Hold Eliquis, start heparin subcutaneous ppx - Check PT/INR/PTT Renal #Chronic kidney disease, stage 3A (baseline Cr ~1.3-1.5) - BMP pending - Monitor electrolytes GI - Protonix ppx while on steroids - Doc/senna prn, was having diarrhea on admission Endo #Diabetes mellitus type 2, insulin dependent at home - On 58u basal insluin at home, will start on 40u here and likely need to increase with steroid use - SSI for now, will adjust once he starts eating ID - Initially has no leukocytosis, afebrile - Will obtain blood, sputum cultures Heme/Onc - No acute concerns Dispo: SICU (on pulm service) Diet: NPO DVT PPx: heparin subcu Code Status: Full Patient staffed with attending physician Dr. (Privacy) Addendum by MD, (Privacy) on December 27, 2021 21:21:52 (Verified) I saw and evaluated the patient. I discussed the management with the resident and the hospital Team. I reviewed the resident's note above and agree with the documented findings and plan of care with the following clarifications/additions: 67 yo male with COVID 19 Pneumonia: vaccinated, sx of worsening dyspnea and GI symptoms Acute on chronic Hypoxic resp failure requiring HFNC COPD with severe obstruction Chronic res failure on home O2 CAD S/P CABG, S/P Stents S/P ICD on AC with eliquis did not take doses yesterday Baseline can walk to kitchen and back cant walk up stairs Plan for repeat labs esp CMP, check coags, ABG, inflammatory markers then likely toci as rapid increase in fio2 requirements to HFNC, start dexamethasone and remdesevir, initiate dvt prophylactic dose heparin holding eliquis for now, PPI, reduce dose of home lyrica, hold trazodone and effexr for now, manage blood glucose levels with insulin, repeat CXR cc time > 35 minutes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: Reason For Exam hypoxia Report EXAMINATION: XR Chest Portable INDICATION: hypoxia VIEWS: 1 COMPARISON: Prior day chest radiograph. FINDINGS: Stable positioning of the left chest dual lead CIED. Median sternotomy wires and post-CABG changes. Stable enlargement cardiomediastinal silhouette. Improvement of the bilateral prominent interstitial opacities disease. Blunted left costophrenic angle. No pneumothorax. No acute osseous abnormalities. IMPRESSION: 1. Improved mild pulmonary interstitial edema. 2. Unchanged trace left pleural effusion with adjacent atelectasis. I have personally reviewed the images and attest to the contents of this report. Signature Line * * *Final Report* * * Electronically Signed by: MD, (Privacy) Signed on: 12/28/21 09:30
Aktuelle Erkrankungen: unknown
Vorgeschichte: This is a 67 y/o male with history of COPD (baseline 5L NC), CAD s/p CABG/multiple PCI (most recent PCI May 2021), recurrent Vtach s/p ICD, HFpEF, DMT2, obesity, OSA who presents with 4 days of worsening dyspnea, cough, and diarrhea (sx onset 12/23).
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2074964

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 90,0
Geschlecht: M
Eingang: 30.01.2022
Impfdatum: 09.02.2021
Beginn: 25.01.2022
Tage bis Beginn: 350,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Blood glucose normal COVID-19 COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Cerebrovascular accident Chest X-ray abnormal Computerised tomogram head abnormal Condition aggravated Echocardiogram Ejection fraction normal Fatigue Gastrooesophageal reflux disease Hyperglycaemia Hypertension Hypoxia

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient received Moderna vaccine (2nd dose in series) on 02/09/21. Patient was hospitalized from 01/25/22 - 01/27/22. Below is copied from discharge summary: Hospital Course: Patient is a 91 y/o M with Hx of chronic CHF, HTN, GERD and DM2 who presents with c/o fatigue x 1 day, found hypoxic at 86% requiring O2 via NC and meeting sepsis criteria in the setting of positive COVID 19. Furthermore with evidence of pleural effusions on Chest Xray and elevated pro bnp indicative of acute on chronic CHF exacerbation. Admitted as inpatient for further management. Sepsis with acute organ dysfunction/ Acute respiratory failure with hypoxia 2/2 COVID 19 PNA: -meeting sepsis criteria based on fever, tachycardia and source of infection -o2 at 95% on 2L NC -chest Xray showed small bil pleural effusions and atypical infection -elevated nflammatory markers- trending down -DVT ppx -started Decadron IV -statin started -symptom management with prn meds -Isolation Home exertion test- home oxygen delivered Acute on chronic CHF with bilateral pleural effusions: -pro BNP> 1.4 K -chest Xray: small bil effusions -start Lasix 20mg IV BID with holding parameters, soft BP -normal EF on ECHO HTN: -Currently soft BP -Albumin IV ordered -Hold coreg and ACE -IV BP meds prn Hyperglycemia 2/2 uncontrolled DM2: -Glucose> 190s -Resume metformin in 48 hrs, received contrast -SS and accuchecks Chronic CVA: -Seen incidentally in CT head -Resume asa -Start statin Fall: -PT eval -Fall precautions GERD: -Resume home ppi

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: SARS-COV-2, NAA, Detected: 01/25/22
Aktuelle Erkrankungen: -
Vorgeschichte: ? CHF (congestive heart failure) (CMS-HCC: 85) ? Diabetes mellitus (CMS-HCC: 19) ? Diverticulitis ? Enlarged prostate ? Hypertension
Andere Medikamente: aspirin 81 MG PO Tablet Chewable Information, Historical carvedilol (COREG) 3.125 MG PO Tablet by mouth. Information, Historical furosemide (LASIX) 20 MG PO Tablet by mouth. Information, Historical lisinopril (PRINIVIL,Z
Allergien: NKA
Vorherige Impfungen: -

VAERS 2074964

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: FL
Alter: 90,0
Geschlecht: M
Eingang: 30.01.2022
Impfdatum: 09.02.2021
Beginn: 25.01.2022
Tage bis Beginn: 350,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Blood glucose normal COVID-19 COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Cerebrovascular accident Chest X-ray abnormal Computerised tomogram head abnormal Condition aggravated Echocardiogram Ejection fraction normal Fatigue Gastrooesophageal reflux disease Hyperglycaemia Hypertension Hypoxia

Symptomtext

Patient was hospitalized due to breakthrough infection. Patient received Moderna vaccine (2nd dose in series) on 02/09/21. Patient was hospitalized from 01/25/22 - 01/27/22. Below is copied from discharge summary: Hospital Course: Patient is a 91 y/o M with Hx of chronic CHF, HTN, GERD and DM2 who presents with c/o fatigue x 1 day, found hypoxic at 86% requiring O2 via NC and meeting sepsis criteria in the setting of positive COVID 19. Furthermore with evidence of pleural effusions on Chest Xray and elevated pro bnp indicative of acute on chronic CHF exacerbation. Admitted as inpatient for further management. Sepsis with acute organ dysfunction/ Acute respiratory failure with hypoxia 2/2 COVID 19 PNA: -meeting sepsis criteria based on fever, tachycardia and source of infection -o2 at 95% on 2L NC -chest Xray showed small bil pleural effusions and atypical infection -elevated nflammatory markers- trending down -DVT ppx -started Decadron IV -statin started -symptom management with prn meds -Isolation Home exertion test- home oxygen delivered Acute on chronic CHF with bilateral pleural effusions: -pro BNP> 1.4 K -chest Xray: small bil effusions -start Lasix 20mg IV BID with holding parameters, soft BP -normal EF on ECHO HTN: -Currently soft BP -Albumin IV ordered -Hold coreg and ACE -IV BP meds prn Hyperglycemia 2/2 uncontrolled DM2: -Glucose> 190s -Resume metformin in 48 hrs, received contrast -SS and accuchecks Chronic CVA: -Seen incidentally in CT head -Resume asa -Start statin Fall: -PT eval -Fall precautions GERD: -Resume home ppi

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: SARS-COV-2, NAA, Detected: 01/25/22
Aktuelle Erkrankungen: -
Vorgeschichte: ? CHF (congestive heart failure) (CMS-HCC: 85) ? Diabetes mellitus (CMS-HCC: 19) ? Diverticulitis ? Enlarged prostate ? Hypertension
Andere Medikamente: aspirin 81 MG PO Tablet Chewable Information, Historical carvedilol (COREG) 3.125 MG PO Tablet by mouth. Information, Historical furosemide (LASIX) 20 MG PO Tablet by mouth. Information, Historical lisinopril (PRINIVIL,Z
Allergien: NKA
Vorherige Impfungen: -

VAERS 2069238

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: FL
Alter: 72,0
Geschlecht: F
Eingang: 27.01.2022
Impfdatum: 16.10.2021
Beginn: 16.01.2022
Tage bis Beginn: 92,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure Azotaemia Blood albumin decreased Blood chloride decreased Blood glucose normal Blood lactic acid Blood urea increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Chest X-ray normal Chills Decreased appetite Diarrhoea Dyspnoea Dyspnoea exertional Electrocardiogram ST segment normal

Symptomtext

presented to the emergency department complaints of shortness of breath. Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath. Patient reports that ever since then, her symptoms have continued to worsen. Patient has had multiple episodes of fevers and chills. Reports that she has had loose stools as well. Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days. Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath. Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia. Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4. Initial troponin 49 and BNP 6200. EKG independently reviewed and negative for any acute ST elevations or depressions. T-wave inversions noted in V6. Patient hospitalized for COVID-19 treatment. Discharged 1/27/2022. Pfizer 9/15/21 & 10/16/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: COVID-19 PCR + 1/23/2022
Aktuelle Erkrankungen: -
Vorgeschichte: cardiomyopathy, anxiety, COPD, CAD, CVA, hypothyroidism, PAD, sleep apnea, aneurysm of left ventricle
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2065236

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 26.01.2022
Impfdatum: -
Beginn: 01.01.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Renal failure SARS-CoV-2 test Suspected COVID-19 Vaccination failure

Symptomtext

KIDNEY FAILURE; SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; STROKE; This spontaneous report received from a physician concerned a 75 year old male (Retired Physician). The patient's height, and weight were not reported. The patient's concurrent conditions included: multiple myeloma, and cited multiple melanoma, and other pre-existing medical conditions included: Patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, 1 total, administered on an unspecified date in 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient had kidney failure and he was on dialysis for kidney failure. On 05-JAN-2022, the patient got COVID (captured as suspected covid-19 infection and hence suspected clinical vaccination failure), 2 days after his wife got positive for COVID-19. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. Reporter called about Paxlovid but they had not taken Paxlovid yet, reporter said she called to get help, she got infected by a patient as she was a physician and then her husband (Patient) got it, they wanted to get information about how to get the Paxlovid medication. The reporter said that patient also had a good positive experience with no allergic reaction to his COVID-19 vaccine. On an unspecified date in earlier this year JAN-2022, the patient had a stroke. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from kidney failure, and the outcome of suspected covid-19 infection, stroke and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0: 20220132972- covid-19 vaccine ad26.cov2.s ? kidney failure, stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20220132972-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Date: 20220105; Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Melanoma; Multiple myeloma
Vorgeschichte: Comments: Patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1526740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: IN
Alter: 39,0
Geschlecht: F
Eingang: 26.01.2022
Impfdatum: 16.07.2021
Beginn: 16.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy Cardio-respiratory arrest Fibrin D dimer increased Headache Heparin-induced thrombocytopenia test Brain death Cardiac arrest Diarrhoea Laboratory test Haemorrhage Life expectancy shortened Organ failure Thrombosis Hepatic vein thrombosis Immunoglobulin therapy Laboratory test normal Magnetic resonance imaging Pancreatitis

Symptomtext

Vomiting, diarrhea, severe headache, passed out, cardiac arrested 4 times, brain dead, organ failure, and pancreatitis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 23,0
Labordaten: Hospitalization July 28 through August 19. Several tests and labs.
Aktuelle Erkrankungen: None
Vorgeschichte: Sinusitis
Andere Medikamente: None
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2061594

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 25.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEAD; This spontaneous report received from a company representative via social media concerned over 300 multiple patients of unspecified race and ethnicity. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, reporter stated "over 300 dead athletes perhaps" . On an unspecified date, the patients died from unknown cause of death. It was unknown if an autopsy was performed (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20220126450, 20220126177, 20220126708, 20220126614, 20220126211, 20220126174 and 20220126701.; Sender's Comments: V0: 20220126582 -Covid-19 vaccine ad26.cov2.s- Dead. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2061572

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: -
Beginn: 15.03.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase Albumin globulin ratio Anaemia Antibody test Asthenia Basophil count Biopsy lymph gland Blood albumin Blood alkaline phosphatase Blood bilirubin Blood calcium Blood chloride Blood creatinine Blood glucose Blood grouping Blood lactate dehydrogenase Blood potassium Blood pressure measurement

Symptomtext

CRANIOTOMY; BRAIN BLEED; ACUTE ON CHRONIC SUBDURAL HEMATOMA; MIXED HYPERLIPIDEMIA; LYMPHOCYTOSIS/SEVERE LYMPHOCYTOSIS; DYSLIPIDEMIA; HYPERTENSION; DEHYDRATION; CHRONIC ANEMIA/WORSENING ANEMIA; POOR ORAL INTAKE; ELEVATED WHITE BLOOD CELL COUNT; NAUSEA; EXTREME FATIGUE; FELT WARM; HEMOGLOBIN DOWN TO 7.7; FEELING UNWELL; FELT VERY WEAK; GENERALIZED WEAKNESS/WEAKNESS PROGRESSIVELY WORSE; HAD BEEN DRY HEAVING; HYPERURICEMIA; HAD NOT BEEN EATING; This solicited report received from a consumer by a Business partner (Agency, US-ABBVIE-21K-163-3972726-00) concerned a 74 year old female of unspecified race and ethnicity. The patient's weight was 99.9 kilograms, and height was 167.6 centimeters. The patient's past medical history included: left mastectomy, familial risk factor, family history of cancer, family history of cardiovascular disorder, and family history of diabetes, and concurrent conditions included: breast cancer, clostridium difficile colitis, subdural hematoma, chemotherapy induced pancytopenia, lymphadenopathy, chemotherapy, chronic lymphocytic leukemia, and anemia secondary to bone marrow suppression from chemotherapy, and other pre-existing medical conditions included: The patient had no known allergies. The patient had family history of grandmother had hypertension. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, intramuscular, batch number: UNKNOWN and expiry: UNKNOWN) dose was not reported, 1 total administered on 15-MAR-2021 for covid-19 vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. The patient was initiated treatment with ibrutinib (tablet, oral, batch number: UNKNOWN) 420 mg, 1 time every 1 day from 17-MAR-2021 to 06-APR-2021 for an unspecified indication. Concomitant medications included venetoclax for chronic lymphocytic leukemia, prochlorperazine maleate for nausea, paracetamol for pain, allopurinol, amlodipine, benzocaine, bisacodyl, calcium carbonate, calcium carbonate/colecalciferol, docusate sodium/senna alexandrina, hydralazine hydrochloride, hydromorphone hydrochloride, lidocaine hydrochloride, magnesium oxide, naloxone hydrochloride, naproxen sodium, oxycodone, sodium chloride, and vitamins nos. On 11-OCT-2015, Laboratory data included: CO2 (NR: not provided) 27.0. On 2021, the patient experienced had been dry heaving, hyperuricemia. On 18-FEB-2021, Laboratory data included: Lymphocyte count (NR: not provided) 147.9. On 22-FEB-2021, Laboratory data included: CT scan neck (NR: not provided) Not reported, and Chest CT (NR: not provided) Not reported. On 25-FEB-2021, Laboratory data included: Lymph node biopsy (NR: not provided) Not reported. On 10-MAR-2021, Laboratory data included: Blood pressure (NR: not provided) Not reported, Body height (NR: not provided) 167.6 cm, Body temperature (NR: not provided) 97 F, Oxygen saturation (NR: not provided) 97 %, Pulse rate (NR: not provided) Not reported, and Respiratory rate (NR: not provided) 20. On 15-MAR-2021, after vaccine the patient had extreme fatigue and felt warm. On 27-MAR-2021, Laboratory data included: Blood urea nitrogen/creatinine ratio (NR: not provided) 20.61.On 31-MAR-2021, Laboratory data included: Red cell distribution width (NR: not provided) Not reported. On 06-APR-2021, the patient admitted to hospital for acute chronic subdural hematoma, left front parietal. The patient stated that post left craniotomy (date unspecified), evacuation of subdural hematoma performed first on 08-APR-2021 and then on 14-APR-2021. The patient also stated that there was no headache, fever, chills, night sweats, cough, shortness of breath, nausea, vomiting or diarrhea and only experienced worm like thickening in craniotomy site at that time. The patient went for acute visit (Date unspecified) and felt very weak and she had been getting weaker and her hemoglobin last week was 7.8, offered packed red blood cell (PRBC) to treat. The patient had no bleeding, no night sweats or fevers and no appetite had been nauseated at that time. Laboratory data included: Absolute lymphocyte count (NR: not provided) 343.8 H, Absolute monocyte count (NR: not provided) 3.7 H, Absolute neutrophil count (NR: not provided) 9.9 H, Alanine aminotransferase (NR: 0 - 55) 12 U/L, Albumin globulin ratio (NR: 1.1 - 2.3) 1.2, Alkaline phosphatase (NR: 40 - 150) 82 U/L, Basophil count (NR: 0.0 - 0.1) 0.1 10*3/uL, Basophils (NR: 0.0 - 1.0) 0.0 %, Bilirubin total (NR: 0.2 - 1.2) 0.8 mg/dL, Blood urea nitrogen (NR: 7.0 - 26.0) 15.0 mg/dL, Blood urea nitrogen/creatinine ratio (NR: not provided) 18.07, Chloride (NR: 98 - 107) 105 mmol/mL, Creatinine (NR: 0.55 - 1.02) 0.83 mg/dL, Eosinophil count (NR: not provided) 0.5 H, Eosinophils (NR: 0.0 - 3.0) 0.1 %, Globulin (NR: 1.3 - 3.2) 3.0 g/dL, Glomerular filtration rate (NR: not provided) 60, Glucose (NR: not provided) 119 H, Hematocrit (NR: not provided) 31.7 L, Hemoglobin (NR: not provided) 7.7 L, Lactate dehydrogenase (NR: 125 - 220) 258 U/L, Lymphocytes (NR: not provided) 94.9 H, MCHC (mean corpuscular hemoglobin concentration) (NR: not provided) 24.3 L, MCV (mean corpuscular volume (NR: not provided) 108.9 H, Mean platelet volume (NR: not provided) Not reported, 10.4 H, Monocytes (NR: not provided) 1.0 L, Neutrophils (NR: not provided) 2.8 L, Platelet count (NR: not provided) 144 L, Potassium (NR: 3.5 - 5.1) 4.9 mmol/L, Protein total (NR: 6.4 - 8.3) 6.5 g/dL, Sodium (NR: 136 - 145) 140 mmol/L, and WBC count (NR: not provided) 362.4 H. On 08-APR-2021, the patient experienced brain bleed. On 01-JUL-2021, the patient was started on second line obintuzumab/Venetoclax, and was continuing Venetoclax 300 mg daily, plan would be a total of a year on Venetoclax, but patient did not receive obintuzumab at the time of report. It was reported that, the patient continue to drink at least 6 to 8 glasses of water a day. On 17-AUG-2021, Laboratory data included: Body height (NR: not provided) 167.6 cm. On 12-NOV-2021, Laboratory data included: Absolute lymphocyte count (NR: not provided) 0.8 L, Absolute monocyte count (NR: 0.1 - 0.7) 0.5 10*3/uL, Alanine aminotransferase (NR: not provided) 36 H, Albumin globulin ratio 1.4, Alkaline phosphatase 77 U/L, Basophils (NR: 0.0 - 0.1) 0.0 10*3/uL, Basophils 0.7 %, Bilirubin total 0.8 mg/dL, Blood pressure (NR: not provided) 137/79 mmHg, Blood urea nitrogen 16.0 mg/dL, Body temperature (NR: not provided) 98.1 F, Calcium (NR: 8.4 - 10.2) 9.8 mg/dL, 8.9 mg/dL, Creatinine 0.73 mg/dL, Eosinophil count (NR: 0.0 - 0.3) 0.0 10*3/uL, Eosinophils (NR: not provided) 0.7, Globulin 3.0 g/dL, Glomerular filtration rate (NR: not provided) 60, Glucose (NR: not provided) 140 H, Hematocrit (NR: 33.0 - 51.0) 37.4 %, Hemoglobin (NR: 12.0 - 16.0) 12.6 g/dL, Lymphocytes (NR: 24.0 - 44.0) 25.3 %, MCHC (mean corpuscular hemoglobin concentration) (NR: 33.0 - 36.0) 33.7 g/dL, MCV (mean corpuscular volume) (NR: not provided) 87.6, Mean platelet volume (NR: 6.5 - 10.0) 9.7 fL, Monocytes (NR: not provided) 16.8 H, Neutrophils (NR: 35.0 - 77.0) 54.9 %, Oxygen saturation (NR: not provided) 95 %, Platelet count (NR: 150 - 450) 175 10*3/uL, Potassium 4.1 mmol/L, Potassium (NR: not provided) 4.1, Protein total 7.1 g/dL, Pulse rate (NR: not provided) 89, RBC count (NR: 4.00 - 5.20) 4.27 10*6/uL, RBC count (NR: not provided) 2.91 L, Red cell distribution width (NR: not provided) 16.1 H, Respiratory rate (NR: not provided) 16, Sodium 140 mmol/L, WBC count (NR: not provided) 3.0 L, and Weight (NR: not provided) 99.9 kg, 98 kg. On 04-DEC-2021, Laboratory data included: Blood pressure (NR: not provided) 138/66 mmHg, Body temperature (NR: not provided) 36.3 Degrees C, Oxygen saturation (NR: not provided) 94 %, Pulse rate (NR: not provided) 86, and Respiratory rate (NR: not provided) 18. On 2021 date unspecified, the patient had generalized weakness and visited clinic, and was feeling unwell, poor oral intake, had not been eating, felt warm on occasion. Since the weakness has gotten progressively worse, the patient had done with follow-up labs and was noted to have worsening chronic anemia with hemoglobin down to 7.7, patient has elevated white blood cell count at 364,000 with severe lymphocytosis. On an unspecified date, the patient also experienced, elevated white blood cell count, mixed hyperlipidemia, lymphocytosis/severe lymphocytosis, dyslipidemia, hypertension, dehydration, chronic anemia/worsening anemia, and nausea. It was reported that, patient lymphadenopathy were improved since the beginning of chemotherapy. The patient had blood transfusion, packed red blood cells (PRBC) for anemia and also had oral chemotherapy for Chronic lymphocytic leukemia (CLL) which was on hold. It was reported that, the patient labs were elevated which was presumed due to Chronic lymphocytic leukemia (CLL). Laboratory data (dates unspecified) included: Absolute neutrophil count (NR: not provided) 1.7, Absolute neutrophil count (NR: 1.5 - 8.5) 1.7 10*3/uL, Albumin (NR: not provided) 4.1, 3.5, Antibody test (NR: not provided) Not reported, Blood grouping (NR: not provided) B, Chloride 103 mmol/L, Head CT (NR: not provided) Not reported, Hemoglobin (NR: not provided) 7.8, Rhesus antigen (NR: not provided) Positive, Uric acid (NR: not provided) 4.7, and White blood cell count (NR: not provided) 364000. It was also reported that The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with ibrutinib was withdrawn on 06-APR-2021. The patient had not recovered from generalized weakness/weakness progressively worse, and chronic anemia/worsening anemia, and the outcome of brain bleed, acute on chronic subdural hematoma, craniotomy, had not been eating, poor oral intake, elevated white blood cell count, felt warm, mixed hyperlipidemia, dyslipidemia, had been dry heaving, felt very weak, hyperuricemia, feeling unwell, hemoglobin down to 7.7, lymphocytosis/severe lymphocytosis, nausea, extreme fatigue, dehydration and hypertension was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and brain bleed, acute on chronic subdural hematoma, craniotomy, had not been eating, poor oral intake, elevated white blood cell count, mixed hyperlipidemia, lymphocytosis/severe lymphocytosis, dyslipidemia, hypertension, dehydration, had been dry heaving, hyperuricemia, chronic anemia/worsening anemia, and hemoglobin down to 7.7 was not related, and between covid-19 vaccine ad26.cov2.s, and feeling unwell, felt very weak, generalized weakness/weakness progressively worse, extreme fatigue, felt warm and nausea was related. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This case, involving the same patient is linked to 20220134969. Additional information was received from reporter on 10-Jan-2022. The following information was updated and incorporated into the case narrative: covid-19 vaccine ad26.cov2.s was added as suspect and re-ranked the product. Following receipt of additional information from reporter on 10-Jan-2022. It was determined that nullification and deletion was required for Manufacturer Report Number (20220134969) as it was duplicate of Manufacturer Case Number (20210702361). All relevant information regarding Manufacturer Report Number (20220134969) will be submitted under Manufacturer Case Number (20210702361).; Sender's Comments: V3- This version updates covid-19 vaccine ad26.cov2.s was added as suspect and re-ranked the product. 20210702361- covid-19 vaccine ad26.cov2.s-Brain bleed, Acute on chronic subdural hematoma, Craniotomy. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: CONMEDS-OTHER SUSPECT DRUGS; MEDICAL HISTORY 20210702361-Imbruvica- Craniotomy. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: UNDERLYING DISEASE 20210702361-Imbruvica-Brain bleed. Acute on chronic subdural hematoma.. Follow-up received regarding Clinical Details. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: Test Date: 20151011; Test Name: CO2; Result Unstructured Data: 27.0; Test Date: 20210218; Test Name: Lymphocyte count; Result Unstructured Data: 147.9; Test Date: 20210222; Test Name: Chest CT; Result Unstructured Data: Not reported; Test Date: 20210222; Test Name: CT scan neck; Result Unstructured Data: Not reported; Test Date: 20210225; Test Name: Lymph node biopsy; Result Unstructured Data: Not reported; Test Date: 20210310; Test Name: Oxygen saturation; Result Unstructured Data: 97 %; Test Date: 20210310; Test Name: Body height; Result Unstructured Data: 167.6 cm; Test Date: 20210310; Test Name: Body temperature; Result Unstructured Data: 97 F; Test Date: 20210310; Test Name: Respiratory rate; Result Unstructured Data: 20; Test Date: 20210310; Test Name: Pulse rate; Result Unstructured Data: Not reported; Test Date: 20210310; Test Name: Blood pressure; Result Unstructured Data: Not reported; Test Date: 20210327; Test Name: Blood urea nitrogen/creatinine ratio; Result Unstructured Data: 20.61; Test Date: 20210331; Test Name: Red cell distribution width; Result Unstructured Data: Not reported; Test Date: 20210406; Test Name: Hematocrit; Result Unstructured Data: 31.7 L; Test Date: 20210406; Test Name: Platelet count; Result Unstructured Data: 144 L; Test Date: 20210406; Test Name: Mean platelet volume; Result Unstructured Data: Not reported; Test Date: 20210406; Test Name: Absolute neutrophil count; Result Unstructured Data: 9.9 H; Test Date: 20210406; Test Name: Neutrophils; Result Unstructured Data: 2.8 L; Test Date: 20210406; Test Name: Absolute lymphocyte count; Result Unstructured Data: 343.8 H; Test Date: 20210406; Test Name: Lymphocytes; Result Unstructured Data: 94.9 H; Test Date: 20210406; Test Name: Absolute monocyte count; Result Unstructured Data: 3.7 H; Test Date: 20210406; Test Name: Monocytes; Result Unstructured Data: 1.0 L; Test Date: 20210406; Test Name: Eosinophil count; Result Unstructured Data: 0.5 H; Test Date: 20210406; Test Name: Eosinophils; Result Unstructured Data: 0.1 %; Test Date: 20210406; Test Name: Basophil count; Result Unstructured Data: 0.1 10*3/uL; Test Date: 20210406; Test Name: Basophils; Result Unstructured Data: 0.0 %; Test Date: 20210406; Test Name: Glucose; Result Unstructured Data: 119 H; Test Date: 20210406; Test Name: Blood urea nitrogen; Result Unstructured Data: 15.0 mg/dL; Test Date: 20210406; Test Name: Creatinine; Result Unstructured Data: 0.83 mg/dL; Test Date: 20210406; Test Name: Glomerular filtration rate; Result Unstructured Data: 60; Test Date: 20210406; Test Name: Blood urea nitrogen/creatinine ratio; Result Unstructured Data: 18.07; Test Date: 20210406; Test Name: Sodium; Result Unstructured Data: 140 mmol/L; Test Date: 20210406; Test Name: Potassium; Result Unstructured Data: 4.9 mmol/L; Test Date: 20210406; Test Name: Chloride; Result Unstructured Data: 105 mmol/mL; Test Date: 20210406; Test Name: Protein total; Result Unstructured Data: 6.5 g/dL; Test Date: 20210406; Test Name: Globulin; Result Unstructured Data: 3.0 g/dL; Test Date: 20210406; Test Name: Albumin globulin ratio; Result Unstructured Data: 1.2; Test Date: 20210406; Test Name: Alanine aminotransferase; Result Unstructured Data: 12 U/L; Test Date: 20210406; Test Name: Alkaline phosphatase; Result Unstructured Data: 82 U/L; Test Date: 20210406; Test Name: Bilirubin total; Result Unstructured Data: 0.8 mg/dL; Test Date: 20210406; Test Name: Hemoglobin; Result Unstructured Data: 7.7 L; Test Date: 20210406; Test Name: WBC count; Result Unstructured Data: 362.4 H; Test Date: 20210406; Test Name: Lactate dehydrogenase; Result Unstructured Data: 258 U/L; Test Date: 20210406; Test Name: MCV; Result Unstructured Data: 108.9 H; Test Date: 20210406; Test Name: MCHC; Result Unstructured Data: 24.3 L; Test Date: 20210406; Test Name: Mean platelet volume; Result Unstructured Data: 10.4 H; Test Date: 20210817; Test Name: Body height; Result Unstructured Data: 167.6 cm; Test Date: 20211112; Test Name: Blood pressure; Result Unstructured Data: 137/79 mmHg; Test Date: 20211112; Test Name: Calcium; Result Unstructured Data: 8.9 mg/dL; Test Date: 20211112; Test Name: Potassium; Result Unstructured Data: 4.1; Test Date: 20211112; Test Name: RBC count; Result Unstructured Data: 2.91 L; Test Date: 20211112; Test Name: Weight; Result Unstructured Data: 99.9 kg; Test Date: 20211112; Test Name: Bilirubin total; Result Unstructured Data: 0.8 mg/dL; Test Date: 20211112; Test Name: Alkaline phosphatase; Result Unstructured Data: 77 U/L; Test Date: 20211112; Test Name: Alanine aminotransferase; Result Unstructured Data: 36 H; Test Date: 20211112; Test Name: Albumin globulin ratio; Result Unstructured Data: 1.4; Test Date: 20211112; Test Name: Globulin; Result Unstructured Data: 3.0 g/dL; Test Date: 20211112; Test Name: Protein total; Result Unstructured Data: 7.1 g/dL; Test Date: 20211112; Test Name: Calcium; Result Unstructured Data: 9.8 mg/dL; Test Date: 20211112; Test Name: Potassium; Result Unstructured Data: 4.1 mmol/L; Test Date: 20211112; Test Name: Sodium; Result Unstructured Data: 140 mmol/L; Test Date: 20211112; Test Name: Glomerular filtration rate; Result Unstructured Data: 60; Test Date: 20211112; Test Name: Creatinine; Result Unstructured Data: 0.73 mg/dL; Test Date: 20211112; Test Name: Blood urea nitrogen; Result Unstructured Data: 16.0 mg/dL; Test Date: 20211112; Test Name: Pulse rate; Result Unstructured Data: 89; Test Date: 20211112; Test Name: Body temperature; Result Unstructured Data: 98.1 F; Test Date: 20211112; Test Name: Respiratory rate; Result Unstructured Data: 16; Test Date: 20211112; Test Name: Weight; Result Unstructured Data: 98 kg; Test Date: 20211112; Test Name: Oxygen saturation; Result Unstructured Data: 95 %; Test Date: 20211112; Test Name: WBC count; Result Unstructured Data: 3.0 L; Test Date: 20211112; Test Name: RBC count; Result Unstructured Data: 4.27 10*6/uL; Test Date: 20211112; Test Name: Hemoglobin; Result Unstructured Data: 12.6 g/dL; Test Date: 20211112; Test Name: Hematocrit; Result Unstructured Data: 37.4 %; Test Date: 20211112; Test Name: MCV; Result Unstructured Data: 87.6; Test Date: 20211112; Test Name: MCHC; Result Unstructured Data: 33.7 g/dL; Test Date: 20211112; Test Name: Red cell distribution width; Result Unstructured Data: 16.1 H; Test Date: 20211112; Test Name: Platelet count; Result Unstructured Data: 175 10*3/uL; Test Date: 20211112; Test Name: Mean platelet volume; Result Unstructured Data: 9.7 fL; Test Date: 20211112; Test Name: Neutrophils; Result Unstructured Data: 54.9 %; Test Date: 20211112; Test Name: Absolute lymphocyte count; Result Unstructured Data: 0.8 L; Test Date: 20211112; Test Name: Lymphocytes; Result Unstructured Data: 25.3 %; Test Date: 20211112; Test Name: Absolute monocyte count; Result Unstructured Data: 0.5 10*3/uL; Test Date: 20211112; Test Name: Monocytes; Result Unstructured Data: 16.8 H; Test Date: 20211112; Test Name: Eosinophil count; Result Unstructured Data: 0.0 10*3/uL; Test Date: 20211112; Test Name: Eosinophils; Result Unstructured Data: 0.7; Test Date: 20211112; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 20211112; Test Name: Basophils; Result Unstructured Data: 0.7 %; Test Date: 20211112; Test Name: Glucose; Result Unstructured Data: 140 H; Test Date: 20211204; Test Name: Respiratory rate; Result Unstructured Data: 18; Test Date: 20211204; Test Name: Body temperature; Result Unstructured Data: 36.3 Degrees C; Test Date: 20211204; Test Name: Pulse rate; Result Unstructured Data: 86; Test Date: 20211204; Test Name: Blood pressure; Result Unstructured Data: 138/66 mmHg; Test Date: 20211204; Test Name: Oxygen saturation; Result Unstructured Data: 94 %; Test Name: Absolute neutrophil count; Result Unstructured Data: 1.7; Test Name: White blood cell count; Result Unstructured Data: 364000; Test Name: Albumin; Result Unstructured Data: 4.1; Test Name: Albumin; Result Unstructured Data: 3.5; Test Name: Blood grouping; Result Unstructured Data: B; Test Name: Head CT; Result Unstructured Data: Not reported; Test Name: Chloride; Result Unstructured Data: 103 mmol/L; Test Name: Hemoglobin; Result Unstructured Data: 7.8; Test Name: Rhesus antigen; Result Unstructured Data: Positive; Test Name: Absolute neutrophil count; Result Unstructured Data: 1.7 10*3/uL; Test Name: Uric acid; Result Unstructured Data: 4.7; Test Name: Antibody test; Result Unstructured Data: Not reported
Aktuelle Erkrankungen: Bone marrow suppression (Anemia secondary to bone marrow suppression from chemotherapy); Breast cancer; Chemotherapy; Chronic lymphocytic leukemia; Clostridium difficile colitis; Lymphadenopathy; Secondary pancytopenia; Subdural hematoma
Vorgeschichte: Medical History/Concurrent Conditions: Familial risk factor; Family history of cancer (Family history of Mother, Brother, Grandmother had cancer and Father had Lung cancer); Family history of cardiovascular disorder (Family history of Father and Grandmother had heart disease); Family history of diabetes (Family history of Grandmother had Diabetes); Mastectomy; Comments: The patient had no known allergies. The patient had family history of grandmother had hypertension
Andere Medikamente: ACETAMINOPHEN; AMLODIPINE; MAGNESIUM OXIDE; PROCHLORPERAZINE MALEATE; CALCIUM CHOLECALCIFEROL BERES; NAPROXEN SODIUM; VENETOCLAX; MULTIVITAMIN; BENZOCAINE; BISACODYL; CALCIUM CARBONATE; APRESOLINE; DILAUDID; LIDOCAINE HCL; NARCAN; OXYCODONE
Allergien: -
Vorherige Impfungen: -

VAERS 2061572

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UNKNOWN

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: -
Beginn: 15.03.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase Albumin globulin ratio Anaemia Antibody test Asthenia Basophil count Biopsy lymph gland Blood albumin Blood alkaline phosphatase Blood bilirubin Blood calcium Blood chloride Blood creatinine Blood glucose Blood grouping Blood lactate dehydrogenase Blood potassium Blood pressure measurement

Symptomtext

CRANIOTOMY; BRAIN BLEED; ACUTE ON CHRONIC SUBDURAL HEMATOMA; MIXED HYPERLIPIDEMIA; LYMPHOCYTOSIS/SEVERE LYMPHOCYTOSIS; DYSLIPIDEMIA; HYPERTENSION; DEHYDRATION; CHRONIC ANEMIA/WORSENING ANEMIA; POOR ORAL INTAKE; ELEVATED WHITE BLOOD CELL COUNT; NAUSEA; EXTREME FATIGUE; FELT WARM; HEMOGLOBIN DOWN TO 7.7; FEELING UNWELL; FELT VERY WEAK; GENERALIZED WEAKNESS/WEAKNESS PROGRESSIVELY WORSE; HAD BEEN DRY HEAVING; HYPERURICEMIA; HAD NOT BEEN EATING; This solicited report received from a consumer by a Business partner (Agency, US-ABBVIE-21K-163-3972726-00) concerned a 74 year old female of unspecified race and ethnicity. The patient's weight was 99.9 kilograms, and height was 167.6 centimeters. The patient's past medical history included: left mastectomy, familial risk factor, family history of cancer, family history of cardiovascular disorder, and family history of diabetes, and concurrent conditions included: breast cancer, clostridium difficile colitis, subdural hematoma, chemotherapy induced pancytopenia, lymphadenopathy, chemotherapy, chronic lymphocytic leukemia, and anemia secondary to bone marrow suppression from chemotherapy, and other pre-existing medical conditions included: The patient had no known allergies. The patient had family history of grandmother had hypertension. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, intramuscular, batch number: UNKNOWN and expiry: UNKNOWN) dose was not reported, 1 total administered on 15-MAR-2021 for covid-19 vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. The patient was initiated treatment with ibrutinib (tablet, oral, batch number: UNKNOWN) 420 mg, 1 time every 1 day from 17-MAR-2021 to 06-APR-2021 for an unspecified indication. Concomitant medications included venetoclax for chronic lymphocytic leukemia, prochlorperazine maleate for nausea, paracetamol for pain, allopurinol, amlodipine, benzocaine, bisacodyl, calcium carbonate, calcium carbonate/colecalciferol, docusate sodium/senna alexandrina, hydralazine hydrochloride, hydromorphone hydrochloride, lidocaine hydrochloride, magnesium oxide, naloxone hydrochloride, naproxen sodium, oxycodone, sodium chloride, and vitamins nos. On 11-OCT-2015, Laboratory data included: CO2 (NR: not provided) 27.0. On 2021, the patient experienced had been dry heaving, hyperuricemia. On 18-FEB-2021, Laboratory data included: Lymphocyte count (NR: not provided) 147.9. On 22-FEB-2021, Laboratory data included: CT scan neck (NR: not provided) Not reported, and Chest CT (NR: not provided) Not reported. On 25-FEB-2021, Laboratory data included: Lymph node biopsy (NR: not provided) Not reported. On 10-MAR-2021, Laboratory data included: Blood pressure (NR: not provided) Not reported, Body height (NR: not provided) 167.6 cm, Body temperature (NR: not provided) 97 F, Oxygen saturation (NR: not provided) 97 %, Pulse rate (NR: not provided) Not reported, and Respiratory rate (NR: not provided) 20. On 15-MAR-2021, after vaccine the patient had extreme fatigue and felt warm. On 27-MAR-2021, Laboratory data included: Blood urea nitrogen/creatinine ratio (NR: not provided) 20.61.On 31-MAR-2021, Laboratory data included: Red cell distribution width (NR: not provided) Not reported. On 06-APR-2021, the patient admitted to hospital for acute chronic subdural hematoma, left front parietal. The patient stated that post left craniotomy (date unspecified), evacuation of subdural hematoma performed first on 08-APR-2021 and then on 14-APR-2021. The patient also stated that there was no headache, fever, chills, night sweats, cough, shortness of breath, nausea, vomiting or diarrhea and only experienced worm like thickening in craniotomy site at that time. The patient went for acute visit (Date unspecified) and felt very weak and she had been getting weaker and her hemoglobin last week was 7.8, offered packed red blood cell (PRBC) to treat. The patient had no bleeding, no night sweats or fevers and no appetite had been nauseated at that time. Laboratory data included: Absolute lymphocyte count (NR: not provided) 343.8 H, Absolute monocyte count (NR: not provided) 3.7 H, Absolute neutrophil count (NR: not provided) 9.9 H, Alanine aminotransferase (NR: 0 - 55) 12 U/L, Albumin globulin ratio (NR: 1.1 - 2.3) 1.2, Alkaline phosphatase (NR: 40 - 150) 82 U/L, Basophil count (NR: 0.0 - 0.1) 0.1 10*3/uL, Basophils (NR: 0.0 - 1.0) 0.0 %, Bilirubin total (NR: 0.2 - 1.2) 0.8 mg/dL, Blood urea nitrogen (NR: 7.0 - 26.0) 15.0 mg/dL, Blood urea nitrogen/creatinine ratio (NR: not provided) 18.07, Chloride (NR: 98 - 107) 105 mmol/mL, Creatinine (NR: 0.55 - 1.02) 0.83 mg/dL, Eosinophil count (NR: not provided) 0.5 H, Eosinophils (NR: 0.0 - 3.0) 0.1 %, Globulin (NR: 1.3 - 3.2) 3.0 g/dL, Glomerular filtration rate (NR: not provided) 60, Glucose (NR: not provided) 119 H, Hematocrit (NR: not provided) 31.7 L, Hemoglobin (NR: not provided) 7.7 L, Lactate dehydrogenase (NR: 125 - 220) 258 U/L, Lymphocytes (NR: not provided) 94.9 H, MCHC (mean corpuscular hemoglobin concentration) (NR: not provided) 24.3 L, MCV (mean corpuscular volume (NR: not provided) 108.9 H, Mean platelet volume (NR: not provided) Not reported, 10.4 H, Monocytes (NR: not provided) 1.0 L, Neutrophils (NR: not provided) 2.8 L, Platelet count (NR: not provided) 144 L, Potassium (NR: 3.5 - 5.1) 4.9 mmol/L, Protein total (NR: 6.4 - 8.3) 6.5 g/dL, Sodium (NR: 136 - 145) 140 mmol/L, and WBC count (NR: not provided) 362.4 H. On 08-APR-2021, the patient experienced brain bleed. On 01-JUL-2021, the patient was started on second line obintuzumab/Venetoclax, and was continuing Venetoclax 300 mg daily, plan would be a total of a year on Venetoclax, but patient did not receive obintuzumab at the time of report. It was reported that, the patient continue to drink at least 6 to 8 glasses of water a day. On 17-AUG-2021, Laboratory data included: Body height (NR: not provided) 167.6 cm. On 12-NOV-2021, Laboratory data included: Absolute lymphocyte count (NR: not provided) 0.8 L, Absolute monocyte count (NR: 0.1 - 0.7) 0.5 10*3/uL, Alanine aminotransferase (NR: not provided) 36 H, Albumin globulin ratio 1.4, Alkaline phosphatase 77 U/L, Basophils (NR: 0.0 - 0.1) 0.0 10*3/uL, Basophils 0.7 %, Bilirubin total 0.8 mg/dL, Blood pressure (NR: not provided) 137/79 mmHg, Blood urea nitrogen 16.0 mg/dL, Body temperature (NR: not provided) 98.1 F, Calcium (NR: 8.4 - 10.2) 9.8 mg/dL, 8.9 mg/dL, Creatinine 0.73 mg/dL, Eosinophil count (NR: 0.0 - 0.3) 0.0 10*3/uL, Eosinophils (NR: not provided) 0.7, Globulin 3.0 g/dL, Glomerular filtration rate (NR: not provided) 60, Glucose (NR: not provided) 140 H, Hematocrit (NR: 33.0 - 51.0) 37.4 %, Hemoglobin (NR: 12.0 - 16.0) 12.6 g/dL, Lymphocytes (NR: 24.0 - 44.0) 25.3 %, MCHC (mean corpuscular hemoglobin concentration) (NR: 33.0 - 36.0) 33.7 g/dL, MCV (mean corpuscular volume) (NR: not provided) 87.6, Mean platelet volume (NR: 6.5 - 10.0) 9.7 fL, Monocytes (NR: not provided) 16.8 H, Neutrophils (NR: 35.0 - 77.0) 54.9 %, Oxygen saturation (NR: not provided) 95 %, Platelet count (NR: 150 - 450) 175 10*3/uL, Potassium 4.1 mmol/L, Potassium (NR: not provided) 4.1, Protein total 7.1 g/dL, Pulse rate (NR: not provided) 89, RBC count (NR: 4.00 - 5.20) 4.27 10*6/uL, RBC count (NR: not provided) 2.91 L, Red cell distribution width (NR: not provided) 16.1 H, Respiratory rate (NR: not provided) 16, Sodium 140 mmol/L, WBC count (NR: not provided) 3.0 L, and Weight (NR: not provided) 99.9 kg, 98 kg. On 04-DEC-2021, Laboratory data included: Blood pressure (NR: not provided) 138/66 mmHg, Body temperature (NR: not provided) 36.3 Degrees C, Oxygen saturation (NR: not provided) 94 %, Pulse rate (NR: not provided) 86, and Respiratory rate (NR: not provided) 18. On 2021 date unspecified, the patient had generalized weakness and visited clinic, and was feeling unwell, poor oral intake, had not been eating, felt warm on occasion. Since the weakness has gotten progressively worse, the patient had done with follow-up labs and was noted to have worsening chronic anemia with hemoglobin down to 7.7, patient has elevated white blood cell count at 364,000 with severe lymphocytosis. On an unspecified date, the patient also experienced, elevated white blood cell count, mixed hyperlipidemia, lymphocytosis/severe lymphocytosis, dyslipidemia, hypertension, dehydration, chronic anemia/worsening anemia, and nausea. It was reported that, patient lymphadenopathy were improved since the beginning of chemotherapy. The patient had blood transfusion, packed red blood cells (PRBC) for anemia and also had oral chemotherapy for Chronic lymphocytic leukemia (CLL) which was on hold. It was reported that, the patient labs were elevated which was presumed due to Chronic lymphocytic leukemia (CLL). Laboratory data (dates unspecified) included: Absolute neutrophil count (NR: not provided) 1.7, Absolute neutrophil count (NR: 1.5 - 8.5) 1.7 10*3/uL, Albumin (NR: not provided) 4.1, 3.5, Antibody test (NR: not provided) Not reported, Blood grouping (NR: not provided) B, Chloride 103 mmol/L, Head CT (NR: not provided) Not reported, Hemoglobin (NR: not provided) 7.8, Rhesus antigen (NR: not provided) Positive, Uric acid (NR: not provided) 4.7, and White blood cell count (NR: not provided) 364000. It was also reported that The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with ibrutinib was withdrawn on 06-APR-2021. The patient had not recovered from generalized weakness/weakness progressively worse, and chronic anemia/worsening anemia, and the outcome of brain bleed, acute on chronic subdural hematoma, craniotomy, had not been eating, poor oral intake, elevated white blood cell count, felt warm, mixed hyperlipidemia, dyslipidemia, had been dry heaving, felt very weak, hyperuricemia, feeling unwell, hemoglobin down to 7.7, lymphocytosis/severe lymphocytosis, nausea, extreme fatigue, dehydration and hypertension was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and brain bleed, acute on chronic subdural hematoma, craniotomy, had not been eating, poor oral intake, elevated white blood cell count, mixed hyperlipidemia, lymphocytosis/severe lymphocytosis, dyslipidemia, hypertension, dehydration, had been dry heaving, hyperuricemia, chronic anemia/worsening anemia, and hemoglobin down to 7.7 was not related, and between covid-19 vaccine ad26.cov2.s, and feeling unwell, felt very weak, generalized weakness/weakness progressively worse, extreme fatigue, felt warm and nausea was related. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This case, involving the same patient is linked to 20220134969. Additional information was received from reporter on 10-Jan-2022. The following information was updated and incorporated into the case narrative: covid-19 vaccine ad26.cov2.s was added as suspect and re-ranked the product. Following receipt of additional information from reporter on 10-Jan-2022. It was determined that nullification and deletion was required for Manufacturer Report Number (20220134969) as it was duplicate of Manufacturer Case Number (20210702361). All relevant information regarding Manufacturer Report Number (20220134969) will be submitted under Manufacturer Case Number (20210702361).; Sender's Comments: V3- This version updates covid-19 vaccine ad26.cov2.s was added as suspect and re-ranked the product. 20210702361- covid-19 vaccine ad26.cov2.s-Brain bleed, Acute on chronic subdural hematoma, Craniotomy. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: CONMEDS-OTHER SUSPECT DRUGS; MEDICAL HISTORY 20210702361-Imbruvica- Craniotomy. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: UNDERLYING DISEASE 20210702361-Imbruvica-Brain bleed. Acute on chronic subdural hematoma.. Follow-up received regarding Clinical Details. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: Test Date: 20151011; Test Name: CO2; Result Unstructured Data: 27.0; Test Date: 20210218; Test Name: Lymphocyte count; Result Unstructured Data: 147.9; Test Date: 20210222; Test Name: Chest CT; Result Unstructured Data: Not reported; Test Date: 20210222; Test Name: CT scan neck; Result Unstructured Data: Not reported; Test Date: 20210225; Test Name: Lymph node biopsy; Result Unstructured Data: Not reported; Test Date: 20210310; Test Name: Oxygen saturation; Result Unstructured Data: 97 %; Test Date: 20210310; Test Name: Body height; Result Unstructured Data: 167.6 cm; Test Date: 20210310; Test Name: Body temperature; Result Unstructured Data: 97 F; Test Date: 20210310; Test Name: Respiratory rate; Result Unstructured Data: 20; Test Date: 20210310; Test Name: Pulse rate; Result Unstructured Data: Not reported; Test Date: 20210310; Test Name: Blood pressure; Result Unstructured Data: Not reported; Test Date: 20210327; Test Name: Blood urea nitrogen/creatinine ratio; Result Unstructured Data: 20.61; Test Date: 20210331; Test Name: Red cell distribution width; Result Unstructured Data: Not reported; Test Date: 20210406; Test Name: Hematocrit; Result Unstructured Data: 31.7 L; Test Date: 20210406; Test Name: Platelet count; Result Unstructured Data: 144 L; Test Date: 20210406; Test Name: Mean platelet volume; Result Unstructured Data: Not reported; Test Date: 20210406; Test Name: Absolute neutrophil count; Result Unstructured Data: 9.9 H; Test Date: 20210406; Test Name: Neutrophils; Result Unstructured Data: 2.8 L; Test Date: 20210406; Test Name: Absolute lymphocyte count; Result Unstructured Data: 343.8 H; Test Date: 20210406; Test Name: Lymphocytes; Result Unstructured Data: 94.9 H; Test Date: 20210406; Test Name: Absolute monocyte count; Result Unstructured Data: 3.7 H; Test Date: 20210406; Test Name: Monocytes; Result Unstructured Data: 1.0 L; Test Date: 20210406; Test Name: Eosinophil count; Result Unstructured Data: 0.5 H; Test Date: 20210406; Test Name: Eosinophils; Result Unstructured Data: 0.1 %; Test Date: 20210406; Test Name: Basophil count; Result Unstructured Data: 0.1 10*3/uL; Test Date: 20210406; Test Name: Basophils; Result Unstructured Data: 0.0 %; Test Date: 20210406; Test Name: Glucose; Result Unstructured Data: 119 H; Test Date: 20210406; Test Name: Blood urea nitrogen; Result Unstructured Data: 15.0 mg/dL; Test Date: 20210406; Test Name: Creatinine; Result Unstructured Data: 0.83 mg/dL; Test Date: 20210406; Test Name: Glomerular filtration rate; Result Unstructured Data: 60; Test Date: 20210406; Test Name: Blood urea nitrogen/creatinine ratio; Result Unstructured Data: 18.07; Test Date: 20210406; Test Name: Sodium; Result Unstructured Data: 140 mmol/L; Test Date: 20210406; Test Name: Potassium; Result Unstructured Data: 4.9 mmol/L; Test Date: 20210406; Test Name: Chloride; Result Unstructured Data: 105 mmol/mL; Test Date: 20210406; Test Name: Protein total; Result Unstructured Data: 6.5 g/dL; Test Date: 20210406; Test Name: Globulin; Result Unstructured Data: 3.0 g/dL; Test Date: 20210406; Test Name: Albumin globulin ratio; Result Unstructured Data: 1.2; Test Date: 20210406; Test Name: Alanine aminotransferase; Result Unstructured Data: 12 U/L; Test Date: 20210406; Test Name: Alkaline phosphatase; Result Unstructured Data: 82 U/L; Test Date: 20210406; Test Name: Bilirubin total; Result Unstructured Data: 0.8 mg/dL; Test Date: 20210406; Test Name: Hemoglobin; Result Unstructured Data: 7.7 L; Test Date: 20210406; Test Name: WBC count; Result Unstructured Data: 362.4 H; Test Date: 20210406; Test Name: Lactate dehydrogenase; Result Unstructured Data: 258 U/L; Test Date: 20210406; Test Name: MCV; Result Unstructured Data: 108.9 H; Test Date: 20210406; Test Name: MCHC; Result Unstructured Data: 24.3 L; Test Date: 20210406; Test Name: Mean platelet volume; Result Unstructured Data: 10.4 H; Test Date: 20210817; Test Name: Body height; Result Unstructured Data: 167.6 cm; Test Date: 20211112; Test Name: Blood pressure; Result Unstructured Data: 137/79 mmHg; Test Date: 20211112; Test Name: Calcium; Result Unstructured Data: 8.9 mg/dL; Test Date: 20211112; Test Name: Potassium; Result Unstructured Data: 4.1; Test Date: 20211112; Test Name: RBC count; Result Unstructured Data: 2.91 L; Test Date: 20211112; Test Name: Weight; Result Unstructured Data: 99.9 kg; Test Date: 20211112; Test Name: Bilirubin total; Result Unstructured Data: 0.8 mg/dL; Test Date: 20211112; Test Name: Alkaline phosphatase; Result Unstructured Data: 77 U/L; Test Date: 20211112; Test Name: Alanine aminotransferase; Result Unstructured Data: 36 H; Test Date: 20211112; Test Name: Albumin globulin ratio; Result Unstructured Data: 1.4; Test Date: 20211112; Test Name: Globulin; Result Unstructured Data: 3.0 g/dL; Test Date: 20211112; Test Name: Protein total; Result Unstructured Data: 7.1 g/dL; Test Date: 20211112; Test Name: Calcium; Result Unstructured Data: 9.8 mg/dL; Test Date: 20211112; Test Name: Potassium; Result Unstructured Data: 4.1 mmol/L; Test Date: 20211112; Test Name: Sodium; Result Unstructured Data: 140 mmol/L; Test Date: 20211112; Test Name: Glomerular filtration rate; Result Unstructured Data: 60; Test Date: 20211112; Test Name: Creatinine; Result Unstructured Data: 0.73 mg/dL; Test Date: 20211112; Test Name: Blood urea nitrogen; Result Unstructured Data: 16.0 mg/dL; Test Date: 20211112; Test Name: Pulse rate; Result Unstructured Data: 89; Test Date: 20211112; Test Name: Body temperature; Result Unstructured Data: 98.1 F; Test Date: 20211112; Test Name: Respiratory rate; Result Unstructured Data: 16; Test Date: 20211112; Test Name: Weight; Result Unstructured Data: 98 kg; Test Date: 20211112; Test Name: Oxygen saturation; Result Unstructured Data: 95 %; Test Date: 20211112; Test Name: WBC count; Result Unstructured Data: 3.0 L; Test Date: 20211112; Test Name: RBC count; Result Unstructured Data: 4.27 10*6/uL; Test Date: 20211112; Test Name: Hemoglobin; Result Unstructured Data: 12.6 g/dL; Test Date: 20211112; Test Name: Hematocrit; Result Unstructured Data: 37.4 %; Test Date: 20211112; Test Name: MCV; Result Unstructured Data: 87.6; Test Date: 20211112; Test Name: MCHC; Result Unstructured Data: 33.7 g/dL; Test Date: 20211112; Test Name: Red cell distribution width; Result Unstructured Data: 16.1 H; Test Date: 20211112; Test Name: Platelet count; Result Unstructured Data: 175 10*3/uL; Test Date: 20211112; Test Name: Mean platelet volume; Result Unstructured Data: 9.7 fL; Test Date: 20211112; Test Name: Neutrophils; Result Unstructured Data: 54.9 %; Test Date: 20211112; Test Name: Absolute lymphocyte count; Result Unstructured Data: 0.8 L; Test Date: 20211112; Test Name: Lymphocytes; Result Unstructured Data: 25.3 %; Test Date: 20211112; Test Name: Absolute monocyte count; Result Unstructured Data: 0.5 10*3/uL; Test Date: 20211112; Test Name: Monocytes; Result Unstructured Data: 16.8 H; Test Date: 20211112; Test Name: Eosinophil count; Result Unstructured Data: 0.0 10*3/uL; Test Date: 20211112; Test Name: Eosinophils; Result Unstructured Data: 0.7; Test Date: 20211112; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 20211112; Test Name: Basophils; Result Unstructured Data: 0.7 %; Test Date: 20211112; Test Name: Glucose; Result Unstructured Data: 140 H; Test Date: 20211204; Test Name: Respiratory rate; Result Unstructured Data: 18; Test Date: 20211204; Test Name: Body temperature; Result Unstructured Data: 36.3 Degrees C; Test Date: 20211204; Test Name: Pulse rate; Result Unstructured Data: 86; Test Date: 20211204; Test Name: Blood pressure; Result Unstructured Data: 138/66 mmHg; Test Date: 20211204; Test Name: Oxygen saturation; Result Unstructured Data: 94 %; Test Name: Absolute neutrophil count; Result Unstructured Data: 1.7; Test Name: White blood cell count; Result Unstructured Data: 364000; Test Name: Albumin; Result Unstructured Data: 4.1; Test Name: Albumin; Result Unstructured Data: 3.5; Test Name: Blood grouping; Result Unstructured Data: B; Test Name: Head CT; Result Unstructured Data: Not reported; Test Name: Chloride; Result Unstructured Data: 103 mmol/L; Test Name: Hemoglobin; Result Unstructured Data: 7.8; Test Name: Rhesus antigen; Result Unstructured Data: Positive; Test Name: Absolute neutrophil count; Result Unstructured Data: 1.7 10*3/uL; Test Name: Uric acid; Result Unstructured Data: 4.7; Test Name: Antibody test; Result Unstructured Data: Not reported
Aktuelle Erkrankungen: Bone marrow suppression (Anemia secondary to bone marrow suppression from chemotherapy); Breast cancer; Chemotherapy; Chronic lymphocytic leukemia; Clostridium difficile colitis; Lymphadenopathy; Secondary pancytopenia; Subdural hematoma
Vorgeschichte: Medical History/Concurrent Conditions: Familial risk factor; Family history of cancer (Family history of Mother, Brother, Grandmother had cancer and Father had Lung cancer); Family history of cardiovascular disorder (Family history of Father and Grandmother had heart disease); Family history of diabetes (Family history of Grandmother had Diabetes); Mastectomy; Comments: The patient had no known allergies. The patient had family history of grandmother had hypertension
Andere Medikamente: ACETAMINOPHEN; AMLODIPINE; MAGNESIUM OXIDE; PROCHLORPERAZINE MALEATE; CALCIUM CHOLECALCIFEROL BERES; NAPROXEN SODIUM; VENETOCLAX; MULTIVITAMIN; BENZOCAINE; BISACODYL; CALCIUM CARBONATE; APRESOLINE; DILAUDID; LIDOCAINE HCL; NARCAN; OXYCODONE
Allergien: -
Vorherige Impfungen: -

VAERS 2051544

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MD
Alter: 21,0
Geschlecht: F
Eingang: 20.01.2022
Impfdatum: 30.12.2021
Beginn: 17.01.2022
Tage bis Beginn: 18,0
Dosis: UNK
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient was found dead in her bed 1/17/22 by a friend at around 4:30 pm. Patient had been observed to be in good health by the same friend that morning. An autopsy is planned.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: no results available at this time
Aktuelle Erkrankungen: none
Vorgeschichte: epilepsy
Andere Medikamente: Lamictal
Allergien: none
Vorherige Impfungen: -

VAERS 2219962

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 19.01.2022
Impfdatum: 09.04.2021
Beginn: 07.01.2022
Tage bis Beginn: 273,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 75yo make patient deceased on 1/7/2022 at hospital. Pt was in dialysis when he passed. Pt presented to this hospital ER on 1/4/2021/ Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 1/4/2022 Community Care Hospital Name: Chief Complaint: Pneumonia Primary Diagnosis Patient Admitting Diagnosis: Pneumonia Community Care Provider: Acute Inpatient Care Problem list: Suspected urothelial cancer Dependence on hemodialysis due to end stage renal disease CHF - Congestive Heart Failure Legal blindness Seen by palliative care medicine serviceChronic kidney disease stage 4 Urinary incontinence Cardiac pacemaker in situ PVD-peripheral vascular disease Neuropathy due to type 2 diabetes mellitus Chronic obstructive lung disease Sleep Apnea Postraumatic stress disorder Benign essential hypertension Diabetes Mellitus Hypothyroidism Major Depressive disorder Hyperlipidemia ?Pt had received covid vaccines on 3/12/2021 & 4/9/2021 from another hospital site. Not sure id pneumonia was confirmed as diagnosis and if bacterial or if pt was covid positive since records of death at hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2218820

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 19.01.2022
Impfdatum: 01.05.2021
Beginn: 04.01.2022
Tage bis Beginn: 248,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Inappropriate schedule of product administration

Symptomtext

Narrative: 73yo male pt died at nursing home "SIGNATUR OF NUSING HOME" on 12/25/2021. Problem list: PMH: Code Description L20.9 Atopic dermatitis J30.9 Allergic rhinitis I25.10 Coronary atherosclerosis N40.1 Benign prostatic hyperplasia M54.5 Low back pain Z79.01 Long-term current use of anticoagulant R60.0 Localized edma H81.13 Vertigo E87.6 Hypokalemia I10. Benign essential Chronic obstructive lung disease K21.9 Gastroesophageal reflux disease I48.91 Atrial fibrillation 564.00 Constipation, unspecified 786.59 Atypical Chest Pain (ICD- 9-CM 786.59) 473.9 Sinusitis (ICD-9-CM 473.9) 309.28 Adj Reac W/Mixed Emotion (ICD-9-CM 309.28) 311. Depression (ICD-9-CM 311.) Pt had received covid vaccines on 4/1/21 & 5/1/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2222730

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: -
Beginn: 26.12.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: - / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 82yo female patient with end-stage renal disease & Heart failure actively dying when signed up for care. Pt had received covid vaccines on 2/8/21 & 3/12/21 from non facility site. Pt died on 12/26/2021. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2222728

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 04.03.2021
Beginn: 31.12.2021
Tage bis Beginn: 302,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chronic obstructive pulmonary disease Death Essential hypertension Hypertension Insomnia Peripheral vascular disorder Persistent depressive disorder Seizure

Symptomtext

Narrative: 71yo female patient with the following problem list. PROBLEM LAST MOD PROVIDER Hypertensive disorder (ICD-10-CM 01/27/2016 I10) Peripheral vascular disease, unspecified (ICD-10-CM I73.9); Peripheral vascular disease Essential (primary) Hypertension 03/27/2018 (ICD-10-CM I10); Benign essential hypertension Chronic obstructive pulmonary disease, 03/14/2017 unspecified (ICD-10-CM J44.9); Chronic obstructive lung disease Other seizures (ICD-10-CM 03/14/2017 G40.89); Seizure Neurotic Depression (ICD-9-CM 300.4); Dysthymia 11/06/2002 Insomnia nec (ICD-9-CM 780.52) Pt received covid vaccines at non facility site on 2/4/21 & 3/4/21. Pt died on 12/31/2021. Not able to assess if covid vaccines were related to pt's death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2219971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 11.03.2021
Beginn: 07.12.2021
Tage bis Beginn: 271,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 80yo male Pt died on 12/7/2021. Pt had received covid vaccines at nonresident site on 2/18/21 & 3/11/21. Pt had moved into assisted living facility where got a new PCP. Last facility chart note on 8/18/2021. Pt died of unknown cause, unknown location & unknown circumstances. Facilities problem list: PROBLE LAST MOD PROVIDER Essential Hypertension (SCT 1201005) (ICD-10-CM 07/06/2016 I10) Chronic Kidney Disease, Unspecified (SCT 07/06/2016 42399005) (ICD-10-CM-N18.9) Abdominal aneurysm without mention of rupture 02/12/2014 (ICD-9-CM 441.4) Other and unspecified hyperlipidemia (SCT 07/06/2016 267434003) (ICD-10-CM E78.2) Peripheral Vascular Disease, Unspecified 02/12/2014 (ICD-9-CM 443.9) Coronary Atherosclerosis (unspecified type 07/06/2016 vessel, native or graft) (SCT 53741008) (ICD-10-CM I25.10) Sensorineural Hearing Loss (SCT 161451004) (ICD-10-CM M10.9) 07/06/2016 Personal History of other Mental Disorders 02/12/2014 (ICD-9-CM V11.8) Chronic airway obstruction, Not Elsewhere 07/06/2016 Classified (SCT 13645005) (ICD- 10-CM J44.9) Personal History of Tobacco Use (SCT 07/06/2016 1221000119103) (ICD-10-CM Z87.891) Diabetes Mellitus without mention of 07/06/2016 Complication, type II or unspecified type, not stated as Uncontrolled (SCT 313436004) (ICD-10-CM E11.9) This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2218952

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 09.11.2021
Beginn: 10.01.2022
Tage bis Beginn: 62,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Chronic obstructive pulmonary disease Condition aggravated Cor pulmonale Death Dyspnoea Enterococcal infection General physical health deterioration Intensive care Pulmonary hypertension

Symptomtext

Narrative: 73yo male Pt with a h/o T2DM, COPD on 2-3L NC at home, CKD stage 3, NPH s/p VP shunt, OSA on CPAP, PTSD/Anxiety, who presented to VA ER on 12/23/2021 for shortness of breath x 3 days. Pt was admitted with Acute on Chronic Hypoxic Respiratory Failure 2/2 COPD Exacerbation vs Cor Pulmonale in the setting of Pulmonary Hypertension, poa diagnosis. Pt given antibiotics, treated in the ICU as pt deteriorating. Pt then died on 1/10/2022. Death was caused by: Severe ARDS secondary to Enterococcus faecium and Enterococcus faecalis. Pt had received covid vaccines on 1/25/21, 2/22/21, & 11/9/21 from other facility site. This death was not related to covid vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2218947

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 17.02.2021
Beginn: 12.11.2021
Tage bis Beginn: 268,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Atrial fibrillation Bacteraemia Cardiac failure acute Cardiac pacemaker insertion Chest pain Computerised tomogram abdomen abnormal Condition aggravated Death Dementia Gallbladder enlargement Hypoxia Klebsiella bacteraemia Klebsiella infection Left ventricular failure Pneumonia Sepsis Ultrasound abdomen abnormal

Symptomtext

Narrative: 91yo male died on 11/12/2021 of unknown cause, unknown place, & unknown circumstances. Pt did have a previous hospitalization at a non-community hospital - Per MD note: "Date of Service" 10/24/2021 - 10/29/2021 Name of Facility: Inpatient Admitted for Chest pain and diagnosed with sepsis, acute respiratory failure with hypoxia, bilateral lower lobe pneumonia, bacteremia from Klebsiella pneumoniae, and acute on chronic systolic heart failure. This is the second episode of bacteremia in the past month. CT abdomen and RUQ U/S showed gallbladder wall thickening. ID consulted and recommended 2 weeks of IV antibiotics, last day 11/9/2021. They state if bacteremia occurs again, that gallbladder could be likely source and would need removal. Hypoxia improved after hypertonic saline treatment and IV diuresis." Problem list: PROBLEM LAST MOD PROVIDER Chronic combined systolic and diastolic heart 10/21/2021 failure Paroxysmal atrial fibrillation, 10/21/2021 Cardiac pacemaker in situ 07/20/2021 Dementia 07/20/2021 Heart failure 04/20/2020 Hearing loss 04/20/2020 Benign prostatic hyperplasia 04/20/2020 Callosity under metatarsal head 06/01/2018 Asthma 01/14/2016 Hyperlipidemia 01/14/2016 Diabetes mellitus type 2 without retinopathy 01/14/2016 Hypothyroidism 01/14/2016 Trigger finger 02/17/2010 Osteoarthrosis, unspecified whether generalized 12/01/2009 or localized, involving unspecif hypertension 01/14/2016 Coronary Artery Disease 01/14/2016 Pt had received covid vaccines from non-facility site on 01/27/21 & 2/17/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2042997

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 04.03.2021
Beginn: 15.12.2021
Tage bis Beginn: 286,0
Dosis: UNK
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal distension Acute kidney injury Acute respiratory failure Atrial fibrillation Body temperature increased Bradycardia COVID-19 COVID-19 pneumonia Cardioversion Endotracheal intubation Hypotension Hypoxia Oxygen saturation decreased Positive airway pressure therapy SARS-CoV-2 test positive Vomiting

Symptomtext

Patient seen in follow up for severe acute hypoxic respiratory failure/ multifocal pneumonia due to COVID + 12/15. Moderna Vaccine 3-4 2021. Patient is requiring 100% BIPAP Critical care has discussed cautious monitoring for potential need for intubation and vent support. High dose Decadron/Remdesivir and Baricitinib in progress 12/26 AKI 1.41 Intermittent Bradycardia ? Related to covid, ? remdesivir

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Patient seen in follow up for severe acute hypoxic respiratory failure/ multifocal pneumonia due to COVID + 12/15. Events of last 24 hrs reviewed. Episode of vomiting on Bipap leading to hypoxia and subsequent intubation yesterday afternoon. Desats and hypotension overnight requiring bagging for over an hour and institution of vasopressor support, Tmax 101.3. Developed afib with RVR and initiated on Amiodarone followed by cardioversion. Vasopressors increased overnight with increasing abdominal distention and peak pressure elevated at 40- surgery evaluating this morning. Currently requiring 35 mcg Levophed, 4 Epinephrine and vasopressin Current Antibiotics: Baricitinib day 5 Decadron 20 day 5 Remdesivir day 5 Current Facility-Administered Medi
Aktuelle Erkrankungen: ? Anemia ? Arthritis ? Back pain ? Basal cell carcinoma ? Blood transfusion 2 UNITS APRIL 2013 AT HOSP ? Gout ? Heart attack ? Hypertension ? Pure hypercholesterolemia ? Rectal bleeding
Vorgeschichte: ? Anemia ? Arthritis ? Back pain ? Basal cell carcinoma ? Blood transfusion 2 UNITS APRIL 2013 AT HOSP ? Gout ? Heart attack ? Hypertension ? Pure hypercholesterolemia ? Rectal bleeding
Andere Medikamente: albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT INHAL Aero Soln inhale 2 Puffs into the lungs every 4 hours as needed for FOR SHORTNESS OF BREATH. (disp insurance-pref prod) atorvastatin (LIPITOR) 40 MG PO Tab azithr
Allergien: none
Vorherige Impfungen: -

VAERS 2039462

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: ME
Alter: 30,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 06.01.2022
Beginn: 09.01.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest pain Dyspnoea Exposure during pregnancy Heart rate increased Pulmonary embolism Venous thrombosis limb

Symptomtext

3 days after getting the second covid-19 injection i had a very fast heart rate and my chest hurt on the left side and I kept getting winded very easily. on the 4th day i went into the ER as the symptoms did not improve. An ultrasound was done and I had 2 blood clots in my left arm (same arm both injections were administered in) the doctor stated she was pretty certain I also had a pulmonary embolism but could not confirm as I am pregnant and it is not smart to get a CT scan while pregnant. I have never had a blood clot or any blood issues ever, there are no clots or blood issues in my family history that are genetically related. I have had 4 previous pregnancies which i have NEVER had a blood clot complication. I do have an incompetent cervix and require a cerclage for my pregnancies. My pregnancies have had births at the following: 23 weeks (1 lb 2 oz), 37 weeks (6 lbs 12 oz), 36 weeks (5lbs 12 oz) and 33 weeks (4 lbs 7oz). This is unrelated to this condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: No abnormalities were found in blood tests 2 blood clots discovered in left arm. Final report word for word as follows: There is expansile intermediately echogenic thrombus within the left brachial vein at the arm and probably the forearm, noncompressible. This appears mildly expansile
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Prenatal vitamins.
Allergien: Latex.
Vorherige Impfungen: Short of breath.

VAERS 2038105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 51,0
Geschlecht: F
Eingang: 15.01.2022
Impfdatum: 25.05.2021
Beginn: 09.01.2022
Tage bis Beginn: 229,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute myocardial infarction Anticoagulant therapy Asymptomatic COVID-19 COVID-19 Chest discomfort Chest pain Computerised tomogram head normal Condition aggravated Device malfunction Dyspnoea Fatigue Gaze palsy Magnetic resonance imaging head normal Neurological symptom Paraesthesia SARS-CoV-2 test positive Somnolence Thirst

Symptomtext

Hospitalized 1.8.22; COVID positive 1.6.22 and 1.9.22; Fully Vaccinated Admission Date: 1/8/2022 Discharge Date: Jan 11, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Chest pain, unspecified type COVID-19 HOSPITAL COURSE: Patient is a 52 year old woman with PMHx of cocaine abuse, CAD, NICM s/p ICD, DM2, CKD. Currently living in rehab facility and has abstained from cocaine since early December. She presented with chest pain and shortness of breath. She also had a reported positive rapid / antigen test at her facility, though she reports she never saw these results with her own eyes. She was admitted with elevated troponins. Repeat COVID swab was positive but patient remained asymptomatic Patient developed non specific neuro symptoms of L side paratsthesias and R gaxe palsy. Symptoms resolved. CT Head, Brain MRI. Orbit MRI were all benign CP and troponins increased while inpatient. Cardiology diagnosed her with NSTEMI type 1 and added Plavix and Entresto to her meds. Heart cath was not pursued since she had a recent cath. 1/11/2021 Pt S+E. Alert. NAD, VSS on RA. No CP. Wants to go home. Stable at diascharge. Patient in agreement with instructions to follow up with cardiology as outpatient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: 12.8.21 - ED visit - AICD PROBLEM (Pt brought in by EMS, Hx of ICD placement in the past year r/t drug abuse/dependance. Pt currently staying at HCF, but "had a bender" this past weekend. Defib fired around 0700 today as well as 2 days ago. Pt wasn't evaluated when it firedthe first time, stating "I was just tired and thirsty and wanted to sleep." Pt reports chest discomfortbut denies SOB. )
Vorgeschichte: ICD (implantable cardioverter-defibrillator) in place Essential hypertension Anxiety Fibromyalgia Alcohol abuse Environmental allergies Arthritis Back pain, chronic Other chest pain Class 2 severe obesity with serious comorbidity in adult (HCC) Migraine without aura and without status migrainosus, not intractable History of drug use Dilated cardiomyopathy (HCC) Asthma OSA treated with BiPAP Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris (HCC) Restrictive lung disease Mediastinal lymphadenopathy Type 2 diabetes mellitus with diabetic nephropathy (HCC) Combined systolic and diastolic cardiac dysfunction Gastroesophageal reflux disease Slow transit constipation Severe episode of recurrent major depressive disorder, without psychotic features (HCC) CHF (congestive heart failure), NYHA class I, acute on chronic, combined (HCC) Stage 3b chronic kidney disease (HCC) Advanced care planning/counseling discussion Ptosis of right eyelid Chronic bilateral low back pain with bilateral sciatica Drug abuse (HCC) Acute kidney injury (HCC) Myocardial injury
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ARIPiprazole (ABILIFY) 2 MG tablet ascorbic acid (VITAMIN C) 1000 MG tablet aspirin 81 MG chewable tablet atorvastat
Allergien: LisinoprilAnaphylaxis Motrin [Ibuprofen]GI Upset
Vorherige Impfungen: -

VAERS 2034105

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 14.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

LOST ANOTHER ONE TO THE JAB; This spontaneous report received from a consumer via media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose and start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died from unknown cause of death. The reporter stated that "Lost another one to the jab ". It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0:20220118906-COVID-19 VACCINE AD26.COV2.S-Lost another one to the jab. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2034100

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 14.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Amnesia Feeling abnormal General physical health deterioration Hypersomnia Loss of consciousness Mental impairment Pulmonary embolism

Symptomtext

CORE EMBOLISM IN BOTH LUNGS; COULD NOT THINK CLEARLY; PASSING OUT; MEMORY LOSS FOR A FEW HOURS; UNAWARE IT WAS IF A FOG WAS OVER MY BRAIN; QUALITY OF LIFE CHANGED; FELT SO TERRIBLE SLEPT FOR 3 DAYS; This spontaneous report received from a patient concerned a 43 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, dose and start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced core embolism in both lungs, could not think clearly, passing out ( In the course of about 2-3 months was passing out, then passing out more often, then It got to the point was passing out every time stood up), on third day memory loss for a few hours, unaware it was if a fog was over my brain, quality of life changed forever due to the sever reaction of the vaccine, and felt so terrible slept for 3 days. While in the middle of other life issues (my Husband abandoning me) and other issues of that nature (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from memory loss for a few hours, and felt so terrible slept for 3 days, had not recovered from passing out, could not think clearly, and quality of life changed, and the outcome of unaware it was if a fog was over my brain and core embolism in both lungs was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220114341-COVID-19 VACCINE AD26.COV2.S- Core embolism in both lungs ,Could not think clearly, Passing out This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2228204

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 52,0
Geschlecht: M
Eingang: 13.01.2022
Impfdatum: 11.04.2021
Beginn: 12.12.2021
Tage bis Beginn: 245,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrioventricular block complete Chest pain Death Dyspnoea exertional Inappropriate schedule of product administration

Symptomtext

Narrative: 51yo male Pt on 12/4/2021 presented to ER with extensive cardiac hx. 2 stents / stemi LAD 8/2012, CATH 5/10/17-stent thrombosis , hyperlipidemia, dm, htn. Substernal chest pain,dyspnea upon exertion. Pt was found to be having an acute MI and was transferred to Hospital cath lab and found 100% blockage. Pt treated at this hospital. Hospital then notified Pt had died on 12/12/2021 at a different hospital (non-resident facility) health facility. Pt had received covid vaccines on 3/14/21 & 4/11/21. This death is not related to covid vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373523

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 06.02.2021
Beginn: 24.12.2021
Tage bis Beginn: 321,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 63yo male in home community GEC care with PMH: Osteoarthritis Schizoaffective disorder, bipolar type Murmur Substance Abuse Negative PPD Tobacco user Essential hypertension Legal blindness died on 12/24/2021. Pt had received covid vaccines from Health dept on 1/16/21 & 2/6/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373515

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 25.02.2021
Beginn: 22.12.2021
Tage bis Beginn: 300,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Dialysis

Symptomtext

Narrative: 73yo male with End Stage Renal Disease died on 12/22/21 at dialysis. He resided at at nursing facility. Pt had received covid vaccines on 2/4/21 & 2/25/21. This death was not related to covid vaccines

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373507

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 29.04.2021
Beginn: 01.01.2022
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Inappropriate schedule of product administration Lung neoplasm malignant

Symptomtext

Narrative: 73yo male died at home in hospice care on 1/1/22 from lung cancer. Pt had received covid vaccines on 3/26/21 & 4/29/21. This death is not related to the covid vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373504

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 21.08.2021
Beginn: 21.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 72 yo male died on 12/19/2021. Pt has record of one covid vaccine given on 8/21/21. No info since 2008 in medical chart. Pt's problem list from 2008 below: PROBLEM LAST MOD PROVIDER HTN (ICD-9-CM 401.9) 06/15/2007 Dupuytren's Contracture (ICD-9-CM 728.6) 6/15/2007 Prolonged posttraumatic stress disorder 12/28/1995 (ICD-9-CM 309.81), Onset 00/00/1993 Adjustment reaction with brief depressive 12/28/1995 reaction (ICD-9-CM 309.0), Onset 00/00/1993 Deviated nasal septum (ICD-9-CM 470.), Onset 12/28/1995 00/00/1993 Major Depressive Disorder, Single Episode, 12/28/1995 Unspecified (ICD-9-CM 296.20), Onset 00/00/1993 Other and unspecified alcohol dependence, in 12/28/1995 remission (ICD-9-CM 303.93), Onset 00/00/1993 Allergic rhinitis (ICD-9-CM 477.9), Onset 12/28/1995 00/00/1993 Acute upper respiratory infections of 12/28/1995 unspecified site (ICD-9-CM 465.9), Onset 00/00/1993 Depression, Neurotic (ICD-9-CM 300.4), Onset 12/28/1995 00/00/1993 Alcoholic gastritis, without mention of 12/28/1995 hemorrhage (ICD-9-CM 535.30), Onset 00/00/1994 Acidosis (ICD-9-CM 276.2), Onset 00/00/1994 12/28/1995 Not able to assess any information about pt's death and if related to covid vaccine. Pt's home address in another state. Likely pt moved there.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373497

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 04.03.2021
Beginn: 03.12.2021
Tage bis Beginn: 274,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Inappropriate schedule of product administration

Symptomtext

Narrative: 85 yo male died on 12/03/2021 with hx of niddm, mild ckd, bph s/p TURP, chronic diffuse low back pain, bilat knee pain on chronic opioids, macular deg/glaucoma, left eye enucleation due to MRSA infection. Pt had received covid vaccines on 2/1/21 & 3/4/21 from another site. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2373491

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 12.03.2021
Beginn: 29.12.2021
Tage bis Beginn: 292,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 73yo male died at community hospital on 12/29/2021 with hx of: Problem List: Cerebral infarction Deposits [accretions] on teeth (ICD-10-CM K03.6) Diabetic neuropathy Diabetes mellitus Essential hypertension Obesity Arthritis Hyperlipidemia Aortic valve stenosis - per cardio APRN note - "severe aortic stenosis" - requesting TAVR vs SAVR Pt had received covid vaccines on 2/12/21 & 3/12/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217969

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 05.03.2021
Beginn: 26.12.2021
Tage bis Beginn: 296,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 90yo male patient has a past medical h.o. malignant bladder cancer with occasional hematuria (denies any recently), HTN, COPD, HLD, pacemaker placement, malignant prostate cancer, and atrial fibrillation (on metoprolol and warfarin), Colonic Pseudo obstruction, who was a home hospice patient but transferred to hospice at nursing home facility with hospice unit. Pt died in hospice unit at this facility on 12/26/2021. Pt had received covid vaccines prior to moving to state from state, so received vaccines from outside city hospital facility on 2/5/21 & 3/5/21. This death was not related to vaccines given pt's hospice status from morbidities and advanced age.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217966

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 47,0
Geschlecht: F
Eingang: 12.01.2022
Impfdatum: 31.08.2021
Beginn: 23.12.2021
Tage bis Beginn: 114,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Cardiac disorder Catheterisation cardiac Death Inappropriate schedule of product administration Myocardial infarction Sinus tachycardia

Symptomtext

Narrative: 46yo female patient died at outside facility on 12/23/2021 with diagnosis of STEMI/Sinus Tachycardia, - heart condition. (pt presented to ER - was evaluated and transferred to hospital for heart cath procedure- where pt later died) Past Medical Condition: Esophageal varices (SCT 28670008) Nondependent alcohol abuse in remission (SCT 191884001) Intracavitary uterine fibroid (SCT 25911Cervical disc disorder (SCT 425878001) Severe alcohol dependence (SCT 713862009Alcohol-induced mood disorder (SCT Depressive disorder (SCT 35489007) Anxiety (SCT 48694002) Alcohol intoxication (SCT 25702006) Alcohol intake exceeds recommended daily limit (SCT 429775004) Heavy cigarette smoker (20-39 cigs/day) Alcoholic liver disease (SCT 41309000) Hepatic fibrosis (SCT 62484002) Alcoholic fatty liver (SCT 50325005) Polyp of colon (SCT 68496003) Liver mass (SCT 300332007) Dislocation of patellofemoral joint (SCTJoint pain (SCT 57676002) Hearing loss (SCT 15188001) Heart murmur (SCT 88610006) Constipation (SCT 14760008) Musculoskeletal pain (SCT 279069000) Pt had received covid vaccines on 8/31/21 & 6/8/21, 5/11/21 at non-facility site (grocery store). Pt died of heart attack. This death is likely not related to the vaccinations due to patient's length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217964

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 02.11.2021
Beginn: 30.12.2021
Tage bis Beginn: 58,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bladder cancer Cardiac disorder Condition aggravated Death

Symptomtext

Narrative: 86yo male patient with bladder cancer and heart conditions died on 12/30/2021 during inpatient at hospital (non-facility). PMH: Bladder cancer (SCT 399326009) Atrial fibrillation (SCT 49436004) Low back pain (SCT 279039007) Cardiac defibrillator in situ (SCT 441769002) History of coronary artery disease with CVA (ICD-9-CM 434.91) Glaucoma (SCT 23986001) Cardiomyopathy (SCT 85898001) Benign essential hypertension (SCT 12010Erectile Dysfunction (ICD-9-CM 302.72) Elevated PSA (ICD-9-CM 790.93) Hyperlipidemia (SCT 55822004) Benign prostatic hyperplasia (ICD-9-CM 6 Pt had received covid vaccines from outside facility site on 1/21/21, 2/23/21, & 11/2/21 from health dept This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217960

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 29.09.2021
Beginn: 15.12.2021
Tage bis Beginn: 77,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: On Nov 2, 2021 78yo patient presented to Primary care to establish care with facility for possible hearing aid as receives his medical care & medications from outside facility providers. Pt had received covid vaccines on on 2/12/21, 3/5/21, & 9/29/21 at store. Pt died of unknown causes & unknown location on 12/15/2021. Not able to assess if covid vaccines are related to this death. Pt medical history included DM & COPD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2215733

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 08.02.2021
Beginn: 10.12.2021
Tage bis Beginn: 305,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 89yo male patient died on 12/10/2021. No information about pt's death available. Last chart note from 9/16/21. Per chart (dated 4/22/21): PROBLEM LIST: Restrictive lung disease (SCT 36485005) Shoulder pain (ICD-9-CM 719.41) Postsurgical Aortocoronary Bypass Status Erectile dysfunction due to general medical condition (SCT 10954100119101) Anemia (ICD-9-CM 285.9) Vitamin B 12 Deficiency (ICD-9-CM 266.2) Anemia, Folic Acid Deficiency (ICD-9-CM Occlusion and Stenosis of Carotid Artery, without Cerebral Infarction (ICD-9-CM 433.10) AF - Atrial fibrillation (SCT 49436004) Insomnia (SCT 193462001) Hearing impaired (SCT 15188001) Presbyopia (ICD-9-CM 367.4) Male erectile disorder (ICD-9-CM 302.72)Coronary Artery Disease (ICD-9-CM 414.9) Essential hypertension (SCT 5961000) Hypothyroidism (ICD-9-CM 244.9) Dyslipidemia (ICD-9-CM 272.4) Pt had received 2 covid vaccines from outside site on 1/11/21 & 2/8/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453315

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 30.08.2021
Beginn: 05.12.2021
Tage bis Beginn: 97,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death Malaise Respiratory failure SARS-CoV-2 test positive

Symptomtext

Narrative: 68yo male patient died on 12/5/2021 of respiratory failure. Per, his family he had tested positive of Covid in November of 2021 and remained ill up until his death. Pt had received one dose of J&J vaccine on 8/30/2021 outside facility, location unknown. Pt struggled with homelessness and mental health issues. See pt's problem list below: PROBLEM LAST MOD PROVIDER Chronic pulmonary embolism 10/29/2020 (ICD-10-CM I27.82) Light cigarette smoker (1-9 cigs/day) (ICD-10-CM F17.210) Impotence (ICD-10-CM N52.9) 06/05/2019 Obstructive sleep apnea of adult (ICD-10-CM G47.33) House rented from housing association (ICD-10-CM Z59.8) Benign prostatic hyperplasia 06/05/2019 (ICD-10-CM N40.1) Impotence (ICD-10-CM N52.8) 12/17/2018 Pain in left knee 12/17/2018 (ICD-10-CM M25.562) Chronic obstructive lung disease 05/22/2018 (ICD-10-CM J44.9) H/O: pulmonary embolus 05/22/2018 (ICD-10-CM Z86.711) Pulmonary hypertension (ICD-10-CM 05/22/2018 I27.20) Homeless single person 05/09/2018 (ICD-10-CM Z59.0) Avascular necrosis of the head of femur (ICD-10-CM M87.052) Cocaine abuse (ICD-10-CM F14.10) 03/06/2018 Pain in left leg (ICD-10-CM 02/19/2016 M79.605) Derangement of meniscus (ICD-9-CM 717.5) 07/24/2015 Chondromalacia of patella (ICD-9-CM 717.7) 07/24/2015 Gastroesophageal reflux disease 02/19/2016 (ICD-10-CM K21.9) Hip pain (ICD-9-CM 719.45) 07/24/2015 Hyperlipidemia (ICD-9-CM 272.4) 07/24/2015 Hypertrophy Breast (ICD-9-CM 611.1) 04/21/2014 Unspecified glaucoma (ICD-9-CM 365.9) 12/30/2013 (ICD-9-CM 266.2); Vitamin B 12 Deficiency 08/28/2013 (ICD-9-CM 266.2 ; will need B12 injections once established in PCC Hypertension (ICD-10-CM I10.) 02/19/2016 (ICD-10-CM F10.20); Alcohol dependence (ICD-10-CM Z59.0); Homeless 06/18/2018 (ICD-9-CM 309.0); Adjustment Disorder with 07/01/2013 depressed mood (ICD-9-CM 309.0) (ICD-10-CM F32.8); Depression No information in records of circumstances or place of pt's death. Pt did not test covid positive at facility. Potentially this is a breakthrough case of covid infection since pt had been vaccinated with J&J dose on 8/30/21 and potentially died of covid infection on 12/5/21, but unable to confirm since pt had not been seen for medical care at facility since 10/15/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453301

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 10.02.2021
Beginn: 29.12.2021
Tage bis Beginn: 322,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Pain Renal cancer

Symptomtext

Narrative: 91yo male patient was admitted into hospice services on Saturday, Dec 18,2021 for renal cancer and uncontrolled pain. Pt died on 12/29/2021 from cancer at hospice house. Pt received one dose of covid vaccine - Moderna on 2/10/2021 from another source. Death is not related to covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2026252

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 71,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 18.08.2021
Beginn: 31.12.2021
Tage bis Beginn: 135,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Anticoagulant therapy Ascites Back pain COVID-19 COVID-19 pneumonia Chills Crohn's disease Cytopenia Deep vein thrombosis Diarrhoea Diffuse large B-cell lymphoma Dizziness Dyspnoea Gastric varices Hypertension Hypotension

Symptomtext

Hospitalized (1.3.22); COVID-19 positive (12.31.21); fully vaccinated PLUS booster DATE OF ADMISSION: 01/03/2022 DATE OF DISCHARGE: 01/08/2022 DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Acute left popliteal deep vein thrombosis. 3. Community-acquired pneumonia ruled out. 4. Chronic left pleural effusion. 5. Diffuse large B-cell lymphoma with splenomegaly and ascites. 6. Hypertension. 7. Iron deficiency anemia. 8. Crohn disease. 9. Chronic back pain. 10. History of prediabetes. 11. Obstructive sleep apnea. 12. Nonischemic troponin elevation due to infection. 13. Mild transaminitis, resolved PROCEDURES 1. CTA thorax. 2. Bilateral upper and lower extremity Dopplers. HOSPITAL COURSE 1. COVID pneumonia. A 71-year-old patient presented to the ER with chills, dyspnea and dizziness (no falls), and diarrhea. Symptoms started 12/23 and patient tested positive outpatient, 12/31. At home, he was hypoxic, using his home pulse oximeter and presented for evaluation. On presentation, his SpO2 was 77% on room air, temp 39.3 with mild tachycardia (109) and tachypnea (26). Initially placed on non-rebreather, but rapidly transitioned to high-flow nasal cannula. CTA of the thorax was negative for PE. Left pleural effusion was present but was unchanged based on prior CTs. He was initially started on Decadron, then changed to Solu-Medrol ***mg/kg per 24 hours. We felt he was extremely high risk to develop PE given his underlying malignancy, and we elected to start full-dose Lovenox 1 mg/kg q.12 hours. This was done despite thrombocytopenia and known gastric varices. Very close monitoring for acute bleeding was done. He did not show any evidence of acute bleeding during the hospitalization. He did have lower extremity venous Doppler that showed an acute nonocclusive left popliteal vein DVT. Right lower extremity negative and both arms negative as well. Aggressive diuresis was performed throughout the hospitalization. He slowly improved and by discharge was on room air with an ambulatory pulse ox of 91% on room air. He received a total of 5 days of steroids during the hospitalization (01/04-01/08) and is being discharged on an additional 5 days of Decadron to complete 10 days of treatment. 2. Acute left popliteal DVT. Treated with Lovenox 90 mg q.12 hours during the hospitalization and discharged on Eliquis. Would recommend 3 months of therapy. 3. Hypertension. Blood pressure was low during the hospitalization. Norvasc and hydralazine held both during the hospitalization and at discharge. Blood pressures ranged from 109/70 to 131/74 on the day of discharge. Would ask PCP to closely follow this and decide when to resume antihypertensives. 4. History of prediabetes. Treated with very low-dose corrective scale during the hospitalization. He was not sent home on any medications for diabetes. 5. Chronic thrombocytopenia. Present since July and felt to be due to chemotherapy. Last platelet count before discharge (on 01/07/2022) is 102. No evidence for bleeding. 6. Stage IV diffuse large B-cell lymphoma. Status post R-CHOP x6 cycles February through June of 2021, requiring multiple dose reductions due to cytopenias. He has known occluded segment of the splenic vein, left upper quadrant splenic and gastric varices and persistent splenomegaly. None of these issues were acutely addressed during this hospitalization. Additionally, his chronic left pleural effusion was not addressed. 7. Crohn disease. On chart review, it is noted he was on Humira until December 2020. This was discontinued when lymphoma was diagnosed with no plans to resume

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Iron deficiency anemia secondary to blood loss (chronic) Cholesterol Goal < 160 Lumbar radiculopathy, chronic left leg Postthrombotic syndrome of left lower extremity Crohn's disease involving terminal ileum (HCC) Gastroesophageal reflux disease without esophagitis History of adenomatous polyp of colon Excessive daytime sleepiness OSA (obstructive sleep apnea) - APAP 6-16 - HTN (hypertension), benign Prediabetes Diffuse large B-cell lymphoma of lymph nodes of multiple regions (HCC) Pancytopenia due to chemotherapy (HCC) History of DVT (deep vein thrombosis) - 2014 -
Andere Medikamente: apixaban (ELIQUIS) 5 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) tablet brimonidine (ALPHAGAN) 0.2 % ophthalmic solution Cholecalciferol (VITAMIN D PO) ciclopirox (PENLAC) 8 % solution dexamethasone (DECADRON) 6 MG tablet famotidine (P
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2026252

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 71,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 18.08.2021
Beginn: 31.12.2021
Tage bis Beginn: 135,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Anticoagulant therapy Ascites Back pain COVID-19 COVID-19 pneumonia Chills Crohn's disease Cytopenia Deep vein thrombosis Diarrhoea Diffuse large B-cell lymphoma Dizziness Dyspnoea Gastric varices Hypertension Hypotension

Symptomtext

Hospitalized (1.3.22); COVID-19 positive (12.31.21); fully vaccinated PLUS booster DATE OF ADMISSION: 01/03/2022 DATE OF DISCHARGE: 01/08/2022 DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Acute left popliteal deep vein thrombosis. 3. Community-acquired pneumonia ruled out. 4. Chronic left pleural effusion. 5. Diffuse large B-cell lymphoma with splenomegaly and ascites. 6. Hypertension. 7. Iron deficiency anemia. 8. Crohn disease. 9. Chronic back pain. 10. History of prediabetes. 11. Obstructive sleep apnea. 12. Nonischemic troponin elevation due to infection. 13. Mild transaminitis, resolved PROCEDURES 1. CTA thorax. 2. Bilateral upper and lower extremity Dopplers. HOSPITAL COURSE 1. COVID pneumonia. A 71-year-old patient presented to the ER with chills, dyspnea and dizziness (no falls), and diarrhea. Symptoms started 12/23 and patient tested positive outpatient, 12/31. At home, he was hypoxic, using his home pulse oximeter and presented for evaluation. On presentation, his SpO2 was 77% on room air, temp 39.3 with mild tachycardia (109) and tachypnea (26). Initially placed on non-rebreather, but rapidly transitioned to high-flow nasal cannula. CTA of the thorax was negative for PE. Left pleural effusion was present but was unchanged based on prior CTs. He was initially started on Decadron, then changed to Solu-Medrol ***mg/kg per 24 hours. We felt he was extremely high risk to develop PE given his underlying malignancy, and we elected to start full-dose Lovenox 1 mg/kg q.12 hours. This was done despite thrombocytopenia and known gastric varices. Very close monitoring for acute bleeding was done. He did not show any evidence of acute bleeding during the hospitalization. He did have lower extremity venous Doppler that showed an acute nonocclusive left popliteal vein DVT. Right lower extremity negative and both arms negative as well. Aggressive diuresis was performed throughout the hospitalization. He slowly improved and by discharge was on room air with an ambulatory pulse ox of 91% on room air. He received a total of 5 days of steroids during the hospitalization (01/04-01/08) and is being discharged on an additional 5 days of Decadron to complete 10 days of treatment. 2. Acute left popliteal DVT. Treated with Lovenox 90 mg q.12 hours during the hospitalization and discharged on Eliquis. Would recommend 3 months of therapy. 3. Hypertension. Blood pressure was low during the hospitalization. Norvasc and hydralazine held both during the hospitalization and at discharge. Blood pressures ranged from 109/70 to 131/74 on the day of discharge. Would ask PCP to closely follow this and decide when to resume antihypertensives. 4. History of prediabetes. Treated with very low-dose corrective scale during the hospitalization. He was not sent home on any medications for diabetes. 5. Chronic thrombocytopenia. Present since July and felt to be due to chemotherapy. Last platelet count before discharge (on 01/07/2022) is 102. No evidence for bleeding. 6. Stage IV diffuse large B-cell lymphoma. Status post R-CHOP x6 cycles February through June of 2021, requiring multiple dose reductions due to cytopenias. He has known occluded segment of the splenic vein, left upper quadrant splenic and gastric varices and persistent splenomegaly. None of these issues were acutely addressed during this hospitalization. Additionally, his chronic left pleural effusion was not addressed. 7. Crohn disease. On chart review, it is noted he was on Humira until December 2020. This was discontinued when lymphoma was diagnosed with no plans to resume

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Iron deficiency anemia secondary to blood loss (chronic) Cholesterol Goal < 160 Lumbar radiculopathy, chronic left leg Postthrombotic syndrome of left lower extremity Crohn's disease involving terminal ileum (HCC) Gastroesophageal reflux disease without esophagitis History of adenomatous polyp of colon Excessive daytime sleepiness OSA (obstructive sleep apnea) - APAP 6-16 - HTN (hypertension), benign Prediabetes Diffuse large B-cell lymphoma of lymph nodes of multiple regions (HCC) Pancytopenia due to chemotherapy (HCC) History of DVT (deep vein thrombosis) - 2014 -
Andere Medikamente: apixaban (ELIQUIS) 5 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) tablet brimonidine (ALPHAGAN) 0.2 % ophthalmic solution Cholecalciferol (VITAMIN D PO) ciclopirox (PENLAC) 8 % solution dexamethasone (DECADRON) 6 MG tablet famotidine (P
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2024950

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: TN
Alter: 80,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 11.05.2021
Beginn: 30.12.2021
Tage bis Beginn: 233,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Case vaccinated with J&J on 5/11/2021. tested positive for covid 19 on 12/30/2021. Admitted to Hospital on 12/30/2021 and expired on 01/07/2022 while still hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2024024

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This spontaneous report received from a consumer via social media from company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the reporter stated that, "I have a friend who was young, took the Johnson shot and died two weeks later" (Dose number in series 1). On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0 20220100327-COVID-19 VACCINE AD26.COV2.S-Died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2658667

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 10.01.2022
Impfdatum: 25.03.2021
Beginn: 28.11.2021
Tage bis Beginn: 248,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 67yo male patient died on 11/28/2021. Pt has not received medical care from this facility since 8/2018. Per MD note 2/2/2018: "PMH:==== Prostate CA 1999 Compression fracture to ankle Bilateral knee pain with blast injury Ventral hernia Lower back pain Cervical neck pain Right eye injury with glass" Pt had record of receiving 2 covid vaccines from outside source. No info provided except dates given on 3/4/21, 3/25/21. Not able to assess if this death is related to covid vaccines given lack of information & no longer an active patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2605748

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 10.01.2022
Impfdatum: 12.03.2021
Beginn: 26.12.2021
Tage bis Beginn: 289,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 80yo male patient died on 12/26/2021 at nursing home (NON-AGENCY facility) under NH placement. Pt had the following: COPD on home 2L O2 NC, SCLC, HFpEF (EF 45 %), CAD, HTN, & T2DM. Pt had received covid vaccines on 2/12/21 & 3/12/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2020983

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: AZ
Alter: 80,0
Geschlecht: M
Eingang: 10.01.2022
Impfdatum: 26.10.2021
Beginn: 16.12.2021
Tage bis Beginn: 51,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Cardiac failure Carditis Death Vaccination complication

Symptomtext

Death, from vaccine induced heart swelling and failure. Died on the evening of December 16th, 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Autopsy by County Medical Examiner.
Aktuelle Erkrankungen: diabetes
Vorgeschichte: obese, high blood pressure, diabetes
Andere Medikamente: Blood thinner, insulin
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2018528

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 41,0
Geschlecht: M
Eingang: 08.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

passed away; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from License Party. Other Case identifier(s): 110772. A 41 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: Unknown) at the age of 41 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "passed away". The patient date of death was unknown. The reported cause of death was "passed away". It was not reported if an autopsy was performed. Addition information: it was reported that: A 41-year-old patient who had no health problems, 48 hours after receiving the vaccine, he passed away. The lot number for bnt162b2 was not provided and will be requested during follow up.; Reported Cause(s) of Death: passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2017466

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 08.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Myocardial infarction

Symptomtext

PASSED AWAY FROM THE J&J BOOSTER SHOT; HEART ATTACK; This spontaneous report received from a consumer via social media through company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose not reported, frequency 1 total, start therapy date were not reported for prophylactic vaccination (dose number in series 1). It was unknown if the patient experienced any adverse event with covid-19 vaccine ad26. cov2. s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose not reported, frequency 1 total, start therapy date were not reported for prophylactic vaccination (dose number in series 2). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced heart attack (Dose number in series 2). On an unspecified date, the patient died from unknown cause. It was unspecified if an autopsy was performed. It was reported that "my brother just passed away from the Johnson and Johnson booster shot, he had a heart attack". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient passed away from the Johnson and Johnson vaccine booster shot on an unspecified date, and the outcome of heart attack was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20211262986-covid-19 vaccine ad26.cov2.s-passed away from the J&J booster shot, heart attack. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992632

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CO
Alter: 29,0
Geschlecht: F
Eingang: 06.01.2022
Impfdatum: 27.09.2021
Beginn: 27.11.2021
Tage bis Beginn: 61,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Bacterial test negative Blood electrolytes normal Blood lactic acid normal Blood gases Blood lactic acid COVID-19 Cough Differential white blood cell count Congestive cardiomyopathy Discomfort Dyspnoea Echocardiogram abnormal COVID-19 pneumonia Cardiac arrest Chest X-ray abnormal Chest pain

Symptomtext

Reason for Hospitalization: This is a 30 yo female w/ PMhx significant for multiple sclerosis that presented to ED for evaluation of shortness of breath and is being transferred to another hospital for higher level of care. >10 days of fever, cough, SOB, myalgia, and pleuritic chest pain. 11/27 had home COVID test that was positive. Is noted to have received full vaccination in the spring and boosted at the end of September. Last rituximab infusion was also in September. Urgent care on 12/3 for the same. CXR showing diffuse infiltrates. Was not hypoxic. Rx doxycycline, decadron, albuterol, robitussin AC. Since then, increasing SOB so went back to ER. In the ED, vitals showing Tmax 39.2, HR 130s, Sp;O2 mid 80s and is now on 4L. WBC and lactic nml. Unable to run other tests there. CTA chest showing no clear PE but moderate extensive bilateral consolidative opacities w/ possible organizing PNA and small bilateral effusions. It is unclear if she got any abx. My partner accepted her admission at noon, but due to delays in transport has arrived about 930p. On exam, is toxic and uncomfortable appearing, but is also having a temp of >104F. Speaking in full sentences w/o accessory muscle usage on 3L. Hospital Course by Problem List: 30-year-old female with: #COVID-19 pneumonia #Acute hypoxemic respiratory failure #Possible superimposed aspiration pneumonia - vaccinated pt, s/p pfizer vaccine x2, most recent dose 6/2021 - Symptoms started 11/22, home test +11/23; COVID19+ upon admission 12/6 - intubated 12/10 post cardiac arrest; extubated 12/17 to BiPAP, weaned to HHFNC and now on NC 2-3L -completed Remdesivir -Decadron weaned off - completed course of Meropenem 12/18 for aspiration pneumonia. - off COVID precautions Critical illness myopathy: -improving, cont PT/OT SVT: from deconditioning, cardiomyopathy -metoprolol xl 25mg daily, changed to 50mg daily on 1/1/22 -improved, CTM Fevers, concern for HAP: covering staph pneumonia and gram negative -MRSA PCR screen: negative -start vanc and cefepime started 12/30/2, vanc stopped 12/31/21, cont cefepime for 7 days, total, last dose at 4pm 1/5/22. Oral Thrush ?micafungin -rons rum mouthrinse Possible oral HSV: HSV pcr: pending Give acyclovir 400mg TID for 7 days #Torsades de Pointe with cardiac arrest #Prolonged QTc #Dilated cardiomyopathy Cardiac arrest 12/10 @ 3:49AM. Review of strips shows torsades. - s/p IV amiodarone & dobutamine - TTE 12/11: LVEF 20-25% - TTE 12/17: LVEF 35-40% - TTE 12/20: LVEF 50-55% - avoid QT prolonging medications - repeat EKG with ongoing QTc despite normal lytes & no longer on QT prolonging medications; discussed with Dr. 12/24 and we reviewed EKGs. Recommends outpatient EP follow up for possible congenital prolonged QT -outpt EP appointment on 3/16/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 30,0
Labordaten: TTE 12/11: LVEF 20-25% TTE 12/17: LVEF 35-40% TTE 12/20: LVEF 50-55% CTA CHEST FOR PE 12/6 No evidence of pulmonary embolism to the segmental level. Moderately extensive bilateral consolidative opacities, most compatible with the documented history of COVID-19. Some areas have central low attenuation (reverse halo/atoll sign) suggesting component of organizing pneumonia. Small bilateral pleural effusions XR CHEST SINGLE VIEW 12/6 Redemonstrated lower lung predominant pulmonary opacities.
Aktuelle Erkrankungen: N/A
Vorgeschichte: multiple sclerosis
Andere Medikamente: B Complex-Folic Acid 0.4 mg Tab, cholecalciferol, vitamin D3, (VITAMIN D3) 1,000 unit tablet, codeine-guaifenesin (ROBITUSSIN AC) 2-20 mg/mL ORAL liquid, Lactobacillus acidophilus 10 billion cell Cap, rituximab-pvvr (RUXIENCE IV), albuterol
Allergien: sulfonamide antibiotics, lorazepam
Vorherige Impfungen: -

VAERS 2006093

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: AZ
Alter: 83,0
Geschlecht: F
Eingang: 05.01.2022
Impfdatum: 01.07.2021
Beginn: 01.07.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Swelling

Symptomtext

Patient swelled up severely very soon after the Johnson and Johnson Covid 19 vaccine....She passed away approximately 3 weeks after the 2nd vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None known
Aktuelle Erkrankungen: Diabetes and couldn't walk (bedridden)
Vorgeschichte: Diabetes and couldn't walk (bedridden)
Andere Medikamente: Insulin....the rest unknown
Allergien: None known
Vorherige Impfungen: -

VAERS 2531924

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 03.01.2022
Impfdatum: 27.02.2021
Beginn: 09.03.2021
Tage bis Beginn: 10,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is a 87y.o. male who died on 03/09/2021 w/ h/o HTN,HLD, BPH, Alzheimer's, Barret's esophagus, carotid occlusion, past hip fracture. Pt received Pfizer Covid-19 Vaccination 2/2 on 02/27/2021. Pt died while in hospice care. Unlikely that Pfizer Covid-19 vaccine caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2530792

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 03.01.2022
Impfdatum: 23.02.2021
Beginn: 30.03.2021
Tage bis Beginn: 35,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is 81y.o. male who died on 03/30/2021 w/ h/o chronic diarrhea, BPH, HLD, HTN, hypothyroidism, T2DM, hemiplegia. Pt received Moderna Covid-19 vaccination 2/2 on 2/23/26. Pt died at home with family present. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1998430

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 03.01.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This spontaneous report received from a consumer via a company representative via social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, dose number in series was 1, 1 total administrated for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reported stated that, a family member died (date unspecified) after being fully vax (dose number in series was 1). It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. On an unspecified date, the patient died of an unknown cause. This report was serious (Death).; Sender's Comments: V0: 20211266789-COVID-19 VACCINE AD26.COV2.S-died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2511467

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 93,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 14.01.2021
Beginn: 04.05.2021
Tage bis Beginn: 110,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is a 92y.o. male who died on 05/04/2021 with h/o DM. Pt received Pfizer Covid-19 vaccination on 01/14/2021. Unlikely Pfrizer Covid-19 caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2509380

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 101,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 14.01.2021
Beginn: 19.02.2021
Tage bis Beginn: 36,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is a 99y.o. male who died on 02/19/2021 w/ h/o CA Prostate, SCC, pacemakers, HTN, AFib, OA, PAD. PT received Pfizer Covid-19 Vaccination 1/2 on 1/14/2021. Facility was notified of pt death on 03/15/2021 by administration. Unlikely that Pfizer Covid-19 Vaccine caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508172

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 95,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 30.03.2021
Beginn: 28.05.2021
Tage bis Beginn: 59,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 93yo pt residing at nursing facility died on 5/28/21 at community hospital. Pt with hx of htn, hdl, dm, arthralgis, bph, arthritis in hip/leg, seasonal allergies. Pt had received covid vaccines on 2/6/21 & 4/19/21. Pt's death appears unrelated to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508144

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 25.02.2021
Beginn: 05.05.2021
Tage bis Beginn: 69,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is a 82y.o. male who died on 05/05/2021 with h/o CKD4, HTN, and DM. Patient received Pfizer Covid-19 on 02/25/2021 at specific location. Location of death was HOSPICE. Unlikely Pfizer Covid-19 vaccination caused/contributed to death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 31.03.2021
Beginn: 22.05.2021
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt homeless, hx of substance abuse, hep-C & depression received one dose of covid vaccine from outside community clinic on 3/31/21. Pt died on 5/22/2021 per record system. Circumstances of death not noted. Not able to assess if covid vaccine related to patient's death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498818

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 13.03.2021
Beginn: 14.05.2021
Tage bis Beginn: 62,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Brain cancer metastatic Condition aggravated Death Disease complication Fall Jaundice Neuroendocrine carcinoma

Symptomtext

Narrative: Pt is a 68y.o male who died on 05/14/2021 w/ h/o COPD, DM-2, HTN, HLD and R ICA stenosis, and metastatic large cell neuroendocrine tumor with diffuse mets to the liver. Notable for 1 ppd smoker since age 10 with intermittent quitting periods (40 pack year smoker). Pt received Jansen Covid-19 Vaccination 1/2 on 03/13/2021. Pt admitted for inpatient hospice care on 05/10/2021 at wife request due to due to metastatic brain cancer, increasing jaundice and falls at home. Pt died on 05/14/2021 with calling physician reporting "Death was caused by: complications of malignancy from poorly differentiated Neuroendocrine carcinoma". Unlikely Jansen Covid-19 vaccine caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2497515

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 10.02.2021
Beginn: 02.05.2021
Tage bis Beginn: 81,0
Dosis: UNK
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chronic obstructive pulmonary disease Condition aggravated Death Dyspnoea Productive cough Respiratory failure Sputum discoloured

Symptomtext

Narrative: Pt is a 86y.o male who died on 05/02/2021 with a h/o COPD (3-4L O2 at home), R lung cancer s/p chemo/XRT and R lobectomy, Chronic diastolic HF with EF 54%, T1DM, HTN, CAD s/p PCI w/ DES to RCA. PPt received Moderna Covid-19 vaccination 2/2 on 02/17/2021. On 02/25/2021 pt presented to ED with c/o increased SOA. cough with yellow sputum, and dyspnea that started 3 days ago. Pt was discharged from ED on 02/25/2021 with physician noting patient has been with non-Hospital hospice for ~2 years. Pt presented for inpatient hospice admission on 04/30/2021. Physician reported in Death Note "Death was caused by: hypoxic respiratory failure secondary to end stage COPD" . Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2516586

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: 19.02.2021
Beginn: 17.06.2021
Tage bis Beginn: 118,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Amyotrophic lateral sclerosis Condition aggravated Death Disease complication

Symptomtext

Narrative: 78yo male with history of ALS - Amyotrophic lateral sclerosis, dysphagia, essential hypertension, acquired dysarthria, malnutrition, HLD, sleep apnea, and placement of gastrotomy tube. Died on 06/17/2021. Patient was administered covid vaccinations on 01/29/2021 and 02/19/2021 at an outside facility. Appears patient died due to complications of ALS and death is not related to the covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2516559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: 08.02.2021
Beginn: 05.06.2021
Tage bis Beginn: 117,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt receivd covid vaccinations on 1/18/2021 & 2/8/2021 at nursing home facility where pt resided. Pt was transfered to home hospice on 6/4/2021. Pt died at home on 6/9/2021. Pt had history of dementia & unable to care for self. ALso pt had other medical issues listed below: J44.9 Chronic obstructive lung disease (SCT 13645005) N18.6 End-stage renal disease (SCT 46177005) D63.1 Anemia in end stage renal disease (SCT 707324008) M79.605 Pain in left lower limb (SCT 287047008) Z99.3 Dependence on wheelchair (SCT 105503008) I10. Benign essential hypertension (SCT 1201005) R63.0 Anorexia (SCT 79890006) M13.0 Polyarthritis (SCT 416956002) E03.9 Hypothyroidism (SCT 40930008) R69. Aggressive behavior (SCT 61372001) Z51.5 Seen by palliative care service (SCT 441874000) R45.1 Restlessness and agitation (SCT 274647009) R53.83 Malaise and fatigue (SCT 271795006) Likely pt's death soon after admission to hospice unrelated to covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2516556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 96,0
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: 20.12.2021
Beginn: 07.06.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt received covid vaccines on 12/20/21 & 01/16/2021. Pt was residing in health care rehab facility who transferred him to hospital on 6/7/2021. Pt died at hospital on same day admitted, 6/7/2021. Pt with large problem list in records system: Urinary incontinence A Decrease in appetite A Malnutrition A Seen by palliative care medicine service A CAD - Coronary artery disease A CHF - Congestive heart failure HFrEF 35% A Hyperlipidemia A AF - Atrial fibrillation A Femoral artery thrombosis Onset 05/27/2020 1. Right 2. S/p thromboebolectomy R SFA, popliteal, tibial arteries A Pleural effusion A Gout A Cardiomyopathy Ischemic A History of left cataract extraction A Glaucoma A OA - Osteoarthritis A Cardiac defibrillator in situ ( A Allergic rhinitis A Benign prostatic hypertrophy without outflow Appears death is unrelated to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2516556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 96,0
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: 20.12.2021
Beginn: 07.06.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt received covid vaccines on 12/20/21 & 01/16/2021. Pt was residing in health care rehab facility who transferred him to hospital on 6/7/2021. Pt died at hospital on same day admitted, 6/7/2021. Pt with large problem list in records system: Urinary incontinence A Decrease in appetite A Malnutrition A Seen by palliative care medicine service A CAD - Coronary artery disease A CHF - Congestive heart failure HFrEF 35% A Hyperlipidemia A AF - Atrial fibrillation A Femoral artery thrombosis Onset 05/27/2020 1. Right 2. S/p thromboebolectomy R SFA, popliteal, tibial arteries A Pleural effusion A Gout A Cardiomyopathy Ischemic A History of left cataract extraction A Glaucoma A OA - Osteoarthritis A Cardiac defibrillator in situ ( A Allergic rhinitis A Benign prostatic hypertrophy without outflow Appears death is unrelated to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2515044

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 62,0
Geschlecht: F
Eingang: 01.01.2022
Impfdatum: 30.03.2021
Beginn: 15.06.2021
Tage bis Beginn: 77,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Colon cancer Death

Symptomtext

Narrative: 60yo female with colon cancer. Died on 06/15/2021. She received covid vaccinations on 03/09/21 and 03/30/21 from facility. Appears patient died of colon cancer and death is not related to the covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1996743

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 31.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Amnesia Cardiac disorder Cerebrovascular accident Death Heart rate irregular Neoplasm

Symptomtext

DEATH; STROKE; VACCINE WEAKENED THE HEART/HEART INFLAMED; HEARTBEATS IRREGULAR; TINY TUMORS; LOSING MEMORY SLOWLY; This spontaneous report received from a consumer via social media through company representative concerned a female of unspecified age race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: unknown expiry : unknown) dose was not reported, 1 total, start therapy date was not reported for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient had tiny tumors appear, and started losing her memory slowly, and soon after had a stroke. The reporter stated that the vaccine weakened the patient's heart and the heart inflamed which led to an irregular heartbeat. On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on an unspecified date, and had not recovered from tiny tumors, losing memory slowly, stroke, heartbeats irregular, and vaccine weakened the heart/heart inflamed. This report was serious (Death, and Other Medically Important Condition). This case, from the same reporter is linked to 20211258139, 20211263643 and 20211263721.; Sender's Comments: V0: 20211256750-covid-19 vaccine ad26.cov2.s-Death, stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1995488

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 31.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, dose number in series 1, 1 total, for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died (Dose number in series 1). It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. On an unspecified date, the patient died from unknown cause of death. This report was serious (Death).; Sender's Comments: V0: 20211264458-COVID-19 VACCINE AD26.COV2.S-Died. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1994558

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 31.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Thrombosis

Symptomtext

This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, reporter reported that "My great aunt's daughter also suffered the jab damage, blood clots in the brain massive stroke. She had not recovered. Unfortunately, they did not get the placebo or the saline jab, they got the actual experimental drug." The action taken with covid-19 vaccine was not applicable. The patient had not recovered from blood clots in brain and massive stroke. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211260743 and 20211260953.; Sender's Comments: V0: 20211261168-covid-19 vaccine Blood clots in brain, massive stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1994539

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 31.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

This spontaneous report received from a consumer via a company representative via social media concerned a patient of unspecified age, sex, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, 1 total administered, (Dose number in series 1), start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient (reporter's friend) had stroke (dose number in series 1). The action taken with covid-19 vaccine was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211248907, 20211258812.; Sender's Comments: V0: 20211258956- JANSSEN COVID-19 VACCINE Stroke. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 88,0
Geschlecht: M
Eingang: 30.12.2021
Impfdatum: 23.03.2021
Beginn: 29.12.2021
Tage bis Beginn: 281,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Asthenia Blood sodium increased Blood test Blood thyroid stimulating hormone normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram head normal Computerised tomogram spine Electrocardiogram Exposure to SARS-CoV-2 Fall Head injury Hypernatraemia Hypoxia Lung opacity Oxygen saturation decreased

Symptomtext

Patient is an 89-year-old male with history of dementia, hypothyroidism and GERD presenting to the emergency department with his daughter For low oxygen saturation. Daughter states patient lives alone and she brought him up here in hopes to place him in a facility, which she states she has been trying to work on. She states ever since December 13 he has had more frequent falls and progressive weakness. She states he fell yesterday and hit his head on the bathtub. He is not on blood thinners. She also noted today while he was eating breakfast his oxygen was 79%. Patient denies any feeling of shortness of breath, denies chest pain. He states the reason he fell yesterday was because he slipped. He has been vaccinated against Covid. He denies abdominal pain, nausea, vomiting or diarrhea. Daughter does note they had a family Christmas party on December 18, and a couple days later they were notified someone at the party was diagnosed with Covid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: Patient seen upon arrival to emerge department. Vitals are reviewed and noted for hypoxia, he is 86% on room air. He is placed on 4 L nasal cannula with an oxygen saturation of 93 to 94%. He does not appear to be in any acute distress. He does also have an abrasion to his forehead from the fall yesterday. He is not on any blood thinners. Patient will have an IV established, blood work performed, EKG, chest x-ray as well as a CT head and C-spine given his fall yesterday. He is also given Decadron 10 mg IV for his hypoxia, and will have a rapid Covid test performed. Did discuss given his hypoxia and progressive weakness with frequent falls, I recommended admission, and daughter at bedside and patient are agreeable to this. He will also be updated on his tetanus. Patient's rapid Covid test is positive. Chest x-ray shows bilateral opacities, left greater than right. Patient will be given Rocephin 1 g IV and azithromycin 500 mg. Abs are reviewed, negative troponin. Sodium evaded at 150. TSH within normal limits. CT C-spine shows no acute fracture. CT head shows no acute findings. Admitting diagnosis Acute hypoxic respiratory failure Covid pneumonia Hypernatremia Frequent falls History of dementia
Aktuelle Erkrankungen: unknown
Vorgeschichte: dementia hypothyroidism GERD
Andere Medikamente: Current Home Medications 1. Aricept 10 mg oral tablet : 1 tab(s) orally once a day (at bedtime) 2. carbidopa-levodopa 50 mg-200 mg oral tablet, extended release : orally 3 times a day 3. levothyroxine 125 mcg (0.125 mg) oral tablet : 1 tab(
Allergien: none known
Vorherige Impfungen: -

VAERS 2523951

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 23.02.2021
Beginn: 23.11.2021
Tage bis Beginn: 273,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 73 yo male patient died of unknown causes on 11/23/2021. No info in chart providing any issues leading to pt's death. Pt had received covid vaccines on 2/23/21 & 2/2/2021. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration. See pts problem list: PROBLEM LAST MOD PROVIDER Diabetes mellitus (SCT 73211009) (ICD-10-CM 03/15/2021 E11.9) Atrial fibrillation (SCT 494436004) (ICD-10-CM 09/14/2020 I48.91) Constipation (SCT 14760008) (ICD-10-CM K59.09) 09/17/2018 Benign essential hypertension (SCT 1201005) 02/03/2016 (ICD-10-CM I10.) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 02/03/2016 Cobalamin deficiency (SCT 190634004) (ICD-10-CM 02/03/2016 D51.8) Decreased vitamin D (SCT 131114008) (ICD-10-CM 02/03/2016 E55.9) Hepatitis B carrier (SCT 235871004) (ICD-10-CM 02/03/2016 Z22.51) Impaired glucose tolerance (SCT 9414007) 02/03/2016 (ICD-10-CM R73.9)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523936

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 09.04.2021
Beginn: 31.10.2021
Tage bis Beginn: 205,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 89yo male patient who receives most of his care outside clinic died on 10/31/2021. No info given on cause of pt's death. No info on events leading up to pt's death. Last note from 5/2021. See pt's clinic problem list below: 8 Active Problems PROBLEM LAST MOD PROVIDER Bilateral arthritis of knees (SCT 03/20/2019 1074871000119108) (ICD-10-CM M17.9) Cognitive disorder (SCT 443265004) (ICD-10-CM 08/19/2016 G31.09) Constipation (SCT 14760008) (ICD-9-CM 564.00) 08/19/2015 Personal History of Venus Thrombosis and 5/12/2014 Embolism (ICD-9-CM V12.51) Long term (current) use of Anticoagulants 10/21/2013 (ICD-9-CM V58.61) (ICD-10-CM E78.5); Hyperlipidemia (SNOMED CT 02/19/2016 55822004) (ICD-10-CM I10.); Benign essential hypertension 02/19/2016 (SNOMED CT 1201005) Cerebrovascular accident (SCT 230690007) 11/12/2013 (ICD-9-CM 436.) Mri 10-2013, r parietal, occipital Pt had received covid vaccines on 3/19/21 & 4/9/21 from outside provider. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523909

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 26.02.2021
Beginn: 17.12.2021
Tage bis Beginn: 294,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bladder cancer stage IV Death Neoplasm malignant Small intestinal obstruction

Symptomtext

Narrative: 83 yo male patient died during inpatient hospice admission on 12/17/2021. Death was caused by: Small Bowel Obstruction in the setting malignancy (stage IV bladder cancer). Pt. had received covid vaccines on 2/5/21 & 2/26/21. This death is not related to covid vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523887

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 11.02.2021
Beginn: 15.12.2021
Tage bis Beginn: 307,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abnormal loss of weight Cardiac failure congestive Chronic obstructive pulmonary disease Chronic sinusitis Cough Death Restlessness Urinary incontinence Vascular dementia

Symptomtext

Narrative: 84 yo male patient with the following problem list: PROBLEM LAST MOD PROVIDER Chronic congestive heart failure (SCT 88805009) 11/29/2021 (ICD-10-CM I50.22) Abnormal weight loss (SCT 267024001) (ICD-10-CM 11/19/2021 R63.4) Chronic sinusitis (SCT 40055000) (ICD-10-CM 11/19/2021 J32.9) Chronic obstructive lung disease (SCT 13645005) 11/19/2021 (ICD-10-CM J44.9) Urinary incontinence (SCT 165232002) (ICD-10-CM 11/19/2021 R32.) Chronic cough (SCT 68154008) (ICD-10-CM R05.3) 11/19/2021 Restlessness behavior (SCT 162221009) (ICD-10-CM 06/30/2021 R45.1) History of alcohol abuse (SCT 371434005) 01/03/2020 (ICD-10-CM F10.21) History of partial gastrectomy (SCT 01/03/2020 107701000119101) (ICD-10-CM Z98.890) Seen by palliative care service (SCT 441874000) 09/21/2021 (ICD-10-CM Z51.5), Onset 12/00/2019 Cerebral infarction (SCT 432504007) (ICD-10-CM 09/06/2019 I63.9) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.2) 11/08/2018 Benign essential hypertension (SCT 1201005) 11/08/2018 (ICD-10-CM I10.) Vascular dementia without behavioral disturbance 11/29/2021 (SCT 16276361000119109) (ICD-10-CM F01.50) Probable Major Vascular Neurocognitive Disorder Gastroesophageal reflux disease (SCT 235595009) 11/08/2018 (ICD-10-CM K21.9) Benign prostatic hyperplasia (SCT 266569009) 11/08/2018 (ICD-10-CM N40.0) Patient passed while in Hospice care on 12/15/21 @ 1145 AM. Pt had received covid vaccines on 1/14/21 & 2/11/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2522794

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 21.03.2021
Beginn: 24.06.2021
Tage bis Beginn: 95,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 68 yo male found deceased at home by his family on 6/24/2021. Pt had received covid vaccines from pharmacy on 2/16/21 & 3/21/21. No information available on cause of pt's death. Likely vaccines not related to pt's death given death was 3 months post most recent vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2522793

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 99,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 14.01.2021
Beginn: 23.06.2021
Tage bis Beginn: 160,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 99yo male died on 06/23/2021. No information provided about his death. Pt does not receive primary care from clinic. Pt received one covid vaccine on 1/14/21 from pharmacy. Likely death is not related to the vaccination given pt's advanced age and given 6 months has pasted since he received the covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2526340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: -
Beginn: 29.06.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 80yo male with hx of Multiple Myeloma treated at facility outside of our facility died at home on 6/29/2021. Pt had received covid-19 vaccines EUA on 2/1/21 & 3/9/2021. Appears death is not related to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2526339

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 95,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 14.01.2021
Beginn: 15.06.2021
Tage bis Beginn: 152,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 94yo male died on 6/15/2021. Pt resided in nursing facility. Pt had received covid vaccine on 1/14/2021. No information in database system about pt's death. Likely death not related to vaccinations given pt's advanced age & 6 months between vaccination & death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2526337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 17.03.2021
Beginn: 02.07.2021
Tage bis Beginn: 107,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Lung disorder

Symptomtext

Narrative: 70yo male in need of lung transplant died on 7/2/21 at hospital. Pt had received covid EAU vaccinations on 2/12/21 & 3/17/21. It appears death is unrelated to covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525151

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 05.05.2021
Beginn: 08.07.2021
Tage bis Beginn: 64,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Respiratory failure Septic shock

Symptomtext

Narrative: 64 yo male with a h/o liposarcoma of liver(dx'd 12/28/20) and associated ascites, ESRD on HD died at Hospital due to SEPTIC SHOCK AND RESP FAILURE. Pt had received covid vaccinations on 4/14/2021 & on 5/5/2021.Further history from PCP note when pt establishing care on 6/25/21: "Liposarcoma of liver per wife pt received his 1st round of CTX 1/2021 and 2nd round 2/2021. On the last day of the second round of chemotherapy, he developed slurring of speech, and was sent for an MRI of the brain. Wife states he went into a coma on 2/6/21, and was declared brain dead. However, 2 days later, he regained consciousness, but developed significant physical disability. During hospitalization on 2/17/21 he was started on hemodialysis. Wife states he did not have a diagnosis of renal failure prior to that time. He was discharged from hospital on 3/10/21 to rehabilitation and skilled nursing where he stayed until 6/14/21. He has been home since then. Patient has also had ascites since the liver cancer was diagnosed, and undergoes paracentesis monthly. He is not being treated for his liver cancer at this time, and had been told by his oncologist that he may seek care at a center where clinical trials are being performed. However, pt decided to establish at the clinic in order to be seen by clinic oncology. He also had a colonoscopy in the summer of 2020 through Dr., at which time multiple polyps were found per wife, but not all of them were removed, and he was to be scheduled for a f/u C scope, which they are requesting through the clinic. Wife also states that he was admitted in November 2020 for shortness of breath 2/2 Covid." No further information regarding pt's death available. Not clear if pt's death is related to covid vaccinations, likely not related given patient's medical history & given that vaccinations were > 60 days since pt had received them.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523931

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 19.02.2021
Beginn: 24.11.2021
Tage bis Beginn: 278,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 90 yo m with hx of cad s/p cabg '91 and stent thereafter, b12 deficiency, oa, rt knee, htn & hld died on 11/24/2021. No info given on cause of pt's death. Most of pt's care outside of facility. Pt had received covid vaccines on 1/22/21 & 2/19/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523884

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 09.03.2021
Beginn: 03.12.2021
Tage bis Beginn: 269,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deafness Death Neck pain

Symptomtext

Narrative: 74yo male died of unknown causes on 12/3/2021 at outside hospital. Last note dated 10/22/21 so no info about pt's condition near death timeframe available. Pt had the following problem list: PROBLEM LAST MOD PROVIDER Neck pain (SCT 81680005) (ICD-10-CM M54.2) 03/09/2021 CAD - Coronary artery disease (SCT 53741008) 05/05/2020 (ICD-10-CM I25.10) CHF - Congestive heart failure (SCT 42343007) 04/29/2020 (ICD-10-CM I50.9) Pneumonia (SCT 233604007) (ICD-10-CM J18.9) 04/29/2020 Subdural hematoma (SCT 95453001) (ICD-10-CM 04/23/2020 S00.80XA) Kidney stone (SCT 95570007) (ICD-10-CM N20.0) 01/13/2020 Solitary nodule of lung (SCT 427359005) 01/13/2020 (ICD-10-CM R91.1) Depression (SCT 35489007) (ICD-10-CM F32.9) 03/12/2019 Knee pain (SCT 30989003) (ICD-10-CM M25.569) 08/21/2018 Shoulder pain (SCT 45326000) (ICD-10-CM M25.519) 08/21/2018 Vertigo (SCT 399153001) (ICD-10-CM H81.10) 11/20/2019 Carotid artery stenosis (SCT 64586002) 12/13/2016 (ICD-10-CM I65.29) Nonspecific (Abnormal) Findings on Radiological 04/08/2014 and other Examination of Musculoskeletal System (ICD-9-CM 793.7) Chronic airway obstruction, Not Elsewhere 01/13/2020 Classified (SCT 13645005) (ICD-10-CM J44.9) (ICD-9-CM 780.57); SLEEP APNEA NOS 09/24/2012 (ICD-10-CM F33.9); Depression (SNOMED CT 12/07/2015 35489007); Orthostatic hypotension 09/25/2018 (SNOMED CT 28651003) (ICD-10-CM H90.5); Hearing loss (SNOMED CT 10/07/2021 15188001) (ICD-9-CM 724.2); Chronic low back pain 03/30/2010 (ICD-9-CM 719.41); Pain in joint involving 03/30/2010 shoulder region (ICD-9-CM 719.41) (ICD-9-CM V67.9); Unspecified Follow-up 10/16/2007 Examination (ICD-9-CM V67.9)(ICD-9-CM 790.29); Hyperglycemia * (ICD-9-CM 10/16/2007 790.29) (ICD-9-CM 592.0); Nephrolithiasis * (ICD-9-CM 08/29/2006 592.0) (ICD-9-CM 702.0); Actinic Keratosis 10/05/2005 (ICD-10-CM E66.3); Overweight (SNOMED CT 12/07/2015 238131007) (ICD-9-CM 709.9); Skin Diseases (ICD-9-CM 709.9) 02/08/2005 (ICD-9-CM 211.3); Colon Polyp (ICD-9-CM 211.3) 08/02/2004 (ICD-9-CM 793.1); Multiple nodules of lung 08/02/2004 (ICD-10-CM Z72.0); Tobacco Use (SNOMED CT 12/07/2015 110483000) (ICD-10-CM E78.2); Hyperlipidemia (SNOMED CT 12/07/2015 55822004) (ICD-9-CM 607.84); Impotence of organic origin 02/05/2003 (ICD-9-CM 607.84) Benign neoplasm of colon (ICD-9-CM 211.3) 11/16/2001 Essential Hypertension (SCT 1201005) (ICD-10-CM 12/07/2015 I10.) Pt had record he has received one J&J covid vaccine on 3/9/21 from outside provider. This death is likely not related to the vaccinations due to the patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1985746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 24.02.2021
Beginn: 23.10.2021
Tage bis Beginn: 241,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Dyspnoea Positive airway pressure therapy

Symptomtext

Patient hospitalized on 10/23/21 with COVID infection, and previously received Pfizer COVID vaccine ( doses reported on 2/24/2021 and 2/3/2021, but no lot number or other information available). Patient came to the emergency department complaining of shortness of breath. He had previously been diagnosed with Covid-19. He was treated with remdesivir, dexamethasone. He was admitted to the progressive care unit. He was started on BiPAP. He has not shown significant improvement. He had worsening oxygen requirement. Critical care was consulted. Patient was made DNR. Patient decided on comfort care. BiPAP was discontinued. Patient expired at 1622 on 11/17/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1984099

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 28.12.2021
Impfdatum: -
Beginn: 03.08.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Thrombosis

Symptomtext

DIED; BLOOD CLOT; This spontaneous report received from a consumer via a company representative concerned a 44 year old female of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown and expiry: unknown) dose, start therapy date were not reported, dose number in series was 1, 01 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that, on 03-AUG-2021, the patient experienced blood clot and next day on 04-AUG-2021, she died from unknown cause of death (dose number in series was 1). It was unknown if an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 04-AUG-2021 from unknown cause of death, and the outcome of blood clot was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20211254542 -JANSSEN COVID-19 VACCINE Ad26.COV2.S- Death, Blood clot. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1981982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 83,0
Geschlecht: F
Eingang: 27.12.2021
Impfdatum: 02.11.2021
Beginn: 14.12.2021
Tage bis Beginn: 42,0
Dosis: 3
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Back pain COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Death Dysstasia Fall Hypoxia Malaise Musculoskeletal chest pain Rib fracture SARS-CoV-2 test positive Spinal compression fracture Tenderness Urinary incontinence Walking aid user

Symptomtext

Patient is DECEASED (12.18.21); Hospitalized (12.14.21); COVID-19 positive (12.14.21); Fully vaccinated PLUS booster Admission Date: 12/14/2021 Date of Death: 12/18/21 Time of Death: 3:38 PM HISTORY OF PRESENT ILLNESS: Patient is a 83 y.o. female who presents today as a transfer from a local hospital there for multiple right-sided rib fractures, compression fracture of thoracic vertebra, pneumonia secondary to COVID-19 and hypoxia. Patient was evaluated at an outside facility after a fall and being too weak to get up from the floor at approximately 4:00 a.m.. Patient reported that she was unsure if she had struck her head and family members found her on the floor and she had been incontinent of urine and was too weak to stand so she was brought to the emergency department. She was noted to been diagnosed with COVID pneumonia approximately 10 days ago. X-rays ordered at the outside facility demonstrated fractures of right ribs 4 through 6 along with age-indeterminate fractures of T5 through T7, T11 and T12. While at the outside facility developed persistent hypoxia satting 88% room air requiring 2 L nasal cannula. She was transferred to our facility for multiple rib fracture, COVID pneumonia and hypoxia. The patient states that today around 4:00 am she was using the bathroom and when she stood up she was attempting to ambulate with her walker but was too weak and fell. The patient states that she remembers the entire fall and denies any syncopal symptoms. Patient states that she was not having any chest pain, vision changes, palpitations, lightheadedness or vertigo. Patient denies any cardiac history, or history of prior seizures or strokes. Patient states that she is not on any blood thinners. The patient's daughter is present at the bedside and states that she had attempted to contact the patient this morning but she did not answer. She went over to the patient's assisted living facility and they let her into the apartment where she found the patient wedged between the toilet and the cabinet. The daughter states that she got there around 10:30am so the patient had been down for approximately 6 hours. The daughter states that when she arrived she did not note any blood on the scene. Daughter also reports that the patient was alert and oriented x 4 when she arrived and displayed no post-ictal or post-concussive symptoms. Daughter contacted EMS as she was not strong enough to lift the patient off of the ground. The patient and daughter endorse that the patient is on day 10 of COVID-19 symptoms, she took a home test that was positive last Friday. The patient also admits to 2 prior falls earlier this month again stating that she fell because she was just feeling too weak. On evaluation here in the ED the patient's oxygen saturation is 95% on 2L NSL. The patient had tenderness to palpation over the right lateral chest wall, breathe sounds were equal and intact bilaterally. Patient states that she has pain in her back while lying flat and has tenderness to palpation over her right elbow and over the right fibular head. The patient was log rolled and had tenderness to palpation in the upper thoracic spine and upper lumbar spine. Gluteal squeeze was intact. Patient had intact sensation and strength throughout all extremities. Patient had multiple coughing episodes during the interview and evaluation. Given her continued chest wall pain a CT scan of the Chest abdomen and pelvis will be obtained to better evaluate her rib fractures. An x-ray of the right elbow, knee and tib-fib will also be obtained as she had tenderness to palpation over these points. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Closed fracture of multiple ribs of right side, initial encounter Multiple fractures of ribs, right side, initial encounter for closed fracture Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: 83-year-old female presents as a transfer from outside facility for fall with multiple right-sided rib fractures, compression fracture of thoracic vertebra, pneumonia secondary to COVID-19 and hypoxia. She was admitted to hospital, she and her family decided to change? to comfort measure only, she deceased at 3:30 p.m. 12/18/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Polymyalgia rheumatica (HCC-CMS) Bilateral leg edema GERD without esophagitis Tremors of nervous system Essential hypertension
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet Calcium Carb-Cholecalciferol (CALCIUM 500/VITAMIN D PO) chlorthalidone (HYGROTON) 50 MG tablet CHOLECALCIFEROL PO denosumab (PROLIA) 60 MG/ML SOSY folic acid (FOLVITE) 1 MG tablet latanoprost (XALATAN)
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1979400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 24.12.2021
Impfdatum: 29.11.2021
Beginn: 29.11.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Cerebral haemorrhage Death Fatigue Feeling abnormal Gingival bleeding Laboratory test normal Leukaemia Pain Platelet count decreased Rash White blood cell count increased

Symptomtext

Did not fee good the day of vaccine 11/28/21 fatigue and body aches, gums started bleeding on 12/2/21 aches and pains all over body for the next several days. Had blood work done for wellness on 11/24/21 everything normal on that date. Developed rash all over body on 12/11/21. Went to ER on 12/15/21 diagnosed with leukemia. Was transferred to another hospital same date and had a brain bleed over night. Symptoms progressed and he passed away on 12/17/21, he had bo underlying health conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: 12/15/21 diagnosed with Leukemia after being at the ED for 1 hour. WBC count 69.5. Platelets 20. 11/24/21 - had all normal labs
Aktuelle Erkrankungen: No other illness some arthritis
Vorgeschichte: -
Andere Medikamente: -
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1978451

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: TN
Alter: 66,0
Geschlecht: M
Eingang: 24.12.2021
Impfdatum: -
Beginn: 16.11.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure measurement COVID-19 COVID-19 pneumonia Cardiac murmur Hypertension Pulmonary embolism SARS-CoV-2 test SARS-CoV-2 test positive Vaccination failure

Symptomtext

COVID-19 PNEUMONIA; PULMONARY EMBOLISM; COVID-19; CONFIRMED CLINICAL VACCINATION FAILURE; SARS-COV-2 TEST POSITIVE; HYPERTENSION; CARDIAC MURMUR; This spontaneous report received from a health care professional (reference number: 1913361) concerned a 66 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetes, and pancreatitis, and other pre-existing medical conditions included: The patient had diabetes due to pancreatitis. The patient had no known allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total administered to the left arm on 12-APR-2021 for an unspecified indication. Dose number in series 1. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. Concomitant medications included insulin, statin and daily vitamin. Patient was preparing to do the booster but patient ended up with a covid-19 breakthrough infection and admitted to hospital 16-NOV-2021 to 19-NOV-2021, number of days hospitalized was 3. Diagnosed with covid-19 pneumonia, confirmed clinical vaccination failure and a pulmonary blood clot. Laboratory data included: SARS-CoV-2 test (NR: not provided) positive. Subsequent with primary care physician follow up, on 01-DEC-2021 patient have high blood pressure 200/101 mmHg and a heart murmur. The heart murmur was not heard during the hospitalization, patient believe this was the result of the covid-19 infection perhaps compounded by vaccination. Laboratory data included: Blood pressure (NR: not provided) 200/101 mmHg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from covid-19, covid-19 pneumonia, cardiac murmur, hypertension, pulmonary embolism, and sars-cov-2 test positive, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This report was associated with product quality complaint: 90000206828. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information was received on 21-DEC-2021. The following information was updated and incorporated in to the case narrative: Product quality complaint investigation result. Upon review following information was amended: medically confirmed field updated from blank to manual check box (checked).; Sender's Comments: V1: Additional information in this version is regarding: Product quality complaint investigation result. Upon review following information was amended: medically confirmed field updated from blank to manual check box (checked). This does not alter company causality of previously reported events 20211225686-covid-19 vaccine ad26.cov2.s-covid-19, covid-19 pneumonia, hypertension, pulmonary embolism, and sars-cov-2 test positive. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211225686-covid-19 vaccine ad26.cov2.s-confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Test Date: 20211116; Test Name: SARS-CoV-2 test; Result Unstructured Data: positive; Test Date: 20211201; Test Name: Blood pressure; Result Unstructured Data: 200/101 mmHg, high
Aktuelle Erkrankungen: Diabetes (Diabetes due to pancreatitis); Pancreatitis
Vorgeschichte: Comments: The patient had diabetes due to pancreatitis. The patient had no known allergy.
Andere Medikamente: INSULIN
Allergien: -
Vorherige Impfungen: -

VAERS 2532927

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 12.02.2021
Beginn: 12.11.2021
Tage bis Beginn: 273,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 94yo male patient who resided at nursing home facility died on 11/17/2021. Place and cause of death not given. Pt with hx of with a h/o HTN, CKD, A. Fib, self-reported CVA, CAD, BPH, hypothyroidism, OSA, cataracts, R ankle pain. Pt had received covid vaccines on 1/20/2021 & 2/12/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2531928

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 44,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 17.09.2021
Beginn: 21.11.2021
Tage bis Beginn: 65,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose decreased Death Myocardial infarction

Symptomtext

Narrative: 43 yo male patient with hx of: PAST MEDICAL HISTORY: E10.621 Diabetic foot ulcer (SCT 371087003) Z59.0 Homeless single person (SCT 160700001) Z51.5 Seen by palliative care service (SCT 441874000) I10. Hypertension (SCT 38341003) - Essential (primary) hypertension (ICD- 10-CM I10.) E10.43 Peripheral neuropathy due to type 1 diabetes mellitus (SCT 71791000119104) E10.311 Diabetic oculopathy due to type I diabetes mellitus (ICD-10-CM E10.311) E10.22 Chronic kidney disease stage 5 due to type 2 diabetes mellitus (SCT 711000119100) N18.5 End stage renal failure on dialysis (SCT 236435004) E10.43 Peripheral neuropathy due to type 1 diabetes mellitus (SCT 71791000119104) E10.22 Chronic kidney disease stage 5 due to type II diabetes mellitus (SCT 711000119100) E55.9 Vitamin D deficiency (SCT 34713006) Z89.511 Amputated right lower extremity below knee (SCT 816964001) Z89.412 History of left great toe amputation (SCT 10996611000119104) K21.9 Gastroesophageal reflux disease (SCT 235595009) K31.84 Gastroparesis due to type 1 diabetes mellitus (SCT 713702000) residing in provided apartment (homeless prior) died on 11/21/2021. Per coroner death likely due to low blood sugar or heart attack. Pt had received one covid vaccine on 9/17/2021 at rehab facility. Likley pt's death not related to covid vaccine given pt's medical condition & coroner's assessment of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2531925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 03.02.2021
Beginn: 10.11.2021
Tage bis Beginn: 280,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 77 yo male patient with Hx of: Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.2) 10/24/2016 Obstructive Sleep Apnea (Adult) (Pediatric) (SCT 10/12/2016 78275009) (ICD-10-CM G47.33) (ICD-9-CM 272.4); Hyperlipidemia * (ICD-9-CM 10/27/2009 272.4) (ICD-9-CM 428.0); CHF * (ICD-9-CM 428.0) 01/30/2007 Asthma (ICD-9-CM 493.90) 06/18/2006 (ICD-9-CM 311.); Depression * (ICD-9-CM 06/15/2006 311./300.4) (ICD-9-CM 250.00); Diabetes Mellitus Type II or 10/07/2004 unspecified * (ICD-9-CM 250.00) (ICD-9-CM 355.9); Peripheral Neuropathy 05/21/2002 (ICD-9-CM 355.9) (ICD-10-CM J44.9); Chronic obstructive lung 10/12/2016 disease (SNOMED CT 13645005) Anxiety state (ICD-9-CM 300.00) 07/17/2000 Tobacco Use Disorder (SCT 110483000) (ICD-10-CM 10/12/2016 Z72.0) died of unknown causes on 11/10/2021. Pt had received covid vaccines on 1/6/21 7 2/3/21 at out rehab facility. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2531896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 24.06.2021
Beginn: 27.11.2021
Tage bis Beginn: 156,0
Dosis: 3
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Death Metabolic acidosis Sepsis Septic shock

Symptomtext

Narrative: 71yo male patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility:Nov 17, 2021 Hospital: Chief complaint: Sepsis with septic shock AFIB with RVR, Acute metabolic acidosis. Pt admitted. Pt then died on 11/27/21 at this hospital. Pt had received covid vaccines on 5/7, 6/5 & 6/24 (2021) from place not specified in chart. This death is not related to vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1346698

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MN
Alter: 76,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 06.03.2021
Beginn: 16.12.2021
Tage bis Beginn: 285,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Death Resuscitation Septic shock Urosepsis

Symptomtext

Dose 1 given 2/6/2021 Moderna Lot # n/A Patient died at hospital, Pt developed septic shock from urinary sepsis, required CPR, made comfort care by family, Not a Covid 19 death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: bladder cancer, COPD,PVD, cardiac disease, liver cirrhosis, pulmonary hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537388

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 10.02.2021
Beginn: 21.11.2021
Tage bis Beginn: 284,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 85yo male patient with CURRENT PROBLEM LIST: Diabetes mellitus without complication Gastroesophageal reflux disease Postsurgical Aortocoronary Bypass Status Hyperlipidemia Hypertension (SCT 38341003) Hypertrophy (Benign) of Prostate TOBACCO USE DISORDER Coronary artery disease IRRITABLE BOWEL SYNDROME Died on 11/21/21 location & cause of death unknown. Pt had received covid vaccines at outside facility provider on 1/13/21 & 2/10/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 25.02.2021
Beginn: 09.11.2021
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 75yo male patient with hx of niddm, htn, hld, anemia/thrombocytosis, b12 def, tinnitus died on 11/9/2021 with no info given on cause or circumstances of pt's death. Pt received most of his medical care outside of clinic. Pt had received covid vaccines on 2/2/21 & 2/25/21 from outside clinic. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536361

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 27.02.2021
Beginn: 08.12.2021
Tage bis Beginn: 284,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Accident Cerebral haemorrhage Cervical vertebral fracture Death Skin laceration

Symptomtext

Narrative: 90yo male pt had passed away at home on 12/8/2021. He had been at hospital after an accident where he broke his neck, had a forehead laceration and bleeding on the brain. He was discharged from hospital with home hospice. Pt had received vaccines on 1/20/21 & 2/27/21 from a medical provider. This death is not related to vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536332

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 08.07.2021
Beginn: 20.11.2021
Tage bis Beginn: 135,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 86yo male pt with: Problem list:-Chronic obstructive lung disease- Primary malignant neoplasm of prostate - Hypertension -BMH - Mild Neurocognitive Disorder - Alcohol Use Disorder (In sustained remission)- Anorexia - weight loss died on 11/20/2021 at long term care nursing facility . Pt had received covid vaccines on 6/7/21 & 7/8/21. This death is likely not related to the vaccinations due to patient's cormorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1963963

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge UNKNOWN

kritisch

Staat: CO
Alter: 74,0
Geschlecht: F
Eingang: 20.12.2021
Impfdatum: 01.11.2021
Beginn: 18.12.2021
Tage bis Beginn: 47,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram Chest discomfort Computerised tomogram thorax abnormal Dyspnoea Dyspnoea exertional Pulmonary embolism Troponin increased

Symptomtext

74-year-old female with a glomus jugulare tumor and no prior history of thromboembolic disease who presented to the emergency department with acute onset dyspnea with exertion and substernal chest pressure was found to have acute hypoxic respiratory failure secondary to acute pulmonary embolism with large clot burden. Upon admission she received a CT a of the chest with PE protocol that showed a saddle pulmonary embolism with extensive lobar, segmental, and subsegmental pulmonary emboli in both lungs. Troponin elevated. The pt reports she received a J&J vaccination in Nov 2021. Hospital DID NOT ADMINISTER THAT VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: CTA Chest on 12/18/2021
Aktuelle Erkrankungen: none
Vorgeschichte: Past Medical History Medical History Brain tumor, recurrent Cervicothoracic somatic dysfunction Enthesopathy of left hip region Facial nerve palsy Facial paralysis Facial spasm Facial weakness Geniculate herpes zoster Glomus jugulare tumor Hearing loss, left Lagophthalmos Localized primary osteoarthritis of right hand Neck pain Nonallopathic lesion of hip region Nonallopathic lesion of pelvic region Osteoarthritis, hand, primary localized Plantar fasciitis Pre-op evaluation Upper extremity pain, lateral
Andere Medikamente: No home meds per the ER note and the H&P
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1963561

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge unknown

kritisch

Staat: MA
Alter: 73,0
Geschlecht: M
Eingang: 20.12.2021
Impfdatum: 07.12.2021
Beginn: 07.12.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram cerebral abnormal Brain oedema CSF glucose normal CSF protein increased Cerebral haemorrhage Cerebral mass effect Computerised tomogram head abnormal Culture negative Endotracheal intubation Headache Herpes simplex test negative Implantable defibrillator insertion Lumbar puncture abnormal Magnetic resonance imaging Mental status changes

Symptomtext

Initially reported HA in afternoon after booster. Then awoke from sleep with altered mental status. Intubated on arrival for airway protection in ER. CTa/CT showed large edema with hemorrhage and mass effect pf right frontal lobe. LP showing polys, elevated protein, normal glucose. Running diagnosed was HSV meningoencephalitis. Culture, however, returned negative. Stated on Decadron for concerns of autoimmune in setting of booster. Transferred to for MRI compatible with AICD leads.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 8,0
Labordaten: as above.
Aktuelle Erkrankungen: None
Vorgeschichte: HTN, HLD, CAD c stents, CKD, prior TIA, prior MI, Cardiomyopathy, Anemia
Andere Medikamente: asa, atorvastatin, Brilinta, Zetia, Lisinopril, metoprolol.
Allergien: None
Vorherige Impfungen: -

VAERS 2538797

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 25.02.2021
Beginn: 02.12.2021
Tage bis Beginn: 280,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 81yo male patient with the following: -Atherosclerotic heart disease of native coronary artery without angina pectoris -Nonrheumatic aortic (valve) stenosis -Chronic obstructive pulmonary disease, unspecified -Obstructive sleep apnea (adult) (pediatric) (ICD-10-CM G47.33) -Unspecified hearing loss, unspecified ear (ICD-10-CM H91.90) -Obesity, unspecified -Low Back Pain -prostate cancer Pt received covid vaccines on 1/7/21 & 2/25/21 at outside provider. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 04.03.2021
Beginn: 26.11.2021
Tage bis Beginn: 267,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardio-respiratory arrest Death

Symptomtext

Narrative: 72yo male patient with the following-PROBLEM LIST: Depression (SCT 35489007) Cervical radiculopathy (SCT 54404000) Diabetes mellitus (SCT 73211009) Essential hypertension (SCT 10725009) Other Unspecified Counseling (ICD-9-CM VCalculus of kidney and ureter (SCT 266556005) Tremor (ICD-9-CM 781.0) Benign hypertension (ICD-9-CM 401.9) Hyperlipidemia (SCT 55822004) Health Maintenance (ICD-9-CM V65.9) Diabetes Mellitus Type II or unspecifiedHypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) Depression (SCT 35489007) Herpes (ICD-9-CM 054.9) died on 11/26/21 after self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 11/26/2021 Chief complaint: Cardiopulmonary arrest Pt had received covid vaccines on 1/29/21 & 3/4/21. This death is not related to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537489

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 52,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 11.03.2021
Beginn: 30.11.2021
Tage bis Beginn: 264,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 52 yo male patient with Metastatic Colon Cancer died during inpatient hospice stay on 11/30/2021. Pt had received covid vaccines on 2/18/21 & 3/11/21. Death is not related to vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537477

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 29.01.2021
Beginn: 16.11.2021
Tage bis Beginn: 291,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Essential hypertension Lumbar spinal stenosis Renal cancer

Symptomtext

Narrative: 89yo patient obtains most of his care outside agency with- CURRENT PROBLEM LIST - per patient and review of Code Description M48.06 Spinal stenosis of lumbar region (SCT 18347007) D49.519 CA - Cancer of kidney (SCT 363518003) I10. Benign essential hypertension (SCT 38341003) V58.89 Patient uses the Hospital primarily for Medications (ICD-9-CM V58.89) Hx of nephrolithiasis Pancreatic cyst CAD CKD 3 Insomnia Constipation Died at home on 11/16/2021. Pt had received covid vaccine from NON-agency provider on 1/8/21 & 1/29/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537444

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: -
Beginn: 08.11.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 62 yo male patient with substance abuse, etOH abuse and colorectal rectal cancer treated outside of agency died on 11/8/2021. Last medical note on 7/27/21. Pt had received covid vaccines on 3/18/21 & 4/15/21 from a church. Likely death not related to vaccines given cancer diagnosis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2534965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 16.11.2021
Beginn: 16.11.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 74yo male patient with PMH: Hyperlipidemia (SCT 55822004) Migraine (SCT 37796009) Lymphedema (SCT 234097001) Cellulitis (SCT 128045006) Hip pain (SCT 49218002) Chronic obstructive lung disease (SCT 13645005) Tobacco Use Disorder (ICD-9-CM 305.1) Essential hypertension (SCT 59621000) Morbid Obesity (ICD-9-CN 278.01 Diabetes (ICD-9-CM 250.00) died at hospital on 11/16/2021. Pt had received covid vaccines at place unknown on 2/4/21 & 2/25/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1961086

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 18.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from consumer via company representative through social media concerned 2 patients of an unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (dose number series 1) (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose and, therapy dates were not reported, 01 total, for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch numbers. No concomitant medications were reported. Reporter stated that, "My daughter knew two people who had the shots and got it and died. I guess if it is time for us to go nothing can stop it. But I did get the booster." On an unspecified date, the patient died from unknown cause. It was unspecified whether autopsy was performed or not. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of event death was reported as fatal. This report was serious (Death).; Sender's Comments: V0: 20211227721-Covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2540347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 46,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 11.02.2021
Beginn: 20.11.2021
Tage bis Beginn: 282,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acidosis Acute pulmonary oedema Blood lactic acid Cardiac arrest Cardio-respiratory arrest Cardiogenic shock Death Endocarditis Endotracheal intubation Haemofiltration Hypotension Pneumothorax Pulseless electrical activity Resuscitation

Symptomtext

Narrative: On 11/8/2021 46yo male patient presented was transfered to outside hospital from inpt hospital with mitral valve infective endocarditis after inpt at hospital since 10/30/2021. Several iv antibiotics given prior to transfer. Pt then died on 11/20/21 at outside hospital. Per MD notes: Unfortunately he developed flash pulm edema and was intubated urgently on 11/18/21. He was in cardiogenic shock and PEA arrested. Code blue called CPR started as per ACLS and ROSC obtained after 11 m. He developed a PTX on the right and CT was placed without issue. He developed worsening acidosis and hypotension despite CRRT and maximum medical treatment. He was found to have a lactic of 18.6. Family at beside and he was transitioned to DNR. He went asystolic at 1235 and pronounced deceased. Pt had received covid vaccines on 1/14/21 & 2/11/21. Likely death not related to covid vaccines given severe infection and cardiac arrest per MD note of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1954109

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 16.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Adverse drug reaction Death

Symptomtext

DIED; REACTION NOS; This spontaneous report received from a consumer via a company representative via social media concerned multiple patients of unknown age, sex, race and ethnicity. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported, 1 total (dose number in series: 1) administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient died from unknown cause of death and reaction nos. The reporter stated that "others who did have a reaction to and died" . "You may have later in life from the vaccine it's your choice to get it .Don't criticize others who didn't .We have neighbors who were healthy get it and died the next day after receiving the vaccine". It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211225095 -COVID-19 VACCINE AD26.COV2.S- Died This event(s) is considered unassessable .The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1944545

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 13.12.2021
Impfdatum: 03.08.2021
Beginn: 03.12.2021
Tage bis Beginn: 122,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute kidney injury Acute respiratory failure Ageusia Anosmia COVID-19 COVID-19 pneumonia Diarrhoea Dyspnoea Hyperkalaemia Hypophagia Metabolic acidosis Nausea SARS-CoV-2 test positive

Symptomtext

Hospitalized (12.3.21); COVID-19 positive (12.3.21); fully vaccinated Admission Date: 12/3/2021 Discharge Date: Dec 9, 2021 PRESENTING PROBLEM: COVID [U07.1] Hospital Course: PT is a 79 y.o. male with pmhx relevant for HTN, CML on bosutinib (follows with UMICH), history of tobacco use and suspected underlying COPD not formally diagnosed who receives most of his care through the VA. Amitted for acute hypoxic respiratory failure secondary to COVID-19 pneumonia as well as AKI with metabolic acidosis and hyperkalemia suspected secondary to poor oral intake during acute viral illness. He is vaccinated with J&J x1 August 2021. Symptoms started 11/25. Tested positive 12/3. Received dexamethasone from 12/3, Remdesivir initially held due to AKI and no longer indicated when renal function improved due to recovery to room air. His AKI was initially treated with fluids and bicarb gtt and improved rapidly. Therapy evaluated and recommended home with home HHC at discharge.symptoms improves and patient was discharged on home O2 in stable condition .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: ED - 12.3.21 - SHORTNESS OF BREATH (Signs and symptoms 1wk. SOB, nausea, diarrhea, lost of taste and smell. Ambulance called for SOB. Per EMS low 80s RA, currently 3L high 90s) - pneumonia due to COVID and AKI - transferred to another hospital for admission.
Vorgeschichte: Chronic kidney disease Chronic myeloid leukemia (CML) Hypertension Dyslipidemia Prediabetes thrombocytopenia osteoarthritis tinnitus vitamin D deficiency
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG enteric coated tablet bosutinib (BOSULIF) 100 MG TABS brimonidine (ALPHAGAN) 0.2 % ophthalmic solution cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) tablet ferrous sulfate 325 (65 Fe) MG tablet
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1944005

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MO
Alter: 81,0
Geschlecht: M
Eingang: 13.12.2021
Impfdatum: 23.02.2021
Beginn: 12.11.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Acute kidney injury Acute respiratory failure Anticoagulant therapy Asthenia Blood creatinine increased COVID-19 COVID-19 pneumonia Chills Computerised tomogram thorax abnormal Dyspnoea Fibrin D dimer increased Full blood count abnormal Lung infiltration Malaise Metabolic function test Metabolic function test abnormal Pain

Symptomtext

Chief Complaint pt presents for SOB, cough, abd pain, fever; tested positive for covid 4 days ago; received both covid vaccines History of Present Illness Patient is a 82-year-old male with a past medical history of hypertension, hyperlipidemia, type 2 diabetes presented to Hospital endorsing shortness of breath, fever, cough since past 4 days. Patient stated that he and his wife started experiencing generalized body aches, cough with greenish productive sputum since past 1 week. Stated that he was having low-grade fever with chills and has been experiencing worsening weakness and generalized malaise. He was tested positive for COVID-19 on 11/11. Stated that his shortness of breath progressively worsened which prompted him to visit Hospital. In the ED patient's white blood cell count was 14.3K but otherwise unremarkable CBC. D-dimer was elevated to 3.52, CMP revealed creatinine of 2.13. Patient was requiring 6 L oxygen to maintain saturation greater than 92%. Patient spiked temperature to 38.9 ?C on ED arrival. Patient was given dexamethasone and admitted to stepdown unit for further care. CT PE: No evidence of PE but bilateral extensive multifocal infiltrates consistent with COVID-19 pneumonia. Review of Systems 14 point review of systems negative except for HPI Physical Exam Vitals & Measurements T: 38.9 ?C HR: 104 RR: 12 BP: 134/67 SpO2: 91% WT: 111.8 kg Gen: AO x3, NAD HEENT: MMM, EMOI, PERRLA Neck: Supple, No LAD CVS: S1,S2 positive, No MRG Lungs: Coarse breath sounds thought ling fields, No accessory muscle use Abd: Soft, NT, ND, no organomegaly, bowel sounds positive Neuro: Non focal Extremities: Warm and dry, no edema Assessment/Plan 82 Y old M admitted to hospital for further management of acute hypoxia 2/2 COVID PNA Problem list: Acute hypoxic respiratory failure: COVID 19 PNA: Symptom onset -- > 11/8 Tested positive -- >11/11 Current O2 requirement -- > 6L Vaccination status -- > Yes Will cover pt empirically with Levaquin for possible superimposed CAP CTPE -- > no PE Bronchodilator therapy protocol Continue dexamethasone 6 mg daily 6 min walk test before discharge Consider Baricitinib/Tocilizumab if symptoms were to worsen Will trend inflammatory markers Remdesivir -- > Hold 2/2 poor renal function AKI?: Gentle hydration Pt received contrast for CTPE, at high risk for contrast induced nephropathy Will trend Cr DM2: Hold OGHA's Insulin sliding scale for now Hypoglycemic precautions HTN: Hold ACEI's and HCTZ HLD: Lipitor 20 mg daily F: As above E: Replete PRN N: regular diet GI: Not indicated DVT: Heparin Fall precautions Code status: Full code

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Date of Admission 11/15/2021 Date of Discharge 11/23/2021 Reason for Hospitalization pt presents for SOB, cough, abd pain, fever; tested positive for covid 4 days ago; received both covid vaccines Hospital Course Patient is an 82yo man with PMHx of HTN, HLD, DM type 2, who was admitted on 11/15 for further management of COVID-19 pneumonia. Sx onset was 11/8, tested positive on 11/11. He was started on dexamethasone & levaquin for treatment of COVID as well as superimposed bacterial infection. On 11/19 patient's GFR had improved to 55 so Remdesivir was started. On 11/21 baricitinib was started given continued improvement in GFR. Hospital course was prolonged by continued need for high amount of O2. By 11/22 he was able to be turned down to 4L but with ambulation desaturated dramatically still. On 11/23 he was feeling better and home O2 eval was done which showed that he maintained O2 sats with 5L with ambulation. Home O2 arranged through medical equipment provider and tank was delivered. He was discharged home with family. Advised to follow up with PCP within 1 week. He was discharged on 3 more days of dexamethasone to complete a 10d course of steroids. Discharge Diagnoses Pneumonia due to COVID-19 virus COVID-19 pneumonia Hypoxemia Superimposed bacterial pneumonia Symptom onset 11/8, positive 11/11, vaccinated - off precautions 11/22 - Chest CT/PE negative for PE - procal on admission 11.2, CRP 48 - Currently on 4L NC, needs 5L with ambulation - dexamethasone 11/15-current (continue for total of 10d course) - s/p baricitinib 11/21-11/23 - s/p remdesivir 11/19-11/23 - s/p levaquin 11/15-11/22 - inflammatory markers downtrended Elevated creatinine--AKI vs. CKD Unknown baseline, likely 2/2 COVID & dehydration - last creat 1.26 - renal US normal - FeNa 0.2% consistent with pre-renal Type II DM - resume home metformin on discharge HTN HLD - continue home lipitor, fenofibrate - advised to continue to hold home HCTZ, lisinopril given normotension without them while inpatient. Advised to resume if BP >150 for 3 consecutive days Ordered: DME - Home Oxygen Discharge Orders: benzonatate, 200 mg = 2 capsule(s), form: Capsule, Oral, tid, first dose 11/23/21 14:00:00 benzonatate, 200 mg = 2 capsule(s), Oral, tid, X 5 day(s), # 30 capsule(s), Refill(s) 0, 11/28/21, Pharmacy: DRUG STORE 186, cm, 11/22/21 1:33:00, Height (cm), kg, 11/21/21 4:15:00, Weight (kg), 106.4 dexAMETHAsone, 6 mg = 1.5 Tablet(s), Oral, Daily, X 3 day(s), # 4.5 Tablet(s), Refill(s) 0, 11/26/21, Pharmacy: DRUG STORE, 186, cm, 11/22/21 1:33:00, Height (cm), kg, 11/21/21 4:15:00, Weight (kg), 106.4 guaiFENesin, 1,200 mg = 2 Tablet(s), Oral, bid, X 3 day(s), # 12 Tablet(s), Refill(s) 0, 11/26/21, Pharmacy: DRUG STORE, 186, cm, 11/22/21 1:33:00, Height (cm), kg, 11/21/21 4:15:00, Weight (kg), 106.4 Discharge Patient Other Diagnoses Ongoing BMI 31.0-31.9,adult Obesity Historical No qualifying data Discharge Disposition Home Medications New, Changed, or Refilled Medications benzonatate (benzonatate 200 mg, 2 capsule(s), Oral, tid, for 5 day(s), 30 capsule(s), 0 Refill(s) dexAMETHAsone (dexAMETHA 6 mg, 1.5 Tablet(s), Oral, Daily, for 3 day(s), 4.5 Tablet(s), 0 Refill(s) guaiFENesin (Mucinex 600 1,200 mg, 2 Tablet(s), Oral, bid, for 3 day(s), 12 Tablet(s), 0 Refill(s) Medications to be Continued Misc. Medication (SAM e) 1 Tablet(s), Oral, Daily acetaminophen (acetamino 1,300 mg, 2 Tablet(s), Oral, bid aspirin (aspirin 325 mg) 325 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) cinnamon (Cinnamon 500 m 1,000 mg, 2 capsule(s), Oral, bid cyanocobalamin (cyanocob 1,000 mcg, 1 Tablet(s), Oral, Daily, 0 Refill(s) docusate (docusate sodiu 100 mg, 1 capsule(s), Oral, bid, 0 Refill(s) fenofibrate (fenofibrate 160 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) magnesium hydroxide (Mil 1.2 g, 15 mL, Oral, Daily, PRN: as needed for constipation metFORMIN (metFORMIN 500 500 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) multivitamin with minera 1 Tablet(s), Oral, Daily omega-3 polyunsaturated 1,000 mg, 1 capsule(s), Oral, bid, 0 Refill(s) pramipexole (pramipexole 0.5 mg, 2 Tablet(s), Oral, At Bedtime, 0 Refill(s) pravastatin (pravastatin 40 mg, 1 Tablet(s), Oral, At Bedtime, 0 Refill(s) senna (senna 15 mg) 30 mg, 2 Tablet(s), Oral, At Bedtime, 0 Refill(s) Discontinued Medications hydrochlorothiazide (hyd 12.5 mg, 1 capsule(s), Oral, Daily, 0 Refill(s) lisinopril (lisinopril 1 10 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s) Physical Exam at Discharge Vitals & Measurements T: 36.6 ?C TMIN: 36.5 ?C TMAX: 36.6 ?C HR: 86 RR: 16 BP: 136/78 SpO2: 94% Constitutional: Patient sitting up on edge of bed, in no acute distress. A&O x4. HEENT: Oral mucosa moist. Conjunctiva without injection. Pulm: Regular respiratory rate & effort. No crackles, rhonchi, or wheezing appreciated. On 4L NC with O2 sats ~95% CV: RRR. Normal S1/S2, no murmurs appreciated. GI: Normoactive bowel sounds. Soft, non-tender, non-distended. MSK: moves all extremities Skin: Warm, dry, intact. Neuro: No focal deficits Psych: Cooperative. Appropriate mood & affect. Time Spent 33 minutes spent. 50% or greater of time spent counseling and/or coordination of care. Collaborating physician agreement. Follow Up Appointments follow up with PCP in 7d Nursing/Other Orders DME - Home Oxygen Discharge. 11/23/21 13:52:00, Once, 11/23/21 13:52:00, 11/23/2021, 88, 93, 78, 90, 5, O2 Liter Flow/FlO2 5, Portable gas needed?, Length of need 99, Nasal Cannula, Patient will need 4L bleed-in with his CPAP at night, Pneumonia due to COVID-19 virus
Aktuelle Erkrankungen: unknown
Vorgeschichte: Patient is a 82-year-old male with a past medical history of hypertension, hyperlipidemia, type 2 diabetes
Andere Medikamente: unknown
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1941703

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 11.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

TWO STROKES; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN), 1 total, dose and start therapy date were not reported administered for prophylactic vaccination. Vaccination dose series was 1. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced two strokes. The reporter stated as, "my sister has lost her peripheral vision permanently, because of vaccine. She had two strokes, it has changed her life forever. She can no longer drive". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of two strokes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: 20211220048 -covid-19 vaccine ad26.cov2.s- two stroke This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1940521

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: KS
Alter: 71,0
Geschlecht: F
Eingang: 10.12.2021
Impfdatum: 16.09.2021
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

ADAMTS13 activity assay Anaemia Angiogram pulmonary abnormal Anticoagulant therapy Beta-2 glycoprotein antibody negative Biopsy bone marrow abnormal Blood chloride normal Blood fibrinogen decreased Blood iron normal Blood lactate dehydrogenase increased Cardiac ventricular thrombosis Chest pain Death Disseminated intravascular coagulation Dyspnoea Echocardiogram Electrocardiogram ST-T segment abnormal Epistaxis

Symptomtext

Note 6 Dec 2021 Patient is a 71 y.o. female. with emphysema, coronary artery disease s/p 3 stents '05, and metastatic bladder cancer admitted for shortness of breath and thrombocytopenia; found to have submassive PE. Rapid responded 12/6 for increased work of breathing, currently on comfort flow. covid vaccines pfizer on 3/3/2021, 3/24/2021, and booster on 9/16/2021, plt count 80,000 on 13 sep 2021 prior to booster, and dropped to 16,000 by 10/21/2021. 1. Thrombocytopenia -since August, admitted at 14K. Currently 41K s/p daily transfusions -previously been attributed to ITP secondary to immunotherapy, however this has not responded to first-line treatments including corticosteroids and IVIG in the outpatient setting -10/29/21 Bone marrow biopsy: Mildly hypercellular bone marrow (50% cellular) with erythroid hyperplasia. No diagnostic immunophenotypic abnormalities are detected by flow cytometry. Cyto was pending. Iron stain demonstrates adequate storage iron. -ADAMTS13 67%-normal -INR 1.1, fibrinogen 183 -B12 734 -haptoglobin 78, LDH 813, 1123 -negative HIT Ab X 2 -s/p Dex 40mg daily X 4; 1gm solumedrol daily 11/30-12/2 -negative drvvt, CL and beta 2 Ab -Started Promacta 50mg po daily 11/12; increased to 75mg po daily 11/25; increased to 100mg 12/1 2. Anemia -Hgb 8.3 -Prior occult GI bleed and was tranfused 1 unit in October 2021 but not scopre was performed; reports dark stools recently -ferritin 200, TIBC 335, % sat 24, iron 81 3. PE, acute; RV thrombus -exertional CP and SOB X 2 weeks -D-dimer 27350 -CTA chest performed and showed Bilateral segmental pulmonary emboli with prominent right heart strain, bowing of the intraventricular septum, dilation of the right atrium.Prominent likely unstable thrombus within the right ventricle, consider ECHO interrogation of the right ventricle, Subpleural nodules within the left lower lung, which are stable to slightly increased in size since prior exam. Differential diagnoses include metastases (given history of bladder cancer) or primary lung malignancy. Infectious/inflammatory etiology is felt less likely. Tissue sample recommended if clinically indicated for further evaluation. -venous doppler of legs showed no DVT -Etiology recent IVIG vs DIC vs. Cancer vs covid vaccine -heparin drip with prn platelet transfusions -11/19 cardiac MRI: suspicious for intracardiac tumor. Starting radiation 12/1 or 12/2. -repeat echo 12/6 pending 4. Metastatic bladder cancer - dx 2020 s/p cystectomy March 2021, chemo, radiation April 2021, hysterectomy -dose dense MVAC in Dec 2020-Feb 2021 -found to have metastatic disease in April 2021. -Developed autoimmune hepatitis with keytruda June 2021 -developed thrombocytopenia with avelumab, last dose 9/28/21 -Onc following- can not get enfortumab inpatient, recommending hospice Recommendations: -Increased SOB and hypoxia today, pending Echo. Also with epistaxis on exam- please repeat CBC this afternoon and continue platelet transfusion to keep >50K while on heparin. -With MRI findings of likely cardiac thrombus, it is more likley that her persistent thrombocytopenia is 2/2 hemolysis from shearing across the tumor and/or DIC and not ITP. Do not plan to administer Rituxan. Patient wants to go home- discussed with oncology that we could aim for platelet transfusion 3X/week and discharge on Lovenox 1 mg/kg BID (ok with DOAC if that's her preference however). -Holding promacta given ongoing transaminitis -pending radiation to intracardiac tumor -Heparin drip with prn platelet transfusion to keep >50K while on heparin -daily CBC, CMP unfortunately she died 8 Dec 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: cancer
Vorgeschichte: -
Andere Medikamente: -
Allergien: Iv Fe and latex
Vorherige Impfungen: -

VAERS 1940516

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: KS
Alter: 70,0
Geschlecht: M
Eingang: 10.12.2021
Impfdatum: 05.10.2021
Beginn: 15.11.2021
Tage bis Beginn: 41,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Anticoagulant therapy Bladder trabeculation Blood creatinine normal Blood loss anaemia Chest wall haematoma Computerised tomogram thorax abnormal Deep vein thrombosis Diastolic dysfunction Echocardiogram abnormal Electrocardiogram ST-T segment abnormal Endotracheal intubation Haematoma Haemorrhage Heparin-induced thrombocytopenia Plasminogen activator inhibitor Prostatomegaly Pulmonary embolism

Symptomtext

note from 11/23/21 had pfizer covid vaccines 2/24/21, 3/19/21, and 10/5/2021, i do not have lot number for the 10/5/2021 dose A/P: Pt is a 70 y.o. male with PMH of HTN, gerd, BPH who is transferred from a HCF with massive PE s/p ROSC and tPA. Placed on eliquis and developed right anterior chest and arm hematoma and need IVC filter placement. Now w/ e/o HIT, suspect classic HIT, w/in 5-10 days of heparin exposure, plt count nadir at 130 (>50% decline from 283) w/ h/o thrombosis and HIT Ab >2 OD (2.765) 4Ts of at least 5 or intermed, and w/ elev OD c/w and diagnostic for HIT. Suspect covid vaccine booster on 5 October 2021 could have been a risk factor for his initial presentation with PE and DVT however as the HIT is greater than 30 days post Covid vaccine and not present at initial presentation, this is not consistent with VITT at this point in time. 1. Massive PE s/p ROSC; acute LLE DVT and HIT -HCF CTA of chest which revealed acute bilateral PE with large clot burden and evidence of pulmonary hypertension and right heart strain -Echo from 11/15/2021 revealed EF of 70%, moderate diastolic dysfunction, right ventricular systolic pressure of 34.6 mmhg -Became pulseless while going to the restroom, was given tPA, intubated, required levophed -Received heparin and then eliquis @ HCF- last dose 11/14/21 2/2 bleeding -11/16/21 BLE U/S: 1. Acute-appearing, occlusive and nonocclusive thrombus in the left low femoral vein, as well as occlusive thrombus in the left popliteal vein. No right lower extremity DVT. -AC back on, apix 2.5 bid, ok to go to 5 mg bid -rec avoiding further covid shots due to poss contribution to clot -avoid heparin, it is an allergy now, w/ dx of HIT -plt already improving, currently on DOAC 2. Acute blood loss anemia -2/2 right anterior chest and arm hematoma while on Eliquis -Patient had right upper extremity arterial Doppler which did not reveal significant stenosis. He also had right upper extremity venous Doppler which revealed large hematoma involving the anterior chest and extending down the medial aspect of the right arm. -Hgb stable/improved -back on AC, ok to go to full dose 3. AKI -Cr 0.9 @ HCF admit, currently 0.82 -Renal ultrasound at HCF revealed renal cortical atrophy bilaterally. Enlarged prostate with palpable trabeculation. Questionable nonobstructing left renal stone. Recommendations: -resume eliquis 5 mg po bid -avoid heparin products -f/u w/ Dr at HCF next wk

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: heparin, now
Vorherige Impfungen: -

VAERS 1940505

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge unknown

kritisch

Staat: KS
Alter: 29,0
Geschlecht: M
Eingang: 10.12.2021
Impfdatum: 01.03.2021
Beginn: 01.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Condition aggravated Deep vein thrombosis Ex-tobacco user Iliac vein occlusion International normalised ratio abnormal Pelvic venous thrombosis Peripheral pulse decreased Pulmonary embolism Pulmonary infarction Thrombosis Treatment noncompliance Ultrasound Doppler abnormal Vena cava thrombosis Venous occlusion Venous stent insertion

Symptomtext

A/P: 29 yo male with PMH of recurrent PE/DVT, HTN and anxiety/depression who is transferred from the medical facility for management of PE/DVT. He has a reported history of protein C deficiency diagnosed at the medical facility. 1. Recurrent PE/DVT; acute PE and LLE DVT -first VTE 2017- RLE, placed on Xarelto -had covid vaccines at outside facility in mar and apr of 2021 -2nd and 3rd clots, both legs, after missing a few doses -4th clot in LLE march/april 2021- changed to coumadin. INRs were hard to control -5th clot LLE September 2021- back to Xarelto -? Protein C def -currently quitting smoking- uses patch and gum -adopted, doesn't know FH -reports might have missed 3-4 doses in the past month -OSH CTA chest: multiple b/l lower lobe PE, and infarcts -11/1/21 BLE U/S: Acute, occlusive deep venous thrombosis in the left iliac vein extending into the popliteal vein and tibioperoneal trunk. There also appears to be acute thrombus in one of the left peroneal veins. 2. Near occlusive thrombus in the lower IVC, without definite mid or upper IVC thrombus. No evidence of deep venous thrombosis in the right lower extremity. There is decreased pulsatility within the right lower extremity consistent with the lower IVC clot. -11/2 IR tPA + heparin drip stopped 11/4 w/ iliac vein stent -By history it seems he has recurrent clotting after missing only a dose or two of anticoagulation, although he was also not taking the Xarelto consistently with food. We recommended Lovenox 1mg/kg BID after thrombolysis completed and then ok to discharge on Lovenox 1.5 mg/kg once daily but he is concerned re: compliance. Therefore will avoid shots, add ASA to Xarelto as that may be the best change as he is young and active and has trouble remembering to take his pills, highly recommend compliance every single day and to get a pillbox and to make sure that he has taken his daily doses of Xarelto and aspirin, can take with food

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: clotting
Andere Medikamente: xarelto
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1931266

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 08.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

SHOT KILLED; This spontaneous report received from a consumer via social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose (dose number series 1), start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the consumer stated "shot killed my loved one" (death). On an unspecified date, the patient died from unknown cause. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211164482-COVID-19 VACCINE AD26.COV2.S-shot killed. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1880780

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NE
Alter: 74,0
Geschlecht: F
Eingang: 08.12.2021
Impfdatum: 01.05.2021
Beginn: 05.10.2021
Tage bis Beginn: 157,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury COVID-19 COVID-19 pneumonia Cardiac arrest Chest tube insertion Condition aggravated Death Deep vein thrombosis Echocardiogram abnormal Ejection fraction decreased Echocardiogram Fraction of inspired oxygen Gastrostomy Mechanical ventilation Pneumonia necrotising Pneumonia pseudomonal Pneumothorax Positive end-expiratory pressure

Symptomtext

CONFIRMED CLINICAL VACCINATION FAILURE; CONDITION AGGRAVATED; DEATH; GASTROSTOMY; TRACHEOSTOMY; MECHANICAL VENTILATION; POSITIVE END-EXPIRATORY PRESSURE; RESUSCITATION; TIDAL VOLUME; CHEST TUBE INSERTION; ECHOCARDIOGRAM ABNORMAL; EJECTION FRACTION DECREASED; FRACTION OF INSPIRED OXYGEN; ACUTE KIDNEY INJURY; CARDIAC ARREST; PULMONARY EMBOLISM; DEEP VEIN THROMBOSIS; RENAL TUBULAR NECROSIS; SEPSIS; COVID-19 PNEUMONIA; PNEUMONIA PSEUDOMONAL; PNEUMONIA NECROTISING; PNEUMOTHORAX; PULSELESS ELECTRICAL ACTIVITY; COVID-19; SARS-COV-2 TEST POSITIVE; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System concerned a 74 year old female of unspecified race and ethnicity. Initial information was processed along with the additional information received on 02-DEC-2021. The patient's height, and weight were not reported. The patient's past medical history included: cholecystectomy, and right knee replacement, and concurrent conditions included: chronic obstructive pulmonary disease, pulmonary embolism, hyperlipidemia, gastroesophageal reflux disease, and hypothyroidism. The patient's son passed away from COVID-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on 01-MAY-2021 for an unspecified indication. (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 05-OCT-2021, the patient tested positive for COVID-19 virus test and experienced covid-19 infection, and was hospitalized (date unspecified). On an unspecified date, patient experienced confirmed clinical vaccination failure. Patient was unable to be weaned off of the ventilator and underwent a tracheostomy on 27-OCT-2021 and gastrostomy placement on 29-OCT-2021. The patient was transferred to bigger hospital from a smaller Hospital with COVID-19 pneumonia and sepsis on 03-NOV-2021. When the patient arrived to bigger hospital the patient had a pulseless electrical activity cardiac arrest requiring chest compressions and 1 dose of epinephrine prior to returning to spontaneous circulation. The patients post cardiac echocardiogram showed an ejection fraction decreased to 23%, the patient also developed acute kidney injury related to acute tubular necrosis. The patient was given tocilizumab, remdesivir and steroids The patient's hospital course was further complicated by deep vein thrombosis and pulmonary embolism. Patient was noted to also have right upper lobe necrotizing pneumonia due to Pseudomonas and was on Meropenem. The patient's family met with palliative care and they wanted to continue current care. On admission the patient was on assit-control mode of ventilation with a tidal volume of 380, Positive end-expiratory pressure of 5 respiratory rate of 14 and FiO2 (Fraction of inspired oxygen) of 40%. The patient also had pneumothoraxes and 2 right sided chest tubes and a chest tube on the left. Patient's condition worsened and on 11-NOV-2021. The surgical additional chest tube placement needed but family decided on comfort cares at that time. Patient was placed on comfort cares. On 12-NOV-2021, at 15:00 the patient died from unknown cause of death. The number of hospitalization days was 36 days. It was unknown whether the autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of from unknown cause of death on 12-NOV-2021, and the outcome of cardiac arrest, pulmonary embolism, acute kidney injury, deep vein thrombosis, renal tubular necrosis, sepsis, covid-19 pneumonia, pneumonia pseudomonal, pneumonia necrotising, pneumothorax, pulseless electrical activity, condition aggravated, covid-19, sars-cov-2 test positive, chest tube insertion, echocardiogram abnormal, ejection fraction decreased, fraction of inspired oxygen, gastrostomy, mechanical ventilation, positive end-expiratory pressure, resuscitation, tidal volume and tracheostomy was fatal, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged). This report was associated with a product quality complaint: 90000205240. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from RA department on 06-DEC-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1 Additional information in this version updates of Product quality complaint investigation result. This updated information does not change the prior causality assessment of reported events. 20211201285- Covid-19 vaccine ad26.cov2.s- Death, cardiac arrest, acute kidney injury, deep vein thrombosis, renal tubular necrosis, sepsis, covid-19 pneumonia, pneumonia pseudomonal, pneumonia necrotising, pneumothorax, pulseless electrical activity, condition aggravated, covid-19, sars-cov-2 test positive, chest tube insertion, echocardiogram abnormal, ejection fraction decreased, fraction of inspired oxygen, gastrostomy, mechanical ventilation, positive end-expiratory pressure, resuscitation, tidal volume, tracheostomy. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 202111201285-Covid-19 vaccine ad26.cov2.-Pulmonary embolism. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20211201285-Covid-19 vaccine ad26.cov2.s-Confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 36,0
Labordaten: Test Date: 20211005; Test Name: COVID-19 virus test; Result Unstructured Data: Positive; Test Date: 20211027; Test Name: Tracheostomy; Result Unstructured Data: Underwent; Test Date: 20211029; Test Name: Percutaneous endoscopic gastrostomy; Result Unstructured Data: Underwent; Test Date: 202111; Test Name: Fraction of inspired oxygen; Result Unstructured Data: 40 %; Test Date: 202111; Test Name: Tidal volume; Result Unstructured Data: 380; Test Date: 202111; Test Name: Positive end-expiratory pressure; Result Unstructured Data: 5; Test Date: 202111; Test Name: Respiratory rate; Result Unstructured Data: 14; Test Date: 202111; Test Name: Echocardiogram; Result Unstructured Data: Ejection factor
Aktuelle Erkrankungen: Chronic obstructive pulmonary disease; Gastroesophageal reflux disease; Hyperlipidemia; Hypothyroidism; Pulmonary embolism
Vorgeschichte: Medical History/Concurrent Conditions: Cholecystectomy; Total knee replacement; Comments: The patient's son passed away from COVID-19 infection.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1554175

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: ME
Alter: 29,0
Geschlecht: F
Eingang: 08.12.2021
Impfdatum: 14.05.2021
Beginn: 20.08.2021
Tage bis Beginn: 98,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Pulmonary embolism SARS-CoV-2 test negative

Symptomtext

Pt developed PE but also was a 2 PPD smoker but recently had cut down to 0.5ppd

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Covid negative
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: lamictal, metformin, tramadol, victoza
Vorherige Impfungen: -

VAERS 1929460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 100,0
Geschlecht: F
Eingang: 07.12.2021
Impfdatum: 23.02.2021
Beginn: 04.12.2021
Tage bis Beginn: 284,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Acute myocardial infarction Agonal respiration COVID-19 Culture urine positive Death Electrocardiogram abnormal Hypertensive crisis Hypoxia Klebsiella test positive Leukopenia Pain SARS-CoV-2 test positive Tachycardia Troponin increased Urinary tract infection Urine analysis abnormal

Symptomtext

Fully vaccinated patient who admitted with positive COVID test. Provider discharge note below: "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: COVID detected test 12/02/21.
Aktuelle Erkrankungen: -
Vorgeschichte: Carpal Tunnel Syndrome (354.0) DJD (degenerative joint disease), multiple sites Hypercholesteremia Osteoporosis Hx of TIA (transient ischemic attack) and stroke Macular degeneration Urinary incontinence AKI (acute kidney injury) (*) Cataract Dissection of thoracic aorta (*) Thyroid nodule HFrEF (heart failure with reduced ejection fraction) (*)
Andere Medikamente: Metorprolol, Norco
Allergien: Aspirin, Atenolol, Maxzide, Lisinolpril
Vorherige Impfungen: -

VAERS 1929460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 100,0
Geschlecht: F
Eingang: 07.12.2021
Impfdatum: 23.02.2021
Beginn: 04.12.2021
Tage bis Beginn: 284,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Acute myocardial infarction Agonal respiration COVID-19 Culture urine positive Death Electrocardiogram abnormal Hypertensive crisis Hypoxia Klebsiella test positive Leukopenia Pain SARS-CoV-2 test positive Tachycardia Troponin increased Urinary tract infection Urine analysis abnormal

Symptomtext

Fully vaccinated patient who admitted with positive COVID test. Provider discharge note below: "Patient is a 101yo F with history of HTN, CKD4, dementia, thoracic aortic aneurysm on hospice who presented with intractable abdominal pain. Patient was found with elevated troponins and EKG findings consistent with NSTEMI, COVID-19 positive (pt vaccinated but without booster), tachycardia, urgent HTN with BP 210/98, leukopenia and dirty UA of which cultures eventually grew Klebsiella. Patient was given a dose of therapeutic lovenox for the NSTEMI and per son wishes cardiology was not consulted for intervention. Troponins improved the day after admission. HTN was controlled with beta blockers and hydralazine. She was given narcotics for pain relief and ceftriaxone for the UTI. Patient did not initially need oxygen on admission but 2 days later developed agonal breathing that caused hypoxia. Patient was given oxygen with improvement, but per son wishes was discontinued and patient switched to comfort care. Patient passed peacefully on 12/4/2021."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: COVID detected test 12/02/21.
Aktuelle Erkrankungen: -
Vorgeschichte: Carpal Tunnel Syndrome (354.0) DJD (degenerative joint disease), multiple sites Hypercholesteremia Osteoporosis Hx of TIA (transient ischemic attack) and stroke Macular degeneration Urinary incontinence AKI (acute kidney injury) (*) Cataract Dissection of thoracic aorta (*) Thyroid nodule HFrEF (heart failure with reduced ejection fraction) (*)
Andere Medikamente: Metorprolol, Norco
Allergien: Aspirin, Atenolol, Maxzide, Lisinolpril
Vorherige Impfungen: -

VAERS 1929259

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: TX
Alter: 85,0
Geschlecht: M
Eingang: 07.12.2021
Impfdatum: 23.09.2021
Beginn: 22.11.2021
Tage bis Beginn: 60,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Death Mental status changes Procalcitonin increased SARS-CoV-2 test positive Urinary tract infection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 12/30/2020, 1/20/2021, and 9/23/2021. Patient with PMHx of lympblastic lymphoma, CHF, Afib on Eloquis, recent UTI on abx presented to ED w/AMS. Admitted for acute hypoxic respiratory failure, Covid-19 pneumonia and CHF. Tx'd w/remdiseivir x5days, dexamethasone D#8/10, completed rocephin and Zithromax x5days for elevated procal. Oxygen demands continued to worsen and continued to deteriorate despite doubling steroids and adding cefepime. Expired on 11/30/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: Positive COVID-19 Test on 11/22/2021 using the Panels test
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia, Atrial Fibrillation, Glaucoma, Lymphoblastic lyphoma, Osteoarthritis, Generalized weakness
Andere Medikamente: Acetaminophen PRN, Allopurinol 300 mg QD, Augmentin 875 mg BID, Apixaban 5 mg BID, Baclofen 10 mg TID, Combigan 1 drop both eyes BID, Doxycycline 100 mg BID, Ergocaclciferol 1250 mcg QWeek, Famotidine 20 mg BID, Furosemide 40 mg QD, Probio
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1928591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MA
Alter: 66,0
Geschlecht: M
Eingang: 07.12.2021
Impfdatum: 12.04.2021
Beginn: 23.11.2021
Tage bis Beginn: 225,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abdominal discomfort Acute respiratory failure Bacterial infection COVID-19 Chest X-ray abnormal Diarrhoea Dyspnoea Inflammatory marker increased Laboratory test normal Legionella test Lung infiltration Nausea Pneumonia Productive cough Respiratory failure SARS-CoV-2 test positive Sputum culture Sputum discoloured

Symptomtext

67 y.o. male with BOOP s/p BOLT 7/2/12 (CMV D-/R+, EBV D+/R+, toxo positive) who is here with worsening respiratory failure. PMH: CLAD, OSA on CPAP, obesity He was diagnosed with COVID on 11/13/21 and received monoclonal antibody on 11/17/21. Since then he continues to have worsening productive cough of green sputum. He could not lay flat or on his side due to cough. Denies sinus pain, rhinorrhea, sore throat. He feels that his cough seems to come from his throat. His breathing is also more labored. He could not keep food down due to N/V and abdominal discomfort. 11/24 he has watery diarrhea. He denies fever, chest pain, or swelling in his legs. He had received COVID booster. In ER, he was placed on 3 LPM O2. CXR with multifocal infiltrates. Elevated inflammatory marker. # Pneumonia with acute hypoxic respiratory failure - COVID-19 vs secondary bacterial infection: Overall getting better - Ceftazidime 11/23 - 11/26 / doxy 11/23 --11/30 - Preliminary respiratory culture with OPF -- > can switch antibiotic to just doxycycline to complete a 7-day course through 11/30 - D/C vancomycin 11/24 - Negative urine streptococcal/ legionella antigen - Discussed with ID, start remdesivir 11/24 -- > can discontinue today to go home - Dexamethasone for 5 days - O2 to keep SpO2 > 90% - Supportive treatment for cough: Bronchodilator, cough suppressant - Pending BDG - Negative serum GG 11/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: 11/13/2021 - COVID positive
Aktuelle Erkrankungen: unknown
Vorgeschichte: ? Obstructive sleep apnea syndrome ? Arthritis ? Status post lung transplantation ? Deep vein thrombosis ? Hyperlipidemia ? History of bronchiolitis obliterans with organizing pneumonia ? Current chronic use of systemic steroids ? Status post right unicompartmental knee replacement ? BOOP (bronchiolitis obliterans with organizing pneumonia) ? Obesity, Class II, BMI 35-39.9 ? Class 2 severe obesity with body mass index (BMI) of 35 to 39.9 with serious comorbidity ? COVID-19
Andere Medikamente: albuterol 2.5 mg /3 mL (0.083 %) nebulizer solution 2.5 mg, Nebulization, Every 6 hours PRN atorvastatin (LIPITOR) 40 MG tablet 40 mg, Oral, Nightly azithromycin (ZITHROMAX) 250 MG tablet 250 mg, Oral, 3 times weekly (MWF) Patient not takin
Allergien: ? Azathioprine Other (See Comments) flu-like symptoms attempted w/ lower dose w/ same flu-like symptoms occuring Other reaction(s): Other flu-like symptoms attempted w/ lower dose w/ same flu-like symptoms occuring Weak and ill feeling , stopped after 2-3 days ? Naprosyn [Naproxen] Per patient, interferes with immunosuppressant medications
Vorherige Impfungen: -

VAERS 2561195

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 102,0
Geschlecht: M
Eingang: 06.12.2021
Impfdatum: 30.12.2020
Beginn: 26.05.2021
Tage bis Beginn: 147,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 101 yo male patient who resides at senior living facility & does not receive facility care died on 5/26/2021. Pt had received covid vaccinations from the facility where he resided on 12/30/21 & 1/20/21. No information provided on the cause of death. Likely covid vaccinations not related to death given 4 months death post last vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 13.01.2021
Beginn: 15.07.2021
Tage bis Beginn: 183,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 77 yo M pt new to medical facility had only been seen for dental exam by medical facility. No information in data system on pt including vo vitals, no med list, no problem list. Pt did receive one covid vaccine at pharmacy noted in data system. Pt died of unknown causes on 7/15/21. Not able to assess if pt's death related to vaccine. Likely was not related given > 90 days btwn vaccination & pt's death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565355

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 15.01.2021
Beginn: 03.07.2021
Tage bis Beginn: 169,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 93yo M with hx of Pathological Fracture, right femur, subsequent encounter for fracture with routine healing, Chronic Kidney disease, Stage 4(severe),Contact with exposure to other viral communicable diseases, Malignant melanoma of skin, Type II diabetes Mellitus with diabetic chronic kidney disease. Vitamin D deficiency, Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, Unspecified chronic Kidney disease, Heart failure,Constipation,Gout,Presence of urogenitalimplants died on 7/3/2021. He had received covid vaccinations on 1/15/21 & 2/12/21. Pt resided in a nursing home. Likely death not related to covid vaccinations given pt's advanced age & medical history & date of death > 90 days from last vaccine given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565349

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 13.03.2021
Beginn: 20.07.2021
Tage bis Beginn: 129,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Dyspnoea

Symptomtext

Narrative: 71yo M died on 7/20/21 on at community hospital after presenting to community hospital ER with Chief complaint: Shortness of Breath. Pt with a h/o Bladder cancer. No Death/DC Summary available. Pt had received covid vaccinations on 2/14/21 & 3/13/21. Appears death is not related to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2564305

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 17.02.2021
Beginn: 23.04.2021
Tage bis Beginn: 65,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal distension Computerised tomogram abdomen abnormal Death Hepatic cancer metastatic Ultrasound abdomen abnormal

Symptomtext

Narrative: 72 yo M died on 4/23/2021 wit History of hepatitis C with successful treatment approximately 10 years ago. He had some abdominal swelling and fullness and ultrasound CT and MRI demonstrated a dramatically locally advanced as well as widely metastatic central liver tumor per 4/14/21 PCP note. Pt was still in diagnosis phase of treatment prior to death on 4/23/21 at outside facility. Pt received covid vaccinations at outide facility on 2/17/21 & 3/18/21. Pt's death likely not related to death given recent advanced liver cancer diagnosis prior to death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2561998

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 16.02.2021
Beginn: 15.07.2021
Tage bis Beginn: 149,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death Vaccination failure

Symptomtext

Narrative: 84yo male with hx of ischemix heart disease, htn, hlp, copd,chronic leg pain from service injury (1969), hearing loss, left hand tremor, spinal stenosis, basal cell skin cancers & pre-DM. Pt had covid infection April 2021 and hospitalized twice at outside hospital for covid infection. Pt also was fully vaccinated at pharmacy on 1/26/21 & 2/16/21 with pzifer vaccines. So one ADE is vaccination failure. Also, pt died on 7/19/2021 at hospital on 7/15/21 @01:25. Cause of death is unknown. Possibly death could have been related to complications from covid infection in April 2021 & therefore death could be related to an ADE of failed vaccinations to provide immunity from the covid infxn after pt was fully vaccinated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557230

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 09.03.2021
Beginn: 17.07.2021
Tage bis Beginn: 130,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Bone pain Cough Death Decreased appetite Fatigue Pyrexia

Symptomtext

Narrative: 71 yo male with PMHx of metastatic prostate cancer (liver, bones), hyponatremia, HLD, who presented to the ED on 7/12/21 d/t fever and R sided abdominal pain for the last week. Wife states temps up to 103. Patient also with cough. Wife states that he has increased cough after eating and drinking. Patient was also with c/o bone pain, fatigue and anorexia.On 7/15/21 pt transfered to home hospice. Pt died on 7/17/21 at home hospice. Pt had received covid vaccinnes outside facility on 2/1/21 & 3/9/21. Appears death is not related to covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 05.03.2021
Beginn: 27.06.2021
Tage bis Beginn: 114,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 73yo male with hx of CAD,HF, COPD,HTN, HDL,PVCs died on 6/27/21 location & circumstances unknown. Pt also received covid vaccines on 2/12/21 & 3/5/21 from outside source. Not able to assess given lack of information if vaccines were related to pt's death but given timeframe likely not related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2564298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 03.06.2021
Beginn: 24.07.2021
Tage bis Beginn: 51,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Gun shot wound Intentional self-injury

Symptomtext

Narrative: 41yo male with recent mental health inpatient admission & substance abuse died on 7/24/2021 from self inflicted gun shot wound. Pt had received covid vaccinations on 5/10/21 & 6/3/21. Vaccines were not related to death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563133

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 04.03.2021
Beginn: 28.07.2021
Tage bis Beginn: 146,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt was a 76yr male died Wednesday, July 28, 2021 at hospital. PMH includes Aortic valve replacement, pacemaker placement, CHF, Atrial Fibrillation, Obstructive Sleep Apnea, COPD - never smoked, agent orange exposure, Depression, HLD, HTN, BPH s/p TURP, Chronic pain syndrome, Degenerative disc disease in the spine L4-5 fusion, Osteoarthrosis, s/p hip replacement, Trigeminal neuralgia, Osteoporosis. Vaccines are likely not related to death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563124

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 27.02.2021
Beginn: 06.08.2021
Tage bis Beginn: 160,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Neoplasm malignant

Symptomtext

Narrative: 81yo M with stage IV cancer - multiple new cancer diagnoses on 6/29/21 died at home on 8/6/2021 in community care home health care. Pt had received covid vaccinations on 2/6/21 & 2/27/21 from non-agency hospital. Death appears not related to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563108

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 97,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 21.01.2021
Beginn: 04.08.2021
Tage bis Beginn: 195,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Ileus Pneumonia SARS-CoV-2 test negative Sepsis Urinary tract infection

Symptomtext

Narrative: 97 yo male died inpatient on 8/4/2021 caused by sepsis with pneumonia and UTI with ileus. Pt was Covid negative on 7/30/21. Pt had covid vaccines on 12/31/20 & 1/21/21. Death appears to not be related to covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563106

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 17.02.2021
Beginn: 07.08.2021
Tage bis Beginn: 171,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Cardio-respiratory arrest Death Respiratory failure

Symptomtext

Narrative: 88yo MALE with a h/o COPD on home O2, chronic diastolic heart failure, pulmoary HTN, chronic orthostatic hypotension, with h/o PE on Apixaban who was admitted on 8/6/21 to the ED from nursing home for episode of soa died on 8/7/21 after transfer to inpatient hospice care.Death was caused by: Acute cardiopulmonary arrest in the setting of Acute on Chronic Hypoxemic Respiratory Failure . Pt had received covid-19 vaccinations in 1/19/21 & 2/17/21. Death is not related to vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1922496

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge unknown

kritisch

Staat: WA
Alter: 40,0
Geschlecht: F
Eingang: 03.12.2021
Impfdatum: 02.11.2021
Beginn: 03.11.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Blood test Cardiac imaging procedure abnormal Chest X-ray abnormal Chest discomfort Chest pain Chills Dyspnoea Electrocardiogram abnormal Fatigue Heart rate increased Inflammation Influenza Malaise Myocardial infarction Pain in jaw Palpitations Pericarditis

Symptomtext

Felt very ill with chills, fever, fatigue and heaviness in chest. Flue symptoms went away after third day, but chest heaviness remained. on 11/12/2021 I had an attack that felt like a heart attack. I had severe chest and back pain, difficulty breathing, palpitations, fast heart rate and jaw pain which led me to the emergency room where they diagnosed me with pericarditis and referred me to a Cardiologist if the symptoms didn't subside. I saw Dr. @ the hospital Cardiology on 11/16/2021 who confirmed pericarditis diagnoses and gave me a round of prednisone which did not work. He then prescribed me colchicine and referred me to a different doctor to manage my inflammation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Hospital Emergency Room: 11/12/2021, EKG, Ultrasound, blood tests, chest X-ray Cardiologist Visit 11/16/2021, Blood Draw, Physical Exam, Ultrasound Rheumatologist Visit 12/1/2021, Blood Draw, Physical Exam
Aktuelle Erkrankungen: none
Vorgeschichte: exercise induced asthma (haven't needed an inhaler for several years)
Andere Medikamente: Prenatal Vitamins (kirkland Brand)
Allergien: Percocet
Vorherige Impfungen: -

VAERS 1919838

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 03.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

7 STROKES; This spontaneous report received from a consumer via media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported,1 total administered for prophylactic vaccination. Dose number series was 1.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter questioned "will it help me see my grandmother again" and added that her "grandmother got JANSSEN covid vaccine and had about 7 strokes in 3 months that ultimately took her life". On an unspecified date, the patient died from 7 strokes. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was fatal. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0- 20211203719-Covid-19 vaccine ad26.cov2.s-7 strokes. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: 7 STROKES

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1919288

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 03.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

STROKE; This spontaneous report received from a patient via media via a company representative concerned a patient of unspecified age and sex and unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown expiry: unknown) dose was not reported, start therapy date were not reported 1 total administered for prophylactic vaccination (dose number series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced stroke. It was reported that " yes just stick up your ass , I had stroke after I coerced into taking your vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211157095-COVID-19 VACCINE AD26.COV2.S-Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1868510

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: KY
Alter: 97,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 17.02.2021
Beginn: 12.09.2021
Tage bis Beginn: 207,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Asthenia COVID-19 Confusional state Death Decreased appetite Dyspnoea Depressed level of consciousness Feeling abnormal Hypertension Hypoxia Impaired driving ability Fatigue Nasal congestion SARS-CoV-2 test positive Malaise Moaning Oxygen saturation decreased

Symptomtext

Received Moderna COVID-19 vaccines on 1/20/21 and 2/17/21. Developed symptoms of COVID-19 on 9/12/21 (nasal congestion, fatigue, loss of appetite, feeling weak, SOB). Tested positive on 9/16/21. Received monoclonal antibody infusion on 9/18/21 (casirivimab-imdevimab). Worsened as of 9/21/21 with hypoxemia. Told his family that he did not want to go to the hospital and preferred transition to hospice care, which was arranged. Died on 9/22/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension, hyperlipidemia
Andere Medikamente: Albuterol, aspirin, fexofenadine, furosemide, metoprolol, olopatadine eye drops, omeprazole, multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2567385

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 05.04.2021
Beginn: 21.07.2021
Tage bis Beginn: 107,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 87yo patient who receives MEDICAL care & pharmacy meds outside facility died on 7/21/21. PROBLEM : Dementia (SCT 52448006) (ICD-10-CM F02.80) 04/29/2021 H/O: rheumatoid arthritis (SCT 161567008) 04/29/2020 (ICD-10-CM M06.9) Automatic implantable cardiac defibrillator in 04/15/2019 situ (SCT 443325000) (ICD-10-CM Z45.02) Coronary arteriosclerosis (SCT 53741008) 03/29/2017 (ICD-10-CM I25.10) (ICD-9-CM 302.72); Male erectile disorder 03/14/2011 (ICD-9-CM 302.72/607.84) (ICD-9-CM 714.0); Arthritis, Rheumatoid * 03/14/2011 (ICD-9-CM 714.0) (ICD-9-CM 414.9); CAD * (ICD-9-CM 414.9) 07/02/2008 (ICD-9-CM V65.9); Health Maintenance (ICD-9-CM 11/07/2006 V65.9) (ICD-9-CM 562.10); Diverticulosis * (ICD-9-CM 11/07/2006 562.10) (ICD-9-CM 530.81); Gastroesophageal Reflux 06/26/2003 Disorder * (ICD-9-CM 530.81) (ICD-9-CM 272.4); Hyperlipidemia * (ICD-9-CM 06/26/2003 272.4) (ICD-9-CM 272.4); Hyperlipidemia * (ICD-9-CM 06/26/2003 272.4) (ICD-9-CM 272.4) (ICD-9-DM 250.00); Diabetes Mellitus Type II or 06/26/2003 unspecified * (ICD-9-CM 250.00) (ICD-9-CM 272.4); Hyperlipidemia * (ICD-9-CM 02/01/2003 272.4) Arteriosclerotic Cardiovascular Disease 04/04/1996 (ICD-9-CM 429.2), Onset 00/00/1995 Essential Hypertension (ICD-9-CM 401.9), Onset 04/04/1996 00/00/1995 Nosie effects on inner ear (ICD-9-CM 388.10), 04/04/1996 Onset 00/00/1996 Pt had received covid vaccines from outside provider.This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567384

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 25.03.2021
Beginn: 14.08.2021
Tage bis Beginn: 142,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Colon cancer Death Neoplasm malignant

Symptomtext

Narrative: 78yo in hospice care with cancer (Primary malignant neoplasm of sigmoid colon ) died at home in home hospice care om 8/14/2021. Pt had received covid vaccines on 2/25/21 & 3/25/21. Death not related to vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566476

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 05.03.2021
Beginn: 14.08.2021
Tage bis Beginn: 162,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Affective disorder Asthenia Chronic obstructive pulmonary disease Culture negative Death Gastrooesophageal reflux disease Headache Hypertension Hypophagia Meningitis Pain Thalamic stroke

Symptomtext

Narrative: 84yo male residing at nursing facility died on 8/14/2021. Pt had history of: 1. Culture Negative Meningitis POA treated, Vanc + Ampicillin + Cefepime.+ Acyclovir with IV Dex 10 mgq6 x 4 days. Stop date for ABX 6/27/21 HAS FINISHED COURSE NOW. 2. Hx of R Thalamic Stroke POA 3. COPD POA 4. HTN POA 5. GERD POA with history of Barrett esophagus 6. GI bleed notPOA PPI accepted but declining GI interventions 7. Mood Disorder POA Psychiatry evaluated for SI 6/17/21 recommended NO 1:1 sitter. Patient is decisional. 8. Chronic pain POA lidocaine patch and Hydrocodone provided 9. Debility POA he desires comfort care with long term care placement, still not eating, palliative aware. 10. Chronic HA, will increase dose of venlafaxine per recs, they discussed with him yesterday and he was agreeable. Pt had received covid 19 vaccines on 2/5/21 & 3/5/21 at grocery store pharmacy. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1916971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MI
Alter: 76,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 24.03.2021
Beginn: 25.10.2021
Tage bis Beginn: 215,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain Acute respiratory failure Asthenia Atrial fibrillation Bilirubin conjugated increased Blood bicarbonate decreased Blood bilirubin increased Blood chloride decreased Blood culture positive Blood sodium decreased Body temperature increased COVID-19 Chest X-ray abnormal Chills Computerised tomogram abdomen normal Condition aggravated Culture urine negative Depression

Symptomtext

a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease. UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20. Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE. Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: Bowel disease years controlled by medication ? Chronic bronchitis (CMS/HCC) Feb. 2019 ? History of recent acute infection Feb 2019 Viral infection ? History of weight change May 2019 during hospitalization ? Malaise and fatigue Feb 2019 worsened since ? Memory disorder 2016 short term ? Neuropathy ? Osteoarthritis unknown joints ? Pancreatitis 2006 ? Psychiatric disorder 2019 depression ? Respiratory abnormality Feb 2019 ? Scoliosis ? Spinal stenosis, lumbar ? Stomach disorder for years acid reflux ? Swallowing difficulty 2016 sometimes
Vorgeschichte: Bowel disease years controlled by medication ? Chronic bronchitis Feb. 2019 ? History of recent acute infection Feb 2019 Viral infection ? History of weight change May 2019 during hospitalization ? Malaise and fatigue Feb 2019 worsened since ? Memory disorder 2016 short term ? Neuropathy ? Osteoarthritis unknown joints ? Pancreatitis 2006 ? Psychiatric disorder 2019 depression ? Respiratory abnormality Feb 2019 ? Scoliosis ? Spinal stenosis, lumbar ? Stomach disorder for years acid reflux ? Swallowing difficulty 2016 sometimes
Andere Medikamente: acetaminophen (TYLENOL) tablet 650 mg ? albuterol (PROVENTIL, VENTOLIN) (2.5 MG/3ML) 0.083% nebulizer solution 2.5 mg 2.5 mg Inhalation Q 4 H PRN ? albuterol-ipratropium (DUONEB) nebulizer solution 3 mL 3 mL Inhalation RT-every 6 hours
Allergien: Allergen Reactions ? Perfumes [Aromatic Oils] Swelling, lips/throat/tongue ? Amoxicillin-Pot Clavulanate Nausea and/or vomiting
Vorherige Impfungen: -

VAERS 1915680

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 02.12.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Myocardial infarction

Symptomtext

DIED FROM HEART ATTACK WITHING 24 HRS OF TAKING SHOT; This spontaneous report received from a consumer via social media via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry- Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Dose number in series-1. No concomitant medications were reported. On an unspecified date, as reporter stated, "his dad's coworker (patient) died from a heart attack within 24 hours of taking the Johnson & Johnson COVID shot". It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0-20211165280-Covid-19 vaccine ad26.cov2.s- died from heart attack. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: HEART ATTACK

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1535195

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: NY
Alter: 29,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 10.06.2021
Beginn: 11.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Death Influenza like illness Laboratory test Myocarditis Unresponsive to stimuli

Symptomtext

Decedent was found unresponsive 2 days after he received 1st dose of Moderna vaccine (unknown lot number). Additional tests show presence of lymphocytic myocarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Well controled diabetes insipidus
Vorgeschichte: -
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 2566463

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 12.02.2021
Beginn: 24.07.2021
Tage bis Beginn: 162,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 60yo male pt who reside at rehab was transferred from facility care to SNF for higher level of care required on 1/30/2019 with Diagnosis: Huntington's chorea. Pt died on 7/24/21 with no info provided on pt's death. Likely not related to pt's death given 5 months since covid vaccine was given prior to death & pt's debilitating disease.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565967

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 29.03.2021
Beginn: 13.08.2021
Tage bis Beginn: 137,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 75yo pt with h/o dementia in Hospice care died on 8/13/2021. Pt had received covid vaccines from local grocery store pharmacy on 3/1/21 & 3/29/21. Pt had outside medical and pharmacy providers. Pt's Problem List: R69. Benign prostatic hypertrophy (SCT 266569009) J84.112 Idiopathic pulmonary fibrosis (SCT 700250006) E78.5 Hyperlipidemia (SCT 55822004) F03.90 Dementia (SCT 52448006) R73.9 Hyperglycemia (SCT 80394007) R91.1 Solitary nodule of lung (SCT 427359005) I10. Hypertension (SCT 38341003) I67.9 Stroke (SCT 230690007) This death is likely not related to the vaccinations due to other comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565476

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 01.04.2021
Beginn: 04.08.2021
Tage bis Beginn: 125,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 89-year-old male with a h/o HTN, HLD, leukemia 2017, A.Fib, depression, anxiety, CAD s/p CABG and bioprosthetic aortic valve replacement in 11/04, mitral valve clip, bladder cancer s/p CTX, cardiac stents x 2, AAA repair, bilateral carotid endarterectomy, lung nodules died on 8/4/2021. Pt had received covid vaccinations on 1/12/2021 & 4/1/2021. This death is likely not related to the vaccinations due to other comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 26.03.2021
Beginn: 17.08.2021
Tage bis Beginn: 144,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Death Dyspnoea Endotracheal intubation Hypoxia Intensive care Pneumonia bacterial SARS-CoV-2 test positive Septic shock Staphylococcal bacteraemia

Symptomtext

Narrative: 65y.o. MALE with a h/o sleep apnea/narcolepsy, HTN, obesity, Gout, Vitamin D deficiency, BPH, arthritis, and T2DM presented to ER on 8/11/21 with SOB. Pt tested positive for covid-19. Pt had previously been vaccinated with covid-19 pfizer on 3/5/21 & 3/26/21 from facility (outside provider). Pt was intubated due to hypoxia and admitted to MICU. Pt was treated with covid medications (tocilizumab & remdesivir), antibiotics, corticosteroids, and anticoagulants. Pt died on 8/17/2021. Death was caused by: Acute hypoxic respiratory failure and septic shock secondary to COVID pneumonia and suspected secondary bacterial pneumonia and Staph aureus bacteremia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 11.04.2021
Beginn: 04.08.2021
Tage bis Beginn: 115,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 73yo male died on 8/4/2021. He had received covid-19 vaccinations on 3/21/21 & 4/11/21. Pt did not receive care, medications or vaccines from medical facility. No information available regarding pt's death. Likely not related to pt's death given length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1943203

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 30.11.2021
Impfdatum: 24.02.2021
Beginn: 18.09.2021
Tage bis Beginn: 206,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Neoplasm malignant

Symptomtext

Narrative: 71yo patient receiving only mental health from facility died on 9/18/2021. Pt was receiving cancer therapy from outside cancer center. No mention of type of cancer however pt was concerned would be dying soon based on mental notes in chart. Pt also had received covid vaccines on 1/27/21 & 2/24/21 from outside hospital. Likely this death is not related given patient's age, comorbidities, and long length of time between date of vaccines and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1908321

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 30.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via social media via a company representative concerned two patients of unspecified age, race and ethnicity. The patients height, and weight were not reported. None of the patients had prior issues. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch numbers were not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patients died from unknown cause of death. One patient died within less than 48 hours and another died 5 days after. It was unspecified if an autopsy was performed. As per the reporter, "3 people within 2 miles of me died after the jab. One less than 48 hours. One 28 years old and the other 5 days after. None had prior issues" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20211154559.; Sender's Comments: V0: 20211154617-COVID-19 VACCINE AD26.COV2.S- Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: None of the patients had prior issues.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1578346

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 30.11.2021
Impfdatum: 04.02.2021
Beginn: 20.08.2021
Tage bis Beginn: 197,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Narrative: 82yo male presented to ER at community hospital on 8/16/21. Pt was admitted with covid positive infection. Pt was treated inpatient with remdesivir & decadron & iv antiviotic. Pt died on 8/20/21 at this hospital. Pt had been vaccinated with covid vaccine on 1/11/21 & 2/4/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1901084

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 26.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative via social media concerned a 28 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no known prior issues. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died after vaccination from unknown cause of death. It was unspecified if an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20211154617.; Sender's Comments: V0: 20211154559-Covid-19 vaccine ad26.cov2.s- Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known prior issues.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1900089

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge unknown

kritisch

Staat: WA
Alter: 80,0
Geschlecht: F
Eingang: 25.11.2021
Impfdatum: 19.11.2021
Beginn: 20.11.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anaemia Condition aggravated Haemoglobin decreased Myocardial infarction Transfusion Troponin increased

Symptomtext

Patient received COVID booster on 11/19, unknown type (I do know that the original series was Pfizer). The following day she was admitted with a myocardial infarction and severe anemia requiring blood transfusion. She has well-established multi-vessel CAD prior to this admission, as well as chronic anemia. At most, the vaccine was only a contributing factor or trigger to something for which she had been liable for years.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 5,0
Labordaten: elevated troponin and low hemoglobin on admission: 11/20/21
Aktuelle Erkrankungen: -
Vorgeschichte: coronary artery disease, anemia of chronic disease, possible myelodysplastic syndrome, atrial fibrillation, diabetes mellitus, hypertension, chronic kidney disease,
Andere Medikamente: amlodipine, apixaban, buspirone, diltiazem, escitalopram, glipizide, hydralazine, hydrocodone, levothyroxine, pantoprazole,
Allergien: penicillin, lactose, statins
Vorherige Impfungen: -

VAERS 1899232

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: OR
Alter: 61,0
Geschlecht: M
Eingang: 25.11.2021
Impfdatum: -
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dependence on respirator Ill-defined disorder SARS-CoV-2 test

Symptomtext

DEATH; PATIENT PLACED ON VENTILATOR; COVID-19 INFECTION; ILLNESS; This spontaneous report received from a consumer concerned a 61 year old male male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was super healthy before. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, 1 total administered on 12-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date in AUG-2021, few days after receiving vaccine, the patient started getting sick. On 12-Aug-2021, as soon as received vaccine patient got deathly ill. On an unspecified date, patient tested positive for covid -19. It was reported that the patient was anti vaxer. On an unspecified date, the patient was hospitalized for unspecified number of days and on ventilator at time in hospital. The reporter thought that getting the vaccine and having Covid complicated patient illness. On 01-SEP-2021, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on 01-SEP-2021, and the outcome of covid-19 infection, patient placed on ventilator and illness was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged and Life Threatening).; Sender's Comments: V0: 20211143152-covid-19 vaccine ad26.cov2.s-Death, Patient placed on ventilator, covid-19 infection, Illness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was super healthy before.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1899228

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 25.11.2021
Impfdatum: -
Beginn: 01.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Brain injury Cardiac arrest Coma Intracardiac thrombus Malaise

Symptomtext

CARDIAC ARREST AND WAS WITHOUT A HEARTBEAT, AND EFFECTIVELY DEAD FOR 18 MINUTES; 2 MASSIVE BLOOD CLOTS TO THE HEART; COMA; EXTENSIVE BRAIN DAMAGE THAT OCCURRED WHEN BRAIN WAS WITHOUT OXYGEN; FEELING REALLY UNWELL; This spontaneous report received from a consumer via a company representative via social media concerned a 51 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On JUL-2021, the patient experienced feeling really unwell and for which patient went to the emergency room. On an unspecified date, the patient experienced 2 massive blood clots to the heart. Due to a number of events, patient went into cardiac arrest and was without a heartbeat, and effectively dead for 18 minutes and was hospitalized (for unspecified duration). Followed two weeks in a coma, the patient faced many months of intensive therapy seven days a week to heal and strengthen patient brain to combat the extensive brain damage that occurred when patient brain was without oxygen. In addition to the daily physical, occupational, and speech therapy the patient would be getting hyperbaric oxygen therapy to accelerate patient brain function and healing. The patient was working so hard every day at improving physical and mental abilities and for which patient already had made amazing progress. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from coma, was recovering from extensive brain damage that occurred when brain was without oxygen, and the outcome of 2 massive blood clots to the heart, feeling really unwell and cardiac arrest and was without a heartbeat, and effectively dead for 18 minutes was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211139814-covid-19 vaccine ad26.cov2.s-cardiac arrest and was without a heartbeat, and effectively dead for 18 minutes; 2 massive blood clots to the heart; Coma; extensive brain damage that occurred when brain was without oxygen. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211139814-covid-19 vaccine ad26.cov2.s-feeling really unwell. This event(s) is labeled per RA and is therefore considered potentially related

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1843715

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: HI
Alter: 67,0
Geschlecht: M
Eingang: 25.11.2021
Impfdatum: 01.04.2021
Beginn: 02.05.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Cardiac disorder Cardiac stress test Chest pain Death Dizziness Dyspnoea Endotracheal intubation Gait disturbance Intensive care Liver disorder Mechanical ventilation Multiple organ dysfunction syndrome Myocardial infarction Nausea Palpitations Renal disorder Sepsis

Symptomtext

The patient had no prior history of Chest pains, dizziness, staggering, heart issues before The Pfizer shots!! ?? after the 2nd shot he had lingering side effects Of nausea, vomiting, awful dizziness ?? chest pains, Racing heart, etc! ??

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 17,0
Labordaten: Lingering side effects from April 2021 to October 2021 At hospital ?? where the patient had to be admitted to ICU!! ?? Was there for over 2 weeks with chest pains, ? Had all kinds of blood ?? tests ,stress test etc. Couldn?t breathe on his own -/ Hospital staff followed protocol, intubated him, ?on ventilator and he passed away pretty quickly then From multi system failure, kidney and liver issues, And coronary pulmonary heart attack, with septis. ??
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Pain medication
Allergien: None
Vorherige Impfungen: -

VAERS 1896468

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 24.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This spontaneous report received from a patient via a social media via a company representative concerned multiple patients of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, 1 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On17-NOV-2021, it was reported on that 3 patients died after being fully vaccinated. Reporter stated that "I know three who died. All fully vaxd". The cause of death was unknown. It was unknown if autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211142701-Covid-19 vaccine ad26.cov2.s-Died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1892686

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 23.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via social media (Twitter) via company representative concerned a patient of unspecified age and sex of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. Patient was healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number and expiry: Unknown) 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. Reporter stated that, on an unspecified date the patient who was perfectly healthy, died. Reportedly, reporter had guaranteed that patient would not had died from the treatment. The cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of event death was fatal. This report was serious (Death). This case, from the same reporter is linked to 20211141893.; Sender's Comments: V0: 20211141837-COVID-19 VACCINE AD26.COV2.S-Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient was healthy.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1892677

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: WA
Alter: -
Geschlecht: U
Eingang: 23.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Back pain Cerebral haemorrhage Cerebral venous sinus thrombosis Death Imaging procedure Nausea Platelet count Portal vein thrombosis Thrombosis with thrombocytopenia syndrome Visceral venous thrombosis Vomiting

Symptomtext

THROMBOTIC THROMBOCYTOPENIA; CEREBRAL VENOUS SINUS THROMBOSIS; SPLANCHNIC VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; INTRAPARENCHYMAL BRAIN HAEMORRHAGE; ABDOMINAL PAIN; BACK PAIN; NAUSEA; VOMITING; DEATH; This spontaneous report received from a consumer concerned multiple patients (6) of unspecified age and sex. The patients' height, and weight were not reported. No past medical histories or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch numbers were not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, five patients presented with initial symptoms of headache and back pain in the sixth patient who subsequently developed headache (subsumed under CVST). It was reported that one patient also had abdominal pain, nausea, and vomiting. The four patients developed focal neurological symptoms focal weakness, aphasia, visual disturbance (subsumed under CVST) prompting presentation for emergency care. The median days from vaccination to hospital admission was 15 days (range 10 to 17 days). All were eventually diagnosed with cerebral venous sinus thrombosis (CVST) by intracranial imaging. The two patients were also diagnosed with splanchnic and portal vein thrombosis. It was unusual for patients presenting with thrombotic events, all six patients showed evidence of thrombocytopenia (less than 150,000 platelets per microliter of blood), consistent with a condition known as thrombotic thrombocytopenia, with platelet nadir counts ranging from 10,000 to 127,000 during their hospitalizations. It was reported that four patients developed intraparenchymal brain hemorrhage and one subsequently died. Laboratory data (dates unspecified) included: Imaging procedure (NR: not provided) Cerebral Venous Sinus Thrombosis, and Platelet count (NR: not provided) ranging from 10000 to 127000. On an unspecified date, one patient died from unknown cause of death. It was unspecified if an autopsy was performed. The outcomes for the multiple patients with cerebral venous sinus thrombosis, thrombotic thrombocytopenia, back pain, abdominal pain, nausea, vomiting, splanchnic vein thrombosis, portal vein thrombosis and intraparenchymal brain haemorrhage was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20210340967.; Sender's Comments: V0: 20211138044- covid-19 vaccine ad26.cov2.s-thrombotic thrombocytopenia, Cerebral venous sinus thrombosis, splanchnic vein thrombosis, portal vein thrombosis. This event(s) is labeled per RSI and is therefore considered potentially related. 20211138044- covid-19 vaccine ad26.cov2.s-Death, intraparenchymal brain haemorrhage. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: Test Name: Platelet count; Result Unstructured Data: ranging from 10000 to 127000; Test Name: Imaging procedure; Result Unstructured Data: Cerebral Venous Sinus Thrombosis
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1891431

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: OR
Alter: 28,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 07.09.2021
Beginn: 14.11.2021
Tage bis Beginn: 68,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute myocardial infarction Alanine aminotransferase increased Anion gap decreased Aspartate aminotransferase increased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood magnesium normal Blood potassium decreased Blood sodium normal Blood urea increased Carbon dioxide normal Electrocardiogram abnormal Haematocrit decreased Haemoglobin decreased

Symptomtext

After his Moderna mRNA vaccines he developed headaches. Then about two months after the Moderna mRNA vaccine series, he developed COVID like symptoms and was seen in the Urgent Care. COVID testing negative. He was found to have very high blood pressure and sent to the ER and admitted to the hospital with elevated cardiac enzymes, abnormal EKG, diagnosed with Posterior reversible encephalopathy syndrome (PRES), Acute Kidney Injury and heart attack (NSTEMI).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: Notable Labs Recent Labs Lab 11/20/21 04:0511/19/21, 12:53 11/18/21 16:04 WBC 5.3 5.5 6.2 HCT 40.7* 42.0 41.3 HGB: 13.5 14.2 14.3 MCV 88.7 86.2 86.9 PLT 252 249 281 Recent Labs Lab 11/20/21 04:05 11/19/21 12:53 11/18/21 16:04. NA: 139,137, 138 K: 3.5,3.3, 3.7 CL: 105, 100 ,101, CO2: 28,30,29. ANIONGAP: 6,7,8 BUN: 22, 19, 23. CREA: 1.54*, 1.55*, 1.54* CALCIUM: 9.3, 9.4 ,9.3 MG: 2.0 Recent Labs Lab: 11/20/21,04:05, 11/19/21 ,12:53,11/18/21, 16:04 ALT: 38, 49,56* AST 22,33,36 ALKPHOS 46, 52, 53 BILITOT 0.39 0.62 0.62 No results for input(s): INR in the last 168 hours. Recent Labs Lab 11/19/21, 16:19 ,11/19/21 ,12:53 TROPONIN 101*, 108*.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1889676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 08.11.2021
Beginn: 13.11.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Blood electrolytes abnormal Blood phosphorus decreased COVID-19 Chest X-ray normal Cough Culture urine positive Echocardiogram normal Ejection fraction normal Lethargy Malaise Mental status changes Pneumonia Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Staphylococcus test positive Supraventricular tachycardia

Symptomtext

Hospitalized (11.13.21); COVID-19 positive (11.13.21); Fully vaccinated Admission Date: 11/13/2021 Discharge Date: 11/16/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE : The patient is an 89-year-old gentleman who presented to the hospital with chief complaints of lethargy and cough. He has a past medical history asthma dementia, CVA, dysphagia, diabetes mellitus her epidural and chronic obstructive pulmonary disease. The patient found to be positive for COVID. Patient received 3rd Moderna shot on 11/8. The patient not been feeling well for about 24-48 hours. He had been having chest congestion along with the fever denies any vomiting or diarrhea abdominal pain lower extremity edema. His cough has been non productive. Also noted to have close ago she also is on the coccyx. He was found to be febrile with temperature of 39.5?. He was started on ceftriaxone. UA was positive for urinary tract infection. X-ray chest did not show any pneumonia. Patient was started on dexamethasone and remdesivir and admitted. he responded very early to the treatment. He was taken off oxygen and did well . Wife at bedside who stated the patient is back to his baseline mental status. The patient had an episode of 11 beats of an SVT. Electrolytes were normal except for mild Lee low phosphorus which was replaced. His echocardiogram was done which showed EF of 63%. Blood cultures grew 1/2 of Staph epidermidis and Staph hominis. I discussed this with Infectious Disease Dr who stated that these are contaminant from the skin and do not needed any treatment. The patient was initially placed on vancomycin for 2 days. Urine cultures grew MRSA and his nares were positive for MRSA as well. The patient the did very well overall and was subsequently discharge with home health care and mupirocin applied twice a day for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Arthritis Kidney stone GERD without esophagitis Elevated PSA CAD in native artery MI (myocardial infarction) (HCC) Hypercholesteremia HTN (hypertension) Diverticulosis DM (diabetes mellitus) (HCC) Hypothyroid history of CVA (cerebral vascular accident) (HCC) with residual left hemiparesis Alzheimer disease (HCC) Benign essential tremor COPD (chronic obstructive pulmonary disease) (HCC) Colon polyp Depression, major Anemia, chronic disease Nuclear sclerotic cataract of right eye Barrett's esophagus MCI (mild cognitive impairment) ACE-inhibitor cough Drug intolerance Dizziness Peripheral neuropathy Thrombocytopenia, unspecified Chronic renal insufficiency, stage 3 (moderate) (HCC) Vitamin D deficiency Acute cystitis without hematuria Coronavirus infection Acute bronchitis due to other specified organisms Acute cystitis Aspiration pneumonia (HCC) Dysphagia Bladder cancer (HCC) Generalized weakness
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ASPIRIN 81 PO atorvastatin (LIPITOR) 40 MG tablet Cholecalciferol (VITAMIN D3) 5000 units CAPS donepezil (ARICEPT) 1
Allergien: CodeineHives, Skin Rashes/Hives Darvocet [Propoxyphene N-apap]Hives, Skin Rashes/Hives DiazepamHives, Skin Rashes/Hives Motrin [Ibuprofen]Hives, Itching Biaxin [Clarithromycin]Itching ClarithromycinSkin Rashes/Hives Doxycycline HyclateSkin Rashes/Hives HydrocodoneItching Ibuprofen MicronizedItching, Skin Rashes/Hives LisinoprilCough OxycodoneHeartburn Tramadol HclSkin Rashes/Hives Valium [Diazepam]Itching
Vorherige Impfungen: -

VAERS 1889676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 08.11.2021
Beginn: 13.11.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Blood electrolytes abnormal Blood phosphorus decreased COVID-19 Chest X-ray normal Cough Culture urine positive Echocardiogram normal Ejection fraction normal Lethargy Malaise Mental status changes Pneumonia Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Staphylococcus test positive Supraventricular tachycardia

Symptomtext

Hospitalized (11.13.21); COVID-19 positive (11.13.21); Fully vaccinated Admission Date: 11/13/2021 Discharge Date: 11/16/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE : The patient is an 89-year-old gentleman who presented to the hospital with chief complaints of lethargy and cough. He has a past medical history asthma dementia, CVA, dysphagia, diabetes mellitus her epidural and chronic obstructive pulmonary disease. The patient found to be positive for COVID. Patient received 3rd Moderna shot on 11/8. The patient not been feeling well for about 24-48 hours. He had been having chest congestion along with the fever denies any vomiting or diarrhea abdominal pain lower extremity edema. His cough has been non productive. Also noted to have close ago she also is on the coccyx. He was found to be febrile with temperature of 39.5?. He was started on ceftriaxone. UA was positive for urinary tract infection. X-ray chest did not show any pneumonia. Patient was started on dexamethasone and remdesivir and admitted. he responded very early to the treatment. He was taken off oxygen and did well . Wife at bedside who stated the patient is back to his baseline mental status. The patient had an episode of 11 beats of an SVT. Electrolytes were normal except for mild Lee low phosphorus which was replaced. His echocardiogram was done which showed EF of 63%. Blood cultures grew 1/2 of Staph epidermidis and Staph hominis. I discussed this with Infectious Disease Dr who stated that these are contaminant from the skin and do not needed any treatment. The patient was initially placed on vancomycin for 2 days. Urine cultures grew MRSA and his nares were positive for MRSA as well. The patient the did very well overall and was subsequently discharge with home health care and mupirocin applied twice a day for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Arthritis Kidney stone GERD without esophagitis Elevated PSA CAD in native artery MI (myocardial infarction) (HCC) Hypercholesteremia HTN (hypertension) Diverticulosis DM (diabetes mellitus) (HCC) Hypothyroid history of CVA (cerebral vascular accident) (HCC) with residual left hemiparesis Alzheimer disease (HCC) Benign essential tremor COPD (chronic obstructive pulmonary disease) (HCC) Colon polyp Depression, major Anemia, chronic disease Nuclear sclerotic cataract of right eye Barrett's esophagus MCI (mild cognitive impairment) ACE-inhibitor cough Drug intolerance Dizziness Peripheral neuropathy Thrombocytopenia, unspecified Chronic renal insufficiency, stage 3 (moderate) (HCC) Vitamin D deficiency Acute cystitis without hematuria Coronavirus infection Acute bronchitis due to other specified organisms Acute cystitis Aspiration pneumonia (HCC) Dysphagia Bladder cancer (HCC) Generalized weakness
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ASPIRIN 81 PO atorvastatin (LIPITOR) 40 MG tablet Cholecalciferol (VITAMIN D3) 5000 units CAPS donepezil (ARICEPT) 1
Allergien: CodeineHives, Skin Rashes/Hives Darvocet [Propoxyphene N-apap]Hives, Skin Rashes/Hives DiazepamHives, Skin Rashes/Hives Motrin [Ibuprofen]Hives, Itching Biaxin [Clarithromycin]Itching ClarithromycinSkin Rashes/Hives Doxycycline HyclateSkin Rashes/Hives HydrocodoneItching Ibuprofen MicronizedItching, Skin Rashes/Hives LisinoprilCough OxycodoneHeartburn Tramadol HclSkin Rashes/Hives Valium [Diazepam]Itching
Vorherige Impfungen: -

VAERS 1889676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 08.11.2021
Beginn: 13.11.2021
Tage bis Beginn: 5,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Blood electrolytes abnormal Blood phosphorus decreased COVID-19 Chest X-ray normal Cough Culture urine positive Echocardiogram normal Ejection fraction normal Lethargy Malaise Mental status changes Pneumonia Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Staphylococcus test positive Supraventricular tachycardia

Symptomtext

Hospitalized (11.13.21); COVID-19 positive (11.13.21); Fully vaccinated Admission Date: 11/13/2021 Discharge Date: 11/16/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE : The patient is an 89-year-old gentleman who presented to the hospital with chief complaints of lethargy and cough. He has a past medical history asthma dementia, CVA, dysphagia, diabetes mellitus her epidural and chronic obstructive pulmonary disease. The patient found to be positive for COVID. Patient received 3rd Moderna shot on 11/8. The patient not been feeling well for about 24-48 hours. He had been having chest congestion along with the fever denies any vomiting or diarrhea abdominal pain lower extremity edema. His cough has been non productive. Also noted to have close ago she also is on the coccyx. He was found to be febrile with temperature of 39.5?. He was started on ceftriaxone. UA was positive for urinary tract infection. X-ray chest did not show any pneumonia. Patient was started on dexamethasone and remdesivir and admitted. he responded very early to the treatment. He was taken off oxygen and did well . Wife at bedside who stated the patient is back to his baseline mental status. The patient had an episode of 11 beats of an SVT. Electrolytes were normal except for mild Lee low phosphorus which was replaced. His echocardiogram was done which showed EF of 63%. Blood cultures grew 1/2 of Staph epidermidis and Staph hominis. I discussed this with Infectious Disease Dr who stated that these are contaminant from the skin and do not needed any treatment. The patient was initially placed on vancomycin for 2 days. Urine cultures grew MRSA and his nares were positive for MRSA as well. The patient the did very well overall and was subsequently discharge with home health care and mupirocin applied twice a day for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Arthritis Kidney stone GERD without esophagitis Elevated PSA CAD in native artery MI (myocardial infarction) (HCC) Hypercholesteremia HTN (hypertension) Diverticulosis DM (diabetes mellitus) (HCC) Hypothyroid history of CVA (cerebral vascular accident) (HCC) with residual left hemiparesis Alzheimer disease (HCC) Benign essential tremor COPD (chronic obstructive pulmonary disease) (HCC) Colon polyp Depression, major Anemia, chronic disease Nuclear sclerotic cataract of right eye Barrett's esophagus MCI (mild cognitive impairment) ACE-inhibitor cough Drug intolerance Dizziness Peripheral neuropathy Thrombocytopenia, unspecified Chronic renal insufficiency, stage 3 (moderate) (HCC) Vitamin D deficiency Acute cystitis without hematuria Coronavirus infection Acute bronchitis due to other specified organisms Acute cystitis Aspiration pneumonia (HCC) Dysphagia Bladder cancer (HCC) Generalized weakness
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ASPIRIN 81 PO atorvastatin (LIPITOR) 40 MG tablet Cholecalciferol (VITAMIN D3) 5000 units CAPS donepezil (ARICEPT) 1
Allergien: CodeineHives, Skin Rashes/Hives Darvocet [Propoxyphene N-apap]Hives, Skin Rashes/Hives DiazepamHives, Skin Rashes/Hives Motrin [Ibuprofen]Hives, Itching Biaxin [Clarithromycin]Itching ClarithromycinSkin Rashes/Hives Doxycycline HyclateSkin Rashes/Hives HydrocodoneItching Ibuprofen MicronizedItching, Skin Rashes/Hives LisinoprilCough OxycodoneHeartburn Tramadol HclSkin Rashes/Hives Valium [Diazepam]Itching
Vorherige Impfungen: -

VAERS 2570335

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 20.11.2021
Impfdatum: 14.01.2021
Beginn: 28.10.2021
Tage bis Beginn: 287,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt is an 83 YO male with PMH of schizophrenia, UTI, AKI, and HTN whose death was reported to the agency by another agency. No evidence that death was caused by COVID-19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566483

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 20.11.2021
Impfdatum: -
Beginn: 04.11.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt was a 61 YO male with PMH of cerebral infarction, bipolar disorder, HTN, hypothyroid, and sleep apnea. Medical facility was notified of pt's death by his daughter. No additional details were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2574869

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 19.11.2021
Impfdatum: 28.02.2021
Beginn: 31.10.2021
Tage bis Beginn: 245,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Pt was an 88 YO Male with PMH of PVD, neuropathy, afib, DM, HTN, CAD, COPD, hypothyroidism, and HLD. Agency was informed of patient's passing by patient's daughter. No additional details available.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1884587

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage

Symptomtext

MASSIVE BRAIN BLEED; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: Unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch and lot numbers. No concomitant medications were reported. On an unspecified date, the reporter stated that "my mother had a massive brain bleed 2 weeks after the you know what". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of massive brain bleed was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211139481 -covid-19 vaccine ad26.cov2.s- massive brain bleed. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1884142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: 27.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Back pain Blood electrolytes Cardiac arrest Electroencephalogram Electroencephalogram normal Electrolyte depletion Illness Respiratory arrest Seizure Vomiting

Symptomtext

they saw brain activity much more on EEG; She had no electrolytes in her body; she was throwing up; she stopped breathing; her heart stopped; she was sick all day; She started having seizures at hospital; she got sick; She threw up; threw her back out; This spontaneous case was reported by a patient family member or friend and describes the occurrence of RESPIRATORY ARREST (she stopped breathing), SEIZURE (She started having seizures at hospital), CARDIAC ARREST (her heart stopped), ELECTROENCEPHALOGRAM NORMAL (they saw brain activity much more on EEG), ILLNESS (she got sick), VOMITING (She threw up), BACK PAIN (threw her back out), ILLNESS (she was sick all day), VOMITING (she was throwing up) and ELECTROLYTE DEPLETION (She had no electrolytes in her body) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced ILLNESS (she got sick) (seriousness criterion life threatening), VOMITING (She threw up) (seriousness criterion life threatening) and BACK PAIN (threw her back out) (seriousness criterion life threatening). In September 2021, the patient experienced SEIZURE (She started having seizures at hospital) (seriousness criteria hospitalization, medically significant and life threatening). On 21-Sep-2021, the patient experienced ILLNESS (she was sick all day) (seriousness criteria hospitalization and life threatening). On 21-Sep-2021 at 11:30 PM, the patient experienced RESPIRATORY ARREST (she stopped breathing) (seriousness criteria hospitalization, medically significant and life threatening), CARDIAC ARREST (her heart stopped) (seriousness criteria hospitalization, medically significant and life threatening) and VOMITING (she was throwing up) (seriousness criteria hospitalization and life threatening). On an unknown date, the patient experienced ELECTROENCEPHALOGRAM NORMAL (they saw brain activity much more on EEG) (seriousness criteria hospitalization and life threatening) and ELECTROLYTE DEPLETION (She had no electrolytes in her body) (seriousness criteria hospitalization and life threatening). The patient was hospitalized on 22-Sep-2021 due to CARDIAC ARREST, ILLNESS, RESPIRATORY ARREST and VOMITING. The patient was treated with FENTANYL at an unspecified dose and frequency; OXYCODONE at an unspecified dose and frequency; LEVETIRACETAM (KEPPRA XR) at an unspecified dose and frequency; LACOSAMIDE (VIMPAT) at an unspecified dose and frequency; Manual therapy (CPR started , EMR shocked her with pads,At hospital, placed her in induced coma and did a cooling) for Respiratory arrest; Manual therapy (CPR started, EMR shocked her with pads,At hospital, placed her in induced coma and did a cooling) for Cardiac arrest and Manual therapy (At hospital, they placed her in induced coma and did a cooling) for Vomiting. At the time of the report, RESPIRATORY ARREST (she stopped breathing), SEIZURE (She started having seizures at hospital), CARDIAC ARREST (her heart stopped), ELECTROENCEPHALOGRAM NORMAL (they saw brain activity much more on EEG), ILLNESS (she got sick), VOMITING (She threw up), BACK PAIN (threw her back out), ILLNESS (she was sick all day), VOMITING (she was throwing up) and ELECTROLYTE DEPLETION (She had no electrolytes in her body) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electroencephalogram: abnormal (abnormal) saw brain activity much more on EEG. On 22-Sep-2021, Blood electrolytes: decreased (abnormal) no electrolytes in her body. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medication provided. The patient had (unspecified) Hearth and Blood pressure treatment medication. Company Comment: This case concerns a 34 year old female with no reported medical history , who experienced Serious, unexpected events of Illness, Vomiting and Back pain which occurred 14 days after vaccination with the 1st dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . After 25 days after vaccination with the 1st dose she experienced serious unexpected events of Illness , Vomiting , respiratory arrest and Cardiac arrest . On the 26th day post vaccination with the 1st dose she had Seiziures and Electrolyte depletion . On an unkown date patient experienced EEG normal (they saw brain activity much more on EEG increased activity . The re-challenge for this case is not applicable since the outcome of the events are unknown. The benefit-risk relationship of mRNA-1273 (Moderna Covid 19 Vaccine ) is not affected by this report.; Sender's Comments: This case concerns a 34 year old female with no reported medical history , who experienced Serious, unexpected events of Illness, Vomiting and Back pain which occurred 14 days after vaccination with the 1st dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . After 25 days after vaccination with the 1st dose she experienced serious unexpected events of Illness , Vomiting , respiratory arrest and Cardiac arrest . On the 26th day post vaccination with the 1st dose she had Seiziures and Electrolyte depletion . On an unkown date patient experienced EEG normal (they saw brain activity much more on EEG increased activity . The re-challenge for this case is not applicable since the outcome of the events are unknown. The benefit-risk relationship of mRNA-1273 (Moderna Covid 19 Vaccine ) is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: Test Date: 20210922; Test Name: She had no electrolytes in her body when she was admitted; Result Unstructured Data: no electrolytes in her body; Test Date: 2021; Test Name: EEG; Result Unstructured Data: saw brain activity much more on EEG
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1878047

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: AZ
Alter: 59,0
Geschlecht: F
Eingang: 17.11.2021
Impfdatum: 01.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 234,0
Dosis: UNK
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Diarrhoea Encephalopathy Productive cough SARS-CoV-2 test positive

Symptomtext

Wet cough, diarrhea, 88% on RA, encephalopathic, DNR patient- expired, etc.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 22,0
Labordaten: Tested at Health Center on 10/21/2021- positive COVID-19 BioFire.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1875746

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 17.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Myocardial infarction Thrombosis

Symptomtext

BLOOD CLOT; HEART ATTACK; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex, race and ethnic origin The patient's height, and weight were not reported. The patient's concurrent conditions included: plaque, and other pre-existing medical conditions included: Good physical condition with no cholesterol issues The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: Unknown) dose, start therapy date were not reported 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient had blood clot which led to a heart attack. Patient went to cardiologist and had to live with taking daily medications and medical bills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clot and heart attack was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0. 20211110262-covid-19 vaccine ad26.cov2.s -blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211110262-covid-19 vaccine ad26.cov2.s -heart attack. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Coronary atherosclerosis
Vorgeschichte: Comments: Good physical condition with no cholesterol issues
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1873265

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: TX
Alter: 83,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: 03.02.2021
Beginn: 23.08.2021
Tage bis Beginn: 201,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Convalescent plasma transfusion Cough Death Hypoxia Respiratory failure Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Presents for cough/congestions x10 days. Hypoxic on RA. COVID + PTA. Seen & tx by PCP twice during previous 10 days (ivermectin, abx & steroids). Admit for severe resp failure r/t COVID pneumonia. Tx: O2, remdesivir, actomera, convalescent plasma, oral decadron & singulair, oral ivermectin, zinc. Failed inpatient therapies & placed on inpatient hospice. Expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1873253

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: TX
Alter: 75,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: 19.02.2021
Beginn: 05.08.2021
Tage bis Beginn: 167,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Atrial fibrillation COVID-19 Cardiac arrest Cardio-respiratory arrest Death Endotracheal intubation Intensive care Lung infiltration Mechanical ventilation Mental status changes Resuscitation SARS-CoV-2 test positive Tachycardia

Symptomtext

Presented with AMS; Covid + in ED; asymptomatic at arrival; pt declined 2 status; started on steroids, remdesivir, Vit C, zinc, and supplemental O2 on 8/7; Intubated 8/10, started on veletri; 8/16 worsening infiltrates, 100% FiO2 on vent; 8/26 remains intubated; FiO2 55%; He was started with Solu-Medrol and also treated with remdesivir. He was treated also with supportive care with montelukast, zinc sulfate, and DVT propHe was started with Solu-Medrol and also treated with remdesivir. He was treated also with supportive care with montelukast, zinc sulfate, and DVT prophylaxis with apixaban. Patient was on mechanical ventilation in the ICU. He was also treated with empiric antibiotics with meropenem and IV micafungin. On September 7, patient noted to have atrial fibrillation, and around 9:43 a.m., then he suddenly developed wide-complex tachycardia with possible LBBB with prompt progression to asystole. There was a code blue called. After the round of ACLS, patient noted to have asystole, and he was pronounced dead at 10:07 by ICU team. anaphylaxis with apixaban. Patient was on mechanical ventilation in the ICU. He was also treated with empiric antibiotics with meropenem and IV micafungin. On September 7, patient noted to have atrial fibrillation, and around 9:43 a.m., then he suddenly developed wide-complex tachycardia with possible LBBB with prompt progression to asystole. There was a code blue called. After the round of ACLS, patient noted to have asystole, and he was pronounced dead at 10:07 by ICU team.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 33,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1873219

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: TX
Alter: 61,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: 08.04.2021
Beginn: 08.08.2021
Tage bis Beginn: 122,0
Dosis: UNK
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia COVID-19 pneumonia Death Diarrhoea Dyspnoea Pyrexia Vomiting

Symptomtext

Presented with weakness/diarrhea/vomiting/fever/SOB; dx with Covid PNA; treated with Vit D/Vit C/Zinc/steroids/antibiotics; discharged home; No oxygen needed. pt died on 8/21/21 during subsequent admission (not covid related)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1872009

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: TX
Alter: 54,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: -
Beginn: 23.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Dyspepsia Electrocardiogram Inappropriate schedule of product administration Off label use Physical examination

Symptomtext

DEATH; OFF LABEL USE; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTRATION; HEARTBURN; This spontaneous report received from a consumer concerned a 54-year-old white and non-Hispanic or Latino male. The patient's height, and weight were not reported. The patient's concurrent conditions included, non-alcoholic, and non-smoker. The patient had no known drug or non-drug allergies. The patient had a physical examination performed (in AUG-2021) a week or two before he received the Janssen Covid-19 vaccine and results were clear. He was pretty healthy, he rode his bike, and ate pretty well. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unkown) dose was not reported, 01 total, administered on 01-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Non-company suspect vaccine included: Covid-19 vaccine (form of admin, route of admin, and batch number were not reported), dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient had inappropriate schedule of vaccine administration (off label use). On 23-SEP-2021, the patient experienced chest pain/tightness. On 24-SEP-2021, he visited physician's office, the electrocardiogram (EKG) was performed and was diagnosed with heartburn. He did not feel comfortable with the diagnosis and booked another appointment for 25-SEP-2021. He did not make the appointment and on 25-SEP-2021, he died from unknown cause. He was not found for 2 days following his death. On an unspecified date, an autopsy was performed, one preliminary (unofficial) report with an undetermined cause of death from the funeral home was received and a more extensive autopsy was requested. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on 25-SEP-2021, and the outcome of heartburn, off label use and inappropriate schedule of vaccine administration was not reported. This report was serious (Death).; Sender's Comments: V0: 20211103199-covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 202108; Test Name: Physical examination; Result Unstructured Data: Results were clear; Test Date: 20210924; Test Name: EKG; Result Unstructured Data: Conclusion was heartburn
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker
Vorgeschichte: Comments: The patient had no known drug or non-drug allergies. The patient had a physical examination performed a week or two before he received the Janssen Covid-19 vaccine. Results were clear. He was pretty healthy, he rode his bike, and ate pretty well.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1869726

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 10.11.2021
Beginn: 11.11.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood test abnormal Chest X-ray abnormal Chills Dyspnoea Hypotension Incorrect dose administered Lung infiltration Pyrexia Sepsis Tachycardia Tachypnoea

Symptomtext

Patient hospitalized the day after receiving COVID-19 vaccine (Moderna) booster. Booster dose was also the wrong dose - given 0.5 mL dose (rather than 0.25 mL dose) Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 11/11/2021 Discharge Date: 11/12/2021 HOSPITAL PROBLEMS: Sepsis; Acute Hypoxic Respiratory Failure; 2/2 CAP; AKI Chief Complaint: Patient presents with FEVER: COVID booster yesterday developed fever and shortness of breath this morning. Pt states booster was a full dose of the vaccine HOSPITAL COURSE Patient is a 75 y/o man w/ PMHx of RA, Asthma, & HTN who is admitted to Hospital on 11/11/2021 for Sepsis 2/2 CAP. Patient reports that he was of his usual health until this morning at 04:00 when he woke up with shaking chills and rigors. He felt very feverish and had his wife call EMS. The patient received his booster dose of Moderna vaccine for COVID-19 yesterday. This was his 3rd vaccine and with confusion in the dosing the patient was given two half doses. Upon presentation emergency department the patient had a fever, tachycardia, and tachypnea. He was mildly hypotensive. Patient was requiring 2 L of oxygen via nasal cannula. Blood work revealed mild AKI and otherwise relatively stable labs. Chest x-ray demonstrated large hazy developing infiltrate in the right mid lung. Patient was revised and 2 L of IV fluids with adequate response in his blood pressure. He was placed on supplemental oxygen. He was given 2 days of Rocephin and azithromycin. He was able to be weaned to room air. On day of discharge the patient ambulated the halls without need of supplemental oxygen. He is discharged with continuation of Omnicef and Azithromycin to complete his Abx course.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 11.11.21 - DR CHEST SINGLE VIEW Impression: Probable large hazy developing infiltrate in the right midlung
Aktuelle Erkrankungen: NA
Vorgeschichte: Hyperlipidemia BPH (Benign Prostatic Hypertrophy) Hypothyroid Diverticulosis History of colon polyps Prostate cancer RLS (restless legs syndrome) Asthma Benign essential hypertension Allergy, unspecified not elsewhere classified Seronegative rheumatoid arthritis Osteoarthritis Overweight (BMI 25.0-29.9) Anemia of chronic disease - Hb 12- 13 -
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet azithromycin (ZITHROMAX) 250 MG tablet cefdinir (OMNICEF) 300 MG capsule dutasteride (AVODART) 0.5 MG capsule levothyroxine
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1869726

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 10.11.2021
Beginn: 11.11.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Blood test abnormal Chest X-ray abnormal Chills Dyspnoea Hypotension Incorrect dose administered Lung infiltration Pyrexia Sepsis Tachycardia Tachypnoea

Symptomtext

Patient hospitalized the day after receiving COVID-19 vaccine (Moderna) booster. Booster dose was also the wrong dose - given 0.5 mL dose (rather than 0.25 mL dose) Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 11/11/2021 Discharge Date: 11/12/2021 HOSPITAL PROBLEMS: Sepsis; Acute Hypoxic Respiratory Failure; 2/2 CAP; AKI Chief Complaint: Patient presents with FEVER: COVID booster yesterday developed fever and shortness of breath this morning. Pt states booster was a full dose of the vaccine HOSPITAL COURSE Patient is a 75 y/o man w/ PMHx of RA, Asthma, & HTN who is admitted to Hospital on 11/11/2021 for Sepsis 2/2 CAP. Patient reports that he was of his usual health until this morning at 04:00 when he woke up with shaking chills and rigors. He felt very feverish and had his wife call EMS. The patient received his booster dose of Moderna vaccine for COVID-19 yesterday. This was his 3rd vaccine and with confusion in the dosing the patient was given two half doses. Upon presentation emergency department the patient had a fever, tachycardia, and tachypnea. He was mildly hypotensive. Patient was requiring 2 L of oxygen via nasal cannula. Blood work revealed mild AKI and otherwise relatively stable labs. Chest x-ray demonstrated large hazy developing infiltrate in the right mid lung. Patient was revised and 2 L of IV fluids with adequate response in his blood pressure. He was placed on supplemental oxygen. He was given 2 days of Rocephin and azithromycin. He was able to be weaned to room air. On day of discharge the patient ambulated the halls without need of supplemental oxygen. He is discharged with continuation of Omnicef and Azithromycin to complete his Abx course.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 11.11.21 - DR CHEST SINGLE VIEW Impression: Probable large hazy developing infiltrate in the right midlung
Aktuelle Erkrankungen: NA
Vorgeschichte: Hyperlipidemia BPH (Benign Prostatic Hypertrophy) Hypothyroid Diverticulosis History of colon polyps Prostate cancer RLS (restless legs syndrome) Asthma Benign essential hypertension Allergy, unspecified not elsewhere classified Seronegative rheumatoid arthritis Osteoarthritis Overweight (BMI 25.0-29.9) Anemia of chronic disease - Hb 12- 13 -
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet azithromycin (ZITHROMAX) 250 MG tablet cefdinir (OMNICEF) 300 MG capsule dutasteride (AVODART) 0.5 MG capsule levothyroxine
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1868757

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the reporter reported that, "My mother died from vaccine injuries." Cause of death was unknown and it was unknown whether an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211127835-Covid-19 vaccine ad26.cov2.s- Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1850722

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: -
Beginn: 27.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abortion spontaneous Amniocentesis Chromosome analysis normal Exposure during pregnancy Foetal death Ultrasound scan Ultrasound antenatal screen abnormal Uterine dilation and curettage

Symptomtext

SPONTANEOUS ABORTION; VACCINE EXPOSURE DURING PREGNANCY; This spontaneous pregnancy report received from a physician concerned a 40 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. It was not reported whether the patient had been pregnant before. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, frequency time 1 total was administered on 27-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-SEP-2021, the patient was vaccinated with Janssen Covid-19 vaccine resulting in vaccine exposure during pregnancy. The date of the patient's last menstrual period and expected delivery date were not reported. Before receiving the vaccine the patient had ultra sound and genetic testing which was normal. On 01-OCT-2021, patient had another ultrasound test and it was normal. On 18-OCT-2021, the patient was 14 weeks and 6 days pregnant and she had an ultra sound test that showed that the baby passed away (fetal demise). On 18-OCT-2021, the pregnancy resulted in a spontaneous abortion. On 21-OCT-2021, she had genetic test again and which was normal. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the spontaneous abortion and vaccine exposure during pregnancy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211114914-COVID-19 VACCINE AD26.COV2.S-spontaneous abortion. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20211114914-COVID-19 VACCINE AD26.COV2.S-vaccine exposure during pregnancy . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: -
Labordaten: Test Date: 20211001; Test Name: Diagnostic ultrasound; Result Unstructured Data: Normal; Test Date: 20211018; Test Name: Diagnostic ultrasound; Result Unstructured Data: Fetal demise; Comments: Ultra sound that showed that the baby passed away (fetal demise); Test Name: Diagnostic ultrasound; Result Unstructured Data: Normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1868356

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: FL
Alter: 54,0
Geschlecht: F
Eingang: 14.11.2021
Impfdatum: 23.04.2021
Beginn: 30.10.2021
Tage bis Beginn: 190,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Hypoxia Pneumonia streptococcal Positive airway pressure therapy SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient was hospitalized for breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/23/2021. Patient was hospitalized from 10/30/21 - 11/11/21. Below is copied from patient discharge summary: 55 yo female admitted with acute hypoxic respiratory failure secondary to COVID-19. Had prolonged course secondary to persistent hypoxia requiring HFNC and BiPAP therapy. She was also found to have Strep pneumoniae positive infection in which she was treated with antibiotics. She has continued to be weaned down from o2 to now only requiring 2-3L NC. Patient now meeting criteria for discharge and desires home discharge with home health and home O2 which have been coordinated for discharge today. Plan for discharge today with follow up with PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: SARS-COV-2, NAA, Detected: 10/30/21
Aktuelle Erkrankungen: -
Vorgeschichte: ? Depression ? Diabetes mellitus ? Hypertension ? Obesity
Andere Medikamente: ? metFORMIN (GLUCOPHAGE) 500 MG Tablet Take 500 mg by mouth 2 times daily (with meals). SrCr: mg/dl [last value] ? VALSARTAN PO by mouth.
Allergien: Lisinopril, Penicillins
Vorherige Impfungen: -

VAERS 1868356

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: FL
Alter: 54,0
Geschlecht: F
Eingang: 14.11.2021
Impfdatum: 23.04.2021
Beginn: 30.10.2021
Tage bis Beginn: 190,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Hypoxia Pneumonia streptococcal Positive airway pressure therapy SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient was hospitalized for breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/23/2021. Patient was hospitalized from 10/30/21 - 11/11/21. Below is copied from patient discharge summary: 55 yo female admitted with acute hypoxic respiratory failure secondary to COVID-19. Had prolonged course secondary to persistent hypoxia requiring HFNC and BiPAP therapy. She was also found to have Strep pneumoniae positive infection in which she was treated with antibiotics. She has continued to be weaned down from o2 to now only requiring 2-3L NC. Patient now meeting criteria for discharge and desires home discharge with home health and home O2 which have been coordinated for discharge today. Plan for discharge today with follow up with PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: SARS-COV-2, NAA, Detected: 10/30/21
Aktuelle Erkrankungen: -
Vorgeschichte: ? Depression ? Diabetes mellitus ? Hypertension ? Obesity
Andere Medikamente: ? metFORMIN (GLUCOPHAGE) 500 MG Tablet Take 500 mg by mouth 2 times daily (with meals). SrCr: mg/dl [last value] ? VALSARTAN PO by mouth.
Allergien: Lisinopril, Penicillins
Vorherige Impfungen: -

VAERS 2574822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 13.11.2021
Impfdatum: 13.02.2021
Beginn: 31.10.2021
Tage bis Beginn: 260,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death Intensive care Resuscitation

Symptomtext

Narrative: Pt was a 72 YO M with PMH of DM2, lung cancer, CHF, COPD, hypothyroidism, stroke, CAD, HLD, HTN, and BPH who was admitted to hospital for cardiac arrest. Pt was admitted to the ICU at hospital with aggressive resuscitative measures. Family made the decision to make patient DNR and he subsequently passed. No evidence that death was related to COVID-19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1866970

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 13.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Thrombosis

Symptomtext

BLOOD CLOTS; EYE STROKE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, it was reported that right after the vaccination, the patient had developed with blood clots which gave an eye stroke. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots and eye stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211124769-covid-19 vaccine ad26.cov2.s-blood clots and eye stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1864429

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 12.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer concerned a patient of unspecified age and sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, therapy start date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that he had a friend who died shortly after the covid vaccine with no other explanation for death. On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211125834-COVID-19 VACCINE AD26.COV2.S-Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1864427

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 12.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that his little brother got the vaccine and on an unspecified date, the patient died from it. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211124581-COVID-19 VACCINE AD26.COV2.S-Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1863353

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: TN
Alter: 64,0
Geschlecht: M
Eingang: 12.11.2021
Impfdatum: -
Beginn: 28.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Antifungal treatment COVID-19 pneumonia Cardiac arrest Cardio-respiratory arrest Central venous catheterisation Dyspnoea Endotracheal intubation Fungaemia Haemofiltration Oxygen saturation Oxygen saturation decreased Renal failure Renal replacement therapy Resuscitation Vaccination failure Vascular catheterisation

Symptomtext

Oxygen saturation decreased; Antifungal treatment; Central venous catheterisation; Endotracheal intubation; Haemofiltration; Renal replacement therapy; Resuscitation; Vascular catheterisation; SUSPECTED CLINICAL VACCINATION FAILURE; Cardiac arrest; Cardio-respiratory arrest; Fungaemia; Renal failure; COVID-19 pneumonia; Dyspnoea; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAERS reference number 1800582) concerned a 64 year old male unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, hyperlipidemia, depression, insomnia, intellectual disability, and chronic bilateral lower extremity pain. Other pre-existing medical conditions included no allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total administered on 07-APR-2021 for an unspecified indication. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 28-SEP-2021, the patient was presented to hospital with worsening of shortness of breath and was diagnosed with covid-19 pneumonia. He received dexamethasone and remdesivir with vapotherm support. His saturations continued to decrease and was intubated. On 16-OCT-2021, he experienced central venous catheterization, haemofiltration, resuscitation, endotracheal intubation, vascular catheterisation, suspected clinical vaccination failure, renal failure and received peripherally inserted central catheter (PICC) line and vascular catheter for renal replacement therapy requiring CRRT (Continuous renal replacement therapy). He developed candid fungemia and given antifungal therapy, also experienced cardiac arrest and cardio-respiratory arrest for which he received 3 rounds of CPR (Cardiopulmonary resuscitation) along with calcium and epinephrine with continued asystole. He died on 16-OCT-2021 and it was unspecified if an autopsy was performed. Laboratory data included: Oxygen saturation (NR: not provided) decreased. Treatment medications (dates unspecified) included: epinephrine, remdesivir, dexamethasone, and calcium. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of antifungal treatment, covid-19 pneumonia, cardiac arrest, cardio-respiratory arrest, central venous catheterisation, dyspnoea, endotracheal intubation, fungaemia, haemofiltration, oxygen saturation decreased, renal failure, renal replacement therapy, resuscitation, vascular catheterisation, and outcome of the suspected clinical vaccination failure was not reported. This report was serious (Death, and Life Threatening). This report was associated with product quality complaint: 90000200122. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from the Regulatory Authority on 08-NOV-2021. The following information was updated and incorporated into the case narrative: The product quality complaint investigation result was added.; Sender's Comments: V2:The following information was updated and incorporated into the case narrative: The product quality complaint investigation result was added.This added information does not alter the causality of previous reported events. 20211061611-covid-19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20211061611-covid-19 vaccine ad26.cov2.s- Renal failure, covid-19 pneumonia, cardiac arrest, cardio-respiratory arrest, fungaemia, dyspnoea, oxygen saturation decreased, antifungal treatment, central venous catheterisation, endotracheal intubation, haemofiltration, renal replacement therapy, resuscitation, vascular catheterisation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: ANTIFUNGAL TREATMENT; COVID-19 PNEUMONIA; CARDIAC ARREST; CARDIO-RESPIRATORY ARREST; CENTRAL VENOUS CATHETERISATION; DYSPNOEA; ENDOTRACHEAL INTUBATION; FUNGAEMIA; HAEMOFILTRATION; OXYGEN SATURATION DECREASED; RENAL FAILURE; RENAL REPLACEMENT THERAPY;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: Test Date: 20211016; Test Name: Oxygen saturation; Result Unstructured Data: decreased
Aktuelle Erkrankungen: Depression; Hyperlipidemia; Hypertension; Insomnia; Intellectual disability; Pain of lower extremities
Vorgeschichte: Comments: no allergies
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1862367

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 11.11.2021
Impfdatum: 02.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 13,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Antiphospholipid antibodies Chest discomfort Chest pain Coagulation test normal Computerised tomogram thorax abnormal Dyspnoea Electrocardiogram normal Exposure to contaminated air Fibrin D dimer increased Laboratory test Pain in extremity Pleuritic pain Pulmonary embolism Respiratory distress Troponin normal Ultrasound scan normal White blood cell count increased

Symptomtext

Patient began to have pain at the back of both legs/popliteal fossa sometime in June 2021 after his vaccination. He began having sharp chest pain when supine starting either in the last week of June or the first week of July 2021. He reported a sensation of chest heaviness as well leading up to his diagnosis of an unprovoked PE on July 24, 2021 (elevated d-dimer). His CT(PE) confirmed the diagnosis on July 25, 2021. He presented to ER with pleuritic chest pain, SOB/resp distress and HR: 117. His symptoms gradually improved on xarelto (x4 months) & hydromorphone (x1 week). He was referred to a hematologist and had a thorough hypercoagulability work-up, which was negative. There were no obvious triggers for his PE; although, he had been exposed to wildfire smoke for at least 1 month and had periods of high intensity activity (biking) prior to his PE. I wonder if more studies are needed to determine if wildfire smoke is a risk factor for PEs (?). Could the PE be from his vaccination (?)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: elevated d-dimer, mildly elevated WBC count. troponin: neg. reportedly normal ECG. CT(PE) confirming a PE. Bedside ultrasound was reportedly negative for pericarditis as per ER physician. No pneumothorax or pneumonia seen on imaging. lupus anticoagulant and other coagulpathy labs were ordered by his family doctor and hematologist
Aktuelle Erkrankungen: None other than episodic headaches.
Vorgeschichte: None
Andere Medikamente: Patient is not on any prescriptions He takes advil prn for headaches (once or twice per week at the most. Once q 2 weeks at the least). We aren't sure if he had any in June around the time of his vaccine. supplements: Vit D 1000 IU PO onc
Allergien: NKAs
Vorherige Impfungen: only a sore arm/small amount of bleeding (drop)

VAERS 1857853

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: 31,0
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: 10.06.2021
Beginn: 10.11.2021
Tage bis Beginn: 153,0
Dosis: UNK
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Foetal death

Symptomtext

Fetal demise at 18 weeks 4 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/a
Andere Medikamente: Aspirin, docusate, prenatal vitamins
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 1857011

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: MI
Alter: -
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Vaccination failure

Symptomtext

DIED; COVID-19; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a consumer via a traditional media report concerned an 82 year old female of unspecified ethnicity. The patient's weight, height and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: UNKNOWN) dose, start therapy date were not reported,1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. It was reported that on 04-NOV-2021(Thursday), at about 2:00, the patient was died after contracting covid-19. The patient's son also reported that after receiving the JANSSEN COVID VACCINE, the patient was still felt ill (suspected clinical vaccination failure). Reporter also stated that the patient had been hospitalized for days before dying at about 2:00, on 04-NOV-2021 (Thursday). The patient died from unknown cause of death. On an unspecified date the patient was hospitalized. Number of days of hospitalization was not reported. It was unknown if patient was discharged. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of died on 04-NOV-2021, had not recovered from covid-19, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged). This report was associated with a product quality complaint 90000200900.; Sender's Comments: V0: 20211115285- Covid-19 vaccine ad26.cov2.s- Died, Covid-19. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). V0: 20211115285- Covid-19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1856604

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 10.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Myocardial infarction Thrombosis

Symptomtext

HEART ATTACK; HUGE BLOOD CLOTS; This spontaneous report received from a consumer via social media through company representative concerned a male of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose, start therapy date were not reported, 01 total administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. Consumer reported that on an unspecified date, the patient got the shot and shortly he was dead from a heart attack caused by huge blood clots of the size of a tennis ball. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of heart attack and huge blood clots on an unspecified date. This report was serious (Death).; Sender's Comments: V0 20211116646-COVID-19 VACCINE AD26.COV2.S- Heart attack, huge blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: HEART ATTACK; HUGE BLOOD CLOTS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1856592

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bacterial test Cardiac valve disease Cardiac valve vegetation Cardiovascular evaluation Death Disseminated intravascular coagulation Myocarditis Pericardial effusion Pleural effusion

Symptomtext

SUCCUMBING; MYOCARDITIS; VEGETATION ON PULMONIC VALVE; VALVE DESTROYED; FLUID PERMEATED LUNGS; PERICARDIAL CENTESIS; DISSEMINATED INTRAVASCULAR COAGULATION; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient never had any health problem. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, 10 days post vaccination patient experienced chest pain and performed cardiac workup which result came negative, a week later patient had same symptoms and performed cardiac workup which showed vegetation on pulmonic valve. On an unspecified date patient had surgery and valve was cultured with result negative for bacteria. It was reported that valve completely destroyed after one week and developed myocarditis, fluid permeated lungs and performed chest tubes, pericardial centesis (1.8 Liter), and thoracotomy. On an unspecified date, patient had disseminated intravascular coagulation (DIC). The patient went through four weeks of torture before succumbing. On an unspecified date, the patient died from unknown cause of death. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of succumbing on an unspecified date, had not recovered from vegetation on pulmonic valve, and valve destroyed, and the outcome of myocarditis, disseminated intravascular coagulation, pericardial centesis and fluid permeated lungs was not reported. This report was serious (Death, and Other Medically Important Condition). This case, from the same reporter is linked to 20211104021.; Sender's Comments: V0: 20211110984-covid-19 vaccine ad26.cov2.s-myocarditis, succumbing, vegetation on pulmonic valve, valve destroyed, fluid permeated lungs, pericardial centesis, disseminated intravascular coagulation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Cardiovascular evaluation; Result Unstructured Data: Negative; Test Name: Bacterial culture; Result Unstructured Data: Negative; Comments: valve was cultured and neg for bacteria; Test Name: Cardiovascular evaluation; Result Unstructured Data: vegetation on pulmonic valve
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient never had any health problem.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1856588

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: LA
Alter: -
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211104021-Covid-19 vaccine ad26.cov2.s- Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1162619

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NV
Alter: 18,0
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: 20.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Alanine aminotransferase increased Antinuclear antibody negative Aspartate aminotransferase increased Beta-2 glycoprotein antibody positive Blood culture negative Angiogram cerebral Magnetic resonance imaging head Superior sagittal sinus thrombosis Blood fibrinogen decreased Blood lactic acid Blood thyroid stimulating hormone normal Cerebral infarction Cerebral venous sinus thrombosis Blood fibrinogen Cerebral haemorrhage Computerised tomogram head Fibrin D dimer Brain operation

Symptomtext

Seizures, blood clots, brain bleeds, 4 strokes, 4 brain surgeries. Life flighted. 3 weeks in coma on ventilator. 3 1/2 months in hospital/rehab. Currently in wheelchair reliant on her father and I for EVERYTHING.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 104,0
Labordaten: Too many to name Call me
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1853138

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: IN
Alter: -
Geschlecht: U
Eingang: 09.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cardiac disorder Dyspnoea Exercise electrocardiogram General physical health deterioration Malaise Myocardial infarction Scan Tinnitus

Symptomtext

FEELING LIKE HAD 2 HEART ATTACKS; BOTTOM OF MY HEART IS NOT RECOVERING; SERIOUS HEALTH ISSUES; CONSTANTLY OUT OF BREATH/STRUGGLE TO BREATH; RUN DOWN AND TIRED; NEVER HAVING ENERGY; EARS ARE SCREAMING CONSTANTLY; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: genetic high cholesterol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN and expiry: UNKNOWN) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, after having the Johnson & Johnson vaccine the patient experienced serious health issues. The patient reported that, the bottom of heart is not recovering from a tread mill test which was done due to the patient feeling like had 2 heart attacks. The patient had performed with scan to see if there was any blockage to arteries, since patient had genetic high cholesterol, results shows zero build up in main arteries. But patient experienced constantly out of breath with no excursion and struggle to breath. The patient also experienced ears are screaming constantly, run down and tired, and never having energy. Laboratory data (dates unspecified) included: Scan (NR: not provided) Zero build up (blockage), and Treadmill test (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bottom of my heart is not recovering, and the outcome of serious health issues, feeling like had 2 heart attacks, constantly out of breath/struggle to breathe, ears are screaming constantly, run down and tired and never having energy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211112604-COVID-19 VACCINE AD26.COV2.S-feeling like had 2 heart attacks. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Name: Scan; Result Unstructured Data: Zero build up (blockage); Test Name: Treadmill test; Result Unstructured Data: Not reported
Aktuelle Erkrankungen: High cholesterol
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1853137

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: -
Beginn: 04.11.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

This spontaneous report received from a consumer via a company representative concerned a 6 decade old female of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, start therapy date were not reported, 1 total for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter reported that his mother was a healthy woman in her 50s. She got the vaccine in the spring. Reporter was so afraid for her. On 04-NOV-2021, patient had a stroke in the morning and was in the hospital (Number of days hospitalized not reported). Patient was just at doctors for yearly and was healthy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211112386-covid-19 vaccine ad26.cov2.s-stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1853136

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: MI
Alter: -
Geschlecht: M
Eingang: 09.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Myocardial infarction

Symptomtext

HEART ATTACK; STROKE 2 WEEKS AFTER VACCINATION; This spontaneous report received from a consumer via a company representative via social media concerned a 40 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. Patient was healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that "My best friend's fiance had a heart attack and a stroke 2 weeks after getting the Johnson and Johnson vaccine. He was 40 and healthy".. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heart attack and stroke 2 weeks after vaccination was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20211112281-COVID-19 VACCINE AD26.COV2.S-Heart attack, stroke 2 weeks after vaccination. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient was healthy.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1853133

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 09.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident SARS-CoV-2 test SARS-CoV-2 test positive Thrombosis

Symptomtext

STROKE; BLOOD CLOT; COVID-19 TEST POSITIVE; This spontaneous report received from a consumer via social media concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, less than a week later after vaccination the patient was at the emergency room and tested positive for Covid-19. Later the patient experienced a stroke and a blood clot on brain. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stroke, blood clot and covid-19 test positive was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000200514; Sender's Comments: V0- 20211110611- covid-19 vaccine ad26.cov2.s- Stroke, Blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1851846

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 08.11.2021
Impfdatum: 27.10.2021
Beginn: 01.11.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Blood bicarbonate decreased Blood electrolytes Blood glucose decreased Blood glucose increased Blood lactic acid Blood magnesium increased Blood pH decreased Blood phosphorus increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Death Diarrhoea Hypoacusis Hypoglycaemia Lactic acidosis

Symptomtext

PATIENT NOW DECEASED (11.7.21) - presented to ED (altered mental status - coded; expired) ED - DX: acute respiratory failure with hypoxia; COVID-19; respiratory arrest; lactic acidosis Hospitalized (11.1.21 - 11.3.21); COVID-19 positive (11.1.21); Fully vaccinated PLUS booster Date of Admission: 11/1/2021, Hospital Day: 3 Discharge Date: 11/3/2021 PRESENTING PROBLEM: Hypoglycemia [E16.2] Diarrhea, unspecified type [R19.7] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 87 y.o. male who presents today with diarrhea . History obtained from medical record and patient. Patient is extremely hard of hearing and severely limiting obtaining history , does not have hearing aids with him . Niece and nephew now on floor however are not informed as to current medical issues. In ed on arrival found to be hypoxic to 87% placed on 3 lnc , cxr findings consistent with covid infection . Tested positive for covind 19 . Blood glucose on arrival found to be 34 , subsequent testin with rather rapid rise with a meal only . He was given decadron in ed . Hospitalist service consulted for admission further evaluation. Patient was continued on supplemental oxygen and administered dexamethasone and Remdesivir. He was weaned to room air with adequate oxygenation. Patient diarrhea improved likely related to COVID-19. PT/OT evaluated advised home with assist home health PT/OT. Case manager was consulted to arrange for outpatient services. Electrolytes were monitored and repleted throughout the admission. Patient was symptomatic lead treated with antitussives, antiemetics, analgesics p.r.n. patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP in 7 days. He will continue 3 additional days of dexamethasone and antitussives. Patient was advised to follow-up outpatient ENT for evaluation of cochlear implant. Patient was advised given difficulties with hearing to stop driving until cochlear implant issues addressed. Patient voiced understanding and was agreeable with the plan of care and discharge. CM arranged for patients niece to pick patient up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Lactic Acid 10.8 High Panic pH Venous 7.06 Low Panic Phosphorus Level 9.6 High Magnesium Level 3.0 HCO3 9 Low Panic Glucose Level 562 pH Arterial 6.95 Low Panic
Aktuelle Erkrankungen: 10.4.21: Patient reported to PCP having diarrhea after every meal for past 3 months 10.27.21: Seen at PCP for complaint of diarrhea 11.1.21: Urgent Care - diarrhea, altered mental status 11.1.21 - 11.3.21: Hospital admission - hypoglycemia, diarrhea, acute hypoxemic respiratory failure, pneumonia due to COVID-19 11.7.21: Emergency department - patient EXPIRED.
Vorgeschichte: Hyperglycemia Dyslipidemia Coronary artery disease OSA (obstructive sleep apnea) Hypothyroid Osteoarthritis Encounter for monitoring of systemic steroid therapy Osteopenia Insomnia w/ sleep apnea COPD, moderate (HCC) Cardiomyopathy, ischemic DOE (dyspnea on exertion) Hypertension, benign Hyperlipidemia Myocardial infarction (HCC) Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin (HCC) Rheumatoid arthritis with negative rheumatoid factor, involving unspecified site (HCC) Bilateral hearing loss, unspecified hearing loss type Coronary artery chronic total occlusion Osteoarthritis of right knee, unspecified osteoarthritis type Bradycardia, drug induced Iatrogenic hypotension Knee osteoarthritis Leukocytosis Acute pain of right knee Encounter for other orthopedic aftercare Knee stiffness, right Difficulty in walking involving lower leg joint Status post total knee replacement, unspecified laterality Exudative age-related macular degeneration of left eye with active choroidal neovascularization (HCC) Chronic disease anemia Prostatism LADA (latent autoimmune diabetes in adults), managed as type 1 (HCC) PAD (peripheral artery disease) (HCC) Diabetic polyneuropathy associated with type 1 diabetes mellitus (HCC) Paroxysmal atrial fibrillation (HCC) PAF (paroxysmal atrial fibrillation) (HCC) Pneumonia due to COVID-19 virus
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler alendronate (FOSAMAX) 70 MG tablet atorvastatin (LIPITOR) 40 MG tablet benzonatate (TESSALON) 100 MG capsule bisoprolol (ZEBETA) 5 MG tablet Blood Glucose
Allergien: DuloxetineUnknown KeflexOther
Vorherige Impfungen: -

VAERS 1851846

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 08.11.2021
Impfdatum: 27.10.2021
Beginn: 01.11.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Blood bicarbonate decreased Blood electrolytes Blood glucose decreased Blood glucose increased Blood lactic acid Blood magnesium increased Blood pH decreased Blood phosphorus increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Death Diarrhoea Hypoacusis Hypoglycaemia Lactic acidosis

Symptomtext

PATIENT NOW DECEASED (11.7.21) - presented to ED (altered mental status - coded; expired) ED - DX: acute respiratory failure with hypoxia; COVID-19; respiratory arrest; lactic acidosis Hospitalized (11.1.21 - 11.3.21); COVID-19 positive (11.1.21); Fully vaccinated PLUS booster Date of Admission: 11/1/2021, Hospital Day: 3 Discharge Date: 11/3/2021 PRESENTING PROBLEM: Hypoglycemia [E16.2] Diarrhea, unspecified type [R19.7] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 87 y.o. male who presents today with diarrhea . History obtained from medical record and patient. Patient is extremely hard of hearing and severely limiting obtaining history , does not have hearing aids with him . Niece and nephew now on floor however are not informed as to current medical issues. In ed on arrival found to be hypoxic to 87% placed on 3 lnc , cxr findings consistent with covid infection . Tested positive for covind 19 . Blood glucose on arrival found to be 34 , subsequent testin with rather rapid rise with a meal only . He was given decadron in ed . Hospitalist service consulted for admission further evaluation. Patient was continued on supplemental oxygen and administered dexamethasone and Remdesivir. He was weaned to room air with adequate oxygenation. Patient diarrhea improved likely related to COVID-19. PT/OT evaluated advised home with assist home health PT/OT. Case manager was consulted to arrange for outpatient services. Electrolytes were monitored and repleted throughout the admission. Patient was symptomatic lead treated with antitussives, antiemetics, analgesics p.r.n. patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP in 7 days. He will continue 3 additional days of dexamethasone and antitussives. Patient was advised to follow-up outpatient ENT for evaluation of cochlear implant. Patient was advised given difficulties with hearing to stop driving until cochlear implant issues addressed. Patient voiced understanding and was agreeable with the plan of care and discharge. CM arranged for patients niece to pick patient up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Lactic Acid 10.8 High Panic pH Venous 7.06 Low Panic Phosphorus Level 9.6 High Magnesium Level 3.0 HCO3 9 Low Panic Glucose Level 562 pH Arterial 6.95 Low Panic
Aktuelle Erkrankungen: 10.4.21: Patient reported to PCP having diarrhea after every meal for past 3 months 10.27.21: Seen at PCP for complaint of diarrhea 11.1.21: Urgent Care - diarrhea, altered mental status 11.1.21 - 11.3.21: Hospital admission - hypoglycemia, diarrhea, acute hypoxemic respiratory failure, pneumonia due to COVID-19 11.7.21: Emergency department - patient EXPIRED.
Vorgeschichte: Hyperglycemia Dyslipidemia Coronary artery disease OSA (obstructive sleep apnea) Hypothyroid Osteoarthritis Encounter for monitoring of systemic steroid therapy Osteopenia Insomnia w/ sleep apnea COPD, moderate (HCC) Cardiomyopathy, ischemic DOE (dyspnea on exertion) Hypertension, benign Hyperlipidemia Myocardial infarction (HCC) Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin (HCC) Rheumatoid arthritis with negative rheumatoid factor, involving unspecified site (HCC) Bilateral hearing loss, unspecified hearing loss type Coronary artery chronic total occlusion Osteoarthritis of right knee, unspecified osteoarthritis type Bradycardia, drug induced Iatrogenic hypotension Knee osteoarthritis Leukocytosis Acute pain of right knee Encounter for other orthopedic aftercare Knee stiffness, right Difficulty in walking involving lower leg joint Status post total knee replacement, unspecified laterality Exudative age-related macular degeneration of left eye with active choroidal neovascularization (HCC) Chronic disease anemia Prostatism LADA (latent autoimmune diabetes in adults), managed as type 1 (HCC) PAD (peripheral artery disease) (HCC) Diabetic polyneuropathy associated with type 1 diabetes mellitus (HCC) Paroxysmal atrial fibrillation (HCC) PAF (paroxysmal atrial fibrillation) (HCC) Pneumonia due to COVID-19 virus
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler alendronate (FOSAMAX) 70 MG tablet atorvastatin (LIPITOR) 40 MG tablet benzonatate (TESSALON) 100 MG capsule bisoprolol (ZEBETA) 5 MG tablet Blood Glucose
Allergien: DuloxetineUnknown KeflexOther
Vorherige Impfungen: -

VAERS 1230891

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: MO
Alter: 68,0
Geschlecht: M
Eingang: 06.11.2021
Impfdatum: -
Beginn: 31.03.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arachnoid cyst Cardiac monitoring Cerebrovascular accident Computerised tomogram head Scan brain Intensive care Speech disorder

Symptomtext

HIGH RIGHT ARACHNOID CYST; STROKE; This spontaneous report received from a patient concerned a 68 year old male. Initial information was processed along with additional information received from patient on 4-NOV-2021. The patient's height, and weight were not reported. The patient's past medical history included: left pyriform cancer, chemotherapy, and thyroid replacement, and concurrent conditions included: hypertension, glaucoma right eye, barrette's esophagus, renal insufficiency, GERD, penicillin allergy, and allergy to any drug that ends with mab. The patient experienced facial swelling when treated with celecoxib. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180518 expiry: 25-MAY-2021) dose was not reported,1 total, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included acetylsalicylic acid, brimonidine, esomeprazole magnesium, and losartan. On 31-MAR-2021 after 3 weeks of vaccination, the patient experienced a severe headache, he did not take anything for it and went to sleep. The next day, on 01-APR-2021, the patient reported headache was gone, but he noted that he was not sounding right, while he was talking on the phone with others and to neighbors. On 02-APR-2021, the patient was taken at emergency department (ER) by his wife who is a physician. The patient reported good speech and no headache at ER, but was not able to say the correct word for items, which was referred to aphasia. The patient underwent laboratory test scan of the head, which told the physician exactly where the problem was. The patient was not sure of the type of scan that was done at ER. The patient was diagnosed with a stroke. The patient was then admitted to hospital for 2 days. During the hospitalization patient underwent a CT (computed tomography) of the head (without contrast) that resulted as (1) interval development of peripheral lateral left frontal hypodensity, mild local mass effect, no significant adjacent white matter edema, most compatible with subacute infarct, consider contrast enhancement for further characterization. (2) Mild scattered supratentorial white matter hypodensities likely representing ischemic changes. (3) High right arachnoid cyst. The patient saw a cardiologist while in hospital, who ordered a 30 days cardiac monitoring, but monitor was malfunctioning and the patient was not able to contact the cardiologist to arrange for a replacement monitor/repeat testing. The patient was not aware of any treatments or medications he underwent during hospitalization, but was sent home with baby aspirin. On unspecified date in JUN or JUL-2021, the patient received training from a speech language pathologist. The patient reported he does not have residual speech problems. On unspecified date on AUG-2021, the patient visited neurologist once, who did not provide any additional care or treatment, but reordered the heart monitor testing. The patient underwent laboratory test cardiac monitoring for 30 days, that resulted nothing wrong as per him. The patient reported he had seen his physician several times, since hospitalization for monitoring after the stroke, and due to other health concerns. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stroke and high right arachnoid cyst was not reported. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20211109968.; Sender's Comments: V0-20211110158-covid-19 vaccine ad26.cov2.s- Stroke, High right arachnoid cyst. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: CT brain scan; Result Unstructured Data: mild local mass effect; Test Date: 20210402; Test Name: Scan brain; Result Unstructured Data: diagnosed with a stroke; Test Date: 202108; Test Name: Cardiac monitoring; Result Unstructured Data: nothing wrong
Aktuelle Erkrankungen: Barrett's esophagus; Drug allergy; GERD; Glaucoma; Hypertension; Penicillin allergy (unknown reaction as a child); Renal insufficiency
Vorgeschichte: Medical History/Concurrent Conditions: Chemotherapy (11 YRS AGO); Malignant neoplasm of pyriform sinus (11 YRS AGO); Thyroid hormone replacement therapy
Andere Medikamente: LOSARTAN; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; BABY ASPIRIN; BRIMONIDINE
Allergien: -
Vorherige Impfungen: -

VAERS 2580129

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 29.01.2021
Beginn: 03.08.2021
Tage bis Beginn: 186,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Blood bicarbonate increased Blood fibrinogen increased Blood gases Blood lactic acid Blood pH normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Emphysema Fibrin D dimer Lung consolidation Lung disorder Lung opacity

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.3 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1362566

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 05.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction Death Myocardial infarction Unresponsive to stimuli Cardiac arrest

Symptomtext

DEATH; ANAPHYLAXIS; HEART ATTACK; UNRESPONSIVE; This spontaneous report received from a consumer via a company representative via a social media concerned a female of unspecified age of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that, "your vaccine killed the patient. Not all and epi does not save everyone anaphylaxis can cause a heart attack. This was how my friend's sister died. Within 13 hours of getting the jab she was unresponsive". The patient died on an unspecified date from an unknown cause. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable The outcome of anaphylaxis, heart attack and unresponsive was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20211107237-covid-19 vaccine ad26.cov2.s -Death, heart attack, unresponsive. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211107237- -covid-19 vaccine ad26.cov2.s-Anaphy?laxis This event(s) is labeled per Regulatory Authority and is therefore considered potentially related.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599263

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: 04.02.2021
Beginn: 26.08.2021
Tage bis Beginn: 203,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Aphasia COVID-19 Cognitive disorder Death SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 Agency Facility 02/06, Pfizer, dose #2 (PHARMACY) 08/12 08/23 08/26 COVID swab , result: not detected 08/16 08/23 08/26 COVID swab , result: not detected 08/19 08/23 08/26 COVID swab , result: not detected 08/23 08/26 COVID swab , result: not detected 08/26 COVID swab , result: detected 08/26 SARS-COV-2 Variant Sequencing results: pending 08/27 pt cognitively impaired admitted to nursing home COVID unit for quarantine and supportive care. 08/27 pt cc: unable to verbalize exposure: unknown 10/03 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1843594

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 52,0
Geschlecht: F
Eingang: 04.11.2021
Impfdatum: 27.03.2021
Beginn: 05.10.2021
Tage bis Beginn: 192,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Angiogram Blood gases normal Blood potassium decreased COVID-19 Catheterisation cardiac Chest X-ray abnormal Chest pain Condition aggravated Diarrhoea Dyspnoea Electrocardiogram Fatigue Fibrin D dimer Hypoxia Laboratory test Leukocytosis Lung disorder

Symptomtext

10/5/2021 Chief Complaint: SOB. "Cardiac rehab sent me her for my low 02" Source of Information: Patient History of Present Illness: This is a 52y.o. female with a PMH of resistant HTN, NSTEMI with recent hx of cardiac cath, and hypertensive urgency presents to the ED with shortness of breath. Patient was starting her first day of cardiac rehabilitation when she was noted to have a low 02 saturation. On 09/01/21 patient was seen for exertional chest pain. During this hospitalization pt underwent cardiac cath for NSTEMI. Angiography was unremarkable and no stents were placed. Patient was discharged on Hydralazine 75mg TID, Nifedipine XL 90mg, Lopressor 100mg BID, and Imdur 30mg daily. Pt describes fatigue, diminished exertional capacity, orthopnea since 09/01 and diarrhea since 09/08 to present. Pt has difficulty describing any symptomatic change over time. Patient was never COVID tested during her last hospitalization. She admits to being covid vaccinated. Denies any pleuritic pain, abdominal pain, nausea, vomiting, fevers or chills. ED course: BP 130/77 | Pulse 60 | Temp 97.7 ?F (36.5 ?C) (Temporal) | Ht 165.1 cm (5' 5") | Wt 90.7 kg (200 lb) | SpO2 (!) 85% | BMI 33.28 kg/m? Covid + ABG 7.52/33/79/27 WBC 12.6 w/left shift 0.32 and dohle bodies Potassium 3 Ddimer 7598 Troponin 0.01x2, 0.02 Platelet 464 CXR notable for right basilar airspace disease ECG sinus rhythm with PAC 90

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 8,0
Labordaten: a 52 year old female with past medical history of resistant HTN, NSTEMI (s/p recent LHC and cardiac evaluation <1 month prior to admission), was admitted to BFH on 10/5/21 with complaints of shortness of breath and was found to be SARS-COV-2 on day of admission. Patient was acutely hypoxic requiring significant increased in oxygen supplementation to HFNC 55-60% FiO2. Pulmonology and Infectious Disease was consulted for further evaluation. Empiric antibiotics was initiated and quickly deescalated per infectious disease recommendations with covid-19 inflammatory markers monitored per protocol. Patient completed 5 days of Remdesivir therapy during her hospital stay and received Tociluzimab on 10/9/21. Pulmonology assisted in management in patient's oxygen requirements and recommended continued self directed proning and supportive care. Imaging studies performed during hospital course significant for LE duplex which demonstrated no evidence of DVT and RUS demonstrating no evidence of obstructive uropathy. Patient's basic labs were closely monitored, electrolytes replaced per protocol and were notable for slowly improving Cr and downtrending leukocytosis, stable anemia on daily labs. Serial CXRs were monitored with similar appearence of mild vascular congestion and bilateral infiltrates noted. Patient's oxygen requirements were slowly weaned as tolerated, with home oxygen evaluation performed by RT demonstrating continued need for 3L. Given no further work-up or treatment planned. Patient was deemed appropriate for discharge with discharge coordination discussed with care providers, care management and patient/family. Follow-up with PCP and specialists with instructions as indicated in provided discharge summary. Changes to patient's medications are noted below.
Aktuelle Erkrankungen: 9/1/2021 STEMI
Vorgeschichte: -
Andere Medikamente: allopurinol (ZYLOPRIM) 100 MG PO Tab take 1 Tablet by mouth once daily. Medication last filled on 9-15-21 with day supply 30 aspirin EC (HALFPRIN) 81 MG PO Tablet Delayed Response take 81 mg by mouth. atorvastatin (LIPITOR) 80
Allergien: Pineapple Swelling, generalized ? Eggs Or Egg-Derived Products Other
Vorherige Impfungen: -

VAERS 1842058

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 04.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram Death

Symptomtext

THE PATIENT DIED (THE PATIENT SURVIVED 2 WEEKS IN ICU BEFORE SHE PAST 2); This spontaneous report received from a patient via a company representative via social media concerned a 3 decade old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included: stage 4 colon cancer, and kidney stone. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry : unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died (the patient survived 2 weeks in icu before she past 2 ) and was hospitalized in ICU (date unspecified). Laboratory data (dates unspecified) included: CT scan (NR: not provided) kidney stone, clear. On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211104964-Covid-19 vaccine ad26.cov2.s - The patient died (the patient survived 2 weeks in icu before she past 2 ). This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: CT scan; Result Unstructured Data: clear; Test Name: CT scan; Result Unstructured Data: kidney stone; Comments: ct scan late 20 for possible kidney stone
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Colon cancer stage IV (Just diagnosed w/stage 4 colon cancer that already metastasized.); Kidney stone (possible kidney stone ct of belly was clear.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1842052

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NH
Alter: 78,0
Geschlecht: F
Eingang: 04.11.2021
Impfdatum: -
Beginn: 01.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Carotid artery thrombosis Cerebrovascular accident Cough Hypersomnia Suspected COVID-19 Vaccination failure

Symptomtext

BLOOD CLOT IN CAROTID ARTERY; SUSPECTED CLINICAL VACCINATION FAILURE; SLEEPING ALL DAY; CHRONIC COUGH; SUSPECTED COVID-19 INFECTION; SMALL STROKE; This spontaneous report received from a patient concerned a 78 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: acid reflux, and allergic to some antibiotics. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported, 1 total administered to left deltoid for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included omeprazole for acid reflux. Patient received Janssen covid-19 vaccine around late May or early June (patient could not find vaccine card). On 18-OCT-2021, she was recently diagnosed with covid-19 (suspected covid-19 infection) and also experienced suspected clinical vaccination failure. On an unspecified date, she was feeling very sick, like 'the grip' from the 50s. she was throwing up, felt feverish at night time, very fatigued and was sleeping all day long. She currently was feeling better, but post nasal drip was causing a chronic cough. On JUL-2021, patient suffered a small stroke (at the end of July, approximately 2 months after getting the Janssen vaccine). Blood clot was discovered in her carotid artery. Surgery has been scheduled to repair some damage done while looking for the blood clot. Patient was put on blood thinners for 10 days post stroke but was not taking any at the time of reporting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from small stroke, was recovering from suspected covid-19 infection, blood clot in carotid artery, and suspected clinical vaccination failure, had not recovered from chronic cough, and the outcome of sleeping all day was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint.; Sender's Comments: V0 20211103276- COVID-19 VACCINE AD26.COV2.S-Blood clot in carotid artery, small stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). V0 20211103276- COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic; Gastrooesophageal reflux disease
Vorgeschichte: Comments: Unknown
Andere Medikamente: OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1842051

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: -
Beginn: 01.10.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) one total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date in OCT-2021, the patient died from unknown cause of death. The patient took a lot of risks after getting the vaccine too. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211103115-covid-19 vaccine ad26.cov2.s- Died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1103186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MI
Alter: 69,0
Geschlecht: F
Eingang: 04.11.2021
Impfdatum: 02.02.2021
Beginn: 04.02.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myeloid leukaemia Band neutrophil count Band neutrophil count increased Blast cell count increased Blast cells Biopsy bone marrow Full blood count Brain stem stroke Death Endotracheal intubation Full blood count abnormal Ischaemic stroke Cerebral haemorrhage Disseminated intravascular coagulation Haemorrhagic stroke Leukaemia Laboratory test Pain in extremity

Symptomtext

Some elevated CBC counts, Feb 4. Sore lower leg Feb 15. Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: All tests and records available at Hospital
Aktuelle Erkrankungen: None
Vorgeschichte: Had breast cancer June 2013. Since surgery and radiation has been cancer free.
Andere Medikamente: Vita C & D;Glucosamine;Magnesium;Omega-3;Turmeric;Multi Vita
Allergien: None
Vorherige Impfungen: -

VAERS 1839579

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: CO
Alter: -
Geschlecht: U
Eingang: 03.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic shock Guillain-Barre syndrome

Symptomtext

ANAPHYLACTIC SHOCK; GUILLAIN BARRE; This spontaneous report received from a patient via social media via company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced anaphylactic shock, and guillain barre. The patient reported via social media that vaccine had caused anaphylactic shock and huge emergency room bill to the patient. Patient could not feel the feet but stated that arms, hands and fingers were mostly back to normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from guillain barre, and the outcome of anaphylactic shock was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211061612-covid-19 vaccine ad26.cov2.s-anaphylactic shock. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211061612-covid-19 vaccine ad26.cov2.s-Guillain Barre. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic shock
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1839420

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 03.11.2021
Impfdatum: -
Beginn: 25.10.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH FROM JANSSEN VACCINE; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was happy and enjoying life. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 25-OCT-2021, the patient experienced death from janssen vaccine. On 25-OCT-2021, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20211103989.; Sender's Comments: V0: 20211102972-JANSSEN COVID-19 VACCINE Ad26.COV2.S- DEATH. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was happy and enjoying life.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1778866

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 03.11.2021
Impfdatum: 09.03.2021
Beginn: 02.09.2021
Tage bis Beginn: 177,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 pneumonia Death Dyspnoea Productive cough Respiratory failure COVID-19 Vaccine breakthrough infection

Symptomtext

pt to ED with increasing SOB and productive cough x 1 wk; hx of COPD, A Fib, HTN, lung CA; hypoxic respiratory failure secondary to COVID pneumonia; given decadron and remdisivir; pt's condition worsened; O2 supplementation via NC; pt refused BiPAP; DNAR/DNI; pt condition continued to decline and he passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 37,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602084

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 10.03.2021
Beginn: 10.09.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Death Pneumonia aspiration SARS-CoV-2 test negative Septic shock

Symptomtext

Narrative: 73YO MALE died inpatient . Death was caused by: Septic Shock and Acute Hypoxic Respiratory Failure secondary to acute respiratory distress syndrome and aspiration pneumonia. Patient was covid negative per 5 different covid lab testsfrom 8/7/20 through 9/8/21. Pt had received covid vaccinations on 2/17/21 & 3/10/21 at non-agency hospital. Death is not related to covid vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602070

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 23.03.2021
Beginn: 02.09.2021
Tage bis Beginn: 163,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Lung neoplasm malignant

Symptomtext

Narrative: 75yo male in home hospice for end stage lung cancer died on 9/2/2021. Pt had received covid vaccines on 2/23/20 &3/23/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 22.03.2021
Beginn: 14.09.2021
Tage bis Beginn: 176,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Hepatic cirrhosis

Symptomtext

Narrative: 69yo male pt died on 9/14/2021 at home in home hospice care due to end stage cirrhosis of liver. Pt received one covid vaccine on 3/22/2021. Pt's death is not related to vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 16.03.2021
Beginn: 08.09.2021
Tage bis Beginn: 176,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 70yo male patient died on 9/8/21 at Hospital (non-agency hospital). Pt with the following medical history: PAST MEDICAL ischemic colitis contributing to hypotension and syncope CAD s/p 4v CABG on Aug 28/2011, PCI in 1995 ICM (last EF of 35% in Aug 2011, 52% on last TTE) PAF HTN PTSD h/o Hep C (txd) GERD # ED. #BL cerumen parital impaction w/ itching and irritation. # RIGHT lower leg dermatitis. PAST SURGICAL Left eye blindness 2/2 shrapnel Right low leg 2/2 osteomyelitis Right palmar hand Pt had covid vaccines on 2/23/21 & 3/16/2021. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 03.02.2021
Beginn: 01.09.2021
Tage bis Beginn: 210,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Aortic arteriosclerosis Blood bicarbonate decreased Blood bicarbonate increased Blood fibrinogen increased Blood gases abnormal Blood lactate dehydrogenase increased Blood lactic acid Blood pH decreased Blood pH increased Blood phosphorus Brain natriuretic peptide normal Bronchoscopy C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/31 pt cc: cough, fatigue, headache, rhinorrhea, congestion, exposure: unknown 09/01 COVID-19 ANTIGEN BINAX results: detected 09/01 CXR impression: No acute cardiopulmonary abnormality. Remainder of findings as above. 09/11 CXR impression: Lungs: There are interstitial and airspace opacities within the peripheral left mid and lower lung and more subtle opacities at the right medial lung base. Findings are suspicious for an infectious/inflammatory process, including atypical such as COVID-19 pneumonia. Pleura: No visible pleural effusion. No pneumothorax. Mediastinum: Heart size is within normal limits. There are aortic calcifications. There is a left chest dual-lead cardiac pacemaker. There is a right chest port with the tip over the SVC. 09/11 CTA impression: 1. No evidence of pulmonary embolism. Note that small segmental and subsegmental pulmonary emboli cannot be excluded due to breathing motion artifact. 2. Bilateral groundglass opacities and alveolar opacities, with a peripheral predominance compatible with multifocal pneumonia. Pattern consistent with reported COVID-19 3. A 8 mm subpleural nodule in the superior segment of the left lower lobe, similar in appearance to prior exams. July 30, 2021 PET/CT reports similar to exams dating back to at least March 2019. Suggest close attention on follow-up imaging given history of malignancy. 09/11 COVID swab, result: detected 09/11 FERRITIN >37840 09/11 SARS-COV-2 TOTAL AB, SPIKE <0.4 09/11 BNP 59.9 09/11 pt admit to medicine cc: dyspnea dx: acute hypoxemic respiratory failure d/t COVID PNA LOS: 18 DAYS 09/11 lactic acid 1.15 09/12 FIBRINOGEN 804 09/12 DDIMER 1.01 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 SARS-COV-2 IGG Eval: 0.01 09/12 i-pH 7.43, i-PCO2 31.5, i-P02 63, i-HCO3 21.0 09/12 ESR 40 09/13 FIBRINOGEN 491 09/13 DDIMER 0.66 09/13 ESR 13 09/16 i-pH 7.47, i-PCO2 33.4, i-P02 67, i-HCO3 24.6 09//16 CXR impression: Increased opacities in the left lung compared to the prior exam. Similar right lower lung opacities. 09/17 DDIMER: 0.38 09/18 i-pH 7.50, i-PCO2 32.1, i-P02 44, i-HCO3 24.7 09/20 i-pH 7.46, i-PCO2 34.0, i-P02 79, i-HCO3 24.2 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.43 09/21 ESR: 30 09/22 CXR impression: Similar bilateral, left greater than right heterogeneous pulmonary opacities. Consistent with COVID pneumonia. 09/23 FIBRINOGEN: 391 09/23 DDIMER: 0.41 09/23 ESR: 30 09/26 CXR impression: Since 9/22/2021: No substantial interval change in bilateral airspace opacities, left greater than right, consistent with multifocal Covid pneumonia. 09/27 FIBRINOGEN: 638 09/27 DDIMER: 0.55 09/27 ESR: 50 09/27 VIRAL RESPIRATORY CULTURE/QUEST results: pending 09/27 MYCOLOGY CULTURE BRONCHUS (quest) results: pending 09/27 ABG: i-pH 7.34, i-PCO2 52, i-P02 60, i-HCO3 28.2 09/27 FUNGUS SMEAR SPUTUM (QUEST) results: pending 09/27 PNEUMOCYSTIS JIROVECII DNA (QUEST) results: pending 09/27 MRSA PCR results: not detected 09/28 ABG: I-pH 7.40, i-PCO2 37.0, i-P02 49, i-HCO3 22.7 09/28 hit-ab: negative 09/28 CXR impression: No significant interval change. 09/29 po4 4.5 09/29 LDH 414.6 09/29 FERRITIN 9572.7 09/29 FIBRINOGEN: 749 09/29 ESR 62 09/29 CRP 18.993 09/29 CXR impression: No significant interval change. 09/29 pt decease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 09/01 COVID-19 ANTIGEN BINAX results: detected 09/01 CXR impression: No acute cardiopulmonary abnormality. Remainder of findings as above. 09/11 CXR impression: Lungs: There are interstitial and airspace opacities within the peripheral left mid and lower lung and more subtle opacities at the right medial lung base. Findings are suspicious for an infectious/inflammatory process, including atypical such as COVID-19 pneumonia. Pleura: No visible pleural effusion. No pneumothorax. Mediastinum: Heart size is within normal limits. There are aortic calcifications. There is a left chest dual-lead cardiac pacemaker. There is a right chest port with the tip over the SVC. 09/11 CTA impression: 1. No evidence of pulmonary embolism. Note that small segmental and subsegmental pulmonary emboli cannot be excluded due to breathing motion artifact. 2. Bilateral groundglass opacities and alveolar opacities, with a peripheral predominance compatible with multifocal pneumonia. Pattern consistent with reported COVID-19 3. A 8 mm subpleural nodule in the superior segment of the left lower lobe, similar in appearance to prior exams. July 30, 2021 PET/CT reports similar to exams dating back to at least March 2019. Suggest close attention on follow-up imaging given history of malignancy. 09/11 COVID swab, result: detected 09/11 FERRITIN >37840 09/11 SARS-COV-2 TOTAL AB, SPIKE <0.4 09/11 BNP 59.9 09/11 lactic acid 1.15 09/12 FIBRINOGEN 804 09/12 DDIMER 1.01 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 SARS-COV-2 IGG Eval: 0.01 09/12 i-pH 7.43, i-PCO2 31.5, i-P02 63, i-HCO3 21.0 09/12 ESR 40 09/13 FIBRINOGEN 491 09/13 DDIMER 0.66 09/13 ESR 13 09/16 CXR impression: Increased opacities in the left lung compared to the prior exam. Similar right lower lung opacities. 09/16 i-pH 7.47, i-PCO2 33.4, i-P02 67, i-HCO3 24.6 09/17 DDIMER: 0.38 09/18 i-pH 7.50, i-PCO2 32.1, i-P02 44, i-HCO3 24.7 09/20 i-pH 7.46, i-PCO2 34.0, i-P02 79, i-HCO3 24.2 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.43 09/21 ESR: 30 09/22 CXR impression: Similar bilateral, left greater than right heterogeneous pulmonary opacities. Consistent with COVID pneumonia. 09/23 FIBRINOGEN: 391 09/23 DDIMER: 0.41 09/23 ESR: 30 09/26 CXR impression: Since 9/22/2021: No substantial interval change in bilateral airspace opacities, left greater than right, consistent with multifocal Covid pneumonia. 09/27 FIBRINOGEN: 638 09/17 DDIMER: 0.55 09/27 ESR: 50 09/27 VIRAL RESPIRATORY CULTURE/QUEST results: pending 09/27 MYCOLOGY CULTURE BRONCHUS (quest) results: pending 09/27 ABG: i-pH 7.34, i-PCO2 52, i-P02 60, i-HCO3 28.2 09/27 FUNGUS SMEAR SPUTUM (QUEST) results: pending 09/27 PNEUMOCYSTIS JIROVECII DNA (QUEST) results: pending 09/27 MRSA PCR results: not detected 09/28 ABG: I-pH 7.40, i-PCO2 37.0, i-P02 49, i-HCO3 22.7 09/28 hit-ab: negative 09/28 CXR impression: No significant interval change. 09/29 po4 4.5 09/29 LDH 414.6 09/29 FERRITIN 9572.7 09/29 FIBRINOGEN: 749 09/29 ESR 62 09/29 CRP 18.99 09/29 CXR impression: No significant interval change.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601566

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 12.08.2021
Beginn: 28.08.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Alveolar lung disease Angiogram pulmonary abnormal Blood bicarbonate increased Blood fibrinogen increased Blood gases abnormal Blood lactic acid Blood pH increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram abdomen abnormal Computerised tomogram thorax abnormal Cough Diverticulum intestinal Dyspnoea Faecaloma

Symptomtext

Narrative: COVID infection following COVID vaccine series 08/12 Janssen, dose #1 08/28 SARS-COV-2 Variant Sequencing RESULT: pending 08/28 COVID swab, result: detected 08/28 pt cc: cough, dyspnea, exposure: unknown 08/28 pt admit to Medicine cc: dysspnea dx: COVID-19 complicated with multifocal pneumonia, acute hypoxemic respiratory failure LOS: 31 days discharged to SNF 08/28 FIBRINOGEN: 515 08/28 DDIMER: 0.94 08/12 CTA PE impression: mild motion, limiting detection of small pulmonary emboli particularly within the subsegmental pulmonary arteries. No evidence of pulmonary embolism identified. Areas of patchy groundglass opacities throughout bilateral lungs, nonspecific but consistent with Covid infection. No pleural effusion or pneumothorax. Few other findings as described above. 08/29 PROCALCITONIN 0.63 08/29 ESR 28 08/30 FIBRINOGEN: 469 08/30 DDIMER: 0.70 08/31 ESR results 14 08/31 FIBRINOGEN: 414 08/31 DDIMER: 0.66 09/01 ESR 44 09/01 FIBRINOGEN: 365 09/01 DDIMER: 0.73 09/01 CXR impression: Bilateral lung opacities, which may reflect the provided clinical history of COVID-19 pneumonia. Note that superimposed edema is difficult to exclude by radiography. Possible cardiomegaly. 09/02 ESR 33 09/02 FIBRINOGEN: 399 09/02 DDIMER: 0.83 09/03 FIBRINOGEN: 353 09/03 DDIMER: 0.98 09/03 ABG result: i-pH 7.47, i-PC02 38.6, i-P02 62, i-HCO3 28.3 09/03 TROPONIN I <0.016 09/03 LACTIC ACID 3.56 09/03 PROCALCITONIN <0.05 09/03 BNP 280.5 09/04 ESR 32 09/04 FIBRINOGEN: 331 09/04 DDIMER: 0.93 09/04 S.PNEUMONIAE AG Eval: result: NEGATIVE 09/04 LEGIONELLAAgUR Eval result: negative 9/07 US DOPPLER IMPRESSION: No evidence of DVT in the bilateral lower extremity. 09/08 ESR result: 19 09/08 FIBRINOGEN: 247 09/08 DDIMER: 1.15 09/15 DDIMER 0.73 09/16 DDIMER 0.56 09/17 DDIMER 0.51 09/18 DDIMER 0.49 09/19 CT ABD/PELVIS Impression: Interval consolidation of diffuse bilateral alveolar disease likely related to stated history of COVID-19 pneumonia. * Moderate colonic stool burden with hyperdense stool throughout the distal colon; this is nonspecific and is likely related to ingestion, but can represent old blood products in the appropriate clinical context. Further evaluation with fecal stool test is suggested. * Indeterminate left lower pole exophytic renal mass; inherent hyperdensity raises possibility of hemorrhagic cyst, though further evaluation with MRI/CT adrenal protocol is recommended to exclude renal neoplasm. * Splenomegaly. * Diverticulosis without evidence of acute diverticulosis. * Nonobstructive bilateral nephrolithiasis versus renal vascular calcifications. 09/19 CT Chest W/O impression: * Interval consolidation of diffuse bilateral alveolar disease likely related to stated history of COVID-19 pneumonia. * Moderate colonic stool burden with hyperdense stool throughout the distal colon; this is nonspecific and is likely related to ingestion, but can represent old blood products in the appropriate clinical context. Further evaluation with fecal stool test is suggested. * Indeterminate left lower pole exophytic renal mass; inherent hyperdensity raises possibility of hemorrhagic cyst, though further evaluation with MRI/CT adrenal protocol is recommended to exclude renal neoplasm. * Splenomegaly. * Diverticulosis without evidence of acute diverticulosis. * Nonobstructive bilateral nephrolithiasis versus real vascular calcifications. 09/23 RETICULOCYTES: 146.3 09/23 RETICULOCYTES: 5.50 09/23 RWT-He: 26.2 09/23 IRF: 22.1 09/23 clinically resolved 09/26 CVR impression: Multifocal opacities unchanged. 09/29 COVID swab, result: detected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 08/28 SARS-COV-2 Variant Sequencing RESULT: pending 08/28 COVID swab, result: detected 08/28 FIBRINOGEN: 515 08/28 DDIMER: 0.94 08/12 CTA PE impression: mild motion, limiting detection of small pulmonary emboli particularly within the subsegmental pulmonary arteries. No evidence of pulmonary embolism identified. Areas of patchy groundglass opacities throughout bilateral lungs, nonspecific but consistent with Covid infection. No pleural effusion or pneumothorax. Few other findings as described above. 08/29 PROCALCITONIN 0.63 08/29 ESR 28 08/30 FIBRINOGEN: 469 08/30 DDIMER: 0.70 08/31 ESR results 14 08/31 FIBRINOGEN: 414 08/31 DDIMER: 0.66 09/01 ESR 44 09/01 FIBRINOGEN: 365 09/01 DDIMER: 0.73 09/01 CXR impression: Bilateral lung opacities, which may reflect the provided clinical history of COVID-19 pneumonia. Note that superimposed edema is difficult to exclude by radiography. Possible cardiomegaly. 09/02 ESR 33 09/02 FIBRINOGEN: 399 09/02 DDIMER: 0.83 09/03 FIBRINOGEN: 353 09/03 DDIMER: 0.98 09/03 ABG result: i-pH 7.47, i-PC02 38.6, i-P02 62, i-HCO3 28.3 09/03 TROPONIN I <0.016 09/03 LACTIC ACID 3.56 09/03 PROCALCITONIN <0.05 09/03 BNP 280.5 09/04 ESR 32 09/04 FIBRINOGEN: 331 09/04 DDIMER: 0.93 09/04 S.PNEUMONIAE AG Eval: result: NEGATIVE 09/04 LEGIONELLAAgUR Eval result: negative 9/07 US DOPPLER IMPRESSION: No evidence of DVT in the bilateral lower extremity. 09/08 ESR result: 19 09/08 FIBRINOGEN: 247 09/08 DDIMER: 1.15 09/15 DDIMER 0.73 09/16 DDIMER 0.56 09/17 DDIMER 0.51 09/18 DDIMER 0.49 09/19 CT ABD/PELVIS Impression: Interval consolidation of diffuse bilateral alveolar disease likely related to stated history of COVID-19 pneumonia. * Moderate colonic stool burden with hyperdense stool throughout the distal colon; this is nonspecific and is likely related to ingestion, but can represent old blood products in the appropriate clinical context. Further evaluation with fecal stool test is suggested. * Indeterminate left lower pole exophytic renal mass; inherent hyperdensity raises possibility of hemorrhagic cyst, though further evaluation with MRI/CT adrenal protocol is recommended to exclude renal neoplasm. * Splenomegaly. * Diverticulosis without evidence of acute diverticulosis. * Nonobstructive bilateral nephrolithiasis versus renal vascular calcifications. 09/19 CT Chest W/O impression: * Interval consolidation of diffuse bilateral alveolar disease likely related to stated history of COVID-19 pneumonia. * Moderate colonic stool burden with hyperdense stool throughout the distal colon; this is nonspecific and is likely related to ingestion, but can represent old blood products in the appropriate clinical context. Further evaluation with fecal stool test is suggested. * Indeterminate left lower pole exophytic renal mass; inherent hyperdensity raises possibility of hemorrhagic cyst, though further evaluation with MRI/CT adrenal protocol is recommended to exclude renal neoplasm. * Splenomegaly. * Diverticulosis without evidence of acute diverticulosis. * Nonobstructive bilateral nephrolithiasis versus real vascular calcifications. 09/23 RETICULOCYTES: 146.3 09/23 RETICULOCYTES: 5.50 09/23 RWT-He: 26.2 09/23 IRF: 22.1 09/23 clinically resolved 09/26 CVR impression: Multifocal opacities unchanged. 09/29 COVID swab, result: detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601565

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 16.02.2021
Beginn: 28.08.2021
Tage bis Beginn: 193,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute respiratory distress syndrome Adenovirus test Angiogram pulmonary abnormal Blood bicarbonate increased Blood fibrinogen increased Blood gases abnormal Blood lactic acid Blood pH decreased Blood pH increased C-reactive protein COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Chest pain Computerised tomogram abdomen abnormal Death

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/25, Pfizer, dose #1 02/16, Pfizer, dose #2 08/28 COVID swab, result: detected 08/28 CXR impression: Findings most compatible with multifocal-Covid pneumonia given the patient's history. 08/28 pt cc: headache, abdominal pain, diarrhea, chest pain exposure: unknown 08/28 SARS-COV-2 Variant Sequencing result: pending 08/28 ESR 16 08/28 TROPONIN I 0.023 08/28 PROCALCITONIN 0.06 08/28 CT ABD & PELVIS Impression: No acute finding in the abdomen and pelvis. 2. Patchy groundglass and reticular opacities in the visualized lung bases with peripheral predominance. Differential considerations include multifocal infection, including Covid infection. 08/28 PT/INR result: 14.2/1.27 09/01 FIBRINOGEN: 528 09/01 DDIMER: 0.84 09/01 ESR 8 09/01 CTA PE IMPRESSION: Negative study for pulmonary embolism. 2. Diffuse, patchy and confluent regions of bilateral lung opacification, most severely involving the upper lobes. In a patient with a history of positive COVID-19 infection findings are consistent with evolving COVID-19 pneumonia. 09/02 ESR 9 09/02 FIBRINOGEN: 449 09/02 DDIMER: 0.94 09/03 ESR 2 09/08 FIBRINOGEN: 281 09/08 DDIMER: 6.83 09/08 ESR 7 09/09 FIBRINOGEN: 300 09/09 DDIMER: 5.67 09/09 ESR 4 09/09 ABG result: i-pH 7.52, i-PC02 31.4, i-P02 73, I-HCO3 25.9 09/10 FIBRINOGEN: 331 09/10 DDIMER: 2.31 09/10 ESR 10 09/11 ESR 12 09/11 PROCALCITONIN <0.05 09/11 FIBRINOGEN 342 09/11 DDIMER 1.54 09/12 ESR 23 09/12 FERRITIN 582.1 09/12 CRP 4.674 09/13 ESR 29 09/13 FIBRINOGEN 469 09/13 FERRITIN 865.0 09/13 CXR impression: Similar appearance of a typical pneumonia/ARDS. 2. Similar mild cardiomegaly. 09/13 CRP 5.861 09/13 DDIMER 1.06 09/14 FIBRINOGEN: 645 09/14 DDIMER: 0.910 09/14 ESR 27 09/15 ABG result: i-pH 7.54, i-PC02 32.3, i-P02 44, i-HCO3 27.7 09/15 ESR result: 22 09/15 FIBRINOGEN result: 391 09/15 DDIMER result: 1.30 09/15 TROPONIN I result: 0.045 09/15 ABG result: i-pH 7.33, i-PC02 57.3, i-P02 67, i-HCO3 30.3 09/15 ABG result: i-pH 7.45, i-PC02 43.5, i-P02 57, i-HCO3 29.9 09/16 FIBRINOGEN: 515 09/16 DDIMER: 1.14 09/16 ESR 34 09/16 ABG result: i-pH 7.20 i-PC02 84.4, i-P02 77, i-HCO3 32.9 09/16 PNEUMOCYSTIS JIROVECHI result: NOT DETECTED 09/16 VIRAL RESP: RESULT Negative for Influenza virus, types A and B, Parainfluenza viruses 1,2 # 3, Adenovirus, and Respiratory Syncytial virus. Reference range: Negative 09/18 FIBRINOGEN: 449 09/18 DDIMER: 1.83 09/18 ESR 35 09/18 ABG result: i-pH 7.42, i-PC02 55.0, i-P02 67, i-HCO3 35.7 09/19 FIBRINOGEN: 308 09/19 DDIMER: 5.49 09/19 ESR 9 09/19 ABG result: i-pH 7.37, i-PC02 59.6, i-P02 70, i-HCO3 34.2 09/20 FIBRINOGEN: 198 09/20 DDIMER: 14.48 09/20 ESR 4 09/20 ABG result: i-pH 7.34, i-PC02 68.4, i-P02 66, i-HCO3 37.3 09/20 ABG result: i-pH 7.22, i-PC02 96.5, i-P02 79, i-HCO3 39.8 09/20 CXR impression: No significant interval change. 09/21 FIBRINOGEN: 160 09/21 DDIMER: 14.96 09/21 ESR 4 09/21 ABG result: i-pH 7.36, i-PC02 63.7, i-P02 5, i-HCO3 36.3 09/21 CXR impression: No significant interval change. 09/22 FIBRINOGEN: 145 09/22 CXR impression: No significant change. 09/22DDIMER: 3.72 09/22 ESR 1 09/22 ABG result: i-pH 7.40, i-PC02 61.5, i-P02 73, i-HCO3 37.8 09/22 abdomen US impression: Nonobstructive bowel gas pattern. 09/23 ABG result: i-pH 7.31, i-PC02 72.9, i-P02 76, i-HCO3 36.6 09/23 FIBRINOGEN: 149 09/23 DDIMER: 4.03 09/23 ESR 2 09/23 LACTIC ACID result: 1.86 09/24 ESR result: 5 09/24 ABG result: i-pH 7.33, i-PC02 69.5, i-P02 58, i-HCO3 35.4 09/24 ABG result: i-pH 7.30, i-PC02 81.9, i-P02 48, i-HCO3 40.2 09/24 CXR impression: Stable chest radiography since 2 days ago as above. 09/24 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 08/28 COVID swab, result: detected 08/28 CXR impression: Findings most compatible with multifocal-Covid pneumonia given the patient's history. 08/28 SARS-COV-2 Variant Sequencing result: pending 08/28 ESR 16 08/28 TROPONIN I 0.023 08/28 PROCALCITONIN 0.06 08/28 CT ABD & PELVIS Impression: No acute finding in the abdomen and pelvis. 2. Patchy groundglass and reticular opacities in the visualized lung bases with peripheral predominance. Differential considerations include multifocal infection, including Covid infection. 08/28 PT/INR result: 14.2/1.27 09/01 FIBRINOGEN: 528 09/01 DDIMER: 0.84 09/01 ESR 8 09/01 CTA PE IMPRESSION: Negative study for pulmonary embolism. 2. Diffuse, patchy and confluent regions of bilateral lung opacification, most severely involving the upper lobes. In a patient with a history of positive COVID-19 infection findings are consistent with evolving COVID-19 pneumonia. 09/02 ESR 9 09/02 FIBRINOGEN: 449 09/02 DDIMER: 0.94 09/03 ESR 2 09/08 FIBRINOGEN: 281 09/08 DDIMER: 6.83 09/08 ESR 7 09/09 FIBRINOGEN: 300 09/09 DDIMER: 5.67 09/09 ESR 4 09/09 ABG result: i-pH 7.52, i-PC02 31.4, i-P02 73, I-HCO3 25.9 09/10 FIBRINOGEN: 331 09/10 DDIMER: 2.31 09/10 ESR 10 09/11 ESR 12 09/11 PROCALCITONIN <0.05 09/11 FIBRINOGEN 342 09/11 DDIMER 1.54 09/12 ESR 23 09/12 FERRITIN 582.1 09/12 CRP 4.674 09/13 ESR 29 09/13 FIBRINOGEN 469 09/13 FERRITIN 865.0 09/13 CXR impression: Similar appearance of a typical pneumonia/ARDS. 2. Similar mild cardiomegaly. 09/13 CRP 5.861 09/13 DDIMER 1.06 09/14 FIBRINOGEN: 645 09/14 DDIMER: 0.910 09/14 ESR 27 09/15 ABG result: i-pH 7.54, i-PC02 32.3, i-P02 44, i-HCO3 27.7 09/15 ESR result: 22 09/15 FIBRINOGEN result: 391 09/15 DDIMER result: 1.30 09/15 TROPONIN I result: 0.045 09/15 ABG result: i-pH 7.33, i-PC02 57.3, i-P02 67, i-HCO3 30.3 09/15 ABG result: i-pH 7.45, i-PC02 43.5, i-P02 57, i-HCO3 29.9 09/16 FIBRINOGEN: 515 09/16 DDIMER: 1.14 09/16 ESR 34 09/16 ABG result: i-pH 7.20 i-PC02 84.4, i-P02 77, i-HCO3 32.9 09/16 PNEUMOCYSTIS JIROVECHI result: NOT DETECTED 09/16 VIRAL RESP: RESULT Negative for Influenza virus, types A and B, Parainfluenza viruses 1,2 # 3, Adenovirus, and Respiratory Syncytial virus. Reference range: Negative 09/18 FIBRINOGEN: 449 09/18 DDIMER: 1.83 09/18 ESR 35 09/18 ABG result: i-pH 7.42, i-PC02 55.0, i-P02 67, i-HCO3 35.7 09/19 FIBRINOGEN: 308 09/19 DDIMER: 5.49 09/19 ESR 9 09/19 ABG result: i-pH 7.37, i-PC02 59.6, i-P02 70, i-HCO3 34.2 09/20 FIBRINOGEN: 198 09/20 DDIMER: 14.48 09/20 ESR 4 09/20 ABG result: i-pH 7.34, i-PC02 68.4, i-P02 66, i-HCO3 37.3 09/20 ABG result: i-pH 7.22, i-PC02 96.5, i-P02 79, i-HCO3 39.8 09/20 CXR impression: No significant interval change. 09/21 FIBRINOGEN: 160 09/21 DDIMER: 14.96 09/21 ESR 4 09/21 ABG result: i-pH 7.36, i-PC02 63.7, i-P02 5, i-HCO3 36.3 09/21 CXR impression: No significant interval change. 09/22 FIBRINOGEN: 145 09/22 CXR impression: No significant change. 09/22DDIMER: 3.72 09/22 ESR 1 09/22 ABG result: i-pH 7.40, i-PC02 61.5, i-P02 73, i-HCO3 37.8 09/22 abdomen US impression: Nonobstructive bowel gas pattern. 09/23 ABG result: i-pH 7.31, i-PC02 72.9, i-P02 76, i-HCO3 36.6 09/23 FIBRINOGEN: 149 09/23 DDIMER: 4.03 09/23 ESR 2 09/23 LACTIC ACID result: 1.86 09/24 ESR result: 5 09/24 ABG result: i-pH 7.33, i-PC02 69.5, i-P02 58, i-HCO3 35.4 09/24 ABG result: i-pH 7.30, i-PC02 81.9, i-P02 48, i-HCO3 40.2 09/24 CXR impression: Stable chest radiography since 2 days ago as above. 09/24 pt deceased
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601555

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 23.02.2021
Beginn: 03.10.2021
Tage bis Beginn: 222,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Dementia Failure to thrive Respiratory arrest

Symptomtext

Narrative: 84yo pt died during inpatient hospice. Death was caused by: Respiratory arrest secondary to failure to thrive to end-stage dementia per MD deah note. Pt had received covid vaccines in unknown location (not agency) on 2/2/21 & 2/23/21. Likely his death is not related given patient's advanced age, comorbidities, and long length of time between date of vaccines and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599948

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 31.03.2021
Beginn: 02.10.2021
Tage bis Beginn: 185,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Condition aggravated Death Hepatic cancer Renal failure

Symptomtext

Narrative: 65yo died at home on 10/2/2021 after non-agency hospital discharge for failing kidneys. Pt also had active liver cancer. See extensive problem list below. Problem list: CVA Hyperthyroidism CHF Hepatocellular carcinoma with mets to spine, bone, lung Arteriosclerosis aorta Insomnia Splenomegaly Left Ventricular Hypertrophy Tricuspid Valve Regurgitation Left Atrio Enlargement Mitral Valve Regurgitation Diabetic Retinopathy Dilatation of Aorta Hemorrhoid Aortoiliac atherosclerosis Diabetes, on insulin Panniculitis Heart Murmur Sleep Apnea GERD OA Constipation Hypertension Anemia Impairment Hyperlipidemia Cataracts Pt had received covid vaccinations from pharmacy store on 3/3/21 & 3/31/21. Likely this death is not related given patient's age, comorbidities, and long length of time between date of vaccines and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2596734

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 27.01.2021
Beginn: 25.05.2021
Tage bis Beginn: 118,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 93yo male blind living in healthcare facility with h/o CHF, COPD, h/o PE, h/o DVT, Glaucoma, Macular degeneration, BPH, CAD, HTN, s/p myocardial infarct, HLD, degenerative lumbar disc. died on 5/25/2021. Pt had received covid vaccines on 1/6/21 and 1/27/21 from pharmacy. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595908

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 18.02.2021
Beginn: 03.09.2021
Tage bis Beginn: 197,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaemia Atrial fibrillation Death Hyperlipidaemia Malnutrition Pulmonary mass

Symptomtext

Narrative: 87yo male with h/o prostate cancer and new pulmonary nodules, AFib, malnutrition, anemia & HLD died on 9/3/2021. Pt had received covid vaccines on 2/8/21 & 2/18/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595895

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 18.03.2021
Beginn: 15.09.2021
Tage bis Beginn: 181,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 71yo male with - COPD, hx of lung CA, s/p R. total pneumectomy, OSA - Dysphagia, hx squamous cell CA of soft neck tissues - Asymptomatic carotid artery stenosis, HLD, BLE edema - GERD, Osteoporosis, Vit D deficiency - BPH, bladder CA, anemia, weight loss, B12 deficiency - Cataracts s/p PHACO died at hospital on 9/15/2021. Pt had received covid vaccines on 2/18/21 & 3/18/21 from his local county health dept.. Likely death not related to covid vaccines given pt's age, existing medical problems & length of time between death and date of vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595894

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 04.04.2021
Beginn: 16.08.2021
Tage bis Beginn: 134,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Blood fibrinogen increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Diarrhoea Fibrin D dimer Headache Lung infiltration Lung opacity Malaise Myalgia Oxygen saturation decreased Paratracheal lymphadenopathy Pyrexia

Symptomtext

Narrative: COVID infection following COVID vaccine series 04/04 Janssen, dose #1 private sector, non-agency 08/16 pt cc: cough, headache, myalgias, fever,diarrhea exposure: unknown 08/18 COVID swab, result: detected 08/19 - 09/05 pt symptoms continue 08/25 cc: low oxygen levelc, dx:Acute hypoxic respiratory failure due to Covid 19 Pneumonia LOS: 7 days 08/25 CRP result: 21.583 08/26 Ferritin result: 876.2 08/25 ddimer result: 0.74 08/25 SARS-COV-2 IGG result 0:05 8/25 SARS-CoV-2 AB, spike result: >25.00 08/25 CXR impression: Moderate bilateral perihilar and peripheral infiltrates suspicious for infection. Covid pneumonia can have this appearance. Recommend clinical correlation. 08/26 FIBRINOGEN result: 480 08/26 DDIMER result: 1.16 08/26 ESR result: 97 08/26 CTA PE impression: No obvious pulmonary embolus. 2. Extensive bilateral changes of COVID 19 pneumonia, involving all pulmonary lobes. 3. Right lower paratracheal adenopathy is potentially reactive. 08/27 SARS-COV-2 IGG result 0.06 08/27 FIBRINOGEN result: 378 08/27DDIMER result: 1.23 08/27 ESR result: 92 08/28 FIBRINOGEN result: 378 08/28 DDIMER result: 1.40 08/28 ESR result: 93 H 08/28 SARS-COV-2 TOTAL AB, SPIKE SEMI QN result: >2500.0 H 08/28 DDIMER result: 1.52 08/29 CTA PE impression: 1. No definite evidence for pulmonary embolus.2. Similar bilateral groundglass opacities, consistent with COVID pneumonia. 08/30 DDIMER result: 2.27 H 08/31FIBRINOGEN result: 347 08/31 DDIMER result: 1.60 08/31 ESR result: 33 H 09/01 FIBRINOGEN result: 312 09/01 DDIMER result: 1.49 09/01 ESR 48 h 09/6 clinically resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 08/18 COVID swab, result: detected 08/19 - 09/05 pt symptoms continue 08/25 CRP result: 21.583 08/26 Ferritin result: 876.2 08/25 ddimer result: 0.74 08/25 SARS-COV-2 IGG result 0:05 8/25 SARS-CoV-2 AB, spike result: >25.00 08/25 CXR impression: Moderate bilateral perihilar and peripheral infiltrates suspicious for infection. Covid pneumonia can have this appearance. Recommend clinical correlation. 08/26 FIBRINOGEN result: 480 08/26 DDIMER result: 1.16 08/26 ESR result: 97 08/26 CTA PE impression: No obvious pulmonary embolus. 2. Extensive bilateral changes of COVID 19 pneumonia, involving all pulmonary lobes. 3. Right lower paratracheal adenopathy is potentially reactive. 08/27 SARS-COV-2 IGG result 0.06 08/27 FIBRINOGEN result: 378 08/27DDIMER result: 1.23 08/27 ESR result: 92 08/28 FIBRINOGEN result: 378 08/28 DDIMER result: 1.40 08/28 ESR result: 93 H 08/28 SARS-COV-2 TOTAL AB, SPIKE SEMI QN result: >2500.0 H 08/28 DDIMER result: 1.52 08/29 CTA PE impression: 1. No definite evidence for pulmonary embolus.2. Similar bilateral groundglass opacities, consistent with COVID pneumonia. 08/30 DDIMER result: 2.27 H 08/31FIBRINOGEN result: 347 08/31 DDIMER result: 1.60 08/31 ESR result: 33 H 09/01 FIBRINOGEN result: 312 09/01 DDIMER result: 1.49 09/01 ESR 48 h
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595892

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 30.03.2021
Beginn: 15.09.2021
Tage bis Beginn: 169,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 75 yo with PROBLEM LIST: Glaucoma Hypertension Hyperlipidemia Diabetes Type II with neuropathy Tobacco use/smoker COPD Neoplasm of uncertain behavior of adrenal gland H/O prostate cancer died on 9/15/2021. pt received most of his care outside agency so little information available of circumstances of pt death. Pt receive one covid vaccine (J&J) on 3/30/21 from outside agency. Likely this death is not related to the covid vaccine given pt's age, comorbidities & long time span between date of death & covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595880

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 103,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 19.04.2021
Beginn: 15.09.2021
Tage bis Beginn: 149,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Death Decreased appetite

Symptomtext

Narrative: 103yo male died at his assisted living facility after having a stroke. Pt's son reported that his father was at an ALF and had a stroke a week ago and wasn't eating. "He just dies of old age. He was 103 years old." Pt had received covid vaccines from same facility on 2/20/2021 & 4/19/2021. This death likely is not related to covid vaccines given pt's advanced age & stroke listed as cause of death. ALso great time between date of vaccines and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1836785

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: TX
Alter: 85,0
Geschlecht: F
Eingang: 02.11.2021
Impfdatum: 02.02.2021
Beginn: 03.08.2021
Tage bis Beginn: 182,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Cough Death Mental status changes Pyrexia SARS-CoV-2 test positive

Symptomtext

Presents for AMS, cough, fever. +COVID PTA. Admit for acute hypoxic resp failure due to COVID pneumonia. Tx: Actemra, solumedrol, zinc,abx, increased O2 requirements; not a candidate for remdesivir. Made comfort care and expired on 8/7.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1836116

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NY
Alter: -
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: -
Beginn: 09.10.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Chest pain Death Headache Hyperhidrosis Limb discomfort Vomiting

Symptomtext

BACK WAS HURTING ON THE RIGHT SIDE; DEATH; CHEST PAIN; SWEATING; ARM TIGHTNESS (LEFT SIDE); HEADACHE; THROWING UP; This spontaneous report received from a consumer concerned a 53 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, expiry: Unknown, batch number: Unknown) dose was not reported, 1 total, administered at left arm on 24-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-OCT-2021, the patient experienced headache, chest pain, arm tightness (left side), sweating, throwing up. Patients back was hurting on the right side. On 21-OCT-2021, the patient died from unknown cause. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache, chest pain, arm tightness (left side), sweating, throwing up and back was hurting on the right side was not reported. This report was serious (Death).; Sender's Comments: V0- 20211061610-covid-19 vaccine ad26.cov2.s- Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 18.02.2021
Beginn: 20.08.2021
Tage bis Beginn: 183,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac disorder Chest pain Death Dyspnoea

Symptomtext

Narrative: 75yo male with the following problem list: PROBLEM LAST MOD PROVIDER HTN - Hypertension (SCT 38341003) (ICD-10-CM 08/13/2021 I10.) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 08/13/2021 Gout (SCT 90560007) (ICD-10-CM M10.9) 08/13/2021 Tobacco user (SCT 110483000) (ICD-10-CM Z72.0) 08/13/2021 Squamous cell carcinoma of tongue (SCT 08/13/2021 276952000) (ICD-10-CM C02.9) Aortic valve stenosis (SCT 60573004) (ICD-10-CM 08/13/2021 I35.0) History of aortic valvuloplasty (SCT 08/13/2021 119481000119105) (ICD-10-CM Z98.890) Hearing loss (SCT 15188001) (ICD-10-CM H91.90) 08/13/2021 Had not been under facility care until 7/2021 with new cardiac diagnosis. Pt had self presented to outside community emergency facility on 8/20/21 due to chest pain & difficulty breathing. Pt then died at this hospital on 8/20/21. Pt had received a covid vaccine on 2/18/2021 at a outside source. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600531

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 12.01.2021
Beginn: 06.08.2021
Tage bis Beginn: 206,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Aggression COVID-19 Confusional state Death SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 12/22, Pfizer, dose #1 (non-agency) 01/12, Pfizer, dose #2 (non-agency) 08/06 pt cc: unknown exposure: unknown 08/06 COVID swab, result: detected 08/06 pt admitted to medicine from non-agency Nursing home, pt is confused, combative 08/16 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599966

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 26.02.2021
Beginn: 25.09.2021
Tage bis Beginn: 211,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 70yo male pt died at home on 09/25/2021. See pt's problem list below. PROBLEM LAST MOD PROVIDER Obstructive sleep apnea of adult (SCT 03/27/2018 1101000119103) (ICD-10-CM G47.30) Atrial fibrillation (SCT 49436004) (ICD-10-CM 01/29/2018 I48.0) Cardiomyopathy (SCT 85898001) (ICD-10-CM I42.9) 11/28/2017 Osteoarthritis of knee (SCT 239873007) 07/14/2016 (ICD-10-CM M17.0) Benign hypertension (SCT 10725009) (ICD-10-CM 12/01/2015 I10.) Diabetes mellitus (SCT 73211009) (ICD-10-CM 12/01/2015 E11.9) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 12/01/2015 Chronic obstructive lung disease (SCT 13645005) 12/01/2015 (ICD-10-CM J44.9) Knee pain (SCT 30989003) (ICD-10-CM M25.569) 12/01/2015 Gout (SCT 90560007) (ICD-10-CM M10.9) 12/01/2015 Gastroesophageal reflux disease (SCT 235595009) 12/01/2015 (ICD-10-CM K21.9) Hyperuricemia (SCT 35885006) (ICD-10-CM E79.0) 12/01/2015 (ICD-9-CM 272.2); Mixed Hyperlipidemia 12/05/2012 (ICD-9-CM 600.20); Benign Localized Hyperplasia 12/15/2010 of Prostate without Urinary obstruction (ICD-9-CM 6 (ICD-9-CM 477.9); Allergic Rhinitis 01/14/2010 (ICD-9-CM 274.9); Gout * (ICD-9-CM 274.9) 09/04/2009 (ICD-9-CM 144.9); Malignant neoplasm of floor of 05/06/2009 mouth (ICD-9-CM 144.9) (ICD-9-CM 272.0); Hypercholesterolemia, Pure 02/12/2008 (ICD-9-CM 496.); COPD * (ICD-9-CM 496.) 01/08/2007 (ICD-9-CM 303.90); Alcohol Dependence * 06/22/2011 (ICD-9-CM 303.90/303.91) In remission (ICD-9-CM 719.46); Knee: arthralgia * (ICD-9-CM 12/17/2004 719.46) (ICD-9-CM 278.00; Obesity * (ICD-9-CM 278.00) 10/22/2003 (ICD-9-CM 530.81); ESOPHAGEAL REFLUX 03/03/2003 (ICD-9-CM 786.09); Sleep Apnea (ICD-9-CM 786.09) 05/23/2001 Family History of Malignant Neoplasm of 02/07/2013 Gastrointestinal Tract (ICD-9-CM V16.0) 1. Colonoscopy 11/07 - no adenomatous polyps 2. Scope 1/13- tics, hemorr., no polyps Diabetes Mellitus Type II or unspecified 05/09/2000 (ICD-9-CM 250.00) Essential Hypertension (ICD-9-CM 401.9) 03/14/2000 Tobacco Use Disorder (ICD-9-CM 305.1) 04/06/2007 In remission This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 24.02.2021
Beginn: 25.09.2021
Tage bis Beginn: 213,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 74yo male with widespread diffuse large B-Cell lymphoma and is followed by heme/onc died at home with home hospice care. Pt had received pfizer covid vaccines on 2/2/21 &2/24/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599962

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 18.03.2021
Beginn: 01.09.2021
Tage bis Beginn: 167,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood bicarbonate normal Blood fibrinogen normal Blood gases abnormal Blood pH increased Blood phosphorus COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Fibrin D dimer PCO2 increased PO2 decreased Pleural effusion Procalcitonin Red blood cell sedimentation rate normal SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 08/03 pt cc: exposure: unknown 09/01 COVID swab, result: detected 09/01 pt admit to medicine dx: COVID-19 pneumonia LOS: 15 days 09/01 CXR impression: Radiographically worsened COVID pneumonitis is suspected as above. Bilateral pleural effusions, RIGHT larger than LEFT. 09/07 ABG i-pH 7.50, i-PCO2 35, i-PO2 53, i-HCO3 27.5 09/08 CXR impression: Stable Covid pneumonia. 09/12 PO4 RESULT: 2.3 09/13 ESR result: 14 09/13 procalcitonin <0.05 09/14 FIBRINOGEN result: 200 L 09/14 DDIMER result: 2.500 H 09/14 CXR impression: No significant interval change. 09/14 ESR result: 8 09/16 pt decease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 09/01 COVID swab, result: detected 09/01 CXR impression: Radiographically worsened COVID pneumonitis is suspected as above. Bilateral pleural effusions, RIGHT larger than LEFT. 09/07 ABG i-pH 7.50, i-PCO2 35, i-PO2 53, i-HCO3 27.5 09/08 CXR impression: Stable Covid pneumonia. 09/12 PO4 RESULT: 2.3 09/13 ESR result: 14 09/13 procalcitonin <0.05 09/14 FIBRINOGEN result: 200 L 09/14 DDIMER result: 2.500 H 09/14 CXR impression: No significant interval change. 09/14 ESR result: 8 09/16 pt decease
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599915

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 97,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 14.01.2021
Beginn: 10.09.2021
Tage bis Beginn: 239,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 97yo male patient who does not receive care from agency died on 9/10/2021. No medical information in pt's chart except pt did receive one covid vaccine from pharmacy on 1/14/2021. Likely this death is not related given patient's advanced age, and length of time between date of vaccine and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599313

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 14.01.2021
Beginn: 14.09.2021
Tage bis Beginn: 243,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 80yo male pt residing in nursing home since 4/2021 died on 9/14/2021. No information given regarding pt's death. Likely death is not related to covid vaccine given on 1/14/2021 from outside agency given pt's advanced age & long time span between vaccine given date & date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1833491

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: OK
Alter: 51,0
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: 25.05.2021
Beginn: 03.08.2021
Tage bis Beginn: 70,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chest discomfort Computerised tomogram thorax abnormal Electrocardiogram abnormal Fatigue Fibrin D dimer increased Pulmonary embolism Sinus bradycardia

Symptomtext

Patient seen for knee pain, chest pressure and chronic fatigue. She eventually went to the emergency room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: EKG, blood work done on 10/26/2021. EKG indicated sinus bradycardia. D-Dimer was abnormal with a value of 2.84. Patient had CT of the chest done at the ER on 10/28/2021 showed "right greater than left segmental and subsegmental pulmonary emboli."
Aktuelle Erkrankungen: n/a
Vorgeschichte: History of blood clots, Ruen Y gastric bypass, bilateral mastectomy (breast cancer), Cholecystectomy, DM type II, HTN
Andere Medikamente: Trazadone Hcl 100 mg, Xanax 1 mg, Sertraline HCl 50 mg, Zolpidem Tartrate ER 12.5 mg, Omeprazole 20 mg, Cyanocobalamin 1000 mcg/mL
Allergien: PCN
Vorherige Impfungen: -

VAERS 2638112

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UNKNOWN

kritisch

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 31.10.2021
Impfdatum: 02.07.2021
Beginn: 03.08.2021
Tage bis Beginn: 32,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acquired diaphragmatic eventration Ageusia Anosmia Atelectasis Blood bicarbonate decreased Blood gases abnormal Blood pH normal COVID-19 Chest X-ray abnormal Death Dizziness Dyspnoea Gait disturbance International normalised ratio increased PCO2 decreased PO2 decreased Prothrombin time prolonged Rhinorrhoea

Symptomtext

Narrative: COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1831619

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge unknown

kritisch

Staat: IN
Alter: 74,0
Geschlecht: M
Eingang: 30.10.2021
Impfdatum: 13.10.2021
Beginn: 14.10.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac arrest Death Dyspnoea Dyspnoea exertional Fatigue Hyperventilation Oxygen saturation decreased Resuscitation

Symptomtext

After my husband got the flu shot, he went home and fell asleep and slept til bedtime, then got up and slept til 9:30 am. next day. When he got up, he had trouble getting his breath when he went up stairs or just going into the bathroom. Just the day before shot he was walking around fine breathing with no problem. I took him to license branch and lab and he had to do a lot of walking and it didn't bother him. The day after the flu shot, he said he must have iron poor tired blood because everything he did wore him out. He got the shot on Wednesday and this kept happening. He was fine if he was just sitting still. On Sunday night, when he got up to go to bed, he really couldn't get a good breath at all. He yelled help me and just barely got sit down. He had me call 911 and they came in with oxygen. They told him to slow down, he was hyperventilating. They made him walk to the stretcher outside and told me he would be okay. Then, I called the hospital to see if I could come see him and they said right away. When I got down there they said his heart stopped as soon as he got there and they tried CPR. They could not revive him and he passed away a little after midnight. This was a man whos oxygen normally ran around 98% and after the flu shot his oxygen was only running around 89-90% and dropped to 72 % right before ambulance got there. I'm not sure if they took oxygen off him or not because they asked me for a mask for him. That didn't make sense.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: acid reflux, rheumatoid arthritis, sinusitis, smoldering multiple myeloma, chronic renal impairment stage 3a., vertigo at times. No real illnesses one month prior. Had just been to 2 doctors who said was stable and didn't have to come back for a year.
Vorgeschichte: acid reflux, rheumatoid arthritis sinusitis, smoldering multiple myeloma, chronic renal impairment stage 3a
Andere Medikamente: lansoprazole - 30mg. daily, aspirin - 81 mg. daily, amlodipine - 10 mg. daily, Zyrtec - 10 mg. dailyalfuzosin HCL ER - 10 mg. daily, vitamin C - 1000 daily, vitamin b-12 - 1000 iu daily.
Allergien: Buspirone- generic only, Augmentin (Amoxicillin & Clavulanate Potassium tablets), Sulfasalazine - causes intestinal pain
Vorherige Impfungen: -

VAERS 1830681

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 30.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Injury

Symptomtext

DEATH; SEVERELY INJURED; This spontaneous report received from a consumer concerned multiple patients with unspecified age, gender, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. It was reported that on an unspecified date multiple patients had died and were severely injured as a direct result of vaccine. The cause of death was unknown. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severely injured was not reported. This report was serious (Death).; Sender's Comments: V0: 20211057445-covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1828804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MI
Alter: 87,0
Geschlecht: F
Eingang: 29.10.2021
Impfdatum: 13.05.2021
Beginn: 23.09.2021
Tage bis Beginn: 133,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Bedridden Blood creatinine increased Blood culture Blood urea increased Brain natriuretic peptide increased COVID-19 Cardiac disorder Cerebral small vessel ischaemic disease Computerised tomogram head abnormal Deep vein thrombosis Electrocardiogram QT prolonged Electrocardiogram ST segment normal Electrocardiogram T wave abnormal Fall Glomerular filtration rate decreased Hypoxia

Symptomtext

History of Present Illness: This is a 88y.o. female with PMH significant for dementia presents to ED as brought by her grandson and DPOA for c/o leg pain and fall. History is limited as pt has hx dementia, A&Ox1 at baseline. Pt denies SOB, chest pain or any acute pain at this time, denies nausea. Pt's grandson states he took pt from nursing home and brought to this facility as he was unsatisfied with her prior care. He confirms pt was being treated for PE and Covid infection. States that she is mostly bed ridden and he does carry her. family has been watching her more closely since her falling In the ED, pt was afebrile normotensive and hypoxic on room air with improvement on 2LNC. BUN 36, creatinine 1.18, GFR 48. BNP 165. Troponin 0.04. WBC 9.9. COVID detected. Blood cultures pending. EKG - ST rate 72 with normal ST and non-specific T waves with prolonged qTc interval. CT head - 1. No acute intracranial process. 2. Nonspecific white matter changes, likely secondary to chronic small vessel ischemic disease. CTA PE protocol - 1. Significant bilateral pulmonary emboli burden with suggestion of right heart strain. 2. Scattered patchy ground glass opacities which could be seen in atypical/viral infectious process. 3. Main pulmonary enlargement which may be secondary to #1 or commonly seen in pulmonary arterial hypertension. Bilateral lower extremity doppler - 1. Deep vein thrombosis of the left common femoral vein. 2. No evidence of deep vein thrombosis of the right lower extremity. In the ED, pt was given 500cc saline bolus, duoneb NMT and IV heparin was initiated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Dementia
Andere Medikamente: acetaminophen (TYLENOL) tablet 650 mg albuterol (PROVENTIL, VENTOLIN) (2.5 MG/3ML) 0.083% nebulizer solution 2.5 mg albuterol (PROVENTIL, VENTOLIN) (2.5 MG/3ML) 0.083% nebulizer solution 2.5 mg guaiFENesin (ROBITUSSIN) solution
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1823367

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via social media company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose were not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died from an unknown cause of death. It was unknown if an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211049949-covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1823361

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: PA
Alter: 61,0
Geschlecht: M
Eingang: 28.10.2021
Impfdatum: -
Beginn: 09.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Blood pressure measurement Hypertension Pulmonary embolism Syncope

Symptomtext

ATRIAL FIBRILLATION; MULTIPLE LARGE EMBOLISM IN BOTH LUNGS; SYNCOPE; BLOOD PRESSURE HAD BEEN UP; This spontaneous report received from a consumer via a company representative concerned a 62 year old, male. The patient's height, and weight were not reported. Patient had no known drug allergies and medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: 23-AUG-2021) dose was not reported, 1 total, administered on 14-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. In FEB-2021 primary medical doctor (PMD) noticed patient's blood pressure had been up, laboratory data (dates unspecified) included: Blood pressure (NR: not provided) slightly elevated and has been monitoring it since then. Patient had a follow up appointment with primary medical doctor on 24-AUG-2021. On the 25-AUG-2021 when patient was moving in the lawn noticed a bit short of breath. Patient had yet to begin taking low dose antihypertensive medication. Reporter and patient was taking routine walks multiple times a week without incident. On 09-SEP-2021 patient was unable to complete routine walk due to being severely short of breath. Later that same evening, patient passed out (syncope) and was taken to the local emergency room where was admitted and diagnosed with atrial fibrillation and multiple large embolism in both lungs. Patient was admitted on 09-SEP-2021 and discharged on 12-SEP-2021. Patient was hospitalized for 4 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from syncope on 09-SEP-2021, and had not recovered from multiple large embolism in both lungs, atrial fibrillation, and blood pressure had been up. This report was serious (Hospitalization Caused / Prolonged); Sender's Comments: V0: 20211049442-COVID-19 VACCINE AD26.COV2.S-multiple large embolism in both lungs, atrial fibrillation, syncope. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: Test Date: 202102; Test Name: Blood pressure; Result Unstructured Data: slightly elevated
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known drug allergies and medical history.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1823359

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 28.10.2021
Impfdatum: -
Beginn: 01.10.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Brain death Brain operation Cerebral infarction Death Laboratory test Syncope

Symptomtext

COLLAPSING; EMERGENCY BRAIN SURGERY; BRAIN DEAD; CEREBRAL INFARCTION; DEATH; This spontaneous report received from a consumer (news article) via a company representative concerned a 57 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included: heart valve surgery (33 years ago). The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown expiry: unknown) dose was not reported, 01 total, administered on 17-SEP-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch numbers. No concomitant medications were reported. On 06-OCT-2021 the patient was collapsed and rushed to a hospital. He was diagnosed with a cerebral infarction there and underwent emergency brain surgery, but was eventually declared brain dead. Number of days hospitalized and discharge information was not reported. It was unknown if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died from unknown cause of death on 10-OCT-2021, and the outcome of brain dead, collapsing, cerebral infarction and emergency brain surgery was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0 20211048955-COVID-19 VACCINE AD26.COV2.S-death, brain dead, cerebral infarction, collapsing, emergency brain surgery. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Brain death
Hospital-Tage: -
Labordaten: Test Date: 202110; Test Name: Laboratory test; Result Unstructured Data: cerebral infarction
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Heart valve operation
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1820408

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 27.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED DAYS AFTER THE SHOT; This spontaneous report received from a consumer via a company representative concerned a 35 year old male with unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was healthy and an Olympian. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported,1 total, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died days after the shot and the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211048841-Covid-19 vaccine ad26.cov2.s-Died days after the shot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was healthy and an Olympian.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1818333

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge UNKNOWN

kritisch

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 26.10.2021
Impfdatum: 20.04.2021
Beginn: 14.10.2021
Tage bis Beginn: 177,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Aspiration Asthenia COVID-19 Chest X-ray abnormal Computerised tomogram head normal Confusional state Dyspnoea Dysstasia Gait disturbance Hypoxia Infection Liver function test increased Mental status changes Pneumonitis aspiration Procalcitonin normal Pyrexia Respiratory tract congestion

Symptomtext

Hospitalized (10.14.21 - 10.21.21); COVID-19 positive (10.14.21); Fully Vaccinated Admission Date: 10/14/2021 Discharge Date: Oct 21, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Transaminitis Hypoxia Generalized weakness AMS (altered mental status) COVID-19 virus infection COVID-19 HOSPITAL COURSE: Patient is an 87-year-old male with past medical history of hypothyroidism, type 2 diabetes, chronic systolic heart failure status post pacemaker, history of CVA with residual left-sided weakness, wheelchair bound who presented to the hospital with COVID-19 infection. Patient was fully vaccinated. Patient was admitted to the hospital due to altered mental status and generalized weakness in the setting of a scope infection. Patient was not hypoxic but for a brief moment during admission. The patient was globally weak and had progressive difficulty ambulating at home until the 20th brought into the ER. In the ER he was found to have elevated LFTs, general weakness. Neurology was consulted who recommended CT of the head which was unremarkable aside from chronic changes. Chest x-ray was done which showed no cardiopulmonary disease. due to his LFT elevation of the liver ultrasound was performed which showed no evidence of portal vein thrombosis. Patient was a candidate for monoclonal antibody therapy which he received and tolerated well. For about 20 the patient had an aspiration event, became more confused, and had 1 fever. Chest x-ray showed aspiration pneumonitis, white blood cell count was normal, procalcitonin was normal. Patient recovered quickly, never required oxygen. Short of breath was consulted who recommended NPO while the patient was confused, this resolved and the patient was able to advance back to a general diet prior to discharge. patient was evaluated by Physical therapy and Occupational therapy who recommended subacute rehab given the patient's profound weakness in the setting of his recent infection. Patient was unable to stand without significant assistance. The patient's wife and daughter were insistent that the patient would do better at home and wanted to set up home health nursing and were adamant that they can't care for the patient better at home than at rehab. Patient's daughter was heavily involved in the patient's care, she was very concerned about specifically his thyroid medication and felt that missing a few doses of his thyroid medication contributed significantly to his acute decompensation in the hospital. Given has improvement in mental status, improvement in his vitals, he was afebrile, he was tolerating a general diet, and received adequate therapy for his COVID-19 infection the patient was considered stable for discharge home with home health care with the family support. I discussed with the daughter that the patient be brought back if caring for him at home becomes unsafe, overwhelming, or cumbersome for the patient and her family. Patient and family were in agreement this plan discharge home in stable condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: 10.14.21: Seen in Urgent Care - weakness, congestion, fever, altered mental status;
Vorgeschichte: CVA (cerebral infarction) x 2 - Carotid arterial disease - R-70-90%, L- 50 % DM (diabetes mellitus) - Diet Controlled Pacemaker Hypercholesterolemia Bladder outflow obstruction - S/S Elevated PSA DDD (degenerative disc disease), lumbar Arthritis, lumbar spine PVC (premature ventricular contraction) Carotid stenosis Cardiomyopathy Mitral regurgitation Hypersomnia, organic Renal insufficiency Hypothyroidism due to medication Hypotension - Ace induced (Intolerant) Benign prostatic hyperplasia CAD in native artery Leg pain LBBB (left bundle branch block) Sigmoid volvulus Chronic combined systolic and diastolic heart failure AMS (altered mental status)
Andere Medikamente: amiodarone (PACERONE) 200 MG tablet aspirin 81 MG tablet atorvastatin (LIPITOR) 10 MG tablet B Complex Vitamins (VITAMIN-B COMPLEX PO) cholecalciferol (VITAMIN D3) 1000 units Coenzyme Q10 (COQ10) 100 MG CAPS cyanocobalamin (VITAMIN B-12) 10
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1810176

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 23.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative via social media concerned more than 88 patients of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patients received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and expiry date: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, it was reported that "88 +people have died from your fault vaccine!!!" It was unknown if an autopsy was performed or not. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211034004- COVID-19 VACCINE AD26.COV2.S- Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1736821

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: TN
Alter: 42,0
Geschlecht: F
Eingang: 23.10.2021
Impfdatum: -
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Anticoagulant therapy COVID-19 pneumonia Cardiac arrest Computerised tomogram thorax abnormal Death Dialysis Echocardiogram abnormal Computerised tomogram thorax Echocardiogram Endotracheal intubation Fungal test General physical health deterioration Haemofiltration Hypoxia Heart rate

Symptomtext

COVID-19 pneumonia; Acute respiratory failure; Acute respiratory distress syndrome; Acute kidney injury; Hypoxia; SUSPECTED CLINICAL VACCINATION FAILURE; Pulse absent; Death; Fungal test; Thrombosis; Ultrasound Doppler normal; Vascular catheterisation; Dialysis; Echocardiogram abnormal; Right ventricular dilatation; Anticoagulant therapy; Cardiac arrest; Endotracheal intubation; Haemofiltration; Computerised tomogram thorax abnormal; Mechanical ventilation; General physical health deterioration; This spontaneous report received from a health care professional via Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAERS ID 1736821), concerned a 42 year old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy, and obesity. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown) with frequency as 1 total, dose was not reported, administered on 26-AUG-2021 for an unspecified indication. The batch number was not reported. Per Procedure, no follow up will be requested for this case. No concomitant medications were reported. The patient recently admitted to outside hospital with COVID-19 pneumonia and associated complications including acute hypoxemic, respiratory failure, acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI). During the course of her hospitalization she was treated with Dexamethasone, Remdesivir, Tofacitinib, Plaquenil and Ivermectin. She required intubation (Endotracheal intubation) on 10-Sep-2021 and developed cardiac arrest after a prolonged period of hypoxia on 12-Sep-2021. She was transferred for higher level care and treatment with continuous renal replacement therapy (CRRT) (Haemofiltration). On 15-SEP-2021, she had a vascular catheter (Vascular catheterisation) placed, initiated dialysis that same night. She had an echocardiogram (Echocardiogram abnormal) on 15-SEP-2021 that most notably showed right ventricular (RV) was mildly dilated (Right ventricular dilatation) with moderately reduced function therefore she was started on therapeutic heparin (anticoagulant therapy) given the concern for possible pulmonary embolism (PE) in the setting of Covid. Laboratory data included: Echocardiogram (NR: not provided) abnormal. On 16-SEP-2021, Lower extremity Dopplers (Ultrasound Doppler normal) were negative for deep vein thrombosis (DVT) (Thrombosis). Laboratory data included: Ultrasound Doppler (NR: not provided) normal. On 17-SEP-2021, the patient underwent dialysis again. From a respiratory standpoint she was treated with flolan and has been continued on Zosyn and Zyvox since admission. She was started on Voriconazole on 17-SEP-2021 and fungal labs (fungal test) fungitel galactomannan blaso histo Ag were ordered for concern of possible underlying fungal infection. On an unspecified date, the patient experienced suspected clinical vaccination failure. Laboratory data included: Fungal test (NR: not provided) unknown. Computed tomography Pulmonary Embolus (CT PE) study (Computerised tomogram thorax abnormal) showed two right ventricular (RV) thrombus. Laboratory data included: Computerised tomogram thorax (NR: not provided) abnormal. Therapeutic heparin was changed to Argatroban to reduce fluid intake. Unfortunately, despite best efforts including maximizing ventilator settings and multiple rounds of hemodialysis (Mechanical ventilation) patient continued to decline without improvement (General physical health deterioration). After discussion with family on 22-SEP-202 decision was made to transition patient to comfort care but to keep her on the ventilator. On the morning of 23-SEP-2021 06:55, patient lost pulse (Pulse absent) and was pronounced dead due to an unknown cause. Laboratory data included: Pulse rate (NR: not provided) absent. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of covid-19 pneumonia, acute respiratory failure, acute respiratory distress syndrome, acute kidney injury, cardiac arrest, hypoxia, thrombosis, endotracheal intubation, haemofiltration, vascular catheterisation, dialysis, echocardiogram abnormal, right ventricular dilatation, anticoagulant therapy, ultrasound doppler normal, fungal test, computerised tomogram thorax abnormal, mechanical ventilation, general physical health deterioration and pulse absent on 23-SEP-2021 06:55, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Death, and Life Threatening). This report is associated with product quality compliant:90000197404. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. a manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 18-Oct-2021. The following information was updated and incorporated into the case narrative: Product quality complaint result was added.; Sender's Comments: V2: Additional information in this version updates: Product quality complaint result. This additional information does not alter the causality of the previously reported events. 20211017574-covid-19 vaccine ad26.cov2.s- Death, covid-19 pneumonia, acute respiratory failure, acute respiratory distress syndrome, acute kidney injury, cardiac arrest, hypoxia, thrombosis, endotracheal intubation, haemofiltration, vascular catheterisation, dialysis, echocardiogram abnormal, right ventricular dilatation, anticoagulant therapy, ultrasound doppler normal, fungal test, computerised tomogram thorax abnormal, mechanical ventilation, general physical health deterioration, pulse absent. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211017574-covid-19 vaccine ad26.cov2.s-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Test Date: 202109; Test Name: Computerised tomogram thorax; Result Unstructured Data: abnormal; Test Date: 20210915; Test Name: Echocardiogram; Result Unstructured Data: abnormal; Test Date: 20210916; Test Name: Ultrasound Doppler; Result Unstructured Data: normal; Test Date: 20210917; Test Name: Fungal test; Result Unstructured Data: unknown; Test Date: 202109230655; Test Name: Pulse rate; Result Unstructured Data: absent
Aktuelle Erkrankungen: Obesity; Penicillin allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1805973

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CA
Alter: 94,0
Geschlecht: F
Eingang: 21.10.2021
Impfdatum: 03.09.2021
Beginn: 04.09.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient died one day after receiving the Pfizer Booster at her skilled nursing home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Dementia, ASCVD, Low Vit D, Hypothyroid, OA, HTN, Depression, Thrombocytopenia
Vorgeschichte: Dementia, ASCVD, OA HTN, Hypothyroid
Andere Medikamente: Vit D, Synthroid, Hydrocodone/APAP,Depakote
Allergien: Macrobid
Vorherige Impfungen: -

VAERS 1804673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MA
Alter: 75,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 04.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 174,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Anticoagulant therapy Aspiration COVID-19 Chest X-ray abnormal Cough Culture positive Death Dizziness Dyspnoea Endotracheal intubation Endotracheal intubation complication Hepatic function abnormal Hypotension Intensive care Laryngeal oedema Lung infiltration

Symptomtext

Hospital Course: =========== Admission HPI =========== Patient first presented to the Hospital 8/25 for low blood pressures and lightheadedness for several days. He had exposure to non-vaccinated friends visiting the week prior and reports he and his wife developed a cough afterwards. Of note he received the COVID vaccine x2 in Feb/March. In the ED, he tested positive for COVID 8/25, CXR at the time with patchy R sided infiltrate. He was admitted to medicine floor. COVID treatment initially deferred as he was doing well without asx, initiated 8/26 with remdesivir and dexamethasone. Was not a tocilizumab candidate given that he was too far out. Convalescent plasma considered but not available. He was also treated for potential superimposed CAP given patchy airspace opacity on CXR in RLL with Ctx and azithro (8/26 - 8/29). Patient also had asx pyuria, felt to be adequately covered by CTX. Patient then began to have desats with increasing O2 requirement, eventually requiring ICU transfer 8/29 for HFNC. Patient endorsing pleuritic chest pain thus treated empirically for PE with heparin gtt, unable to transfer safely to CT-PE, though recent 8/28 CT-PE negative. LENIs negative for DVT. On 8/31 decision was made to intubate given worsening respiratory status.In the setting of intubation, patient was hypotensive with systolics down to 60s. He was started on levophed and antibiotics broadened to cefepime due to concern for shock. He was transferred to main campus. On arrival to the ICU, patient was intubated and sedated. ========================= MICU Hospital Course (8/31 - 10/6/2021) ========================= #Acute Hypoxemic Respiratory Failure 2/2 COVID-19 #ARDS Patient presented initially with hypotension and lightheadedness to Hospital, found to be COVID+ (PCR date 8/26) for which he has been initiated on a 5 day course of remdesivir and 10 day course of decadron. Then developed progressive O2 requirement, intubated for acute hypoxemic respiratory failure. Patient with bilateral opacities on CXR, clear injury within 1 week (COVID infection and ARDS). P/F ratio 135 at admission, consistent with moderate risk. He treated empirically for PNA with vanc (9/2 - 9/7) +cefepime (8/29 - 9/4) and broad infectious workup sent. Tracheal aspirate ultimately grew coag negative staff thus continued on vanc empirically and d/ced cefepime, ultimately repeat tracheal aspirate negative for growth thus vanc discontinued 9/7. For treatment of COVID, he ultimately was treated with additional 5 days of remdesivir (8/26-8/30, 9/1-9/5), complete 10 days of dexamethasone (8/26 - 9/4) and baricitinib 4mg (total 14 days). After multiple days of improved P:F ratio and tolerating pressure control then subsequently pressure support the patient was extubated on 9/13. At the time of extubation he was following commands and had positive cuff leak. However, shortly after extubation he was noted to have quite severe stridor that didn't resolve with racemic epinephrine or dexamethasone. He was ultimately re-intubated within the hour by anesthesia who noted edema/swelling of the glottic structures. Upon re-intubation he immediately tolerated SBT again and was ultimately extubated on 9/16 to high flow, which he tolerated with some subjective dyspnea. Unfortunately in the setting of likely aspiration event (rapid increase in O2 requirement, fever, HDUS) patient was re-intubated for a third time on 9/18 and treated with broad spectrum abx, paralysis, and proning with resolution of fevers and improved oxygenation. Given hx of immigration and rising covid cycle threshold (clearing virus effectively) w/ continued lung pathology ID recommended empiric treatment for strongiloides w/ ivermectin x2 doses + TB PCR which was ultimately negative. Unfortunately, despite initially improving, he continued to struggle when sedation or paralysis were weaned down producing vent dyssynchrony. Additionally, despite broad spectrum antibiosis he developed a worsening pressor requirement and third spacing resulting in broad edema with intravascular dryness. Liver and kidney function continued to deteriorate, and after long discussion with the family, the decision was made to transition to comfort care. HE was extubated on 10/6 and passed away peacefully at 2:46 PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 37,0
Labordaten: 8/25/21 - COVID PCR positive.
Aktuelle Erkrankungen: unk
Vorgeschichte: hypertension, second degree av block, gerd, paf, bph, bronchiectasis.
Andere Medikamente: acetaminophen, amlodipine, meloxicam, metoprolol, omeprazole, crestor, flomax.
Allergien: hctz, lisinopril, losartan, oxycodone,
Vorherige Impfungen: -

VAERS 1683324

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 21.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Activated partial thromboplastin time shortened Antibody test positive Anticoagulant therapy Blood fibrinogen decreased Brain death Cerebral haemorrhage Cerebral mass effect Death Blood lactate dehydrogenase normal Computerised tomogram head abnormal Craniotomy Cerebral venous sinus thrombosis Fibrin D dimer increased Haemoglobin normal Haemostasis Haptoglobin normal Decompressive craniectomy

Symptomtext

DEATH; This spontaneous report received from a consumer via social media concerned a 37 year old female with unspecified race and ethnicity The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry: UNKNOWN) dose and therapy start date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died from an unknown cause of death. It was unknown whether the autopsy was done. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211031299-COVID-19 VACCINE AD26.COV2.S-Death. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Brain death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1800232

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 20.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer via a company representative concerned a 35 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the consumer's lawyer's husband got the johnson and johnson shot and died days later. On 2021, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211033764- Covid-19 vaccine ad26.cov2.s-Death. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1797428

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a consumer (social media) via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown expiry: unknown) dose, start therapy date were not reported, frequency time 1 total for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the reporter stated that, "vaccine killed my brother". The patient died from an unknown cause of death. It was unknown if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died from unknown cause of death This report was serious (Death).; Sender's Comments: V0 20211031250-COVID-19 VACCINE AD26.COV2.S-death. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1229547

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: FL
Alter: 68,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: -
Beginn: 15.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Angina pectoris Angiogram Arteriogram coronary abnormal Atrial fibrillation Cardiac arrest Cardiogenic shock Cardioversion Catheterisation cardiac abnormal Condition aggravated Coronary angioplasty Coronary artery occlusion Coronary artery thrombosis Electrocardiogram Electrocardiogram ST segment elevation Endotracheal intubation Intensive care Platelet count decreased

Symptomtext

CORONARY ARTERY THROMBOSIS; THROMBOSIS; PLATELET COUNT DECREASED; ANGINA PECTORIS; ARTERIOGRAM CORONARY ABNORMAL; ATRIAL FIBRILLATION; CARDIAC ARREST; CARDIOVERSION; CATHETERISATION CARDIAC ABNORMAL; CONDITION AGGRAVATED; Coronary angioplasty; CORONARY ARTERY OCCLUSION; ELECTROCARDIOGRAM ST SEGMENT ELEVATION; ENDOTRACHEAL INTUBATION; INTENSIVE CARE; RESUSCITATION; THROMBECTOMY; VENTRICULAR ASSIST DEVICE INSERTION; VENTRICULAR FIBRILLATION; ACUTE MYOCARDIAL INFARCTION; CARDIOGENIC SHOCK; MECHANICAL VENTILATION; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (ID1229547, 1263503) concerned a 68 year old male. The patient's height, and weight were not reported. The patient's past medical history included CAD (Coronary artery disease), cardiomyopathy, LifeVest , AFIB (atrial fibrillation), and HTN (hypertension), and concurrent conditions included non-ST-segment elevation myocardial infarction (NSTEMI), DM (diabetes mellitus), and stage III CKD. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A expiry: unknown) dose was not reported, 1 total, administered on 05-APR-2021 to left arm for drug used for unknown indication. No concomitant medications were reported. On 15-APR-2021, 10 days after receiving the vaccine, the patient went to the emergency department with complaints of anginal symptoms found to be in rapid atrial fibrillation. An EKG showed ST elevation in later precordial leads (acute myocardial infarction) and the patient went for an emergent left heart catheterization. During the catherization he went ventricular fibrillation (V-fib) and Lung Specialist stated he was arrest sedated/intubated and placed on mechanical ventilation due to clinical condition requiring defibrillation twice. The patient was in cardiogenic shock. In addition to the cardiopulmonary resuscitation (CPR) in the catheter laboratory, the angiogram was abnormal and showed acute thrombotic occlusions of left main artery (LM), left anterior descending (LAD) and ramus intermedius (RI), thrombosis. The patient underwent mechanical thrombectomy of LM and LAD with balloon angiogram of RI (recent cardiac catheterization in March 2020 showed clearly patent stents). Placed on Impella bypass and intubated. The patient was hospitalizes for 12 days in the cardiovascular intensive care unit. Platelet count (NR: not provided) 272 (units unspecified). On 19-APR-2021 platelet count was 76 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from angina pectoris, arteriogram coronary abnormal, atrial fibrillation, cardiac arrest, cardioversion, catheterization cardiac abnormal, condition aggravated, coronary angioplasty, coronary artery occlusion, coronary artery thrombosis, electrocardiogram st segment elevation, endotracheal intubation, intensive care, platelet count decreased, resuscitation, thrombectomy, ventricular assist device insertion, ventricular fibrillation, acute myocardial infarction, thrombosis, cardiogenic shock and mechanical ventilation. This report was serious (Hospitalization Caused / Prolonged and Life Threatening). This case is a duplicate of 20210515208. Additional information was received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (ID 1229547, 1263503) on 13-OCT-2021. It was determined that [20210515208] was a duplicate of this case. All relevant information regarding this case will be submitted under [20210502221] The following information was updated and incorporated into the case narrative: (Hospitalization date and no of days hospitalized, Event - Acute myocardial infarction, Thrombosis, Cardiogenic shock, Mechanical ventilation, Batch number of added).; Sender's Comments: V1:Follow up information updates: No. of days hospitalized and hospitalization date, new events, batch number. This case obtained via VAERS (ID 1229547, 1263503) concerns a 68-year-old male of unknown race/ethnicity who was hospitalized for life-threatening acute thrombotic occlusions of the coronary arteries 10 days after receiving Janssen Covid-19 vaccine. Medical history is significant for coronary artery disease (CAD) with cardiomyopathy (CM), use of a LifeVest (wearable defibrillator), atrial fibrillation (AF), hypertension (HTN), diabetes (DM), stage III chronic kidney disease (CKD); cardiac catheterization 13 months prior (after non-ST elevation myocardial infarction) had shown patent coronary stents. Ten days post-vaccination, the patient presented to the emergency department (ED) with complaints of anginal symptoms and was found to be in rapid AF. EKG showed ST elevation in the precordial leads (Acute myocardial infarction). While in the cardiac catheterization lab, ventricular fibrillation with cardiac arrest requiring CPR and defibrillation twice occurred. He was in cardiogenic shock. Angiography showed acute thrombotic occlusions of the left main (LM), left anterior descending (LAD), and ramus intermedius (RI) coronary arteries; mechanical thrombectomy of LM & LAD with balloon angio of RI was performed. He was placed on Impella bypass. Platelet count on the day of admission was 272 and was 76 four days later. Corrective medicinal treatments, such as anticoagulation, was not reported. As of the time of the report, he was in the ICU and intubated with Impella. The patient's underlying CAD, CM, DM, HTN, CKD, & AF likely increased the risk for the events to occur. Of note, platelet count was normal at the time of presentation. However, considering the temporal relationship with vaccination (Brighton Collaboration Criteria level 1), a relationship with Janssen Covid-19 vaccine cannot be ruled out. Therefore, the relationship is considered indeterminate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 12,0
Labordaten: Test Date: 20210415; Test Name: EKG; Result Unstructured Data: ST elevation in precordial leads; Test Date: 20210415; Test Name: Angiography; Result Unstructured Data: Abnormal; Test Date: 20210415; Test Name: Platelet count; Result Unstructured Data: 272; Test Date: 20210419; Test Name: Platelet count; Result Unstructured Data: 76; Test Name: Arteriogram coronary abnormal; Result Unstructured Data: Abnormal; Test Name: Catheterisation cardiac abnormal; Result Unstructured Data: Abnormal
Aktuelle Erkrankungen: Non STEMI (with patent cardiac stents)
Vorgeschichte: Medical History/Concurrent Conditions: AFib; Cardiomyopathy; Chronic renal failure; Coronary artery disease; Diabetes mellitus; Hypertension; Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1229547

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: FL
Alter: 68,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: -
Beginn: 15.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Angina pectoris Angiogram Arteriogram coronary abnormal Atrial fibrillation Cardiac arrest Cardiogenic shock Cardioversion Catheterisation cardiac abnormal Condition aggravated Coronary angioplasty Coronary artery occlusion Coronary artery thrombosis Electrocardiogram Electrocardiogram ST segment elevation Endotracheal intubation Intensive care Platelet count decreased

Symptomtext

CORONARY ARTERY THROMBOSIS; THROMBOSIS; PLATELET COUNT DECREASED; ANGINA PECTORIS; ARTERIOGRAM CORONARY ABNORMAL; ATRIAL FIBRILLATION; CARDIAC ARREST; CARDIOVERSION; CATHETERISATION CARDIAC ABNORMAL; CONDITION AGGRAVATED; Coronary angioplasty; CORONARY ARTERY OCCLUSION; ELECTROCARDIOGRAM ST SEGMENT ELEVATION; ENDOTRACHEAL INTUBATION; INTENSIVE CARE; RESUSCITATION; THROMBECTOMY; VENTRICULAR ASSIST DEVICE INSERTION; VENTRICULAR FIBRILLATION; ACUTE MYOCARDIAL INFARCTION; CARDIOGENIC SHOCK; MECHANICAL VENTILATION; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (ID1229547, 1263503) concerned a 68 year old male. The patient's height, and weight were not reported. The patient's past medical history included CAD (Coronary artery disease), cardiomyopathy, LifeVest , AFIB (atrial fibrillation), and HTN (hypertension), and concurrent conditions included non-ST-segment elevation myocardial infarction (NSTEMI), DM (diabetes mellitus), and stage III CKD. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A expiry: unknown) dose was not reported, 1 total, administered on 05-APR-2021 to left arm for drug used for unknown indication. No concomitant medications were reported. On 15-APR-2021, 10 days after receiving the vaccine, the patient went to the emergency department with complaints of anginal symptoms found to be in rapid atrial fibrillation. An EKG showed ST elevation in later precordial leads (acute myocardial infarction) and the patient went for an emergent left heart catheterization. During the catherization he went ventricular fibrillation (V-fib) and Lung Specialist stated he was arrest sedated/intubated and placed on mechanical ventilation due to clinical condition requiring defibrillation twice. The patient was in cardiogenic shock. In addition to the cardiopulmonary resuscitation (CPR) in the catheter laboratory, the angiogram was abnormal and showed acute thrombotic occlusions of left main artery (LM), left anterior descending (LAD) and ramus intermedius (RI), thrombosis. The patient underwent mechanical thrombectomy of LM and LAD with balloon angiogram of RI (recent cardiac catheterization in March 2020 showed clearly patent stents). Placed on Impella bypass and intubated. The patient was hospitalizes for 12 days in the cardiovascular intensive care unit. Platelet count (NR: not provided) 272 (units unspecified). On 19-APR-2021 platelet count was 76 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from angina pectoris, arteriogram coronary abnormal, atrial fibrillation, cardiac arrest, cardioversion, catheterization cardiac abnormal, condition aggravated, coronary angioplasty, coronary artery occlusion, coronary artery thrombosis, electrocardiogram st segment elevation, endotracheal intubation, intensive care, platelet count decreased, resuscitation, thrombectomy, ventricular assist device insertion, ventricular fibrillation, acute myocardial infarction, thrombosis, cardiogenic shock and mechanical ventilation. This report was serious (Hospitalization Caused / Prolonged and Life Threatening). This case is a duplicate of 20210515208. Additional information was received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (ID 1229547, 1263503) on 13-OCT-2021. It was determined that [20210515208] was a duplicate of this case. All relevant information regarding this case will be submitted under [20210502221] The following information was updated and incorporated into the case narrative: (Hospitalization date and no of days hospitalized, Event - Acute myocardial infarction, Thrombosis, Cardiogenic shock, Mechanical ventilation, Batch number of added).; Sender's Comments: V1:Follow up information updates: No. of days hospitalized and hospitalization date, new events, batch number. This case obtained via VAERS (ID 1229547, 1263503) concerns a 68-year-old male of unknown race/ethnicity who was hospitalized for life-threatening acute thrombotic occlusions of the coronary arteries 10 days after receiving Janssen Covid-19 vaccine. Medical history is significant for coronary artery disease (CAD) with cardiomyopathy (CM), use of a LifeVest (wearable defibrillator), atrial fibrillation (AF), hypertension (HTN), diabetes (DM), stage III chronic kidney disease (CKD); cardiac catheterization 13 months prior (after non-ST elevation myocardial infarction) had shown patent coronary stents. Ten days post-vaccination, the patient presented to the emergency department (ED) with complaints of anginal symptoms and was found to be in rapid AF. EKG showed ST elevation in the precordial leads (Acute myocardial infarction). While in the cardiac catheterization lab, ventricular fibrillation with cardiac arrest requiring CPR and defibrillation twice occurred. He was in cardiogenic shock. Angiography showed acute thrombotic occlusions of the left main (LM), left anterior descending (LAD), and ramus intermedius (RI) coronary arteries; mechanical thrombectomy of LM & LAD with balloon angio of RI was performed. He was placed on Impella bypass. Platelet count on the day of admission was 272 and was 76 four days later. Corrective medicinal treatments, such as anticoagulation, was not reported. As of the time of the report, he was in the ICU and intubated with Impella. The patient's underlying CAD, CM, DM, HTN, CKD, & AF likely increased the risk for the events to occur. Of note, platelet count was normal at the time of presentation. However, considering the temporal relationship with vaccination (Brighton Collaboration Criteria level 1), a relationship with Janssen Covid-19 vaccine cannot be ruled out. Therefore, the relationship is considered indeterminate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 12,0
Labordaten: Test Date: 20210415; Test Name: EKG; Result Unstructured Data: ST elevation in precordial leads; Test Date: 20210415; Test Name: Angiography; Result Unstructured Data: Abnormal; Test Date: 20210415; Test Name: Platelet count; Result Unstructured Data: 272; Test Date: 20210419; Test Name: Platelet count; Result Unstructured Data: 76; Test Name: Arteriogram coronary abnormal; Result Unstructured Data: Abnormal; Test Name: Catheterisation cardiac abnormal; Result Unstructured Data: Abnormal
Aktuelle Erkrankungen: Non STEMI (with patent cardiac stents)
Vorgeschichte: Medical History/Concurrent Conditions: AFib; Cardiomyopathy; Chronic renal failure; Coronary artery disease; Diabetes mellitus; Hypertension; Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1795462

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: WI
Alter: 88,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 15.09.2021
Beginn: 21.09.2021
Tage bis Beginn: 6,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Cough Dyspnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

Admitted to hospital 9/21/2021 with cough, fever, SOB, acute hypoxemic respiratory failure. Placed on oxygen, plan for Remdesivir, Solumedrol, cefepime or azithromycin. Client vaccinated for Covid - Pfizer 2/10/2021, 3/3/2021 and booster 9/15/2021. Flu vaccine reportedly also given 9/15/2021. Submitter does not have access to information on further hospital course, discharge date, or outcomes. If further information is needed, please contact admitting hospital:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 9/21/2021 - Covid-19 positive by PCR
Aktuelle Erkrankungen: unknown
Vorgeschichte: COPD - asbestosis, basal cell and squamous cell carcinoma, CKD, HTN
Andere Medikamente: unknown
Allergien: ace inhibitors - hyperkalemia amlodipine - ankle swelling sulfa antibiotics - rash
Vorherige Impfungen: -

VAERS 1794956

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 10.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Alanine aminotransferase increased Angiogram pulmonary abnormal Anticoagulant therapy Aspartate aminotransferase increased Aspergillus test negative Blood beta-D-glucan negative Blood bilirubin normal Blood lactic acid normal Brachiocephalic vein thrombosis C-reactive protein abnormal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest tube insertion Condition aggravated Cough

Symptomtext

Hospitalized 09/21/2021; COVID-19 positive 09/17/2021; fully vaccinated Admission note 09/21/2021: ASSESSMENT Principal Problem: Pneumonia due to COVID-19 virus Pertinent Results: - CT angio thorax Showed 1. Negative for pulmonary embolism. 2. Redemonstration of chronic bilateral pulmonary infiltrates which have pattern that can be seen in the setting of Wegener's granulomatosis. Patient on 6 L nasal cannula without respiratory distress. Procalcitonin elevated at 0.33 Normal white blood cell count Normal lactic acid Mildly elevated AST and ALT; normal bili. Plan: continue close monitoring and continuous pulse ox; wean oxygen as tolerated to maintain saturations greater than 92%. continue Decadron for total of 10 days. continue remdesivir x5 days. low threshold to consider coverage for bacterial pneumonia patient worsens clinically or develops productive cough; patient states that his current cough is dry and nonproductive. consider benefit pulm consult tomorrow if patient worsens clinically requires more oxygen support dresser given history of granulomatosis with polyangiitis trend COVID inflammatory labs including a complete blood count, CRP, D-dimer also trend AST and ALT with repeat CMP tomorrow morning Note from 09/25/2021: Acute hypoxic respiratory failure - stable COVID pneumonia COVID positive 9/17 w/ symptom onset around 9/10. CT angio thorax consistent with COVID w/ also chronic pulmonary infiltrates seen with GPA, negative for PE. Worsening respiratory status since admission requiring BiPAP and transfer to ICU on 9/22. Now remains stable on HFNC with slightly decreased oxygen reuirements. -steroids increased to 20 mg for 5 days, then 10 mg for 5 days - 3 days of azithromycin complete, Day 3/5 of CTX -CRP trending down, DD trending up, will monitor -low threshold for intubation -Remdesivir ordered -self proning encouraged and patient completing successfully -MICU on consult, trend COVID labs, lovenox DVT ppx 09/28/2021 note: Worsening respiratory status since admission requiring BiPAP and transfer to ICU on 9/22-23 but he was not intubated and then transferred back to the floor. 3 days of azithromycin complete, 5 days of CTX completed 9/26. Remdesivir completed x5 days 9/25. Plan: CTA thorax 9/27 demonstrated worsening of bilateral consolidations. Will change steroids to Solu-medrol 30mg BID and add PCP ppx with bactrim D dimer increasing (4k to 12k), will repeat today and if continuing to increase would consider evaluation of upper extremities with dopplers. self prone as able will obtain ABG now to evaluate patient's oxygenation status, patient currently appears comfortable and is saturating high 90s with high-flow nasal cannula and non-rebreather. No current need for intubation however patient is very high risk. Would avoid BiPAP given his pneumomediastinum. Pneumomediastinum Noted on CTA thorax 9/27. Likely 2/2 COVID/ARDS. Free air present in the anterior mediastinum and left hilum. No evidence of esophageal or tracheal perforation on CTA. Plan: daily CXR, repeat CXR today shows widening of the mediastinum consistent with known pneumomediastinum. no need for antibiotics at this time Additional note on 09/28/2021: Since transfer out of ICU, patient had worsening O2 requirements last night with tachypnea and HFNC 100% FiO2 a/ NRB so was transferred back to the ICU. Since ICU transfer, has been stable and does not appear to be in any respiratory distress. steroids increased to Solumedrol 40 mg q8 hours Restarted on antibiotics: Vanc/Cefepime for empiric coverage 10/1/2021 note: Since GPA is not likely large contributing factor, will start to wean from steroids starting with 40 mg methylprednisolone BID for 3 days followed by 40 mg daily for 3 days and then will discontinue steroids. Continue PCP ppx with bactrim until off steroids. Continue cefepime through 10/4 for a total of 7 days Encourage patient to self-prone as tolerated Patient continues to require high flow and nonrebreather with 60 L O2 and 100% FiO2. Wean as tolerated with goal of >90% O2 saturation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 27,0
Labordaten: 10/7/2021 note: 10/6/21: new right pneumothorax, improving GGO bilaterally, worsening consolidative changes, no PE 10/7/21: chest tube placed for worsening pneumothorax, intubated and started on MV Plan: Start IV diuresis Start Broad spectrum Abx pending bronch cultures given elevation in WBC and procalcitonin Start Inhaled Veletri Obtain echocardiogram Patient has single organ failure currently, His case was discussed with ECMO staff, CTCCU unable to offer ECMO due to lack of circuits Continue to monitor. We are still able to effectively ventilate. 10/13/2021 note: COVID PNA Remdesivir 9/21-9/25 Previously on dexamethasone; currently on Solumedrol 40mg q 12 hours MRSA screen negative Pseudomonas pneumonia Cx (+) on 10/7 BAL, resistant to meropenem and ceftazidime Small Right Pneumothorax - s/p right chest tube 10/7 Pneumomediastinum CXR 10/9 showed 1.4 cm right apical PTX - CT was not tidalling, chest tube flushed F/u CXR showed PTX apparently resolved 10/17/2021 note: Acute Respiratory Failure w/Hypoxemia ETT 10/7-Present NMB 10/7- Present, failed paralytic wean 10/14 Prone 10/7-10/12 Inhaled Veletri 10/7-10/14, restarted 10/16- present with some improvement in pO2 Lung protective ventilation, 6 ml/kg PBW = 438 Steroid taper changed to methylpred 60mg IV BID 10/15, decrease to 30mg BID 10/17 Beta d glucan and aspergillus negative Bilateral upper and lower extremity ultrasounds 10/13 (+) right cephalic vein superficial thrombophlebitis CT angio thorax 10/15 negative for PE, widespread peripheral fibrotic changes and patchy consolidative disease COVID PNA Remdesivir 9/21-9/25
Aktuelle Erkrankungen: -
Vorgeschichte: GERD (gastroesophageal reflux disease) HTN (hypertension) Hypogonadism male Hypertriglyceridemia IBS (irritable bowel syndrome) Microalbuminuria Personal history of colonic polyps Diverticulosis PPD positive Primary osteoarthritis of right hip Granulomatosis with polyangiitis (Wegener's) Tobacco abuse Acute hypoxemic respiratory failure due to COVID-19 (HCC) Transaminitis Pneumomediastinum (HCC) Secondary spontaneous pneumothorax AKI (acute kidney injury) (HCC) Pneumonia due to COVID-19 virus Shock (HCC) A-fib (HCC
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet calcium carbonate (TUMS) 500 MG chewable tablet enalapril (VASOTEC) 10 MG tablet folic acid (FOLVITE) 1 MG tablet ibuprofen (MOTRIN) 200 MG tablet metoprolol succinate-XL (TOPROL-XL) 25 MG 24 hr tablet
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1790077

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NC
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Headache

Symptomtext

DEATH; HEADACHE; This spontaneous report received from a health care professional via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose, start therapy date were not reported, frequency time 1 total was administered for prophylactic vaccination The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, after receiving the covid-19 vaccine patient complained of a headache that day. The next day he died due to unknown cause of death. It was reported that the patient did not have anything else going on with him. Reporter did not know whether it was related to the covid-19 vaccine and was going to talk about it to his cousin. It was unknown if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died from an unknown cause on an unspecified date, and the outcome of headache was not reported. This report was serious (Death).; Sender's Comments: V0: 20211025751-COVID-19 VACCINE AD26.COV2.S-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1790073

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: OH
Alter: 79,0
Geschlecht: F
Eingang: 16.10.2021
Impfdatum: -
Beginn: 24.06.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

STROKE; This spontaneous report received from a patient concerned an 80 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had always good cholesterol and was physically active. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 30-MAR-2021 to left deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 24-JUN-2021, the patient experienced stroke and had weakness on the left side of body (left arm and left leg). The patient was recovering from the symptoms but it was slow and was still doing physical therapy and occupational therapy for the stroke. The patient attributed the stroke to the Janssen Covid-19 vaccine. The patient was in therapy at the hospital for 29 days. On 24-JUN-2021, the patient was admitted and discharged on 22-JUL-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211025160- COVID-19 VACCINE AD26.COV2.S- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 29,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had always good cholesterol and was physically active.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1790033

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac failure congestive Cerebrovascular accident Myocardial infarction

Symptomtext

TWO HEART ATTACKS; CONGESTIVE HEART FAILURE; STROKE; This spontaneous report received from a patient via a company representative concerned a 63 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient has a past medical history of 2 heart attacks and heart issues of congestive heart failure, concurrent conditions included moderate to severe ulcerative colitis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: unknown, expiry: unknown) with frequency time 1 total, dose and start therapy date were not reported for Covid-19 vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included Humira (adalimumab) for moderate to severe ulcerative colitis. On APR-2021, the patient experienced stroke. On an unspecified date, the patient experienced two heart attacks and congestive heart failure. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from stroke, and the outcome of heart attack and congestive heart failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20211021607-COVID-19 VACCINE AD26.COV2.S-stroke, two heart attacks, congestive heart failure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Ulcerative colitis
Vorgeschichte: Medical History/Concurrent Conditions: Congestive heart failure; Heart attack (2 heart attacks.)
Andere Medikamente: HUMIRA
Allergien: -
Vorherige Impfungen: -

VAERS 1789881

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Thinking abnormal Thrombosis

Symptomtext

STROKE; BLOOD CLOT; OUT OF HIS GOURD; This spontaneous report received from a consumer concerned a 7 decade old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose were not reported, 1 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced stroke, blood clot. As per reporter, patient was out of his gourd, but at the time of reporting patient was some what normal but patient would never be normal and also stated that the Janssen COVID-19 vaccine was 2 doses of mRNA. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from blood clot, stroke, and out of his gourd. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211014628 and 20211014552.; Sender's Comments: V0: 20211014652-covid-19 vaccine ad26.cov2.s-stroke, blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1789877

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: NJ
Alter: -
Geschlecht: F
Eingang: 16.10.2021
Impfdatum: -
Beginn: 22.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral haemorrhage Thrombosis

Symptomtext

BLOOD CLOT; HEMORRHAGE IN BRAIN; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient was admitted to the hospital and on 22-SEP-2021, she was found to have a blood clot with hemorrhage in the brain. The reporter stated that the patient remained sedated by in stable condition but had at least three surgeries. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clot, and hemorrhage in brain. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 20211014208-COVID-19 VACCINE AD26.COV2.S-blood clot, hemorrhage in brain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1776518

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: KY
Alter: 51,0
Geschlecht: F
Eingang: 11.10.2021
Impfdatum: 17.05.2021
Beginn: 19.09.2021
Tage bis Beginn: 125,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Chest discomfort Chest pain Cough Dyspnoea Fatigue Hyperhidrosis Immunodeficiency Inflammatory marker decreased Peripheral swelling Pyrexia SARS-CoV-2 test positive Wheezing

Symptomtext

a 51 y.o. female with a PMH of ALL on active treatment, anemia, type 1 diabetes on insulin pump, HTN, Sjogren's syndrome, Parkinson's disease, chronic nausea complicated by GERD with esophagitis, gastroparesis, active chemo regimen, sleep apnea, anxiety, and vitamin D who presents with a chief complaint of worsening symptoms regarding COVID. She states that she was diagnosed on 09/17 but has had symptoms for one week since coming to the ER and reports that she was told to come for further work-up. She states that she initially thought her fatigue was caused by recent chemo infusion (10 days ago) but it continued, and her symptoms worsened throughout the week. She reports that she began to have shortness of breath, chest pain, cough, fever (patient reports it was 103), diaphoresis that began 3-4 days ago. Respiratory: Positive for cough, chest tightness, shortness of breath and wheezing. Cardiovascular: Positive for chest pain and leg swelling. Negative for palpitations. Acute Hypoxic Respiratory Failure secondary to COVID-19 infection | Immunocompromised due to dasatinib therapy - Diagnosed on 09/17, symptomatic starting 09/12. On admission, dexamethasone and remdesivir were prescribed. Given her immunocompromised state, infectious disease was consulted for consideration of prolonged remdesivir course. She received supportive care with supplemental oxygen, albuterol and anti-tussive medications as needed. Per ID recommendations she was continued on remdesivir for the duration of her stay, 8 days, during which time her inflammatory markers were trended and noted to steadily fall. On day 8 of hospitalization patient no longer required supplemental oxygen at rest or with ambulation. She welcomed and requested discharge and was given strict return precautions. She was discharged to complete 3 additional days of dexamethasone, for 10d total as well as with antitussive medications and albuterol to use as needed. Discharged home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: COVID PCR positive on 9/19/21
Aktuelle Erkrankungen: None
Vorgeschichte: ? Anxiety ? Cancer ? Conversions - Other Herniated disc ? Conversions - Other Myocardial Infarction Arrhythmias ? Cyst and mucocele of nose and nasal sinus Cyst, sinus nasal ? Diabetes mellitus ? Enthesopathy, unspecified Bone spur ? GERD (gastroesophageal reflux disease) ? Hypertension ? Parkinson's disease ? Personal history of leukemia History of leukemia
Andere Medikamente: acyclovir (Zovirax) 400 MG tablet buPROPion XL (Wellbutrin XL) 300 MG 24 hr tablet busPIRone (Buspar) 30 MG tablet carbidopa-levodopa (Sinemet) 25-100 MG tablet carbidopa-levodopa CR (Sinemet CR) 50-200 MG ER tablet cholecalciferol (Vit
Allergien: codeine levothyroxine gabapentin
Vorherige Impfungen: -

VAERS 1775928

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 11.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEAD; This spontaneous report received from a consumer concerned a 24 year old female with an unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, with frequency time 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, reporter said that after vaccination his cousin was dead. It was unknown, if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died from an unknown cause of death. This report was serious (Death). This case, from the same reporter is linked to 20211014628 and 20211014652.; Sender's Comments: V0:20211014552-covid-19 vaccine ad26.cov2.s-dead. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1770392

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: GA
Alter: -
Geschlecht: M
Eingang: 08.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Pneumonia Pulmonary embolism Suspected COVID-19 Vaccination failure

Symptomtext

PULMONARY EMBOLISM; ACUTE RESPIRATORY FAILURE; PNEUMONIA; SUSPECTED COVID-19 INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a parent concerned a male of unspecified age of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date in JUN-2021 (in third week of the month), patient received the vaccine because patient was doing shows on ship in the second week of July and had to be vaccinated to do the cruise. On 10-SEP-2021, the patient passed away from a pulmonary embolism and lack of oxygen as per parent but patient's neurologist could not understand why patient died because the rest of organs were functioning well. On 10-SEP-2021, the patient died from pulmonary embolism, acute respiratory failure, pneumonia, and covid-19 (suspected clinical vaccination failure) as per the death certificate. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of pulmonary embolism, acute respiratory failure, pneumonia, suspected covid-19 infection on 10-SEP-2021, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition). This report was associated with product quality complaint: 90000196332.; Sender's Comments: V0 20211009924-COVID-19 VACCINE AD26.COV2.S-pulmonary embolism, acute respiratory failure, pneumonia, suspected covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). V0 20211009924-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: PULMONARY EMBOLISM; ACUTE RESPIRATORY FAILURE; PNEUMONIA; COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1766857

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 07.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Myocardial infarction

Symptomtext

HEART ATTACK; This spontaneous report received from a patient via a company representative concerned a male of unspecified age and other race. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was physically fit, regularly exercises, did not had any underlying health conditions and had zero risk factors for cardiovascular events. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-OCT-2021, the patient was admitted to a local hospital due to tachycardia and after further evaluation, the medical team was able to confirm that the patient had suffered a heart attack. Number of days of hospitalization were not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of heart attack was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211008873 - Covid-19 vaccine ad26.cov2.s-heart attack. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was physically fit, regularly exercises, did not had any underlying health conditions and had zero risk factors for cardiovascular events.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1763976

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 06.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

PASSES FROM LIFE TO DEATH; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, as per the reporter "my mom passes from life to death from your vaccine". Patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211006389-covid-19 vaccine ad26.cov2.s -Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1759418

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 19.02.2021
Beginn: 02.10.2021
Tage bis Beginn: 225,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Intensive care Positive airway pressure therapy Respiratory failure SARS-CoV-2 test positive

Symptomtext

Fully COVID vaccinated patient who admitted through emergency department with COVID positive test on 09/19/21. Patients respiratory status continued to decline, he required CCU admission high flow oxygen, and subsquently BiPAP. Medical team reviewed ongoing respiratory decline and grave status with patient and family who declined intubation. Patient moved to comfort care and died on 10/02/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID positive swab on 09/19/21.
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic back pain, HTN, DM2, extracranial carotid artery stenosis, arthritis, hyperlipidemia, B12 deficiency, cerebral thrombosis with cerebral infarction, vitiligo, obstructive pattern present on pulmonary function testing, aortic extasia (abdominal), monoclonal gammopathy of unknown significance, spinal stenosis, neuropathy, anemia, history of cerebrovascular accident, benign prostatic hyperplasia.
Andere Medikamente: Aspirin, lipitor, calcium carbonate, Zyrtec, temovate, vitamin B12, Avodart, Ferocon, Flonase, Neurontin, Zestril, Glucophage, Aleve, Saw Palmetto, Flomax, ultram, kenalog cream.
Allergien: "Seasonal allergies"
Vorherige Impfungen: -

VAERS 1759181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 28.05.2021
Beginn: 03.10.2021
Tage bis Beginn: 128,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal wall haematoma Acute kidney injury Acute respiratory distress syndrome Angiogram pulmonary abnormal Anticoagulant therapy Anuria Biopsy cartilage Blood culture positive Blood loss anaemia COVID-19 Chest discomfort Culture positive Death Dyspnoea Endotracheal intubation Enterobacter infection Hepatic failure Herpes simplex

Symptomtext

Fully vaccinated patient admitted for COVID. Provider discharge summary below: "Presented with 8/30 with worsening shortness of breath and chest discomfort following testing positive for COVID-19 on 8/25. He was vaccinated against COVID-19 with the Pfizer series on 5/3 and 5/28. He was admitted and started on oxygen and completed 5 days of remdesivir and a steroid course. Bilateral PE were found on CTA pulm on 9/5/21 and heparin was started. He continued to worsen despite HiFlo and NIPPV. He required intubation and transfer to CCU on 9/13, and started on pressors for support. CCU course was complicated by ARDS, shock, AKI and anuria requiring CRRT (managed by nephology), metabolic acidosis, liver failure, as well as acute blood loss anemia from a rectus sheath bleed causing an abdominal wall hematoma that required 1U pRBC and an abdominal binder. He was found with Serratia odorifera, Enterobacter cloacae on respiratory cultures suggesting aspiration pneumonia. HSV was detected on skin culture. Staph simulans that grew on one blood culture was deemed a contaminant. He received vancomycin, Zosyn, meropenem, metronidazole, acyclovir with antibiotic management guided by Infectious disease. ENT performed a biopsy of an ulcer of his left nare on 9/25, but pathology was pending at time of discharge. Patient did not improve despite treatment and had persistent respiratory acidosis and required maximum vasopressin and norephinephrine support. Palliative care was consulted and the grim prognosis of the patient communicated to family given his multiple organ failure. Patient was switched to comfort care status per family on 10/3/21. Patient died at 3:45 PM on October, 3, 2021."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA, dyslipidemia, right colectomy, eustachian tube dysfunction, homonymous hemianopsia due to cerebrovascular accident, left bundle branch block, chronic anticoagulation, protrusion of intervertebral disc, stenosis of cervical spine, laminectomy.
Andere Medikamente: Allopurinol, Cartia XT, Coreg, Colcrys, Maxidex eye drops, trulicity, Vasotec, metformin, novofine, crestor, xarelto kenalog ointment.
Allergien: NKA
Vorherige Impfungen: -

VAERS 1759181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 28.05.2021
Beginn: 03.10.2021
Tage bis Beginn: 128,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal wall haematoma Acute kidney injury Acute respiratory distress syndrome Angiogram pulmonary abnormal Anticoagulant therapy Anuria Biopsy cartilage Blood culture positive Blood loss anaemia COVID-19 Chest discomfort Culture positive Death Dyspnoea Endotracheal intubation Enterobacter infection Hepatic failure Herpes simplex

Symptomtext

Fully vaccinated patient admitted for COVID. Provider discharge summary below: "Presented with 8/30 with worsening shortness of breath and chest discomfort following testing positive for COVID-19 on 8/25. He was vaccinated against COVID-19 with the Pfizer series on 5/3 and 5/28. He was admitted and started on oxygen and completed 5 days of remdesivir and a steroid course. Bilateral PE were found on CTA pulm on 9/5/21 and heparin was started. He continued to worsen despite HiFlo and NIPPV. He required intubation and transfer to CCU on 9/13, and started on pressors for support. CCU course was complicated by ARDS, shock, AKI and anuria requiring CRRT (managed by nephology), metabolic acidosis, liver failure, as well as acute blood loss anemia from a rectus sheath bleed causing an abdominal wall hematoma that required 1U pRBC and an abdominal binder. He was found with Serratia odorifera, Enterobacter cloacae on respiratory cultures suggesting aspiration pneumonia. HSV was detected on skin culture. Staph simulans that grew on one blood culture was deemed a contaminant. He received vancomycin, Zosyn, meropenem, metronidazole, acyclovir with antibiotic management guided by Infectious disease. ENT performed a biopsy of an ulcer of his left nare on 9/25, but pathology was pending at time of discharge. Patient did not improve despite treatment and had persistent respiratory acidosis and required maximum vasopressin and norephinephrine support. Palliative care was consulted and the grim prognosis of the patient communicated to family given his multiple organ failure. Patient was switched to comfort care status per family on 10/3/21. Patient died at 3:45 PM on October, 3, 2021."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA, dyslipidemia, right colectomy, eustachian tube dysfunction, homonymous hemianopsia due to cerebrovascular accident, left bundle branch block, chronic anticoagulation, protrusion of intervertebral disc, stenosis of cervical spine, laminectomy.
Andere Medikamente: Allopurinol, Cartia XT, Coreg, Colcrys, Maxidex eye drops, trulicity, Vasotec, metformin, novofine, crestor, xarelto kenalog ointment.
Allergien: NKA
Vorherige Impfungen: -

VAERS 1754036

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: MI
Alter: 45,0
Geschlecht: M
Eingang: 01.10.2021
Impfdatum: 13.03.2021
Beginn: 18.09.2021
Tage bis Beginn: 189,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory distress syndrome Acute respiratory failure Alanine aminotransferase increased Anticoagulant therapy Aspartate aminotransferase increased Blood sodium decreased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Deep vein thrombosis Diarrhoea Dyspnoea Endotracheal intubation Exposure to SARS-CoV-2 Fluid balance negative Lung opacity Lymphopenia

Symptomtext

Hospitalized (9.24.21 - present); COVID-19 positive (9.18.21); fully vaccinated Principal Problem: Pneumonia due to COVID-19 virus Active Problems: Acute respiratory failure with hypoxia History of Present Illness Patient is a 46 y.o. male who presents to ER today with c/o severe worsening cough, fever, increasing SOB. Patient has a 14 yo son that was recently sick with Covid. He is in school and unmasked and has completed his isolation. Patient's spouse is also sick with Covid 19. Patient has not been able to sleep the last two nights due to severe cough. His cough is productive at times with greenish/yellow secretions. Patient denies wheezing, chest pain, edema, orthopnea. He does snore sometimes. He denies OSA. Patient has been alternating taking acetaminophen and ibuprofen at home for his fevers and myalgias. Patient reports that he is having watery diarrhea about 2 to 3 in last 24 hours. Patient has a PMhx of psoriatic arthritis, hyperthyroid, h/o light tobacco use. Patient follows with endocrinology and rheumatology. Covid vaccination Janssen on 3/13/21. Patient was ill last October and thought this may have been due to Covid. Covid 19 IGG antibody in Dec was negative. ER evaluation today Fever 38.4, 87% sats on RA, HR 105, RR up to 22. 2L oxygen w/sats up to 93%. CXY bilateral lung opacities consistent w/covid pneumonia +Covid 9/18/21. Patient was prescribed albuterol inhaler and tessalon perles 2 days ago. Na 131, AST 86, ALT 77, WBC 3.5, lymphopenia In the ER patient was given dexamethasone 6 mg IV, tessalon perles, albuterol MDI and acetaminophhen. Patient is being admitted for acute hypoxia due to Covid pneumonia w/sepsis. Notes from 10.1.21: SUBJECTIVE: Significant events in the last 24 hours: intubated 9/27; tolerated prone positioning; slight negative fluid balance; tol heparin gtt no evidence of bleeding. CHIEF COMPLAINT: Pneumonia due to COVID-19 virus Length of Stay: 7 days Assessment/Plan ASSESSMENT / PLAN: * Pneumonia due to COVID-19 virus Assessment & Plan S/p remdesivir S/p Dexamethasone 6mg -> 20 9/27 Worsening hypoxia Acute Respiratory Failure with hypoxia - secondary to ARDS from COVID-19 pna; worsening COVID-19 pneumonia - dx 9/18; admitted 9/24 -Intubated 9/27 -sedation for vent synchrony - RASS -5 -NMRB - trial holding today --lung protective ventilation - goal pplat < 30 driving pressure < 15 -daily prone positioning for p/f < 150 - 16 hours minimum per 24 hrs. -empiric abx -remdesivir -dexamethasone - 20mg daily x5 days then 10mg daily x 5 days -corpak - I/o goal even to - 500 DVT - LE/ U/s w/ peroneal dvt 9/28 -heparin gtt Psoriatic arthritis - h/o immunosuppression Hyperthyroidism - methimazole; free T4 nml Proph GI- H2B VTE- heparin gtt VAP- Chlorhexadine Full Code

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: COVID-19 positive 9.18.21
Vorgeschichte: Goiter Graves' disease Hashimoto's thyroiditis arthritis plantar fasciitis psoriasis
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler benzonatate (TESSALON) 100 MG capsule ibuprofen (MOTRIN) 200 MG tablet leflunomide (ARAVA) 20 MG tablet meloxicam (MOBIC) 7.5 MG tablet methIMAzole (TAPAZ
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1753012

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: MA
Alter: 62,0
Geschlecht: F
Eingang: 01.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Candida infection Gait disturbance Laryngeal oedema Pulmonary embolism Pulmonary thrombosis

Symptomtext

PULMONARY EMBOLISM; BLOOD CLOT IN LUNGS; EDEMA IN HER VOCAL CORDS; ORAL THRUSH, THAT SPREAD TO ESOPHAGUS AND ALL OVER BODY AND INTO HER LUNGS; TROUBLE WALKING DOWN THE STAIRS/CAN NOT WALK; BODY IS WEAK; This spontaneous report received from a consumer concerned an adult white female of an unspecified ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included: neck surgery, and concurrent conditions included: COPD (Chronic obstructive pulmonary disease), alcohol consumer, and smoker. The patient had no known drug allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, frequency time 1 total was administered on JUN-2021 to right arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. Reporter stated that, the patient was fine at the first. On an unspecified date, (couple of weeks later) the patient had difficulty breathing and trouble walking down the stairs and patient's throat was swollen (edema in her vocal cords). Patient went to the emergency room (ER) few times at night. At the ER, patient was treated with the Medrol IV (intravenous)- (methylprednisolone) and sent back to home with steroid as they thought it was from the edema and they did not checked if she had blood clots. Within a month after getting the vaccine, patient had difficulty breathing again but she didn't go get checked. Patient started experiencing oral thrush, that spreads to her esophagus and all over her body. It went through her body, esophagus then into her lung. She went to the hospital and there she was diagnosed with the blood clot in her lungs and pulmonary embolism. She was on the ventilator and incubated in the hospital for 9 to 10 days. She was off ventilator now and was discharged from hospital to rehab. Her body became weak because she was on ventilator for longer time. She would be able to came home once she could walk again. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pulmonary embolism (difficulty breathing), and blood clot in lungs, had not recovered from trouble walking down the stairs/can not walk, and body became weak, and the outcome of oral thrush, that spread to esophagus and all over body and into her lungs and her throat was swollen (edema in her vocal cords) was not reported. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0: 20210958344-covid-19 vaccine ad26.cov2.s-Pulmonary embolism, blood clot in lungs, edema in her vocal cords, oral thrush that spread to esophagus and all over body and into her lungs, trouble walking down the stairs/can not walk. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210958344-covid-19 vaccine ad26.cov2.s- body is weak. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcoholic; COPD; Smoker
Vorgeschichte: Medical History/Concurrent Conditions: Neck surgery; Comments: The patient had no known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1751732

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: IL
Alter: -
Geschlecht: M
Eingang: 01.10.2021
Impfdatum: -
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Suspected COVID-19 Vaccination failure

Symptomtext

DECEASED; SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION (DELTA VARIANT); This solicited report received from a consumer: concerned a 51 year old male of unknown race. The patient's weight, height, and medical history were not reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: Unknown) dose, start therapy date were not reported, 1 total administered in FEB-2021 or MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On SEP-2021, the patient experienced suspected clinical vaccination failure and suspected covid-19 infection (delta variant), and was hospitalized (date unspecified). Patient was released from the hospital and then re-admitted to the hospital. On SEP-2021 Patient was deceased. It was unspecified if autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection (delta variant) and suspected clinical vaccination failure was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and deceased was related, and between covid-19 vaccine ad26.cov2.s, and suspected clinical vaccination failure, and suspected covid-19 infection (delta variant) was not related. This report was serious (Death, and Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20210953828.; Sender's Comments: V0: 20210953961-covid-19 vaccine ad26.cov2.s-deceased. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210953961-covid-19 vaccine ad26.cov2.s-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20210953961-covid-19 vaccine ad26.cov2.s-suspected covid-19 infection (delta variant). This event(s) is considered not related. The event(s) shows an incompatible temporal relationship.; Reported Cause(s) of Death: DECEASED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1751730

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: FL
Alter: -
Geschlecht: U
Eingang: 01.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Thrombocytopenia

Symptomtext

DEATH; THROMBOCYTOPENIA; This spontaneous report received from a health care professional via social media (media) concerned multiple patients of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. The reporter stated that "he was aware of media reports and various other avenues of reporting for 6 deaths (cause of death unspecified) and other severe adverse events like thrombocytopenia following vaccination with Janssen covid-19 vaccine." The reporter stated he could not recall where or when they first heard of these media reports and had no additional information to provide. It was not reported if an autopsy was performed for the patients who died. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of thrombocytopenia was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20210952656 - Covid-19 vaccine ad26.CoV-2.s- Death, Thrombocytopenia. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1943197

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: NC
Alter: 57,0
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: 03.08.2021
Beginn: 03.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Blood potassium decreased Cerebrovascular accident Glomerular filtration rate decreased Hepatic enzyme Renal impairment

Symptomtext

Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Benign essential HTN CVA (cerebral vascular accident) Essential hypertension Hypertensive emergency Infraction of left basal ganglia Lacunar stroke Right Hemiparesis AKI (acute kidney injury) Class 1 obesity due to excess calories with serious comorbidity and body mass index (BMI) of 31.0 to 31.9 in adult Dyslipidemia Family history of stroke (cerebrovascular) History of stroke with residual effects Hypokalemia Transaminitis
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet amLODipine (NORVASC) 10 MG tablet aspirin 81 mg chewable tablet atorvastatin (LIPITOR) 80 MG tablet losartan-hydrochlorothiazide (HYZAAR) 100-25 MG tablet potassium chloride (KLOR-CON) 10 MEQ tablet
Allergien: amoxicillin
Vorherige Impfungen: -

VAERS 1747682

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 30.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Death Organ failure

Symptomtext

DEATH; STROKE; MASSIVE ORGAN FAILURE; This spontaneous report received from a consumer via a company representative via social media concerned a two elderly patients of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. Both patients were healthy and had full physical before taking vaccination. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown, expiry: unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. The reporter reported that, know of two over 65 folks who died two weeks after Johnson and Johnson shot. Stroke and massive organ failure. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patients died of unknown cause on an unspecified date and the outcome of stroke and massive organ failure was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20210955453-Covid-19 vaccine ad26.cov2.s- Death, Stroke, Massive organ failure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Both patients were healthy and had full physical before taking vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1747671

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: -
Beginn: 01.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arterial rupture Catheterisation cardiac Myocardial infarction Myocarditis Reproductive tract disorder Troponin

Symptomtext

APPARENT HEART ATTACK; MYOPERICARDITIS AND INFLAMED HEART; CORONARY TEAR; GYNECOLOGICAL PROBLEMS; This spontaneous report received from a Company representative concerned a 34 year old female of unknown race and ethnic origin. The patient's height, and weight were not reported. The patient had no pre-existing conditions. The patient never had coronavirus. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: Unknown) dose was not reported, 1 total, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. The patient did not notice complications until three months later on 09-JUL-2021 the pain started with what felt like heartburn or indigestion, but three days later on 12-JUL-2021 pain intensified to the point that she was breathing into a paper bag for relief and body aches kept her up at night. After three days on 12-JUL-2021, the patient experienced apparent heart attack. By the time patient went to an emergency room, where the amount of troponin in her blood was 7.3 nanograms per milliliter (normal range between 0 to 0.04.), which indicates heart injury. They asked her to get done cardiac catheterization. They sent her by ambulance to hospital for treatment. Catheterization was done and they did not find any blockages and it was normal. The patient also experienced inflamed heart (myopericarditis and inflamed heart) and a coronary tear that will take six to eight months to heal. She met the next day with an infectious diseases team, which recommended additional testing before noting on her admissions paperwork. In addition to continuing to heal, she said she has also developed gynecological problems and her doctors have mentioned the potential for a hysterectomy. On an unspecified date patient was hospitalized. Number of days hospitalized was unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from myopericarditis and inflamed heart and coronary tear and the outcome of apparent heart attack, gynecological problems was not reported. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20210953564.; Sender's Comments: V0: 20210953105 -COVID-19 VACCINE AD26.COV2.S-Apparant Heart attack, Myopericarditis and inflamed heart ,Coronary tear. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Date: 202107; Test Name: Troponin; Result Unstructured Data: 7.3 ng/mL; Test Date: 202107; Test Name: Cardiac catheterization; Result Unstructured Data: Normal, no blockages were found
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no pre-existing conditions. Patient never had coronavirus.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1747669

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: TX
Alter: -
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: -
Beginn: 22.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral thrombosis Cerebrovascular accident

Symptomtext

STROKE/ LEFT SIDE IMPAIRED; BLOOD CLOT ON BRAIN; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on 21-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 22-SEP-2021, the patient was admitted to the hospital with a blood clot on brain causing a stroke which left patients' left side impaired. The number of days hospitalized was unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stroke/ left side impaired and blood clot on brain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210952881-COVID-19 VACCINE AD26.COV2.S-stroke/ left side impaired and blood clot . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1745408

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 29.09.2021
Impfdatum: 23.06.2021
Beginn: 12.09.2021
Tage bis Beginn: 81,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Decreased appetite Diarrhoea Dyspnoea Fluid intake reduced Headache Hypoxia Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Acute respiratory failure due to COVID-19 (CMS/HCC) Assessment & Plan Symptom onset: 9/13/2021 Test date: 9/18/2021 Elderly male who received 2 doses of Moderna vaccine, last on 6/23. Symptoms consistent with mild to moderate Covid infection with hypoxemia. Following discussion with the patient will initiate therapy with Dexamethasone and Remdesivir COVID steroid recommendations are for 10 days duration or stopped on discharge, whichever comes first. Remdesivir is a typical 5 day IV duration, however can be stopped earlier if recovery is unexpectedly rapid Prophylactic Lovenox dosing, monitor d-dimer for 2500 level where empiric therapeutic dosing is indicated, refer to BH covid treatment guidelines Monitor closely for progression to advanced O2 management devices. Discussed expectations of care Encourage incentive spirometry and self proning

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: Patient complaining of HA, not eating or drinking for the last 5 days. He also noted shortness of breath and diarrhea. Once admitted he was noted to be hypoxic and placed on supplemental O2 at 4 L/min. Therapy was started with dexamethasone 6 mg/day. When seen in the room the patient was difficult to understand due to his accent and masking. He was wearing nasal oxygen at 4 L/min but not yet on a pulse ox monitor. He has no previous history of Covid infection. After testing positive in the emergency room he was placed on dexamethasone. Nursing was asked to remove his nasal oxygen during their intake and confirm hypoxia. His SPO2 dropped immediately into the 80s and did not recover until supplemental O2 was replaced. Patient was seen in November 2019 for possible pneumonia enteritis and abnormal CT scan. He was also noted that his QuantiFERON gold was positive and treated for LTBI
Aktuelle Erkrankungen: Anxiety disorder ? Arthritis ? Bipolar disorder (CMS/HCC) ? BPH (benign prostatic hyperplasia) ? Depression ? Diabetes mellitus, type II (CMS/HCC) ? Dyslipidemia ? GERD (gastroesophageal reflux disease) ? H/O TB (tuberculosis) 1952 possible ? Headache ? History of chemotherapy last 10-28-19 ? History of ETOH abuse ? Hypertension ? Neuropathy feet ? Overactive bladder ? Postoperative nausea and vomiting ? Rectal cancer 12/2017 chemo/radiation ? TB lung, latent 04/2019 possible; completed treatment course 10/2019 - ? Urinary incontinence
Vorgeschichte: Anxiety disorder ? Arthritis ? Bipolar disorder (CMS/HCC) ? BPH (benign prostatic hyperplasia) ? Depression ? Diabetes mellitus, type II (CMS/HCC) ? Dyslipidemia ? GERD (gastroesophageal reflux disease) ? H/O TB (tuberculosis) 1952 possible ? Headache ? History of chemotherapy last 10-28-19 ? History of ETOH abuse ? Hypertension ? Neuropathy feet ? Overactive bladder ? Postoperative nausea and vomiting ? Rectal cancer 12/2017 chemo/radiation ? TB lung, latent 04/2019 possible; completed treatment course 10/2019 ? Urinary incontinence
Andere Medikamente: alot
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1744398

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: FL
Alter: 86,0
Geschlecht: F
Eingang: 29.09.2021
Impfdatum: 26.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

The patient is deceased six days after Pfizer vaccination (first dose)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1741201

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: WI
Alter: 78,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: 16.02.2021
Beginn: 21.09.2021
Tage bis Beginn: 217,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Computerised tomogram thorax normal Cough Dyspnoea Fatigue Hypophagia Osteoarthritis SARS-CoV-2 test positive

Symptomtext

Patient completed Moderna COVID-19 vaccination series on 2/16/21. Patient presented to reporting hospital with symptoms of general fatigue, decreased oral intake, shortness of breath, cough and found to be in acute hypoxic respiratory failure with a positive COVID-19 test recently. Patient reported that friend was also COVID positive and brought this friend to COVID testing without a mask on. Admission testing was positive for COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: COVID 19 PCR Test 9/17/21 COVID CT 9/21/21 The cardiomediastinal contours and pulmonary vasculature are within normal limits. Mild interstitial opacities are similar to prior exams. No new focal consolidation There is no pneumothorax or pleural effusion. Degenerative changes are present at the acromioclavicular joints.
Aktuelle Erkrankungen: history of heart failure with preserved ejection fraction, hypertensive chronic kidney disease stage I, insulin-dependent diabetes, chronic low back pain, hyperlipidemia, diabetic retinopathy, major depressive disorder history, ostial arthritis of her hip and a history of pneumonia in 2018 and thyroid disease
Vorgeschichte: history of heart failure with preserved ejection fraction, hypertensive chronic kidney disease stage I, insulin-dependent diabetes, chronic low back pain, hyperlipidemia, diabetic retinopathy, major depressive disorder history, ostial arthritis of her hip and a history of pneumonia in 2018 and thyroid disease
Andere Medikamente: Norvasc 2.5mg, aspirin 325mg, Wellbutrin XL 150mg, Temovate, Lexapro 20mg, gabapentin 600mg, Insulin Lispro, Levothyroxine 50mg, Cozaar 25mg, Magnesium, Pravachol 40mg, albuterol 2.5mg/3mL
Allergien: Sulfa antibiotics
Vorherige Impfungen: -

VAERS 1740528

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 28.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident SARS-CoV-2 test

Symptomtext

TWO STROKES; This spontaneous report received from a patient via social media concerned a patient of unspecified age, sex, unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced two strokes and felt that people only told the good stuff and no one told the bad stuff. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) no covid (negative). The action taken with covid-19 vaccine was not applicable. The outcome of two strokes was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210950516.; Sender's Comments: V0-20210951067-Covid-19 vaccine - Two Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Result Unstructured Data: no covid (negative)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1740523

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 28.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Vaccination failure Vaccine breakthrough infection

Symptomtext

DEATH; BREAKTHROUGH INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a physician via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included: hypertension, dyslipidemia, type 2 diabetes, and Chronic renal failure (CKD). The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, 1 total administered on unspecified therapy start date for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced breakthrough infection with Covid-19 vaccine ad26.cov2.s(suspected clinical vaccine failure), and died. On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of breakthrough infection and suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: 20210949213-covid-19 vaccine ad26.cov2.s-Suspected Clinical Vaccination Failure. This event(s) is considered not related. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20210949213-covid-19 vaccine ad26.cov2.s-Death, breakthrough infection. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s); Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Chronic renal failure; Dyslipidemia; Hypertension; Type II diabetes mellitus
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1402918

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: LA
Alter: 33,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: -
Beginn: 31.03.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Activated partial thromboplastin time Angiogram cerebral abnormal Arteriogram carotid abnormal Blood glucose CSF glucose Cerebrovascular accident Pyrexia CSF protein CSF white blood cell differential Chest X-ray abnormal Computerised tomogram head abnormal Differential white blood cell count Drug screen Echocardiogram abnormal Electrocardiogram abnormal Full blood count Glycosylated haemoglobin HIV test

Symptomtext

STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1736789

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: MI
Alter: 88,0
Geschlecht: F
Eingang: 27.09.2021
Impfdatum: 01.03.2021
Beginn: 01.09.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Animal bite COVID-19 Computerised tomogram thorax Cough Culture throat Dyspnoea Fatigue Haemoptysis Influenza A virus test negative Influenza B virus test Influenza like illness Knee arthroplasty Nucleic acid test Pain Polymerase chain reaction Pulmonary embolism Respiratory syncytial virus test negative SARS-CoV-2 test positive

Symptomtext

a 88y.o. year old female with PMH dementia,depression/anxiety, paroxysmal afib who presents for COVID concern. Patient recently had a L total knee arthroplasty done at hospital on 8/16. Patient was transferred to SAR and began having flu like symptoms. Patient's son at bedside helps with most of history as patient is very somnolent. Son states the patient was having a cough, body aches, fatigue. Patient took a COVID test and was positive 8/26/2021. Patient's son states the facility wanted to transfer the patient to a "COVID friendly facility", but the son did not feel comfortable with that and wanted to bring her home. Patient then came home and symptoms began to worsen. Yesterday, patient became much more short of breath and this made the son bring her into the hospital. Since arrival, patient has been started on antibiotics, heparin d/t a PE found on CTA. However, patient began having hemoptysis. Patient will answer yes/no to questions and sometimes will describe she has "trouble breathing". Patient denies fevers/chills, but does endorse cough, shortness of breath. She did receive both doses of Moderna vaccine early this year Patient was previously a school teacher. No history of TB, frequently tested as teacher and all negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 17,0
Labordaten: Contains abnormal data Covid-19, Flu, RSV Status: Final result Visible to patient: Yes (seen) Next appt: 10/06/2021 at 04:00 PM in Cardiology Specimen Information: Nasopharyngeal; Swab 0 Result Notes Ref Range & Units Influenza A Not Detected Not Detected Influenza B Not Detected Not Detected RSV Not Detected Not Detected SARS-CoV-2 (COVID-19), Micro Not Detected Detected Abnormal Narrative Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR) The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified to perform high complexity testing. This test has not been FDA cleared or approved. Specimen Collected: 09/01/21 5:27 PM Last Resulted: 09/01/21 6:30 PM
Aktuelle Erkrankungen: AAA (abdominal aortic aneurysm) ? Anxiety disorder ? Back pain ? Cat bite of forearm 06/2021 ? Constipation ? Dementia ? Diverticulosis ? Dry eyes ? GERD (gastroesophageal reflux disease) ? Growth on larynx ? History of recurrent UTIs ? HTN (hypertension) ? Hyperlipidemia ? Nocturia ? Osteoarthritis ? Osteoporosis ? PAD (peripheral artery disease) ? PAF (paroxysmal atrial fibrillation) ? Skin cancer ? Spinal stenosis ? Ulcer of lower extremity ? Urinary incontinence
Vorgeschichte: AAA (abdominal aortic aneurysm) ? Anxiety disorder ? Back pain ? Cat bite of forearm 06/2021 ? Constipation ? Dementia ? Diverticulosis ? Dry eyes ? GERD (gastroesophageal reflux disease) ? Growth on larynx ? History of recurrent UTIs ? HTN (hypertension) ? Hyperlipidemia ? Nocturia ? Osteoarthritis ? Osteoporosis ? PAD (peripheral artery disease) ? PAF (paroxysmal atrial fibrillation) ? Skin cancer ? Spinal stenosis ? Ulcer of lower extremity ? Urinary incontinence
Andere Medikamente: albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT inhaler 1 Puff 1 Puff Inhalation RT-every 6 hours ? aspirin (ECOTRIN) EC tablet 81 mg 81 mg Oral Q 12 H ? baricitinib (OLUMIANT) tablet 4 mg 4 mg Oral DAILY ? cefepime (M
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1736466

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: -
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; .This spontaneous report received from a consumer via a company representative via social media concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date; Unknown) dose was not reported, 1 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On SEP-2021, the patient experienced death from unknown cause. Reporter stated that "attending a funeral this Saturday for a fully vaccinated man". It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20210946753-covid-19 vaccine ad26.cov2.s-death. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1736190

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 27.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a health care professional and concerned multiple patients of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, 1 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patients died of unknown cause of death after receiving Janssen vaccine. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20210940869-COVID-19 VACCINE AD26.COV2.S-Death. This event(s) is considered unassessable. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1628639

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: AR
Alter: 78,0
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: -
Beginn: 15.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Cardiac arrest Catheterisation cardiac abnormal Chest discomfort Device occlusion Catheterisation cardiac Electrocardiogram Electrocardiogram abnormal Endotracheal intubation Mechanical ventilation Resuscitation Stent placement Vaccination failure

Symptomtext

SUSPECTED CLINICAL VACCINATION FAILURE; CATHETERISATION CARDIAC ABNORMAL; ELECTROCARDIOGRAM ABNORMAL; CARDIAC ARREST; CHEST DISCOMFORT; DEVICE OCCLUSION; ENDOTRACHEAL INTUBATION; MECHANICAL VENTILATION; RESUSCITATION; STENT PLACEMENT; COVID-19 PNEUMONIA; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAER ID 1628639) concerned a 78 year old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose was not reported, 1 total, administered on 16-JUN-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 15-AUG-2021, two days ago the patient was admitted with COVID-19 pneumonia. On 24-AUG-2021, in the morning around 9:30 AM, the patient developed chest discomfort which was progressed. The patient's Electrocardiogram (EKG) progressed over time (Electrocardiogram abnormal). On the same day, the patient had catheterisation cardiac which showed abnormal result. It was reported that, the patient underwent a cardiac arrest and was resuscitated after three rounds of epinephrine 300 mg, amiodarone IV (amiodarone) and debrillation x1 (Defibrillation). Patient was intubated (Endotracheal intubation) and put on a ventilator (Mechanical ventilation). The patient was transferred to another Hospital via helicopter and taken to emergently to cardiac cath lab (Cardiac catheterization laboratories). patient lab was occluded with (Device occlusion) and stented (Stent placement). On an unspecified date, the patient experienced suspected clinical vaccination failure. The patient was hospitalized for 9 days. At the time of this report, the patient was continues to be inpatient. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the covid-19 pneumonia, cardiac arrest, catheterisation cardiac abnormal, chest discomfort, device occlusion, electrocardiogram abnormal, endotracheal intubation, mechanical ventilation, resuscitation, stent placement and suspected clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is associated with product quality complaint: 90000192511. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified. based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 23-SEP-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1:The additional information in this version is Product quality complaint investigation result.This does not alter causality of previously reported events. 20210908194-COVID-19 VACCINE AD26.COV2.S- COVID-19 pneumonia, Cardiac arrest, Chest discomfort, Device occlusion, Endotracheal intubation, Mechanical ventilation, Resuscitation, Stent placement, Catheterisation cardiac abnormal, Electrocardiogram abnormal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210908194-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 9,0
Labordaten: Test Date: 20210824; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal; Test Date: 20210824; Test Name: Catheterisation cardiac; Result Unstructured Data: Abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1733856

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: TX
Alter: -
Geschlecht: M
Eingang: 25.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DIED; This solicited report received from a patient via JS2021-30756: COVID 19 Consumer. The patient's weight, height, and medical history were not reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and died was not related. This report was serious (Death). This case, from the same reporter is linked to 20210941085 and 20210941906.; Sender's Comments: V0: 20210947994-COVID-19 VACCINE AD26.COV2.S -Died. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1733812

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: SC
Alter: -
Geschlecht: U
Eingang: 25.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATH; This spontaneous report received from a pharmacist through reports (from other doctors and nurses) concerned 6 or 7 patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose, start therapy date were not reported, frequency time 1 total was administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. The reporter stated that, on an unspecified date 6 or 7 patients died due to unknown cause of death after receiving the Janssen covid-19 vaccine around the time of the food and drug administration (FDA) pause of vaccine. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20210943888-covid-19 vaccine ad26.cov2.s-death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1730175

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 24.09.2021
Impfdatum: -
Beginn: 02.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Body temperature Fatigue Headache Laboratory test Pain in extremity Platelet count Pulmonary embolism Pyrexia Thrombocytopenia Thrombosis

Symptomtext

BLOOD CLOT; BILATERAL PULMONARY EMBOLISM; THROMBOCYTOPENIA; PAIN IN LEFT THIGH; EXHAUSTION; FEVER; SEVERE HEADACHE; This spontaneous report received from a consumer concerned a 37 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included controlled high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total, administered on 24-AUG-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 02-SEP-2021, the patient started having severe headache. On 04-SEP-2021, the patient had pain in left thigh, shortness of breath, 2 episodes of fever and exhaustion. On 09-SEP-2021, the patient was admitted to the Intensive Care Unit (ICU) and according to reporter, patient was diagnosed with blood clot, bilateral pulmonary embolism and thrombocytopenia(low platelets). The reporter stated that according to the doctors the events were related to the vaccine. The patient had done genetic testing and was negative for any clotting disorder. The patient spent two days in inflammatory floor from 11-SEP-2021 to 13-SEP-2021 and was discharged on 13-SEP-2021. The reporter mentioned that the patient almost died and was told at the ICU (intensive care unit) that it was a miracle that the patient was still alive. The reporter also stated that the patient could not receive any COVID-19 vaccine or booster shot anymore. Laboratory data included: Body temperature (NR: not provided) 101.3 F, 100.8 F. Laboratory data included: Lab test (NR: not provided) diagnosed with blood clot, bilateral pulmonary embolism with thrombocytopenia (low platelets) and Platelet count (NR: not provided) Low. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bilateral pulmonary embolism, thrombocytopenia, blood clot, fever, severe headache, pain in left thigh and exhaustion was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210941148-covid-19 vaccine ad26.cov2.s-bilateral pulmonary embolism, blood clot, thrombocytopenia. This event(s) is labeled per RA and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 5,0
Labordaten: Test Date: 20210904; Test Name: Body temperature; Result Unstructured Data: 101.3 F; Test Date: 20210904; Test Name: Body temperature; Result Unstructured Data: 100.8 F; Test Date: 20210909; Test Name: Platelet count; Result Unstructured Data: Low; Test Date: 20210909; Test Name: Lab test; Result Unstructured Data: diagnosed with blood clot, bilateral PE with thrombocytopenia; Comments: diagnosed with blood clot, bilateral pulmonary embolism with thrombocytopenia (low platelets).
Aktuelle Erkrankungen: Blood pressure high
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1725262

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 23.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DEATHS; This spontaneous report received from a consumer via a company representative concerned 3 patients of unspecified sex, age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown expiry: unknown) dose, start therapy date were not reported 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. "It was reported that, on an unknown date, JNJ vaccine caused 3 known deaths". The patients died from unknown cause of death. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the event death was fatal This report was serious (Death).; Sender's Comments: V0: 20210936591-covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1670427

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge unknown

kritisch

Staat: WI
Alter: 69,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 17.02.2021
Beginn: 22.09.2021
Tage bis Beginn: 217,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anaemia COVID-19 Chest X-ray abnormal Chronic kidney disease Cough COVID-19 pneumonia Clostridium difficile colitis Computerised tomogram head abnormal Death Endotracheal intubation Diarrhoea Dyspnoea Lung opacity Oxygen saturation decreased Pneumonia Haemorrhage intracranial Intensive care Loss of consciousness

Symptomtext

****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID. This addendum is to report that patient died 9/22/2021 from COVID related complications. Hospital course: Patient admitted with COVID pneumonia and treated for same. Course was complicated by Stenotrophomonas pneumonia and C diff colitis. He was gradually improving and down to 3-5 liters of oxygen by nasal cannula. He was considering transitioning to comfort cares after discharge. On morning of 9/21 he had abrupt loss of consciousness. Intubated for airway protection and brought to ICU. CT showed large intracranial hemorrhage. Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care. Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances. Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1722712

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge Unknown

kritisch

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 22.09.2021
Impfdatum: 13.01.2021
Beginn: 20.08.2021
Tage bis Beginn: 219,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Hospitalization and death due to COVID-19 . Details unknown

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 26,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1717840

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: -
Beginn: 05.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Respiratory disorder Septic shock Vaccination complication

Symptomtext

REACTION ASSOCIATED WITH VACCINE; SEPTIC SHOCK; RESPIRATORY ILLNESS; PASSED AWAY; This spontaneous report received from a consumer via social media concerned a male of unspecified age, race and ethnicity. Initial information was processed along with the additional information received on 16-SEP-2021. The patient's height, and weight were not reported. The patient was completely healthy before taking the vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported. On 05-JUL-2021, the patient was admitted to hospital with a respiratory illness, within hours he went into septic shock and was admitted to the Intensive Care Unit (ICU) on a ventilator. After more than nine weeks the patient was still in the ICU on a ventilator and he had shown some signs of improvement. The cause of his severe illness was determined to be a reaction associated with the vaccine that he received a week earlier. On an unspecified date in SEP-2021, the patient had passed away from an unknown cause of death. It was unknown if an autopsy was performed. The duration of hospitalization was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from respiratory illness, septic shock, and reaction associated with vaccine. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0;- 20210931824-covid-19 vaccine ad26.cov2. s- Passed away, Respiratory illness, Septic shock, and Reaction associated with vaccine. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was completely healthy before taking the vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1717832

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: AK
Alter: -
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Balance disorder Cardiomegaly Computerised tomogram Cyst Decreased appetite Deep vein thrombosis Disseminated intravascular coagulation Echocardiogram Full blood count Haematocrit Haemoglobin Heart rate increased Laboratory test Malaise Pulmonary embolism SARS-CoV-2 test Thrombocytopenia Thrombosis

Symptomtext

DISSEMINATED INTRAVASCULAR COAGULATION; VACCINE-INDUCED THROMBOTIC THROMBOCYTOPENIA; THROMBOCYTOPENIA; DEEP VEIN THROMBOSIS; BILATERAL PULMONARY EMBOLISM; HEART WAS ENLARGED; CYST OF SOME SORT; BALANCE WAS STILL A BIT OFF; DECREASED APPETITE; MALAISE; This spontaneous report received from a consumer concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no previous underlining or pre-existing health conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry :unknown) dose was not reported, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. It was reported that the vaccine resulted in a severe reaction, placing the patient in a life-threatening position. Approximately 6-7 days after receiving the vaccine with having no previous underlining or pre-existing health conditions his symptoms worsened. He was having severe issues. Malaise set in, decreased appetite, dry cough along with other symptoms. The patient went to emergency department (ED) and was discharged home with unspecified antibiotics, an unspecified antispasmodic & was negative for corona virus disease (COVID). He went home for 2 days after spending the night in the ER. No signs of improvement, he just progressively getting worse and had bilateral lower extremity edema setting in. On 08-AUG-2021 he went back to the ED and was hospitalized back again after nothing had improved. Though he did not feel well another concern was the prolonged sitting in the same spot not moving about or getting up, he could very well develop a deep vein thrombosis (DVT), not to mention anemia. He went back to the ED and was hospitalized back again on 08-AUG-2021 after nothing had improved. His labs were drawn and his platelet levels had dropped to a critical value needing a platelet transfusion. Most of the labs were within normal range (WNR), however his platelets barely increased causing concern, thus dropping down again. The chest computerized tomogram (CT) was remarkable for bilateral pulmonary embolisms as well as an ultrasound (US) on his lower extremities, which confirmed a DVT in one of his legs. Specialists were consulted due the concern that his body was attacking & destroying the platelets that had been infused yet it was baffling to all that most of his other labs were "okay". His hemoglobin and hematocrit levels did drop but not enough to need a transfusion despite the prolonged bleeding. It was concluded that he was indeed suffering from vaccine induced thrombotic thrombocytopenia with symptomatic disseminated intravascular coagulation. Two rounds of IVIG (immunoglobulin) were given along with low dose anticoagulants to help dissolve the clots. He had been in the hospital sitting in the ICU with a foley catheter, unspecified intravenous (IV's), oxygen, some leg compression device and a ton of leads stuck to his body being monitored. He had multiple CT scans, multiple ultrasounds, an echocardiogram, an unspecified transfusion, lab work done daily. He had blood clots in his leg and in both lungs, he was short on breath and tired. Never he had been so sick. It turns out that everything he was going through was a severe reaction to the COVID19 vaccine. He was in the hospital living through those concerns right now. After spending 6 days in the intensive care unit (ICU)/ progressive care unit (PCU) they were able to get him discharged and bring him home to continue the current regimen he was on while hospitalized. Treatments would continue for months. The battle continued, but they were hopeful. Since his platelets have increased significantly after receiving 2 rounds of IVIG & most of the other labs were WNR, and other diagnostic studies were unremarkable. They still need to complete the Magnetic Resonance Venography (MRV) scan as an out-patient. He regained a good amount of his strength; he was not 100% but he could get up and move around and he had graduated from a walker to a cane. He had to use the cane as his balance was still a bit off and he could not afford to fall since he was on unspecified blood thinners. He still had blood clots in both of his lungs and his leg. The clots in his lungs make it difficult to breath and he had a cough that comes on quick if he talked too much. He got winded and tired very quickly if he move around too much and he needed to sit back down. His heart was also enlarged due to the extra work it has to do pushing blood through partially blocked vessels in his lungs. The effect was that he felt really cyst and his heart began to race so again he need to sit and rest. He also had a new lump appear on his leg that he was unsure as to what it was, initial concern was another clot. He had an ultrasound done to check it and he was awaiting the results. The doctors after further inspection thought it might be a cyst of some sort. He had multiple appointments with specialists over the next few weeks as follow-ups to his hospital stay. In the meantime, he had to wait for his body to break down the clots which he was told would take months. Treatment medications (dates unspecified) included: platelets, unspecified blood thinners, anticoagulants, and IVIG and his treatment included foley catheter, unspecified intravenous (IV's), oxygen, some leg compression device and a ton of leads stuck to his body being monitored. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vaccine-induced thrombotic thrombocytopenia, disseminated intravascular coagulation, cyst of some sort, balance was still a bit off, deep vein thrombosis, thrombocytopenia, bilateral pulmonary embolism, malaise, and decreased appetite, and the outcome of heart was enlarged was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210916371-COVID-19 VACCINE AD26.COV2.S- Disseminated intravascular coagulation, Heart was enlarged, Cyst of some sort, Balance was still a bit off, Decreased appetite. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210916371-COVID-19 VACCINE AD26.COV2.S- Vaccine-induced thrombotic thrombocytopenia, Thrombocytopenia, Bilateral pulmonary embolism, Deep vein thrombosis, Malaise. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Name: CT scan; Result Unstructured Data: NOT REPORTED; Test Name: Diagnostic ultrasound; Result Unstructured Data: Not reported; Test Name: Echocardiogram; Result Unstructured Data: awaiting results; Test Name: Lab test; Result Unstructured Data: Not reported; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Name: Haemoglobin; Result Unstructured Data: Level dropped; Test Name: Hematocrit; Result Unstructured Data: level dropped; Test Name: Complete blood count; Result Unstructured Data: not reported; Test Name: Heart rate high; Result Unstructured Data: Increased; Test Name: Blood count; Result Unstructured Data: Not reported
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no previous underlining or pre-existing health conditions.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689312

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: MN
Alter: 86,0
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: 10.02.2021
Beginn: 20.09.2021
Tage bis Beginn: 222,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Unevaluable event

Symptomtext

Previously submitted VAERS report on this pt E report # 640946 updating with pts death 9/20/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1706584

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

STROKE; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: unknown) dose, start therapy date were not reported, 01 total, administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced stroke within12 hours of the jab. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210926436- COVID-19 VACCINE AD26.COV2.S-stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1706576

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 17.09.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

THREE DEATHS; This spontaneous report received from a consumer via a company representative via social media concerned 3 multiple patients. The patient's weight, height, and medical histories were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified dates, the 3 multiple patients experienced deaths. As per the reporter, "Well, investigations happened and so far, three deaths in total have been confirmed, connected to the J and J vaccine. On an unspecified dates, the 3 multiple patients died from unknown cause of death. It was unknown whether autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0:20210925983-CDOVID-19 VACCINE AD26.COV2.S-Three deaths. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1706511

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: CA
Alter: -
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: -
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Respiratory arrest

Symptomtext

DEATH; SUDDENLY STOPPED BREATHING; This spontaneous report received from a consumer concerned a 34 year old female of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) dose was not reported, 1 total, administered on unspecified date in AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified in AUG-2021, after one week of vaccination, the patient suddenly stopped breathing at home. The patient was trying to be brave and tough it out and she decided not to go to the emergency room (ER). On an unspecified date in 2021, the patient died from unknown cause of death at home. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 2021, and the outcome of suddenly stopped breathing was not reported. This report was serious (Death, and Other Medically Important Condition). This case, from the same reporter is linked to 20210921562.; Sender's Comments: V0: 20210923692-covid-19 vaccine ad26.cov2.s -Death, Suddenly stopped breathing . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1703517

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge UNKNOWN

kritisch

Staat: FL
Alter: 59,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: -
Beginn: 16.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy COVID-19 Cardiac arrest Chest X-ray Chest X-ray abnormal Computerised tomogram Computerised tomogram thorax Computerised tomogram thorax abnormal Death Dyspnoea Hypoxia Intensive care Lung infiltration Mechanical ventilation Oxygen saturation Oxygen saturation decreased Positive airway pressure therapy Productive cough

Symptomtext

DEATH; CARDIAC ARREST; PULMONARY EMBOLISM; HYPOXIA; COVID-19 INFECTION; LUNG INFILTRATION; ANTICOAGULANT THERAPY; CHEST X-RAY ABNORMAL; COMPUTERISED TOMOGRAM THORAX ABNORMAL; CONTINUOUS POSITIVE AIRWAY PRESSURE; DYSPNOEA; INTENSIVE CARE; MECHANICAL VENTILATION; OXYGEN SATURATION DECREASED; PRODUCTIVE COUGH; TACHYPNOEA; SARS-COV-2 TEST POSITIVE; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a health care professional via a Regulatory Authority [VAERS FDA Inbound Unit] concerned a 59 year old male unspecified race and ethnicity. Initial information was processed along with the additional information received from Central Complaint Vigilance on 17-Aug-2021 The patient's height, and weight were not reported. The patient's concurrent conditions included: Degenerative joint disease of the spine, hyperlipidemia, obesity, sinus problems, and penicillin allergy. The patient experienced drug allergy when treated with codeine for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN) dose was not reported, 1 in total administered on 26-FEB-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included acetylsalicylic acid, acetylsalicylic acid/oxycodone hydrochloride/oxycodone terephthalate, desloratadine/pseudoephedrine sulfate, pravastatin and triamcinolone acetonide for drug used for unknown indication. On 16-JUL-2021, the patient's laboratory data included COVID-19 virus test (NR: not provided) which was positive and had covid-19 infection. On 27-JUL-2021, the patient had lung infiltration, pulmonary embolism, hypoxia, anticoagulant therapy, chest x-ray abnormal, computerized tomogram thorax abnormal, continuous positive airway pressure, dyspnoea, intensive care, mechanical ventilation, oxygen saturation decreased, productive cough, tachypnoea, and was hospitalized. Laboratory data included: chest x-ray(CXR) (NR: not provided) which shown bilateral infiltrate's. On 27-JUL-2021, the patient was admitted in hospital intensive care unit with shortness of breath, productive cough and oxygen saturation on 86%. On 31-JUL-2021, the patient had more shortness of breath and was on continuous positive airway pressure high flow and CT of the chest was done showing pulmonary embolism (PE). Treatment medications included: heparin. The patient was put on heparin drip and was decompensated, was connected to minute volume (MV) and went to cardiac arrest, and the patient had passed at 09:57 on 02-AUG-2021. The cause of death was cardiac arrest. It was unknown if autopsy was performed. The patient was hospitalized for 7 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of cardiac arrest, death, pulmonary embolism, hypoxia, covid-19 infection, lung infiltration, sars-cov-2 test positive, anticoagulant therapy, chest x-ray abnormal, computerised tomogram thorax abnormal, continuous positive airway pressure, dyspnoea, intensive care, mechanical ventilation, oxygen saturation decreased, productive cough and tachypnoea on 02-AUG-2021, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition). This report was associated with product quality complaint: 90000189962. The suspected product quality complaint has been confirmed to be non voided as the reported allegation could not be confirmed, and a manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 13-SEP-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1: The follow up adds about product quality complaint investigation result. This follow up information does not alter the causality of previously reported events. 20210832915-Covid-19 vaccine ad26.cov2.s- Death,cardiac arrest, pulmonary embolism, hypoxia, covid-19 infection, lung infiltration, sars-cov-2 test positive, anticoagulant therapy,chest x-ray abnormal, computerized tomogram thorax abnormal, continuous positive airway pressure, dyspnoea, intensive care, mechanical ventilation, oxygen saturation decreased, productive cough and tachypnoea. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210832915- covid-19 vaccine ad26.cov2.s -Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: CARDIAC ARREST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 7,0
Labordaten: Test Date: 20210716; Test Name: COVID-19 virus test; Result Unstructured Data: positive; Test Date: 20210727; Test Name: Oxygen saturation; Result Unstructured Data: 86 %; Test Date: 20210727; Test Name: CXR; Result Unstructured Data: bilateral infiltrate's patient was hypoxic and tachypneic; Test Date: 20210731; Test Name: CT scan; Result Unstructured Data: pulmonary embolism; Test Name: Computerised tomogram thorax; Result Unstructured Data: unknown
Aktuelle Erkrankungen: Degenerative joint disease; Hyperlipidemia; Obesity; Penicillin allergy; Sinus disorder
Vorgeschichte: Comments: Unknown
Andere Medikamente: CLARINEX-D 24-HOUR; NASACORT; PERCOCET-5; ECOTRIN; PRAVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 1703515

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: OR
Alter: 81,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: -
Beginn: 28.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Altered state of consciousness Anti-platelet antibody Antinuclear antibody Antinuclear antibody negative Aortic valve replacement Basal ganglia infarction Blood creatine phosphokinase Blood creatine phosphokinase normal Blood culture Blood culture positive Blood gases Blood gases normal Blood magnesium Blood magnesium decreased Cerebral artery occlusion Cerebral small vessel ischaemic disease Chest X-ray

Symptomtext

VENOGRAM NORMAL; MAGNETIC RESONANCE IMAGING HEAD NORMAL; SARS-COV-2 TEST NEGATIVE; ANTINUCLEAR ANTIBODY NEGATIVE; BLOOD CREATINE PHOSPHOKINASE NORMAL; BLOOD GASES NORMAL; PYREXIA; SCAN WITH CONTRAST NORMAL; URINE ANALYSIS NORMAL; HEPATIC ENZYME INCREASED (ELEVATED LIVER ENZYMES); RENAL FUNCTION TEST NORMAL; BLOOD CULTURE POSITIVE; EMBOLISM VENOUS; CEREBRAL ARTERY OCCLUSION; CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE; ACUTE MYOCARDIAL INFARCTION; ENDOCARDITIS; SEPSIS; RHABDOMYOLYSIS; SEPTIC ENCEPHALOPATHY; ALTERED STATE OF CONSCIOUSNESS; HYPOXIA; LACTIC ACIDOSIS; BASAL GANGLIA INFARCTION; ENTEROCOCCAL BACTERAEMIA; LACUNAR INFARCTION; MENTAL STATUS CHANGES; METABOLIC ACIDOSIS; CONFUSIONAL STATE; HYPERTENSION; HYPOMAGNESAEMIA; HYPOVOLAEMIA; FALL; WHITE MATTER LESION; TACHYCARDIA; AORTIC VALVE REPLACEMENT; TROPONIN INCREASED; BLOOD MAGNESIUM DECREASED; RESPIRATORY RATE INCREASED; ANTI-PLATELET ANTIBODY; CHEST X-RAY NORMAL; COMPUTERISED TOMOGRAM HEAD ABNORMAL; COMPUTERISED TOMOGRAM THORAX NORMAL; ECHOCARDIOGRAM; ELECTROCARDIOGRAM NORMAL; LABORATORY TEST ABNORMAL; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (reference number 1286545), in addition to information received via literature and concerned an 81 year old female. The patient's height, and weight were not reported. The patient's past medical history included transcatheter aortic valve replacement, and concurrent conditions included atrial fibrillation, peanut allergy, hypertension, aortic stenosis, and diabetes, and other pre-existing medical conditions included oranges allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included insulin for diabetes, atorvastatin, furosemide, and glipizide. Patient was on the ground in the room for 3 days. The patient was found covered in feces. The patient was unable to know how she was on ground and denied fall or syncope. On 28-APR-2021, the patient was feeling slightly tachycardic and febrile, slightly hypertensive, had an exam without any significant acute findings. There were no obvious skin source of ulcer or infection, no focal neurological deficits, no pain. Electrocardiogram was appearing to be normal with no signs of ischemia or arrhythmia. Lab test had shown slightly elevated troponin, low magnesium, metabolic acidosis and lactic acidosis. Venous blood gas was relatively normal. Urine analysis was found to be negative for infection. The chest x-ray was found to be normal without evidence of pneumonia. There were no clinical signs or symptoms to identify source of infection. Computerised Tomogram of head was found to be negative. Unclear source of fever however empirically treated with antibiotics and fluids. Patient remained hemodynamically stable with no hypotension. The patient was feeling slightly hypoxic and with increased respiratory rate however clear lung sounds and no indications of heart failure, COPD/asthma. Computerised Tomogram of chest (thorax) was having no evidence of pulmonary embolism, focal pneumonia, or fluid overload. Respiratory status was possibly related to compensation for metabolic acidosis that was likely due to lack of fluid intake due to being on the ground. Blood Creatine phosphokinase and kidney function both were normal. The patient consulted for medicine for admission for further evaluation and treatment. On 28-APR-2021, the patient also experienced embolism venous, acute myocardial infarction, cerebral small vessel ischaemic disease, cerebral artery occlusion, rhabdomyolysis, hypomagnesemia, altered mental status, septic encephalopathy, sepsis, enterococcal bacteremia, altered state of consciousness, basal ganglia infarction, confusional state, endocarditis, hypovolaemia, lacunar infarction, mental status changes and white matter lesion was hospitalized. On 28-APR-2021, the patient has done laboratory tests such as Anti-platelet antibody which was found to be negative, Blood culture which was found to be positive for enterococcal bacteremia, Echocardiogram was found to be normal, hepatic enzyme was increased, laboratory test was abnormal, Scan with contrast was normal. On 29-APR-2021, the patient underwent magnetic resonance imaging head which was normal, sars-cov-2 test which was found to be negative and antinuclear antibody which was negative. On 03-MAY-2021, patient had undergone for venogram which was normal. For non-ST elevated myocardial infarction the patient was told to start argatroban drip until cerebral vein sinus thrombosis is excluded then the patient will switch to heparin drip and also aspirin and statin. HCP had also told patient to check fasting lipid panel and monitor on telemetry. For Rhabdomyolysis, patient was told to stay hydrated and recheck CPK. For Elevated liver enzymes, the patient was told to check hepatitis panel and monitor levels. For fever, the patient was told to follow up on blood cultures, check CT of the abdomen and pelvis and to start empiric antibiotics Vancomycin and Zosyn. For hypomagnesemia, the patient was told start with magnesium sulfate and repeat magnesium level in the morning. For diabetes, the patient was told to start with sliding scale insulin, monitor fingersticks and check hemoglobin A1c. For hypertension, as patient was hemodynamically stable, the patient will have to cautiously start metoprolol and adjust antihypertensives to optimal blood pressure control. For lactic acidosis the patient was told to stay hydrated. For altered mental status and septic encephalopathy due to sepsis the patient was told to continue antibiotics. For Enterococcal bacteremia and endocarditis, the patient was told to repeat blood cultures which were pending. Patient was currently on Unasyn for Enterococcal bacteremia and will need 4 weeks of IV antibiotics The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from embolism venous, cerebral artery occlusion, cerebral small vessel ischaemic disease, acute myocardial infarction (non-st elevated myocardial infarction), endocarditis, sepsis, rhabdomyolysis, septic encephalopathy, altered state of consciousness, lacunar infarction, mental status changes, hypoxia, lactic acidosis, metabolic acidosis, basal ganglia infarction, confusional state, enterococcal bacteraemia, hypertension, hypomagnesaemia, hypovolaemia, fall, white matter lesion, tachycardia, aortic valve replacement, troponin increased, blood magnesium decreased, respiratory rate increased, anti-platelet antibody, chest x-ray normal, computerised tomogram head abnormal, computerised tomogram thorax normal, echocardiogram, electrocardiogram normal, laboratory test abnormal, magnetic resonance imaging head normal, hepatic enzyme increased (elevated liver enzymes), renal function test normal, sars-cov-2 test negative, scan with contrast normal, urine analysis normal, venogram normal, blood culture positive, antinuclear antibody negative, blood creatine phosphokinase normal, blood gases normal, and pyrexia. This report was serious (Hospitalization Caused / Prolonged). Additional information was received via literature on 07-SEP-2021. The following information was updated and incorporated into the case narrative: a literature citation was added to this case, as the patient involved was quoted in a table of similar events contained within the article.; Sender's Comments: V1: Follow up information updated includes literature citation, which doesn't alter causality of previously reported events. 20210528129-COVID-19 VACCINE AD26.COV2.S - Acute Myocardial Infarction (Non-St Elevated Myocardial Infarction), Endocarditis, Hypertension, Tachycardia, Aortic Valve Replacement, Respiratory Rate Increased. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE 20210528129-COVID-19 VACCINE AD26.COV2.S ? Embolism Venous, Cerebral Artery Occlusion, Cerebral Small Vessel Ischaemic Disease, Sepsis, Rhabdomyolysis, Lacunar Infarction, Basal Ganglia Infarction, Septic Encephalopathy, Altered State Of Consciousness, Mental Status Changes, Hypoxia, Lactic Acidosis, Metabolic Acidosis, Confusional State, Enterococcal Bacteraemia, Hypomagnesaemia, Hypovolaemia, Fall, White Matter Lesion, Troponin Increased, Blood Magnesium Decreased, Anti-Platelet Antibody, Chest X-Ray Normal, Computerised Tomogram Head Abnormal, Computerised Tomogram Thorax Normal, Echocardiogram, Electrocardiogram Normal, Laboratory Test Abnormal, Magnetic Resonance Imaging Head Normal, Hepatic Enzyme Increased, Renal Function Test Normal, Sars-Cov-2 Test Negative, Scan With Contrast Normal, Urine Analysis Normal, Venogram Normal, Blood Culture Positive, Antinuclear Antibody Negative, Blood Creatine Phosphokinase Normal, Blood Gases Normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210528129-COVID-19 VACCINE AD26.COV2.S -Pyrexia. This event(s) is labeled per Resource and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 6,0
Labordaten: Test Date: 20210428; Test Name: Scan with contrast; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Blood culture; Result Unstructured Data: positive; Test Date: 20210428; Test Name: Renal function test; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Laboratory test; Result Unstructured Data: abnormal; Test Date: 20210428; Test Name: Blood creatine phosphokinase; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Computerised tomogram head; Result Unstructured Data: Negative; Test Date: 20210428; Test Name: Anti-platelet antibody; Result Unstructured Data: negative; Test Date: 20210428; Test Name: Electrocardiogram; Result Unstructured Data: normal with no signs of ischemia or arrhythmia; Test Date: 20210428; Test Name: Troponin; Result Unstructured Data: slightly elevated; Test Date: 20210428; Test Name: Blood magnesium; Result Unstructured Data: low; Test Date: 20210428; Test Name: Blood gases; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Urine analysis; Result Unstructured Data: negative for infection; Test Date: 20210428; Test Name: Respiratory rate; Result Unstructured Data: Increased; Test Date: 20210428; Test Name: Computerised tomogram thorax; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Chest X-ray; Result Unstructured Data: normal; Test Date: 20210428; Test Name: Hepatic enzyme; Result Unstructured Data: increased; Test Date: 20210428; Test Name: Echocardiogram; Result Unstructured Data: normal; Test Date: 20210429; Test Name: Antinuclear antibody; Result Unstructured Data: negative; Test Date: 20210429; Test Name: SARS-CoV-2 test; Result Unstructured Data: negative; Test Date: 20210429; Test Name: Magnetic resonance imaging head; Result Unstructured Data: normal; Test Date: 20210503; Test Name: Venogram; Result Unstructured Data: normal, no vegetation
Aktuelle Erkrankungen: Atrial fibrillation; Diabetes; Fruit allergy; Hypertension; Peanut allergy
Vorgeschichte: Medical History/Concurrent Conditions: Aortic stenosis; Aortic valve replacement (2 years ago.); Comments: Oranges allergy.
Andere Medikamente: INSULIN; ATORVASTATIN; GLIPIZIDE; FUROSEMIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1694650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: CA
Alter: 74,0
Geschlecht: M
Eingang: 13.09.2021
Impfdatum: 10.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 168,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Immunosuppression Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient received his Pfizer COVID vaccines on 3/10/21 and 3/31/21 and was admitted to the hospital on 8/25/2021 with COVID-19. Due to MD note #COVID19 PNA #Acute hypoxic respiratory failure Continued on Dexamethasone (started 8/25 in ER), Ceftriaxone (started 8/30), Azithromycin (started 8/30). 5-day course of remdesivir was completed on 8/29. Now on BiPAP. Desaturating with any activity. Baricitinib was going to be started on 9/3 but just before giving Tocilizumab was delivered. He received 600 mg Tocilizumab. Baricitinib was not given. Duoneb q6h sch. I have concern of occult underlying infection such as fungal or other lung disease that is worsening with immunosuppression due to COVID treatment. It is odd to

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: 08/25/2021, COVID-19 (NAA), Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1694648

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 13.09.2021
Impfdatum: 10.03.2021
Beginn: 31.08.2021
Tage bis Beginn: 174,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient received COVID vaccine on 3/10/2021 and was admitted to the hospital for COVID-19. Discharge date: Sep 3, 2021 Admitting diagnosis(es): (1) Acute respiratory failure with hypoxia **DISCHARGE DIAGNOSIS: (1) COVID-19 (2) Acute respiratory failure with hypoxia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 08/31/2021, COVID-19 (NAA), DETECTED
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1694645

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge unknown

kritisch

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 13.09.2021
Impfdatum: 22.07.2021
Beginn: 04.09.2021
Tage bis Beginn: 44,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Alanine aminotransferase increased Anxiety Aspartate aminotransferase increased Blood albumin decreased Blood bilirubin increased Blood creatinine increased Blood culture positive Blood potassium increased Blood sodium normal Blood urea increased COVID-19 Cardiac telemetry Coma Death Hypotension Pain Pulmonary mass

Symptomtext

HOSPITAL COURSE: This is a 66-year-old male with history of hep C cirrhosis, BPH with chronic retention, methamphetamine/tobacco/PTSD/homelessness, mesothelioma and non-small cell carcinoma of the lung s/p chemo/XRT, and middle lobectomy/thoracotomy at medical facility in 2013. He had a hospitalization in July 2020 where he was noted to have recurrent pulmonary malignancy, but was not a surgical candidate. He was counseled to discharge to Transitional Care but he instead requested discharge to the street. He repeated has declined appropriate care when in the hospital, and he has repeatedly left the hospital against medical advice and without appropriate follow-up plan in place. He was interviewed by Dr. on 7/2 who documented fixed delusions but capacity to make his own medical decisions, feeling patient's interpretation of facts "did not appear to be unduly influenced by delusion". I discussed the patient's care with admitting physician, and we agreed that in the combination of social and medical chaos, and noting a prior decision by another Dr. not to proceed with surgical intervention of a pulmonary mass, that heroic resuscitative efforts would be futile, and patient should be limited code - no compressions or intubation. Dr., palliative care, reviewed chart and also agrees that No Code is appropriate. On the last day of hospitalization, September 8, 2021, this patient was seen and examined at the bedside and he was comatose and did not respond to voice, touch, or a sternal rub. For maintenance of an adequate blood pressure this patient was on a maximal dose of vasopressin at 20 mL/h. This patient was noted with severe acute kidney injury on admission and on the day of discharge his sodium was 139, potassium 5.6, BUN 144, and creatinine 5.22. This patient was seen in consultation by the nephrology service but his blood pressure was too low to allow hemodialysis. If the patient's white blood count was 16.7 on the day of discharge. Total bilirubin was elevated at 3.7, AST 49, ALT 74, and serum albumin was low at 1.4. Blood cultures on admission September 4, 2021 were positive for Streptococcus pneumonia a and Staphylococcus hominis. This patient was receiving appropriate IV antibiotic therapy during this hospitalization. The patient again was comatose and given the constellation of the severe end organ damage in the setting of severe sepsis the patient was subsequently transitioned to comfort care and end-of-life care. I discussed this case with Dr. with the nephrology service and Dr. with the palliative care service and we all agreed that a transition to comfort care was the best treatment plan for this patient. In the morning on September 8, 2021 I did not renew the patient's treatment with IV vasopressin and I discontinued all IV antibiotic therapy. Telemetry was also discontinued. IV morphine and IV Ativan were ordered for treatment of pain and anxiety respectively. This patient subsequently expired at 12:45 PM on September 8, 2021. I was unable to make contact with any family members or any possible DURABLE POWER OF ATTORNEY for this patient. The mortuary on duty was contacted this afternoon. This patient was pronounced expired on September 8, 2021 at 12:45 PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma
Hospital-Tage: 4,0
Labordaten: 09/04/2021, COVID-19 (NAA), Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1627980

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge unknown

kritisch

Staat: ME
Alter: 58,0
Geschlecht: M
Eingang: 13.09.2021
Impfdatum: 01.04.2021
Beginn: 01.08.2021
Tage bis Beginn: 122,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram abnormal Anticoagulant therapy Arteriogram coronary abnormal Computerised tomogram thorax abnormal Condition aggravated Deep vein thrombosis Dizziness Dyspnoea Dyspnoea exertional Electrocardiogram ST segment abnormal Exercise tolerance decreased Muscle spasms Pain in extremity Fibrin D dimer normal Heart rate irregular Incontinence Loss of consciousness Malaise

Symptomtext

Patient admit to hospital with 3 month hx of increased SOB and left calf pain and cramping. Found to have PE & DVT, pt prior to diagnosis is every day exerciser, non smoker

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: Zytrec, flonase, multivitamin
Allergien: NKA
Vorherige Impfungen: -

VAERS 1225942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Unknown

kritisch

Staat: WI
Alter: 16,0
Geschlecht: F
Eingang: 13.09.2021
Impfdatum: 19.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Pulmonary embolism Cardiac arrest Circulatory collapse Computerised tomogram thorax abnormal Death Lung assist device therapy Laboratory test Oral contraception Resuscitation

Symptomtext

pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: autopsy
Aktuelle Erkrankungen: -
Vorgeschichte: asthma
Andere Medikamente: albuterol, Flovent, doxycycline, drospirenone and ethinyl estradiol, and Zoloft
Allergien: -
Vorherige Impfungen: -

VAERS 1691360

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge Unknown

kritisch

Staat: VA
Alter: -
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: -
Beginn: 06.06.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Internal haemorrhage Myocardial infarction Pulmonary thrombosis Thrombosis

Symptomtext

BLOOD CLOTS IN LUNGS; BLOOD CLOTS IN LIVER; INTERNAL BLEEDING; HEART ATTACK; DEATH; This spontaneous report received from a consumer via a company representative concerned a 52 year old male of unknown race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and expiry: Unknown) dose was not reported, 1 total, administered on 03-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-JUN-2021, 3 days after vaccination the patient had heart attack on the golf course. On an unspecified date, the patient had internal bleeding and blood clots in his liver and lungs. The patient was in intensive care for 13 weeks and was put on liver transplant list but they could not stop the internal bleeding. The patient hospitalized for unspecified date and days. The patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of heart attack, internal bleeding, blood clots in lungs and blood clots in liver was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210916075-COVID-19 VACCINE AD26.COV2.S-Death, Heart attack, Blood clots in lungs, Blood clots in liver, Internal bleeding. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -